Pharmaceutical reference substances and impurities ... - Kriticos.eu

Pharmaceutical 

reference substances 

and impurities - 2008

List of LGC Standards offices 

France 

LGC Standards 

6, Rue Kastler 

B.P. 83076 

67123 Molsheim 

France 

Tel: +33 (0)3 88 04 82 82 

Fax: +33 (0)3 88 04 82 90 

Email: fr@lgcstandards.com 

Countries served 

- Algeria 

- Belgium 

- France 

- Ivory Coast 

- Jordan 

- Lebanon 

- Libya 

- Madagascar 

- Morocco 

- Senegal 

- Syria 

- Tanzania 

- Tunisia 

Germany 

LGC Standards GmbH 

Mercatorstrasse 51 

46485 Wesel 

Germany 

Tel: +49 (0)281 9887 0 

Fax: +49 (0)281 9887 199 

Email: de@lgcstandards.com 


- Austria 

- China (Hong Kong, 

Singapore) 

- Croatia 

- Cyprus 

- Egypt 

- Germany 

- Greece 

- Hungary 

- Iran 

- Israel 

- Japan 

- Korea 

- Macau 

- Netherlands 

- Romania 

- Slovenia 

- Switzerland 

- Thailand 

- Turkey 

India 


P.O. Box 8061 

No.142, 3 rd Floor, 5 th Cross 

Rajmahal Vilas Extension 

Bangalore 560 080 

India 

Tel: +91 (0)80 2361 1256 

Fax: +91 (0)80 2361 3859 

Email:in@lgcstandards.com 


- Bangladesh 

- India 

- Malaysia 

- Nepal 

- Pakistan 

Italy 

LGC Standards s.r.l. 

Via Venezia, 23 

20099 Sesto San Giovanni 

Milan 

Italy 

Tel: +39 02 2412 6830 

Fax: +39 02 2412 6831 

Email:it@lgcstandards.com 


- Italy 

Poland 


ul. M. Konopnickiej 1 

Dziekanów Lesny 

05-092 Lomianki 

Poland 

Tel: +48 (0)22 751 31 40 

Fax: +48 (0)22 751 58 45 

Email:pl@lgcstandards.com 


- Belorussia 

- Bulgaria 

- Czech Republic 

- Lithuania 

- Poland 

- Russia 

- Slovakia 

- Ukraine 

Spain 


C/Salvador Espriu 59, 2º 

planta 

08005 Barcelona 

Spain 

Tel: +34 93 308 4181 

Fax: +34 93 307 3612 

Email:es@lgcstandards.com 


- Andorra 

- Portugal 

- Spain 

- Latin America 

Sweden 


Box 1737 

SE-501 17 Borås 

Sweden 

Tel: +46 (0)33 20 90 60 

Fax: +46 (0)33 20 90 79 

Email:se@lgcstandards.com 


- Denmark 

- Estonia 

- Finland 

- Iceland 

- Latvia 

- Norway 

- Sweden 

United Kingdom 

(Head office) 


Queens Road 

Teddington 

Middlesex 

TW11 0LY 

United Kingdom 

Tel: +44 (0)20 8943 8480 

Fax: +44 (0)20 8943 7554 

Email: 

uksales@lgcstandards.com 


- Australia 

- Brunei 

- Canada 

- Channel Islands 

- Ireland 

- Kenya 

- Kuwait 

- Malta 

- New Zealand 

- Philippines 

- Saudi Arabia 

- South Africa 

- United Arab Emirates 

- United Kingdom 

Your LGC Standards account number 

Your contact at LGC Standards is 

Name: 

Tel: 

Fax: 

Email: 

www.lgcstandards.com 

For countries not listed above, please contact our head office.

Introduction 

Standards 

Excellence through measurement

Europe’s most 

comprehensive source 

of reference materials 

LGC Standards combination of expertise in analytical 

science and experience in international standards offers 

laboratories throughout Europe the ideal solution 

to sourcing high quality certified reference materials. 

Our expert technical support staff provide unrivalled 

knowledge in the use of certified reference materials 

across a broad range of analytical activities. 

• Partnership with the world’s key producers of RMs 

• Expert local customer service and technical support 

• Supply of all major pharmacopeia and RMs 

• Assistance in finding the right materials to suit your 

need 

• Over 25,000 reference materials in our range 

Environmental 

Food and agriculture 

Matrix materials 

Clinical and forensic 

ATCC cultures and bioproducts 

Pure materials 


Phytochemicals 

Chromatography 

High purity solvents 

For further information or to receive any one of our 

catalogues please contact your local office or visit 

our website. 

Industrial materials 

www.lgcstandards.com

Contents 

Contents 

Introduction 

Introduction 1 

Publications and subscriptions 5 

United States Pharmacopeia and National Formulary 9 

ATCC microbiological products 61 

European Pharmacopoeia 63 


Certified liquids for viscosity measurements 116 

International commission on pharmaceutical enzymes 117 

European Pharmacopoeia reagents 118 

British Pharmacopoeia 123 


Pharmacopée Française 138 

Pharmacopoeia Helvetica 140 

International Pharmacopeia 141 

Institute of Dyes and Organic products 147 

Refractive index CRMs 150 

Pharmaceutical impurities 151 

Background 153 

Certificate of Analysis 155 

List of products 159 

Physical Standards 333 

High purity solvents 387 

Edition 2008 All your needs for pharmaceutical analysis - email pharma@lgcstandards.com 1

Introduction 

Introduction 

About LGC Standards 

LGC Standards has successfully established a global reputation for the production of impurities and working 

standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom 

services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging 

and distribution, adds value to the scientific support we provide to our pharmaceutical customers. 

Our relationships with the world’s leading pharmacopoeias and their range of Chemical Reference 

Substances (CRS) and Reference Standards (RS), combined with in-house production of certified reference 

materials and pharmaceutical impurities, enable us to meet our customers’ specific needs. LGC Standards 

is also the exclusive European distributor for ATCC ® cultures and bio products. 

LGC Standards’ extensive network of sales offices and distribution centres mean we offer the widest range 

of reference materials from one single source for rapid delivery. Our staff can provide scientific and technical 

guidance, including shipping and customs advice, in the local language. 

Our range of products also includes reference materials for clinical and forensic applications, phytochemicals, 

environmental analysis, physical properties determination, and food and beverage analysis. 

For more information about our range of services, or to receive any of our catalogues, please refer to 

our website www.lgcstandards.com or contact your local office. 

About LGC 

LGC Standards is part of LGC. LGC, whose Research and Technology Division acts as the designated 

UK National Measurement Institute (NMI) for Chemical and Biochemical measurement, has a long history 

in the development and validation of analytical methods and the production of reference materials. 

Many of the analytical methods, which cover the food, environment, industrial, clinical and pharmaceutical 

sectors, are accredited to ISO/IEC 17025 (Requirements for the competency of testing and calibration 

laboratories). Full details of the accreditation schedule can be found on the UKAS website www.ukas.com. 

LGC’s Research and Technology Division is accredited to ISO Guide 34 (General Requirements for the 

competence of reference materials producers) for the production of reference materials. The measurement 

capabilities used to produce certified reference materials in its capacity as the UK NMI are verified through 

participation on key comparison studies organised by the Consultative Committee for the Amount of 

Substance (CCQM) of the International Weights and Measures Organisation (BIPM). The certificates 

are recognised by other National Measurement Institutes, under the Mutual Recognition Arrangement. 

In its role as the NMI, LGC serves on the International Organisation for Standardisation (ISO) Committee 

for Reference Materials (REMCO), which aims to carry out and encourage a broad international effort for 

the harmonization, production and application of certified reference materials (CRM’s). 

About the catalogue 

The 2008 edition of the LGC Standards catalogue ‘Pharmaceutical reference substances and impurities’, 

replaces the ‘Pharmaceutical reference substances and impurities’ 2006/2007 edition and 

the three newsletter updates. 

The information provided in this catalogue as regards compendial articles is based on the ‘official’ 

pharmacopoeial lists and is correct at the time of print. Original descriptions and spellings used by the 

producers are retained. In some cases additional information has been included to make the lists more 

convenient to use. 

The catalogue will be updated with three newsletters; these will be downloadable under 

www.lgcstandards.com. You can also contact your local LGC Standards office and ask to be 

provided with the newsletters once they are published. 

2 All your needs for pharmaceutical analysis - email pharma@lgcstandards.com Edition 2008

Pharmaceutical reference substances 


Certification 

The products described in this catalogue include pharmacopeial reference substances for use in 

pharmaceutical analysis. Pharmacopeial CRSs and RSs should be distinguished from certified reference 

materials (CRMs), which are produced in conformity with the ISO guides 30 to 35, and supplied with a 

detailed certification document. 

Pharmacopeial reference substances are produced for a specific purpose, and the manufacturers follow 

rigorous protocols to ensure the reference substance is fit for the intended purpose. The ‘certification’ 

processes follow the basic requirements of the relevant ISO REMCO guides, but are modified by the 

pharmacopoeias to reflect the particular demands of the associated pharmaceutical monograph. 

Details are given in the introduction to each section listing the various CRS collections in this catalogue. 

Shelf Life, storage and expiry dates 

Pharmacopeial CRSs and RSs should be purchased when required and not stored for a prolonged period. 

Pack sizes are designed to allow a limited number of replicate analyses, as required by Good Analytical 

Practice, but the opened pack should not be kept for future use. Please check all individual storage 

temperature requirements and note that the substances should be kept away from humidity and light 

(unless otherwise stated). 

Specific lot numbers or letters are allocated to all pharmacopeial reference substances, but no expiry 

dates are set. New lots are normally prepared well in advance of the expected "sell-out" of the current lot. 

When a substance is withdrawn from sale because the lot has depleted a final expiry date is given, by 

which any material from the outgoing lot held by users must be used. This means that for a period of time 

both lots are ‘official’. Lot information is provided by USP and EP in their literature and is available from 

LGC Standards. 

If a material is withdrawn by the producer, then all stocks held by the users are no longer valid and have 

to be destroyed. Should this occur, LGC Standards will inform all customers who have purchased the 

withdrawn substance. Please note that such a situation is outside LGC Standards’ control and products 

are not refundable. 



Impurity standards 

Impurities in a pharmaceutical substance can change the effects and side effects of a drug significantly. 

Therefore, it is important to have an accurate detection of impurities. The pharmaceutical monographs 

regulate the legal definition, the analysis and the limits of impurities of a given substance. An official range 

of impurity standards is available from the main pharmacopoeias where a CRS or RS is required in the 

monograph. 

Over 2200 other impurity standards are listed in the ‘pharmaceutical impurities’ section of the catalogue. 

These materials are produced by LGC, whose Research & Technology Division acts as the designated 

UK National Measurement Institute for Chemical and Biochemical Measurements. They are produced at 

our facility in Luckenwalde near Berlin, Germany and are supplied with a certificate of analysis. 

Controlled substances 

A number of the pharmaceutical substances, such as narcotics and tranquillisers, described in this catalogue 

are Controlled Substances in their country of origin and are marked ‘Controlled Substance’ against the 

product description. 

The purchase, possession and use of Controlled Substances are subject to national and international 

regulations designed to limit their abuse. It is the responsibility of the customer to obtain any authorisation 

necessary to both purchase and possess Controlled Substances, complying with the laws of the importing 

country, before ordering. 

Customers wishing to obtain Controlled Substances must contact their LGC Standards sales office before 

ordering, and clarify with the sales specialists the relevant national requirements, the associated charges 

and consequential delivery times. All orders for Controlled Substances must be provided in writing and 

signed by an authorised person. The orders must be accompanied with the original import permit and / or 

possession permit. 

Use, safety and handling 

Please read any documents supplied with the product before opening or using it. Particular attention must 

be paid to instructions referring to pre-mixing, addition of diluent to lyophilised materials and to the minimum 

size of sample to be used. 

The latter point is particularly important as it has normally been set by the producer after considering fully 

the homogeneity testing data obtained as a part of the certification exercise. The use of smaller than 

recommended samples is one of the most common sources of error. 

Some pharmaceutical substances are toxic and require special handling. Virtually all pharmaceutical 

reference substances have a pharmacological and/or biological activity. We therefore recommend that all 

the products described in this catalogue should be handled as if they were bio-active, toxic or infective, 

and that opened packs should only be handled by trained laboratory personnel. 

All pharmaceutical reference substances and standards are for laboratory analytical use only and 

not for use in humans. 

General ordering information 

Prices and delivery procedures are described in the price list that accompanies this catalogue, or are 

available from your local LGC Standards office. For products requiring special delivery procedures 

(cooled shipping, special licensing, Controlled Substances) additional charges may be applied. 

Please note that once delivered to the customer, reference substances are not returnable. 

Customers requiring assistance with the purchase, use or application of a particular reference substance 

should contact LGC Standards where technical staff are available to advise on the use and suitability of 

the products. 


Publications 

and subscriptions 



Reference materials 

for sports drugs, 

clinical analysis and 

forensic toxicology 

LGC Standards, Europe’s most comprehensive single 

source of reference materials, offers over 900 reference 

materials suitable for use in forensic and sports drug 

testing, therapeutic drug monitoring, clinical testing, 

forensic toxicology and employment drug testing. 

A wide selection of high quality standards in solution, 

including isotope labelled materials, is listed in our 

catalogue, ranging from primary standards of the highest 

metrological order to clinical controls for routine testing. 

A selection of the analytes is also available in matrices 

such as urine, blood, hair or serum. New materials are 

continually being developed and added to our product 

range. 

LGC Standards’ partnerships with the world’s leading 

reference material producers, such as the National 

Measurement Institute of Australia (NMIA), the US 

National Institute of Standards and Technology (NIST), 

the European Institute for Reference Materials and 

Measurement (IRMM), SERO, Medichem and Cerilliant, 

combined with our high level of technical expertise, 

enable us to assist our customers in identifying the 

most appropriate materials available for their specific 

applications. 

For further information and advice please visit : 

Blood grouping 

Coagulation factors 

Drugs of abuse 

Enzymes 

Ethanol 

Hormones 

Metabolites and 

substrates 

Micronutrients 

Proteins 

Sports drugs 

Steroids 

Trace elements 

Vitamins 


Publications and subscriptions 

Printed versions USP 


Code Product Unit 

USP2310001 

1 year subscription: 

USP31-NF26 [2008 Print Subscription]; 

(2008 book, Supplement 1 & 2) 

USP2PF0801 2008 Pharmacopoeial Forum Print unit 

Electronic versions USP 

USP2100000 

USP2310009 

1 year subscription:USP NF Online 

(3 electronic issues) 

-access to the USP-NF data on the website with passwords 

1 year subscription: 

USP31-NF26 CD-ROM [2008 Single-user subscription] 

unit 

per user 

USP2PF0021 Pharmacopoiea Forum Online 1-Year Subscription per user 

Printed versions EP 

PHEUR2008-2SE EP 2008 Book Subscription 6th Edition English (6.0-6.2) unit 

PHEUR2008-2SF EP 2008 Book Subscription 6th Edition French (6.0-6.2) unit 

PHPA2007E PHARMEUROPA 2007 - vol.19. 1-4 English(includes online access) unit 

PHPA2007F PHARMEUROPA 2007 - vol.19. 1-4 French(includes online access) unit 

Electronic versions EP, BP 

CD60-62-001E EP 6th Edition 2008 CD ROM Subscription(6.0-6.2) 1 user English unit 

CD60-62-001F EP 6th Edition 2008 CD ROM Subscription(6.0-6.2) 1 user French unit 

CD60-62-001B EP 6th Edition 2008 CD ROM Subscription(6.0-6.2) 1 user Bilingual unit 

ON60-62-PW ONLINE Subscription 6th Edition 2008(incl.Vol.6.0-6.2) Trilingual unit 

BP 2008 

British Pharmacopoeia 2008 Multimedia Package [2008 book(5 volumes), 

single-user CD-ROM, Password for one user for Online-access] 

unit 

unit 



We constantly add new products to our range, so 

please call us to find out about new products and 

services and to make sure you are automatically 

kept up to date by subscribing to our free newsletter. 

Just send an email to 

pharma-news@lgcstandards.com 


United States 

Pharmacopeia 

and 

National 

Formulary 



Phytochemical 

reference standards 

LGC Standards, a range of over 30,000 reference 

materials includes over 2,500 materials of natural 

origin. 

Our product range includes Certified Reference 

Materials from the US National Institute of Standards 

and Technology (NIST) and LGC, as well as primary, 

secondary and working phytochemical standards 

produced by ChromaDex. 

Phytochemical or herbal standards have a wide range 

of application in the pharmaceutical, dietary supplement 

and food industries, but are also of interest to 

medical, environmental and forensic laboratories, 

and to institutes for occupational health. 

Phytochemical reference standards to underpin analytical 

testing are available as pure active ingredients, 

as botanical materials and as extracted reference 

materials, each supported by detailed certificates of 

analysis. Advice, reference to the American Herbal 

Pharmacopeia, assistance with developing analytical 

methods and custom isolation or purification are also 

available within the extensive range of services 

offered by LGC Standards. 

Artichoke 

Belladonna 

Bilberry 

Black cohosh 

Carotinoids 

Cat´s claw 

Devil´s claw 

Echinacea 

Ginseng 

Kava kava 

Reishi mushroom 

Rosemary 

Salvia 

Soyasporins 

St. John´s wort 

Tribulus terrestris 

Valerian 

...and many more 


United States Pharmacopeia and National Formulary 


Background 

USP reference standards are highly purified substances that are provided specifically for use in the official 

test methods of the United States Pharmacopeia and National Formulary. When used as a part of the 

relevant official monograph they provide the means to verify the compliance of a material with USP-NF 

standards for identity, concentration, quality and purity. 

Official USP and NF Reference Standards are made available as required for use in assays and tests 

appearing in the current edition of the USP-NF. They are collaboratively tested and approved for such use 

by the USP Reference Standards Committee and released only under the authority of the USP Board of 

Trustees. 

The range of USP reference standards includes: 

1. Official USP and NF Reference Standards. 

2. Former USP and NF Reference Standards, not required in the current USP or NF, 

but for whichsufficient demand remains. 

3. Food Chemicals Codex (FCC) reference standards, specified in the current edition 

of the Food Chemicals Codex. 

4. Authentic Substances (AS), which are highly purified samples of chemicals, that are 

collaboratively tested and made available as a service to analysts. 

The list in this catalogue includes all amendments and new products made official by USP 

to November 2007. 

Production and certification 

The development of USP reference standards is a multi-step process that makes much use of voluntary 

cooperation from the pharmaceutical industry, government agencies including the United States Food and 

Drug Administration (FDA), and both USP in-house scientific staff and the members of the Committee of 

Revision. 

The following steps are adhered to, and the process takes from one to two years. 

1. Preparation and purification of candidate material. 

2. Testing and characterisation through a collaborative study (ring test). 

3. Initial scientific and statistical review. Further analytical work is often required, and at this stage 

it is possible that the candidate material is rejected and the procedure restarted. 

4. Preparation of a USP Reference Standards Committee letter, containing the data from the 

collaborative study for use by the Reference Standards Committee. This document is USP’s 

internal equivalent of a certification report. Approval of the document must be unanimous or further 

analytical work will be requested, or the whole cycle restarted. 

5. Packaging and final quality control testing for homogeneity, integrity of the package, etc. 

USP generally does not provide certificates of analysis for USP reference standards (as outlined in their 

Document Disclosure Policy). USP reference standards are solely for use in the official tests and methods 

of the current official compendia. When handled in accordance with labelled instructions and monographs, 

they are considered as a value of 100.0% for compendial purposes, unless otherwise stated. In response 

to requests from LGC Standards, USP began listing the labelled purity values for reference standards and 

authentic substances. Each value is followed by a code to indicate the basis of the assignment. For example, 

a reference standard with a labelled purity of 0.998 mg/mg calculated on the "as is" basis, will be listed as 

"0.998 mg/mg (ai)". From now on, the values will be included for new lots released since January 1, 2004 

and they will be included for all lots as they are released in the future. Below is a list of the basis codes 

and their meaning: 

(ai) as is 

(dr) dried 

(an) anhydrous 

(fb) free base. 

It must be noted that any other use of a USP reference standard in non-official procedures becomes the 

responsibility of the user. 

Proper use 

A full description of the background to, proper use of and lot control procedures for USP-NF reference 

standards is given in General Chapter of the current USP-NF publication. Analysts are strongly advised 

to review this section on a regular basis. More information on USP publications and subscriptions is given in 

the ‘Publications and subscriptions’ section of this catalogue. 



Shelf life and expiry dates 

USP reference standards are not labeled with an expiry date. The official lot number system provides greater 

flexibility than a simple expiry date system. USP reference standards stocks are regularly and rigorously 

checked. Under normal circumstances a new lot is made official and held for future use, before the old lot 

is sold out. The old lot remains official for a period of time so that in-house reference substances can be 

recertified against the out-going and incoming lots and also to prevent unnecessary waste. 

The official lot number index is printed six times a year in Pharmacopeial Forum (PF) so that the official 

status of all lots can be verified. The PF list shows the lot identification code for the current lot as well as any 

previous lot still official under the column headed “previous lot / date". Any lot shown in this column is official 

until the end of the month indicated in brackets. For example M0D211 (03/07) means lot M0D211 is official 

until 31 March 2007. No information or "NONE" in the column means that only the current lot may officially 

be used. 

It is the responsibility of each analyst to ensure that his particular supply of USP reference substance is 

current. 

Validation of secondary standards against USP reference substances 

Our customers regularly share with us their experiences of FDA inspectors, and we would like to pass these 

on to all our customers: 

All secondary in-house working standards have to be validated against the CURRENT lot of the USP 

reference standard, so we advise you to check that you have current lot numbers. 

As your supplier of choice, LGC Standards can provide lists of current lot numbers of USP reference 

standards, so call us to receive these today. We can provide the same service for EP chemical reference 

substances, which are listed in the EP chapter of this catalogue. Please take this opportunity to subscribe to 

this free service by contacting your local LGC Standards office. 

Replacement lots and back orders 

Because of the rigorous nature of the approval process and the time taken, it is not always possible for USP 

to have a new lot available before an existing lot is depleted. USP provides LGC Standards with regular 

information about the projected availability of back-ordered USP RS. Please contact LGC Standards for any 

enquiry. 

Storage conditions 

The USP-NF states that “generally, reference standards should be stored in their original sealed containers 

away from heat and protected from light. Avoid humid storage areas in particular”. In addition, the USP-NF 

recommends in its General Notices, that “where no specific storage directions or limitations are provided in 

the individual monograph, it is to be understood that conditions of storage include protection from moisture, 

freezing and excessive heat”. 

Controlled Substances 

The USP list contains substances subject to Controlled Substance Regulations Schedules I, II, III, IV and 

V. Special ordering procedures apply, please contact LGC Standards for details and costs. 

Restricted Reference Standards 

The United States Government restricts the export of chemicals appearing on the US Munition list, the 

Commerce Control list or in the Chemical Weapons Convention Annex on chemicals. Listed below are 

USP reference standards that are now currently restricted and may not be exported to any country outside 

the U.S.A. 

USP1106001 Chlorambucil 

USP1157002 Cyclophosphamide 

USP1376505 Mechlorethamine Hydrochloride 

USP1379300 Melphalan Hydrochloride 

USP1598008 3-Quinuclidinyl Benzilate 

USP1706009 Uracil Mustard 

Currently, LGC Standards is in discussion with USP to get the small amounts, in which USP reference 

standards are supplied, exempted from the above mentioned regulations. 




USP1000601 Acebutolol HCl 125 mg 

New USP1000612 

Acebutolol Related Compound A 

N-(3-acetyl-4-hydroxyphenyl)butanamide (AS) 

USP1001003 Acenocoumarol 200 mg 

USP1001502 Acepromazine Maleate 250 mg 

USP1002505 Acesulfame Potassium 200 mg 

USP1003009 Acetaminophen 400 mg 

USP1004001 Acetanilide Melting Point Standard (Approximately 114°C) 500 mg 

USP1005004 Acetazolamide 2 g 

USP1005706 Glacial Acetic Acid (AS) 3x1.5 mL 

USP1006007 Acetohexamide 250 mg 

USP1006506 Acetohydroxamic Acid 200 mg 

USP1006801 Acetone 3x1.5 mL 

USP1007000 Acetophenazine Maleate 200 mg 

USP1008501 Acetylcholine Chloride 200 mg 

USP1009005 Acetylcysteine 200 mg 

USP1009901 Acetyltributyl Citrate 500 mg 

USP1009923 Acetyltriethyl Citrate 500 mg 

USP1011007 Acitretin 200 mg 

USP1011018 Acitretin Related Compound A 

20 mg 

(2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid 

USP1011029 

Acitretin Related Compound B 

ethyl(all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate 

USP1012065 Acyclovir 300 mg 

USP1012076 

Acyclovir Related Compound A 

2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate (AS) 

USP1012134 Ademetionine Disulfate Tosylate 500 mg 

USP1012101 Adenine 200 mg 

USP1012123 Adenosine 200 mg 

USP1012190 Adipic Acid 100 mg 

USP1012145 Agigenin 25 mg 

USP1012203 Agnuside 25 mg 

USP1012495 Beta Alanine 100 mg 

USP1012509 L-Alanine 200 mg 

USP1012553 Albendazole 200 mg 

USP1012600 Albuterol 200 mg 

USP1012633 Albuterol Sulfate 200 mg 

USP1012757 Alclometasone Dipropionate 300 mg 

USP1012768 Alcohol 5x1.2 mL 

USP1012772 Dehydrated Alcohol 5x1.2 mL 

USP1012699 Alcohol Determination-Acetonitrile 5x5 mL 

USP1012688 Alcohol Determination-Alcohol 5x5 mL 

USP1012780 Alendronate Sodium 200 mg 

USP1012906 Alfentanil HCl Controlled Substance CII 500 mg 

USP1012939 Allantoin 200 mg 

USP1012950 Alliin 25 mg 

USP1013002 Allopurinol 250 mg 

USP1013024 



Allopurinol Related Compound A 

3-Amino-4-carboxamidopyrazole Hemisulfate 

Allopurinol Related Compound B 

5-(formylamino)-1H-pyrazole-4-carboxamide 

Allopurinol Related Compound C 

5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide 

20 mg 

20 mg 

50 mg 

50 mg 

25 mg 

25 mg 







Allopurinol Related Compound D 

ethyl 5-amino-1H-pyrazole-4-carboxylate 

Allopurinol Related Compound E 

ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate 

Allopurinol Related Compound F 

ethyl-(E/Z)-5-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate 

USP1013057 S-Allyl-L-Cysteine 25 mg 

USP1014005 Alphaprodine HCl Controlled Substance CII 250 mg 

USP1015008 Alprazolam Controlled Substance CIV 200 mg 

USP1016000 Alprostadil 25 mg 

USP1017105 Altretamine 500 mg 

USP1017364 Aluminum Sulfate (AS) 2 g 

USP1017502 Dried Aluminum Hydroxide Gel 200 mg 

USP1018505 Amantadine HCl 200 mg 

USP1019202 Amcinonide 200 mg 

USP1019417 Amifostine Disulfide 25 mg 

USP1019508 Amikacin 300 mg 

USP1019701 Amiloride HCl 500 mg 

USP1019712 

Amiloride Related Compound A 

Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate (AS) 

USP1019756 Aminobenzoate Potassium 200 mg 

USP1019767 Aminobenzoate Sodium 200 mg 

USP1019803 

Aminobenzoic Acid 

p-aminobenzoic acid 

35 mg 

25 mg 

25 mg 

30 mg 

200 mg 

USP1020008 Aminobutanol 500 mg 

USP1021000 Aminocaproic Acid 200 mg 

USP1021204 4-Aminophenol 100 mg 

USP1022808 2-Amino-5-chlorobenzophenone 25 mg 

USP1025205 Aminoglutethimide 200 mg 

USP1025307 m-Aminoglutethimide 100 mg 

USP1025351 Aminohippuric Acid 200 mg 

New USP1025602 Amino Methacrylate Copolymer 1.5 g 

USP1025806 2-[3-Amino-5-(n-methylacetamido)-2,4,6-triiodobenzamido]-2-deoxy-d-glucose 25 mg 

USP1025908 Aminopentamide Sulfate 200 mg 

USP1026004 m-Aminophenol 300 mg 

USP1026401 Aminosalicylic Acid 125 mg 

USP1026605 3-Amino-2,4,6-triiodobenzoic Acid 50 mg 

USP1027007 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid 50 mg 

USP1027302 Amiodarone HCl 200 mg 

USP1028000 Amitraz 200 mg 

USP1029002 Amitriptyline HCl 200 mg 



Amitriptyline Related Compound A 

Dibenzosuberone 

Amitriptyline Related Compound B 

5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol 

USP1029501 Amlodipine Besylate 350 mg 

USP1029909 Ammonio Methacrylate Copolymer Type A 100 mg 

USP1029910 Ammonio Methacrylate Copolymer Type B 100 mg 

USP1029942 Ammonium Carbonate (AS) 2 g 

USP1029953 Ammonium Chloride 200 mg 

USP1029986 Ammonium Phosphate Dibasic (AS) 1 g 

USP1030001 Amobarbital Controlled Substance CII 200 mg 

USP1031004 Amodiaquine HCl 500 mg 

30 mg 

25 mg 




USP1031401 Amoxapine 200 mg 

USP1031503 Amoxicillin 200 mg 

USP1032007 Amphotericin B 125 mg 

USP1033000 Ampicillin 200 mg 

USP1033203 Ampicillin Sodium 125 mg 

USP1033407 Ampicillin Trihydrate 200 mg 

USP1034002 Amprolium 200 mg 

USP1034308 Amrinone 500 mg 

USP1034320 

USP1034341 

USP1034363 

Amrinone Related Compound A 

5-carboxamide[3,4'-bipyridin]-6(1H)-one 

Amrinone Related Compound B 

N-(1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-yl)-2-hydroxypropanamide 

Amrinone Related Compound C 

1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-carbonitrile 

100 mg 

100 mg 

USP1034909 Anecortave Acetate 200 mg 

USP1034910 

Anecortave Acetate Related Compound A 

9(11)-dehydrocortisol 

USP1035005 Anethole (AS) 2 mL 

USP1036008 Anileridine HCl Controlled Substance CII 250 mg 

USP1036507 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile (AS) 25 mg 

USP1037011 Anisole 3x1.2 mL 

USP1038003 Antazoline Phosphate 200 mg 

USP1039006 Anthralin 200 mg 

USP1040005 Antipyrine 200 mg 

USP1040708 Apigenin-7-glucoside 30 mg 

USP1041008 Apomorphine HCl 250 mg 

USP1041609 Apraclonidine HCl 100 mg 

USP1042102 L-Arabinitol 500 mg 

USP1042500 L-Arginine 200 mg 

USP1042601 Arginine HCl 125 mg 

USP1042703 Arsanilic Acid 25 mg 

USP1043003 Ascorbic Acid (Vitamin C) 1 g 

USP1043105 Ascorbyl Palmitate (AS) 2 g 

USP1043502 Asparagine Anhydrous 200 mg 

USP1043513 Asparagine Monohydrate 200 mg 

USP1043706 Aspartame 200 mg 

USP1043728 

Aspartame Related Compound A 

5-Benzyl-3,6-dioxo-2-piperazineacetic Acid 

USP1043750 Aspartame Acesulfame 200 mg 

USP1043819 Aspartic Acid 100 mg 

USP1044006 Aspirin 500 mg 

USP1044301 Astemizole 200 mg 

USP1044403 Atenolol 200 mg 

USP1044651 Atovaquone 200 mg 

USP1044662 

Atovaquone Related Compound A 

cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone 

USP1044800 Atracurium Besylate 100 mg 

USP1045009 Atropine Sulfate 500 mg 

USP1045337 Avobenzone 500 mg 

USP1045508 Aurothioglucose 100 mg 

USP1045600 

Azaerythromycin A 

9-Deoxo-9a-aza-9a-homoerythromycin A 

50 mg 

20 mg 

25 mg 

25 mg 

100 mg 

USP1045756 Azaperone 200 mg 




USP1045803 Azatadine Maleate 200 mg 

USP1046001 Azathioprine 200 mg 

USP1046056 Azithromycin 100 mg 

New USP1046067 Azithromycin Identity 75 mg 

New USP1046090 Azithromycin N-Oxide 15 mg 

USP1046147 Azo-Aminoglutethimide 100 mg 

USP1046205 Aztreonam 200 mg 

USP1046307 Aztreonam E-Isomer 50 mg 

USP1046409 Open Ring Aztreonam 25 mg 

USP1047300 Bacampicillin HCl 200 mg 

USP1047503 Bacitracin (Susceptibility disk standard) 1 g 

USP1048007 Bacitracin Zinc 200 mg 

USP1048200 Baclofen 500 mg 

USP1048222 

Baclofen Related Compound A 

4-(4-Chlorophenyl)-2-pyrrolidinone 

USP1048506 Beclomethasone Dipropionate 200 mg 

New USP1048572 Bemotrizinol 200 mg 

USP1048619 Benazepril HCl 125 mg 

USP1048620 

USP1048630 

USP1048641 

USP1048652 


USP1048674 

USP1048685 

Benazapril Related Compound A 

(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H- 

1-benazapine-1-acetic acid, monohydrochloride 

Benazepril Related Compound B 

(3S)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H- 

1-benazapine-1-acetic acid, monohydrochloride 

Benazepril Related Compound C 

(3S)-3-[[(1S)-1-(carboxy)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine]- 

1-acetic acid 

Benazepril Related Compound D 

3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)- 

benzazepine-1-acetic acid monohydrochloride 

Benazapril Related Compound E 

3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride 

Benazepril Related Compound F 

3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, tert-butyl ester 

Benazepril Related Compound G 

3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)- 

benzazepine-1-acetic acid, ethyl ester 

USP1049000 Bendroflumethiazide 200 mg 

USP1050009 Benoxinate HCl 200 mg 

New USP1050905 Benzaldehyde Controlled Substance 1 mL 

USP1051001 Benzalkonium Chloride 5 mL 

USP1051500 Benzethonium Chloride 500 mg 

USP1054000 Benzocaine 500 mg 

USP1055002 Benzoic Acid 300 mg 

USP1056005 Benzonatate 1 g 

USP1056504 1,4-Benzoquinone 200 mg 

USP1057507 

Benzothiadiazine Related Compound A 

4-Amino-6-chloro-1,3-benzenedisulfonamide 

50 mg 

15 mg 

15 mg 

50 mg 

15 mg 

25 mg 

15 mg 

15 mg 

100 mg 

USP1059003 Benzphetamine HCl Controlled Substance CIII (AS) 200 mg 

USP1061005 Benztropine Mesylate 200 mg 

USP1061901 Benzyl Alcohol 500 mg 

USP1062008 Benzyl Benzoate 5 g 

USP1064003 1-Benzyl-3-methyl-5-aminopyrazole HCl 25 mg 

USP1065006 Bephenium Hydroxynaphthoate 500 mg 

USP1065210 Berberine Chloride 50 mg 




USP1065618 Betahistine HCl 200 mg 

USP1065709 Betaine HCl 200 mg 

USP1066009 Betamethasone 200 mg 

USP1067001 Betamethasone Acetate 500 mg 

USP1067307 Betamethasone Benzoate 200 mg 

USP1067704 Betamethasone Dipropionate 125 mg 

USP1068004 Betamethasone Sodium Phosphate 500 mg 

USP1069007 Betamethasone Valerate 200 mg 

USP1069018 

Betamethasone Valerate Related Compound A 

Betamethasone 21-valerate (AS) 

USP1069903 Betaxolol HCl 200 mg 

USP1070006 Betazole HCl 200 mg 

USP1071009 Bethanechol Chloride 200 mg 

USP1071202 Bicalutamide 200 mg 

USP1071213 


Bicalutamide Related Compound A 

N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methylpropanamide 

Bicalutamide Related Compound B 

(RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfonyl)-2-hydroxy- 

2-methylpropanamide 

USP1071304 Bile Salts 10 g 

USP1071439 Positive Bioreaction 3 strips 

USP1071508 Biotin 200 mg 

USP1072001 Biperiden 200 mg 

USP1073004 Biperiden HCl 200 mg 

USP1074007 Bisacodyl 125 mg 

USP1074700 2,5-Bis-(D-arabino-1,2,3,4-tetrahydroxybutyl)pyrazine 25 mg 

USP1075203 Bis(2-ethylhexyl)maleate 2 mL 

USP1075509 p-Bis(di-n-propyl)carbamylbenzenesulfonamide 50 mg 

USP1075531 Bismuth Citrate 100 mg 

USP1075600 Bismuth Subcarbonate (AS) 1 g 

USP1075622 Bismuth Subgallate (AS) 2 g 

USP1075644 Bismuth Subnitrate (AS) 1.5 g 

USP1075553 Bismuth Subsalicylate 100 mg 

USP1075677 Bisoctrizole 200 mg 

USP1075688 

Bisoctrizole Related Compound A 

2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol 

USP1075699 Bisoctrizole Resolution Mixture 50 mg 

USP1075757 Bisoprolol Fumarate 200 mg 

USP1076206 Powdered Black Cohosh Extract 1.5 g 

USP1076308 Bleomycin Sulfate 15 mg 

USP1076341 Boric Acid (AS) 1 g 

USP1076352 Bretylium Tosylate 200 mg 

USP1076363 Brinzolamide 200 mg 

USP1076374 

USP1076385 

Brinzolamide Related Compound A 

(S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine- 

6-sulfonamide-1,1-dioxide 

Brinzolamide Related Compound B 

(R)-4-amino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide- 

1,1-dioxide ethanedioate 

USP1076465 Bromazepam Controlled Substance CIV (AS) 100 mg 

USP1076501 Bromocriptine Mesylate 150 mg 

USP1077005 Bromodiphenhydramine HCl 200 mg 

USP1077708 8-Bromotheophylline 400 mg 

50 mg 

25 mg 

10 mg 

25 mg 

50 mg 

50 mg 




USP1078008 Brompheniramine Maleate 125 mg 

USP1078201 Budesonide 200 mg 

USP1078303 Bumetanide 250 mg 

USP1078325 

USP1078336 

Bumetanide Related Compound A 

3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid 

Bumetanide Related Compound B 

3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid 

USP1078507 Bupivacaine HCl 1 g 

USP1078518 

USP1078529 

Bupivacaine Related Compound A 

6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide (AS) 

Bupivacaine Related Compound B 

(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (AS) 

USP1078700 Buprenorphine HCl Controlled Substance CIII 50 mg 

USP1078711 

Buprenorphine Related Compound A 

21-[3-(1-propenyl)]7-alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano- 

6,7,8,14-tetrahydrooripavine Controlled Substance CII 

USP1078733 Bupropion HCl 200 mg 

USP1078744 

USP1078755 

USP1078766 

USP1078799 

Bupropion HCl Related Compound A 

2-(tert-butylamino)-4'-chloropropiophenone hydrochloride 

Bupropion HCl Related Compound B 

2-(tert-butylamino)-3'-bromopropiophenone hydrochloride 

Bupropion HCl Related Compound C 

1-(3-chlorophenyl)-2-hydroxy-1-propanone 

Bupropion HCl Related Compound F 

1-(3-chlorophenyl)-1-hydroxy-2-propanone 

USP1078802 Buspirone HCl 200 mg 

USP1079000 Butabarbital Controlled Substance CIII 200 mg 

USP1080000 Butacaine Sulfate 600 mg 

USP1081002 Butalbital Controlled Substance CIII 200 mg 

USP1081501 Butamben 200 mg 

USP1081807 1-Butanol 3x1.2 mL 

USP1081829 2-Butanol 3x1.2 mL 

USP1082300 Butoconazole Nitrate 200 mg 

USP1082504 Butorphanol Tartrate Controlled Substance CIV 500 mg 

USP1082606 Butyl Acetate 3x1.2 mL 

USP1082708 Butylated Hydroxytoluene (AS) 500 mg 

USP1082800 Monotertiary-butyl-p-benzoquinone (FCC) 100 mg 

USP1082901 Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate 25 mg 

USP1083008 2-tert-Butyl-4-hydroxyanisole 200 mg 

USP1083100 3-tert-Butyl-4-hydroxyanisole 200 mg 

New USP1083303 tert-Butylmethyl ether 3x1.2 mL 

USP1084000 Butylparaben 200 mg 

USP1085003 Caffeine 200 mg 

USP1086006 Caffeine Melting Point Standard (Approximately 236°C) 1 g 

USP1086108 Calcifediol 75 mg 

USP1086301 Calcitriol 10 mg 

USP1086312 Calcitriol Solution 5 mL 

USP1086334 Calcium Acetate (AS) 1 g 

USP1086356 Calcium Ascorbate 200 mg 

USP1086403 Calcium Carbonate (AS) 1 g 

USP1086436 Calcium Chloride (AS) 1 g 

USP1086800 Calcium Gluceptate 200 mg 

USP1086855 Calcium Hydroxide (AS) 1 g 

USP1086888 Calcium Lactate 1 g 

10 mg 

25 mg 

50 mg 

50 mg 

50 mg 

15 mg 

15 mg 

40 mg 

30 mg 




USP1086902 Calcium Lactobionate 200 mg 

USP1086935 Calcium Levulinate (AS) 1 g 

USP1087009 Calcium Pantothenate (Vitamin B 5) 200 mg 

USP1087031 Tribasic Calcium Phosphate (AS) 1 g 

USP1087202 Calcium Saccharate 200 mg 

USP1087359 Calcium Stearate (AS) 2 g 

USP1087406 Calcium Sulfate (AS) 1 g 

USP1087508 Camphor 1 g 

USP1087701 Candelilla Wax 250 mg 

USP1088001 Candicidin 200 mg 

New USP1090706 Capecitabine 200 mg 




Capecitabine Related Compound A 

5'-deoxy-5-fluorocytidine 

Capecitabine Related Compound B 

5'-deoxy-5-fluorouridine 

Capecitabine Related Compound C 

2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl) cytidine 

USP1091006 Capreomycin Sulfate 250 mg 

USP1091040 Caprylic Acid 300 mg 

USP1091505 Caprylocaproyl Polyoxylglycerides 200 mg 

USP1091108 Capsaicin 100 mg 

USP1091200 Captopril 200 mg 

USP1091221 Captopril Disulfide 100 mg 

USP1092009 Carbachol 200 mg 

USP1093001 Carbamazepine 100 mg 



Carbamazepine Related Compound A 

10,11-dihydrocarbamazepine 

Carbamazepine Related Compound B 

Iminostilbene 

USP1093205 Carbarsone 200 mg 

USP1093500 Carbenicillin Indanyl Sodium 300 mg 

USP1094004 Carbenicillin Monosodium Monohydrate 200 mg 

USP1095506 Carbidopa 400 mg 

USP1095517 

Carbidopa Related Compound A 

3-O-Methylcarbidopa 

USP1096000 Carbinoxamine Maleate 200 mg 

USP1096407 Carboplatin 100 mg 

USP1096509 Carboprost Tromethamine 25 mg 

USP1096531 Carboxymethylcellulose Calcium (AS) 1.5 g 

USP1096553 Carboxymethylcellulose Sodium 1.5 g 

USP1096600 Carisoprodol 1 g 

USP1096699 Carprofen (AS) 200 mg 

USP1096702 

Carprofen Related Compound A 

Carbazole 

USP1096757 Carteolol HCl 200 mg 

USP1096779 Casticin 25 mg 

USP1096804 

Cathinone HCl 

alpha-Aminopropiophenone HCl Controlled Substance CI 

USP1096906 Cefaclor 400 mg 

USP1096917 Cefaclor, Delta-3-Isomer 30 mg 

USP1097104 Cefadroxil 125 mg 

USP1097308 Cefamandole Lithium 200 mg 

USP1097400 Cefamandole Nafate 200 mg 

20 mg 

20 mg 

20 mg 

50 mg 

50 mg 

25 mg 

50 mg 

50 mg 




USP1097603 Cefazolin 400 mg 

USP1097636 Cefepime HCl 500 mg 

USP1097647 Cefepime HCl System Suitability 25 mg 

USP1097658 Cefixime 500 mg 

USP1097771 Cefmenoxime HCl 350 mg 

USP1097782 Cefmetazole 200 mg 

USP1097750 Cefonicid Sodium 1 g 

USP1097705 Cefoperazone Dihydrate 200 mg 

USP1097807 Ceforanide 200 mg 

USP1097909 Cefotaxime Sodium 250 mg 

USP1097975 Cefotetan 500 mg 

USP1098005 Cefotiam HCl 325 mg 

USP1098107 Cefoxitin 500 mg 

USP1098118 Cefpiramide 300 mg 

USP1098027 Cefpodoxime Proxetil 350 mg 

USP1098049 Cefprozil (E)-Isomer 50 mg 

USP1098050 Cefprozil (Z)-Isomer 200 mg 

USP1098129 Ceftazidime, Delta-3-Isomer 15 mg 

USP1098130 Ceftazidime Pentahydrate 300 mg 

USP1098173 Ceftizoxime 350 mg 

USP1098184 Ceftriaxone Sodium 350 mg 

USP1098195 Ceftriaxone Sodium E-Isomer 25 mg 

USP1098209 Cefuroxime Sodium 200 mg 

USP1098220 Cefuroxime Axetil 500 mg 

USP1098231 Cefuroxime Axetil Delta-3-Isomers 10 mg 

USP1098300 Cellulose Acetate 125 mg 

USP1098322 Cellaburate (Cellulose Acetate Butyrate) 350 mg 

USP1098355 Cellacefate (Cellulose Acetate Phthalate) 125 mg 

USP1098388 Microcystalline Cellulose (AS) 1 g 

USP1098402 Powdered Cellulose (AS) 1 g 

USP1098708 Cephaeline HBr 200 mg 

USP1099008 Cephalexin 400 mg 

USP1102000 Cephalothin Sodium 200 mg 

USP1102408 Cephapirin Benzathine 100 mg 

USP1102500 Cephapirin Sodium 500 mg 

USP1102805 Cephradine 200 mg 

New USP1102929 Cetirizine Hydrochloride 250 mg 


Cetirizine Related Compound A 

(RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester 

New USP1102974 Cetrimonium Bromide 1 g 

USP1103003 Cetyl Alcohol 100 mg 

USP1103105 Cetyl Palmitate 50 mg 

USP1104006 Cetylpyridinium Chloride 500 mg 

USP1105009 Powdered Chaste Tree Extract 1.5 g 

USP1107004 Chloramphenicol 200 mg 

USP1107300 Chloramphenicol Palmitate 200 mg 

USP1107401 Chloramphenicol Palmitate Nonpolymorph A 200 mg 

USP1107503 Chloramphenicol Palmitate Polymorph A 100 mg 

USP1109000 Chlordiazepoxide Controlled Substance CIV 200 mg 

USP1110009 Chlordiazepoxide HCl Controlled Substance CIV 200 mg 

20 mg 




USP1110020 

Chlordiazepoxide Related Compound A 

7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide 

USP1111001 Chlorhexidine 200 mg 

USP1111103 Chlorhexidine Acetate 500 mg 

USP1111307 Chlorhexidine Related Compounds 50 mg 

USP1112503 Chlorobutanol 200 mg 

USP1115545 Chlorogenic Acid 50 mg 

USP1115556 β-Chlorogenin 20 mg 

USP1117008 Chloroprocaine HCl 200 mg 

USP1118000 Chloroquine Phosphate 500 mg 

USP1121005 Chlorothiazide 200 mg 

USP1122700 Chloroxylenol 125 mg 

USP1122722 

Chloroxylenol Related Compound A 

2-chloro-3,5-dimethylphenol 

USP1123000 Chlorpheniramine Maleate 125 mg 

USP1123102 

Chlorpheniramine Maleate Extended-Release Tablets 

Drug Release Calibrator, Single Unit 

25 mg 

25 mg 

60 tablets 

USP1124003 Chlorphenoxamine HCl 200 mg 

USP1125006 Chlorpromazine HCl 200 mg 

USP1126009 Chlorpropamide 200 mg 

USP1129007 Chlortetracycline HCl 200 mg 

USP1130006 Chlorthalidone 200 mg 

USP1119309 

Chlorthalidone Related Compound A 

4'-Chloro-3'-sulfamoyl-2-benzophenone Carboxylic Acid 

USP1130505 Chlorzoxazone 500 mg 

USP1130527 

Chlorzoxazone Related Compound A 

2-Amino-4-chlorophenol 

USP1131009 Cholecalciferol (Vitamin D 3) 5x30 mg 

USP1131803 Delta-4,6-cholestadienol 30 mg 

USP1132001 Cholesteryl Caprylate 200 mg 

USP1133004 Cholestyramine Resin 500 mg 

USP1133503 Cholic Acid (AS) 2 g 

USP1133536 Choline Bitartrate 200 mg 

USP1133547 Choline Chloride 200 mg 

USP1133570 Chondroitin Sulfate Sodium 300 mg 

USP1133638 Chromium Picolinate 100 mg 

USP1134007 Chymotrypsin 300 mg 

USP1134018 Ciclopirox 50 mg 

USP1134029 

Ciclopirox Related Compound A 

3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxayzolyl acetic acid 

USP1134030 Ciclopirox Olamine 125 mg 

USP1134040 

Ciclopirox Related Compound B 

6-Cyclohexyl-4-methyl-2-pyrone 

USP1134051 Cilistatin Ammonium Salt 100 mg 

USP1134062 Cimetidine 200 mg 

USP1134073 Cimetidine HCl 200 mg 

USP1134109 Cinoxacin 200 mg 

New USP1134153 Cilostazol 200 mg 



Cilostazol Related Compound A 

6-hydroxy-3,4-dihydro-1H-quinolin-2-one 

Cilostazol Related Compound B 

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one 

15 mg 

50 mg 

25 mg 

25 mg 

50 mg 

50 mg 





Cilostazol Related Compound C 

1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)- 

3,4-dihydroquinolin-2(1H)-one 

USP1134233 Citalopram HBr 200 mg 


USP1134255 


USP1134277 

USP1134288 

USP1134299 


Citalopram Related Compound A 

1-(3-(dimethyl)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide 

Citalopram Related Compound B 

1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran- 

5-carbonitrile oxylate 

Citalopram Related Compound C 

3-[3-(dimethylamino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate 

Citalopram Related Compound D 

1-(4'-fluorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile 

hydrochloride 

Citalopram Related Compound E 

1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-Noxide 

hydrochloride 

Citalopram Related Compound F 

dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride 

Citalopram Related Compound H 

1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide 

50 mg 

25 mg 

25 mg 

25 mg 

15 mg 

25 mg 

200 mg 

USP1134313 Ciprofloxacin 200 mg 

USP1134324 Ciprofloxacin Ethylenediamine Analog 25 mg 

USP1134335 Ciprofloxacin HCl 400 mg 

USP1134346 

Ciprofloxacin Related Compound A 

7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 

hydrochloride salt (AS) 

USP1134357 Cisplatin 100 mg 

USP1134368 Citric Acid 200 mg 

New USP1134200 Cladribine 200 mg 

USP1134211 

Cladribine Related Compound A 

2-methoxy-2'-deoxyadenosine 

USP1134379 Clarithromycin 75 mg 

USP1134380 

Clarithromycin Related Compound A 

6,11-di-O-methylerythromycin A 

USP1134390 Clarithromycin Identity 100 mg 

USP1134404 Clavam-2-carboxylate Potassium 4 µg 

USP1134426 Clavulanate Lithium 200 mg 

New USP1134459 Ciprofloxacin Formamide 125 mg 

USP1134506 Clemastine Fumarate 250 mg 

USP1135000 Clidinium Bromide 2 g 

USP1135021 

Clidinium Bromide Related Compound A 

3-Hydroxy-1-methylquinuclidinium Bromide 

25 mg 

25 mg 

20 mg 

50 mg 

250 mg 

USP1136002 Clindamycin HCl 200 mg 

USP1137005 Clindamycin Palmitate HCl 500 mg 

USP1138008 Clindamycin Phosphate 125 mg 

USP1138201 Clioquinol 500 mg 

USP1138405 Clobetasol Propionate 200 mg 

USP1138427 

Clobetasol Propionate Related Compound A 

9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxo-androsta-1,4-diene-17(R)-spiro-2'- 

[4'-chloro-5'-ethylfuran-3'(2'H)-one] 

USP1138507 Clocortolone Pivalate 200 mg 

USP1138904 Clofazimine 200 mg 

USP1139000 Clofibrate 1 g 

USP1140000 Clomiphene Citrate 500 mg 

USP1140101 

Clomiphene Related Compound A 

(E,Z)-2-[4-(1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride 

50 mg 

100 mg 




USP1140247 Clomipramine HCl 200 mg 

USP1140305 Clonazepam Controlled Substance CIV 200 mg 

USP1140327 

USP1140338 

USP1140349 

Clonazepam Related Compound A 

3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril 

Clonazepam Related Compound B 

2-Amino-2'-chloro-5-nitrobenzophenone 

Clonazepam Related Compound C 

2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide 

USP1140393 Clonidine 200 mg 

USP1140407 Clonidine HCl 200 mg 

USP1140418 

USP1140429 

Clonidine Related Compound A 

Acetylclonidine 

Clonidine Related Compound B 

2-[(E)-2,6-Dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}- 

ethyl)-imidazolidine 

USP1140430 Clopidogrel Bisulfate 125 mg 

USP1140586 

USP1140597 

USP1140600 

Clopidogrel Related Compound A 

(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5-(4H)- 

acetic acid, hydrochloride 

Clopidogrel Related Compound B 

(Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothienol[2,3-c]pyridine-6(7H)-acetate, hydrochloride 

Clopidogrel Related Compound C 

methyl(-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen 

sulfate 

USP1140509 Clorazepate Dipotassium Controlled Substance CIV 125 mg 

USP1140702 Clorsulon 200 mg 

USP1141002 Clotrimazole 200 mg 

USP1141024 

Clotrimazole Related Compound A 

(o-chlorophenyl)diphenylmethanol 

USP1141909 Cloxacillin Benzathine 200 mg 

USP1142005 Cloxacillin Sodium 200 mg 

USP1142107 Clozapine 100 mg 

USP1143008 Cocaine HCl Controlled Substance CII 250 mg 

USP1143802 Codeine N-Oxide Controlled Substance CI 50 mg 

USP1144000 Codeine Phosphate Controlled Substance CII 100 mg 

USP1145003 Codeine Sulfate Controlled Substance CII 250 mg 

USP1145207 Cod Liver Oil 1 g 

USP1146006 Colchicine 300 mg 

USP1146505 Colestipol HCl 200 mg 

USP1147009 Colistimethate Sodium 200 mg 

USP1148001 Colistin Sulfate 200 mg 

USP1148500 Copovidone 100 mg 

USP1148806 Corn Oil (AS) 1 g 

USP1149004 Corticotropin 5 vials 

USP1150003 Cortisone Acetate 150 mg 

USP1150207 Cottonseed Oil (AS) 1 g 

USP1150353 Creatinine 100 mg 

USP1150502 Cromolyn Sodium 500 mg 

USP1150513 

Cromolyn Sodium Related Compound A 

1,3-Bis-(2-acetyl-3-hydroxyphenoxy)-2-propanol (AS) 

USP1150706 Crospovidone 200 mg 

USP1151006 Crotamiton 200 mg 

USP1151709 Cumene 3x1.2 mL 

USP1152009 Cyanocobalamin (Vitamin B 12) 1.5 g 

USP1152701 Cyclandelate 200 mg 

25 mg 

25 mg 

25 mg 

25 mg 

25 mg 

20 mg 

20 mg 

20 mg 

25 mg 

25 mg 




USP1154004 Cyclizine HCl 200 mg 

USP1154503 Cyclobenzaprine HCl 200 mg 

USP1154558 Alpha Cyclodextrin 50 mg 

USP1154569 Beta Cyclodextrin 250 mg 

New USP1154605 Cyclohexylmethanol 2x1mL 

USP1154707 Cyclomethicone 4 200 mg 



USP1156000 Cyclopentolate HCl 300 mg 

USP1157501 2-Cyclopropylmethylamino-5-chlorobenzophenone 50 mg 

USP1158005 Cycloserine 250 mg 

USP1158504 Cyclosporine 50 mg 

USP1158650 Cyclosporine Resolution Mixture 25 mg 

USP1159008 Cyclothiazide (AS) 200 mg 

USP1161000 Cyproheptadine HCl 500 mg 


Cyproheptadine Related Compound A 

5H-dibenzo[a,d]cycloheptene (AS) 

USP1161509 L-Cysteine HCl 200 mg 

USP1162002 Cytarabine 250 mg 

USP1162148 Cytosine 100 mg 

USP1162308 Dacarbazine 125 mg 

USP1162320 

USP1162330 

Dacarbazine Related Compound A 

5-aminoimidazole-4-carboxamide HCl 

Dacarbazine Related Compound B 

2-azahypoxanthine 

USP1162400 Dactinomycin 50 mg 

USP1162501 Danazol 200 mg 

New USP1163140 Dantrolene 200 mg 

New USP1163151 Dantrolene Sodium 100 mg 




Dantrolene Related Compound A 

5-(4-nitrophenyl)-2-furaldehyde azine 

Dantrolene Related Compound B 

5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl)semicarbazone 

Dantrolene Related Compound C 

(5-(4-nitrophenyl)-2-furancarboxyaldehyde 

USP1164008 Dapsone 125 mg 

USP1164700 Daunorubicin HCl 200 mg 

USP1165000 Decamethonium Bromide 250 mg 

USP1166003 Deferoxamine Mesylate 500 mg 

New USP1165408 Decoquinate 200 mg 

USP1166309 Dehydroacetic Acid 200 mg 

USP1166400 Dehydrocarteolol HCl 100 mg 

USP1166502 Dehydrocholic Acid 200 mg 

USP1169001 Demecarium Bromide 250 mg 

USP1170000 Demeclocycline HCl 200 mg 

USP1046089 N-Demethylazithromycin 15 mg 

USP1171003 Denatonium Benzoate 200 mg 

USP1171251 2-Deoxy-D-Glucose (AS) 100 mg 

USP1171706 Desacetyl Diltiazem HCl 50 mg 

USP1171900 Desflurane 0.5 mL 

USP1171910 

Desflurane Related Compound A 

bis-(1,2,2,2-tetrafluoroethyl) ether 

40 mg 

50 mg 

50 mg 

50 mg 

50 mg 

50 mg 

0.1 mL 

USP1172006 Desipramine HCl 125 mg 




USP1173009 Deslanoside 100 mg 

USP1173235 Desogestrel 50 mg 

USP1173246 

USP1173257 

USP1173268 

Desogestrel Related Compound A 

13-Ethyl-11-methylene-18,19-dinor-5alpha, 17alpha-preg-3-en-20-yl-17-ol, 

desogestrel delta-3 isomer 

Desogestrel Related Compound B 

3-Hydroxy-desogestrel 

Desogestrel Related Compound C 

3-Keto-desogestrel 

USP1046078 Desosaminylazithromycin 15 mg 

USP1173508 Desoximetasone 200 mg 

USP1174001 Desoxycorticosterone Acetate 200 mg 

USP1175004 Desoxycorticosterone Pivalate 125 mg 

USP1176007 Dexamethasone 125 mg 

USP1176506 Dexamethasone Acetate 200 mg 

USP1177000 Dexamethasone Phosphate 200 mg 

USP1178002 Dexbrompheniramine Maleate 200 mg 

USP1179005 Dexchlorpheniramine Maleate 300 mg 

USP1179504 Dexpanthenol 500 mg 

USP1179628 Dextran 1 50 mg 

USP1179650 Dextran T-10 200 mg 


USP1179720 Dextran 40 System Suitability 200 mg 


USP1179763 Dextran 70 System Suitability 200 mg 

USP1179800 Dextran Vo Marker 100 mg 

USP1179854 Dextran 4 Calibration 100 mg 





USP1180004 Dextroamphetamine Sulfate Controlled Substance CII 500 mg 

USP1180503 Dextromethorphan 2 g 

USP1181007 Dextromethorphan HBr 500 mg 

USP1181302 Dextrose 500 mg 

USP1181506 Diacetylated Monoglycerides 200 mg 

USP1182000 Diacetylfluorescein 200 mg 

USP1183002 Diacetylmorphine HCl (Heroin HCl) (AS) Controlled Substance CI 25 mg 

USP1184005 Diatrizoic Acid 100 mg 

USP1184027 

Diatrizoic Acid Related Compound A 

5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid 

USP1185008 Diazepam Controlled Substance CIV 100 mg 

USP1185020 

USP1023403 

Diazepam Related Compound A 

2-Methyl-amino-5-chlorobenzophenone 

Diazepam Related Compound B 

3-Amino-6-chloro-1-methyl-4-phenylcarbostyril 

USP1186000 Diazoxide 200 mg 

USP1187003 Dibucaine HCl 200 mg 

USP1187080 Dibutyl Phthalate 200 mg 

USP1187091 Dibutyl Sebacate (AS) 1 mL 

USP1187207 Dichloralphenazone Controlled Substance CIV 200 mg 

USP1187954 2,4-Dichlorophenol 100 mg 

USP1188006 Dichlorphenamide 200 mg 

15 mg 

15 mg 

25 mg 

50 mg 

25 mg 

25 mg 




USP1188301 

Dichlorvos 

2,2-dichlorovinyl dimethyl phosphate (AS) 

150 mg 

New USP1188709 Diclofenac Potassium 200 mg 

USP1188800 Diclofenac Sodium 200 mg 

USP1188811 

Diclofenac Related Compound A 

N-(2,6-dichlorophenyl)indolin-2-one 

USP1189009 Dicloxacillin Sodium 500 mg 

USP1190008 Dicumarol 200 mg 

New USP1190904 Dicyclohexyl 2x2 mL 

USP1191000 Dicyclomine HCl 125 mg 

New USP1191204 Didanosine 200 mg 

New USP1191215 Didanosine System Suitability Mixture 10 mg 



Didanosine Related Compound A 

Hypoxanthine 

Didanosine Related Compound B 

2',3'-dideoxyadenosine 

USP1192003 Dienestrol 125 mg 

USP1192808 Diethanolamine 3 mL 

USP1193006 Diethylcarbamazine Citrate 200 mg 

USP1193301 Diethylene Glycol Monoethyl Ether 0.5 mL 

USP1193505 Diethyl Phthalate 200 mg 

USP1194009 Diethylpropion HCl Controlled Substance CIV 200 mg 

USP1195001 Diethylstilbestrol 200 mg 

USP1197007 Diethyltoluamide 3 g 

USP1197302 Diflorasone Diacetate 200 mg 

USP1197506 Diflunisal 200 mg 

USP1198000 Digitalis 3 g 

USP1199002 Digitoxin 200 mg 

USP1200000 Digoxin 250 mg 

USP1200600 Dihydrocapsaicin 25 mg 

USP1200804 Dihydrocodeine Bitartrate Controlled Substance CII 200 mg 

USP1201002 17α-Dihydroequilin 50 mg 

USP1202005 Dihydroergotamine Mesylate 250 mg 

USP1203008 Dihydrostreptomycin Sulfate 200 mg 

USP1204000 Dihydrotachysterol 4x30 mg 

USP1204102 Dihydroxyacetone 250 mg 

USP1204805 Diloxanide Furoate 200 mg 

USP1205003 Diltiazem HCl 200 mg 


Diltiazem Related Compound A (AS) 

trans-diltiazem hydrochloride 

USP1206006 Dimenhydrinate 100 mg 

USP1208001 Dimethisoquin HCl 2 g 

USP1211006 Dimethyl Sulfoxide 3 g 

USP1213001 Dinoprost Tromethamine 50 mg 

USP1213103 Dinoprostone 50 mg 

USP1214004 Dioxybenzone 150 mg 

USP1217909 Diphenhydramine Citrate 125 mg 

USP1218005 Diphenhydramine HCl 200 mg 

USP1219008 Diphenoxylate HCl Controlled Substance CII 200 mg 

USP1220302 Dipivefrin HCl 200 mg 

USP1220506 Dipyridamole 200 mg 

USP1220700 Dirithromycin 200 mg 

25 mg 

25 mg 

25 mg 

25 mg 




USP1221000 Disodium Guanylate (FCC) 300 mg 

USP1222002 Disodium Inosinate (FCC) 500 mg 

USP1222501 Disopyramide Phosphate 200 mg 

USP1223005 2,4-Disulfamyl-5-trifluoromethylaniline 125 mg 

USP1224008 Disulfiram 200 mg 

USP1224507 Dobutamine HCl 600 mg 

New USP1224664 Docosyl Ferulate 50 mg 

USP1224700 Docusate Calcium 500 mg 

USP1224802 Docusate Sodium 500 mg 

USP1224904 Docusate Potassium 100 mg 

USP1224959 Dolasetron Mesylate 200 mg 

USP1224960 

Dolasetron Mesylate Related Compound A 

Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one HCl 

USP1225204 Dopamine HCl 200 mg 

USP1225281 Dorzolamide HCl 200 mg 

USP1225292 

Dorzolamide Hydrochloride Related Compound A 

(4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno 

[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride 

USP1225000 Doxapram HCl 200 mg 

USP1225419 Doxazosin Mesylate 200 mg 

USP1225500 Doxepin HCl 500 mg 




Doxepin Related Compound A 

dibenzo[b,e]oxepin-11(6H)-one 

Doxepin Related Compound B 

(11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol 

Doxepin Related Compound C 

(E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine HCl 

USP1225703 Doxorubicin HCl 50 mg 

USP1226003 Doxycycline Hyclate 200 mg 

USP1227006 Doxylamine Succinate 300 mg 

USP1229001 Droperidol 250 mg 

New USP1229409 Drospirenone 200 mg 

USP1230000 Dyclonine HCl 200 mg 

USP1231003 Dydrogesterone 200 mg 

USP1231502 Dyphylline 200 mg 

USP1231706 Powdered Echinacea Angustifolia Extract 1 g 

USP1231728 Powdered Echinacea Purpurea Extract 1 g 

USP1231808 Econazole Nitrate 200 mg 

USP1232006 Edetate Calcium Disodium 200 mg 

USP1233009 Edetate Disodium 200 mg 

USP1233508 Edetic Acid 200 mg 

USP1234001 Edrophonium Chloride 200 mg 

USP1234668 Eleutheroside B (Syringin) 15 mg 

USP1234680 Eleutheroside E (Syringaresinol diglucoside) 15 mg 

USP1234704 Powdered Eleuthero Extract 1.5 g 

USP1234806 Emedastine Difumarate 100 mg 

USP1235004 Emetine HCl 300 mg 

USP1235274 Enalaprilat 300 mg 

USP1235300 Enalapril Maleate 200 mg 

USP1235503 Endotoxin unit 

USP1235809 Enflurane 1 mL 

USP1235900 Enrofloxacin (AS) 200 mg 

USP1236007 Ephedrine Sulfate Controlled Substance 200 mg 

25 mg 

20 mg 

50 mg 

50 mg 

25 mg 




USP1236506 4-Epianhydrotetracycline HCl 50 mg 

USP1236801 Epilactose 200 mg 

USP1237000 Epinephrine Bitartrate 200 mg 

USP1237509 Epitetracycline HCl (AS) 200 mg 

USP1238002 Equilin 25 mg 

USP1239005 Ergocalciferol (Vitamin D 2) 5x30 mg 

USP1239504 Ergoloid Mesylates 300 mg 

USP1240004 Ergonovine Maleate Controlled Substance 100 mg 

USP1241007 Ergosterol 50 mg 

USP1241506 Ergotamine Tartrate Controlled Substance 150 mg 

USP1241550 Ergotaminine 100 mg 

USP1241903 Erythritol 200 mg 

USP1242000 Erythromycin 250 mg 

USP1242010 Erythromycin B 100 mg 

USP1242021 Erythromycin C 50 mg 

USP1242032 

Erythromycin Related Compound N 

N-Demethylerythromycin A 

USP1243002 Erythromycin Estolate 200 mg 

USP1245008 Erythromycin Ethylsuccinate 200 mg 

USP1246000 Erytromycin Gluceptate 200 mg 

USP1247003 Erythromycin Lactobionate 200 mg 

USP1248006 Erythromycin Stearate 200 mg 

USP1249009 Erythrosine Sodium 100 mg 

USP1249202 Escin 350 mg 

New USP1249789 Esomeprazole Magnesium 10 mg 

USP1250008 Estradiol 500 mg 

USP1251000 Estradiol Benzoate (AS) 250 mg 

USP1252003 Estradiol Cypionate 200 mg 

USP1254009 Estradiol Valerate 100 mg 

USP1254508 Estriol 100 mg 

USP1255001 Estrone 200 mg 

USP1255500 Estropipate 500 mg 

USP1256004 Ethacrynic Acid 200 mg 

USP1257007 Ethambutol HCl 200 mg 

USP1258305 Ethchlorvynol Contolled Substance CIV 0.7 mL 

USP1260001 Ethinyl Estradiol 150 mg 

USP1260012 

Ethinyl Estradiol Related Compound A 

6-Keto-ethinyl estradiol 

USP1261004 Ethionamide 200 mg 

USP1262801 Ethopabate 125 mg 

USP1262823 

Ethopabate Related Compound A 

Methyl-4-acetamido-2-hydroxybenzoate 

USP1264002 Ethosuximide 500 mg 

USP1264501 Ethotoin 200 mg 

USP1265005 Ethoxzolamide 200 mg 

USP1265402 Ethyl Acetate 3x1.2 mL 

New USP1265457 Ethylbenzene 3x0.5 mL 

USP1265504 Ethylcellulose 1 g 

New USP1265606 Ethyl Formate 3x1.2 mL 

USP1266008 Ethyl Maltol (FCC) 1 g 

USP1266507 Ethylnorepinephrine HCl 200 mg 

USP1267000 Ethylparaben 200 mg 

50 mg 

20 mg 

25 mg 




USP1267500 Ethyl Vanillin 200 mg 

USP1268003 Ethynodiol Diacetate 200 mg 

USP1268502 Etidronate Disodium 200 mg 

USP1268513 

Etidronate Disodium Related Compound A 

Sodium phosphite dibasic pentahydrate 

300 mg 

USP1268604 Etidronic Acid Monohydrate 1 g 

USP1268706 Etodolac 400 mg 

USP1268728 

Etodolac Related Compound A 

(+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid 

USP1268808 Etoposide 300 mg 

USP1268852 Etoposide Resolution Mixture 30 mg 

USP1268965 Eugenol (AS) 500 mg 

USP1269200 Famotidine 125 mg 


Famotidine Related Compound B 

3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphany]ethyl]-4H- 

1,2,4,6-thiatriazine1,1-dioxide (AS) 

USP1269389 Felodipine 200 mg 

USP1269390 

Felodipine Related Compound A 

ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate 

USP1269403 Fenbendazole 100 mg 

USP1269414 

USP1269425 

Fenbendazole Related Compound A 

Methyl(1H-benzimidazole-2-yl)carbamate 

Fenbendazole Related Compound B 

Methyl[5(6)-chlorobenzimidazole-2-yl]carbamate 

USP1269447 Fenofibrate 200 mg 

USP1269458 Fenoldopam Mesylate 200 mg 

USP1269469 

USP1269470 

Fenoldopam Related Compound A 

N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol HCl 

Fenoldopam Related Compound B 

1H-3-Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate 

USP1269505 Fenoprofen Calcium 500 mg 

USP1269550 Fenoprofen Sodium 500 mg 

USP1269607 

USP1269618 

USP1269629 

Fenofibrate Related Compound A 

(4-chlorophenyl)(4-hydroxyphenyl) methanone 

Fenofibrate Related Compound B 

2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid 

Fenofibrate Related Compound C 

1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]- 

2-methylpropanoate 

USP1270005 Fentanyl Citrate Controlled Substance CII 100 mg 

USP1270355 Ferrous Sulfate (AS) 1.5 g 

USP1270377 Fexofenadine HCl 200 mg 

USP1270388 

USP1270399 

USP1270446 

Fexofenadine Related Compound A 

4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl 

benzeneacetic acid 

Fexofenadine Related Compound B 

3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl 

benzeneacetic acid hydrochloride 

Fexofenadine Related Compound C 

(+)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene (AS) 

USP1270402 Finasteride 200 mg 

USP1270800 Flecainide Acetate 200 mg 

USP1270821 

Flecainide Related Compound A 

3-[2,5-bis(2,2,2-trifluoroethoxy) phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine HCl 

USP1271008 Floxuridine 250 mg 

USP1271700 Fluconazole 200 mg 

25 mg 

25 mg 

25 mg 

30 mg 

30 mg 

20 mg 

20 mg 

25 mg 

25 mg 

25 mg 

25 mg 

25 mg 

15 mg 

75 mg 




USP1271711 

USP1271722 

USP1271733 

Fluconazole Related Compound A 

2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol 

Fluconazole Related Compound B 

2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol 

Fluconazole Related Compound C 

1,1'-(1,3-phenylene)di(1H-1,2,4-triazole) 

USP1272000 Flucytosine 200 mg 

USP1272204 Fludarabine Phosphate 300 mg 

USP1272907 Fludeoxyglucose 100 mg 

USP1272918 

Fludeoxyglucose Related Compound A 

4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane 

USP1273003 Fludrocortisone Acetate 250 mg 

USP1273808 Flumazenil 200 mg 

USP1273819 

USP1273820 

Flumazenil Related Compound A 

8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] 

[1,4]benzodiazepine-3-carboxylic acid 

Flumazenil Related Compound B 

Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] 

[1,4]benzodiazepine-3-carboxylate 

USP1274006 Flumethasone Pivalate 200 mg 

USP1274505 Flunisolide 200 mg 

USP1274607 Flunixin Meglumine 300 mg 

USP1275009 Fluocinolone Acetonide 100 mg 

USP1276001 Fluocinonide 100 mg 

USP1277004 Fluorescein 200 mg 

USP1277252 Fluoride Dentifrice: Sodium Fluoride/Silica 4.5 oz 

USP1277274 Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder 4 oz 

USP1277300 Fluoride Dentifrice: Sodium Monofluorophosphate - Calcium Carbonate 4.6 oz 

USP1277354 Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate 4.6 oz 

USP1277401 Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica 5.25 oz 

USP1277423 Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica 5.25 oz 

USP1277456 Fluoride Dentifrice: Stannous Fluoride-Silica 4 oz 

USP1278007 Fluorometholone 200 mg 

USP1278109 Fluorometholone Acetate 200 mg 

USP1278302 Fluoroquinolonic Acid 50 mg 

USP1279000 Fluorouracil 250 mg 

USP1279804 Fluoxetine HCl 200 mg 

USP1279815 

USP1279826 

USP1279837 

Fluoxetine Related Compound A 

N-methyl-3-phenyl-3-[(alpha,alpha,alpha-(trifluoro-m-tolyl)oxy]propylamine HCl 

Fluoxetine Related Compound B 

N-methyl-3-phenylpropylamine Controlled Substance 

Fluoxetine Related Compound C 

N-Methyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl] succinamic acid 

USP1280009 Fluoxymesterone Controlled Substance CIII 200 mg 

USP1280803 Fluphenazine Decanoate Dihydrochloride 500 mg 

USP1281001 Fluphenazine Enanthate Dihydrochloride 125 mg 

USP1282004 Fluphenazine HCl 125 mg 

USP1284000 Flurandrenolide 100 mg 

USP1285002 Flurazepam HCL Controlled Substance CIV 200 mg 

USP1285308 

USP1285603 

Flurazepam Related Compound C 

5-chloro-2-(2-diethylaminoethyl(amino)-2'-fluorobenzophenone HCl 

Flurazepam Related Compound F 

7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one) 

USP1285750 Flurbiprofen 200 mg 

10 mg 

10 mg 

10 mg 

15 mg 

20 mg 

20 mg 

15 mg 

5 mL 

15 mg 

50 mg 

50 mg 




USP1285760 

Flurbiprofen Related Compound A 

2-(4-Biphenylyl)propionic Acid 

100 mg 

USP1285807 Flurbiprofen Sodium 200 mg 

USP1285851 Flutamide 200 mg 

USP1285862 o-Flutamide 50 mg 

USP1285873 Fluticasone Propionate 100 mg 

New USP1285840 Fluticasone Propionate Related Compounds Mixture 25 mg 

USP1285884 Fluticasone Propionate Resolution Mixture 25 mg 

New USP1285910 Fluticasone Propionate Nasal Spray Resolution Mixture 25 mg 

USP1285895 

Fluticasone Propionate System Suitability Mixture 

Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D 

USP1285931 Fluvastatin Sodium 350 mg 

USP1285942 

USP1285964 

Fluvastatin for System Suitability 

Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E](+/-)-7-[3-(4-fluorophenyl)- 

1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt 

Fluvastatin Related Compound B 

[R*,S*-E](+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic 

acid 1,1-dimethylethyl ester 

USP1285909 Fluvoxamine Maleate 200 mg 

USP1286005 Folic Acid (Vitamin M or Vitamin Bc) 500 mg 

USP1286027 

Folic Acid Related Compound A 

Calcium Formyltetrahydrofolate 

USP1286060 Formononetin 50 mg 

USP1286300 10-Formylfolic Acid 25 mg 

New USP1283404 Fosinopril Sodium 200 mg 









Fosinopril Related Compound A 

(4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]-acetyl-L-proline 

Fosinopril Related Compound B 

((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl- 

D-proline propionate (ester), hemibarium salt, sesquihydrate) 

Fosinopril Related Compound C 

(4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-Lproline 

propionate (ester),sodium salt 

Fosinopril Related Compound D 

(4R)-4-cyclohexyl-1-[(R)-[(S]-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-Lproline 

propionate (ester), sodium salt 

Fosinopril Related Compound E 

(4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl]phospinyl]acetyl-Lproline 

propionate (ester), sodium salt 

Fosinopril Related Compound F 

(4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phospinyl]acetyl-L-proline 

propionate (ester),sodium salt 

Fosinopril Related Compound G 

(4-phenylbutyl)phosphinyl acetic acid, disodium salt 

Fosinopril Related Compound H 

4-phenylbutyl phosphonic acid 

USP1286366 Fosphenytoin Sodium 250 mg 

USP1286504 Fructose 125 mg 

USP1286606 L-Fucose (AS) 200 mg 

USP1286708 Fumaric Acid 200 mg 

USP1286800 Furazolidone 200 mg 

USP1287008 Furosemide 125 mg 

USP1287020 

USP1287030 

Furosemide Related Compound A 

2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid 

Furosemide Related Compound B 

4-Chloro-5-sulfamoylanthranilic Acid 

25 mg 

25 mg 

15 mg 

50 mg 

25 mg 

15 mg 

15 mg 

15 mg 

15 mg 

15 mg 

15 mg 

25 mg 

50 mg 

100 mg 

USP1287303 Gabapentin 250 mg 




USP1287325 

USP1287347 

USP1287358 

USP1287369 

Gabapentin Related Compound A 

3,3-pentamethylene-5-butyrolactam 

Gabapentin Related Compound B 

(1-cyanocyclohexyl)acetic acid 

Gabapentin Related Compound D 

(1-(3-oxo-2-aza-spiro[4,5]dec-2-ylmethyl)-cyclohexyl)acetic acid 

Gabapentin Related Compound E 

carboxymethyl-cyclohexanecarboxylic Acid 

USP1287507 Gadodiamide 500 mg 

USP1287518 

USP1287529 

Gadodiamide Related Compound A 

gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide 

Gadodiamide Related Compound B 

gadolinium disodium diethylenetriamine pentaacetic Acid 

USP1287609 Gadopentetate Monomeglumine 500 mg 

USP1287631 Gadoteridol 500 mg 

USP1287642 

USP1287653 

USP1287664 

Gadoteridol Related Compound A 

10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclodedodecane-1,4,7-triaacetic Acid 

Gadoteridol Related Compound B 

1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt 

Gadoteridol Related Compound C 

1,4,7,10-Tetraaza-11-oxo-bicylco[8.2.2]tetradecan-4,7-diacetic Acid 

USP1287675 Gadoversetamide 200 mg 

USP1287686 

Gadoversetamide Related Compound A 

Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato 

(4-)]gadolinium 

50 mg 

30 mg 

20 mg 

25 mg 

50 mg 

50 mg 

50 mg 

50 mg 

50 mg 

200 mg 

USP1287711 Galactitol 500 mg 

New USP1287722 Galactosamine HCl 300 mg 

USP1287700 Galactose 200 mg 

USP1288000 Gallamine Triethiodide 200 mg 

USP1288306 Ganciclovir 200 mg 

USP1288317 

Ganciclovir Related Compound A 

(RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydropurin-6-one 

USP1288463 Gemcitabine Hydrochloride 200 mg 

USP1288500 Gemfibrozil 200 mg 

USP1288510 

Gemfibrozil Related Compound A 

2,2-dimethyl-5-[2,5-dimethyl-4-propene-1-yl)phenoxy]valeric acid 

USP1289003 Gentamicin Sulfate 200 mg 

USP1290002 Gentian Violet 650 mg 

USP1291005 Gibberellic Acid (FCC) 200 mg 


Ginger Constituent Mixture 

6-gingerol and 6-shogaol 

15 mg 

20 mg 

0.2 mg 

New USP1291548 Ginkgolic Acids 10 mg 

New USP1291559 Ginkgo Terpene Lactones 50 mg 

USP1291504 Powdered Ginger 500 mg 

New USP1291683 Powdered American Ginseng Extract 1.5 g 

USP1291708 Powdered Asian Ginseng Extract 1.5 g 

USP1292008 Gitoxin 50 mg 

USP1292303 Glimepiride 200 mg 

USP1292314 

USP1292325 

USP1292336 

USP1292347 

Glimepiride Related Compound A 

Glimepiride cis-isomer 

Glimepiride Related Compound B 

Glimepiride Sulfonamide 

Glimepiride Related Compound C 

Glimepiride urethane 

Glimepiride Related Compound D 

Glimepiride-3-isomer 

20 mg 

20 mg 

20 mg 

20 mg 




USP1292507 Glipizide 125 mg 

USP1292609 



Glipizide Related Compound A 

N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide 

Glipizide Related Compound B 

6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide 

Glipizide Related Compound C 

1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea 

USP1294207 Glucosamine HCl 200 mg 

USP1294976 Glutamic Acid 200 mg 

USP1294808 Glutamine 100 mg 

USP1294848 gamma-Glutamyl-S-allyl-L-cysteine 25 mg 

USP1295006 Glutethimide Controlled Substance CII 500 mg 

USP1295505 Glyburide 200 mg 

USP1295516 

USP1295527 

Glyburide Related Compound A 

5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide 

Glyburide Related Compound B 

methyl-[[4-[2-[5(-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate (AS) 

USP1295607 Glycerin 2 mL 

USP1295709 Glyceryl Behenate 200 mg 

New USP1295724 Glyceryl Distearate 500 mg 

New USP1295731 Glyceryl Monolinoleate 500 mg 

New USP1295742 Glyceryl Monooleate 90% 250 mg 

USP1295800 Glycine 200 mg 

USP1296009 Glycopyrrolate 200 mg 

USP1295888 Glycyrrhizic Acid 25 mg 

New USP1296756 Gonadorelin Acetate 50 mg 


Gonadorelin Acetate Related Compound A 

Gonadorelin free acid trifluoroacetate salt 

USP1297001 Human Chorionic Gonadotropin - 5,760 USP units per package vial 

USP1298004 Gramicidin 200 mg 

USP1299007 Griseofulvin 200 mg 

USP1299200 Griseofulvin Permeability Diameter 2 g 

USP1300004 Guaiacol 1 g 

USP1301007 Guaifenesin 200 mg 

USP1301404 Guanabenz Acetate 200 mg 

USP1301608 Guanadrel Sulfate 200 mg 

USP1301801 Guanethidine Monosulfate 200 mg 

USP1302000 Guanethidine Sulfate 500 mg 

USP1302101 Guanfacine HCl 125 mg 

USP1302305 Halazepam Controlled Substance CIV 200 mg 

USP1302509 Halcinonide 200 mg 

USP1303002 Haloperidol 200 mg 

USP1303013 

Haloperidol Related Compound A 

4,4-Bis[(4-p-chlorophenyl)-4-hydroxy-piperidino]butyrophenone 

USP1303501 Halothane 1 mL 

USP1304005 Heparin Sodium 10x1 mL 

New USP1304209 Heptane 3x1.2 mL 

USP1305008 Hexachlorophene 500 mg 

USP1305303 Hexacosanol 100 mg 

USP1305507 2E,4E-Hexadienoic Acid Isobutylamide 25 mg 

USP1307003 Hexobarbital Controlled Substance CIII 500 mg 

USP1308006 Hexylcaine HCl 1 g 

USP1308200 Hexylene Glycol 125 mg 

25 mg 

15 mg 

15 mg 

25 mg 

25 mg 

10 mg 

15 mg 




USP1308307 Hexylresorcinol 200 mg 

USP1308505 L-Histidine 200 mg 

USP1309009 Histamine Dihydrochloride 250 mg 

USP1310008 Homatropine HBr 200 mg 

USP1311000 Homatropine Methylbromide 250 mg 

USP1311306 Homopolymer Polypropylene 3 strips 

USP1311408 Homosalate 500 mg 

USP1313006 Hydralazine HCl 200 mg 

USP1313210 Hydrastine 10 mg 

USP1314009 Hydrochlorothiazide 200 mg 

USP1315001 Hydrocodone Bitartrate Controlled Substance CII 100 mg 

USP1315012 

Hydrocodone Bitartrate Related Compound A 

Morphinan-6-one, 4-hydroxy-3-methoxy-17-methyl Controlled Substance CII 

USP1316004 Hydrocortisone 200 mg 

USP1317007 Hydrocortisone Acetate 200 mg 

USP1317302 Hydrocortisone Butyrate 200 mg 

USP1318000 Hydrocortisone Cypionate 200 mg 

USP1319002 Hydrocortisone Hemisuccinate 200 mg 

USP1320001 Hydrocortisone Phosphate Triethylamine 200 mg 

USP1321004 Hydrocortisone Valerate 200 mg 

USP1322007 Hydroflumethiazide 200 mg 

USP1323000 Hydromorphone HCl Controlled Substance CII 50 mg 

USP1324002 Hydroquinone 500 mg 

USP1325005 Hydroxyamphetamine HBr 200 mg 

USP1327000 Hydroxychloroquine Sulfate 200 mg 

USP1329006 Hydroxyprogesterone Caproate 200 mg 

USP1329709 Hydroxypropyl Betadex 200 mg 

USP1329800 Hydroxypropyl Cellulose 200 mg 

USP1332000 Hydroxyurea 200 mg 

USP1333003 Hydroxyzine HCl 500 mg 

USP1333058 

Hydroxyzine Related Compound A 

p-Chlorobenzhydrylpiperazine 

USP1334006 Hydroxyzine Pamoate 500 mg 

USP1335009 Hyoscyamine Sulfate 125 mg 

USP1335010 

Hyoscyamine Related Compound A 

Norhyoscyamine Sulfate 

USP1335202 Hyperoside 50 mg 

USP1330005 Hypromellose (Hydroxypropyl Methylcellulose) 250 mg 

USP1335279 Hypromellose Acetate Succinate 100 mg 

USP1335304 Hypromellose Phthalate 100 mg 

USP1335508 Ibuprofen 750 mg 

USP1335541 

Ibuprofen Related Compound C 

4-isobutylacetophenone 

70 mg 

25 mg 

10 mg 

3x0.2 mL 

USP1335701 Idarubicin HCl 50 mg 

USP1336001 Idoxuridine 250 mg 

USP1336205 Ifosfamide 500 mg 

USP1336500 Imidazole 200 mg 

USP1336806 Imidurea 200 mg 

USP1337004 Iminodibenzyl 25 mg 

USP1337809 Imipenem Monohydrate 100 mg 

USP1338007 Imipramine HCl 200 mg 

USP1338801 Indapamide 250 mg 




USP1338812 

Indapamide Related Compound A 

4-Chloro-N-(2-methyl-indol-1-yl)-3-sulfamoylbenzamide (AS) 

USP1339000 Indigotindisulfonate Sodium 500 mg 

USP1339178 Indinavir 100 mg 

USP1339189 Indinavir System Suitability 100 mg 

USP1340009 Indocyanine Green 200 mg 

USP1341001 Indomethacin 200 mg 

USP1342004 Insulin 100 mg 

USP1342106 Insulin Human 100 mg 

USP1342208 Insulin (Beef) 100 mg 

USP1342300 Insulin (Pork) 100 mg 

USP1342321 Insulin Lispro 5.97 mg 

USP1343007 Iodipamide 200 mg 

USP1343517 Iodixanol 200 mg 

USP1343540 

USP1343550 

USP1343561 

Iodixanol Related Compound C 

5-Acetyl[3-[[3,5-bis[[2,3-dihydroxypropyl) 

amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis- 

(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide 

Iodixanol Related Compound D 

5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N'-bis(2,3-dihydroxypropyl) 

2,4,6-triiodo-1,3-benzenedicarboxamide 

Iodixanol Related Compound E 

5-[[3-[[3-[[(2,3-Dihydoxypropyl)amino]carbonyl]-5-[[amino]carbonyl]- 

2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N'- 

bis(2,3-dihydoxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide 

USP1344305 o-Iodohippuric Acid 100 mg 

USP1344509 Iodoquinol 100 mg 

USP1344600 Iohexol 200 mg 

USP1344622 

USP1344644 

USP1344666 

Iohexol Related Compound A 

5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide 

Iohexol Related Compound B 

5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide 

Iohexol Related Compound C 

N,N'-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide 

50 mg 

25 mg 

50 mg 

25 mg 

100 mg 

50 mg 

100 mg 

USP1344702 Iopamidol 200 mg 

USP1344724 

USP1344735 

Iopamidol Related Compound A 

N,N'Bis-(1,3-dihydroxy-2-propyl)5-amino-2,4,6-triiodoiso-phthalamide 

Iopamidol Related Compound B 

5-Glycolamido-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide 

50 mg 

100 mg 

USP1344804 Iopromide 400 mg 

USP1344826 

USP1344837 

Iopromide Related Compound A 

5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide 

Iopromide Related Compound B 

5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl- 

1,3-benzenedicarboxamide 

USP1345002 Iothalamic Acid 200 mg 

USP1345104 Ioversol 200 mg 

USP1345115 

USP1345126 

Ioversol Related Compound A 

5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide 

Ioversol Related Compound B 

N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbonyl)methoxy]- 

2,4,6-triiodoisophthalamide 

USP1345159 Ioxaglic Acid 100 mg 

USP1345206 Ioxilan 400 mg 

USP1345228 

Ioxilan Related Compound A 

5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic Acid 

50 mg 

50 mg 

50 mg 

50 mg 

100 mg 

USP1347008 Ipodate Sodium 200 mg 




New USP1347507 Ipratropium Bromide 100 mg 




Ipratropium Bromide Related Compound A 

endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide 

Ipratropium Bromide Related Compound B 

(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8- 

(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide 

Ipratropium Bromide Related Compound C 

(2-RS)-3-hydroxy-2-phenylpropanoic acid 

New USP1347700 Irbesartan 200 mg 

USP1347711 

Irbesartan Related Compound A 

1-pentanoylaminocyclopentanecarboxylic acid[2'-(1H-tetrazol-5-yl)- 

biphenyl-4-ylmethyl]-amide 

USP1347755 Isoamyl Methoxycinnamate 750 mg 

USP1347802 Isobutyl acetate 3x1.2 mL 

USP1348000 Isocarboxazid 200 mg 

USP1348500 Isoetharine HCl 250 mg 

USP1348907 Isoflupredone Acetate 200 mg 

USP1349003 Isoflurane 1 mL 

USP1349014 

USP1349025 

Isoflurane Related Compound A 

1-chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether 

Isoflurane Related Compound B 

2,2,2-Trifluoroethyldifluoromethyl ether 

10 mg 

10 mg 

15 mg 

25 mg 

0.1 mL 

0.1 mL 

USP1349502 L-Isoleucine 200 mg 

USP1349604 Isomalathion 50 mg 

USP1349626 Isomalt 200 mg 

USP1349659 Isometheptene Mucate 200 mg 

USP1349706 Isoniazid 200 mg 

USP1350002 Isopropamide Iodide 200 mg 

USP1350104 Isopropyl Acetate 3x1.2 mL 

USP1350308 Isopropyl Alcohol (AS) 3x1.5 mL 

USP1350400 Isopropyl Myristate 500 mg 

USP1350603 Isopropyl Palmitate 500 mg 

USP1351005 Isoproterenol HCl 125 mg 

USP1352008 Isosorbide (75% solution) 1 g 

USP1353000 Diluted Isosorbide Dinitrate 500 mg 

New USP1353102 Diluted Isosorbide Mononitrate 350 mg 


Diluted Isosorbide Mononitrate Related Compound A 

1,4;3,6-dianhydro-D-glucitol 2-nitrate 

100 mg 

USP1353500 Isotretinoin 200 mg 

USP1354003 Isoxsuprine HCl 200 mg 

USP1354207 Isradipine 200 mg 

USP1354218 

Isradipine Related Compound A 

Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinecarboxylate 

USP1354309 Ivermectin 200 mg 

USP1355006 Kanamycin Sulfate 200 mg 

USP1355709 Powdered Kava Extract 1 g 

USP1355753 Kawain 200 mg 

USP1356009 Ketamine HCl Controlled Substance CIII 250 mg 

USP1356020 

Ketamine Related Compound A 

1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol 

USP1356508 Ketoconazole 200 mg 

USP1356632 Ketoprofen 200 mg 

USP1356643 

Ketoprofen Related Compound A 

alpha-Methyl-3-(4-methylbenzoyl) benzeneacetic Acid (AS) 

25 mg 

50 mg 

25 mg 




USP1356665 Ketorolac Tromethamine 200 mg 

USP1356654 Labetalol HCl 200 mg 

USP1356698 Lactase 200 mg 

USP1356734 Lactic Acid (AS) 3x1.5 mL 

USP1356676 Anhydrous Lactose 100 mg 

USP1356687 Lactitol 500 mg 

USP1356701 Lactose Monohydrate 500 mg 

USP1356803 Lactulose 1 g 

USP1356836 Lamivudine 200 mg 

USP1356847 Lamivudine Resolution Mixture A 10 mg 

USP1356858 Lamivudine Resolution Mixture B 10 mg 

USP1356880 Lanolin 20 g 

USP1356905 Lanolin Alcohols 5 g 

USP1356916 Lansoprazole 150 mg 

USP1356927 

Lansoprazole Related Compound A 

2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole 

USP1356950 Lauroyl Polyoxylglycerides 500 mg 

USP1356971 Letrozole 200 mg 

USP1356982 

Letrozole Related Compound A 

4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile 

USP1357001 L-Leucine 200 mg 

USP1358004 Leucovorin Calcium 500 mg 

USP1358503 Leuprolide Acetate 200 mg 

New USP1358784 Levalbuterol HCl 200 mg 








Levalbuterol Related Compound A 

4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol 

Levalbuterol Related Compound B 

alpha-[{(1,1-Dimethylethyl)amino}methyl[-4-hydroxy-3-methyl-benzenemethanol 

Levalbuterol Related Compound C 

alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol 

Levalbuterol Related Compound D 

5-[2-{(1,1-dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde benzenesulfonic 

acid salt 

Levalbuterol Related Compound E 

alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol 

Levalbuterol Related Compound F 

alpha-[{(1,1-Dimethylethyl)amino}methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol 

Levalbuterol Related Compound G 

alpha[{(1,1-Dimethylethyl)amino}methyl]-4,5-dihydroxy-1,3-benzenedimethanol 

USP1359302 Levamisole HCl 125 mg 

USP1359506 Levmetamfetamine Controlled Substance CII 75 mg 

USP1359801 Levobunolol HCl 200 mg 

USP1359903 Levocarnitine 400 mg 

USP1359925 

Levocarnitine Related Compound A 

3-carboxy-N,N,N-trimethyl-2-propen-1-aminium chloride 

25 mg 

25 mg 

30 mg 

20 mg 

30 mg 

30 mg 

30 mg 

30 mg 

20 mg 

100 mg 

USP1361009 Levodopa 200 mg 

USP1361010 

USP1420006 

Levodopa Related Compound A 

3-(3,4,6-Trihydroxyphenyl)-alanine 

Levodopa Related Compound B 

3-Methoxytyrosine 

USP1362500 Levonordefrin 200 mg 

USP1363004 Levopropoxyphene Napsylate 300 mg 

USP1364007 Levorphanol Tartrate Controlled Substance CII 500 mg 

USP1365000 Levothyroxine 500 mg 

USP1366002 Lidocaine 250 mg 

50 mg 

50 mg 




USP1367005 Lincomycin HCl 200 mg 

USP1367504 Lindane 200 mg 

USP1367708 Linoleoyl Polyoxylglycerides 100 mg 

USP1368008 Liothyronine 250 mg 

USP1368609 Lisinopril 300 mg 

USP1369000 Lithium Carbonate 300 mg 

USP1370000 Loperamide HCl 200 mg 

USP1370203 Loracarbef 200 mg 

USP1370225 Loracarbef L-Isomer 25 mg 

USP1370270 Loratadine 200 mg 

USP1370280 

USP1370291 

Loratadine Related Compound A 

8-chloro-6,11-dihydro-11(4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine 

Loratadine Related Compound B 

8-chloro-6,11-dihydro-11(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta 

[1,2-b]pyridine 

USP1370305 Lorazepam Controlled Substance CIV 200 mg 

USP1370327 

USP1370338 

USP1370349 

USP1370350 

USP1370360 

Lorazepam Related Compound A 

7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepine-2-one 

Controlled Substance 

Lorazepam Related Compound B 

2-Amino-2',5-dichlorobenzophenone 

Lorazepam Related Compound C 

6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde 

Lorazepam Related Compound D 

6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid 

Lorazepam Related Compound E 

6-Chloro-4-(o-chlorophenyl)-2-quinazoline Methanol 

USP1370462 Losartan Potassium 250 mg 

USP1370600 Lovastatin 125 mg 

USP1370611 

Lovastatin Related Compound A 

Dihydro-lovastatin 

USP1370702 Loxapine Succinate 125 mg 

USP1370804 Lutein 1 mL 

USP1370906 Lynestrenol 20 mg 

USP1371002 Lysergic Acid Diethylamide Tartrate (AS) (LSD) Controlled Substance CI 10 mg 

USP1371501 L-Lysine Acetate 200 mg 

USP1372005 L-Lysine HCl 200 mg 

USP1373008 Mafenide Acetate 400 mg 

USP1286209 

Mafenide Related Compound A 

4-Formylbenzenesulfonamide 

USP1374000 Magaldrate 200 mg 

USP1374226 Magnesium Carbonate (AS) 2 g 

USP1374248 Magnesium Chloride (AS) 1 g 

USP1374260 Magnesium Hydroxide (AS) 1 g 

USP1374292 Magnesium Phosphate (AS) 2 g 

USP1374306 Magnesium Salicylate 200 mg 

USP1374340 Magnesium Stearate (AS) 5 g 

USP1374361 Magnesium Sulfate (AS) 1 g 

USP1374408 Malathion 500 mg 

USP1374500 Maleic Acid 300 mg 

USP1374601 Malic Acid 200 mg 

USP1374907 Maltitol 200 mg 

USP1375003 Maltol (FCC) 4 g 

USP1375025 Maltose Monohydrate 500 mg 

15 mg 

15 mg 

25 mg 

25 mg 

25 mg 

25 mg 

25 mg 

10 mg 

50 mg 




USP1375058 Mandelic Acid 500 mg 

USP1375069 Mangafodipir Trisodium 200 mg 

USP1375070 

USP1375080 

USP1375091 

Mangafodipir Related Comound A 

Manganese (II) dipyridoxyl monophosphate sodium salt 

Mangafodipir Related Comound B 

Manganese (II) dipyridoxyl diphosphate mono-overalkylated sodium salt 

Mangafodipir Related Comound C 

Manganese (III) dipyridoxyl diphosphate sodium salt 

USP1375127 Manganese Chloride (AS) 1 g 

USP1375149 Manganese Sulfate (AS) 1 g 

USP1375105 Mannitol 200 mg 

New USP1375182 Mannose 300 mg 

USP1375207 Maprotiline HCl 200 mg 

USP1375309 Mazindol Controlled Substance CIV 350 mg 

USP1375502 Mebendazole 200 mg 

USP1375706 Mebrofenin 100 mg 

USP1376006 Mecamylamine HCl 200 mg 

USP1376017 

Mecamylamine Related Compound A 

N,1,7,7-tetramethyl bicyclo[2.2.1]heptan-2-amine hydrochloride 

USP1377009 Meclizine HCl 500 mg 

USP1377508 Meclocycline Sulfosalicylate 300 mg 

USP1377803 Meclofenamate Sodium 500 mg 

USP1378001 Medroxyprogesterone Acetate 200 mg 

USP1378012 

Medroxyprogesterone Acetate Related Compound A 

4,5-beta-Dihydromedroxyprogesterone acetate 

USP1379004 Medrysone 500 mg 

USP1379605 Mefenamic Acid 200 mg 

USP1379059 Mefloquine Hydrochloride 100 mg 

USP1379060 

Mefloquine Related Compound A 

threo-mefloquine 

USP1379106 Megestrol Acetate 500 mg 

USP1379140 Meglumine (AS) 500 mg 


Melamine 

2,4,6-Triamino-1,3,5-triazine 

15 mg 

15 mg 

15 mg 

10 mg 

25 mg 

20 mg 

250 mg 

USP1380105 Melatonin (AS) 100 mg 

USP1379254 Melengestrol Acetate 125 mg 

USP1379265 

USP1379276 

Melengestrol Acetate Related Compound A 

17-hydroxy-16-methylenepregna-4-ene-3,20-dione 17-acetate 

Melengestrol Acetate Related Compound B 

6,16-dimethylene-17-hydroxypregna-4-ene-3,20-dione 17-acetate 

USP1379401 Meloxicam 400 mg 

USP1379412 

USP1379423 

USP1379434 

USP1379445 

Meloxicam Related Compound A 

4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide 

Meloxicam Related Compound B 

2-Amino-5-methyl-thiazole 

Meloxicam Related Compound C 

Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide 

Meloxicam Related Compound D 

4-Methoxy-2-methyl-(5-methyl-1,3-thiazol-2yl)- 

2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide 

USP1381006 Menadione (Vitamin K 3) 200 mg 

USP1381709 Menthol 250 mg 

USP1381742 Menthyl Anthranilate 500 mg 

USP1382009 Mepenzolate Bromide 200 mg 

USP1383001 Meperidine HCl Controlled Substance CII 200 mg 

25 mg 

25 mg 

25 mg 

25 mg 

30 mg 

30 mg 




USP1385007 Mephenytoin 250 mg 

USP1386000 Mephobarbital Controlled Substance CIV 250 mg 

USP1387002 Mepivacaine HCl 200 mg 

USP1388005 Meprednisone 200 mg 

USP1389008 Meprobamate Controlled Substance CIV 200 mg 

USP1390007 Meprylcaine HCl 200 mg 

USP1391000 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt 75 mg 

USP1392002 Mercaptopurine 500 mg 

USP1392454 Meropenem 300 mg 

USP1392705 Mesalamine 200 mg 

USP1393005 Mesoridazine Besylate 250 mg 

USP1394008 Mestranol 200 mg 

USP1395500 Metaproterenol Sulfate 200 mg 

USP1396003 Metaraminol Bitartrate 200 mg 

USP1396309 Metformin HCl 200 mg 

USP1396310 

USP1396331 

USP1396342 

Metformin Related Compound A 

1-Cyanoguanidine 

Metformin Related Compound B 

1-Methylbiguanide hydrochloride 

Metformin Related Compound C 

N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine 

USP1396364 Methacholine Chloride (AS) 500 mg 

USP1396400 Methacrylic Acid Copolymer Type A 200 mg 

USP1396502 Methacrylic Acid Copolymer Type B 200 mg 

USP1396604 Methacrylic Acid Copolymer Type C 200 mg 

USP1397006 Methacycline HCl 200 mg 

USP1398009 Methadone HCl Controlled Substance CII 200 mg 

USP1399001 Methamphetamine HCl Controlled Substance CII 125 mg 

USP1401001 Methantheline Bromide 200 mg 

USP1402004 Methapyrilene Fumarate 200 mg 

USP1404000 Methaqualone Controlled Substance CI 500 mg 

USP1405002 Metharbital Controlled Substance CIII 200 mg 

USP1406005 Methazolamide 500 mg 

USP1408000 Methdilazine HCl 200 mg 

USP1409003 Methenamine 500 mg 

USP1409502 Methenamine Hippurate 200 mg 

USP1409604 Methenamine Mandelate 200 mg 

USP1410002 Methicillin Sodium (AS) 500 mg 

USP1411005 Methimazole 200 mg 

USP1411504 L-Methionine 200 mg 

USP1412008 Methocarbamol 200 mg 

USP1413000 Methohexital Controlled Substance CIV 500 mg 

USP1414003 Methotrexate 500 mg 

USP1415006 Methotrimeprazine 125 mg 

USP1416009 Methoxamine HCl 200 mg 

USP1417001 Methoxsalen 500 mg 

USP1418004 Methoxyflurane 1 mL 

USP1419007 Methoxyphenamine HCl 250 mg 

USP1421009 Methscopolamine Bromide 200 mg 

USP1422001 Methsuximide 500 mg 

USP1424007 Methyclothiazide 200 mg 

50 mg 

25 mg 

25 mg 




USP1424018 

Methyclothiazide Related Compound A 

4-amino-6-chloro-N-3-methyl-m-benzenedisulfonamide 

100 mg 

USP1424051 Methyl Acetate 3x1.2 mL 

USP1424109 Methyl Alcohol 3x1.5 mL 

USP1424153 3-Methyl-1-butanol 3x1.2 mL 

USP1424211 Methylbenzethonium Chloride 500 mg 

USP1424222 Methyl Benzylidene Camphor 200 mg 

USP1424233 Methyl Caprate 300 mg 

USP1424244 Methyl Caproate 300 mg 

USP1424255 Methyl Caprylate 300 mg 

USP1424506 Methylcellulose (AS) 1 g 

USP1425000 4-Methyl-2,5-dimethoxyamphetamine HCl (STP) (AS) Controlled Substance CI 25 mg 

USP1426002 Methyldopa 500 mg 

USP1427005 Methyldopate HCl 200 mg 

USP1428008 Methylene Blue 250 mg 

USP1429000 Methylenedioxy-3,4-amphetamine HCl (MDA) (AS) Controlled Substance CI 25 mg 

USP1430000 Methylergonovine Maleate 50 mg 

New USP1430101 Methyl Ethyl Ketone 3x1.2 mL 

New USP1430203 Methyl Isobutyl Ketone 3x1.2 mL 

USP1430305 Methyl Laurate 500 mg 

USP1430327 Methyl Linoleate 5x50 mg 

USP1430349 Methyl Linolenate 5x50 mg 

USP1430509 3-O-Methylmethyldopa 50 mg 

USP1431002 Methyl 5-methyl-3-isoxazolecarboxylate 25 mg 

USP1431501 Methyl Myristate 300 mg 

USP1431556 Methyl Oleate 500 mg 

USP1431603 Methyl Palmitate 300 mg 

USP1431625 Methyl Palmitoleate 300 mg 

USP1432005 Methylparaben 125 mg 

USP1433008 Methylphenidate HCl Controlled Substance CII 125 mg 

USP1434011 Methylphenidate HCl Erythro Isomer Solution Controlled Substance CII 0.5 mL 

USP1434022 

Methylphenidate Related Compound A 

alpha-Phenyl-2-piperidineacetic Acid HCl 

USP1435003 Methylprednisolone 200 mg 

USP1436006 Methylprednisolone Acetate 200 mg 

USP1437009 Methylprednisolone Hemisuccinate 200 mg 

USP1437053 2-Methyl-1-propanol 3x1.2 mL 

USP1437450 Methyl Salicylate (AS) 2 mL 

USP1437508 Methyl Stearate 300 mg 

New USP1437600 Methylsulfonylmethane 200 mg 

USP1438001 Methyltestosterone Controlled Substance CIII 200 mg 

USP1440003 Methysergide Maleate 350 mg 

USP1440808 Metoclopramide HCl 500 mg 

USP1441200 Metolazone 200 mg 

USP1441232 

USP1441243 

USP1441254 

USP1441265 

Metoprolol Related Compound A 

(+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol 

Metoprolol Related Compound B 

(+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propane 

Metoprolol Related Compound C 

(+/-)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde 

Metoprolol Related Compound D 

(+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl] 

(1-methylethyl)amine hydrochloride 

50 mg 

20 mg 

50 mg 

20 mg 

50 mg 




USP1441287 Metoprolol Fumarate 200 mg 

USP1441298 Metoprolol Succinate 200 mg 

USP1441301 Metoprolol Tartrate 200 mg 

USP1441505 Metrizamide 500 mg 

USP1442009 Metronidazole 100 mg 

New USP1442100 Metronidazole Benzoate 100 mg 

USP1443001 Metyrapone 200 mg 

USP1443205 Metyrosine 200 mg 

USP1443250 Mexiletine HCl 200 mg 

USP1443307 Mezlocillin Sodium 350 mg 

USP1443409 Miconazole 200 mg 

USP1443500 Miconazole Nitrate 200 mg 

USP1443850 Powdered Milk Thistle Extract 250 mg 

USP1443908 Milrinone 500 mg 

USP1443919 

Milrinone Related Compound A 

1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carboxamide 

USP1444004 Minocycline HCl 200 mg 

USP1444208 Minoxidil 125 mg 

USP1444279 Mirtazapine 350 mg 

USP1444707 Mitomycin 50 mg 

USP1445007 Mitotane 500 mg 

USP1445200 Mitoxantrone HCl 400 mg 

USP1445211 Mitoxantrone System Suitability Mixture 0.3 mg 

USP1445404 Modafinil Controlled Substance CIV 200 mg 





Modafinil Related Compound A 

2-[(diphenylmethyl)sulfinyl]acetic acid 

Modafinil Related Compound C 

2-[(diphenylmethyl)sulfenyl]acetamide 

Modafinil Related Compound D 

Bis (diphenylmethyl)ether 

Modafinil Related Compound E 

Bis(diphenylmethyl)disulfide 

50 mg 

500 mg 

500 mg 

USP1445459 Molindone HCl 500 mg 

USP1445470 Mometasone Furoate 200 mg 

USP1445481 Monensin Sodium 200 mg 

USP1445506 Monobenzone 200 mg 

USP1445925 Monoethanolamine 1 mL 

USP1446000 Monoglycerides 125 mg 

USP1446600 Monosodium Glutamate (AS) 1 g 

USP1446804 Monostearyl Maleate 100 mg 

USP1446906 Morantel Tartrate 100 mg 

USP1446950 Moricizine HCl 250 mg 

USP1447002 Morphine Monohydrate (AS) Controlled Substance CII 50 mg 

USP1448005 Morphine Sulfate Controlled Substance CII 500 mg 

USP1448901 Mupirocin 50 mg 

USP1448912 Mupirocin Calcium 200 mg 

USP1448923 Mupirocin Lithium 100 mg 

USP1448990 Myristic Acid 200 mg 

USP1449008 Myristyl Alcohol 1 g 

USP1449518 Nabumetone 200 mg 

USP1449530 

Nabumetone Related Compound A 

1-(6-methoxy-2-naphthyl)-but-1-en-3-one 

USP1449700 Nadolol 200 mg 

20 mg 

20 mg 

15 mg 




USP1450007 Nafcillin Sodium 200 mg 

USP1450404 Naftifine HCl 200 mg 

USP1451000 Nalidixic Acid 200 mg 

USP1452002 Nalorphine HCl Controlled Substance CIII 250 mg 

USP1453005 Naloxone 125 mg 

USP1453504 Naltrexone 200 mg 

USP1453526 

Naltrexone Related Compound A 

N-(3-butenyl)-noroxymorphone HCl Controlled Substance CII 

USP1454008 Nandrolone Controlled Substance CIII 50 mg 

USP1455000 Nandrolone Decanoate Controlled Substance CIII 250 mg 

USP1456003 Nandrolone Phenpropionate Controlled Substance CIII 250 mg 

USP1457006 Naphazoline HCl 200 mg 

USP1457301 Naproxen 200 mg 

USP1457403 Naproxen Sodium 200 mg 

USP1457469 Naratriptan HCl 125 mg 

USP1457491 Naratriptan Resolution Mixture 20 mg 

USP1457505 Natamycin 200 mg 

New USP1457844 Near IR System Suitability unit 

USP1457902 Nefazodone HCl 200 mg 

USP1457913 

USP1457924 

Nefazodone Related Compound A 

1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride 

Nefazodone Related Compound B 

2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H- 

1,2,4-triazol-3-one hydrochloride 

USP1458009 Neomycin Sulfate 200 mg 

USP1459001 Neostigmine Bromide 200 mg 

USP1460000 Neostigmine Methylsulfate 200 mg 

USP1460204 Neotame 200 mg 

USP1460215 

Neotame Related Compound A 

N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 

USP1460500 Netilmicin Sulfate 500 mg 

USP1460703 Nevirapine Anhydrous 100 mg 

USP1460714 Nevirapine Hemihydrate 100 mg 

USP1460725 

USP1460736 

Nevirapine Related Compound A 

5,11-Dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b2',3'-e][1,4]diazepin-6-one 

Nevirapine Related Compound B 

5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 

USP1461003 Niacin 200 mg 

USP1462006 Niacinamide (Vitamin B 3) 500 mg 

USP1463304 Nicotine Bitartrate Dihydrate 500 mg 

USP1463508 Nifedipine 125 mg 

USP1463600 Nifedipine Nitrophenylpyridine Analog 25 mg 

USP1463701 Nifedipine Nitrosophenylpyridine Analog 25 mg 

USP1463858 Nimodipine 125 mg 

USP1463870 

USP1463869 

Nimodipine Related Compound A 

2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate 

Nimodipine Related Compound B 

bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl) 

-1,4-dihydropyridine-3,5-dicarboxylate (AS) 

USP1464001 Nitrofurantoin 500 mg 

USP1021703 

Nitrofurantoin Related Compound A 

N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine 

USP1465004 Nitrofurazone 200 mg 

USP1465503 Nitrofurfural Diacetate 100 mg 

30 mg 

25 mg 

25 mg 

15 mg 

15 mg 

15 mg 

50 mg 

50 mg 

25 mg 




USP1466007 

Nitrofurazone Related Compound A 

5-Nitro-2-furfuraldazine 

500 mg 

USP1466506 Diluted Nitroglycerin 5 ampules 

USP1467804 Nizatidine 200 mg 

USP1467950 Nonoxynol 9 0.5 mL 

USP1468002 Nonoxynol 10 200 mg 

USP1468400 

Nordazepam Controlled Substance CIV 

7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 

USP1468501 Norepinephrine Bitartrate 125 mg 

USP1469005 Norethindrone 200 mg 

USP1470004 Norethindrone Acetate 100 mg 

USP1471007 Norethynodrel 200 mg 

USP1471506 Norfloxacin 200 mg 

USP1471914 Norgestimate 200 mg 

USP1471925 

USP1471958 

Norgestimate Related Compound A 

Levonorgestrel Acetate 

Deacetylnorgestimate 

(E)- and (Z)-17-deacetyl norgestimate mixture 

USP1472000 Norgestrel 125 mg 

USP1473002 Noroxymorphone HCl Controlled Substance CII 50 mg 

USP1473206 Norphenylephrine Hydrochloride 25 mg 

USP1474005 Nortriptyline HCl 200 mg 

USP1474504 Noscapine 500 mg 

USP1475008 Novobiocin 200 mg 

USP1476000 Nylidrin HCl 200 mg 

USP1477003 Nystatin 200 mg 

USP1477900 Octinoxate (Octyl Methoxycinnamate) 500 mg 

USP1477943 Octisalate (Octyl Salicylate) 400 mg 

USP1477411 Octocrylene 500 mg 

USP1477502 Octoxynol 9 200 mg 

USP1477808 Octyldodecanol 200 mg 

USP1478108 Ofloxacin 200 mg 

USP1478119 

Ofloxacin Related Compound A 

(RS)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(piperazin-1-yl)-7H-pyrido[1,2,3-de]- 

1,4-benzoxazine-6-carboxylic acid 

USP1478130 Oleic Acid 1 g 

USP1478152 Oleoyl Polyoxylglycerides 100 mg 

USP1478254 Olive Oil (AS) 1 g 

USP1478505 Omeprazole 200 mg 

USP1478516 

Omeprazole Related Compound A 

Omeprazole Sulfone (AS) 

New USP1478549 Omeprazole Magnesium 10 mg 

USP1478571 Ondansetron 300 mg 

USP1478582 Ondansetron HCl 300 mg 

USP1478593 

USP1478618 

USP1478629 

Ondansetron Related Compound A 

3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl 

-4H-carbazol-4-one hydrochloride 

Ondansetron Related Compound C 

1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one 

Ondansetron Related Compound D 

1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one 

USP1478630 Ondansetron Resolution Mixture 50 mg 

New USP1478800 Orlistat 10 mg 

50 mg 

25 mg 

25 mg 

25 mg 

15 mg 

50 mg 

30 mg 

30 mg 







Orlistat Related Compound A 

(3S,4S)3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 

Orlistat Related Compound B 

diisopropyl bicarbamate 

Orlistat Related Compound C 

Triphenylphosphine oxide 

USP1479009 Orphenadrine Citrate 200 mg 

USP1479010 

Orphenadrine Related Compound A 

(RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate (AS) 

USP1481000 Oxacillin Sodium 200 mg 

USP1482003 Oxandrolone Controlled Substance CIII 50 mg 

USP1482014 

USP1482025 

USP1482036 

Oxandrolone Related Compound A 

17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one 

Controlled Substance CIII 

Oxandrolone Related Compound B 

17 beta-hydroxy-17-alpha-methyl-4-oxa-5 alpha-androsta-3-one 


Oxandrolone Related Compound C 

17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one 


USP1482207 Oxaprozin 200 mg 

USP1483006 Oxazepam Controlled Substance CIV 200 mg 

USP1483301 Oxfendazole 200 mg 

USP1483505 Oxprenolol HCl 200 mg 

USP1484009 Oxtriphylline 500 mg 

USP1485001 Oxybenzone 150 mg 

USP1485103 Oxybutynin Chloride 200 mg 

USP1485114 

USP1485125 

USP1485136 

Oxybutynin Related Compound A 

Phenylcyclohexylglycolic Acid 

Oxybutynin Related Compound B 

Cyclohexyl mandelic acid methyl ester 

Oxybutynin Related Compound C 

4-(Ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride 

25 mg 

10 mg 

25 mg 

50 mg 

20 mg 

20 mg 

20 mg 

100 mg 

USP1485191 Oxycodone Controlled Substance CII 200 mg 

USP1486004 Oxymetazoline HCl 200 mg 

USP1487007 Oxymetholone Controlled Substance CIII 200 mg 

USP1488000 Oxymorphone Controlled Substance CII 500 mg 

USP1490103 Oxyquinoline Sulfate 200 mg 

USP1491004 Oxytetracycline 200 mg 

USP1491015 Oxytetracycline HCl (AS) 200 mg 

USP1491300 Oxytocin 5 vials 

USP1491332 Paclitaxel 200 mg 

USP1491343 

USP1491354 

Paclitaxel Related Compound A 

Cephalomannine 

Paclitaxel Related Compound B 

10-Deacetyl-7-epipaclitaxel 

USP1491503 Padimate O 300 mg 

USP1492040 Palm Oil (AS) 1 g 

USP1492007 Palmitic Acid 500 mg 

USP1492801 Pamidronate Disodium 100 mg 

USP1493000 Pamoic Acid 250 mg 

USP1494057 Pancreatin Amylase and Protease 2 g 

USP1494079 Pancreatin Lipase 2 g 

USP1494217 Pancuronium Bromide 200 mg 

USP1494501 Panthenol, Racemic 200 mg 

20 mg 

20 mg 

20 mg 

20 mg 




USP1494807 Pantolactone 500 mg 

USP1495005 Papain 1 g 

USP1496008 Papaverine HCl 200 mg 

USP1496802 Parachlorophenol 500 mg 

New USP1496904 Paraffin 1 g 

USP1497000 Paramethadione 500 mg 

USP1498003 Paramethasone Acetate 200 mg 

USP1498706 Parbendazole 200 mg 

USP1499006 Pargyline HCl 200 mg 

USP1499403 Paricalcitol 10 mg 

New USP1499414 Paricalcitol Solution 3 mL 

USP1500003 Paromomycin Sulfate 125 mg 

USP1500218 Paroxetine HCl 350 mg 

USP1500230 

USP1500240 

USP1500251 

USP1500262 

USP1500273 

USP1500284 

Paroxetine Related Compound B 

trans-4-phenyl-3-([(3,4-methylenedioxy)phenoxymethyl]piperidine HCl 

Paroxetine Related Compound C 

(+)-trans-Paroxetine HCl 

Paroxetine Related Compound D 

cis-Paroxetine HCl (AS) 

Paroxetine Related Compound E Mixture 

1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix 

Paroxetine Related Compound F 

trans(-)-1-methyl-3-[(1,3-benzodioxol-5-yloxy)Methyl]-4-(4-fluorophenyl)piperidine 

Paroxetine Related Compound G 

(+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine HCl 

15 mg 

15 mg 

10 mg 

25 mg 

10 mg 

0.4 mg 

USP1500353 Paroxetine System Suitability Mixture A 50 mg 

USP1500400 Parthenolide 25 mg 

USP1500502 Particle Count Set unit 

USP1500557 Peanut Oil (AS) 1 g 

USP1500808 Penbutolol Sulfate 200 mg 

USP1501006 Penicillamine 200 mg 

USP1501108 Penicillamine Disulfide 200 mg 

USP1502009 Penicillin G Benzathine 200 mg 

USP1502508 Penicillin G Potassium 200 mg 

USP1502552 Penicillin G Procaine 200 mg 

USP1502701 Pencillin G Sodium 150 mg 

USP1504489 Penicillin V 200 mg 

USP1504503 Penicillin V Potassium 200 mg 

New USP1504933 Pentane 3x1.2 mL 

USP1504955 1-Pentanol 3x1.2 mL 

USP1505007 Pentazocine Controlled Substance CIV 500 mg 

USP1505506 Pentetic Acid 100 mg 

USP1507002 Pentobarbital Controlled Substance CII 200 mg 

USP1508901 Pentoxifylline 200 mg 

USP1510007 Pepsin 5 g 

USP1510801 Perflubron 0.5 mL 

USP1510845 Pergolide Mesylate 200 mg 

USP1510867 Pergolide Sulfoxide 50 mg 

USP1511000 Perphenazine 200 mg 

USP1511203 Perphenazine Sulfoxide 100 mg 

USP1513005 Phenacetin 500 mg 

USP1514008 Phenacetin Melting Point Standard (Approximately 135°C) 500 mg 

USP1515000 Phenazopyridine HCl 200 mg 




USP1516003 Phencyclidine HCl (AS) Controlled Substance CII 25 mg 

USP1516502 Phendimetrazine Tartrate Controlled Substance CIII 350 mg 

USP1517006 Phenelzine Sulfate 200 mg 

USP1517301 D-Phenethicillin Potassium 200 mg 

USP1517607 L-Phenethicillin Potassium 200 mg 

USP1520000 Phenformin HCl 200 mg 

USP1522006 Phenindione 250 mg 

USP1522301 Pheniramine Maleate 100 mg 

USP1523009 Phenmetrazine HCl Controlled Substance CII 200 mg 

USP1524001 Phenobarbital Controlled Substance CIV 200 mg 

USP1524806 Phenol 500 mg 

USP1524908 Phenolphthalein 250 mg 

USP1525004 Phenolsulfonphthalein 100 mg 

USP1525707 Phenothiazine (AS) 500 mg 

USP1526007 Phenoxybenzamine HCl 250 mg 

USP1526200 

Phenoxyethanol 

2-Phenoxyethanol 

500 mg 

USP1528002 Phensuximide 500 mg 

USP1528501 Phentermine HCl Controlled Substance CIV 200 mg 

USP1529005 Phentolamine HCl 300 mg 

USP1530004 Phentolamine Mesylate 200 mg 

USP1530503 L-Phenylalanine 200 mg 

USP1530809 Phenylbenzimidazole Sulfonic Acid 200 mg 

USP1531007 Phenylbutazone 250 mg 

USP1533002 Phenylephrine HCl 125 mg 

USP1533250 Phenylethyl Alcohol 1 mL 

USP1533308 5-Phenylhydantoin 100 mg 

USP1533851 Phenylpropanediol 100 mg 

USP1533909 Phenylpropanolamine Bitartrate Controlled Substance 100 mg 

USP1534005 Phenylpropanolamine HCl Controlled Substance 250 mg 

USP1534402 Phenyltoloxamine Citrate 100 mg 

USP1534413 

Phenyltoloxamine Related Compound A 

2-(2-benzylphenoxy)ethylmethylamine hydrochloride 

USP1535008 Phenytoin 200 mg 

USP1535019 

USP1535020 

Phenytoin Related Compound A 

2,2-Diphenylglycine 

Phenytoin Related Compound B 

alpha-((aminocarbonyl)amino)-alpha-phenyl benzeneacetic acid 

USP1535507 Phenytoin Sodium 200 mg 

USP1535700 Phosphated Riboflavin 100 mg 

USP1535802 Phosphoric Acid (AS) 3x1.5 mL 

USP1537003 Physostigmine Salicylate 200 mg 

USP1538006 Phytonadione (Vitamin K 1) 500 mg 

USP1538505 Pilocarpine 300 mg 

USP1538902 Pilocarpine HCl 200 mg 

USP1539009 Pilocarpine Nitrate 200 mg 

USP1539508 Pimozide 200 mg 

USP1539701 Pindolol 200 mg 

USP1541000 Piperacetazine 250 mg 

USP1541500 Piperacillin 500 mg 

USP1541703 Piperazine Adipate 200 mg 

USP1541805 Piperazine Citrate 200 mg 

50 mg 

50 mg 

50 mg 




USP1541907 Piperazine Dihydrochloride 200 mg 

USP1542003 Piperazine Phosphate 200 mg 

USP1543006 Piperidolate HCl 200 mg 

USP1544304 Pirbuterol Acetate 200 mg 

USP1544508 Piroxicam 200 mg 

USP1545205 Plicamycin 50 mg 

USP1545409 Polacrilex Resin 100 mg 

USP1545500 Polacrilin Potassium 200 mg 

USP1546106 Poloxalene 500 mg 

USP1546300 Polydimethylsiloxane 500 mg 

USP1546401 Polyethylene Glycol 200 1 g 















USP1546707 Polyethylene, High Density 3 strips 

USP1546809 Polyethylene, Low Density 3 strips 

USP1546853 Polyethylene Oxide 100 mg 

USP1546900 Polyethylene Terephthalate (PET) 3 strips 

USP1546922 Polyethylene Terephthalate G (PETG) 3 strips 

USP1546966 Polyisobutylene 1 g 

USP1547007 Polymyxin B Sulfate 200 mg 

USP1547200 Polyoxyl 35 Castor Oil 1 g 

USP1547302 Polyoxyl 10 Oleyl Ether 1 mL 

USP1547346 Polyoxyl 2 Stearyl Ether (AS) 1 g 

New USP1372606 Polyoxyl 10 Stearyl Ether 1 g 

USP1547368 Polyoxyl 20 Stearyl Ether (AS) 1 g 

USP1547404 Polyoxyl 50 Stearate 200 mg 

USP1547801 Polyoxyl 20 Cetostearyl Ether 100 mg 

USP1547903 Polyoxyl 40 Stearate 200 mg 

USP1372402 Polyoxyl Lauryl Ether 500 mg 

USP1372504 Polyoxyl Oleate 500 mg 

USP1547925 Polysorbate 20 (AS) 2 g 




USP1548101 Potassium Benzoate (AS) 1 g 

USP1548134 Potassium Bicarbonate (AS) 1 g 

USP1548167 Potassium Carbonate (AS) 1 g 

USP1548190 Potassium Chloride (AS) 1 g 

USP1548225 Potassium Citrate (AS) 1 g 




USP1548280 Potassium Iodide (AS) 1 g 

USP1548349 Potassium Nitrate (AS) 5 g 

USP1548407 Potassium Sorbate (AS) 1 g 

USP1549807 Potassium Acetate (AS) 500 mg 

USP1549840 Potassium Bitartrate (AS) 3 g 

USP1550001 Potassium Gluconate 200 mg 

USP1551004 Potassium Guaiacolsulfonate 500 mg 

USP1551128 Dibasic Potassium Phosphate (AS) 5 g 

USP1551139 Monobasic Potassium Phosphate (AS) 5 g 

USP1551140 Potassium Sodium Tartrate (AS) 2 g 

USP1551150 Potassium Sucrose Octasulfate 300 mg 

USP1551300 Potassium Trichloroammineplatinate 20 mg 

USP1551503 Povidone 100 mg 

USP1553000 Pralidoxime Chloride 200 mg 

USP1554002 Pramoxine HCl 500 mg 

New USP1554192 Pravastatin 1,1,3,3-Tetramethylbutylamine 200 mg 

New USP1554206 Pravastatin Sodium 50 mg 



Pravastatin Related Compound A 

Sodium(3R,5R)-3,5-dihydroxy-7-[(1S,2S,3S,8S,8aR)-3-hydroxy-2methyl-8-[[(2S)- 

2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]heptanoate 

Pravastatin Related Compound B 

sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)- 

2-methylbutanoyl]oxy]1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate 

USP1554501 Prazepam Controlled Substance CIV 500 mg 

USP1554603 Praziquantel 200 mg 

USP1554658 

USP1554669 

USP1554670 

Praziquantel Related Compound A 

2-benzoyl-1,2,3,6,7,11b-hexahydro-4 H-pyrazino[2,1-a]isoquinolin-4-one 

Praziquantel Related Compound B 

2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]isoquinolin-4-one 

Praziquantel Related Compound C 

2-(N-formylhexahydrohippuroyl-1,2,3,4-tetrahydroisoquinolin-1-one 

USP1554705 Prazosin HCl 500 mg 

USP1554909 Prednicarbate 200 mg 

USP1554910 



Prednicarbate Related Compound A 

1,2-dihydroprednicarbate 

Prednicarbate Related Compound B 

prednisolone-17-ethylcarbonate 

Prednicarbate Related Compound C 

prednisolone-21-propionate 

USP1555005 Prednisolone 200 mg 

USP1556008 Prednisolone Acetate 200 mg 

USP1556507 Prednisolone Hemisuccinate 125 mg 

USP1557000 Prednisolone Sodium Phosphate 100 mg 

USP1558003 Prednisolone Tebutate 200 mg 

USP1559006 Prednisone 250 mg 

USP1559505 

Prednisone Tablets 

Dissolution calibrator tablets,Disintegrating 

15 mg 

20 mg 

50 mg 

50 mg 

50 mg 

20 mg 

20 mg 

20 mg 

30 tablets 

USP1560990 Prilocaine 200 mg 

USP1561008 Prilocaine HCl 200 mg 

USP1561019 

USP1561020 

Prilocaine Related Compound A 

o-toluidine hydrochloride 

Prilocaine Related Compound B 

(RS)-N-(4-methylphenyl)-2-(propylamino)propanamide 

100 mg 

USP1561507 Primaquine Phosphate 200 mg 

USP1562000 Primidone 200 mg 

50 mg 




USP1563003 Probenecid 200 mg 

USP1563309 Probucol 200 mg 

USP1563320 

USP1563331 

USP1563342 

Probucol Related Compound A 

2,2',6,6'-tetra-tert-butyldiphenoquinone 

Probucol Related Compound B 

4,4'-dithio-bis(2,6-di-tert-butylphenol) 

Probucol Related Compound C 

4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol 

USP1563502 Procainamide HCl 200 mg 

USP1564006 Procaine HCl 200 mg 

USP1565009 Procarbazine HCl 200 mg 

USP1566001 Prochlorperazine Maleate 200 mg 

USP1567004 Procyclidine HCl 200 mg 

USP1568007 Progesterone 200 mg 

USP1568506 L-Proline 200 mg 

USP1569000 Promazine HCI 200 mg 

USP1570009 Promethazine HCl 500 mg 

USP1570304 Propafenone HCl 200 mg 

New USP1570406 1-Propanol 3x1.2 mL 

USP1570428 2-Propanol 3x1.2 mL 

USP1570508 Propantheline Bromide 200 mg 

USP1329505 

Propantheline Bromide Related Compound A 

9-Hydroxypropantheline Bromide 

USP1571001 Proparacaine HCl 200 mg 

USP1572208 Propionic Acid (AS) 3x1.5 mL 

USP1572503 Propofol 200 mg 

USP1572525 

USP1572536 

USP1572547 

USP1572558 

Propofol Resolution Mixture 

Propofol;2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol 

Propofol Related Compound A 

3,3',5,5'-Tetraisopropyldiphenol 

Propofol Related Compound B 

2,6-diisopropylbenzoquinone 

Propofol Related Compound C 

2,6-diisopropylphenyl isopropylether 

25 mg 

25 mg 

25 mg 

50 mg 

100 mg 

USP1573007 Propoxycaine HCl 200 mg 

USP1574000 Propoxyphene HCl Controlled Substance CII 1 g 

USP1575002 Propoxyphene Napsylate Controlled Substance CII 1 g 

USP1575206 

USP1008002 

Propoxyphene Related Compound A 

alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol HCl 

Propoxyphene Related Compound B 

alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane 

USP1576005 Propranolol HCl 200 mg 

New USP1576402 Propyl Acetate 3x1.2 mL 

USP1576504 Propylene Carbonate 200 mg 

USP1576708 Propylene Glycol 1 mL 

USP1576800 Propyl Gallate 200 mg 

USP1577008 Propylparaben 200 mg 

USP1578000 Propylthiouracil 200 mg 

USP1578500 Prostaglandin A1 25 mg 

USP1578554 

Prostaglandin B1 

(13E,15S,)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic Acid 

USP1580002 Protriptyline HCl 200 mg 

USP1581005 Pseudoephedrine HCl Controlled Substance 125 mg 

USP1581504 Pseudoephedrine Sulfate Controlled Substance 200 mg 

25 mg 

50 mg 

50 mg 

50 mg 

50 mg 

25 mg 




New USP1583805 Pygeum Extract 150 mg 

USP1584003 Pyrantel Pamoate 1 g 

USP1585006 Pyrazinamide 200 mg 

USP1586009 Pyridostigmine Bromide 200 mg 

USP1587001 Pyridoxine HCl (Vitamin B 6) 200 mg 

USP1588004 Pyrilamine Maleate 200 mg 

USP1589007 Pyrimethamine 200 mg 

USP1592001 Pyrvinium Pamoate 500 mg 

USP1592205 Quazepam Controlled Substance CIV 200 mg 

USP1592227 

Quazepam Related Compount A 

7-Chloro-1-(2,2,2-trifluoroethyl)-5-(2-fluorophenyl)-1,3-dihydro- 

2H-1,4-benzodiazepine-2-one 

USP1592409 Quercetin 500 mg 

USP1593004 Quinacrine HCl 200 mg 

New USP1593401 Quinapril HCl 400 mg 

USP1593412 

USP1593423 

Quinapril Related Compound A 

Ethyl[3S-[2(R*),3a,11a beta]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-alpha- 

(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate 

Quinapril Related Compound B 

3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]- 

1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]-) 

USP1594007 Quinethazone 1.5 g 

USP1594506 Quinic Acid 200 mg 

USP1595000 Quinidine Gluconate 200 mg 

USP1595509 Quinidine Sulfate 500 mg 

USP1596807 Quinine HCl Dihydrate 1 g 

USP1597005 Quinine Sulfate 500 mg 

USP1597504 Quininone 50 mg 

USP1598303 Ramipril 200 mg 

USP1598314 

USP1598323 

USP1598338 

USP1598347 

Ramipril Related Compound A 

(2S,3aS,6aS)-1[(S)2-[[(S)1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]- 

octahydrocyclopenta[b]pyrrole-2-carboxylic acid 

Ramipril Related Compound B 

Ramipril Isopropylester 

Ramipril Related Compound C 

Hexahydroramipil HCl 

Ramipril Related Compound D 

Ramipril Diketopiperazine 

USP1598405 Ranitidine HCl 200 mg 

USP1598450 Ranitidine Resolution Mixture 20 mg 

USP1598507 

USP1598609 

USP1598700 

Ranitidine Related Compound A 

5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumarate 

Ranitidine Related Compound B 

N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine 

Ranitidine Related Compound C 

N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro- 

1,1-ethenediamine 

USP1599000 Rauwolfia Serpentina 15 g 

USP1599500 Powdered Red Clover Extract 500 mg 

USP1600813 Repaglinide 200 mg 

USP1600824 

USP1600835 

USP1600846 

Repaglinide Related Compound A 

(S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate Salt 

Repaglinide Related Compound B 

3-Ethoxy-4-ethoxycarbonyl-phenylacetic Acid 

Repaglinide Related Compound C 

(S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl]benzoic Acid 

30 mg 

50 mg 

50 mg 

20 mg 

20 mg 

20 mg 

20 mg 

50 mg 

50 mg 

50 mg 

50 mg 

50 mg 

25 mg 




USP1601000 Reserpine 200 mg 

USP1601102 Residual Solvent Mixture - Class 1 3x1.2 mL 

USP1601146 Residual Solvent Class 1 - Benzene 3x1.2 mL 

USP1601168 Residual Solvent Class 1 - Carbon Tetrachloride 3x1.2 mL 

USP1601180 Residual Solvent Class 1 - 1,2-Dichloroethane 3x1.2 mL 

USP1601204 Residual Solvent Class 1 - 1,1-Dichloroethene 3x1.2 mL 

USP1601226 Residual Solvent Class 1 - 1,1,1-Trichloroethane 3x1.2 mL 

USP1601281 Residual Solvent Class 2 - Mixture A 3x1.2 mL 

USP1601292 Residual Solvent Class 2 - Mixture B 3x1.2 mL 

USP1601306 Residual Solvent Class 2 - Mixture C 3x1.2 mL 

USP1601340 Residual Solvent Class 2 - Acetonitrile 3x1.2 mL 

USP1601361 Residual Solvent Class 2 - Chlorobenzene 3x1.2 mL 

USP1601383 Residual Solvent Class 2 - Chloroform 3x1.2 mL 

USP1601408 Residual Solvent Class 2 - Cyclohexane 3x1.2 mL 

USP1601420 Residual Solvent Class 2 - 1,2-Dichloroethene 3x1.2 mL 

USP1601441 Residual Solvent Class 2 - Methylene Chloride 3x1.2 mL 

USP1601463 Residual Solvent Class 2 - 1,2-Dimethoxyethane 3x1.2 mL 

USP1601485 Residual Solvent Class 2 - N,N-Dimethylacetamide 3x1.2 mL 

USP1601500 Residual Solvent Class 2 - N,N-Dimethylformamide 3x1.2 mL 

USP1601521 Residual Solvent Class 2 - 1,4-Dioxane 3x1.2 mL 

USP1601543 Residual Solvent Class 2 - 2-Ethoxyethanol 3x1.2 mL 

USP1601565 Residual Solvent Class 2 - Ethylene Glycol 3x1.2 mL 

USP1601587 Residual Solvent Class 2 - Formamide 3x1.2 mL 

USP1601601 Residual Solvent Class 2 - Hexane 3x1.2 mL 

USP1601623 Residual Solvent Class 2 - Methanol 3x1.2 mL 

USP1601645 Residual Solvent Class 2 - 2-Methoxyethanol 3x1.2 mL 

USP1601667 Residual Solvent Class 2 - Methylbutylketone 3x1.2 mL 

USP1601689 Residual Solvent Classe 2 - Methylcyclohexane 3x1.2 mL 

USP1601703 Residual Solvent Classe 2 - N-Methylpyrrolidone 3x1.2 mL 

USP1601725 Residual Solvent Class 2 - Nitromethane 3x1.2 mL 

USP1601747 Residual Solvent Class 2 - Pyridine 3x1.2 mL 

USP1601769 Residual Solvent Class 2 - Sulfolane 3x1.2 mL 

USP1601770 Residual Solvent Class 2 - Tetrahydrofuran 3x1.2 mL 

USP1601780 Residual Solvent Class 2 - Tetralin 3x1.2 mL 

USP1601805 Residual Solvent Class 2 - Toluene 3x1.2 mL 

USP1601827 Residual Solvent Class 2 - Trichloroethylene 3x1.2 mL 

USP1601849 Residual Solvent Class 2 - Xylenes 3x1.2 mL 

USP1602003 Resorcinol 200 mg 

USP1602706 Ribavirin 200 mg 

USP1603006 Riboflavin (Vitamin B 2) 500 mg 

New USP1603108 Ribose 300 mg 

USP1603800 Rifabutin 50 mg 

USP1604009 Rifampin 300 mg 

USP1604202 Rifampin Quinone 50 mg 

USP1604508 Rimantadine HCl 300 mg 

USP1604600 Rimexolone 100 mg 

New USP1604654 Risperidone 200 mg 

New USP1604665 Risperidone System Suitability Mixture 10 mg 

USP1604701 Ritodrine HCl 200 mg 

USP1604803 Ritonavir 200 mg 

USP1604814 Ritonavir Related Compounds Mixture 50 mg 




USP1605500 Ropivacaine HCl 200 mg 

USP1605512 

USP1605523 

Ropivacaine Related Compound A 

2,6-dimethylaniline hydrochloride 

Ropivacaine Related Compound B 

(R)-(+)-1-Propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)- 

amide hydrochloride monohydrate 

USP1606208 Roxarsone 200 mg 

USP1606503 Rutin 100 mg 

USP1607007 Saccharin 200 mg 

New USP1607029 Saccharin Calcium 100 mg 

USP1607040 Saccharin Sodium 100 mg 

USP1608000 Salicylamide 200 mg 

USP1609002 Salicylic Acid 125 mg 

USP1609013 

USP1609024 

USP1609501 

Salicylic Acid Related Compound A 

4-hydroxybenzoic acid 

Salicylic Acid Related Compound B 

4-hydroxyisophthalic acid 

Salicylic Acid Tablets 

Dissolution Calibrator, Non-disintegrating 

25 mg 

50 mg 

100 mg 

100 mg 

30 tablets 

USP1609807 Salsalate 125 mg 

USP1609829 Saquinavir Mesylate 200 mg 

USP1609831 

Saquinavir Related Compound A 

N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-Dasparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide 

USP1610001 Scopolamine HBr 250 mg 

USP1610090 Scopoletin 20 mg 

USP1611004 Secobarbital Controlled Substance CII 200 mg 

USP1611900 Selegiline HCl 200 mg 

USP1611955 Selenomethionine 100 mg 

USP1612007 Sennosides 500 mg 

USP1612404 Sesame Oil (AS) 2x1 mL 

USP1612415 

USP1612426 

Sesame Oil Related Compound A 

1,2-dilinoleoyl-3-oleoyl-rac-glycerol 

Sesame Oil Related Compound B 

1,2-dilinoleoyl-3-palmitoyl-rac-glycerol, PLL 

25 mg 

3x6 mg 

3x6 mg 

USP1612506 L-Serine 200 mg 

USP1612540 Sevoflurane 1 mL 

USP1612550 

USP1612572 

USP1612594 

Sevoflurane Related Compound A 

1,1,3,3,3-Pentafluoroisopropenyl fluoromethyl ether 

Sevoflurane Related Compound B 

1,1,1,3,3,3-hexafluoro-2-methoxypropane 

Sevoflurane Related Compound C 

1,1,1,3,3,3-hexafluoro-2-propanol 

0.2 mL 

0.2 mL 

0.2 mL 

USP1612608 Silver Sulfadiazine 200 mg 

USP1612630 Silybin 50 mg 

USP1612641 Silydianin 20 mg 

USP1612652 Simethicone 50 g 

USP1612700 Simvastatin 200 mg 

USP1612801 Sisomicin Sulfate 500 mg 

USP1612947 Beta-Sitosterol 300 mg 

USP1613407 Sodium Acetate (AS) 1 g 

USP1613509 Sodium Ascorbate 200 mg 

USP1613564 Sodium Benzoate 1 g 

USP1613655 Sodium Bicarbonate (AS) 3 g 

USP1613600 Sodium Butyrate 25 mg 




USP1613757 Sodium Carbonate Anhydrous (AS) 1 g 

USP1613804 Sodium Chloride (AS) 1 g 

USP1613859 Sodium Citrate (AS) 1 g 

USP1614002 Sodium Fluoride 1 g 

USP1614308 Sodium Lactate 200 mg 

USP1614363 Sodium Lauryl Sulfate (AS) 1 g 

USP1614396 Sodium Metabisulfite (AS) 1 g 

USP1614454 Sodium Nitrite (AS) 1 g 

USP1614501 Sodium Nitroprusside 500 mg 

USP1614603 Sodium Propionate 200 mg 

USP1614636 Sodium Salicylate 500 mg 

USP1614669 Sodium Starch Glycolate Type A 400 mg 

USP1614670 Sodium Starch Glycolate Type B 400 mg 

USP1614705 Sodium Stearyl Fumarate 200 mg 

USP1614807 Sodium Sulfate Anhydrous (AS) 1 g 

USP1615107 Sodium Thiosulfate (AS) 1 g 

USP1615708 Somatropin unit 

USP1615956 Sorbic Acid (AS) 1 g 

USP1616008 1,4-Sorbitan 300 mg 

USP1617000 Sorbitol 125 mg 

USP1617408 Sotalol HCl 300 mg 

USP1617419 

USP1617420 

USP1617430 

Sotalol Related Compound A 

N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride 

Sotalol Related Compound B 

N(4-Formylphenyl)methanesulfonamide 

Sotalol Related Compound C 

N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide HCl 

USP1618003 Spectinomycin HCl 200 mg 

USP1619006 Spironolactone 125 mg 

USP1619017 

Spironolactone Related Compound A 

Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21,17-carbolactone) (AS) 

50 mg 

50 mg 

50 mg 

100 mg 

USP1619505 Squalane 500 mg 

USP1620005 Stanozolol Controlled Substance CIII 200 mg 

USP1620209 Stavudine 250 mg 

USP1620220 Stavudine System Suitability Mixture 20 mg 

USP1621008 Stearic Acid 500 mg 

USP1621507 Stearoyl Polyoxyglycerides 100 mg 

USP1622000 Stearyl Alcohol 125 mg 

USP1623003 Streptomycin Sulfate 200 mg 

USP1623502 Succinylcholine Chloride 500 mg 

USP1623604 Succinylmonocholine Chloride 150 mg 

USP1623626 Sucralose 400 mg 

USP1623637 Sucrose 100 mg 

New USP1623615 Sucrose Octaacetate 500 mg 

USP1623648 Sufentanil Citrate Controlled Substance CII 25 mg 

USP1623670 Sulbactam 250 mg 

USP1623681 Sulconazole Nitrate 200 mg 

USP1623706 Sulfabenzamide 200 mg 

USP1623808 Sulfacetamide 300 mg 

USP1624006 Sulfacetamide Sodium 500 mg 

USP1624505 Sulfachlorpyridazine 200 mg 

USP1625009 Sulfadiazine 200 mg 




USP1626001 Sulfadimethoxine 200 mg 

USP1626500 Sulfadoxine 200 mg 

USP1628007 Sulfamerazine 500 mg 

USP1629000 Sulfamethazine 1 g 

USP1630009 Sulfamethizole 200 mg 

USP1631001 Sulfamethoxazole 200 mg 

USP1631500 Sulfamethoxazole N 4-glucoside 25 mg 

USP1632004 Sulfanilamide 5 g 

USP1633007 Sulfanilamide Melting Point Standard (Approximately 165°C) 500 mg 

USP1633506 Sulfanilic Acid 200 mg 

USP1634000 Sulfapyridine 200 mg 

USP1635002 Sulfapyridine Melting Point Standard (Approximately 191°C) 1 g 

USP1635206 Sulfaquinoxaline 200 mg 

USP1635228 

Sulfaquinoxaline Related Compound A 

N1-N2-diquinoxalin-2-ylsulfanilamide 

USP1636005 Sulfasalazine 125 mg 

USP1636504 Sulfathiazole 350 mg 

USP1637008 Sulfinpyrazone 200 mg 

USP1638000 Sulfisoxazole 200 mg 

USP1639003 Sulfisoxazole Acetyl 200 mg 

USP1642008 Sulindac 200 mg 

USP1642019 

Sulindac Related Compound A 

trans-sulindac 

USP1642100 Sulisobenzone 500 mg 

USP1642154 Sumatriptan 50 mg 

USP1642201 Sumatriptan Succinate 200 mg 

USP1642212 

USP1642223 

Sumatriptan Succinate Related Compound A 

[3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol- 

5-yl]-N-methylmethansulfonamide, succinate Salt 

Sumatriptan Succinate Related Compound C 

[3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]- 

N-methylmethanesulfonamide succinate salt 

USP1642256 Sumatriptan Succinate Related Impurities 25 mg 

USP1642507 Suprofen 200 mg 

USP1642700 Tacrine HCl 500 mg 

USP1642904 Tagatose 200 mg 

USP1643000 Talbutal Controlled Substance CIII 250 mg 

USP1643306 Tamoxifen Citrate 200 mg 

USP1643328 Tannic Acid (AS) 2 g 

USP1643340 Tartaric Acid (AS) 1 g 

USP1643361 Taurine 100 mg 

New USP1643383 Tazobactam 200 mg 


Tazobactam Related Compound A 

2-amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid 

USP1643408 Temazepam Controlled Substance CIV 200 mg 

USP1643452 Terazosin HCl 200 mg 

USP1643463 

USP1643474 

USP1643485 

Terazosin Related Compound A 

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride 

Terazosin Related Compound B 

1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine 

Terazosin Related Compound C 

1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride 

USP1643500 Terbutaline Sulfate 125 mg 

25 mg 

20 mg 

15 mg 

50 mg 

20 mg 

50 mg 

50 mg 

25 mg 




USP1643510 

Terbutaline Related Compound A 

tert-butylamino-3,5-dihydroxyacetophenone sulfate 

USP1643703 Terconazole 200 mg 

USP1643805 Terfenadine 200 mg 

USP1643907 

USP1643929 

Terfenadine Related Compound A 

1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butanone 

Terfenadine Related Compound B 

Terfenadine-N-oxide 

50 mg 

100 mg 

USP1644003 Terpin Hydrate 750 mg 

USP1645006 Testolactone Controlled Substance CIII 125 mg 

USP1646009 Testosterone Controlled Substance CIII 125 mg 

USP1647001 Testosterone Cypionate Controlled Substance CIII 200 mg 

USP1648004 Testosterone Enanthate Controlled Substance CIII 200 mg 

USP1649007 Testosterone Propionate Controlled Substance CIII 200 mg 

USP1650006 Tetracaine HCl 200 mg 

USP1651009 Tetracycline HCl 200 mg 

New USP1651621 Delta-9-Tetrahydrocannabinol Controlled Substance 1 mL 

New USP1090014 Exo-tetrahydrocannabinol Controlled Substance 1 mL 

USP1652001 Tetrahydrozoline HCl 200 mg 

USP1652500 Thalidomide 200 mg 

USP1653004 Theophylline 200 mg 

USP1655000 Thiabendazole 100 mg 

USP1656002 Thiamine HCl (Vitamin B 1 HCl) 500 mg 

USP1656308 Thiamylal Controlled Substance CIII 200 mg 

USP1657005 Thiethylperazine Malate 200 mg 

USP1658008 Thiethylperazine Maleate 200 mg 

USP1659000 Thimerosal 500 mg 

USP1660000 Thioguanine 200 mg 

USP1661002 Thiopental Controlled Substance CIII 250 mg 

USP1662504 Thioridazine 200 mg 

USP1663008 Thioridazine HCl 200 mg 

USP1663700 Thiostrepton 200 mg 

USP1664000 Thiotepa 500 mg 

USP1665003 Thiothixene 250 mg 

USP1666006 (E)-Thiothixene 100 mg 

USP1667100 Thonzonium Bromide 200 mg 

USP1667202 L-Threonine 200 mg 

USP1667213 Thymol 500 mg 

USP1667280 Tiagabine Hydrochloride 300 mg 

USP1667224 

USP1667235 

Tiagabine Related Compound A 

(R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, HCl 

Racemic Tiagabine Hydrochloride Mixture 

(S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, HCl 

USP1667355 Tiamulin 100 mg 

USP1667290 Tiamulin Fumarate 250 mg 

USP1667304 Ticarcillin Monosodium Monohydrate 350 mg 

USP1667337 

Tiamulin Related Compound A 

Tosyl pleuromutilin 

USP1667359 Tiletamine HCl 200 mg 

USP1667370 Tilmicosin 400 mg 

USP1667406 Timolol Maleate 200 mg 

USP1667520 Tinidazole 200 mg 

50 mg 

15 mg 

25 mg 

50 mg 




USP1667530 

USP1667541 

Tinidazole Related Compound A 

2-methyl-5-nitroimidazole 

Tinidazole Related Compound B 

(1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) 

100 mg 

USP1667439 Tioconazole 200 mg 

USP1667450 

USP1667461 

USP1667472 

Tioconazole Related Compound A 

1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole HCl 

Tioconazole Related Compound B 

1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole HCl 

Tioconazole Related Compound C 

1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole HCl 

USP1667585 Titanium Dioxide (AS) 1 g 

New USP1667905 Tizanidine Hydrochloride 200 mg 

USP1667916 

USP1667924 

USP1667938 

Tizanidine Related Compound A 

4-amino-5-chloro-2,1,3-benzothiadiazole 

Tizanidine Related Compound B 

N-acetyltizanidine 

Tizanidine Related Compound C 

1-acetylimidazolidine-2-thione 

USP1667508 Tobramycin 350 mg 

USP1667552 Tocainide HCl 125 mg 

USP1667600 Alpha Tocopherol (Vitamin E Alcohol) 250 mg 

USP1667701 Alpha Tocopheryl Acetate (Vitamin E Acetate) 250 mg 

USP1667803 Alpha Tocopheryl Acid Succinate (Vitamin E Succinate) 250 mg 

USP1668001 Tolazamide 200 mg 

USP1669004 Tolazoline HCl 300 mg 

USP1670003 Tolbutamide 200 mg 

USP1670207 Tolcapone 200 mg 

USP1670218 

USP1670229 

Tolcapone Related Compound A 

4'-methyl-3,4-dihydroxybenzophenone 

Tolcapone Related Compound B 

4-hydroxy-3-methoxy-4'-methyl-5-nitrobenzophenone 

USP1670502 Tolmetin Sodium 500 mg 

USP1671006 Tolnaftate 200 mg 

USP1672010 o-Toluenesulfonamide 200 mg 

USP1672020 p-Toluenesulfonamide 200 mg 

New USP1672206 Topiramate 200 mg 

USP1672210 

Topiramate Related Compound A 

2,3,4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose 

USP1672304 Torsemide 200 mg 

USP1672315 

USP1672326 

USP1672337 

Torsemide Related Compound A 

4-[(3-methylphenyl)amino]-3-pyridinesulfonamide 

Torsemide Related Compound B 

N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide 

Torsemide Related Compound C 

N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide 

USP1672803 Transplatin 25 mg 

USP1673500 Trazodone HCl 200 mg 

New USP1673715 Trehalose 400 mg 

USP1673806 Trenbolone Controlled Substance CIII 50 mg 

USP1673828 Trenbolone Acetate Controlled Substance CIII 200 mg 

USP1674004 Tretinoin 5x30 mg 

USP1675007 Triacetin 1 g 

USP1676000 Triamcinolone 250 mg 

USP1677002 Triamcinolone Acetonide 500 mg 

20 mg 

25 mg 

25 mg 

25 mg 

50 mg 

50 mg 

50 mg 

25 mg 

25 mg 

25 mg 

75 mg 

75 mg 

75 mg 




USP1678005 Triamcinolone Diacetate 350 mg 

USP1679008 Triamcinolone Hexacetonide 200 mg 

USP1680007 Triamterene 200 mg 

USP1680506 Triazolam Controlled Substance CIV 200 mg 

USP1680608 Tributyl Citrate 500 mg 

USP1680801 Trichlorfon 200 mg 

USP1681000 Trichlormethiazide 200 mg 

USP1682206 Triclosan 200 mg 

USP1682217 Triclosan Related Compounds Mixture A 3x1.2 mL 

USP1683005 Tridihexethyl Chloride 200 mg 

USP1683504 Trientine HCl 125 mg 

USP1683606 Triethyl Citrate 500 mg 

USP1685000 Trifluoperazine HCl 200 mg 

USP1685500 2-[N-(2,2,2-Trifluoro-ethyl)amino-5]-chlorobenzophenone 25 mg 

USP1686003 Triflupromazine HCI 200 mg 

USP1686309 Trifluridine 200 mg 

USP1686310 

Trifluridine Related Compound A 

5-Carboxy-2'-deoxyuridine 

USP1687006 Trihexyphenidyl HCl 200 mg 

USP1689001 Trimeprazine Tartrate 200 mg 

USP1690000 Trimethadione 200 mg 

USP1692006 Trimethobenzamide HCl 500 mg 

USP1692505 Trimethoprim 300 mg 



Trimethoprim Related Compound A 

4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol (AS) 

Trimethoprim Related Compound B 

(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone 

New USP1692709 Trimipramine Maleate 50 mg 


Trimipramine Related Compound A 

dehydro trimipramine 

USP1693009 Trioxsalen 200 mg 

USP1695004 Tripelennamine HCl 200 mg 

USP1696007 Triprolidine HCl 500 mg 

USP1696109 Triprolidine HCl Z-Isomer 100 mg 

USP1696200 Trisalicylic Acid 100 mg 

USP1696958 Trolamine 3 mL 

USP1697000 Troleandomycin 250 mg 

USP1698002 Tromethamine 125 mg 

USP1699005 Tropicamide 200 mg 

USP1700002 Trypsin Crystallized 300 mg 

USP1700501 L-Tryptophan 200 mg 

USP1702008 Tubocurarine Chloride 250 mg 

USP1703805 Tylosin 250 mg 

USP1703850 Tylosin Tartrate 100 mg 

USP1704003 Tyloxapol 600 mg 

USP1705006 L-Tyrosine 500 mg 

USP1705301 Ubidecarenone 200 mg 

USP1705312 Ubidecarenone for System Suitability 25 mg 

USP1705323 

Ubidecarenone Related Compound A 

Coenzyme Q 9 

USP1705505 Undecylenic Acid 200 mg 

USP1705800 Uracil Arabinoside 50 mg 

20 mg 

25 mg 

25 mg 

25 mg 

15 mg 




USP1706698 Urea 200 mg 

USP1706701 Urea C 13 100 mg 

USP1707806 Ursodiol 125 mg 

USP1707908 Valerenic Acid 15 mg 

USP1708503 L-Valine 200 mg 

USP1708707 Valproic Acid 500 mg 

USP1708729 

USP1708718 

Valproic Acid Related Compound A 

Diallylacetic Acid 

Valproic Acid Related Compound B 

(2RS)-2-(1-methylethyl) pentanoic acid (AS) 

0.25 mL 

USP1708762 Valsartan 350 mg 

USP1708773 


USP1708795 

Valsartan Related Compound A 

(R)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-methyl)-valine 

Valsartan Related Compound B 

(S)-N-butyryl-N-{[2'-(1-H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine 

Valsartan Related Compound C 

(S)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-methyl)-valine benzyl ester 

USP1709007 Vancomycin HCl 4 vials 

USP1709018 Vancomycin B with Monodechlorovancomycin 350 mg 

USP1710006 Vanillin 200 mg 

USP1711009 Vanillin Melting Point Standard (Approximately 82°C) 1 g 

USP1711155 Vecuronium Bromide 50 mg 

USP1711166 




Vecuronium Bromide Related Compound A 

3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan 

Vecuronium Bromide Related Compound B 

Piperidinium,1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy- 

2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide 

Vecuronium Bromide Related Compound C 

[Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy- 

2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide] 

Vecuronium Bromide Related Compound F 

Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy- 

2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide 

USP1711202 Verapamil HCl 200 mg 

USP1711304 

USP1711406 

USP1711428 



Verapamil Related Compound A 

3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile 

monoHCl 

Verapamil Related Compound B 

alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxy-alpha- 

(1-methylethyl)-benzeneacetonitrile monohydrochloride 

Verapamil Related Compound D 

5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)- 

2-(1-methylethyl)pentanenitrile]hydrochloride 

Verapamil Related Compound E 

3,4-dimethoxybenzaldehyde 

Verapamil Related Compound F 

3,4-Dimethoxybenzyl alcohol 

50 mg 

10 mg 

10 mg 

10 mg 

25 mg 

15 mg 

15 mg 

15 mg 

50 mg 

50 mg 

50 mg 

50 mg 

150 mg 

USP1711461 Verteporfin 200 mg 

USP1711472 

Verteporfin Related Compound A 

(+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25Hbenzo[b]prophine-9,13-dipropanoic 

Acid 

USP1711508 Vidarabine 200 mg 

USP1713004 Vinblastine Sulfate 50 mg 

USP1714007 Vincristine Sulfate 50 mg 

USP1714506 Vinorelbine Tartrate 200 mg 

USP1714528 

Vinorelbine Related Compound A 

4-O-Deacetylvinorelbine Tartrate 

USP1715000 Viomycin Sulfate 200 mg 

50 mg 

25 mg 




USP1716002 Vitamin A unit 

USP1717504 Vitamin D Assay System Suitability 1.5 g 

USP1717708 Vitexin 30 mg 

USP1719000 Warfarin 200 mg 

USP1719102 

Warfarin Related Compound A 

3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one 

USP1720000 Xanthanoic Acid 100 mg 

USP1720203 Xanthone 100 mg 

USP1720407 Xylazine 200 mg 

USP1720429 Xylazine HCl 200 mg 

USP1720600 Xylitol 1 g 

USP1721002 Xylometazoline HCl 125 mg 

USP1722005 Xylose 1 g 

USP1724000 Yohimbine HCl 200 mg 

USP1724306 Zalcitabine 200 mg 

USP1724317 

Zalcitabine Related Compound A 

2',3'-Didehydro-2',3'-dideoxycytidine 

USP1724500 Zidovudine 400 mg 

USP1724521 

USP1724532 

Zidovudine Related Compound B 

3'-chloro-3'-deoxythymidine 

Zidovudine Related Compound C 

Thymine 

50 mg 

50 mg 

25 mg 

100 mg 

USP1724656 Zileuton 150 mg 

USP1724667 

USP1724678 

USP1724689 

Zileuton Related Compound A 

N-(1-Benzo[b]thien-2-ylethyl)urea 

Zileuton Related Compound B 

2-(Benzo[b]thien-2-oyl)benzo[b]thiophene 

Zileuton Related Compound C 

1-Benzo[b]thien-2-ylethanone 

USP1724747 Zinc Oxide (AS) 2 g 

USP1724769 Zinc Sulfate (AS) 1 g 

USP1724805 Zolazepam HCl 500 mg 

50 mg 

50 mg 

50 mg 


ATCC microbiology products 


As a scientist you know the importance of using the best materials to support your quality control programme. 

As Europe’s only officially authorized distributor of ATCC ® cultures, LGC Standards can supply all ATCC 

organisms specified in the pharmacopoeia. 

ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures 

to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of 

biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, 

contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never 

subcultured or transferred in any way from ATCC’s strains and our European stock-holding means orders 

are usually filled within 3 - 5 working days. 

So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, 

or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with 

authentic, high-quality ATCC materials - exclusively from LGC Standards. 


USP27 - Chondroitin sulfate sodium Monograph 

ATCC-11437 Clostridium sporogenes amp. 

USP27 - Oil- and water-soluble vitamins with minerals tablets Monograph 

ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp. 

ATCC-8014 Lactobacillus plantarum 17-5 amp. 

USP27 - Penicillamine Monograph 

ATCC-9341 Kocuria rhizophila amp. 

USP27 - Penicillin G Procaine and novobiocin sodium intramammary infusion...... 

ATCC-12692 Staphylococcus aureus ss.aureus amp. 

USP27 - Sargraostim Monograph 

ATCC-CRL-2003 TF-1 Cells amp. 

USP27 - Tetracycline hydrochloride and novobiocin sodium tablets Monograph 

ATCC-10536 Escherichia coli amp. 

USP27 - Water-soluble vitamins capsules Monograph 

ATCC-8042 Pediococcus acidilactici amp. 

USP27 Antimicrobial effectiveness testing 

ATCC-16404 Aspergillus niger amp. 

ATCC-10231 Candida albicans amp. 


ATCC-9027 Pseudomonas aeruginosa amp. 

ATCC-6538 Staphylococcus aureus ss. aureus amp. 

USP27 Biological indicator for dry-heat sterilization, paper carrier 

ATCC-9372** Bacillus subtilis amp. 

USP27 Biological indicator for ethylene oxide sterilization, paper carrier 


USP27 Biological indicator for steam sterilization, paper carrier 

ATCC-7953** Bacillus stearothermophilus amp. 

ATCC-12980 Bacillus stearothermophilus amp. 

USP27 Biological indicator for steam sterilization, self contained 


ATCC-12980 Bacillus stearothermophilus amp. 

USP27 Sterility tests 


ATCC-6633 Bacillus subtilis amp. 

ATCC-8482 Bacteroides vulgatus amp. 










USP27 Antibiotics assays 


ATCC-4617 Bordetella bronchiseptica amp. 

ATCC-10541 Enterococcus hirae (as Streptococcus faecalis) amp. 


ATCC-10031 Klebsiella pneumoniae ss. pneumoniae amp. 


ATCC-10240 Micrococcus luteus amp. 

ATCC-607 Mycobacterium smegmatis amp. 


ATCC-2601 Saccharomyces cerevisiae amp. 




ATCC-12228 Staphylococcus epidermidis amp. 

USP27 Biological reactivity tests, in-vitro amp 

ATCC-CCL-1 L-929 mammalian fibroblasts NCTC Clone 929 amp. 

USP27 Calcium pantothenate assay 


USP27 Dexpanthenol assay 

ATCC-8042 Pediococcus acidilactici amp. 

USP27 Vitamin B12 activity assay 

ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp. 

USP27 Niacin or niacinamide assay 


USP27 Analytical methodologies 

ATCC-VR-1448 Hybrid Moloney Amphotropic murine leukemia virus amp. 

ATCC-VR-1450 Hybrid Moloney Amphotropic murine leukemia virus amp. 

USP27 Sterilzation and sterility assurance of compendial articles 

ATCC-27142** Bacillus pumilus amp. 



ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp. 

ATCC-14756 Serratia marcescens amp. 

USP27 Microbial enumeration tests - Dietary supplements 





ATCC-13311 Salmonella choleraesuis ss. choleraesuis serotype typhimurium (as Salmonella typhimurium) amp. 


** = Alternative strain 

All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to 

confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures 

as described in the Pharmacopoeia. 


European 

Pharmacopoeia 

Certified liquids 

for viscosity 

measurements 

International 

commission on 

pharmaceutical 

enzymes 

European 

pharmacopoeia 

reagents 



From Acebutolol 

to Zopiclone - 

2,100 pharmaceutical 

impurities 

LGC Standards offers over 2,100 reference standards for 

pharmaceutical impurities to support the pharmaceutical 

industry worldwide. We have a technical support team 

and expert customer service to aid you with any specific 

query you may have. 

• Impurities linked to the European Pharmacopoeia 

(EP) wherever possible 

• Customised pharmaceutical impurities created on 

request 

• Supply of mg or g quantities 

• Detailed certificates of analysis provided 

• Tailored certificates with additional documentation 

available 

• Assistance in finding the right material to suit your 

analyses 

For further information or to receive any one of our 

catalogues please contact your local office or visit 

our website. 

Acebutolol 

Clotrimazole 

Ethinylestradiol 

Flucloxacillin 

Ibuprofen 

Naproxen 

Omeprazole 

Piroxicam 

Sildenafil 

Testosterone 

Verapamil 

Zopiclone 


European Pharmacopoeia 

Background 


The European Pharmacopoeia (EP) Commission includes in its membership delegates from nations who 

have adopted the European Pharmacopoeia. 

The EP Commission is in charge of judging the suitability of monographs. Prior to release, a new monograph 

must be adopted by the EP Commission, and then published in the annual ‘Fascicule’. Member States then 

officially adopt the new monograph on 1 st January of the following year. 

To support the monographs of the European Pharmacopoeia, a collection of reference substances has 

been made available which includes: 

1. Current, official, European Pharmacopoeia Chemical Reference Substances (EP CRS) and 

Biological Reference Preparations (BRP) 

2. Reference Spectra 

3. Other reference preparations, including Enzymes and Substrates from the 

International Commission on Pharmaceutical Enzymes and Certified Viscosity Standards 

from Van Swinden Laboratories. 

4. With supplement 4.3, the revised EP general method 2.2.6 replaces CRS reference liquids with 

certified reference materials available from suppliers of chemical reagents or materials certified 

for metrology. Ten liquid CRMs, certified by the Physical Chemistry Division of the Central Office 

of Measures (GUM), Warsaw in Poland, cover the wide range of refractive index from 1,333 

(water) to 1,657 (1-bromonaphthalene). More detailed information is given in the chapter 

"Dyes and refractive index CRMs" of this catalogue. 

5. European Pharmacopoeia Reagents. 

New lists of EP CRS/BRP are published three times a year. The list in this catalogue is taken from 

EP list No. 49 of August 2007. 

Relationship with other pharmacopoeias in Europe 

Any reference substance, spectra or preparation required for a new EP monograph, is made available as 

soon as the monograph comes into force. 

Many of the member countries of the European Pharmacopoeia Commission have adopted the EP in full, 

and their monographs require only EP CRS/BRP. When an EP monograph is adopted by the pharmacopoeia 

of a member state of the Council of Europe then any reference material that may have been available from 

a national pharmacopoeia, e.g. BP or PF, will usually be discontinued in favour of the EP reference 

substance. However, a number of member countries of the EP Commission maintain national 

pharmacopoeial monographs, especially for finished dosage forms, which require the use of separate 

reference substances. 

A separate chapter in this catalogue includes lists of the reference substances produced for the British, 

French, Swiss and International pharmacopoeia monographs. The International Pharmacopoeia (IP) 

reference substances are described in the section referring to the WHO (World Health Organization). 


European Pharmacopoeia reference substances and preparations are selected and verified by the EP 

laboratories as being suitable for the use as prescribed in the relevant monograph of the European 

Pharmacopoeia. 

Since CRS and BRP are officially certified by the European Pharmacopoeia Commission, it should be 

noted that neither certificates of analysis nor data not relevant to the use of the products as defined by 

the EP monograph are provided with the reference product or substance. 



Storage, shelf life and expiry dates 

European Pharmacopoeia CRS/BRP are subject to regular inspection and repeated analysis by EP scientific 

staff. Each EP CRS/BRP is, on receipt by the customer, fit for the intended use. 

No expiry date is indicated on the reference materials because the products or substances comply with 

the requirements of the corresponding monograph and are monitored regularly. When batches are to be 

changed, the EP CRS catalogue shows the date on which the lot will no longer be official. 

In specific cases for reasons related to filling or labeling, sub-batches are obtained from the same batch of 

bulk material. However, all the necessary precautions are taken in order to guarantee that the quality and 

specifications of the sub-batches do not differ from one to another. The EP changed the labeling structure 

of the sub-batches recently. Sub-batches are now labeled for example as 2.1, 2.2, 2.3 instead of 2a, 2b, 2c. 

The EP is also currently over-labelling all its reference standards vials with a secondary label. This new 

secondary label is useful for customs purposes as it can be peeled off. It can also be stuck onto your 

laboratory book to prove the use of the reference standard. All the required information to perform the 

tests described in the European Pharmacopoeia monographs are stated on the primary label. 

EP recommends only sufficient material should be purchased for immediate use and that unopened vials 

should be stored in the dark unless otherwise stated. Whilst most EP CRS/BRP can be shipped at ambient 

temperature, certain items have to be maintained at controlled temperatures at all times and are subject to 

special shipping charges and storage conditions (details are available on request). 

Where no drying conditions are stated, the substance is to be used as received. 

Once opened, EP can no longer guarantee the stability of the material and any of the CRS/BRP not used 

should be disposed of and not kept for future use. 

Validation of secondary standards 

All secondary in-house working standards have to be validated against the CURRENT batch of the EP 

CRS/BRP, so we advise you to check that you have current batch numbers. 

As your supplier of choice, LGC Standards can provide lists of current batch numbers of EP 

CRS/BRP, so call us to receive these today. We can provide the same service for USP reference 

standards, which are listed in the USP chapter of this catalogue. Please take this opportunity to subscribe 

to this free service by contacting your local LGC Standards office. 

Proper use 

EP discontinued their use code number system as of January 2006. 

For information on the use of the substances please refer to the monograph or contact your local 

LGC Standards office. 

Opening 

For reference substances and preparations supplied in sealed glass ampoules the following technique is 

suitable for opening the ampoule: tap gently to collect the material at the lower end, score the ampoule with 

a file, heat a glass rod to white heat and apply firmly to the file mark. If the glass does not crack, deepen and 

extend the file mark, and repeat the process. Eye and hand protection MUST be used. 

Many reference substances are supplied as lyophilised material in a septum vial. No attempt should be 

made to open the vial and weigh out the powder. It is important to strictly follow the monograph instructions, 

reconstitute the material in a buffer solvent and handle the resultant solution volumetrically. 

Toxicity 

The potential toxicity of certain reference substances is such that special precautions should be taken to 

avoid contact. 

Such substances should be manipulated in a glove box. If this is not possible, gloves, eye protection and 

a mask should be worn. 

Following the guidelines suggested by the EP does not replace the need to carry out a full hazard 

assessment. 

Biological and blood products should be regarded as potentially hazardous to health and therefore used 

and disposed of according to established laboratory safety procedures. 

Controlled Substances 

The EP list contains substances subject to Controlled Substance regulations schedules. Special ordering 

procedures apply, so please contact LGC Standards for details and costs. 




EPY0000055 Acamprosate calcium - Reference Spectrum unit 

EPY0000116 

Acamprosate impurity A 

3-aminopropane-1-sulphonic acid 

EPY0000500 Acarbose 94.7 mg 

EPY0000354 Acarbose for identification 10 mg 

EPY0000427 Acarbose for peak identification 40 mg 

EPA0040000 Acebutolol hydrochloride 50 mg 

EPY0000359 

EPY0000127 

EPY0000128 

Acebutolol impurity B 

N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl) 

amino]propoxy]phenyl]acetamide (diacetolol) 

Acebutolol impurity C 

N-(3-acetyl-4-hydroxyphenyl)butanamide 

Acebutolol impurity I 

N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl) 

butanamide 

50 mg 

10 mg 

20 mg 

0.004 mg 

EPY0000056 Aceclofenac - Reference Spectrum unit 

EPY0000085 

New EPY0000086 

Aceclofenac impurity F 

benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate 

Aceclofenac impurity H 

[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy]acetic acid 

New EPY0000810 Acemetacin 100 mg 


Acemetacin impurity A 

4-chlorobenzoic acid 

EPA0050000 Acenocoumarol 20 mg 

EPA0070000 Acesulfame potassium 50 mg 

EPA0070020 

Acesulfame potassium impurity B 

5-chloro-6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide 

EPA0100000 Acetazolamide 100 mg 

EPY0000002 Acetylcholine chloride 50 mg 

EPA0150000 Acetylcysteine 50 mg 

EPA0152000 

EPA0153000 

Acetylcysteine impurity C 

N,N'-diacetyl-L-cystine 

Acetylcysteine impurity D 

N,S-diacetyl-L-cysteine 

EPY0000565 β-Acetyldigoxin 30 mg 

EPY0000642 β-Acetyldigoxin for peak identification 10 mg 

EPA0200000 Acetylsalicylic acid 100 mg 

EPA0208000 N-Acetyltryptophan 125 mg 

EPA0202000 N-Acetyltyrosine 200 mg 

EPY0000693 Acholeplasma laidlawii BRP 1 mL 

EPA0220000 Aciclovir 75 mg 

EPA0221000 

Aciclovir impurity A 

2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate 

EPA0225000 Acitretin 100 mg 

EPY0000360 Acriflavinium monochloride 1 mg 

EPA0230000 Adenine 50 mg 

EPA0230200 Adenosine 50 mg 

EPY0000110 Adipic acid 50 mg 

EPA0300000 Adrenaline tartrate 200 mg 

New EPY0000740 Adrenaline impurity mixture 0.005 mg 

New EPY0000707 Adrenaline tartrate with impurity A 15 mg 

EPA0325000 Alanine 50 mg 

New EPY0000728 Agnus castus fruit standardised dry extract 200 mg 

EPA0325100 Albendazole 50 mg 

EPA0325200 Alcuronium chloride 100 mg 

20 mg 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 

15 mg 




EPA0325450 Alfacalcidol 5 mg 

EPA0325451 Alfacalcidol - Reference Spectrum unit 

EPA1225000 Alfadex 150 mg 

EPA0325500 Alfentanil hydrochloride - Reference Spectrum unit 

EPA0325800 Alfuzosin hydrochloride 50 mg 

EPA0325801 

Alfuzosin impurity A 

N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)-amino]propyl] 

furan-2-carboxamide 

New EPY0000832 Alfuzosin for system suitability 10 mg 

EPA0349000 Allantoin 60 mg 

EPA0350000 Allopurinol 50 mg 

EPA0350010 

EPA0350020 

EPA0350030 

EPA0350040 

EPA0350050 

Allopurinol impurity A 

5-amino-1H-pyrazole-4-carboxamide 

Allopurinol impurity B 

5-formylamino-1H-pyrazole-4-carboxamide 

Allopurinol impurity C 

N-(4H-1,2,4-triazol-4-yl)1H-pyrazole-4-carboxamide 

Allopurinol impurity D 

ethyl 5-amino-1H-pyrazole-4-carboxylate 

Allopurinol impurity E 

ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate 

EPA0351000 Allylstrychnine bromide 10 mg 

EPY0000235 Almagate 25 mg 

EPY0000255 Almagate - Reference Spectrum unit 

EPA0357000 Alprazolam Controlled Substance 100 mg 

EPA0360000 Alprenolol hydrochloride 100 mg 

EPY0000054 Alprostadil 50 mg 

EPY0000606 Altizide 5 mg 

EPY0000687 Alverine citrate 5 mg 

EPY0000595 Alverine for peak identification 0.125 mg 

EPY0000607 

Alverine impurity D 

N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine 

EPA0363000 Amantadine hydrochloride 100 mg 

EPA0363700 Ambroxol hydrochloride 125 mg 

EPA0900000 Amfetamine sulphate - Reference Spectrum unit 

EPA0365000 Amidotrizoic acid dihydrate 100 mg 

EPA0368000 Amikacin 200 mg 

EPA0368010 

Amikacin Impurity A 

4-O-(3-amino-3-desoxy-alpha-D-glycopyranosyl)-6-O-(6-amino-6-desoxy-alpha-Dglucopyranosyl)-N1-[(2S)-4-amino-2-hydroxybutanoyl]-2-desoxy-L-streptamine 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 

20 mg 

10 mg 

2x10 mg 

EPA0365900 Amikacin sulphate 200 mg 

EPA0370000 Amiloride hydrochloride 100 mg 

EPY0000020 

Amiloride impurity A 

methyl-3,5-diamino-6-chloropyrazine-2-carboxylate 

EPY0000173 4-Aminobenzoic acid 60 mg 

EPA0420000 Aminocaproic acid 50 mg 

EPA0460000 7-Aminodesacetoxycephalosporanic acid 100 mg 

EPA0496000 Aminoglutethimide 125 mg 

EPA0496005 

EPA0496020 

Aminoglutethimide impurity A 

(3RS)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; 

(3-aminoglutethimide) 

Aminoglutethimide impurity D 

3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) (azoglutethimide) 

EPA0560000 5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid 20 mg 

EPA0575000 Amiodarone hydrochloride 100 mg 

10 mg 

20 mg 

10 mg 




EPY0000129 

EPY0000130 

Amiodarone impurity D 

(2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone 

Amiodarone impurity E 

(2-butyl-benzofuran-3-yl)-(4-hydroxyphenyl)methanone 

EPA0590000 Amisulpride 50 mg 

EPA0590004 

Amisulpride impurity B 

4-amino-N-[[(2RS )-1-ethylpyrrolidin-2-yl] methyl-5-(ethylsulphonyl)-2-hydroxybenzamine 

New EPY0000563 Amitriptyline hydrochloride 10 mg 

EPA0600000 Amitriptyline hydrochloride - Reference Spectrum unit 

EPY0000049 Amlodipine besilate 150 mg 

EPY0000302 Ammonio methacrylate copolymer (type A) - Reference Spectrum unit 

EPY0000303 Ammonio methacrylate copolymer (type B) - Reference Spectrum unit 

EPA0650000 Amobarbital Controlled Substance 500 mg 

EPA0700000 Amobarbital sodium Controlled Substance 500 mg 

EPA0800000 Amoxicillin trihydrate 100 mg 

EPY0000005 Amphotericin B 500 mg 

EPA1000000 Ampicillin (anhydrous) 250 mg 

EPA1100000 Ampicillin trihydrate 150 mg 

EPA1200000 Anhydrotetracycline hydrochloride 10 mg 

EPA1210000 Antazoline hydrochloride 50 mg 

EPY0000172 Apomorphine hydrochloride - Reference Spectrum unit 

EPA1220000 Alpha-apo-oxytetracycline 20 mg 

EPA1230000 Beta-apo-oxytetracycline 20 mg 

EPA1250000 Aprotinin solution BRP 0.5 mL 

EPA1269000 L-Arabinitol 10 mg 

New EPY0000806 Arbutin 100 mg 

EPA1270000 Arginine 50 mg 

EPY0000304 Arginine aspartate 20 mg 

EPA1271000 Arginine hydrochloride 50 mg 

EPY0000079 Articaine hydrochloride 100 mg 

EPY0000080 

EPY0000081 

Articaine impurity A 

methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2-carboxylate 

Articaine impurity E 

methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl] 

amino]thiophene-2-carboxylate 

EPA1300000 Ascorbic acid (Vitamin C) 100 mg 

New EPY0000800 Ascorbyl palmitate 10 mg 

EPA1315000 Ascorbyl palmitate - Reference Spectrum unit 

EPY0000305 Asparagine monohydrate 60 mg 

EPA1320000 Aspartame 40 mg 

EPA1321000 

Aspartame impurity A 

2-(5-benzyl-3,6-dioxopiperazin-2-yl)acetic acid (diketopiperazine) 

EPA1330000 Aspartic acid 50 mg 

EPA1335000 Astemizole 150 mg 

EPA1340000 Atenolol 100 mg 

EPA1341000 Atenolol for column validation 100 mg 

EPY0000424 Atracurium besilate 120 mg 

EPY0000503 Atracurium for impurity F identification 5 mg 

EPY0000504 Atracurium for peak identification 5 mg 

EPY0000231 Atropine - Reference Spectrum unit 

EPA1400000 Atropine sulphate 50 mg 

EPY0000230 Atropine for system suitability 0.4 mg 

EPY0000029 Azaperone 50 mg 

20 mg 

20 mg 

10 mg 

10 mg 

10 mg 

10 mg 




EPA1500000 Azathioprine 100 mg 

EPY0000326 Azelastine hydrochloride 25 mg 

EPY0000327 

EPY0000328 

EPY0000329 

Azelastine impurity B 

1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane 

Azelastine impurity D 

4-(4-chlorobenzyl)phthalazin-1(2H)-one 

Azelastine impurity E 

3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one 

EPY0000306 Azithromycin 120 mg 

EPY0000637 Azithromycin for peak identification 15 mg 

EPY0000641 Azithromycin for system suitability 0.05 mg 

EPY0000307 

EPY0000308 

Azithromycin impurity A 

6-demethylazithromycin 

Azithromycin impurity B 

3-deoxyazithromycin 

5 mg 

5 mg 

5 mg 

10 mg 

0.04 mg 

EPY0000285 B19 virus DNA for NAT testing BRP 150 mg 

EPB0070000 Bacampicillin hydrochloride 120 mg 

EPB0100000 Bacitracin zinc 150 mg 

EPB0200000 Baclofen 50 mg 

EPB0200050 

Baclofen impurity A 

(RS)-4-amino-3-(4-chlorophenyl)butyric acid lactam 

EPB0250000 Bambuterol hydrochloride 100 mg 

EPB0300000 Barbital Controlled Substance 500 mg 

EPY0000295 Basic butylated methacrylate copolymer - Reference Spectrum unit 

EPB0305000 Beclometasone dipropionate anhydrous 150 mg 

EPY0000351 Beclometasone dipropionate monohydrate 10 mg 

EPY0000352 Beclometasone dipropionate for system suitability 10 mg 

EPY0000469 Beclometasone dipropionate for peak identification 10 mg 

EPB0400000 Bendroflumethiazide 100 mg 

EPY0000564 

Bendroflumethiazide impurity A 

4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide 

EPY0000044 Benfluorex hydrochloride 50 mg 

EPY0000043 Benfluorex hydrochloride for system suitability 360 mg 

EPB0470000 Benperidol 100 mg 

EPB0477000 Benserazide hydrochloride 50 mg 

EPB0477010 

Benserazide impurity A 

(RS)-2-amino-3-hydroxypropanohydrazide 

EPB0490000 Benzarone 10 mg 

EPB0500000 Benzathine benzylpenicillin 125 mg 

New EPY0000775 Benzbromarone 10 mg 

EPB0505000 Benzbromarone - Reference Spectrum unit 

EPB0550000 Benzethonium chloride 100 mg 

EPB0600000 Benzocaine 50 mg 

EPY0000647 Benzophenone 40 mg 

EPY0000167 Benzyl alcohol 50 mg 

EPB0670000 Benzyl benzoate - Reference Spectrum unit 

EPB0680000 S-Benzylmercaptoacetyltriglycin 10 mg 

EPB0700000 Benzylpenicillin potassium 50 mg 

EPB0900000 Benzylpenicillin sodium 200 mg 

EPB0950000 Betadex 200 mg 

EPY0000391 Betahistine dihydrochloride 50 mg 

EPB0990000 Betahistine mesilate 100 mg 

EPB1000000 Betamethasone 75 mg 

50 mg 

5 mg 

20 mg 




EPB1030000 Betamethasone acetate 100 mg 

EPB1040000 Betamethasone diproprionate 100 mg 

EPB1045000 Betamethasone sodium phosphate 100 mg 

EPB1054000 Betamethasone-17-valerate 100 mg 

EPB1055000 Betamethasone-21-valerate 15 mg 

EPB1103000 Betaxolol hydrochloride 60 mg 

EPB1103100 

Betaxolol impurity A 

(RS)-3-(4-ethylphenoxy)-1-[(1-methylethyl)-amido]propan-2-ol 

EPB1115000 Bezafibrate 100 mg 

EPB1110000 Bifonazole 100 mg 

EPB1110004 

Bifonazole impurity B 

4-[(RS)-(biphenyl-4-yl)phenylmethyl]-1H-imidazole trifluoroacetate 

EPB1116000 Biotin (Vitamin H) 50 mg 

EPB1120000 Biperiden hydrochloride 60 mg 

EPB1121000 

Biperiden impurity A 

(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3- 

(piperidin-1-yl)propan-1-ol (endo form) 

EPB1130000 1,3-bis(2-acetyl-3-hydroxyphenoxy)-2-propanol 50 mg 

EPB1140000 Bisacodyl 50 mg 

EPY0000608 Bisacodyl for peak identification 10 mg 

New EPY0000694 Bisacodyl for system suitability 5 mg 

EPB1141000 Bleomycin sulphate 7 mg 

EPY0000434 Boldine 30 mg 

EPB1142000 Bordetella pertussis mouse antiserum BRP 0.5 mg 

EPB1143000 Bromazepam Controlled Substance 60 mg 

EPY0000645 Bromazepam for system suitability Controlled Substance 10 mg 

EPB1145000 Bromhexine hydrochloride 100 mg 

EPY0000200 

Bromhexine impurity C 

N-(2-aminobenzyl)-N-methylcyclohexanamine 

EPB1150000 Bromocriptine mesilate 30 mg 

EPY0000677 Bromocriptine mesilate for system suitability 5 mg 

EPB1152000 Bromperidol 100 mg 

EPB1152050 Bromperidol decanoate 60 mg 

EPB1153000 Brompheniramine maleate 100 mg 

EPY0000468 Brotizolam Controlled Substance 10 mg 

EPY0000470 

Brotizolam impurity B 

2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine 

(demethylbrotizolam) 

EPB1155000 Brucella melitensis Rev. 1 strain BRP 1 mg 

EPB1157300 Budesonide 110 mg 

EPB1156000 Bufexamac 100 mg 

EPB1157400 Buflomedil hydrochloride 100 mg 

EPB1157410 

Buflomedil impurity B 

4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one 

EPB1158000 Bumetanide 150 mg 

EPY0000309 

EPY0000310 

Bumetanide impurity A 

3-nitro-4-phenoxy-5-sulphamoylbenzoic acid 

Bumetanide impurity B 

3-amino-4-phenoxy-5-sulphamoylbenzoic acid 

EPB1160000 Bupivacaine hydrochloride 100 mg 

EPY0000088 

EPY0000089 

Bupivacaine impurity B 

(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 

Bupivacaine impurity E 

6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide 

10 mg 

10 mg 

30 mg 

10 mg 

10 mg 

20 mg 

5 mg 

5 mg 

20 mg 

20 mg 




EPB1160490 Buprenorphine - Reference Spectrum unit 

EPB1160500 Buprenorphine hydrochloride - Reference Spectrum unit 

EPB1168000 Buserelin 4.92 mg 

EPB1168020 D-His-Buserelin 0.5 mg 

EPY0000131 Buspirone hydrochloride 5 mg 

EPY0000471 Buspirone for system suitability 2 mg 

EPB1170000 Busulfan 50 mg 

EPB1217000 Butyl parahydroxybenzoate 50 mg 

EPB1212000 Butylhydroxyanisole 50 mg 

EPB1215000 

Butylhydroxytoluene 

Plastic additive 07 

EPY0000472 Cabergoline 100 mg 

EPC0100000 Caffeine 70 mg 

New EPY0000787 Caffeine for system suitability 20 mg 

EPC0166000 Calcifediol 5 mg 

EPC0166001 Calcifediol - Reference Spectrum unit 

EPY0000499 Calcipotriol (anhydrous) - Reference Spectrum unit 

EPY0000473 Calcipotriol monohydrate 5 mg 

EPY0000474 Calcipotriol monohydrate - Reference Spectrum unit 

EPC0200000 Calcitonin (salmon) 2x0.98 mg 

EPY0000632 Calcitonin-Gly 0.4 mL 

EPC0200010 N-acetyl-cys1-calcitonin 0.1 mg 

EPC0225000 Calcitriol 10 mg 

EPC0226000 Calcitriol - Reference Spectrum unit 

EPC0249000 Calcium ascorbate - Reference Spectrum unit 

EPC0250000 Calcium folinate 100 mg 

EPC0299000 Calcium glucoheptonate 60 mg 

EPC0300000 Calcium gluconate 100 mg 

EPC0340000 Calcium levulinate dihydrate 250 mg 

EPC0350000 Calcium oxalate monohydrate 500 mg 

EPC0400000 Calcium pantothenate 60 mg 

EPC0405000 Camphor (racemic) 50 mg 

EPC0410000 Canrenone 50 mg 

EPC0426000 Caprylic acid 200 mg 

EPY0000671 Capsaicin 50 mg 

EPC0430000 Captopril 10 mg 

EPY0000113 Carbachol 50 mg 

EPC0450000 Carbamazepine 200 mg 

EPY0000033 Carbamazepine impurity A 

10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide 

(10,11-dihydrocarbamazepine) 

10 mg 

EPC0451000 Carbasalate calcium - Reference Spectrum unit 

EPC0455000 Carbenicillin sodium 50 mg 

EPC0460000 Carbidopa 50 mg 

EPC0465000 Carbimazole 100 mg 

EPC0470000 Carbocisteine 50 mg 

EPC0499900 Carbon dioxide - Reference Spectrum unit 

EPC0550000 Carboplatin - Reference Spectrum unit 

EPY0000475 Carboprost trometamol 40 mg 

EPY0000536 Carboprost trometamol - Reference Spectrum unit 

EPY0000035 Carisoprodol 50 mg 

50 mg 




EPY0000036 

Carisoprodol impurity A 

(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate 

EPC0580004 Carmustine - Reference Spectrum unit 

EPC0580010 

Carmustine impurity A 

1,3-bis(2-chloroethyl)urea 

EPY0000192 Carteolol hydrochloride - Reference Spectrum unit 

EPY0000193 Carteolol for system suitability 30 mg 

EPY0000075 Carvedilol - Reference Spectrum unit 

EPY0000103 

Carvedilol impurity C 

(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy) propan-2-ol 

EPC0600000 Casein BRP 100 g 

EPC0630000 Cefaclor 450 mg 

EPC0640000 Delta-3-Cefaclor 20 mg 

EPC0650000 Cefadroxil 250 mg 

EPC0675000 Cefalexin monohydrate 150 mg 

EPC0682000 Cefalotin sodium 100 mg 

EPY0000505 Cefalotin for impurity B identification 10 mg 

EPC0682300 Cefamandole nafate 125 mg 

EPY0000240 Cefapirin sodium 100 mg 

EPC0682400 Cefatrizine propylene glycol 150 mg 

EPC0682410 

Cefatrizine impurity A 

7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8-oxo-5-thia- 

1-azabicyclo[4.2.O]oct-2-ene-2-carboxylic acid(7-ACA triazole) 

EPC0682800 Cefazolin 150 mg 

EPY0000633 Cefepime dihydrochloride monohydrate 150 mg 

EPY0000634 Cefepime dihydrochloride monohydrate for system suitability 15 mg 

EPC0684000 Cefixime 200 mg 

EPC0684750 Cefoperazone dihydrate 100 mg 

EPC0684800 Cefoperazone sodium - Reference Spectrum unit 

EPY0000420 Cefotaxime acid 80 mg 

EPC0685000 Cefotaxime sodium 30 mg 

EPY0000506 Cefotaxime sodium for peak identification 10 mg 

EPC0688000 Cefoxitin sodium 250 mg 

EPC0690000 Cefradine 300 mg 

EPY0000568 Cefradine for peak identification 6 mg 

EPC0690500 Ceftazidime 200 mg 

EPC0690510 

Ceftazidime impurity A 

(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-1 

-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)-methyl] 

-5-thia-1-azabicyclo[4.2.O]oct-3-ene-2-carboxylate 

(delta-2-ceftazidime) 

EPC0691000 Ceftriaxone sodium 80 mg 

EPC0692000 

Ceftriaxone impurity A 

E-isomer 

EPC0694990 Cefuroxime axetil 60 mg 

EPC0695000 Cefuroxime sodium 150 mg 

EPY0000311 Celiprolol hydrochloirde 10 mg 

EPY0000312 

Celiprolol impurity I 

1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea 

10 mg 

20 mg 

10 mg 

60 mg 

15 mg 

10 mg 

0.02 mg 

EPY0000239 Celiprolol for peak identification 20 mg 

EPC0698000 Cellulose acetate - Reference Spectrum unit 

EPC0698005 Cellulose acetate butyrate - Reference Spectrum unit 

EPC0698020 Cellulose acetate phthalate - Reference Spectrum unit 

EPC0700000 Cephaeline hydrochloride 10 mg 




EPC0980650 Cetirizine dihydrochloride 100 mg 

EPC0980651 

Cetirizine impurity A 

(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine 

EPC0984100 Cetostearyl isononanoate - Reference Spectrum unit 

EPC0990000 Cetyl alcohol 250 mg 

EPY0000073 Cetyl palmitate 15 60 mg 

EPY0000074 Cetyl palmitate 95 50 mg 

EPC1000000 Cetylpyridinium chloride 50 mg 

EPC1050000 Chenodeoxycholic acid 125 mg 

EPY0000104 Chitosan hydrochloride 30 mg 

EPC1100000 Chlorambucil 100 mg 

EPC1200000 Chloramphenicol 500 mg 

EPC1300000 Chloramphenicol dipalmitate 100 mg 

EPC1350000 Chloramphenicol disodium disuccinate 25 mg 

EPC1400000 Chloramphenicol palmitate isomer 100 mg 

EPC1425000 Chloramphenicol sodium succinate 1.5 g 

EPC1435000 Chlorcyclizine hydrochloride 100 mg 

EPC1450000 Chlordiazepoxide Controlled Substance 2x50 mg 

EPC1500000 Chlordiazepoxide hydrochloride Controlled Substance 100 mg 

EPY0000476 

Chlordiazepoxide impurity A 

7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide 

EPC1510000 Chlorhexidine 50 mg 

EPC1520000 Chlorhexidine diacetate 10 mg 

EPC1540000 Chlorhexidine dihydrochloride 50 mg 

EPC1530000 Chlorhexidine for performance test 50 mg 

EPY0000569 Chlorogenic acid 20 mg 

EPC1600000 Chloromethylnitroimidazole 100 mg 

EPC1605000 (2-Chlorophenyl) diphenylmethanol 20 mg 

EPC2223030 

1-(4-Chlorophenyl)-1-phenylethanol 

Clemastine fumarate impurity C 

EPC1650000 Chloroquine sulphate 200 mg 

EPC1700000 Chlorothiazide 100 mg 

EPC1800000 Chlorphenamine maleate 100 mg 


EPY0000437 

Chlorphenamine impurity A 

2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile 

Chlorphenamine impurity C 

(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine 

10 mg 

10 mg 

20 mg 

0.01 mg 

EPC1900000 Chlorpromazine hydrochloride 200 mg 

EPY0000507 

EPY0000479 

EPY0000508 

Chlorpromazine impurity A 

3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide (chlorpromazine 

sulphoxide) 

Chlorpromazine impurity D 

3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (demethylchlorpromazine) 

Chlorpromazine impurity E 

2-chloro-10H-phenothiazine 

EPC1905000 Chlorpropamide 100 mg 

EPC1905020 

Chlorpropamide impurity B 

1,3-Dipropylurea 

EPC1915000 Chlorprothixene hydrochloride 50 mg 

EPC1950000 Chlortalidone 50 mg 

New EPY0000779 Chlortalidone for peak identification 1 mg 

EPC1950020 

Chlortalidone impurity B 

2-(4-chloro-3-sulfamoylbenzoyl)benzoic acid 

EPC2000000 Chlortetracycline hydrochloride 100 mg 

10 mg 

10 mg 

10 mg 

10 mg 

50 mg 

10 mg 




EPC2100000 Cholecalciferol 500 mg 

EPC2150000 Cholecalciferol for performance test 1 mL 

EPC2155000 Cholesterol 60 mg 

EPC2158000 Cholic acid 60 mg 

EPY0000280 Chondroitin sulphate sodium 250 mg 

EPY0000593 Chondroitin sulphate sodium (marine) 100 mg 

EPC2160000 Chymotrypsin BRP 100 mg 

EPY0000639 Cladribine 50 mg 

EPY0000609 Cladribine for peak identification 10 mg 

EPY0000610 

Cladribine impurity C 

2-chloro-7H-purin-6-amine 

New EPY0000758 Clozapine for peak identification 0.41 mg 

EPY0000040 Ciclopirox 100 mg 

EPC2162701 

EPC2162702 

Ciclopirox impurity A 

(RS)-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl) 

acetic acid 

Ciclopirox impurity B 

6-cyclohexyl-4-methyl-2H-pyran-2-one 

EPC2162700 Ciclopirox olamine 150 mg 

EPC2163000 Ciclosporin 120 mg 

EPY0000361 Ciclosporin for system suitability 5 mg 

EPC2170000 Cilastatin sodium 10 mg 

EPC2174000 Cilazapril 50 mg 

EPC2174002 

EPC2174005 

Cilazapril impurity A 

1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]amino] 

-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate 

Cilazapril impurity D 

(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10-oxo-octahydro-6Hpyridazino[1,2a][1,2]diazepine-1-carboxylic 

acid 

EPC2175000 Cimetidine 50 mg 

EPC2175500 Cimetidine hydrochloride 100 mg 

EPC2177000 Cinchocaine hydrochloride 60 mg 

EPY0000176 Cineole 180 mg 

EPC2180000 Cinnarizine 100 mg 

EPY0000362 Ciprofibrate 5 mg 

EPY0000363 Ciprofibrate for system suitability 5 mg 

EPY0000198 Ciprofloxacin 20 mg 

EPC2190000 Ciprofloxacin hydrochloride 100 mg 

EPY0000199 Ciprofloxacin hydrochloride for peak identification 10 mg 

EPC2190050 

Ciprofloxacin impurity A 

7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid 

(fluoroquinolonic acid) 

EPC2205000 Cisapride monohydrate 30 mg 

EPC2205100 Cisapride tartrate 100 mg 

EPC2210000 Cisplatin 150 mg 

EPA1202000 Citric acid (anhydrous) 50 mg 

EPC2219000 Citric acid monohydrate 50 mg 

EPY0000320 Clarithromycin 160 mg 

EPY0000321 Clarithromycin for peak identification 30 mg 

EPY0000269 Clazuril for system suitability 10 mg 

EPY0000262 Clazuril for veterinary use - Reference Spectrum unit 

EPC2221000 Clebopride malate 100 mg 

EPC2223000 Clemastine fumarate 100 mg 

EPC2248000 Clenbuterol hydrochloride 50 mg 

5 mg 

20 mg 

20 mg 

25 mg 

10 mg 

10 mg 




EPC2248010 

Clenbuterol impurity B 

1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanone (clenbuterol ketone) 

EPC2250000 Clindamycin hydrochloride 200 mg 

EPC2269000 Clindamycin phosphate 250 mg 

EPY0000364 Clioquinol 5 mg 

EPY0000205 Clobazam - Reference Spectrum unit 

EPY0000241 

Clobazam impurity A 

7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione 

EPY0000559 Clobetasol propionate 40 mg 

EPY0000570 Clobetasol for peak identification 2 mg 

EPY0000571 

Clobetasol impurity J 

(17R)-4'-chloro-5'-ethyl-9-fluoro-11ß-hydroxy-16ß-methylspiro[androsta-1,4-diene-17,2'(3'H)- 

furan]-3,3'-dione (17 alpha-spiro compound) 

20 mg 

10 mg 

0.4 mg 

EPC2285000 Clobetasone butyrate 50 mg 

EPY0000313 Clofazimine 150 mg 

EPY0000358 Clofazimine for system suitability 10 mg 

EPC2300000 Clofibrate 0.5 mL 

EPC2320000 Clomifene citrate 50 mg 

EPC2332000 Clomifene citrate for performance test 50 mg 

EPC2360000 Clomipramine hydrochloride 100 mg 

EPY0000132 

EPY0000133 

EPY0000134 

Clomipramine impurity C 

3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine 

Clomipramine impurity D 

3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl) 

N,N-dimethylpropan-1-amine 

Clomipramine impurity F 

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine 

EPC2385000 Clonazepam Controlled Substance 50 mg 

EPC2385010 

EPC2385015 

Clonazepam impurity A 

2-Amino-2'-chloro-5-nitrobenzophenone 

Clonazepam impurity B 

3-Amino-4-(2-chlorophenyl)-6-nitro-1H-quinolin-2-one 

EPY0000286 Clonazepam - Reference Spectrum unit 

EPC2400000 Clonidine hydrochloride 100 mg 


Clonidine impurity B 

10 mg 

10 mg 

5 mg 

25 mg 

25 mg 

20 mg 

1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole 

EPY0000392 Closantel sodium dihydrate 20 mg 

EPY0000393 Closantel for system suitability 20 mg 

EPC2424400 

EPC2424550 

EPC2424500 

EPC2425600 

Clostridia (multi-component) rabbit antiserum 

(for vaccines-vet.use) BRP 

Clostridium tetani guinea pig antiserum 

(for vaccines-human use) BRP 

Clostridium tetani guinea pig antiserum 

(for vaccines - vet.use) BRP 

Clostridium tetani rabbit antiserum 

(for vaccines - vet.use) BRP 

1 mg 

3x1 mL 

EPC2430000 Clotrimazole 100 mg 


Clotrimazole impurity E 

(2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) 

EPC2450000 Cloxacillin sodium 125 mg 

EPC2460000 Clozapine 60 mg 

New EPY0000758 Clozapine for peak identification 0.41 mg 

EPY0000162 Cocaine hydrochloride - Reference Spectrum unit 

EPC2480000 Cocoyl caprylocaprate 40 mg 

New EPY0000722 Codeine Controlled Substance 20 mg 

EPC2500000 Codeine - Reference Spectrum unit 

1 mg 

1 mg 

10 mg 




EPY0000334 

Codeine impurity A 

7,8-didehydro-4,5α-epoxy-3,6α-dimethoxy-17-methylmorphinan (methylcodeine) 


EPC2500100 Codeine hydrochloride dihydrate - Reference Spectrum unit 

EPC2510000 Codergocrine mesilate 60 mg 

EPC2580000 Colchicine 50 mg 

EPY0000209 Colchicine for system suitability 50 mg 

EPY0000374 Colestyramine 10 mg 

EPC2600000 Colistimethate sodium 100 mg 

EPY0000277 Colistin sulphate 25 mg 

EPC2700000 Colistin sulphate for microbiological assay 25 mg 

EPC2725000 Copovidone - Reference Spectrum unit 

EPC2800000 Cortisone acetate 250 mg 

EPY0000438 Coumarin 80 mg 

EPC2900000 Cotton wool.standard for neps 1000 mg 

EPC2950000 Crospovidone - Reference Spectrum unit 

EPC2970000 Crotamiton 100 mg 

EPC2970005 

Crotamiton impurity A 

N-ethyl-N-(2-methylphenyl)but-3-enamide 

EPC3000000 Cyanocobalamin 20 mg 

EPC3090000 Cyclizine hydrochloride 50 mg 

EPC3200000 Cyclobenzaprine hydrochloride 100 mg 

EPC3230000 Cyclohexa-1,4-dienylglycine 80 mg 

EPC3245000 Cyclopentolate hydrochloride 60 mg 

EPC3250000 Cyclophosphamide 50 mg 

EPC3280000 Cyproheptadine hydrochloride 30 mg 

EPC3283000 Cyproterone acetate 30 mg 

EPC3290000 Cysteine hydrochloride monohydrate 50 mg 

EPC3300000 Cystine 100 mg 

EPC3350000 Cytarabine 150 mg 

New EPY0000733 Dacarbazine 20 mg 



Dacarbazine impurity A 

2-azahypoxanthine 

Dacarbazine impurity B 

5-amino-1H-imidazole-carboxamide 

EPD0070000 Dalteparin sodium 250 mg 

EPY0000600 Danaparoid sodium 10 mg 

EPD0100000 Dapsone 100 mg 

EPD0125000 Daunorubicin hydrochloride 100 mg 

EPD0120000 

Daunorubicinone 

Daunorubicin aglycone 

EPD0160000 Deferoxamine mesilate 30 mg 

EPD0201000 Dehydrohexetidine 50 mg 

EPY0000611 Dembrexine hydrochloride monohydrate 10 mg 

EPD0300000 Demeclocycline hydrochloride 100 mg 

EPD0350000 N-Demethylerythromycin A 10 mg 

EPY0000228 Demethylflumazenil - Reference Spectrum unit 

EPD0406000 Deoxyminoxidil 0.25 mg 

EPD0406200 Deptropine citrate 60 mg 

EPD0430000 Dequalinium chloride 50 mg 

EPD0431000 Dequalinium chloride for performance test 50 mg 

EPD0480000 Desacetylvinblastine 2x1 mg 

10 mg 

30 mg 

10 mg 

10 mg 

10 mg 





Desflurane impurity A 

1,1'-oxybis(1,2,2,2-tetrafluoroethane) 

EPD0500000 Desipramine hydrochloride 100 mg 

EPD0600000 Deslanoside 150 mg 

EPD0630000 Desmethylmetrifonate 30 mg 

EPD0650000 Desmopressin 0.98 mg 

EPY0000509 Desogestrel 50 mg 

EPY0000510 Desogestrel for system suitability 10 mg 

EPD0400000 Desoxycortone acetate 250 mg 

EPY0000001 Detomidine hydrochloride 100 mg 

EPD0660020 

Detomidine impurity B 

(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol 

EPD0700000 Dexamethasone 60 mg 

EPD0710000 Dexamethasone acetate 100 mg 

EPY0000538 Dexamethasone isonicotinate 10 mg 

EPY0000511 Dexamethasone isonicotinate for impurity C identification 10 mg 

EPD0718000 Dexamethasone pivalate 50 mg 

EPD0720000 Dexamethasone sodium phosphate 50 mg 

EPD0720800 Dexchlorpheniramine maleate 60 mg 

EPD0730000 Dexpanthenol 5 mg 

EPD0731000 Dextran 25 mg 

EPD0731005 Dextran 1 50 mg 

EPD0732000 Dextran Vo 10 mg 

EPD0733000 Dextran 4 for calibration 50 mg 





EPD0738000 Dextran 40 for performance test 50 mg 

EPD0739000 Dextran 60/70 for performance test 50 mg 

New EPY0000744 Dextranomer 50 mg 

EPD0740000 Dextromethorphan hydrobromide 100 mg 

EPY0000261 

Dextromethorphan impurity A 

ent-3-methoxymorphinan 

EPD0940000 Diazepam Controlled Substance 30 mg 

EPY0000596 Diazepam for system suitability Controlled Substance 0.5 mg 

EPD0950000 Diazoxide 50 mg 

EPD0970000 Dibenzocycloheptene 20 mg 

EPD1000000 Dibenzosuberone 100 mg 

EPY0000480 Dibrompropamidine diisetionate 10 mg 

EPY0000481 Dibrompropamidine for system suitability 20 mg 

EPD1010000 Dibutyl phthalate 1 mL 

EPY0000275 Dichlorodiaminocyclohexaneplatinum 10 mg 

EPY0000259 Diclazuril for system suitability 20 mg 

EPY0000264 Diclazuril for veterinary use - Reference Spectrum unit 

EPD1039990 Diclofenac potassium 100 mg 

EPD1040000 

Diclofenac impurity A 

1-(2,6-dichlorophenyl)-indolin-2-one 

1 mL 

20 mg 

5 mg 

0.005 mg 

EPD1050000 Dicloxacillin sodium 250 mg 

EPD1060000 Dicycloverine hydrochloride 100 mg 

EPY0000439 Didanosine 10 mg 

EPY0000440 Didanosine for system suitability 10 mg 




EPY0000441 

EPY0000442 

Didanosine impurity A 

1,7-dihydro-6H-purin-6-one (hypoxanthine) 

Didanosine impurity G 

9-(2,3-dideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine 

(2',3'-dideoxyadenosine) 

EPD1200000 Dienestrol 150 mg 

EPD1250000 Diethanolamine fusidate 50 mg 

EPD1300000 Diethylcarbamazine citrate 250 mg 

EPY0000217 Diethylene glycol (monoethyl ether) - Reference Spectrum unit 

EPD1410000 Diethyl phthalate 1 mL 

EPD1500000 Diethylstilbestrol 100 mg 

EPD1600000 Diethylstilbestrol dimethyl ether 10 mg 

EPD1700000 Diethylstilbestrol monomethyl ether 10 mg 

EPD1750000 Diflunisal 30 mg 

EPD1800000 Digitoxin 250 mg 

EPY0000640 Digoxigenin 5 mg 

EPD1900000 Digoxin 30 mg 

EPY0000554 Digoxin for peak identification 10 mg 

EPY0000232 Dihydralazine for system suitability 10 mg 

EPD1940001 Dihydralazine sulphate (hydrated) - Reference Spectrum unit 

EPY0000216 Dihydrocodeine hydrogen tartrate - Reference Spectrum unit 

EPY0000053 17 alpha-dihydroequilin 10 mg 

EPD1945000 Dihydroergocristine mesilate 250 mg 

New EPY0000831 Dihydroergotamine for peak identification 10 mg 

EPD1950000 Dihydroergotamine mesilate 100 mg 

EPD1952000 Dihydroergotamine tartrate 150 mg 

EPD1954000 Dihydrostreptomycin sulphate (for LC assay) 25 mg 

EPY0000544 Dihydrotachysterol 10 mg 

EPY0000482 Dihydrotachysterol for system suitability 5 mg 

EPD1980000 Diltiazem hydrochloride 200 mg 

EPD1982000 

Diltiazem impurity A 

(2R,3S)-3-acetyloxy-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl) 

-2,3-dihydro-1,5-benzothiazepin-4(5H)-one 

EPD2000000 Dimenhydrinate 100 mg 

EPD2046000 (2,6-Dimethylphenoxy)acetone 50 mg 

EPY0000234 N,N-Dimethylacetamide - Reference Spectrum unit 

EPD2050000 Dimethyl sulfoxide 1 mL 

EPD2200000 Dimeticone 200 mg 

EPD2205000 Dimetindene maleate 50 mg 

EPD2255000 Dinoprost trometamol 60 mg 

EPD2250000 Dinoprostone 100 mg 

EPD2250015 

Dinoprostone impurity C 

(E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]-hept-5-enoic 

acid (5-trans-PGE 2;(5E)-PGE 2) 

EPY0000094 Diosmin 50 mg 

EPY0000095 Diosmin for system suitability 5 mg 

EPD2600000 Diphenhydramine hydrochloride 100 mg 

EPY0000135 

Diphenhydramine impurity A 

2-(diphenylmethoxy)-N-methylethanamine 

EPD2630000 Diphenoxylate hydrochloride - Reference Spectrum unit 

EPY0000258 Diphtheria toxin BRP 1 mL 

EPD2700000 Diphtheria vaccine (absorbed) BRP 32 mg 

EPY0000376 Dipivefrine hydrochloride 100 mg 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 




EPY0000394 Dipivefrine for system suitability 10 mg 

EPD2750100 Dipotassium clorazepate - Reference Spectrum unit 

EPD2800000 Diprophylline 100 mg 

EPD2850000 Dipyridamole 50 mg 

New EPY0000802 Dipyridamole for peak identification 2 mg 

EPD2880000 Dirithromycin 100 mg 

EPD2900000 Disodium edetate 100 mg 

EPD2920000 Disopyramide 100 mg 

EPD2922000 Disopyramide phosphate 100 mg 

EPD2950000 Disulfiram 100 mg 

EPD2953000 Dithranol 125 mg 

EPD2953025 

EPD2953050 

Dithranol impurity C 

Dithranol-dimer 

4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione 

Dithranol impurity D 

1-hydroxyanthracen-9(10H)-one 

EPD2954000 Dobutamine hydrochloride 100 mg 

EPD2954600 Docosahexaenoic acid ethyl ester 150 mg 

EPD2954500 Docusate sodium - Reference Spectrum unit 

EPY0000365 Dodecyl gallate 30 mg 

EPD2955000 Domperidone 150 mg 

EPD2957000 Domperidone maleate 150 mg 

EPD2960000 Dopamine hydrochloride 50 mg 

EPY0000612 Dopexamine dihydrochloride 10 mg 

EPY0000613 

EPY0000614 


Dopexamine impurity B 

2-methoxy-4-[2-[[6-[(2-phenylethyl)hexyl]amino]ethyl]phenol 

Dopexamine impurity F 

4-Chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol 

Dorzolamide impurity A 

(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulphonamide 

7,7-dioxide 

New EPY0000726 Dorzolamide hydrochloride 50 mg 

New EPY0000750 Dorzolamide for system suitability 5 mg 

EPD2962000 Dosulepin hydrochloride 100 mg 

EPD2962005 

Dosulepin impurity A 

(E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)- 

N,N'-dimethylpropan-1-amine S-oxide 

EPD2963000 Doxapram hydrochloride 50 mg 

EPY0000208 

Doxapram impurity B 

(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one 

EPY0000553 Doxazosin mesilate 60 mg 

EPY0000551 

EPY0000552 

Doxazosin impurity D 

6,7-dimethoxyquinazoline-2,4(1H,3H)-dione 

Doxazosin impurity F 

2-chloro-6,7-dimethoxyquinazolin-4-amine 

EPD2964500 Doxepin hydrochloride - Reference Spectrum unit 

EPD2964510 

EPD2964520 

Doxepin impurity A 

dibenzo[b,e]oxepin-11(6H)-one 

Doxepin impurity B 

(11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol 

EPD2975000 Doxorubicin hydrochloride 150 mg 

EPD3000000 Doxycycline hyclate 50 mg 

EPY0000163 Doxylamine hydrogen succinate - Reference Spectrum unit 

EPY0000160 

Doxylamine impurity A 

N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridin-4-yl)ethoxy]ethanamine 

20 mg 

20 mg 

10 mg 

10 mg 

5 mg 

50 mg 

10 mg 

10 mg 

10 mg 

20 mg 

25 mg 

50 mg 




EPD3100000 Droperidol 150 mg 

EPY0000249 Ebastine - Reference Spectrum unit 

EPY0000247 

EPY0000248 

Ebastine impurity C 

4-(diphenylmethoxy)piperidine 

Ebastine impurity D 

1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one 

EPY0000270 Econazole - Reference Spectrum unit 

EPY0000254 Econazole for system suitability 20 mg 

EPE0050000 Econazole nitrate 100 mg 

EPY0000296 Econazole nitrate - Reference Spectrum unit 

EPE0085000 Eicosapentaenoic acid ethyl ester 150 mg 

EPY0000537 Emedastine difumarate 10 mg 

EPY0000512 

Emedastine impurity E 

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole 

EPE0100000 Emetine hydrochloride 100 mg 

EPE0110000 Enalapril for system suitability 20 mg 

EPE0109000 Enalapril maleate 50 mg 

EPY0000615 Enalaprilat dihydrate 100 mg 

EPY0000629 Enalaprilat for system suitability 10 mg 

EPY0000678 

Enalaprilat impurity G 

(2SR)-2[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)- 

4-phenylbutanoic acid 

10 mg 

10 mg 

10 mg 

0.005 mg 

EPY0000136 Enilconazole 60 mg 

EPY0000137 

Enilconazole impurity E 

(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol 

EPE0150000 Endotoxin standard BRP 11 mg 

EPE0180000 Enoxaparin sodium 200 mg 

EPE0180500 Enoxolone 100 mg 

EPE0200000 Enterokinase BRP 500 mg 

EPE0305000 Ephedrine hydrochloride (racemic) Controlled Substance 50 mg 

EPE0300000 Ephedrine hydrochloride Controlled Substance 150 mg 

EPE0400000 4-Epianhydrotetracycline hydrochloride 10 mg 

EPE0430000 4-Epichlortetracycline hydrochloride 20 mg 

EPE0440000 4-Epidemeclocycline hydrochloride 20 mg 

EPE0500000 6-Epidoxycycline hydrochloride 50 mg 

EPE0530000 4-Epioxytetracycline 40 mg 

EPE0550000 Epirubicin hydrochloride 100 mg 

EPE0600000 4-Epitetracycline hydrochloride 20 mg 

EPY0000052 Equilin 15 mg 

EPE0850010 Eq influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP 3x1 mg 

EPE0850021 Eq influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP 3x1 mg 

EPE0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP 3x1 mg 

EPY0000712 Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP 1 mg 

EPE0900000 Ergocalciferol 500 mg 

EPE1000000 Ergometrine maleate Controlled Substance 50 mg 

EPE1100000 Ergosterol 20 mg 

EPE1200000 Ergotamine tartrate Controlled Substance 100 mg 

EPY0000051 Erysipelas ELISA coating antigen BRP 0.4 mg 

EPY0000177 Erythritol 1000 mg 

EPE1300000 Erythromycin 250 mg 

EPE1305000 Erythromycin A 250 mg 

EPE1310000 Erythromycin B 50 mg 

EPE1320000 Erythromycin C 50 mg 

20 mg 




EPE1400000 Erythromycin estolate 100 mg 

EPE1500000 Erythromycin ethylsuccinate 100 mg 

EPE1500800 Erythromycin stearate 50 mg 

EPE1515000 Erythropoietin BRP 37.5 mg 

EPY0000324 Esketamine hydrochloride - Reference Spectrum unit 

EPY0000338 

Esketamine impurity D 

(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone 


New EPY0000749 Essential oils 1000 mg 

EPE1600000 Estradiol benzoate 250 mg 

EPY0000201 Estradiol benzoate impurity E 

10 mg 

17alpha-hydroxyestra-1,3,5(10)-trien-3-yl benzoate 

EPY0000045 Estradiol butyrate 10 mg 

EPE1620000 Estradiol hemihydrate 100 mg 

EPY0000314 Estradiol for peak identification 10 mg 

EPY0000046 Estradiol valerate 50 mg 

EPE1680000 Estriol 50 mg 

EPE1680005 

Estriol impurity A 

9,11-didehydroestriol 

EPE1700000 Estrone 15 mg 

EPE1800000 Etacrynic acid 100 mg 

EPE1830000 Etamsylate 30 mg 

EPE1840000 Ethacridine lactate monohydrate 50 mg 

EPE1850000 Ethambutol hydrochloride 250 mg 

New EPY0000803 Ethambutol for system suitability 10 mg 

EPA1202800 Ethanol (anhydrous) - Reference Spectrum unit 

EPE1860100 Ethanol 96% - Reference Spectrum unit 

EPE1900000 Ethinylestradiol 100 mg 

EPE2000000 Ethionamide 100 mg 

EPE2150000 Ethosuximide 30 mg 

EPE2250000 

Ethosuximide impurity A 

2-Ethyl-2-methylsuccinic acid 

EPE2195000 Ethyl acetate - Reference Spectrum unit 

EPE2195900 Ethylcellulose - Reference Spectrum unit 

EPE2202000 1-N-Ethylgaramin sulphate 125 mg 

EPE2205500 1,1'-Ethylidenebistryptophan 5 mg 

EPY0000617 Ethyl indole-3-carboxylate 10 mg 

EPE2300000 Ethylmorphine hydrochloride - Reference Spectrum unit 

EPE2400000 Ethylnicotinamide 150 mg 

EPE2425000 Ethyl parahydroxybenzoate 50 mg 

EPE2450000 Etifenin 25 mg 

EPE2451000 Etilefrine hydrochloride 75 mg 

EPE2451010 

Etilefrine impurity A 

2-ethylamino-1-(3-hydroxyphenyl)ethanone (etilefrone) 

EPY0000572 Etidronate disodium 10 mg 

EPE2470000 Etodolac 60 mg 

EPE2470050 

Etodolac impurity H 

2-(7-ethylindol-3-yl)ethanol 

New EPY0000768 Etodolac for peak identification 10 mg 

EPE2499900 Etofenamate 40 mg 

EPE2499901 Etofenamate for peak identification 15 mg 

EPE2499914 

Etofenamate impurity G 

2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate 

10 mg 

20 mg 

50 mg 

20 mg 

10 mg 

20 mg 




EPE2500000 Etofylline 100 mg 

EPE2503000 Etomidate 100 mg 

EPE2503004 

Etomidate impurity B 

methyl-1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate 

EPE2600000 Etoposide 150 mg 

EPE5000000 Eugenol 500 µL 

EPF0005000 Famotidine 100 mg 

EPY0000382 Famotidine for system suitability 10 mg 

EPF0006000 

EPF0007000 

EPY0000409 

Famotidine impurity A 

3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]-thio]propanamide 

Famotidine impurity B 

3,5-bis[2-[[[2-[(diaminomethylene)amino] thiazol-4-yl]methyl]thio]-ethyl]- 

4H-1,2,4,6-thiatriazine1,1-dioxide 

Famotidine impurity D 

3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide 

EPY0000556 Febantel 110 mg 

EPY0000660 Febantel for system suitability 10 mg 

New EPY0000731 Felbinac 10 mg 

EPY0000732 

Felbinac impurity A 

4-acetyl biphenyl 

EPF0030000 Felodipine 120 mg 

EPY0000415 Felypressin 0.994 mg 

EPF0040000 Fenbendazole 150 mg 

EPF0040010 

EPF0040020 

Fenbendazole impurity A 

methyl(1H-benzimidazol-2-yl)carbamate 

Fenbendazole impurity B 

methyl[5(6)-chlorobenzimidazol-2-yl]carbamate 

EPF0041000 Fenbufen 100 mg 

EPF0048000 Fenofibrate 100 mg 

EPF0048005 

EPF0048010 

EPF0048035 

Fenofibrate impurity A 

(4-chlorophenyl)(4-hydroxyphenyl)methanone 

Fenofibrate impurity B 

2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid) 

Fenofibrate impurity G 

1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] 

oxy]-2-methylpropanoate 

New EPY0000756 Fenoterol for peak identification 1.2 mg 

EPF0050000 Fenoterol hydrobromide 100 mg 

EPF0051000 Fenoterol hydrobromide - Reference Spectrum unit 

EPF0054990 Fentanyl - Reference Spectrum unit 

EPF0055000 Fentanyl citrate - Reference Spectrum unit 

EPF0060000 Fenticonazole nitrate 50 mg 

EPF0060040 

Fenticonazole impurity D 

(RS)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3- 

[4-(phenylsuphanyl)benzyl]imidazolium nitrate 

EPF0100000 Ferrous gluconate 1000 mg 

New EPY0000789 Fexofenadine hydrochloride 60 mg 




Fexofenadine impurity A 

2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2-methylpropanoic acid 

Fexofenadine impurity B 

2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl]- 

2-methylpropanoic acid 

Fexofenadine impurity C 

(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol 

25 mg 

10 mg 

10 mg 

10 mg 

20 mg 

20 mg 

20 mg 

20 mg 

10 mg 

25 mg 

20 mg 

5 mg 

0.01 mg 

EPY0000090 Finasteride 50 mg 

EPY0000091 Finasteride for system suitability 100 mg 

5 mg 




New EPY0000736 Flavoxate hydrochloride 10 mg 



Flavoxate impurity A 

3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 

Flavoxate impurity B 

ethyl3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate 

EPF0120000 Flecainide acetate 200 mg 

EPF0120005 

EPF0120010 

Flecainide impurity A 

3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo 

[1,5-a]pyridine 

Flecainide impurity B 

(piperidin-2-yl)methanamine 

EPY0000138 Flubendazole 25 mg 

EPY0000139 Flubendazole for system suitability 20 mg 

EPF0150000 Flucloxacillin sodium 250 mg 

EPY0000557 Fluconazole 50 mg 

EPY0000558 Fluconazole for peak identification 10 mg 

EPY0000573 

EPY0000574 

Fluconazole impurity B 

2-[2-fluro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol 

Fluconazole impurity C 

1,1´-(1,3-phenylene)di-1H-1,2,4-triazole 

EPF0175000 Flucytosine 100 mg 

EPY0000419 Fludarabine phosphate 100 mg 

EPF0180000 Fludrocortisone acetate 100 mg 

EPF0188000 Flumazenil - Reference Spectrum unit 

EPY0000335 

Flumazenil impurity B 

ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine- 

3-carboxylate 

EPF0189000 Flumequine 60 mg 

EPF0189020 

Flumequine impurity B 

ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] 

quinolizine-2-carboxylate (flumequine ethyl ester) 

10 mg 

10 mg 

50 mg 

25 mg 

10 mg 

5 mg 

5 mg 

0.1 mg 

EPF0188500 Flumetasone pivalate 100 mg 

EPF0189900 Flunarizine dihydrochloride 100 mg 

EPY0000265 Flunarizine dihydrochloride - Reference Spectrum unit 

EPY0000266 Flunarizine dihydrochloride for system suitability 20 mg 

EPF0190000 Flunitrazepam Controlled Substance 100 mg 

EPY0000169 Flunitrazepam - Reference Spectrum unit 

EPY0000443 Flunixin meglumine 10 mg 

EPY0000444 

EPY0000445 

Flunixin impurity B 

2-methyl-3-(trifluoromethyl)aniline 

Flunixin impurity C 

ethyl 2-chloropyridine-3-carboxylate 

EPF0200000 Fluocinolone acetonide 100 mg 

EPF0230000 Fluocortolone pivalate 100 mg 

New EPY0000796 Fluorescein 120 mg 


Fluorescein impurity C 

2-(2,4-dihydroxybenzoyl)benzoic acid 

10 mg 

50 mg 

0.01 mg 

EPY0000454 Diacetylfluorescein 100 mg 

EPF0245000 Fluoresceine sodium - Reference Spectrum unit 

EPF0250000 Fluorouracil 50 mg 




Fluorouracil impurity A 

pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) 

Fluorouracil impurity B 

dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil) 

Fluorouracil impurity C 

pyrimidine-2,4(1H,3H)-dione (uracil) 

10 mg 

10 mg 

10 mg 





Fluorouracil impurity F 

2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) 

New EPY0000791 Fluorouracil impurity mixture 0.0002 mg 

EPF0253000 Fluoxetine hydrochloride 250 mg 

EPF0253020 

EPF0253030 

Fluoxetine impurity B 

methyl (3-phenylpropyl)amine Controlled Substance 

Fluoxetine impurity C 

(RS)-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl]amine 

EPY0000064 Flupentixol dihydrochloride 120 mg 

EPY0000067 

EPY0000078 

Flupentixol impurity D 

2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] 

piperazin-1-yl]ethoxy]ethanol 

Flupentixol impurity F 

2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl)prop-2-enyl]- 

piperazin-1-yl]ethanol 

EPF0260000 Fluphenazine decanoate 60 mg 

EPY0000009 Fluphenazine enantate 100 mg 

EPF0280000 Fluphenazine dihydrochloride 50 mg 

New EPY0000708 Fluphenazine impurity mixture 0.07 mg 

EPY0000298 Fluphenazine octanoate 10 mg 

EPY0000299 Fluphenazine sulphoxide 10 mg 

EPY0000211 Flurazepam monohydrochloride - Reference Spectrum unit 

EPF0285200 Flurbiprofen 50 mg 

EPF0285202 

Flurbiprofen impurity A 

(2RS)-2-(biphenyl-4-yl)propanoic acid 

EPY0000236 Fluspirilene 20 mg 

EPY0000375 

Fluspirilene impurity C 

8-[4,4-bis((4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan- 

4-one 

EPF0285600 Flutamide 50 mg 

EPF0285603 

Flutamide impurity C 

N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide 

EPY0000284 Fluticasone propionate 100 mg 

EPY0000221 

Fluticasone impurity D 

S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-propionyloxy-androsta- 

1,4-diene-17β-carbothioate (S-methyl derivative) 

EPF0290000 Flutrimazole 100 mg 

EPF0290010 

EPY0000386 

Flutrimazole impurity B 

(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol 

Foeniculin for peak identification 

Star anise oil 

10 mg 

5 mg 

5 mg 

15 mg 

25 mg 

20 mg 

10 mg 

20 mg 

10 mg 

60 mg 

100 mg 

EPF0300000 Folic acid 250 mg 

EPF0372000 Formoterol fumarate dihydrate 10 mg 

EPY0000339 Formoterol fumarate dihydrate for impurity I identification 10 mg 

EPY0000340 Formoterol fumarate for system suitability 10 mg 

EPF0380000 

Formylfolic acid 

10-Formylfolic acid 

EPF0389000 Foscarnet sodium hexahydrate 50 mg 

EPF0389004 

Foscarnet impurity B 

disodium(ethoxyoxydophosphanyl)formate 

EPF0399900 Fosfomycin calcium - Reference Spectrum unit 

EPF0399950 Fosfomycin sodium - Reference Spectrum unit 

EPF0400000 Fosfomycin trometamol 1500 mg 

EPF0450000 Framycetin sulphate 2x25 mg 

EPF0550000 Fructose 100 mg 

EPF0600000 Fumaric acid 100 mg 

30 mg 

10 mg 




EPF0700000 Furosemide 100 mg 

EPF0702000 

Furosemide impurity A 

2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid 

EPF1000000 Fusidic acid - Reference Spectrum unit 

EPG0049000 Galactitol 50 mg 

EPG0050000 Galactose 60 mg 

EPG0100000 Gallamine triethiodide 100 mg 

EPG0150000 Gammacyclodextrin 50 mg 

EPY0000675 Gemcitabine hydrochloride 50 mg 

EPY0000676 

Gemcitabine impurity A 

4-aminopyrimidin-2(1H)-one (Cytosine) 

EPY0000513 Gemfibrozil 5 mg 

EPY0000514 Gemfibrozil for system suitability 0.196 mg 

EPG0200000 Gentamicin sulphate 2x25 mg 

EPG0300000 Gitoxin 30 mg 

EPG0325000 Glibenclamide 100 mg 

EPG0325010 

EPY0000242 

Glibenclamide impurity A 

4-[2-(5-Chloro-2-methoxybenzamido)ethyl] 

benzenesulphonamide 

Glibenclamide impurity B 

methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate 

EPG0326000 Gliclazide 20 mg 

EPG0326004 

EPG0326012 

Gliclazide impurity B 

2-nitroso-octahydrocyclopenta[c]pyrrole 

Gliclazide impurity F 

1-(hexahydrocyclopenta[c]pyrrol-2-(1H)-yl-3-[(2-methylphenyl)sulphonyl]urea 

EPY0000515 Glimepiride 60 mg 

EPY0000516 Glimepiride for system suitability 0.012 mg 

EPG0340000 Glipizide 50 mg 

EPG0342000 

EPY0000523 

EPY0000643 

Glipizide impurity A 

4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide 

Glipizide impurity C 

ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate 

Glipizide impurity D 

6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide 

EPY0000191 Human glucagon 2x0.952 mg 

EPG0350500 Glucose 100 mg 

EPG0355000 Glutamic acid 50 mg 

EPY0000517 Glutathione 10 mg 

EPG0360000 Glutethimide Controlled Substance 50 mg 

EPG0400000 Glycerol (85 per cent) - Reference Spectrum unit 

EPG0400002 Glycerol dibehenate 2000 mg 

EPG0400004 Glycerol distearate 2000 mg 

New EPY0000794 Glycerol monocaprylate 400 mg 

New EPY0000795 Glycerol monocaprylocaprate 400 mg 

EPG0400006 Glycerol monolinoleate 2000 mg 

EPG0400007 Glycerol mono-oleate 2000 mg 

EPG0400008 Glycerol monostearate 40-55 2000 mg 

EPG0400101 Glyceryl trinitrate - Reference Spectrum unit 

EPG0400100 Glyceryl trinitrate solution 0.5 mL 

EPG0450000 Glycine 50 mg 

EPY0000433 Ammonium glycyrrhizate 70 mg 

EPG0460000 Glycyrrhizate (monoammonium) 300 mg 

EPG0525000 Gonadorelin 5.08 mg 

5 mg 

20 mg 

10 mg 

10 mg 

25 mg 

30 mg 

10 mg 

10 mg 

10 mg 




EPY0000125 Goserelin 4.93 mg 

EPY0000126 Gosereline - Reference Spectrum unit 

EPY0000019 4-D-Ser-goserelin 0.1 mg 

EPY0000194 Goserelin validation mixture 1 mg 

EPG0550000 Gramicidin 250 mg 

EPY0000396 Granisetron hydrochloride 120 mg 

EPY0000477 

EPY0000478 

EPY0000395 

Granisetron impurity A 

2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide 

Granisetron impurity B 

N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide 

Granisetron impurity E 

endo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonane 

EPG0600000 Griseofulvin 50 mg 

EPY0000619 Guaiacol 2200 mg 

EPG0700000 Guaifenesin 100 mg 

EPY0000117 Halofantrine hydrochloride 125 mg 

EPY0000118 

Halofantrine impurity C 

[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol 

EPH0100000 Haloperidol 50 mg 

EPH0100100 Haloperidol decanoate 60 mg 

EPH0150000 Halothane - Reference Spectrum unit 

EPH0185000 Heparin Low-Molecular-Mass for assay BRP 5x1 mL 

EPH0190000 Heparin Low-Molecular-Mass for calibration CRS 25 mg 

EPH0200000 Heparin sodium BRP 2 mL 

EPH0205010 Hepatitis A vaccine (inactivated,absorbed) Type B BRP 3x0.5 mL 

EPY0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) 2x0.5 mL 

EPH0210010 Hepatitis B vaccine (rDNA) BRP method B 2x1 mL 

EPH0215000 Hepatitis C Virus BRP 5x40 mg 

EPH0220000 Heptadecanol 600 mg 

EPY0000063 Heptaminol hydrochloride 150 mg 

EPY0000057 

Heptaminol impurity A 

(2RS)-6-methylhept-5-en-2-amine 

EPH0250000 alpha-Hexachlorocyclohexane 10 mg 

EPH0330000 Hexamidine diisetionate 50 mg 

EPH0325000 Hexetidine 100 mg 

EPH0400000 Hexobarbital 500 mg 

EPH0420000 Hexylresorcinol 100 mg 

EPH0500000 Hide Powder 500 mg 

EPH0600000 Histamine dihydrochloride 250 mg 

EPH0700000 Histamine phosphate 250 mg 

EPH0750000 Histidine 100 mg 

EPH0755000 Histidine hydrochloride monohydrate 100 mg 

EPH0800000 Homatropine hydrobromide 100 mg 

EPH0830000 Homatropine methylbromide 25 mg 

EPH0837000 L-Homocycsteine thiolactone hydrochloride - Reference Spectrum unit 

EPH0900000 Human albumin for electrophoresis BRP 1000 mg 

EPY0000219 Human anti-D immunoglobulin BPR unit 

EPY0000667 Human coagulation factor VII concentrate BRP 2x26 mg 

EPH0920000 Human coagulation factor VIII concentrate BRP 5x34 mg 

EPH0920500 Human coagulation factor IX concentrate BRP 5x30 mg 

EPH0950000 Human hepatisis A immunoglobulin BRP 3x10 mg 

EPH0990000 Human immunoglobulin BRP 15800 mg 

1 mg 

1 mg 

10 mg 

10 mg 

20 mg 




EPH1000000 Human immunoglobulin for electrophoresis BRP 96 mg 

EPY0000488 Human immunoglobulin (molecular size) BRP 3x700 mg 

EPH1005000 Human Plasma Pools for NAT Validation 3502 mg 

EPH1100000 Human rabies immunoglobulin BRP 3x170 mg 

EPH1110000 Human tetanus immunoglobulin BRP 87 mg 

EPY0000502 Human vaccinia immunoglobulin 3x1 mL 

EPH1115000 Hyaluronidase BRP 50 mg 

EPH1120000 Hydralazine hydrochloride 20 mg 

EPH1200000 Hydrochlorothiazide 150 mg 

EPY0000646 

Hydrocodone hydrogen tartrate 2.5-hydrate 


EPY0000710 Hydrocodone for peak identification Controlled Substance 10 mg 

EPH1300000 Hydrocortisone 100 mg 

EPH1400000 Hydrocortisone acetate 125 mg 

EPH1425000 Hydrocortisone hydrogen succinate 100 mg 

EPH1426000 Hydrogenated wool fat 250 mg 

EPY0000446 Hydromorphone Hydrochloride Controlled Substance 10 mg 

EPB0650000 Hydrous benzoyl peroxide - Reference Spectrum unit 

EPH1428000 Hydroxocobalamin 10 mg 

EPY0000119 Hydroxycarbamide 175 mg 

EPH1429400 Hydroxyethyl salicylate 125 mg 

EPH1429700 4-Hydroxyphenoxymethylpenicillin 20 mg 

EPH1430000 D-alpha-(4-Hydroxy-phenyl)glycine 50 mg 

EPY0000186 Hydroxypropylbetadex 10 mg 

EPH1435000 Hydroxyzine hydrochloride 600 mg 

EPY0000011 Hymecromone 100 mg 

EPY0000012 

EPY0000013 

Hymecromone impurity A 

Resorcinol 

Hymecromone impurity B 

7-hydroxy-2-methyl-4H-1-benzopyran-4-one 

EPY0000483 Hyoscine 10 mg 

EPY0000484 

Hyoscine impurity A 

(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy- 

2-phenylpropanoate (norhyoscine) 

EPH1450000 Hyoscine butylbromide 20 mg 

EPY0000447 

Hyoscine butylbromide impurity E 

(1R,2R,4S,5S,7S)-9-butyl-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-3-oxa-9-azoni 

atricyclo[3.3.1.02,4]nonane 

EPH1500000 Hyoscine hydrobromide 50 mg 

EPY0000448 

Hyoscine hydrobromide impurity B 

(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl(2S)- 

3-hydroxy-2-phenylpropanoate 

EPH1600000 Hyoscyamine sulphate 100 mg 

EPY0000449 

Hyoscyamine impurity E 

(1R,3s,5S)-8-azabicyclo[3.2.1] oct-3-yl(2S)-3-hydroxy-2-phenylpropanoate 

EPH5000000 Hypromellose phthalate - Reference Spectrum unit 

EPI0020000 Ibuprofen 160 mg 

EPB1220000 

EPY0000140 

Ibuprofen impurity B 

(2RS)-2-(4-Butylphenyl)propionic acid (0,06% solution in Acetonitrile) 

Ibuprofen impurity F 

3-[4-(2-methylpropyl)phenyl]propanoic acid 

10 mg 

25 mg 

25 mg 

10 mg 

10 mg 

10 mg 

10 mg 

1.15 mL 

EPI0050000 Idoxuridine 50 mg 

EPI0060000 Ifosfamide 50 mg 

EPI0060100 Ifosfamide - Reference Spectrum unit 

5 mg 




EPI0060002 

EPI0060004 

EPI0060010 

EPI0060012 

Ifosfamide impurity A 

3-[(2-chloroethyl)amino]propyl dihydrogen phosphate 

Ifosfamide impurity B 

bis[3-[(2-chloroethyl)amino]propyl]dihydrogen diphosphate 

Ifosfamide impurity E 

3-chloro-N-(2-chloroethyl)propan-1-amine 

Ifosfamide impurity F 

(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide 

EPI0086000 Imidazole 100 mg 

EPI0090000 Imipenem 100 mg 

EPI0100000 Imipramine hydrochloride 50 mg 

EPY0000540 Immunoglobulin panel for anti-D antibodies test BRP 2000 mg 

EPI0150000 Indapamide 150 mg 

EPI0150020 

Indapamide impurity B 

4-chloro-3-sulphamoyl-N-(2-methyl-1H-indol-1-yl)benzamide 

New EPY0000788 Indinavir 100 mg 

New EPY0000880 Indinavir sulphate - Reference Spectrum unit 

New EPY0000746 Indinavir for system suitability 20 mg 

EPI0200000 Indometacin 50 mg 

EPY0000349 Insulin aspart 3.89 mg 

EPI0305000 Insulin (bovine) 7.99 mg 

EPI0310000 Insulin (human) 7.03 mg 

EPY0000348 Insulin lispro 5.93 mg 

EPI0320000 Insulin (porcine) 8.61mg 

EPI0320300 Interferon alfa-2a unit 

EPI0320301 Interferon alfa-2b 0.2 mL 

EPI0320330 Interferon gamma 1b 2x0.6 mL 

EPI0320331 Interferon gamma-1b validation solution 0.2 mL 

EPI0328000 Iobenguane sulphate 25 mg 

New EPY0000839 Iobenguane sulphate - Reference Spectrum unit 

EPI0320800 Iohexol 150 mg 

EPI0320810 

EPI0320820 

Iohexol impurity A 

5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3- dicarboxamide 

Iohexol impurity J 

5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3-dicarboxamide 

30 mg 

20 mg 

10 mg 

10 mg 

5 mg 

50 mg 

125 mg 

EPY0000672 Iohexol for peak identification 10 mg 

EPI0329000 Iopamidol 50 mg 

EPI0329010 

EPY0000406 

Iopamidol impurity A 

N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethy]- 

5-amino-2,4,6-tri-iodoisophthalamide 

Iopamidol impurity H 

4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)- 

5-(2-hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide 

EPI0330000 Iopanoic acid 100 mg 

EPI0340000 Iotalamic acid 100 mg 

EPY0000555 Iotrolan 100 mg 

EPY0000658 Iotrolan for system suitability 5 mg 

EPY0000141 Ioxaglic acid 125 mg 

EPY0000142 

Ioxaglic acid impurity A 

3-amino-5[[(2-hydroxyethyl)amino]carbonyl]-2,4,6-trioiodobenzoic acid 

EPI0360000 Ipratropium bromide 120 mg 

EPY0000276 

Ipratropium bromide impurity A 

(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane 

10 mg 

10 mg 

20 mg 

5 mg 




EPI0361000 

Ipratropium bromide impurity B 

(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)- 

8-azoniabicyclo[3.2.1]octane 

EPI0375000 Isoconazole 200 mg 

EPI0380000 Isoconazole nitrate 200 mg 

EPI0400000 Isoemetine hydrobromide 25 mg 

EPY0000037 Isoflurane - Reference Spectrum unit 

EPI0460000 Isoleucine 50 mg 

EPI0465000 Isomalt 3000 mg 

EPY0000070 Isomaltooligosaccharide 0.9 mg 

EPI0500000 Isoniazid 100 mg 

EPI0599990 Isoprenaline hydrochloride 50 mg 

EPI0600000 Isoprenaline sulphate 500 mg 

EPI0725000 Isopropyl hexadecanoate 100 mg 

EPI0750000 Isopropyl tetradecanoate 2 mL 

EPI0775000 Isosorbide dinitrate 250 mg 

EPI0775010 Isosorbide mononitrate 100 mg 

EPI0775020 Isosorbide-2-nitrate 50 mg 

EPI0800000 Isotretinoin 60 mg 

EPI0900000 Isoxsuprine hydrochloride 50 mg 

EPY0000366 Isradipine 125 mg 

EPY0000367 

Isradipine impurity D 

methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)- 

2,6-dimethylpyridine-3,5-dicarboxylate 

EPI7000000 Itraconazole 150 mg 

EPI8000010 Ivermectin 150 mg 

New EPY0000575 Ivy leaf standardised tincture 2 mL 

EPY0000041 Josamycin 150 mg 

EPY0000042 Josamycin propionate 150 mg 

EPK0100000 Kanamycin B sulphate 20 mg 

EPK0200000 Kanamycin monosulphate 150 mg 

EPY0000450 Ketamine hydrochloride Controlled Substance 10 mg 

EPK0551000 

Ketamine impurity A 

1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol 

EPY0000246 Ketobemidone hydrochloride - Reference Spectrum unit 

EPY0000244 

EPY0000245 

Ketobemidone impurity B 

1-(4-(3-hydroxyphenyl)-1-methyl-4-piperidyl)ethanone 

Ketobemidone impurity C 

1-(4-(3-hydroxyphenyl)-4-piperidyl)propan-1-one 

EPK0600000 Ketoconazole 150 mg 

EPK1000000 3-Ketofusidic acid 10 mg 

EPK2000000 Ketoprofen 50 mg 

EPK2000010 

EPK2000015 

Ketoprofen impurity A 

3-acetylbenzophenone 

Ketoprofen impurity C 

2-(3-carboxyphenyl)propionic acid 

EPY0000486 Ketorolac trometamol 10 mg 

EPY0000626 Ketorolac trometamol for peak identification 5 mg 

EPY0000164 Ketotifen hydrogen fumarate - Reference Spectrum unit 

EPY0000161 

Ketotifen impurity G 

4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta 

(1,2-b)thiophen-9,10-dione 

EPL0050000 Labetalol hydrochloride 80 mg 

EPL0129000 Lactitol monohydrate 60 mg 

10 mg 

5 mg 

50 mg 

5 mg 

5 mg 

5 mg 

5 mg 

3 mg 




EPY0000257 Lactobionic acid 100 mg 

EPA1206000 Lactose (anhydrous) 100 mg 

EPL0100000 Lactose 100 mg 

EPL0130000 Lactulose 3000 mg 

EPY0000188 Lactulose for system suitability 12 mg 

EPY0000425 Lamivudine 150 mg 

EPY0000518 Lamivudine for system suitability 1 10 mg 

EPY0000426 Lamivudine for system suitability 2 10.3 mg 

New EPY0000773 Lansoprazole 60 mg 

New EPY0000654 Leflunomide 100 mg 

EPY0000487 

Leflunomide impurity A 

4-(trifluoromethyl)aniline 

EPY0000674 Leflunomide for peak identification 1 mg 

EPY0000685 Letrozole 70 mg 

EPL0375000 Leucine 50 mg 

EPL0376000 Leuprorelin 0.925 mg 

EPL0376001 Leuprorelin - Reference Spectrum unit 

EPY0000047 Levamisole for system suitability 80 mg 

EPL0380000 Levamisole hydrochloride 50 mg 

EPY0000048 Levamisole - Reference Spectrum unit 

EPL0390000 Levocabastine hydrochloride 125 mg 

EPL0390008 

Levocabastine impurity D 

1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenyl-4-piperidine 

carboxylic aicd 

EPL0399900 Levocarnitine 125 mg 

EPL0399905 

Levocarnitine impurity A 

4-(trimethylammonio)but-2-enoate 

EPL0400000 Levodopa 100 mg 

EPL0420000 Levodropropizine 60 mg 

EPL0420002 

Levodropropizine impurity A 

(2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol(dextrodropropizine) 

EPL0500000 Levomepromazine hydrochloride 100 mg 

EPL0505000 Levomepromazine maleate 50 mg 

EPL0551000 Levonorgestrel 30 mg 

EPL0570000 Levothyroxine sodium 100 mg 

EPL0595000 Lidocaine 50 mg 

EPL0600000 Lidocaine hydrochloride 100 mg 

EPL0650000 Lincomycin hydrochloride 250 mg 

EPL0655000 Lindane 250 mg 

EPL0700000 Liothyronine sodium 50 mg 

EPL0702000 Lisinopril dihydrate 50 mg 

EPL0702100 Lisinopril dihydrate for performance test 2x2 mg 

EPL0720000 Lithium clavulanate 125 mg 

EPL0720800 Lithocholic acid 60 mg 

EPY0000112 Lobeline hydrochloride 50 mg 

EPL0745000 Lomustine 50 mg 

EPL0750000 Loperamide hydrochloride 150 mg 

EPY0000322 Loperamide hydrochloride for system suitability 15 mg 

EPY0000341 Loperamide oxide monohydrate 20 mg 

EPY0000688 Loratadine 60 mg 

EPY0000603 Loratadine for system suitability 20 mg 

25 mg 

20 mg 

50 mg 

20 mg 




EPY0000604 

EPY0000605 

Loratadine impurity F 

ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta 

[1,2-b]pyridin-11-yl]piperidine-1-carboxylate 

Loratadine impurity H 

ethyl 4-oxopiperidine-1-carboxylate 

EPL0750500 Lorazepam Controlled Substance 100 mg 

EPY0000576 Lorazepam for system suitability Controlled Substance 0.8 mg 

EPY0000718 

Lorazepam impurity D 

(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione 

EPL0790000 Lovastatin 40 mg 

EPL0800000 Lynestrenol 50 mg 

EPY0000397 Lysine acetate 60 mg 

EPL0900000 Lysine hydrochloride 50 mg 

New EPY0000745 Macrogol 40 sorbitol heptaoleate 20 mg 

EPM0088000 Magnesium aspartate dihydrate 60 mg 

EPM0120000 Malathion 250 mg 

EPM0120005 

EPM0120010 

Malathion impurity A 

diethyl(2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] 

butane dioate (isomalathion) 

Malathion impurity B 

diethyl(2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate (maloxon) 

EPM0100000 Maleic acid 100 mg 

EPY0000143 Malic acid - Reference Spectrum unit 

EPM0160000 Maltitol 1200 mg 

EPM0200000 Mannitol 1200 mg 

EPM0206000 Maprotiline hydrochloride 100 mg 

EPM0206040 

Maprotiline impurity D 

3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine; 

(dehydromaprotiline) 

New EPY0000819 Marbofloxacin 10 mg 

EPM0210000 Measles vaccine (live) BRP 5x80 mg 

EPM0215000 Mebendazole 20 mg 

EPY0000144 Mebendazole for system suitability 20 mg 

EPY0000168 Mebendazole - Reference Spectrum unit 

EPM0220000 Meclozine hydrochloride 150 mg 

EPM0240000 Medronic acid 20 mg 

EPM0250000 Medroxyprogesterone acetate 100 mg 

EPM0250010 Medroxyprogesterone acetate for performance test 50 mg 

EPY0000598 Medroxyprogesterone acetate for system suitability 10 mg 

EPM0252600 Mefenamic acid 50 mg 

EPM0253000 Mefloquine hydrochloride 100 mg 

EPM0260000 Megestrol acetate 50 mg 

EPM0260100 Megestrol acetate - Reference Spectrum unit 

EPY0000267 Meglumine - Reference Spectrum unit 

EPM0300000 Menadione 100 mg 

EPM0350000 Menthol 150 mg 

EPM0370000 Mepivacaine hydrochloride 100 mg 

EPM0370020 

Mepivacaine impurity B 

(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 

EPM0400000 Meprobamate Controlled Substance 100 mg 

EPM0500000 Mepyramine maleate 1000 mg 

EPY0000679 

Mepyramine impurity A 

N-(4-methoxybenzyl)pyridin-2-amine 

10 mg 

50 mg 

10 mg 

10 mg 

10 mg 

25 mg 

60 mg 

10 mg 




EPY0000680 

Mepyramine impurity C 

pyridin-2-amine 

EPY0000297 Mesalazine 125 mg 

EPY0000337 Mesna - Reference Spectrum unit 

EPY0000316 

EPY0000317 

Mesna impurity C 

2-(acetylsulphanyl)ethanesulphonic acid 

Mesna impurity D 

2,2'-disulphanediyl)bis(ethanesulphonic acid) 

EPY0000227 Meso-rich exametazime 0.5 mg 

EPY0000097 Mesterolone 60 mg 

EPY0000096 

Mesterolone impurity A 

17β-hydroxy-1-alpha-methylandrost-4-en-3-one 

EPM0600000 Mestranol 100 mg 

EPY0000301 Metacresol - Reference Spectrum unit 

EPM0600500 Metacycline hydrochloride 50 mg 

EPM0600900 Metamizole sodium 100 mg 

EPM0600905 

Metamizole impurity A 

4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one 

EPM0605000 Metformin hydrochloride 50 mg 

EPY0000770 Methacrylic acid-ethylacrylate copolymer (1:1) type A 200 mg 

New EPY0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B 200 mg 

EPM0610000 Methacrylic acid-ethylacrylate copolymer (1:1) - Reference Spectrum unit 

EPM0610030 Methacrylic acid-ethyl acrylate copolymer (1:1), dispersion 30% - Reference Spectrum unit 

EPM0620000 Methacrylic acid-methylmethacrylate copolymer (1:1) - Reference Spectrum unit 

EPM0630000 Methacrylic acid-methylmethacrylate copolymer (1:2) - Reference Spectrum unit 

EPM0800000 Methadone hydrochloride - Reference Spectrum unit 

EPY0000428 Methanol - Reference Spectrum unit 

EPM0900000 Methaqualone - Reference Spectrum unit 

EPM0920001 Methenamine - Reference Spectrum unit 

New EPY0000754 Methenamine 10 mg 

EPM0950000 DL-Methionine 50 mg 

EPM0960000 Methionine 50 mg 

EPM1000000 Methotrexate 100 mg 

EPY0000602 Methotrexate for peak identification 20 mg 


EPM1000008 


Methotrexate impurity C 

(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin- 

6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid (N-methylfolic acid, 

methopteridine) 

Methotrexate impurity D 

4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino]benzoic acid 

Methotrexate impurity E 

4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino-N10-methylpteroic 

acid, APA) 

EPM1100000 3-Methoxymethyldopa 20 mg 

EPM1300000 Methylatropine bromide 100 mg 

EPM1400000 Methylatropine nitrate 100 mg 

EPM1450000 Methylcarbidopa 1 mg 

EPM1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate 0.5 mL 

EPM1500000 Methyldopa 50 mg 

EPM1550000 Methylene chloride 2 mL 

EPM1551000 2-(1-Methylethyl)pentanoic acid 25 mg 

EPM1556000 Methyl 12-hydroxystearate 100 mg 

EPY0000398 Methyl nicotinate 25 mg 

New EPY0000776 Methylergometrine maleate 10 mg 

10 mg 

10 mg 

10 mg 

30 mg 

10 mg 

10 mg 

10 mg 

10 mg 




New EPY0000777 Methylergometrine maleate for system suitability 0.53 mg 

EPM1625000 Methylnitrosoindoline 100 mg 

EPM1650000 Methyl parahydroxybenzoate 50 mg 

EPM1700000 Methylphenobarbital Controlled Substance 500 mg 

EPM1750000 Methylprednisolone 150 mg 

EPM1755000 Methylprednisolone acetate 100 mg 

EPM1755200 Methylprednisolone hydrogen succinate 125 mg 

EPM1755220 Methylprednisolone hydrogen succinate for performance test 50 mg 

EPY0000190 N-Methylpyrrolidone - Reference Spectrum unit 

EPM1770180 Methyl ricinoleate 125 mg 

EPY0000418 Methylrosanilinium chloride 40 mg 

EPY0000407 Methylrosanilinium chloride for system suitability 10 mg 

EPM1770200 Methyl stearate 100 mg 

EPM1800000 Methyltestosterone 100 mg 

EPM1800900 

EPM1800902 

Methylthioninium chloride 

methylene blue 

Methylthioninium impurity A 

3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium 

EPM1808000 Metixene hydrochloride 75 mg 

EPM1824990 Metoclopramide 100 mg 

EPM1825000 Metoclopramide hydrochloride 50 mg 

EPM1824995 

EPM1825010 

Metoclopramide impurity A 

4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide 

Metoclopramide impurity E 

N,N-diethylethane-1,2-diamine 

New EPY0000701 Metolazone 80 mg 

New EPY0000702 Metolazone for system suitability 10 mg 

EPY0000171 Metoprolol succinate - Reference Spectrum unit 

EPM1830000 Metoprolol tartrate 60 mg 

EPY0000145 

Metoprolol impurity A 

(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol 

EPM1845000 Metrifonate 100 mg 

EPM1850000 Metronidazole 50 mg 

EPM1851000 Metronidazole benzoate 50 mg 

EPY0000069 Metronidazole benzoate - Reference Spectrum unit 

EPY0000087 

Metronidazole impurity A 

2-methyl-4-nitroimidazole 

EPM1860000 Mexiletine hydrochloride 100 mg 

EPY0000202 

EPY0000203 

Mexiletine impurity C 

1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy] dipropan-2-amine 

Mexiletine impurity D 

(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine 

EPM1875000 Mianserin hydrochloride 50 mg 

EPM1880000 Miconazole 70 mg 

EPM1900000 Miconazole nitrate 100 mg 

EPY0000562 

Midazolam impurity C 

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid 

50 mg 

20 mg 

25 mg 

20 mg 

10 mg 

10 mg 

2 mg 

2 mg 

0.08 mg 

EPM2200000 Midazolam Controlled Substance 50 mg 

EPY0000599 Midazolam for system suitability Controlled Substance 1 mg 

New EPY0000539 Milk thistle standardised dry extract 120 mg 

EPM2280000 Minocycline hydrochloride 125 mg 

EPM2300000 Minoxidil 50 mg 

New EPY0000705 Mirtazapine 10 mg 

New EPY0000721 Mirtazapine for system suitability 10 mg 




EPY0000490 Misoprostol 30 mg 

EPY0000491 

Misoprostol impurity A 

mixture of methyl 7-[(1RS,2SR, 3SR)-3-hydroxy-2-[(1E,4RS)-4-hydroxy-4-methyloct1-enyl] 

-5-oxocyclopentyl]heptanoate and methyl- 7-[(1RS,2SR,3SR)-3-hydroxy-2-[(1E,4SR) 

-4-hydroxy4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate (8-epimisoprostol) 

EPY0000378 Mitomycin 120 mg 

EPM2305000 Mitoxantrone hydrochloride 60 mg 

EPM2305005 

Mitoxantrone impurity A 

1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl]amino] 

anthracene-9,10-dione 

EPY0000635 Modafinil Controlled Substance 110 mg 

EPY0000636 Modafinil for system suitability Controlled Substance 0.1 mg 

EPY0000251 Molgramostim 0.3 mL 

New EPY0000821 Molsidomine 5 mg 



Molsidomine impurity B 

N-Nitrosomorpholine 

Molsidomine impurity D 

morpholine-4-carbaldehyde 

EPM2900000 Mometasone furoate 100 mg 

EPY0000028 Morantel hydrogen tartrate 50 mg 

EPY0000451 Morphine hydrochloride (trihydrate) Controlled Substance 25 mg 

EPY0000452 Morphine sulphate Controlled Substance 40 mg 

New EPY0000772 Moxidectin 70 mg 

New EPY0000747 Moxidectin for system suitability 10 mg 

New EPY0000703 Moxifloxacin hydrochloride 110 mg 

New EPY0000717 Moxifloxacin for peak identification 10 mg 

EPY0000226 Moxonidine 50 mg 

EPY0000222 

Moxonidine impurity A 

4,6-dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2-methyl-5-pyrimidinamine 

EPM3600000 Mumps vaccine (live) BRP 5x33 mg 

EPM3805000 Mupirocin - Reference Spectrum unit 

EPM3805500 Mupirocin calcium - Reference Spectrum unit 

EPM3806000 Mupirocin lithium 100 mg 

EPY0000489 Mycophenolate mofetil 30 mg 

EPY0000519 Mycophenolate mofetil for peak identification 10 mg 

EPY0000692 Mycoplasma fermentans BRP 1 mL 

EPY0000690 Mycoplasma hyorhinis BRP 1 mL 

EPY0000691 Mycoplasma orale BRP 1 mL 

EPY0000689 Mycoplasma synoviae BRP 1 mL 

EPY0000485 Myo-inositol 1020 mg 

EPN0020020 

EPN0020030 

Nabumetone impurity D 

(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one 

Nabumetone impurity F 

6,6'-dimethoxy-2,2'-binaphthalenyl 

EPY0000146 Nadolol 100 mg 

EPN0025000 Nadroparin calcium 250 mg 

EPY0000077 Naftidrofuryl - Reference Spectrum unit 

EPY0000120 

EPY0000121 

EPY0000122 

EPY0000331 

Naftidrofuryl impurity A 

2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid 

Naftidrofuryl impurity B 

ethyl 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoate 

Naftidrofuryl impurity C 

2-(diethylamino)ethyl 3-[(naphtalen-1-yl)-2-[(naphtalen-1-yl)methyl]propanoate 

Naftidrofuryl impurity F 

2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3-(tetrahydrofuran-2-yl) propanoate 

5 mg 

5 mg 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 

25 mg 

50 mg 

10 mg 




EPN0050000 Nalidixic acid 100 mg 

EPN0075000 Naloxone hydrochloride dihydrate 100 mg 

EPY0000695 Naloxone for peak identification 10 mg 

EPY0000400 Naltrexone hydrochloride 50 mg 

EPY0000410 

Naltrexone impurity C 

N-(3-butenyl)-noroxymorphone 

EPY0000542 Nandrolone decanoate 5 mg 

EPY0000547 Nandrolone decanoate for peak identification 10 mg 

EPY0000548 Nandrolone decanoate for system suitability 10 mg 

EPN0080000 Naphazoline hydrochloride 50 mg 

EPY0000252 Naphazoline hydrochloride - Reference Spectrum unit 

EPN0100000 Naphazoline nitrate 10 mg 

EPN0200000 

Naphazoline impurity A 

N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide (Naphthylacetylethylenediamine) 

EPN0250000 Naproxen 100 mg 

EPY0000399 Naproxen (racemic) 10 mg 

EPY0000631 

Naproxen impurity L 

1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin) 

EPN0300000 Neamine 0.5 mg 

EPN0399000 Neohesperidin dihydrochalcone 125 mg 

EPN0399004 

Neohesperidin dihydrochalcone impurity B 

7-[[2-O-(6-deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy- 

4-methoxyphenyl)-4H-1-benzopyran-4-one (neodiosmin) 

EPN0400000 Neomycin sulphate 50 mg 

EPN0401000 Neomycin sulphate for microbiological assay 25 mg 

EPN0500000 Neostigmine bromide 50 mg 

EPN0550000 Neostigmine metilsulfate 50 mg 

EPN0559000 Netilmicin sulphate 2x25 mg 

New EPY0000520 Nevirapine (anhydrous) 30 mg 

EPY0000521 Nevirapine for peak identification 0.058 mg 

EPY0000388 Newcastle Disease Vaccine (inacativated) BRP 4 uc 

EPY0000287 Nicergoline - Reference Spectrum unit 

EPY0000283 

Nicergoline impurity A 

[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindol 

[4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate 

EPN0560000 Niclosamide (anhydrous) 50 mg 

EPN0600000 Nicotinamide 50 mg 

EPN0590000 Nicotine - Reference Spectrum unit 

EPN0590200 Nicotine ditartrate 120 mg 

EPN0700000 Nicotinic acid 100 mg 

EPN0750000 Nifedipine 50 mg 

EPN0750010 

EPN0750015 

Nifedipine impurity A 

Dimethyl 2,6-dimethyl-4-(2-nitrophenyl) pyridine-3,5-dicarboxylate 

Nifedipine impurity B 

Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl) pyridine-3,5-dicarboxylate 

New EPY0000824 Niflumic acid 10 mg 




Niflumic acid impurity A 

2-chloropyridine-3-carboxylic acid 

Niflumic acid impurity B 

2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide 

Niflumic acid impurity E 

6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid 

New EPY0000836 Nifuroxazide 10 mg 

EPY0000178 Nifuroxazide - Reference Spectrum unit 

15 mg 

25 mg 

10 mg 

10 mg 

10 mg 

20 mg 

20 mg 

10 mg 

10 mg 

15 mg 




EPN0800000 Nikethamide 1 mL 

EPN0845000 Nimesulide 100 mg 

EPN0845008 

Nimesulide Impurity D 

4-nitro-2-phenoxyaniline 

0.004 mg 

EPN0850000 Nimodipine 50 mg 

EPN0850010 

Nimodipine impurity A 

2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) 

pyridine-3,5-dicarboxylate 

EPN0900000 Nitrazepam Controlled Substance 100 mg 

EPN0900010 

Nitrazepam impurity A 

3-amino-6-nitro-4-phenylquinol-2-one 

EPN0905000 Nitrendipine 60 mg 

EPN0905005 

Nitrendipine impurity A 

ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate; 

(nitrophenylpyridine analogue) 

EPN0930000 Nitric oxide - Reference Spectrum unit 

EPN0950000 Nitrofural 100 mg 

EPN1000000 Nitrosotriaminopyrimidine 50 mg 

EPN1090000 Nizatidine 250 mg 

EPN1090060 

Nizatidine impurity F 

(EZ)N 1 ,N 1 ,-[thiazole-2,4-diylbis(methylenesulphanediylethylene)] 

bis(N’-methyl-2-nitroethene-1,1-diamine) 

EPN1080000 Nomegestrol acetate 100 mg 

EPN1080005 

Nomegestrol acetate impurity A 

17α-acetoxy-6α-methyl-19-norpregn-4-ene-3,20-dione 

EPY0000670 Nonivamide 10 mg 

New EPY0000755 Nonoxinol 9 10 mg 

EPN1084000 Nonoxinol 9 - Reference Spectrum unit 

EPN1100000 Noradrenaline tartrate 200 mg 

EPY0000681 

EPY0000682 

EPY0000686 

Noradrenaline impurity D 

4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (Noradrenaline methyl ether) 

Noradrenaline impurity E 

2-chloro-1-(3,4-dihydroxyphenyl)ethanone 

Noradrenaline impurity F 

N-benzyl-1-phenylmethanamine 

EPN1130000 Norcyclobenzaprine 25 mg 

EPN1140000 

Nordazepam Controlled Substance 

Dipotassium clorazepate impurity B 

EPN1200000 Norethisterone 100 mg 

EPN1225000 Norethisterone acetate 100 mg 

EPY0000522 Norethistherone for system suitability 10 mg 

EPN1230000 Norfloxacin 50 mg 

EPN1230010 

Norfloxacin impurity A 

7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 

New EPY0000724 Norgestimate 10 mg 

New EPY0000725 Norgestimate for system suitability 5 mg 

EPN1250000 Norgestrel 30 mg 

EPN1279000 Norpseudoephedrine hydrochloride Controlled Substance 50 mg 

EPN1280000 Nortriptyline hydrochloride 10 mg 

EPN1300000 Noscapine 100 mg 

EPN1400000 Nystatin 300 mg 

EPO0100900 Octoxinol 10 300 mg 

EPY0000368 Octyl gallate 30 mg 

EPO0101000 Octyldodecanol 400 mg 

EPO0120000 Ofloxacin 50 mg 

1 mL 

25 mg 

20 mg 

10 mg 

50 mg 

15 mg 

10 mg 

10 mg 

50 mg 

20 mg 




EPO0120010 

EPO0120050 

Ofloxacin impurity A 

(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido 

[1,2,3-de][1,4]benzoxazine-6-carboxylic acid (FPA) 

Ofloxacin impurity E 

(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] 

[1,4]benzoxazine-6-carboxylic acid 

New EPY0000805 Oleuropein 20 mg 

EPO0146000 Olsalazine sodium 60 mg 

EPO0146010 Olsalazine sodium for performance test 60 mg 

EPO0150000 Omeprazole 50 mg 

EPO0151000 

Omeprazole impurity D 

Omeprazole sulphone 

EPY0000218 Ondansetron hydrochloride dihydrate 200 mg 

EPY0000197 Ondansetron for LC system suitability 10 mg 

EPY0000196 Ondansetron for TLC system suitability 30 mg 

EPY0000195 

Ondansetron impurity D 

9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one 

EPO0180000 Orciprenaline sulphate 100 mg 

EPY0000101 Orphenadrine citrate 100 mg 

EPY0000100 Orphenadrine hydrochloride 100 mg 

EPY0000102 

Orphenadrine impurity E 

(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine 

(meta-methylbenzyl isomer) 

EPO0200000 Ouabain 150 mg 

EPY0000638 Oxacillin sodium monohydrate 110 mg 

EPY0000560 Oxacillin for peak identification 10 mg 

EPY0000271 Oxaliplatin 250 mg 

EPY0000272 

EPY0000273 

EPY0000274 

Oxaliplatin impurity B 

(SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']platinum 

(diaquodiaminocyclohexaneplatinum) 

Oxaliplatin impurity C 

(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- 

kO¹,kO²]dihydroxyplatinum 

Oxaliplatin impurity D 

(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- 

kO¹,kO² ]platinum (S,S-enantiomer of oxaliplatin) 

EPO0225000 Oxazepam Controlled Substance 50 mg 

EPY0000543 Oxazepam for peak identification 0.008 mg 

EPY0000350 Oxeladin hydrogen citrate 50 mg 

EPY0000404 

EPY0000390 

Oxeladin impurity C 

2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate 

Oxeladin impurity D 

2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate 

EPO0225800 Oxfendazole for veterinary use 50 mg 

EPY0000224 

Oxfendazole impurity B 

methyl[5-[phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate 

EPY0000225 Oxfendazole with impurity D 10 mg 

EPY0000709 Oxitropium bromide 50 mg 

EPY0000715 

EPY0000713 

Oxitropium bromide impurity B 

(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa- 

9-azoniatricyclo[3.3.1.0]nonane (methylhyoscine) 

Oxitropium bromide impurity D 

(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa- 

9-azoniatricyclo[3.3.1.0]nonane (apo-N-ethylhyoscine) 

EPO0240000 Oxolinic acid 50 mg 

EPO0240005 

Oxolinic acid impurity A 

8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid 

20 mg 

20 mg 

5 mg 

10 mg 

30 mg 

20 mg 

10 mg 

5 mg 

10 mg 

20 mg 

10 mg 

15 mg 

10 mg 

20 mg 




EPO0240010 

Oxolinic acid impurity B 

ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7-carboxylate 

EPO0250000 Oxprenolol hydrochloride 50 mg 

EPO0260000 Oxybendazole 100 mg 

EPO0270000 Oxybuprocaine hydrochloride 150 mg 

EPO0288000 Oxybutynin hydrochloride 150 mg 

EPO0288005 

Oxybutynin impurity A 

4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3-enyl)-2-cyclohexyl-2-hydroxyacetate 

EPY0000492 Oxycodone hydrochloride Controlled Substance 100 mg 

EPY0000453 

Oxycodone impurity D 

7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one 

(14-hydroxycodeinone) 

EPO0290000 Oxymetazoline hydrochloride 80 mg 

EPO0400000 Oxytetracycline 100 mg 

EPO0500000 Oxytetracycline hydrochloride 20 mg 

EPO0700000 Oxytocin 41 mg 

EPO0770000 Oxytocin/Desmopressin validation mixture 0.2 mg 

New EPY0000698 Paclitaxel 40 mg 


Paclitaxel impurity C 

N-debenzoyl-N-hexanoylpaclitaxel 

New EPY0000700 Paclitaxel natural for peak identification 10 mg 

New EPY0000719 Paclitaxel semi-synthetic for peak identification 10 mg 

New EPY0000739 Paclitaxel semi-synthetic for system suitability 1 mg 

EPP0090000 Palmitic acid 100 mg 

EPY0000524 Pamidronate disodium pentahydrate 10 mg 

EPP0100000 Pancrease powder (amylse and lipase) BRP 2000 mg 

EPP0200000 Pancreas powder (protease) BRP 2000 mg 

EPP0250000 

Pancuronium bromide 

Vecuronium impurity B 

EPY0000577 Pancuronium bromide for system suitability 20 mg 

New EPY0000835 Pantoprazole sodium sesquihydrate 20 mg 

EPP0270000 Papaverine hydrochloride 25 mg 

EPP0300000 Paracetamol 50 mg 

EPP0302000 Paraffin (hard) - Reference Spectrum unit 

New EPY0000780 Paraffin (hard) 10 mg 

EPY0000058 Paraffin (liquid) - Reference Spectrum unit 

EPY0000293 Paraffin (white soft) - Reference Spectrum unit 

EPP0302500 Paraffin (yellow soft) - Reference Spectrum unit 

EPP0305000 Parnaparin sodium 250 mg 

EPY0000578 Paroxetine hydrochloride (anhydrous) 100 mg 

EPY0000281 Paroxetine hydrochloride hemihydrate 100 mg 

EPY0000233 

EPY0000579 

EPY0000256 

EPY0000580 

EPY0000581 

Paroxetine impurity A 

(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine) 

Paroxetine hydrochloride (anhydrous) impurity C 

(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine 

(N-benzylparoxetine) 

Paroxetine impurity D 

(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-transparoxetine) 

Paroxetine impurity E 

(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine) 

Paroxetine hydrochloride (anhydrous) impurity H 

[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol 

EPY0000630 Paroxetine for system suitability 5 mg 

EPP0309000 Pefloxacin mesilate dihydrate 200 mg 

20 mg 

10 mg 

25 mg 

5 mg 

20 mg 

5 mg 

10 mg 

5 mg 

5 mg 

10 mg 




EPP0309020 

EPP0309030 

Pefloxacin impurity B 

1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 

(chlorinated homologue of pefloxacin) 

Pefloxacin impurity C 

1-ethyl-6-fluoro-5-(4-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 

(isopefloxacin) 

10 mg 

0.01 mg 

EPP0307000 Penbutolol sulphate 100 mg 

EPP0307005 

Penbutolol impurity A 

(2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl)amino]propan-2-ol 

EPP0310000 Penicillamine 100 mg 

EPP0320000 Penicillamine disulphide 100 mg 

EPP0400100 Pentaerythrityl tetranitrate diluted 600 mg 

EPP0405000 Pentamidine diisetionate 30 mg 

EPP0405500 Pentazocine - Reference Spectrum unit 

EPP0405510 Pentazocine hydrochloride - Reference Spectrum unit 

EPY0000417 Pentazocine lactate - Reference Spectrum unit 

EPP0500000 Pentobarbital Controlled Substance 500 mg 

EPP0510000 Pentoxifylline 100 mg 

EPY0000076 Pentoxyverine hydrogen citrate - Reference Spectrum unit 

EPY0000098 

EPY0000099 

Pentoxyverine impurity A 

1-phenylcyclopentanecarboxylic acid 

Pentoxyverine impurity B 

2-(diethylamino)ethyl-1-phenylcyclopentanecarboxylate (caramiphen) 

EPP0525000 Pepsin powder BRP 2000 mg 

EPY0000010 Pergolide mesilate 150 mg 

EPY0000237 

Perindopril impurity A 

(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid 

EPY0000207 Perindopril for stereochemical purity 40 mg 

EPY0000206 Perindopril for system suitability 30 mg 

EPY0000238 Perindopril tert-butylamine 40 mg 

New EPY0000771 Perindopril for peak identification 5 mg 

EPP0550000 Perphenazine 100 mg 

EPY0000021 Pertussis toxin BRP 2x0.05 mg 

EPP0600000 Pethidine hydrochloride - Reference Spectrum unit 

EPP0600002 Pethidine impurity A 

20 mg 

1-methyl-4-phenylpiperidine (MPP) 

EPP0800000 Phenazone 20 mg 

EPP0850000 Pheniramine maleate 250 mg 

EPP0900000 Phenobarbital Controlled Substance 250 mg 

EPP0950000 Phenoxyethanol 2 mL 

EPP1000000 Phenoxymethylpenicillin 250 mg 

EPP1100000 Phenoxymethylpenicillin potassium 250 mg 

EPP1109000 Phentolamine mesilate - Reference Spectrum unit 

EPP1150000 Phenylalanine 60 mg 

EPP1200000 Phenylbutazone 100 mg 

EPY0000147 

Phenylbutazone impurity B 

(4-butyl-4-hydroxy-1,2-diphenyl-3,5)pyrazolidinedione 

EPP1240000 Phenylephrine 60 mg 

EPP1250000 Phenylephrine hydrochloride 50 mg 

EPY0000683 Phenylephrine hydrochloride for peak identification 2 mg 

EPY0000229 Phenylmercuric acetate - Reference Spectrum unit 

EPP1255100 Phenylmercuric borate - Reference Spectrum unit 

EPP1260000 Phenylpropanolamine hydrochloride Controlled Substance 50 mg 

EPP1290000 Phenytoin 100 mg 

20 mg 

10 mg 

10 mg 

10 mg 

20 mg 




EPP1300000 Phenytoin sodium 250 mg 

EPY0000493 Phloroglucinol (anhydrous) 210 mg 

New EPY0000761 Pholcodine Controlled Substance 10 mg 

EPP1400000 Pholcodine - Reference Spectrum unit 

New EPY0000798 Pholcodine for peak identification Controlled Substance 10 mg 

New EPY0000766 Phthalic acid 20 mg 

EPP1500000 Phthalylsulfathiazole 100 mg 

EPP1600000 Physostigmine salicylate 100 mg 

EPP1605000 Physostigmine sulphate 100 mg 

EPP1609000 Phytomenadione 150 mg 

EPP1609010 trans-Epoxyphytomenadione 10 mg 

EPP1645000 Picotamide monohydrate 125 mg 

EPP1645005 

EPY0000124 

Picotamide impurity A 

4-methoxybenzene-1,3-dicarboxylic acid 

Pidolate impurity B 

(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid 

EPY0000123 Pidolic acid 125 mg 

EPP1650000 Pilocarpine hydrochloride 50 mg 

EPP1700000 Pilocarpine nitrate 50 mg 

EPY0000106 Pilocarpine nitrate for system suitability 20 mg 

EPY0000525 Pimobendan 10 mg 

EPY0000401 Pimobendan for system suitability 0.1 mg 

EPP1750000 Pimozide 150 mg 

EPP1800000 Pindolol 100 mg 

EPY0000061 Pipemidic acid trihydrate - Reference Spectrum unit 

EPP1890000 Piperacillin 100 mg 

EPP1900000 Piperazine adipate 250 mg 

EPP2000000 Piperazine citrate 250 mg 

EPP2100000 Piperazine hydrate 250 mg 

EPY0000288 Piracetam 120 mg 

EPY0000038 Pirenzepine dihydrochloride monohydrate 250 mg 

EPP2120000 Piretanide 100 mg 

EPP2120002 

Piretanide impurity A 

4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid 

EPP2130000 Piroxicam 100 mg 

EPP2130100 Piroxicam for system suitability 10 mg 

EPP2150000 Pivampicillin 50 mg 

EPP2152000 Pivmecillinam hydrochloride 100 mg 

EPP2152015 

Pivmecillinam impurity C 

methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo-1H-azepin-1-yl) 

methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate 

EPP2155001 Plastic additive 01 

(2RS)-2-ethylhexyl)benzene-1,2-dicarboxylate Synonym: di(2-ethylhexyl) 

phthalate 


N,N'-ethylenedialcanamide 

Synonym: N,N'-diacylethylenediamines 

EPE0800000 Plastic additive 04 

Epoxidised soya oil 


Epoxidised linseed oil 


Ethylene bis [3,3-di(3-1,1-dimethylethyl -4-hydroxyphenyl)-butyrate]R 

25 mg 

50 mg 

20 mg 

10 mg 

2 mL 

100 mg 

500 mg 

500 mg 

500 mg 

EPP2155009 Plastic additive 09 250 mg 





4,4',4''-[(2,4,6-trimethylbenzene-1,3,5-triyl)tris(methylene)]- 

tris[2,6-bis(1,1-dimethylethyl)phenol] Synonym:2,2',2'',6,6',6''-hexatert-butyl-4,4',4''- 

[2,4,6-trtimethyl-1,3,5-benzenetriyl)trismethylene]triphenol 


Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate 


Tris(2,4-di-1,1-dimethylethylphenyl)phosphite R 


1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5-triazine-2,4,6-trione 


2,2'-Di(octadecycloxy)5,5'-spirobi(1,3,2,-dioxaphosphorinane)R 


Dioctadecyl disulphide 


Didodecyl 3,3'-thiodipropionate R 


Dioctadecyl 3,3'-thiodipropionate R 

250 mg 

500 mg 

200 mg 

250 mg 

200 mg 

500 mg 

500 mg 

500 mg 

EPP2155018 Plastic additive 18 100 mg 

EPO0140000 Plastic additive 20 

Oleamide R 

EPE1260000 Plastic additive 21 

Erucamide R 


Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol 

Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin- 

1-yl)ethanol 


di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate containing about 27% of 

(tri(isooctyl)2,2',2''-[monooctylstannylidyne)tris(thio)]triacetate. 

Tin-content of 15.4% 

100 mg 

100 mg 

100 mg 

200 mg 

EPP2160000 Poliomyelitis vaccine (inactivated) BRP 5x0.6 mg 

EPP2161000 Poliomyelitis vaccine (oral) BRP 5x1 mL 

EPP2163920 Poloxamer 124 30 mg 





EPP2170000 Polyacrylate - Reference Spectrum unit 

EPP2400000 Polymyxin B sulphate 120 mg 

EPY0000355 Polymyxin B sulphate for microbiological assay 25 mg 

EPY0000289 Polysorbate 20 - Reference Spectrum unit 




New EPY0000792 Poly(vinyl acetate) dispersion 30% 2x20 mg 

EPP2600000 Poly(vinyl chloride) 100 mg 

EPP2649610 Potassium clavulanate - Reference Spectrum unit 

EPY0000315 Potassium hydrogen aspartate hemihydrate 50 mg 

EPP2650000 Potassium sorbate 100 mg 

EPP2660000 Povidone 50 mg 

EPY0000466 Povidone (iodinated) 10 mg 

EPY0000215 Pravastatin sodium - Reference Spectrum unit 

EPY0000223 

Pravastatin impurity A 

(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)- 

2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid 

(6'-epipravastatin) 

10 mg 




EPY0000204 Pravastatin 1,1,3,3-tetramethylbutylamine 30 mg 

EPP2669000 Prazepam Controlled Substance 50 mg 

EPP2670000 Praziquantel 150 mg 

EPP2675000 

Praziquantel impurity A 

(RS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one 

EPP2680000 Prazosin hydrochloride 50 mg 

EPP2698000 Prednicarbate 100 mg 

EPP2698060 

Prednicarbate impurity F 

1,2-dihydroprednicarbate 

EPP2700000 Prednisolone 150 mg 

EPP2800000 Prednisolone acetate 120 mg 

EPY0000582 Prednisolone acetate for peak identification 10 mg 

EPP2804000 Prednisolone hexanoate 10 mg 

EPP2805000 Prednisolone pivalate 100 mg 

EPP2810000 Prednisolone sodium phosphate 150 mg 

EPP2900000 Prednisone 50 mg 

EPP2920000 Pregnenolone isobutyrate 150 mg 

EPY0000263 Prekallikrein activator in albumin BRP 3x1 mL 

EPP2939000 Prilocaine 150 mg 

EPP2939060 Prilocaine hydrochloride 100 mg 

EPP2939025 

Prilocaine impurity E 

(RS)-N-(methylphenyl)-2-(propylamino)propanamide 

EPP2940000 Primaquine diphosphate 500 mg 

EPP2950000 Primidone 150 mg 

EPY0000369 Primidone for peak identification 5 mg 

EPP3000000 Probenecid 100 mg 

EPP3050000 Procainamide hydrochloride 100 mg 

EPP3090000 Procaine benzylpenicillin 250 mg 

EPP3100000 Procaine hydrochloride 100 mg 

EPP3200000 Prochlorperazine maleate 100 mg 

EPP3300000 Progesterone 250 mg 

EPY0000148 

Progesterone impurity C 

(20R)-20-hydroxypregn-4-en-3-one 

EPY0000179 Proguanil hydrochloride - Reference Spectrum unit 

EPY0000181 

EPY0000182 

Proguanil impurity C 

1,5-bis(4-chlorophenyl)biguanide 

Proguanil impurity D 

1,5-bis(1-methylethyl)biguanide 

EPP3350000 Proline 60 mg 

EPP3390000 Promazine hydrochloride 100 mg 

EPP3400000 Promethazine hydrochloride 50 mg 


Promethazine impurity D 

(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide 

New EPY0000797 Promethazine for peak identification 10 mg 

EPP3490000 Propacetamol hydrochloride - Reference Spectrum unit 

EPY0000455 Propafenone hydrochloride 10 mg 

EPY0000456 

Propafenone impurity B 

1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropenone 

EPY0000278 Propanol - Reference Spectrum unit 

EPY0000016 Propofol 290 mg 

EPY0000017 Propofol for peak identification 0.1 mL 

EPY0000018 

Propofol impurity J 

2,6-bis (1-methylethyl)-1,4-benzoquinone 

EPP3500000 Propranolol hydrochloride 30 mg 

10 mg 

10 mg 

25 mg 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 

20 mg 




EPP3600000 Propranolol hydrochloride for performance test 20 mg 

EPY0000318 Propylene glycol dilaurate 100 mg 

EPY0000319 Propylene glycol monolaurate 100 mg 

EPP3640000 Propyl gallate 50 mg 

EPP3650000 Propyl parahydroxybenzoate 100 mg 

EPP3700000 Propylthiouracil 100 mg 

EPP3750000 Propyphenazone 200 mg 

EPP3760000 Protirelin 2x5.03 mg 

EPP3760020 D-His Protirelin 0.1 mg 

EPP3800000 Proxyphylline 100 mg 

EPP3850000 Pseudoephedrine hydrochloride Controlled Substance 100 mg 

EPY0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification 100 mg 

EPP3900000 Purpureaglycoside A 25 mg 

EPP4000000 Purpureaglycoside B 25 mg 

EPY0000402 Pyrantel embonate 10 mg 

EPY0000403 

Pyrantel impurity A 

1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrim idine 

EPP4050000 Pyrazinamide 30 mg 

EPP4099900 Pyridostigmine bromide 50 mg 

EPP4099910 

Pyridostigmine impurity A 

pyridin-3-yl-dimethylcarbamate 

EPP4100000 Pyridoxine hydrochloride 100 mg 

EPP4200000 Pyrimethamine 250 mg 

EPY0000659 Pyrrolidone 20 mg 

EPQ0100000 Quinidine sulphate 300 mg 

EPQ0200000 Quinine sulphate 300 mg 

EPR0100000 Rabies vaccine (inactivated) for veterinary use BRP 3x86 mg 

EPR0145000 Ramipril 20 mg 

EPR0145005 

EPR0145010 

EPR0145015 

EPR0145020 

Ramipril impurity A 

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino] 

propanoly]octahydrocyclopenta[b]pyrrole-2-carboxylic acid 

(ramipril methylester) 

Ramipril impurity B 

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3-phenylpropyl] 

amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid 

(ramipril isopropyl ester) 

Ramipril Impurity C 

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino] 

propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (hexahydroramipril) 

Ramipril impurity D 

ethyl(2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro 

-1H-cyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate 

(ramipril diketopiperazine) 

EPR0150000 Ranitidine hydrochloride 100 mg 

EPY0000416 

Ranitidine impurity J 

1,1'-N-[methylenebis(sulphanediylethylene)]bis 

(N'-methyl-2-nitroethene-1,1-diamine) 

20 mg 

20 mg 

10 mg 

10 mg 

10 mg 

10 mg 

0.00025 mg 

EPY0000411 Ranitidine for system suitability 20 mg 

EPY0000457 Repaglinide 20 mg 

EPY0000458 Repaglinide for system suitability 6 mg 

EPY0000459 

Repaglinide impurity E 

2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl) phenyl]butyl] 

amino]-2-oxoethyl]benzoic acid 

EPR0200000 Reserpine 100 mg 

EPR0250000 Residual solvents solution class I 1500 mg 

New EPY0000767 Resorcinol 20 mg 

5 mg 




EPR0300000 Retinol acetate 1000 mg 

EPR0290000 Retinol ester 100 mg 

EPR0500500 Reviparin sodium 250 mg 

EPY0000377 Ribavirin 100 mg 

EPY0000353 Ribavirin for system suitability 1 mg 

EPR0600000 Riboflavin (Vitamine B 2) 100 mg 

New EPY0000757 Riboflavin for peak identification 0.1 mg 

EPR0630000 Riboflavine sodium phosphate 250 mg 

EPY0000662 Ribonucleic acid 100 mg 

EPY0000149 Rifabutin 150 mg 

EPY0000184 

Rifabutin impurity A 

N-(2-methylpropyl)-4-piperidone 

EPR0700000 Rifampicin 500 mg 

EPR0800000 Rifampicin quinone 100 mg 

EPR0900000 Rifamycin B 50 mg 

EPR0950000 Rifamycin S 50 mg 

EPR1000000 Rifamycin sodium 300 mg 

EPY0000250 Rilmenidine dihydrogenophosphate - Reference Spectrum unit 

EPY0000187 Rilmenidine for system suitability 30 mg 

EPR1000600 Risperidone 50 mg 

EPY0000370 Risperidone for system suitability 20 mg 

EPR1300000 

RK 13 cells 

cell lines (kidney,rabbit) titration of live measles, 

mumps and rubella vaccines 

20 mg 

2x1 mL 

New EPY0000714 Ritonavir 80 mg 

New EPY0000706 Ritonavir for peak identification 10 mg 

EPY0000527 Rocuronium for peak identification 10 mg 

EPY0000594 Rocuronium bromide - Reference Spectrum unit 

New EPY0000742 Ropivacaine hydrochloride monohydrate 10 mg 


Ropivacaine impurity G 

(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)-ropivacaine) 

EPR1500000 Roxithromycin 125 mg 

EPY0000220 Roxithromycin for system suitability 5 mg 

EPR2000000 Rubella vaccine (live) BRP 5x18 mg 

EPY0000494 Ruscogenins 10 mg 

EPY0000105 Rutoside trihydrate 100 mg 

New EPY0000669 Salicin 50 mg 

EPS0040000 Saccharin 30 mg 

EPS0050000 Saccharin Sodium 50 mg 

EPS0100000 Salbutamol 50 mg 

EPY0000030 

EPY0000071 

EPY0000031 

EPY0000034 

EPY0000032 

Salbutamol impurity B 

(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol 

Salbutamol impurity D 

(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2- 

hydroxybenzaldehyde 

Salbutamol impurity F 

1,1'[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis 

[2-[(1,1-dimethylethyl)amino]ethanol] 

Salbutamol impurity G 

2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-hydroxymethyl) 

phenyl]ethanone 

Salbutamol impurity I 

(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4-benzyloxyphenyl] ethanol 

5 mg 

5 mg 

5 mg 

5 mg 

5 mg 

0.006 mg 

EPS0150000 Salbutamol sulphate 50 mg 




EPS0200000 Salicylic acid 100 mg 

EPY0000405 

Salicylic acid impurity B 

4-hydroxyisophthalic acid 

EPY0000422 Salmeterol xinafoate 40 mg 

EPY0000423 Salmeterol for system suitability 25 mg 

EPS0360000 Selegiline hydrochloride 50 mg 

EPS0360090 (RS)-Selegiline hydrochloride 25 mg 

EPS0400000 Senna extract 50 mg 

EPS0450000 Serine 50 mg 

EPS0460000 Sertaconazole nitrate 125 mg 

EPY0000371 Sestamibi labelling kit unit 

EPS0500000 Silicone elastomer 2000 mg 

EPS0600000 Silicone oil 1 mL 

EPS0650000 Simvastatin 100 mg 

EPS0660000 Sisomicin sulphate 50 mg 

EPY0000014 Sodium alendronate 150 mg 

EPS0695000 Sodium amidotrizoate 125 mg 

EPY0000300 Sodium aminosalicylate dihydrate - Reference Spectrum unit 

EPY0000039 Sodium ascorbate 50 mg 

EPS0700000 Sodium calcium edetate 100 mg 

EPS0710000 Sodium cetostearylsulphate 100 mg 

EPS0750000 Sodium cromoglicate 10 mg 

EPS0760000 Sodium cyclamate 100 mg 

EPS0765000 Sodium diclofenac 100 mg 

EPS0781000 Sodium hyaluronate - Reference Spectrum unit 

EPS0780000 Sodium hyaluronate BRP 300 mg 

EPY0000620 Sodium laurilsulfate 40 mg 

New EPY0000808 Sodium phenylbutyrate 5 mg 


Sodium phenylbutyrate impurity C 

4-cyclohexylbutanoic acid 

EPS0785000 Sodium picosulphate 100 mg 

EPY0000210 Sodium polystyrene sulphonate - Reference Spectrum unit 

EPY0000268 Sodium propionate - Reference Spectrum unit 

EPS0800000 Sodium salicylate 100 mg 

EPS0808000 Sodium stearyl fumarate 50 mg 

EPS0808060 Sodium stearyl maleate 10 mg 

EPS0900000 Sodium taurocholate BRP 10000 mg 

EPS0930000 Sodium valproate 150 mg 

EPS0945000 Somatostatin 2.55 mg 

EPS0947000 Somatropin 35 mg 

EPY0000711 Somatropin/desamidosomatropin resolution mixture 33 mg 

EPS0950000 Sorbic acid 100 mg 

EPY0000385 1,4-Sorbitan 50 mg 

EPS1000000 Sorbitol 1200 mg 

EPY0000114 Sotalol hydrochloride 25 mg 

EPY0000115 

Sotalol impurity B 

N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide 

EPY0000597 Spectinomycin hydrochloride 100 mg 

EPY0000549 Spectinomycin for system suitability 20 mg 

EPY0000655 Spectinomycin sulphate tetrahydrate 10 mg 

EPS1100000 Spiramycin 200 mg 

EPY0000381 Spirapril hydrochloride monohydrate 60 mg 

10 mg 

10 mg 

20 mg 




EPY0000332 Spirapril for system suitability 15 mg 

EPS1200000 Spironolactone 100 mg 

EPY0000185 Squalane 0.25 mL 

EPS1250000 Stanozolol 125 mg 

EPS1250010 

Stanozolol impurity A 

(5α,17β)-17-hydroxy-17-methylandrostan-3-one 

EPS1300000 Starch BRP 50000 mg 

EPY0000408 Stavudine 100 mg 

EPY0000421 Stavudine for system suitability 10 mg 

EPS1340000 

Stearic acid 

Plastic additive 19 

10 mg 

100 mg 

EPS1350000 Stearyl alcohol 250 mg 

EPS1400000 Streptomycin sulphate 100 mg 

EPS1500000 Succinylsulfathiazole 100 mg 

EPS1600000 Sucrose 100 mg 

EPS1608100 Sufentanil - Reference Spectrum unit 

EPS1609000 Sufentanil citrate - Reference Spectrum unit 

EPY0000529 Sulbactam sodium 10 mg 

EPY0000528 Sulbactam 150 mg 

EPY0000550 Sulbactam for peak identification 20 mg 

EPS1700000 Sulfacetamide sodium 50 mg 

EPS1800000 Sulfadiazine 100 mg 

EPS1900000 Sulfadimidine 100 mg 

EPS1950000 Sulfadoxine 50 mg 

EPS1975000 Sulfafurazole 100 mg 

EPS1975600 Sulfaguanidine 60 mg 

EPS2000000 Sulfamerazine 100 mg 

EPS2050000 Sulfamethizole 100 mg 

EPS2100000 Sulfamethoxazole 50 mg 

EPY0000412 

EPY0000413 

Sulfamethoxazole impurity A 

N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide 

Sulfamethoxazole impurity F 

4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide 

EPS2150000 Sulfamethoxypyridazine 50 mg 

EPS2151000 Sulfanilamide 100 mg 

EPS2159100 Sulfapyridine 20 mg 

EPS2155000 Sulfasalazine 2x250 mg 

EPS2155010 

Sulfasalazine derivative for resolution 

2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]- 

sulfonyl]phenyl]azo]benzoic acid 

EPS2158000 Sulfathiazole 100 mg 

EPS2159000 Sulfinpyrazone 30 mg 

EPS2159010 

EPS2159015 

Sulfinpyrazone impurity A 

1,2-diphenyl-4-(2-phenylsulphonylethyl)pyrazolidine-3,5-dione 

Sulfinpyrazone impurity B 

1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione 

EPS2160000 Sulfisomidine 50 mg 

EPS2180000 Sulindac 50 mg 

EPS2190000 Sulpiride 100 mg 

EPS2191000 

EPS2192000 

Sulpiride impurity A 

2-aminomethyl-1-ethylpyrrolidine 

Sulpiride impurity B 

methyl 5-sulphamoyl-2-methoxybenzoate 

EPY0000530 Sultamicillin 10 mg 

5 mg 

5 mg 

20 mg 

20 mg 

20 mg 

20 mg 

30 mg 




EPY0000531 Sultamicillin tosilate 200 mg 

EPY0000532 Sultamicillin for peak identification 10 mg 

EPY0000022 Sumatriptan succinate 50 mg 

EPY0000026 Sumatriptan impurity mixture 3 mg 

EPY0000027 Sumatriptan for system suitability 2 mg 

EPS2200000 Suxamethonium chloride 1000 mg 

EPS2400000 Suxibuzone 50 mg 

EPS2400004 

EPS2400006 

Suxibuzone impurity B 

(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate 

Suxibuzone impurity C 

4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione 

EPS5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines-vet.use) BRP 1 mg 

EPS5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines-vet.use) BRP 1 mg 

EPT0010000 Talampicillin hydrochloride 50 mg 

EPT0014000 Tamoxifen citrate 80 mg 

EPT0015000 Tamoxifen citrate for performance test 50 mg 

EPY0000650 Tamsulosin hydrochloride 10 mg 

EPY0000653 Tamsulosin racemate 10 mg 

EPY0000651 

EPY0000652 

Tamsulosin impurity D 

2-methoxy-5[(2R)-2-[[2-(2-methyoxyphenoxy)ethyl]amino]propyl]benzenesulfonamide 

Tamsulosin impurity H 

(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine 

EPT0040000 Temazepam Controlled Substance 50 mg 

EPY0000344 

EPY0000345 

EPY0000346 

EPY0000347 

Temazepam impurity C 

(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate 


Temazepam impurity D 

(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 


Temazepam impurity F 

(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H- 

1,4-benzodiazepine-2,3-dione 

Temazepam impurity G 

(5RS)-7-chloro-1,4-methyl-5-phenyl-4,5-dihydro- 

1H-1,4-benzodiazepine-2,3-dione 

EPT0040800 Tenoxicam 100 mg 

EPY0000621 Terazosin hydrochloride dihydrate 40 mg 

EPY0000666 Terazosin for system suitability 0.5 mg 

EPY0000622 

EPY0000665 

EPY0000623 


Terazosin impurity A 

2-chloro-6,7-dimethoxyquinazolin-4-amine 

Terazosin impurity E 

2,2`-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) 

Terazosin impurity L 

1-(furan-2-ylcarbonyl)piperazine 

Terazosin impurity N 

1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine 

EPY0000535 Terbinafine hydrochloride 10 mg 

EPT0050000 Terbutaline sulphate 100 mg 

EPT0050015 

Terbutaline impurity C 

1-(3,5-dihydroxyphenyl)-2-[(1,1- dimethylethyl)amino]-ethanone 

EPT0060000 Terconazole 250 mg 

EPT0071000 Terfenadine 100 mg 

EPT0080000 

Terfenadine impurity A 

1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butan-1-one 

(ketone) 

EPT0100000 Testosterone 250 mg 

EPT0200000 Testosterone acetate 10 mg 

10 mg 

10 mg 

10 mg 

10 mg 

5 mg 

5 mg 

5 mg 

5 mg 

10 mg 

10 mg 

10 mg 

10 mg 

15 mg 

20 mg 




EPT0210000 Testosterone caproate 50 mg 

EPT0240000 Testosterone decanoate 25 mg 

New EPY0000696 Testosterone decanoate for system suitability 0.4 mg 

EPT0250000 Testosterone enantate 100 mg 

EPY0000342 Testosterone for impurity D identification 15 mg 

EPY0000343 Testosterone for system suitability 15 mg 

EPT0260000 Testosterone isocaproate 25 mg 

New EPY0000716 Testosterone isocaproate for system suitability 5 mg 

EPT0300000 Testosterone propionate 50 mg 

EPY0000170 Testosterone propionate - Reference Spectrum unit 

EPT0400000 Tetanus vaccine (adsorbed) BRP 11 mg 

EPT0499000 1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethane-sulphonyl-ßD-mannopyranose - 

Reference Spectrum 

EPT0500000 Tetracaine hydrochloride 100 mg 

EPT0550000 Tetracosactide 2x0.365 mg 

EPT0600000 Tetracycline hydrochloride 100 mg 

EPY0000015 Tetrazepam - Reference Spectrum unit 

EPY0000008 

Tetrazepam impurity C 

7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 

EPY0000460 Tetryzoline hydrochloride 10 mg 

New EPY0000723 Thebaine Controlled Substance 10 mg 

EPT0700000 Theobromine 100 mg 

EPT0800000 Theophylline 100 mg 

EPY0000294 Theophylline - Reference Spectrum unit 

EPY0000336 Thiamazol 125 mg 

EPY0000372 

EPY0000373 

Thiamazol impurity A 

2,2-dimethoxy-N-methylethanamine 

Thiamazol impurity C 

1-methyl-2-(methylsulphanyl)-1H-imidazole 

EPY0000467 Thiamine hydrochloride 10 mg 

EPY0000059 

Thiamine impurity E 

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl) 

4-methyl-4-thiazolidine-2-thione 

EPY0000060 Thiamine nitrate - Reference Spectrum unit 

EPT1100000 Thiamphenicol 125 mg 

EPY0000546 Thioctic acid 110 mg 

EPY0000592 Thioctic acid for system suitability 10 mg 

EPY0000545 Thioctic acid containing impurity B 30 mg 

EPY0000109 Thiomersal 30 mg 

EPT1200000 Thiopental 500 mg 

New EPY0000704 Thioridazine 10 mg 

EPY0000150 Thioridazine - Reference Spectrum unit 

EPT1300000 Thioridazine hydrochloride 50 mg 

EPY0000541 Thioridazine for system suitability 0.21 mg 

EPT1305100 Thioxanthene 20 mg 

EPT1305000 Thioxanthone 10 mg 

EPT1340000 Threonine 50 mg 

EPT1350000 Thymol 50 mg 

EPT1410000 Tiabendazole 50 mg 

EPY0000414 Tiamulin for peak identification 10 mg 

EPY0000333 Tiamulin hydrogen fumarate 450 mg 

EPY0000379 Tiamulin - Reference Spectrum unit 

EPY0000151 Tianeptine sodium - Reference Spectrum unit 

unit 

20 mg 

10 mg 

20 mg 

10 mg 




EPY0000152 Tianeptine for system suitability 30 mg 

EPY0000153 

Tianeptine impurity A 

ethyl 7-bromoheptanoate 

EPT1405000 Tiapride hydrochloride 60 mg 

EPT1405050 Tiapride N-oxide 20 mg 

EPT1410900 Tiaprofenic acid 50 mg 

EPT1410910 

Tiaprofenic acid impurity C 

(RS)-2-(5-benzoyl-3-thienyl)propanoic acid 

New EPY0000748 Tibolone - Reference Spectrum unit 

EPY0000668 Tibolone for system suitability 10 mg 

EPY0000465 Ticarcillin monosodium 250 mg 

EPT1420010 

Ticarcillin impurity A 

(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]-amino]-4-thia-1- 

azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin) 

EPT1423000 Ticlopidine hydrochloride 50 mg 

EPT1423025 

Ticlopidine impurity F 

6-(2-chlorobenzyl)4,5,6,7-tetrahydrothieno [3,2-c]pyridine 

EPY0000325 Tilidine hydrochloride hemihydrate - Reference Spectrum unit 

EPT1450000 Timolol maleate 50 mg 

EPY0000644 (R)-timolol 20 mg 

EPT1470000 Tinidazole 100 mg 

EPT1471000 

Tinidazole impurity B 

1-(2-ethylsulphonylethyl)-2-methyl-4-nitroimidazole 

EPT1490000 Tinzaparin sodium 250 mg 

EPY0000292 Tioconazole - Reference Spectrum unit 

EPY0000282 Tioconazole for system suitability 50 mg 

EPT1500000 Tobramycin 250 mg 

EPY0000383 All-rac-alpha-tocopherol for peak identification 15 mg 

EPY0000384 All-rac-alpha-tocopheryl acetate for peak identification 15 mg 

EPT1550000 alpha-Tocopherol 250 mg 

EPT1600000 alpha-Tocopheryl acetate 250 mg 

EPT1610000 RRR-alpha-Tocopheryl hydrogen succinate 125 mg 

EPT1700000 Tolbutamide 100 mg 

EPY0000154 Tolfenamic acid 100 mg 

EPT1707000 Tolnaftate 60 mg 

EPY0000461 Torasemide anhydrous 10 mg 

EPY0000462 Torasemide for system suitability 0.4 mg 

EPY0000155 Tramadol hydrochloride 75 mg 

EPY0000156 

EPY0000157 

Tramadol impurity A 

(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol 

Tramadol impurity E 

(2RS)-2-[(dimethylamino)methyl]cyclohexanone 

EPY0000072 Tramazoline hydrochloride monohydrate 20 mg 

EPY0000065 

EPY0000066 

Tramazoline impurity A 

N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine 

Tramazoline impurity B 

mixture of: 1-acetyl-2-[(5,6,7,8-tetrahydronaphthalen-1-yl)amino]-4,5-dihydro-1H-imidazole 

and N-(4,5-dihydro-1H-imidazol-2-yl)-N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide 

EPY0000501 Trandolapril 10 mg 

EPY0000495 

EPY0000496 

Trandolapril impurity C 

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl- 

1-(ethoxycarbonyl)propyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid 

(hexahydrotrandolapril) 

Trandolapril impurity D 

ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]- 

4-phenylbutanoate (trandolapril diketopiperazine) 

20 mg 

20 mg 

50 mg 

10 mg 

20 mg 

15 mg 

10 mg 

10 mg 

10 mg 

10 mg 

10 mg 




EPT1810000 Tranexamic acid 50 mg 

EPT1810030 

Tranexamic acid impurity C 

4-(aminomethyl)cyclohex-1-enecarboxylic acid 

EPT1820000 Trapidil 50 mg 

EPT1820002 

EPT1820004 

Trapidil impurity A 

5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol 

Trapidil impurity B 

1,2,4-triazol-3-amine 

EPT1850000 Tretinoin 50 mg 

EPT1899000 3,4,6-Tri-O-acetyl-D-glucal - Reference Spectrum unit 

EPG0400010 Triacetin - Reference Spectrum unit 

EPT1899990 Triamcinolone 150 mg 

EPT1900000 Triamcinolone acetonide 100 mg 

EPT1950000 Triamcinolone hexacetonide 100 mg 

EPY0000050 

Triamcinolone impurity C 

9-fluoro-11ß-16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione (pretriamcinolone) 

EPT1975000 Triazolam Controlled Substance 10 mg 

EPY0000165 Tribenoside 150 mg 

EPY0000166 

Tribenoside impurity A 

3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-α-D-glucofuranose 

EPY0000330 Tributyl acetylcitrate - Reference Spectrum unit 

EPY0000279 Tri-n-butyl phosphate 300 µL 

EPT1977990 Tricaprin 150 mg 

EPT1977995 Tricaproin 40 mg 

EPT1978000 Tricaprylin 225 mg 

EPY0000111 Trichloroacetic acid - Reference Spectrum unit 

EPT1985000 Trichlorotrifluoroethane 2x2.5 mL 

EPT1986000 Triethyl citrate - Reference Spectrum unit 

EPT2000000 Trifluoperazine hydrochloride 100 mg 

EPT2005000 Triflusal 50 mg 

EPT2005010 

Triflusal impurity B 

2-hydroxy-4-(trifluoromethyl)benzoic acid; (4-(trifluoromethyl)salicylic acid) 

New EPY0000720 Triglycerol diisostearate 200 mg 

EPY0000108 Trihexyphenidyl hydrochloride 100 mg 

EPY0000068 

Trihexyphenidyl impurity A 

1-phenyl-3-(piperidin-1-yl)propan-1-one 

EPT2009000 Trilaurin 1250 mg 

EPY0000092 Trimetazidine dihydrochloride - Reference Spectrum unit 

EPY0000093 Trimetazidine for system suitability 50 mg 

EPT2100000 Trimethadione 250 mg 

EPT2200000 Trimethoprim 50 mg 

EPY0000684 Trimethoprim for system suitability 0.00075 mg 

EPT2200010 

Trimethoprim impurity B 

(2,4-diaminopyrimidin-5-yl)(3,4,5- trimethoxyphenyl)methanone 

EPT2450000 Trimethyltetradecylammonium bromide 200 mg 

EPT2500000 Trimipramine maleate 100 mg 

EPT2500100 Trimyristin 500 mg 

EPT2501200 Tristearin 100 mg 

EPT2545000 Trolamine 2250 mg 

EPT2550000 Trometamol 100 mg 

EPT2580000 Tropicamide 50 mg 

EPY0000616 Tropisetron hydrochloride 40 mg 

EPY0000618 

Tropisetron impurity B 

1H-indole-3-carboxylic acid 

10 mg 

20 mg 

20 mg 

10 mg 

30 mg 

25 mg 

20 mg 

10 mg 

10 mg 




EPT2580300 Tropine 50 mg 

EPY0000429 Trospium chloride 10 mg 

EPY0000432 

EPY0000431 

EPY0000430 

Trospium impurity A 

Hydroxydiphenylacetic acid (benzilic acid) 

Trospium impurity B 

(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate 

Trospium impurity C 

(1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] 

EPY0000497 Troxerutin 30 mg 

EPT2600000 Trypsin BRP 100 mg 

EPT2610000 Tryptophan 100 mg 

EPT2800000 Tubocurarine chloride 100 mg 

EPT2880000 Tylosin 150 mg 

EPT2880100 Tylosin D 5 mg 

EPY0000498 Tylosin phosphate for peak identification 10 mg 

EPT2880200 Tylosin tartrate - Reference Spectrum unit 

EPT2900000 Tyrosine 50 mg 

EPT3000000 Tyrothricin 10 mg 

EPU0020000 Ubidecarenone 50 mg 

EPU0020001 Ubidecarenone for system suitability 10 mg 

EPU0020008 

Ubidecarenone impurity D 

5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35- 

nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl] 

benzene-1,4-dione (ubiquinone-9) 

EPU0100000 Uracil arabinoside 30 mg 

EPU0600000 Urea 100 mg 

EPU0800000 Ursodeoxycholic acid 60 mg 

EPY0000583 Valerian standardised dry extract 400 mg 

EPV0030000 Valine 50 mg 

EPY0000584 Valnemulin hydrochloride 10 mg 

EPY0000533 Valnemulin hydrogen tartrate 120 mg 

EPY0000585 Valnemulin for peak identification 10.25 mg 

EPY0000586 

Valnemulin impurity E 

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro- 

3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin) 

EPV0033000 Valproic acid 100 mg 

EPV0045000 Vancomycin hydrochloride 100 mg 

EPV0050000 Vanillin 100 mg 

EPY0000561 Vecuronium bromide 10 mg 

EPY0000625 Vecuronium for peak identification 10 mg 

EPY0000587 Venlafaxine hydrochloride 50 mg 

EPY0000588 Venlafaxine for system suitability 1 mg 

EPV0100000 Verapamil hydrochloride 100 mg 

EPV0100018 

EPV0100026 

Verapamil impurity I 

(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4)dimethoxyphenyl)- 

ethyl](methyl)amino]ethyl]3-methylbutanenitrile 

Verapamil impurity M 

5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)- 

2-(1-methylethyl)pentanenitrile 

EPY0000661 Verbenalin 11 mg 

EPV0180000 VERO cells 2x1 mL 

EPV0200000 Viscosimeter calibration liquids 250 mL 

EPV0300000 Vinblastine sulphate 5 mg 

EPV0305000 Vinblastine sulphate - Reference Spectrum unit 

20 mg 

15 mg 

5 mg 

5 mg 

10 mg 

5 mg 

20 mg 




EPV0400000 Vincristine sulphate 4.98 mg 

EPV0405000 Vincristine sulphate - Reference Spectrum unit 

EPV0500000 Vindesine sulphate 5.11 mg 

EPV0500010 Vindesine sulphate - Reference Spectrum unit 

EPY0000463 Vinorelbine tartrate 40 mg 

EPY0000464 

Vinorelbine impurity B 

4-O-deacetylvinorelbine 

New EPY0000589 Vinpocetine 10 mg 





Vinpocetine impurity A 

ethyl(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate 

(ethyl vincaminate) 

Vinpocetine impurity B 

Methyl(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate 

(apovincamine) 

Vinpocetine impurity C 

ethyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate 

(methoxyvinpocetine) 

Vinpocetine impurity D 

Ethyl(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H- 

indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- 

carboxylate (dihydrovinpocetine) 

New EPY0000793 Vinyl acetate 10 mg 

EPW0100000 Warfarin sodium 100 mg 

New EPY0000778 Warfarin sodium clathrate 10 mg 

EPX0075000 Xylazine hydrochloride 125 mg 

EPY0000158 

EPY0000159 

Xylazine impurity C 

2,6-dimethylphenyl isothiocyanate 

Xylazine impurity E 

N-(2,6-dimethylphenyl)-S-methyldithiourea 

EPX0080000 Xylitol 500 mg 

EPX0100000 Xylometazoline Hydrochloride 100 mg 

EPX0101000 

Xylometazoline impurity A 

N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide 

EPX0200000 Xylose 100 mg 

New EPY0000656 Yohimbine hydrochloride 20 mg 

EPZ1900000 Zidovudine 60 mg 

EPZ1902000 

EPZ1904000 

Zidovudine impurity A 

1-[(2R,5S)-5-hydroxymethyl-2,5-dihydro-2-furyl]- 

5-methylpyrimidine-2,4(1H,3H)-dione 

Zidovudine impurity B 

1-(3-chloro-2,3-dideoxy-ß-D-ribofuranosyl)- 

5-methylpyrimidine-2,4(1H,3H)-dione 

EPZ2000000 Zinc acexamate 50 mg 

EPZ2000010 

Zinc acexamate impurity A 

6-[[6-(acetylamino)hexanoyl]amino] hexanoic acid 

EPZ2500000 Zolpidem tartrate Controlled Substance 150 mg 

EPZ2500010 

Zolpidem impurity A 

N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol 

[1,2-a]pyridin-3-yl] acetamide 

EPZ3000000 Zopiclone Controlled Substance 60 mg 

EPZ3001000 Zopiclone oxide 20 mg 

EPY0000062 Zuclopenthixol decanoate - Reference Spectrum unit 

EPY0000534 Zuclopenthixol for system suitability 0.1 mg 

EPY0000083 

Zuclopenthixol impurity B 

2-chloro-9H-thioxanthen-9-one 

7 mg 

10 mg 

10 mg 

10 mg 

10 mg 

50 mg 

50 mg 

10 mg 

10 mg 

10 mg 

50 mg 

10 mg 

10 mg 




As a scientist you know the importance of using the best materials to support your quality control 

programme. As Europe’s only officially authorized distributor of ATCC ® cultures, LGC Standards can 

supply all ATCC organisms specified in the pharmacopoeia. 

ATCC maintains the highest standards for its biological materials, employing stringent quality control 

procedures to produce cultures which are well characterized and have low passage numbers. Long-term 

subculturing of biological materials can have adverse effects on the culture population, including genetic 

drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by 

LGC Promochem are never subcultured or transferred in any way from ATCC’s strains and our European 

stock-holding means orders are usually filled within 3 - 5 working days. 


or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies 

with authentic, high-quality ATCC materials - exclusively from LGC Standards. 

European Pharmacopoeia, 5th Edition 2005 


EP 2.6.1 - Sterility 









EP 2.6.2 - Mycobacterium tuberculosis 

ATCC-25177 Mycobacterium tuberculosis amp. 

EP 2.6.7 - Mycoplasma 

ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp. 

ATCC-19610 Mycoplasma gallisepticum amp. 

ATCC-17981 Mycoplasma hyorhinis Switzer amp. 

ATCC-23714 Mycoplasma orale amp. 

ATCC-15531 Mycoplasma pneumoniae amp. 

ATCC-25204 Mycoplasma synoviae amp. 

EP 2.6.12 - Microbiological examination of non-sterile products (total.......... 






ATCC-6538P Staphylococcus aureus subsp. aureus amp. 

EP 2.6.2 - EP 2.6.13 Microbial contamination of products not required........ 

ATCC-13124 Clostridium perfringens amp. 







European Pharmacopoeia, 5th Edition 2005 


EP 2.7.2 - Microbiological assay of antibiotics 

ATCC-14884 Bacillus pumilus amp. 




ATCC-10541 Enterococcus hirae (as Streptococcus faecalis) amp. 










EP 5.1.2 - Biological indicators of sterilisation 




EP 5.1.3 - Efficacy of antimicrobial preservation 







All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia 

directly to confirm the testing requirements and recommended organisms before ordering or undertaking the 

testing procedures as described in the Pharmacopoeia. 


Certified Liquids for Viscosity Measurements in the European Pharmacopoeia 

Certified Liquids for Viscosity Measurements in the European 

Pharmacopoeia 

Newtonian liquids with a certified viscosity are supplied by Van Swinden Laboratorium BV and are 

distributed by LGC Standards. 

Liquids are available with kinematic viscosities up to 48000 mm 2·s-1 and certified at temperatures between 

15°C and 140°C. 

Viscosities are certified in mm 2·s-1 (kinematic viscosity, v) or in mPa . s (dynamic viscosity,η) 

1 mPa . s = 1 cps (centipoise) 1 mm 2. s -1 = 1 cst (centistoke) 

Standard liquids are available from stock, in 250 ml packs and certified at 20°C to following viscosities: 

v = 0,6 ; 1,0 ; 2,2; 4,9 ; 1; 20 ; 31 ; 56 ; 67 ; 85 ; 100 ; 132 ; 167 ; 217 ; 262; 340 ; 423 ; 537 ; 644 ; 783 ; 

1000 ; 1260 ; 1800 ; 3650 ; 5075 ; 10175 ; 18400 ; 46500 

η= 0,4 ; 1,0 ; 1,8; 4,0 ; 8,9 ; 17,0 ; 26,0 ; 48,0 ; 58,0 ; 74,0 ; 87,0 ; 116,0 ; 146,0 ; 191,0 ; 230,0 ; 300,0 ; 

375,0 ; 474,0 ; 572,0 ; 700,0 ; 862,0 ; 1085 ; 1560 ; 3175 ; 4430 ; 8935 ; 16300 ; 41300 

All viscosities are calibrated relative to the viscosity of pure water. Stated values are nominal values, 

certified values will not deviate more than 10% from the nominal value. 

The uncertainty of the certified viscosities is at least 0.3% at the lowest viscosity, increasing up to 0.5% 

at 48000 mm 2. s -1 . 

Shelf life 

Standards up to 500 mPa . s are mineral oil based, and have a shelf life of 12 months from date of 

certification. Above 500 mPa . s Polyisobutylene is used, these materials have a shorter shelf life, and should 

be ordered as needed. 

Liquids can be prepared and certified to any viscosity between 0.6 mm 2. s -1 and 80,000 mm 2. s -1 . 

The price depends on the viscosity required, the degree of precision between nominal viscosity required and 

certified viscosity achieved, and temperature of certification. 

Additional charges are applied for extra certification temperatures and for certification of dynamic viscosity. 

Please ask for a quotation. 

Liquids supplied by customers may be certified for viscosity, charges vary: please ask for a quotation. 


International Commission on Pharmaceutical Enzymes 

International Commission on Pharmaceutical Enzymes 

The Commission on Pharmaceutical Enzymes was formed in 1960, with a remit to establish quantitative 

methods and an exact definition of enzyme activity for pharmacologically significant enzymes. 

One consequence of the work of FIP “Federation International Pharmaceutique” has been the production 

and certification of reference substances for both enzymes and substrates. 

More recently the work of the Commission has been reflected in those monographs of the European 

Pharmacopoeia which call for enzyme standards. The FIP products marked (EP) in this list are those 

which are required in certain EP monographs. 

Enzymes 


FIP1 Fungal Amylase 2 g 

FIP2(EP) Amylase (pancreatic) 2 g 

FIP3 Fungal Protease 2 g 

FIP4 Bromelain 250 mg 

FIP5 Endocellulase 1 g 

FIP6(EP) Chymotrypsin 100 mg 

FIP7 Fungal Lipase 500 mg 

FIP8(EP) Lipase (pancreatic) 2 g 

FIP9 Lysozyme hydrochloride 250 mg 

FIP10 Papain 2 g 

FIP11(EP) Pepsin 2 g 

FIP12(EP) Protease (pancreatic) 2 g 

FIP13(EP) Trypsin 100 mg 

FIP14(EP) Hyaluronidase 50 mg 

Substrates 

FIP15(EP) Enterokinase 500 mg 

FIP16 Micrococcus Luteus sp. 1 g 

FIP17 Starch (EP) 50 g 

FIP18(EP) Casein 100 g 

FIP19 Hemoglobin 10 g 

FIP20 Hydroxyethylcellulose 100 g 

FIP21 Sodium Taurocholate 10 g 

FIP22(EP) Sodium hyaluronate 300 mg 


European Pharmacopoeia Reagents from Reagecon 


Chapters 2 and 4 of the European Pharmacopoeia describe the preparation of several hundred reagents 

and standards used for the testing of pharmaceutical raw materials. 

LGC Standards is pleased to introduce a large number of these ready-to-use reagents and standard 

solutions within the spectrum of this new catalogue. 

The primary solutions for coloration are produced by LGC Standards, the other reagents are manufactured 

by Reagecon. All are manufactured and tested in compliance with the prescriptions of EP. The products are 

supplied with certificates of analysis. Lot numbers and expiry dates are stated on all product labels as well. 

The reagents are always supplied as per the most recently issued EP supplement. 

Reagents from other pharmacopoeias are also available on request. Please contact your local 

LGC Standards office for further details. 

Reagents as outlined in Chapter 2 


REAEPPOSO1 Primary opalescence suspension 100 mL 

Coloration: primary solutions 

New WESEPYS01 Coloration-primary solution yellow 100 mL 

New WESEPRS01 Coloration-primary solution red 100 mL 

New WESEPBS01 Coloration-primary solution blue 100 mL 

Coloration: standard solutions 

REAEP703 Standard solution B (brown) 125 mL 

REAEP704 Standard solution BY (brownish yellow) 125 mL 

REAEP706 Standard solution Y (yellow) 125 mL 

REAEP705 Standard solution GY (greenish yellow) 125 mL 

REAEP707 Standard solution R (red) 125 mL 

REAHADM1 HCL dilution matrix (10 g/l HCl) 1 L 

Reference buffer solutions - all @ 25°C 

REAEP168 ph Buffer solution 1.68 500 mL 





Conductivity & resistivity solutions - @ 20°C 

REAEP1330 

REAEP133 

REAEP266 

Conductivity standard 

Electrolytic conductivity.............1330 µS/cm at 20°C 

Resistivity...................................................752 Ω⋅cm 


Electrolytic conductivity...............133 µS/cm at 20°C 

Resistivity.................................................7519 Ω⋅cm 


Electrolytic conductivity..............26.6 µS/cm at 20°C 

Resistivity...............................................37594 Ω⋅cm 

500 mL 

500 mL 

500 mL 

Reagents as outlined in Chapter 4 (4.1.1) of Ph.Eur. 

REA1000401 Acetic acid (30%) 1 L 

REA1000402 Acetic acid, dilute (12%) 1 L 

REA1000501 Acetic anhydride solution R1 1 L 

REA1002501 Alcohol, aldehyde free 1 L 

REA1004702 Ammonia, dilute R1 1 L 

REA1004703 Ammonia, dilute R2 1 L 

REA105201 Ammonium carbonate, solution (short shelf life) 1 L 

REA1007301 Anisaldehyde, solution 100 mL 

REA1007302 Anisaldehyde, solution R1 100 mL 

REA1009301 Barium chloride, solution R1 1 L 




REA1009401 Barium hydroxide, solution 1 L 

REA1011601 Biuret reagent 1 L 

REA1012601 Bromocresol green solution 100 mL 

REA1012602 Bromocresol green-methyl red solution 100 mL 

REA1012701 Bromocresol purple solution 100 mL 

REA1012801 Bromophenol blue solution 100 mL 

REA1012803 Bromophenol blue solution R2 100 mL 

REA1012901 Bromothymol blue solution R1 100 mL 

REA1015201 Calcium sulphate solution 1 L 

REA1022901 Crystal violet solution 100 mL 

REA1023100 Cupri-citric solution 1 L 

REA1023300 Cupri-tartaric (Solution I 500 mL & Solution II 500 mL) 1 L 

REA1031101 Dimidium bromide - sulphan blue mixed solution 1 L 

REA1032101 Diphenylamine solution 1 L 

REA1032102 Diphenylamine solution R1 1 L 

REA1037702 Ferric ammonium sulphate solution R2 100 mL 

REA1038100 Ferroin 100 mL 

REA1039101 Formaldehyde solution 100 mL 

REA1039401 Fuchsin solution, decolorised 100 mL 

REA1039402 Fuchsin solution, decolorised R1 100 mL 

REA1043101 Holmium perchlorate solution 1 L 

REA1043501 Hydrochloric acid R1 1 L 

REA1043503 Hydrochloric acid, dilute 1 L 

REA1043504 Hydrochloric acid, dilute R1 1 L 

REA1045901 Iodine bromide solution 1 L 

REA1046300 Iodoplatinate reagent 200 mL 

REA1048001 Lanthanum nitrate solution 1 L 

REA1048101 Lead acetate cotton 10 g 

REA1048102 Lead acetate paper Pack of 50 

REA1052101 Mercuric bromide paper Pack of 50 

REA1053601 Methoxyphenylacetic reagent 100 mL 

REA1054801 Methyl orange mixed solution 100 mL 

REA1054802 Methyl orange solution 100 mL 

REA1055101 Methyl red mixed solution 100 mL 

REA1055102 Methyl red solution 100 mL 

REA1056700 Molybdovanadic reagent 100 mL 

REA1056801 Mordant black 11 triturate 100 mL 

REA1057601 Naphtobenzein solution 100 mL 

REA1058201 Nile blue A solution 100 mL 

REA1058303 Ninhydrin, solution 100 mL 

REA1058304 Ninhydrin solution R1 100 mL 

REA1058305 Ninhydrin solution R2 100 mL 

REA1058402 Acide nitrique dilué 100 mL 

REA1062901 Perchloric acid solution 100 mL 

REA1063601 Phenol red solution 100 mL 

REA1063603 Phenol red solution R2 500 mL 

REA1063702 Phenolphthalein solution 100 mL 

REA1063703 Phenolphthalein solution R1 100 mL 

REA1065000 Phosphomolybdotungstic reagent 100 mL 

REA1065200 Phosphomolybdotungstic solution 100 mL 

REA1065801 Picric acid solution 100 mL 

Edition 2008 All your needs for pharmaceutical analyis - email pharma@lgcstandards.com 119



REA1065802 Picric acid solution R1 100 mL 

REA1069101 Potassium chloride, 0.1 M 1 L 

REA1069201 Potassium chromate, solution 1 L 

REA1069501 Potassium dichromate, solution 1 L 

REA1069801 Potassium ferrocyanide, solution 100 mL 

REA1070001 Potassium hydrogen phthalate, 0.2 M 1 L 

REA1070302 Potassium hydroxide in alcohol (10% v/v) 1 L 

REA1070303 Potassium hydroxide solution alcoholic 100 mL 

REA1070501 Potassium iodide and starch solution 125 mL 

REA1070502 Potassium iodide solution 1 L 

REA1070600 Potassium iodobismuthate, solution 100 mL 

REA1070602 Potassium iodobismuthate, solution R2 (short shelf life) 100 mL 

REA1070902 Potassium permanganate, solution 1 L 

REA1071301 Potassium pyroantimonate, solution 125 mL 

REA1071600 Potassium tetraiodomercurate, solution alkaline (100 ml of both solutions) 200 mL 

REA1075201 Ruthenium red solution 100 mL 

REA1078301 Silver nitrate solution R1 1 L 

REA1078302 Silver nitrate solution R2 1 L 

REA1079301 Sodium carbonate solution 1 L 

REA1081401 Sodium hydroxide solution 1 L 

REA1081402 Sodium hydroxide solution dilute 1 L 

REA1081404 Sodium hydroxide solution strong 1 L 

REA10816005 Sodium hypochlorite solution strong 500 mL 

REA1083901 Sodium sulfure solution 100 mL 

REA1085103 Starch, solution 100 mL 

REA1086804 Sulphuric acid, dilute 1 L 

REA1089602 Thiocetamide solution 1 L 

REA1090701 Thymolphthalein solution 100 mL 

REA1102301 Zinc acetate solution 1 L 

REA1096601 Zinc chloride formic acid solution 1 L 

REA1096602 Zinc chloride solution, iodinated 1 L 

Standard solutions for limit tests as outlined in Chapter 4 (4.1.2) of Ph.Eur. 

REA5000200 Aluminium standard solution (200 ppm Al) 100 mL 

REA5000300C Ammonium standard solution (100 ppm NH 4) 100 mL 

REA5000500C Arsenic standard solution (10 ppm As) 100 mL 

REA5000700C Cadmium standard solution (0.1% Cd) 100 mL 

REA5000800C Calcium standard solution (400 ppm Ca) 100 mL 

REA5000802C Calcium standard solution alcoholic (400 ppm Ca) 1 L 

REA5000900C Chloride standard solution (8 ppm CI) 100 mL 

REA5001000 Chromium standard solution (100 ppm Cr) 1 L 

REA5001100 Copper standard solution (0.1% Cu) 100 mL 

REA5001200C Ferrocyanide standard solution (100 ppm Fe) 100 mL 

REA5001400C Fluoride standard solution (10 ppm F) 100 mL 

REA5001600C Iron standard solution (20 ppm Fe) 100 mL 

REA5001602C Iron standard solution (8 ppm Fe) 100 mL 

REA5001701C Lead standard solution (100 ppm Pb) 100 mL 

REA5001800C Lagnesium standard solution (100 ppm Mg) 100 mL 

REA5002000C Nickel standard solution (10 ppm Ni) 100 mL 

REA5002100C Nitrate standard solution (100 ppm NO 3) 100 mL 




REA5002200C Phosphate standard solution (5 ppm PO 4) 100 mL 

REA5002400C Potassium standard solution (100 ppm K) 100 mL 

REA5002500 Selenium standard solution (100 ppm Se) 1 L 

REA5002700C Sodium standard solution (200 ppm Na) 100 mL 

REA5002800C Sulphate standard solution (10 ppm SO 4) 100 mL 

REA5003100C Tin standard solution (5 ppm Sn) 1 L 

REA5003401C Zinc standard solution (100 ppm Zn) 100 mL 

Buffer solutions as outlined in Chapter 4 (4.1.3) of Ph.Eur. 

REA4000100 Buffered acetone solution 1 L 

REA4000600 Buffer solution pH 3.5 1 L 

REA4001400 Acetate buffer solution pH 4.6 1 L 

REA4004800 Phosphate buffer solution pH 7.4 1 L 

REA4008300 Buffer (phosphate) solution pH 9.0 1 L 

REA4007200 Ammonium chloride buffer solution pH 9.5 1 L 

REA4007300 Ammonium chloride buffer solution pH 10.0 1 L 

Volumetric solutions as outlined in Chapter 4 (4.2.2) of Ph.Eur. 

REA3000100 0.1M Ammonium and cerium nitrate 1 L 

REA3000200 0.01M Ammonium and cerium nitrate 1 L 

REA3000300 0.1M Ammonium and cerium sulphate 1 L 

REA3000500 0.1M Ammonium thiocyanate 1 L 

REA3000600 0.1M Barium chloride 1 L 

REA3000900 0.004M Benzethonium chloride 1 L 

REA3001100 0.1M Cerium sulphate 1 L 

REA3008700 1M Cupriethylenediamine hydroxide solution 1 L 

REA3001300 0.1M Ferric ammonium sulphate 1 L 

REA3001500 6M Hydrochloric acid 1 L 



REA3002100 0.1M Hydrochloric acid 1 L 

REA3008800 0.1M Hydrochloric acid, alcoholic 1 L 

REA3002700 0.05M Iodine 1 L 

REA3003100 0.1M Lead nitrate 1 L 

REA3003300 0.1M Lithium methoxide 1 L 

REA3003500 0.02M Mercuric nitrate 1 L 

REA3003900 0.1M Perchloric acid 1 L 

REA3004200 0.033M Potassium bromate 1 L 

REA3002900 0.01M Iodine 1 L 

REA3009100 11M Potassium hydroxide 1 L 

REA3004800 0.1M Potassium hydroxide 1 L 

REA3004900 0.5M Potassium hydroxide 1 L 

REA3005000 0.5M Potassium hydroxide, alcoholic 1 L 

REA3005100 0.1M Potassium hydroxide, alcoholic 1 L 

REA3005300 0.02M Potassium permanganate 1 L 

REA3005600 0.1M Silver nitrate 1 L 

REA3005800 0.1M Sodium arsenite 1 L 

REA3005900 0.1M Sodium edetate 1 L 

REA3006300 1M Sodium hydroxide 1 L 

REA3006600 0.1M Sodium hydroxide 1 L 

REA3007100 0.1M Sodium methoxide 1 L 

REA3007200 0.1M Sodium nitrate 1 L 

Edition 2008 All your needs for pharmaceutical analyis - email pharma@lgcstandards.com 121



REA3007300 0.1M Sodium thiosulphate 1 L 

REA3007800 0.5M Sulphuric acid 1 L 

REA3008000 0.05M Sulphuric acid 1 L 

REA3008300 0.1M Tetrabutylammonium hydroxide 1 L 

REA3008400 0.1M Tetrabutylammonium hydroxide in 2-propanol 1 L 

REA3008600 0.1M Zinc sulphate 1 L 


British 

Pharmacopoeia 

Pharmacopée 

Française 

Pharmacopoeia 

Helvetica 

International 

Pharmacopeia 



High purity 

solvents 

LGC Standards, Europe´s most comprehensive single 

source of reference materials, cell cultures and 

bioproducts, offers a full range of high purity solvents 

for use in the laboratory. 

We provide a wide range of over 80 different solvents 

including Picograde ® solvents for residue analysis, 

Optigrade ® sovents for HPLC, special grades for the 

analysis of volatile, halogenated or aromatic organic 

compounds as well as our new range of LC-MS 

solvents and customised solvents mixes. 

Through our extensive distribtion network of European 

offices, and our expertise in technical support, LGC 

Standards is the ideal source for all your 

solvents. 


• Solvents available in range of different bottle sizes 

(1 to 4 L glass bottles and Cyclotainers ® ) 

For further information or to receive any of our 

catalogues, please contact your local office or visit 

our website. 

Range of over 80 solvents 

Picograde ® solvents for 

residue analysis 

Optigrade ® solvents for 

HPLC 

New LC-MS solvents 

Customised solvent mixes 

Special grades for highly 

volatile halogenated and 

aromatic hydrocarbons 

Solvents for high accuracy 

measurements 


British Pharmacopoeia 

Background 


British Pharmacopoeia chemical reference substances (BPCRS) available from BP are issued under the 

authority of the British Pharmacopoeia Commission and are solely for use in tests and assays of the British 

Pharmacopoeia or the British Pharmacopoeia (Veterinary). 

The list in this catalogue is current as of June 2007, and includes all available BPCRS needed to follow 

the current official monographs. Most BP monographs for active substances conform with the monographs 

issued by the European Pharmacopoeia, and so require the use of European Pharmacopoeia chemical 

reference substances. Details of these are to be found under the ‘European Pharmacopoeia’ section of 

this catalogue. 


British Pharmacopoeia reference substances and preparations are selected and verified by the BP 

Laboratories as being suitable for the use as prescribed in the relevant monographs of the British 

Pharmacopoeia. 

Documentation 

BPCRS are of two types – normal CRS for identification purposes and Assay Standards. Assay Standards 

are provided with a documented assay value, determined by the BP Laboratories. The values are given in 

a booklet provided with the reference substance. 

The BP laboratories do not make available any other BPCRS certificates of analysis or other information, 

in connection with the prescribed use of the BPCRS. 


Controlled drugs are subject to import and export control restrictions. Please contact LGC Standards for 

details. 


British Pharmacopoeia chemical reference substances are subjected to regular inspection and repeat 

analysis by BP scientific staff. Each BPCRS is, on receipt by the customer, fit for the intended use. All 

BPCRS are supplied with at least three months shelf life. 

BP supplies only current lots. For this reason users are advised to order only as required. 


BP 001 Acepromazine maleate 50 mg 

BP 681 4-Acetyl 2-fluorobiphenyl 25 mg 

BP 438 Aciclovir Assay Standard 100 mg 

BP 003 Adrenaline (epinephrine) acid tartrate Assay Standard 100 mg 

New BP 763 Albendazole Assay Standard 100 mg 

BP 436 Alexandrian senna fruit powder Assay Standard 1 g 

BP 006 Alfadolone acetate Assay Standard 100 mg 

BP 007 Alfaxalone Assay Standard 100 mg 

BP 415 Alimemazine tarate Assay Standard 100 mg 

BP 560 9-Allyl-2-chlorothioxanthen-9-ol 25 mg 

BP 725 Alverine citrate Assay Standard 100 mg 

BP 724 Alverine citrate impurity standard solution 1.0 mL 

BP 530 Amantadine hydrochloride Assay Standard 200 mg 

BP 008 Amiloride hydrochloride Assay Standard 100 mg 

BP 010 4-Amino-6-chlorobenzene-1-3-disulphonamide 50 mg 

BP 374 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2-ol 50 mg 

BP 012 2-Amino-4,6-Dichlorophenol hydrochloride 50 mg 

BP 602 (E)-4-Amino-2-ethylidenebutyric acid hydrochloride 25 mg 

BP 684 Aminoglutethimide Assay Standard 100 mg 

BP 417 2-Amino-1-(4-nitrophenyl)propane-1,3-diol 50 mg 




BP 601 3-Aminopent-4-ene-1,1-dicarboxylic acid 25 mg 

BP 536 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid 25 mg 

BP 014 3-Amino-4-propoxybenzoic acid 50 mg 

BP 532 Amiodarone hydrochloride Assay Standard 100 mg 

BP 015 Amitraz Assay Standard 200 mg 

BP 016 Amitriptyline hydrochloride Assay Standard 150 mg 

BP 748 Amoxicillin impurity standard 25 mg 

BP 546 Apramycin 250 mg 

BP 694 Arginine hydrochloride Assay Standard 100 mg 

BP 617 Aspirin Assay Standard 100 mg 

BP 492 Atenolol Assay Standard 100 mg 

BP 370 Atenolol impurity standard 50 mg 

BP 023 Atropine sulphate Assay Standard 200 mg 

BP 366 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-o-tolylsulphonylurea 30 mg 

BP 024 2-Azahypoxanthine 50 mg 

BP 025 Azaperone Assay Standard 100 mg 

BP 534 Azapropazone Assay Standard 100 mg 

BP 515 Azapropazone impurity A 10 mg 

BP 516 Azapropazone impurity B 10 mg 

BP 517 Azapropazone impurity C 10 mg 

BP 527 Azapropazone impurity standard 50 mg 

BP 028 Baclofen Assay Standard 150 mg 

BP 535 Baclofen lactam 25 mg 

BP 030 Beclometasone dipropionate Assay Standard 100 mg 

New BP 760 Beclometasone 17-propionate 25 mg 

New BP 761 Beclometasone 21-propionate 25 mg 

BP 685 Benserazide hydrochloride Assay Standard 100 mg 

BP 036 Benzatropine mesilate Assay Standard 100 mg 

BP 610 Benzydamine hydrochloride Assay Standard 100 mg 

BP 426 Benzyl benzoate Assay Standard 0.1 mL 

BP 611 1-Benzyl-3-(3-diethylamino-propoxy)-1H-indazole 50 mg 

BP 037 

(1S,2R)-1-benzyl-3-dimethylamino-2 

-methyl-1-phenylpropyl acetate 

BP 609 1-Benzyl-1-H-indazol-3-ol 50 mg 

BP 575 Betamethasone Assay Standard 100 mg 

BP 041 Betamethasone sodium phosphate 100 mg 

BP 042 Betamethasone valerate Assay Standard 100 mg 

BP 043 Betamethasone 21-valerate 50 mg 

BP 686 Betaxolol hydrochloride Assay Standard 100 mg 

New BP 755 Bezafibrate Assay Standard 100 mg 

BP 046 2-(Biphenyl-4-yl)propionic acid 25 mg 

BP 612 Bretylium tosilate Assay Standard 200 mg 

BP 613 2-Bromobenzyldimethylamine hydrochloride 25 mg 

BP 050 Bromocriptine Mesilate Assay Standard 100 mg 

BP 440 Buclizine hydrochloride impurity standard 100 mg 

BP 537 Bumetanide Assay Standard 100 mg 

BP 479 Bupivacaine hydrochloride Assay Standard 100 mg 

BP 403 Busulfan Assay Standard 25 mg 

BP 192 2-tert-Butylamino-1-(4-hydroxy-3-methylphenyl)ethanol sulphate 25 mg 

BP 531 2-Butyl-3-(4-hydroxy-3,5-di-iodobenzoyl)benzofuran 25 mg 

New BP 766 Caffeine Assay Standard 100 mg 

25 mg 




BP 355 Calcitonin (salmon) Assay Standard ca. 10 µg 

BP 059 Capreomycin sulphate 50 mg 

BP 538 Captopril Assay Standard 100 mg 

BP 500 Captopril disulphide 25 mg 

BP 477 2-Carbamoyl-1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride 25 mg 

BP 523 Carbaryl Assay Standard 100 mg 

BP 060 Carbidopa Assay Standard 100 mg 

BP 749 Carbimazole Assay Standard 100 mg 

BP 711 Carboplatin Assay Standard 100 mg 

New BP 767 Carmellose sodium Assay Standard 100 mg 

BP 567 Carteolol hydrochloride Assay Standard 100 mg 

BP 562 Cefalonium Assay Standard 100 mg 

BP 502 Cefuroxime axetil Assay Standard 100 mg 

New BP 757 Celiprolol hydrochloride Assay Standard 100 mg 

BP 064 Chlorambucil Assay Standard 100 mg 

BP 067 Chlorcyclizine hydrochloride 100 mg 

BP 068 Chlorhexidine acetate Assay Standard 100 mg 

BP 441 1,4-bis(4-Chlorobenzhydryl)piperazine 25 mg 

New BP 756 N-p-chlorobenzoyltyramine 25 mg 

BP 604 4-Chlorobenzylphthalazinone 25 mg 

BP 376 6-Chloro-4-(2-chlorophenyl)quinazoline-2-carboxaldehyde 50 mg 

BP 442 6-Chloro-1,4-dihydro-1-methyl-4-phenylquinazolin-4-ol 25 mg 

BP 470 7-Chloro-1-5-dihydro-5-phenyl-1,5-benzodiazepine-2,4(3H)-dione 25 mg 

BP 049 

17β,17'β-bis{3-[bis-(2-chloroethyl)carbamoyloxy] 

estra-1,3,5,(10)-trienyl}pyrophosphate 

BP 446 5-(2-Chloroethyl)-4-methyl-3-[2-(4-methylthiazol-5-yl)ethyl]thiazolium chloride 25 mg 

BP 071 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide 25 mg 

BP 378 5-Chloro-2-methylaminobenzophenone 50 mg 

BP 443 

6-(2-Chlorophenyl)-2,4-dihydro-2-[(dimethylamino)methylene] 

8-nitroimidazo[1,2-a][1,4]benzodiazepin-1-one 

BP 074 4-Chloro-5-sulphamoylanthranilic acid 25 mg 

BP 559 2-Chlorothioxanthone 25 mg 

BP 077 2-(6-Chlorothymoxy)ethyldimethylamine hydrochloride 25 mg 

BP 079 2-Chlorotritanol 25 mg 

BP 080 Chloroxylenol Assay Standard 500 mg 

BP 081 Chlorphenamine maleate Assay Standard 100 mg 

BP 467 Chlorpromazine sulphoxide 50 mg 

BP 491 Chlortalidone Assay Standard 100 mg 

BP 618 Cholic acid Assay Standard 100 mg 

BP 475 Cimetidine Assay Standard 100 mg 

BP 747 Clavulanate polymer 25 mg 

BP 525 Clemastine fumarate Assay Standard 200 mg 

BP 084 Clioquinol Assay Standard 200 mg 

BP 507 Clobazam Assay Standard Controlled Substance 100 mg 

BP 522 Clobetasol impurity A 25 mg 

BP 521 Clobetasol propionate Assay Standard 100 mg 

BP 482 Clobetasone butyrate Assay Standard 100 mg 

BP 406 Clocortolone hexanoate 100 mg 

BP 663 Clofazimine Assay Standard 100 mg 

BP 543 Clomethiazole edisilate Assay Standard 100 mg 

BP 085 Clonidine hydrochloride Assay Standard 100 mg 

25 mg 

25 mg 




BP 565 trans-Clopenthixol acetate dihydrochloride 50 mg 

BP 566 trans-Clopenthixol decanoate dihydrochloride 25 mg 

BP 561 trans-Clopenthixol hydrochloride 25 mg 

BP 628 Cloprostenol sodium Assay Standard 20 mg 

BP 379 Clotrimazole Assay Standard 50 mg 

BP 088 Cloxacillin benzathine Assay Standard 250 mg 

BP 091 Co-dergocrine mesilate Assay Standard 50 mg 

BP 715 Cocaine hydrochloride Assay Standard Controlled Substance 100 mg 

BP 514 Codeine hydrochloride Assay Standard Controlled Substance 100 mg 

BP 090 Codeine Phosphate Assay Standard Controlled Substance 200 mg 

BP 614 Colestipol hydrochloride 50 mg 

BP 551 Colestyramine Assay Standard 500 mg 

BP 585 Cortisone acetate Assay Standard 100 mg 

BP 094 Crotamiton Assay Standard 100 mg 

BP 466 Cyanocobalamin Assay Standard 100 mg 

BP 478 2-Cyano-1-methyl-3-[2-(5-methylimidazol-4-yl-methylsulphinyl)ethyl]guanidine 25 mg 

BP 096 Cyclizine hydrochloride Assay Standard 100 mg 

BP 098 Cyclopenthiazide 100 mg 

BP 380 Cyclopentolate hydrochloride Assay Standard 100 mg 

BP 688 Cyproterone acetate Assay Standard 100 mg 

BP 383 Cytarabine Assay Standard 100 mg 

BP 100 Dacarbazine 25 mg 

New BP 771 Dantrolene Assay Standard 100 mg 

BP 428 Dantron 50 mg 

BP 429 Dantron impurity standard 100 mg 

BP 102 Dapsone Assay Standard 100 mg 

BP 103 Debrisoquine sulphate 100 mg 

BP 104 Decoquinate 50 mg 

BP 572 Deltamedrane 25 mg 

BP 631 Deltamethrin Assay Standard 100 mg 

BP 632 Deltamethrin impurity standard 40 mg 

BP 504 Desacetylmetipranolol 25 mg 

BP 730 N-Desalkylflurazepam 25 mg 

BP 689 Desmethyl benzatropine hydrochloride 50 mg 

BP 594 Desogestrel ∆ 3- isomer 25 mg 

BP 578 Dexamethasone Assay Standard 100 mg 

BP 108 Dexamethasone sodium phosphate 50 mg 

BP 646 Dexamethasone phosphate Assay Standard 100 mg 

BP 465 Dextropropoxyphene hydrochloride Assay Standard Controlled Substance 100 mg 

BP 549 Diacetylfluorescein Assay Standard 200 mg 

BP 111 Diazepam Controlled Substance 100 mg 

BP 114 Dibenzo[b,e]thiepin-11(6H)-one 25 mg 

BP 124 

3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylaminopropan-1-amine-S-oxide 

hydrochloride 

BP 608 3-(1,5-Dibenzyl-1H-indazole-3-yl)oxypropyl dimethylamine hydrochloride 25 mg 

BP 116 Dichlorophen Assay Standard 100 mg 

BP 420 Dichlorophen impurity standard Assay Standard 100 mg 

BP 721 1-(2,5-Dichlorophenyl)-5-isopropylbiguanide hydrochloride 25 mg 

BP 598 Diclofenac diethylamine 100 mg 

BP 619 Diclofenac sodium Assay Standard 100 mg 

BP 118 Diethanolamine fusidate Assay Standard 100 mg 

25 mg 




BP 361 2-Diethylaminoethyl-3-(1-naphthyl)-2-(1-naphthylmethyl)propionate oxalate 25 mg 

BP 737 Diethylcarbamazine citrate 100 mg 

BP 119 Diethyl-4-decyloxy-3-ethoxyanilinomethylenemalonate 50 mg 

BP 677 Diethylstilbestrol monophosphate 25 mg 

BP 401 Diflucortolone valerate Assay Standard 100 mg 

BP 397 Diflucortolone valerate impurity standard 25 mg 

BP 431 Dihydrocodeine tartrate Assay Standard Controlled Substance 100 mg 

BP 120 Dihydroergocristine mesilate 25 mg 

BP 122 2,3-Dihydro-6-phenylimidazo [2,1-b] thiazole 50 mg 

BP 582 6,6-Dimethoxy-2,2'-binaphthyl 25 mg 

BP 195 4-Dimethylamino-3-methyl-1,2-diphenylbutan-2-ol hydrochloride 25 mg 

BP 607 3-Dimethylaminopropyl 2-benzylaminobenzoate hydrochloride 25 mg 

BP 456 1,5-Dimethylhexyl(methyl)amine 50 mg 

BP 511 Dimethyl{5-[2-(1-methylamino-2-nitrovinylamino) ethylsulphinylmethyl]furfuryl}amine 25 mg 

BP 303 

Gemfibrozil impurity A 

2,2-dimethyl-5-(4-propen-1-yl)-2,5-xylyloxy)valeric acid 

BP 364 2,2-Dimethyl-5(2,4-xylyloxy)valeric acid 25 mg 

BP 690 Dimpylate Assay Standard 0.1 mL 

BP 691 Dimpylate for chromatography 0.1 mL 

BP 128 Dipipanone hydrochloride Assay Standard Controlled Substance 100 mg 

BP 673 Dipivefrine hydrochloride Assay Standard 100 mg 

BP 659 Dipivefrine impurity standard 100 mg 

BP 589 Diprenorphine Assay Standard 100 mg 

BP 131 Dipyridamole Assay Standard 100 mg 

BP 384 N1,N2-Diquinoxalin-2-ylsulphanilamide 25 mg 

BP 615 Disodium pamidronate Assay Standard 100 mg 

BP 132 Disulfiram Assay Standard 50 mg 

BP 385 Dithranol Assay Standard 100 mg 

BP 674 Dobutamine hydrochloride Assay Standard 100 mg 

BP 133 Docusate sodium Assay Standard 200 mg 

BP 669 Domperidone maleate Assay Standard 100 mg 

BP 468 Dopamine hydrochloride Assay Standard 100 mg 

BP 134 Dosulepin hydrochloride Assay Standard 100 mg 

BP 135 Doxapram hydrochloride Assay Standard 100 mg 

BP 136 Doxepin hydrochloride Assay Standard 100 mg 

BP 675 Droperidol Assay Standard 100 mg 

BP 139 Econazole nitrate Assay Standard 100 mg 

BP 741 Enalapril maleate 100 mg 

BP 742 Enalaprilat 20 mg 

BP 743 Enalapril diketopiperazine 20 mg 

BP 387 Ephedrine hydrochloride Assay Standard Controlled Substance 100 mg 

BP 405 Ergometrine maleate Assay Standard Controlled Substance 100 mg 

BP 141 Ergotamine tartrate Assay Standard Controlled Substance 50 mg 

BP 488 Erythromycin stearate Assay Standard 100 mg 

BP 396 Estradiol benzoate Assay Standard 50 mg 

BP 729 Estradiol hemihydrate Assay Standard 100 mg 

BP 142 Estramustine 25 mg 

New BP 752 Estriol Assay Standard 100 mg 

New BP 753 Estriol impurity standard 25 mg 

BP 616 Estropipate Assay Standard 100 mg 

BP 143 Etacrynic acid Assay Standard 100 mg 

25 mg 




BP 421 Ethinylestradiol Assay Standard 100 mg 

BP 145 Ethopabate Assay Standard 100 mg 

BP 146 Ethosuximide Assay Standard 200 mg 

BP 437 N-Ethylglucamine hydrochloride 500 mg 

BP 149 Ethyl meclofenamate 25 mg 

BP 529 Etodolac Assay Standard 150 mg 

BP 533 Etodolac acid dimer 25 mg 

BP 541 Etodolac 1-methyl analogue 25 mg 

BP 542 Etodolac 8-methyl analogue 25 mg 

BP 653 Famotidine Assay Standard 100 mg 

BP 655 Famotidine degradation impurity 1 25 mg 

BP 656 Famotidine degradation impurity 2 25 mg 

BP 654 Famotidine impurity C 25 mg 

BP 620 Felbinac Assay Standard 100 mg 

BP 692 Fenbendazole 100 mg 

BP 693 

Fenbendazole impurity C 

5-(phenylthio)-2-aminobenzimidazole 

BP 354 Fenbufen Assay Standard 100 mg 

BP 661 Fenoterol degradation impurity A 25 mg 

BP 660 Fenoterol hydrobromide Assay Standard 100 mg 

BP 665 Fentanyl citrate Assay Standard Controlled Substance 100 mg 

BP 666 Fentanyl impurity A 25 mg 

BP 156 Fenthion Assay Standard 0.25 mL 

BP 740 Finasteride Assay Standard 100 mg 

BP 571 Flavoxate hydrochloride Assay Standard 100 mg 

BP 676 Flecainide acetate Assy Standard 100 mg 

BP 159 Fludrocortisone acetate Assay Standard 50 mg 

BP 160 Fluocinolone acetonide Assay Standard 50 mg 

BP 489 Fluocinonide Assay Standard 100 mg 

BP 161 Fluocortolone hexanoate Assay Standard 50 mg 

BP 162 Fluocortolone pivalate Assay Standard 50 mg 

BP 163 4'-Fluoro-4-chlorobutyrophenone 0.5 mL 

BP 573 Fluorometholone Assay Standard 100 mg 

BP 164 Fluoxymesterone 50 mg 

BP 738 cis-Flupentixol 25 mg 

BP 554 Flupentixol decanoate dihydrochloride Assay Standard 100 mg 

BP 556 trans-Flupentixol decanoate dihydrochloride 25 mg 

BP 597 cis-Flupenthixol propionate dihydrochloride 100 mg 

BP 167 Fluphenazine hydrochloride Assay Standard 100 mg 

BP 574 Flurbiprofen sodium Assay Standard 100 mg 

BP 587 Fluticasone propionate Assay Standard 100 mg 

BP 588 Fluticasone S-methyl impurity 25 mg 

BP 600 Fluvoxamine maleate Assay Standard 100 mg 

BP 671 Fluvoxamine maleate impurity standard 100 mg 

BP 627 3-Formylrifamycin SV 25 mg 

BP 639 Form-2',4'-xylidide 25 mg 

BP 623 Foscarnet sodium Assay Standard 100 mg 

BP 678 Fosfestrol sodium 50 mg 

BP 172 Furazolidone 50 mg 

BP 547 Furosemide Assay Standard 100 mg 

BP 643 Gallamine impurity standard 100 mg 

25 mg 




BP 363 Gemfibrozil Assay Standard 100 mg 

BP 365 Gemfibrozil methyl ester 0.1 mL 

BP 175 Glibenclamide Assay Standard 100 mg 

BP 368 Gliclazide Assay Standard 200 mg 

BP 580 Gliquidone Assay Standard 150 mg 

BP 581 Gliquidone sulphonamide 25 mg 

BP 180 Griseofulvin Assay Standard 100 mg 

BP 181 Guanethidine monosulphate Assay Standard 100 mg 

BP 407 Haloperidol Assay Standard 150 mg 

BP 182 Haloxon Assay Standard 300 mg 

BP 185 Homatropine hydrobromide Assay Standard 100 mg 

BP 186 Hydrochlorothiazide Assay Standard 200 mg 

BP 576 Hydrocortisone Assay Standard 100 mg 

BP 584 Hydrocortisone acetate Assay Standard 100 mg 

BP 188 Hydrocortisone sodium phosphate 100 mg 

BP 190 Hydroflumethiazide 100 mg 

New BP 770 4'Hydroxyacetophenone 25 mg 

BP 197 Hydroxycarbamide Assay Standard 200 mg 

BP 526 2-(2-Hydroxyethyl)-1-methylpyrrolidine 0.1 mL 

BP 196 5-[1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl]salicylic acid hydrochloride 50 mg 

BP 193 Hydroxyprogesterone caproate (hexanoate) Assay Standard 50 mg 

BP 194 2-(6-Hydroxythymoxy)ethyldimethylamine hydrochloride 25 mg 

BP 198 Hyoscine butylbromide Assay Standard 100 mg 

BP 199 Hyoscine Hydrobromide Assay Standard 200 mg 

New BP 774 Hypromellose Assay Standard 100 mg 

BP 539 Ibuprofen Assay Standard 200 mg 

BP 202 Idoxuridine Assay Standard 100 mg 

BP 664 Iminophenazine 25 mg 

BP 625 Ipratropium bromide Assay Standard 100 mg 

BP 557 4'-Isobutylacetophenone 0.1 mL 

BP 550 Isoconazole nitrate Assay Standard 100 mg 

BP 205 Isoprenaline hydrochloride Assay Standard 100 mg 

BP 499 4'-(2-Isopropylaminoethyl)methanesulphonanilide hydrochloride 25 mg 

BP 626 8s-Isopropyl-3β-hydroxytropanium bromide 25 mg 

BP 621 Isradipine Assay Standard 100 mg 

BP 622 Isradipine impurity B 25 mg 

BP 624 Isradipine impurity D 25 mg 

BP 736 Ketamine Hydrochloride Controlled Substance 100 mg 

BP 668 Ketoprofen Assay Standard 100 mg 

BP 667 Ketoprofen ethyl ester 0.1 mL 

BP 707 Lacidipine Assay Standard 100 mg 

BP 647 Lacidipine impurity Standard 25 mg 

BP 212 Levamisole hydrochloride 100 mg 

BP 356 Levobunolol hydrochloride Assay Standard 100 mg 

BP 213 Levodopa Assay Standard 100 mg 

New BP 772 Levomenthol Assay Standard 100 mg 

BP 723 Levomepromazine maleate Assay Standard 100 mg 

BP 634 Levomepromazine sulphoxide 25 mg 

BP 501 Levonorgestrel Assay Standard 100 mg 

BP 727 Lidocaine Assay Standard 100 mg 

BP 733 Linseed oil 0.5 mL 




BP 695 Lisinopril dihydrate Assay Standard 100 mg 

BP 696 Lisinopril diketopiperazine 25 mg 

BP 433 Lithium lactate Assay Standard 100 mg 

BP 697 Lofepramine hydrochloride Assay Standard 100 mg 

BP 635 Loperamide hydrochloride Assay Standard 100 mg 

BP 636 Loperamide N-oxide 25 mg 

BP 447 Loprazolam mesilate Controlled Substance 50 mg 

BP 434 Lorazepam Assay Standard Controlled Substance 50 mg 

BP 528 Lormetazepam Assay Standard Controlled Substance 100 mg 

BP 218 Lymecycline 100 mg 

BP 221 Medroxyprogesterone acetate Assay Standard 100 mg 

BP 222 Megestrol 25 mg 

BP 223 Megestrol acetate Assay Standard 100 mg 

BP 629 Meloxicam Assay Stadard 100 mg 

BP 630 Meloxicam impurity standard 50 mg 

BP 391 Melphalan Assay Standard 100 mg 

BP 699 Mepivacaine hydrochloride Assay Standard 100 mg 

BP 583 Meptazinol hydrochloride Assay Standard 100 mg 

New BP 773 Mercaptopurine Assay Standard 100 mg 

BP 496 Mesoridazine besilate 50 mg 

BP 226 Metaraminol tartrate 100 mg 

BP 552 Methadone hydrochloride Assay Standard Controlled Substance 100 mg 

BP 359 5-(6-methoxy-2-naphthyl)-3-methylcyclohexan-1-one 25 mg 

BP 232 1-(2-Methoxyphenyl)piperazine 25 mg 

BP 644 Methyl 4-acetamido-2-hydroxybenzoate 25 mg 

BP 606 1-Methylazepan-4-one hydrochloride 25 mg 

BP 605 1-Methyl-4-(2-benzoylhydrazino)azepan hydrochloride 25 mg 

BP 239 3-Methyl-2,2-diphenyl-4-piperidinobutyronitrile 50 mg 

BP 240 Methyldopa Assay Standard 100 mg 

BP 241 Methyldopate hydrochloride Assay Standard 100 mg 

BP 569 3-Methylflavone-8-carboxylic acid 25 mg 

BP 570 3-Methylflavone-8-carboxylic acid ethyl ester 25 mg 

BP 444 4-methyl-5-(2-hydroxyethyl)thiazole 25 mg 

BP 457 2-Methyl-6-methylaminoheptan-2-ol 50 mg 

BP 233 Methyl[2-(2-methylbenzhydryloxy)ethyl]amine hydrochloride 25 mg 

BP 476 1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride 25 mg 

BP 237 

Methyl N-4[2-(5-chloro- 

2-methoxybenzamido)ethyl]benzenesulphonyl carbamate 

BP 244 2-Methyl-5-Nitroimidazole 50 mg 

BP 245 (1-Methyl-5-nitroimidazol-2-yl)methanol 25 mg 

BP 641 N-Methyl-N'-(2,4-xylyl)formamidine hydrochloride 25 mg 

BP 662 Methylphenobarbital Assay Standard Controlled Substance 100 mg 

BP 248 Methylprednisolone Assay Standard 100 mg 

BP 249 Methylprednisolone acetate Assay Standard 200 mg 

BP 445 4-Methyl-5-vinylthiazole edisilate 25 mg 

BP 409 Methysergide maleate Assay Standard 50 mg 

BP 642 Metipranolol Assay Standard 100 mg 

BP 357 Metoclopramide hydrochloride Assay Standard 100 mg 

BP 540 Metoprolol tartrate Assay Standard 100 mg 

BP 603 Metronidazole Assay Standard 150 mg 

BP 735 Metronidazole benzoate 100 mg 

25 mg 




BP 251 Mexenone 100 mg 

BP 252 Mianserin hydrochloride Assay Standard 100 mg 

BP 253 Miconazole nitrate Assay Standard 100 mg 

BP 722 Midazolam Assay Standard Controlled Substance 100 mg 

BP 637 Minoxidil Assay Standard 100 mg 

New BP 768 Mometasone furoate Assay Standard 100 mg 

BP 254 Monosulfiram 100 mg 

BP 648 Morphine sulphate Assay Standard Controlled Substance 100 mg 

BP 358 Nabumetone Assay Standard 200 mg 

BP 362 Naftidrofuryl oxalate Assay Standard 100 mg 

BP 548 Naloxone hydrochloride Assay Standard 100 mg 

BP 257 Nandrolone Assay Standard Controlled Substance 100 mg 

BP 425 Nandrolone decanoate Controlled Substance 50 mg 

BP 259 Nandrolone laurate Controlled Substance 50 mg 

BP 260 Nandrolone Phenylpropionate Assay Standard Controlled Substance 100 mg 

BP 360 3-(1-Naphthyl)-2-tetrahydrofurfurylpropionic acid 25 mg 

BP 435 Naproxen Assay Standard 100 mg 

BP 460 Nicotinamide Assay Standard 100 mg 

BP 395 Nicotinyl alcohol tartrate 50 mg 

BP 462 Nifedipine Assay Standard 100 mg 

BP 651 Nimodipine Assay Standard 100 mg 

BP 262 Nitrazepam Assay Standard Controlled Substance 100 mg 

BP 263 Nitrofurfural diacetate 50 mg 

BP 367 3-Nitroso-3-azabicyclo[3.3.O]octane 0.1 mL 

BP 512 Noradrenaline (norepinephrine) acid tartrate 100 mg 

BP 266 Norethisterone Assay Standard 50 mg 

New BP 267 Norethisterone acetate Assay Standard 100 mg 

BP 670 Norfloxacin Assay Standard 100 mg 

BP 714 Norgestrel 100 mg 

BP 269 Nortriptyline hydrochloride Assay Standard 200 mg 

New BP 765 Omeprazole Assay Standard 100 mg 

BP 272 Orciprenaline sulphate 100 mg 

New BP 764 Oxibendazole 25 mg 

BP 700 Oxybuprocaine hydrochloride Assay Standard 100 mg 

BP 701 Oxybutynin hydrochloride Assay Standard 100 mg 

BP 273 Oxyclozanide 200 mg 

BP 276 Pancuronium bromide Assay Standard 25 mg 

New BP 769 Paeoniflorin Assay Standard 20 mg 

BP 277 Papaverine hydrochloride Assay Standard 100 mg 

BP 371 Paracetamol Assay Standard 100 mg 

BP 746 Paroxetine impurity standard 25 mg 

BP 278 Pentagastrin 0.1 mg 

BP 422 Perphenazine Assay Standard 100 mg 

BP 683 Pethidine hydrochloride Assay Standard Controlled Substance 100 mg 

BP 282 Phenoxymethylpenicillin potassium Assay Standard 500 mg 

BP 520 Phentolamine mesilate 50 mg 

BP 703 Phenylcyclohexylglycolic acid 25 mg 

BP 284 Phenylephrine Hydrochloride Assay Standard 100 mg 

BP 035 1-Phenyl-3-pyrrolidinopropan-1-one hydrochloride 50 mg 

BP 503 Pilocarpine nitrate Assay Standard 200 mg 

BP 682 Pimozide Assay Standard 100 mg 




BP 450 3-Piperidylpropiophenone hydrochloride 50 mg 

BP 463 Piroxicam Assay Standard 100 mg 

BP 411 Pizotifen malate Assay Standard 50 mg 

BP 288 Poldine metisulfate Assay Standard 100 mg 

BP 289 Polythiazide Assay Standard 100 mg 

BP 510 Potassium trichloroammineplatinate 25 mg 

BP 399 Prazosin hydrochloride Assay Standard 100 mg 

BP 464 Prednisolone Assay Standard 100 mg 

BP 292 Prednisolone sodium phosphate Assay Standard 100 mg 

BP 553 Prednisone Assay Standard 250 mg 

BP 497 Prilocaine hydrochloride Assay Standard 100 mg 

BP 293 Primidone Assay Standard 100 mg 

BP 295 Procaine benzylpenicillin Assay Standard 100 mg 

BP 638 Prochlorperazine maleate Assay Standard 100 mg 

BP 493 Prochlorperazine mesilate Assay Standard 100 mg 

BP 494 Prochlorperazine sulphoxide 25 mg 

BP 296 Procyclidine hydrochloride Assay Standard 100 mg 

BP 449 Progesterone Assay Standard 50 mg 

BP 297 Proguanil hydrochloride Assay Standard 100 mg 

BP 412 Promethazine hydrochloride Assay Standard 100 mg 

BP 505 Promethazine sulphoxide 25 mg 

BP 698 Propofol dimer 25 mg 

BP 413 Pseudoephedrine hydrochloride Assay Standard Controlled Substance 100 mg 

BP 717 Pseudomorphine trihydrate 25 mg 

BP 458 Pyridoxine hydrochloride Assay Standard 100 mg 

New BP 751 Ramipril Assay Standard 100 mg 

New BP 754 

Ramipril impurity K 

Ramipril diketopiperazine acid Assay Standard 

BP 471 Ranitidine hydrochloride Assay Standard 100 mg 

BP 593 Ribavirin Assay Standard 100 mg 

BP 592 Ribavirin impurity standard 50 mg 

BP 459 Riboflavin sodium phosphate 50 mg 

BP 400 Rifampicin N-oxide 25 mg 

BP 586 Ritodrine hydrochloride Assay Standard 200 mg 

BP 451 Salbutamol Assay Standard 100 mg 

BP 712 Salbutamol aldehyde impurity 25 mg 

BP 704 Salbutamol ketone impurity 25 mg 

BP 302 Salbutamol sulphate Assay Standard 100 mg 

BP 705 Selegiline hydrochloride Assay Standard 100 mg 

BP 739 Simvastatin Assay Standard 100 mg 

BP 750 Sodium alginate 200 mg 

BP 453 Sodium nitroprusside Assay Standard 200 mg 

BP 490 Sodium picosulfate Assay Standard 100 mg 

BP 452 Sodium valproate Assay Standard 500 mg 

BP 498 Sotalol hydrochloride 100 mg 

BP 312 Sulfadiazine Assay Standard 100 mg 

BP 310 Sulfadoxine Assay Standard 100 mg 

BP 314 Sulfamethoxazole Assay Standard 100 mg 

BP 679 Sulpiride Assay Standard 100 mg 

BP 745 Sumatriptan impurity standard 25 mg 

BP 455 Temazepam Assay Standard Controlled Substance 100 mg 

25 mg 




BP 708 Tenoxicam Assay Standard 100 mg 

BP 709 Tenoxicam degradation impurity standard 100 mg 

BP 318 Terbutaline sulphate Assay Standard 100 mg 

BP 650 Terfenadine Assay Standard 100 mg 

BP 319 Testosterone decanoate Controlled Substance 100 mg 

BP 321 Testosterone isocaproate Controlled Substance 100 mg 

BP 322 Testosterone phenylpropionate Assay Standard Controlled Substance 100 mg 

BP 702 Testosterone propionate Assay Standard Controlled Substance 100 mg 

BP 327 Theophylline Assay Standard 100 mg 

BP 414 Thiamine mononitrate Assay Standard 100 mg 

BP 495 Thioridazine Assay Standard 100 mg 

BP 331 Thiotepa Assay Standard 100 mg 

BP 332 2-Thymoxyethyldimethylamine hydrochloride 25 mg 

BP 645 Tioconazole Assay Standard 100 mg 

BP 687 Tioconazole impurity standard 100 mg 

BP 744 Tramadol hydrochloride 100 mg 

BP 734 Tranexamic acid impurity standard 25 mg 

BP 544 Transplatin 25 mg 

BP 591 Trazodone hydrochloride impurity standard 50 mg 

BP 338 Triamcinolone Assay Standard 100 mg 

BP 339 Triamcinolone acetonide Assay Standard 50 mg 

BP 680 Triamcinolone hexacetonide Assay Standard 100 mg 

BP 340 Triamterene Assay Standard 100 mg 

BP 341 3,5,6-Trichloro-2-hydroxybenzoic acid 50 mg 

BP 555 2-Trifluoromethylthioxanthone 25 mg 

BP 034 Trihexyphenidyl hydrochloride Assay Standard 100 mg 

BP 344 Trimethoprim Assay Standard 100 mg 

BP 346 z-Triprolidine hydrochloride 50 mg 

BP 347 Triprolidine hydrochloride 100 mg 

BP 349 Tylosin 50 mg 

BP 350 Urea Assay Standard 1 g 

BP 706 Ursodeoxycholic acid Assay Standard 150 mg 

BP 563 Vigabatrin Assay Standard 150 mg 

BP 564 5-Vinyl-2-pyrrolidone 25 mg 

BP 672 Warfarin Assay Standard 100 mg 

BP 353 Xylometazoline hydrochloride Assay Standard 100 mg 

BP 640 N,N'-bis(2,4-Xylyl)formamidine 25 mg 

BP 599 Zuclopenthixol acetate dihydrochloride Assay Standard 100 mg 

BP 596 Zuclopenthixol decanoate dihydrochloride 25 mg 

BP 558 Zuclopenthixol hydrochloride Assay Standard 100 mg 




As a scientist you know the importance of using the best materials to support your quality control 

programme. As Europe’s only officially authorized distributor of ATCC ® cultures, LGC Standards can 

supply all ATCC organisms specified in the pharmacopoeia. 

ATCC maintains the highest standards for its biological materials, employing stringent quality control 

procedures to produce cultures which are well characterized and have low passage numbers. Long-term 

subculturing of biological materials can have adverse effects on the culture population, including genetic 

drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold 

by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European 

stock-holding means orders are usually filled within 3 - 5 working days. 


or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies 

with authentic, high-quality ATCC materials - exclusively from LGC Standards. 

British Pharmacopoeia 2003, volume IV and Addenda 


BP 2003 Appendix XIV A - Biological assay of antibiotics 

ATCC-11778 Bacillus cereus amp. 

ATCC-14884 Bacillus pumilus amp. 














BP 2003 Appendix XVI - Test for absence of Mycoplasma 




ATCC-15531 Mycoplasma pneumoniae amp. 


ATCC-CCL-81 Vero cells amp. 

BP 2003 Appendix XVI A - Test for sterility 










BP 2003 Appendix XVI B - Tests for microbial contamination 




ATCC-13124 Clostridium perfringens amp. 






BP Appendix XVI C - Efficacy of antimicrobial preservation 






BP Appendix XVIII - Methods of sterilization 




ATCC-7955 Clostridium sporogenes (Metchnikoff) Bergey et al. amp. 

ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp. 

BP Appendix XVI (Vet) 3 - Test for absence of mycoplasmas 



ATCC-17981 Mycoplasma hyorhinis Switzer amp. 



ATCC-CCL-81 Vero cells amp. 


All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia 

directly to confirm the testing requirements and recommended organisms before ordering or undertaking the 

testing procedures as described in the Pharmacopoeia. 


Pharmacopée Française 


The list of reference substances and reference spectra available from the Pharmacopée Française (PF) 

are issued under the authority of the PF and are solely for use in tests and assays of the Pharmacopoeia 

Française and Pharmacopoeia Française (Vétérinaire). 

The list in this catalogue is based on the PF list of January 2007. 

All PF CRS are available in restricted quantity and orders for multiple units will be reduced to a single unit. 

Proper use 

Reference substances from the PF are designed for specific applications, which can be identified 

by consulting the monographs in which the corresponding reference substances are used. 

Uses other than those are possible, but the user is responsible for checking the suitability of the 

PF CRS for any non-monograph use. 

The list below is for information purposes only. 

It was included in former lot lists of FP but is not included as of January 2007. 

1 Identification by infrared spectrophotometry 

2 Identification by thin layer chromatography 

3 Test for related substances by thin layer chromatography 

4 Test for related substances by liquid chromatography 

5 Test for related substances by gas chromatography 

6 Assay by UV spectrophotometry by gas chromatography 

7 Assay by fluorimetry 

8 Assay by liquid chromatography 

9 Assay by gas chromatography 

10 Microbiological assay 

11 Assay by volumetric titration 


French Pharmacopoeia chemical reference substances are subject to regular inspection and repeated 

analysis by PF scientific staff. Each PF CRS is, on receipt by the customer, fit for the intended use. The 

shelf life and the expiry date are not given, and PF advises that unopened vials should not be stored for 

a long period of time. 


FPC2700 Adrénaline Reference Spectrum unit 

FPC0050 Alimémazine tartrate 25 mg 

FPC0071 Amodiaquine chlorhydrate 25 mg 

FPC0072 Amprolium chlorhydrate (usage vétérinaire) 25 mg 

FPC0073 Arécoline bromhydrate (usage vétérinaire) 100 mg 

FPC0141 Benzododecinium bromure 1000 mg 

FPC0172 Bithionol 500 mg 

FPC0173 Bithionol dioxyde 500 mg 

FPC0174 Bithionoloxide (usage vétérinaire) 2000 mg 

FPC0190 Bleu patente V 1000 mg 

FPC0200 Boldine 100 mg 

FPC0210 Butoformé 150 mg 

FPC0271 Chlormadinone acetate 100 mg 

FPC0320 Chloro-2 nicotinique acide 100 mg 

FPC0422 Diavéridine (usage vétérinaire) 250 mg 

FPC0423 Dichlorvos (usage vétérinaire) 1000 mg 

FPC0600 Eosine disodique 200 mg 

FPC0610 Epivincamine 50 mg 

FPC0510 Erythromycine propionate 200 mg 

FPC0722 Furaltadone (usage vétérinaire) 250 mg 

FPC0730 Furazolidone Reference Spectrum unit 

FPC0892 Histamine 50 mg 

FPC0898 Hydroquinidine chlorhydrate 100 mg 




FPC0930 Hydroxy-2 N-(trifluorométhyl-3'phényl) nicotinamide 60 mg 

FPC1222 Linalyle acétate 2 mL 

FPC2900 Lysine acétylsalicylate Reference Spectrum unit 

FPC1350 Methylanthranilate de methyle 2 mL 

FPC1540 Niflumique acide 120 mg 

FPC1560 Nifurtimox 250 mg 

FPC1572 Nitro-5 furaldazine (usage vétérinaire) 50 mg 

FPC1576 Nitroxinil (usage vétérinaire) 500 mg 

FPC1600 Oxyquinol Reference Spectrum unit 

FPC3300 Polytétrafluoroéthylène Reference Spectrum unit 

FPC1780 Potassium gluconate 50 mg 

FPC1785 Prasterone 300 mg 

FPC2032 Strychnine sulfate (usage vétérinaire) 225 mg 

FPC2034 Suc de papayer 500 mg 

FPC2036 Sulconazole nitrate 200 mg 

FPC2044 Sulfadiméthoxine 100 mg 

FPC2090 Sulfaquinoxaline 100 mg 

FPC2100 Sulfaquinoxaline sodique 100 mg 

FPC2120 Sulfogaiacol 100 mg 

FPC2122 Sulfogaiacol (exempt de gaiacol) 1000 mg 

FPC2210 Terpine 1000 mg 

FPC2212 Tétramisole chlorhydrate 50 mg 

FPC2230 Thiocolchicoside 300 mg 

FPC2520 Vincamine 250 mg 


Pharmacopoeia Helvetica 

Pharmacopoeia Helvetica 

Background 

The range of reference substances available from the Pharmacopoeia Helvetica is issued under the authority 

of the Pharmacopoeia Helvetica, and is solely for use in tests and assays of the Pharmacopoeia Helvetica. 

The Pharmacopoeia Helvetica contains, in addition to harmonised European Pharmacopoeia monographs, 

a number of national monographs. Some of the national monographs require CRS described in the list 

below. 

The list in this catalogue is based on the current Pharmacopoeia Helvetica. 


SPC 015 α-(2-Piperidyl)phenylessigsäure 50 mg 

SPC 170 Diamorphinhydrochlorid wasserfrei Reference Spectrum unit 

SPC 190 Drofeninhydrochlorid 1 g 

SPC 204 Ethanol 70% Reference Spectrum unit 

SPC 210 Ethanol with 2 % Ketone Reference Spectrum unit 

SPC 285 Hydrocodon Reference Spectrum unit 

SPC 300 Methacholinchlorid Reference Spectrum unit 

SPC 335 Methylphenidathydrochlorid Reference Spectrum unit 

SPC 320 Moclobemid Reference Spectrum unit 

SPC 340 2-Naphthol Reference Spectrum unit 

SPC 380 Oxychinolinsulfat Reference Spectrum unit 

SPC 455 Saponin 500 mg 

SPC 505 Terpinhydrat Reference Spectrum unit 

SPC 515 Thiethylperazinhydrogenmaleat 200 mg 


International Pharmacopeia 

Background 


The World Health Organization (WHO) as a specialised agency of the United Nations with a primary 

responsibility for international health matters and public health, is the issuing body of the substances 

described in the International Pharmacopoeia. Progress towards better health requires international 

cooperation in the establishment of international standards for biological substances and pharmaceuticals. 

The WHO has therefore authorised the establishment and maintenance of a number of reference collections. 

Two are of particular interest to analysts involved in pharmaceutical and clinical measurement sciences: the 

collections of international biological reference substances and international chemical reference substances. 

International biological reference substances 

The range of biological reference substances was established to provide a means of ensuring International 

uniformity in the designation of the potency, activity or specificity of preparations that are used in the 

prevention, treatment or diagnosis of human or animal diseases, and for which chemical and physical 

assay terms are inappropriate. 

WHO biological reference substances are needed for certain antibiotic and hormone assays described in 

a number of pharmacopoeia. The majority of the preparations of interest to the analyst working in the fields 

of pharmaceutical analysis are held by the NIBSC in England. 

International chemical reference substances 

International chemical reference substances are established upon the advice of the WHO expert committee 

on specifications for pharmaceutical preparations. They are intended for use in physical and chemical tests 

and assays described in the specifications for quality control published in the International Pharmacopoeia 

(IP CRS), or as proposed in draft monographs. 

The list in this catalogue is based on the current WHO information. 

Proper use 

Whilst the primary application of IP CRS is in physical and chemical tests and assays as described in the 

International Pharmacopoeia, IP CRS do have applications in other aspects of pharmaceutical analysis 

where a certificate of purity is required. 

Documentation 

Directions for use and analytical data are provided in certificates distributed with the IP CRS. The certificates 

show how the identity and purity of the material was confirmed, and in many cases demonstrate traceability 

to another PRM. This information fulfills most of the requirements of a Certification Report as defined by the 

ISO Guides on the preparation and use of Certified Reference Materials. 


International Pharmacopoeia chemical reference substances are subject to regular inspection and repeated 

analysis by the WHO Collaborating Centre. Each IP CRS is, on receipt by the customer, suitable for the 

intended use. Shelf life and expiry dates are not given, and IP advises that once opened, vials should not 

be stored for long periods of time. 

Only current lots are supplied by IP. For this reason users are advised to order only as required. Once 

opened IP can no longer guarantee the stability of the material and any of the CRS not used should be 

disposed of. 


For information on ordering please contact LGC Standards. 


WHO9931422 Abacavir sulfate 100 mg 

WHO9930375 p-Acetamidobenzalazine 25 mg 

WHO9930201 Acetanilide (116°C) Melting Point Standard 1 g 

WHO9930202 Acetazolamide 100 mg 

WHO9930204 Allopurinol 100 mg 

WHO9930206 Amidotrizoic acid 100 mg 

WHO9930191 2-Amino-5-nitrothiazole 25 mg 




WHO9930194 3-Aminopyrazole-4-carboxamide hemisulfate 100 mg 

WHO9930193 3-Amino-2,4,6-triiodobenzoic acid 100 mg 

WHO9930208 Amitriptyline hydrochloride 100 mg 

WHO9930209 Amodiaquine hydrochloride 200 mg 

WHO9930210 Amphotericin B 400 mg 

WHO9930211 Ampicillin (anhydrous) 200 mg 

WHO9930212 Ampicillin sodium 200 mg 

WHO9930213 Ampicillin trihydrate 200 mg 

WHO9930214 Anhydrotetracycline hydrochloride 25 mg 

WHO9931408 Artemether 100 mg 

WHO9931406 Artemisinin 100 mg 

WHO9931407 Artemotil 100 mg 

WHO9931410 Artenimol 100 mg 

WHO9931409 Artesunate 100 mg 

WHO9930215 Atropine sulfate 100 mg 

WHO9930216 Azathioprine 100 mg 

WHO9930217 Azobenzene (69°C) Melting Point Standard 1 g 

WHO9930218 Bacitracin zinc 200 mg 

WHO9930219 Beclometasone dipropionate 200 mg 

WHO9930221 Benzanilide (165°C) Melting Point Standard 1 g 

WHO9930222 Benzil (96°C) Melting Point Standard 1 g 

WHO9930225 Benzylpenicillin potassium 200 mg 

WHO9930226 Benzylpenicillin sodium 200 mg 

WHO9930227 Bephenium hydroxynaphthoate 100 mg 

WHO9930228 Betamethasone 100 mg 

WHO9930229 Betamethasone sodium phosphate 100 mg 

WHO9930230 Betamethasone valerate 100 mg 

WHO9930233 Bupivacaine hydrochloride 100 mg 

WHO9930234 Caffeine 100 mg 

WHO9930235 Caffeine (237°C) Melting Point Standard 1 g 

WHO9930236 Calcium folinate (Leucovorin calcium) 100 mg 

WHO9930237 Captopril 100 mg 

WHO9930238 Captopril disulfide 25 mg 

WHO9930239 Carbamazepine 100 mg 

WHO9930240 Carbenicillin monosodium 200 mg 

WHO9930241 Chloramphenicol 200 mg 

WHO9930242 Chloramphenicol palmitate 1 g 

WHO9930243 Chloramphenicol palmitate (Polymorph A) 200 mg 

WHO9930199 5-Chloro-2-methylaminobenzophenone 100 mg 

WHO9930245 Chloroquine sulfate 200 mg 

WHO9930190 2-(4-Chloro-3-sulfamoylbenzoyl)benzoic acid 50 mg 

WHO9930246 Chlorphenamine hydrogen maleate 100 mg 

WHO9930247 Chlorpromazine hydrochloride 100 mg 

WHO9930248 Chlortalidone 100 mg 

WHO9930249 Chlortetracycline hydrochloride 200 mg 

WHO9930250 Cimetidine 100 mg 

WHO9930256 Ciprofloxacin hydrochloride 400 mg 

WHO9930252 Ciprofloxacin by compound A 20 mg 

WHO9930253 Ciprofloxacin desfluoro-compound 20 mg 

WHO9930254 Ciprofloxacin ethylenediamine-compound 20 mg 

WHO9930255 Ciprofloxacin fluoroquinolonic acid 20 mg 




WHO9930258 Cisplatin 100 mg 

WHO9930259 Clomifene citrate 100 mg 

WHO9930261 Cloxacillin sodium 200 mg 

WHO9930262 Colecalciferol (Vitamin D 3) 500 mg 

WHO9930263 Cortisone acetate 100 mg 

WHO9930265 Dapsone 100 mg 

WHO9930266 Desoxycortone acetate 100 mg 

WHO9930267 Dexamethasone 100 mg 

WHO9930268 Dexamethasone acetate 100 mg 

WHO9930269 Dexamethasone phosporic acid 100 mg 

WHO9930270 Dexamethasone sodium phosphate 100 mg 

WHO9930282 Diazoxide 100 mg 

WHO9930283 Dicloxacillin sodium 200 mg 

WHO9930285 Dicoumarol 100 mg 

WHO9930286 Dicyanodiamide (210°C) Melting Point Standard 1 g 

WHO9930287 Diethylcarbamazine dihydrogen citrate 100 mg 

WHO9930288 Digitoxin 100 mg 

WHO9930289 Digoxin 100 mg 

WHO9930290 Dopamine hydrochloride 100 mg 

WHO9930292 Doxorubicin hydrochloride 100 mg 

WHO9930294 Emetine hydrochloride 100 mg 

WHO9930197 4-Epianhydrotetracycline hydrochloride 25 mg 

WHO9930295 Ergocalciferol (Vitamin D 2) 500 mg 

WHO9930296 Ergometrine hydrogen maleate Controlled Substance 50 mg 

WHO9930297 Ergotamine tartrate Controlled Substance 50 mg 

WHO9930298 Erythromycin 250 mg 

WHO9930300 Erythromycin C 25 mg 

WHO9930301 Estradiol benzoate 100 mg 

WHO9930302 Estrone 100 mg 

WHO9930304 Ethambutol hydrochloride 100 mg 

WHO9930305 Ethinylestradiol 100 mg 

WHO9930306 Ethisterone 100 mg 

WHO9930307 Ethosuximide 100 mg 

WHO9930309 Flucloxacillin sodium 200 mg 

WHO9930310 Flucytosine 100 mg 

WHO9930311 Fludrocortisone acetate 200 mg 

WHO9930312 Fluorouracil 100 mg 

WHO9930313 Fluphenazine decanoate dihydrochloride 100 mg 

WHO9930314 Fluphenazine enantate dihydrochloride 100 mg 

WHO9930315 Fluphenazine hydrochloride 100 mg 

WHO9930316 Folic acid 100 mg 

WHO9930195 3-Formylrifamycin 200 mg 

WHO9930355 Framycetin sulfate (Neomycin B sulfate) 200 mg 

WHO9930318 Furosemide 100 mg 

WHO9930322 Griseofulvin 200 mg 

WHO9930323 Haloperidol 100 mg 

WHO9930324 Hydrochlorothiazide 100 mg 

WHO9930325 Hydrocortisone 100 mg 

WHO9930326 Hydrocortisone acetate 100 mg 

WHO9930327 Hydrocortisone sodium succinate 200 mg 

WHO9930188 (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-hydrazino-2-methylalanine (3-O-Methylcarbidopa) 25 mg 




WHO9930189 (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-methylalanine (3-O-Methylmethyldopa) 25 mg 

WHO9930328 Ibuprofen 100 mg 

WHO9930329 Imipramine hydrochloride 100 mg 

WHO9931415 Indinavir 100 mg 

WHO9930330 Indometacin 100 mg 

WHO9930331 Isoniazid 100 mg 

WHO9930332 Kanamycin monosulfate 12 mg 

WHO9930333 Lanatoside C 100 mg 

WHO9930334 Levodopa 100 mg 

WHO9930335 Levonorgestrel 200 mg 

WHO9930336 Levothyroxine sodium 100 mg 

WHO9930337 Lidocaine 100 mg 

WHO9930338 Lidocaine hydrochloride 100 mg 

WHO9930339 Liothyronine sodium 50 mg 

WHO9930340 Loperamide hydrochloride 100 mg 

WHO9930341 Mebendazole 200 mg 

WHO9930345 Methotrexate 100 mg 

WHO9930346 Methyldopa 100 mg 

WHO9930347 Methyltestosterone 100 mg 

WHO9930348 Meticillin sodium 200 mg 

WHO9930350 Metronidazole 100 mg 

WHO9930351 Nafcillin sodium 200 mg 

WHO9930354 Neamine hydrochloride (Neomycin A hydrochloride) 0.5 mg 

WHO9931417 Nelfinavir mesilate 100 mg 

WHO9930356 Neostigmine metilsulfate 100 mg 

WHO9931412 Nevirapine anhydrous 100 mg 

WHO9930357 Nicotinamide 100 mg 

WHO9930358 Nicotinic acid 100 mg 

WHO9930359 Nifurtimox 100 mg 

WHO9930360 Niridazole 200 mg 

WHO9930361 Niridazole-chlorethylcarboxamide 25 mg 

WHO9930366 Norethisterone 100 mg 

WHO9930367 Norethisterone acetate 100 mg 

WHO9930369 Nystatin 200 mg 

WHO9930371 Oubain 100 mg 

WHO9930372 Oxacillin sodium 200 mg 

WHO9930373 Oxytetracycline dihydrate 200 mg 

WHO9930374 Oxytetracycline hydrochloride 200 mg 

WHO9930376 Papaverine hydrochloride 100 mg 

WHO9930377 Paracetamol 100 mg 

WHO9930378 Paromomycin sulfate 75 mg 

WHO9930380 Phenacetin (136°C) Melting Point Standard 1 g 

WHO9930382 Phenolphthalein (263°C) Melting Point Standard 1 g 

WHO9930383 Phenoxymethylpenicillin 200 mg 

WHO9930384 Phenoxymethylpenicillin calcium 200 mg 

WHO9930385 Phenoxymethylpenicillin potassium 200 mg 

WHO9930387 Phenytoin 100 mg 

WHO9930388 Piperazine adipate 100 mg 

WHO9930389 Piperazine citrate 100 mg 

WHO9930390 Praziquantel 100 mg 

WHO9930391 Prednisolone 100 mg 




WHO9930392 Prednisolone acetate 100 mg 

WHO9930393 Prednisolone hemisuccinate 200 mg 

WHO9930394 Prednisolone sodium phosphate 200 mg 

WHO9930395 Prednisone 100 mg 

WHO9930396 Prednisone acetate 100 mg 

WHO9930397 Probenecid 100 mg 

WHO9930398 Procaine hydrochloride 100 mg 

WHO9930399 Procarbazine hydrochloride 100 mg 

WHO9930400 Progesterone 100 mg 

WHO9930402 Propanolol hydrochlorid 100 mg 

WHO9930403 Propylthiouracil 100 mg 

WHO9930404 Pyrantel embonate (Pyrantel pamoate) 500 mg 

WHO9930405 Pyridostigmine bromide 100 mg 

WHO9930406 Reserpine 100 mg 

WHO9930408 Riboflavin 250 mg 

WHO9930409 Rifampicin 300 mg 

WHO9930410 Rifampicin quinone 200 mg 

WHO9931421 Ritonavir 100 mg 

WHO9930411 Saccharin (229°C) Melting Point Standard 1 g 

WHO9931418 Saquinavir mesilate 100 mg 

WHO9930412 Sodium amidotrizoate 100 mg 

WHO9930413 Sodium cromoglicate 100 mg 

WHO9930415 Spectinomycin hydrochloride 200 mg 

WHO9931419 Stavudine 100 mg 

WHO9930416 Streptomycin sulfate 100 mg 

WHO9930417 Sulfacetamide 100 mg 

WHO9930419 Sulfamethoxazole 100 mg 

WHO9930420 Sulfamethoxypyridazine 100 mg 

WHO9930421 Sulfanilamide 100 mg 

WHO9930422 Sulfanilamide (166°C) Melting Point Standard 1 g 

WHO9930423 Sulfapyridine (193°C) Melting Point Standard 4 g 

WHO9930424 Sulfasalazine 100 mg 

WHO9930425 Tamoxifen citrate 100 mg 

WHO9930426 Tamoxifen citrate E-isomer 10 mg 

WHO9930427 Testosterone enantate 200 mg 

WHO9930428 Testosterone propionate 100 mg 

WHO9930429 Tetracycline hydrochloride 200 mg 

WHO9930430 Thioacetazone 100 mg 

WHO9930196 4,4'-Thiodianiline 50 mg 

WHO9930431 Tolbutamide 100 mg 

WHO9930432 Tolnaftate 100 mg 

WHO9930433 Toluene-2-sulfonamide 100 mg 

WHO9930434 Trimethadione 200 mg 

WHO9930435 Trimethoprim 100 mg 

WHO9930438 Vanillin (83°C) Melting Point Standard 1 g 

WHO9930440 Vincristine sulfate 9.7 mg/vial 

WHO9930439 Warfarin 100 mg 

WHO9930260 Zuclomifene 50 mg 










Institute of Dyes 

and Organic 

Products 

Refractive index 

CRMs 



National Measurement Institute, 

Australia (NMI A) 

Over 300 materials from the National Measurement 

Institute of Australia (NMI A) for a variety of 

applications: 

• Forensic drugs - e.g. 

Amphetamines, Cocaine, Heroin etc. 

• Anabolic steroids and metabolites e.g. Trenbolone, 

Nandrolone, Dehydroepiandrosterone (DHEA) etc. 

• Growth promotants, stimulants and metabolites e.g. 

Zearalenone, Cropropamide, 6-Hydroxybromantan 

etc. 

Certified reference 

materials for: 

Sports drugs analysis 

Forensic analysis 

Agricultural and 

Veterinary Residue 

Analysis 

Features: 

• Certified property values with associated uncertainty 

statements 

• Traceability of assigned values to the international 

system of units 

• Comprehensive analysis report 

• Third-party accreditation as a reference materials 

producer operating to ISO Guide 34 

For further information on these products or to receive 

any one of our catalogues, please contact your local 

office or visit our web site. 




Institute of Dyes and Organic Products 

Institute of Dyes and Organic Products 

The use of colouring agents in pharmaceutical preparations and dose forms is widespread. In most 

cases food colouring materials are used. 

The following standards of dyes, used in the pharmaceutical and food industry, are listed with common 

description, E code and colour index number (C.I.) for an easy assignment. 

The IBPO is accredited by the Polish Centre for Testing and Certification according to the standard 

PN-EN 45001 and ISO/IEC Guide 25:1990. 

Each colour reference standard is supplied with a detailed certificate of analysis, which includes dye 

content value determined by spectrophotometry and values of impurities. 

Black 


IBPO010 Brilliant Black PN (E 151) 1 g 

Blue 

IBPO015 Brilliant Blue FCF (E 133) 1 g 

IBPO002 Indigotine (E 132) 1 g 

IBPO012 Patent Blue V (E 131) 1 g 

Brown 

IBPO017 Brown HT(E 155) 1 g 

Green 

IBPO016 Brilliant Green BS (E 142) 1 g 

Red 

IBPO014 Allura Red AC (E 129) 1 g 

IBPO005 Amaranth (E 123) 1 g 

IBPO003 Azorubin (E 122) 1 g 

IBPO011 Erythrosine (E 127) 1 g 

IBPO004 Ponceau 4R (E 124) 1 g 

IBPO013 Red 2 G (E 128) 1 g 

Yellow 

IBPO007 Quinoline Yellow (E 104) 1 g 

IBPO009 Sunset Yellow FCF (E 110) 1 g 

IBPO008 Tartrazine (E 102) 1 g 


Refractive index CRMs 

Refractive index CRMs 

The revised EP general method 2.2.6 replaces CRS reference liquids with certified reference materials 

available from suppliers of chemical reagents or materials certified for metrology. 

11 liquid CRMs, certified by the Physical Chemistry Division of the Central Office of Measures (GUM), 

Warsaw in Poland, cover the wide range of refractive index from 1,333 (water) to 1,657 

(1-bromonaphthalene). 

These CRMs are intended for calibration and checking refractive index scales of laboratory refractometers 

of an uncertainty expected not less than ±0,00005. 

The n values were determined on a Pulfrich refractometer, previously calibrated with solid class 1 CRMs, 

for which values were established using goniometric procedures. 

All CRMs are supplied with a certificate. Certified values to 5 significant figures for the refractive index 

λ at = 589.3 nm t = 20°C and associated uncertainties are given. 

Reference liquids are packed in glass ampoules or plastic drop-bottles. 


PRG 7.21 

PRG 7.1 

PRG 7.11 

PRG 7.2 

Water 

Refractive index ................................. 1.333 at 20 °C 

2,2,4-Trimethylpentane 


Methylsilicone oil 


Methylcyclohexane 


10 mL 

10 mL 

10 mL 

10 mL 

PRG 7.12 Silicone oil DC 556 


10 mL 

PRG 7.20 

PRG 7.5 

PRG 7.6 

Paraffin oil 


Toluene 


Chlorobenzene 


10 mL 

10 mL 

10 mL 

PRG 7.13 Silicone oil AN 140 

Refractive index .................................. 1.560 at 20°C 

10 mL 

PRG 7.8 

PRG 7.9 

1-Bromonaphthalene 


1-Iodonaphthalene 


10 mL 

10 mL 



impurities 



CERTAN ® 

The ampoule in a bottle 

Unopened glass ampoules are ideal for storing 

volatile standards, but once opened they are no 

longer suitable for storage. The alternative use of 

screw cap bottles can result in evaporation through 

the thread. There is also a risk of contamination 

from the cap. 

The CERTAN ® bottle is a sample container with a 

capillary-opening. It has been specifically developed 

for use with organic reference solutions. Using the 

CERTAN ® bottle makes the problems of storing 

volatile solutions a thing of the past. 

Advantages of CERTAN ® 

• Minimal change in concentration, even when open 

• Totally secure, free of losses 

• Less risk of contamination 

• Aliquots easily removed using a standard GC 

syringe 

• Proven usability from -30 o C to +50 o C 

• Almost impossible to spill 

For further information on these products or to 

receive any one of our catalogues, please contact 

your local office or visit our web site. 

Applications for CERTAN ® 

Supply of 

standard solutions 

Long term storage for 

solutions from ampoules 

Storage of stock solution 

Archiving of production 

samples 

Holding difficult samples, 

such as volatile organic 

compounds (VOCs) 

Transport and storage of 

ring-test samples 


Pharmaceutical impurities 


Background 

The pharmacopeial monographs regulate the legal definition but also the analysis and the limits of impurities 

in a given substance. Impurities in a pharmaceutical substance can change the effects and side effects of 

a drug significantly. It is therefore important to have an accurate detection of impurities. 

The increasing importance of impurity reference materials is also becoming apparent in the registration of 

drugs, where an exact identification and quantification of susceptible impurities is required for an assured 

documentation. 

A wide range of known impurities is listed in individual pharmacopeial monographs. However, impurities that 

are still protected by a patent, as well as those that are only known to the manufacturer, are not listed. 

Guidelines and limits for impurities have been laid out in compendial monographs, in specifications from 

the manufacturer internally or in the International Conference on Harmonisation (ICH) Guidelines which 

have been agreed by Europe, Japan and the United States. The ICH conducted three guidelines on impurity 

issues: 

ICH Q3A (R1): Impurities in New Drug Substances 

ICH Q3B (R2): Impurities in New Drug Products 

ICH Q3C (R3): Impurity Guidelines for Residual Solvents. 

The full wording of the ICH guidelines is available at the official website of the ICH: www.ich.org. 

About LGC 

Certification 

The pharmaceutical impurities listed in this section are produced by LGC, whose Research & Technology 

Division acts as the designated UK National Measurement Institute for Chemical and Biochemical 

Measurements. 

LGC is an independent, science-based service company providing chemical, biochemical and DNA based 

analytical and diagnostic services, and reference standards. Europe's largest, independent analytical 

laboratory, LGC's services include analytical testing, research, consultancy, validation, training and 

knowledge transfer. 

LGC Standards, a division of LGC, provides the most comprehensive source of certified reference materials 

and standards, pharmaceutical reference substances and impurities, biomaterials, cell lines and high purity 

solvents to the scientific community worldwide. 

LGC Standards has successfully established a global reputation for the production of impurities and working 

standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom 

services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging 

and distribution, adds value to the scientific support we provide to our pharmaceutical customers. 

For more information about these services, please contact your local LGC Standards office. 

Each product is accompanied by a detailed certificate of analysis, which gives information on the identity 

and purity, together with the various analytical methods and their conditions. A sample of such a certificate 

is printed on the following pages. 

In the past, we received some inquiries from a few customers wondering why there is no declaration on the 

certificates of analysis (CofA) for LGC products stating that the substances are fulfilling the specifications 

for reagents, as described for example in chapter 4 of the European Pharmacopeia. 

The LGC impurity standards are thoroughly tested chemical reference substances and are used for reliable 

identification and quantification of impurities of pharmaceutical ingredients and products. 

The abbreviations EP, Pharmeuropa, BP and USP in the article description are indicating that the particular 

substance is mentioned as an impurity in that particular compendial publication. They do not indicate that 

certain specification of reagents or drug substances mentioned in the publications are fulfilled. The 

standards - where they are actually listed as reagents or drug substances - may fulfill this specification, 

but this is not the intention and is not certified on the CofA. 

Production of our 2000+ LGC impurities reference standards now follow the principles of ISO Guide 34 

"General requirements for the competence of reference materials producers". This applies to new products 

and new batches of already existing products. In combination with ISO 17025, the ISO Guide 34 principles 

provide the best approach to the production of reference materials. Due to this new approach, you will notice 

two differences in associated products: 

-The reference standards will now be valid for twelve months from the date of despatch, in contrast to the 

fixed date given on the certificates before. There will still be the potential for recertification after twelve 

months, provided that the stability data supports this. 

- Furthermore, newly released batches of reference standards will be filled in tamper evident bottles, giving 

confidence to the user on the integrity of the product on arrival. However, this lies in the responsibility of the 

user once the product has been received and opened. 



Narcotics 

Some of the substances described in this section are subject to narcotics legislation. These are marked 

as [Controlled Substance]. Please contact your local LGC Standards office for information on the legal 

requirements in order to purchase these products. 

Delivery time 

The majority of products mentioned in this section are available from stock; others may have a delivery time 

of approximately four weeks. For substances marked with "on request", longer delivery times may apply. For 

custom synthesis, the time is estimated from previous experience. Customers will be notified if unforeseen 

complications arise during the synthesis. In the unlikely event that a synthesis does not reach the expected 

result, LGC Standards reserves the right to cancel the order. 



Code Product Category Unit 

Acebutolol Hydrochloride 

MM 0435.00 Acebutolol Hydrochloride 

O 

O 

OH H 

O N 

(A) 500 mg 

N 

H 

x HCl 

MM 0435.02 

Imp. B (EP) as Hydrochloride:N-[3-Acetyl-4-[(2RS)- 

2-hydroxy-3-[(1-methylethyl)amino]- 

propoxy]phenyl]acetamide Hydrochloride 

(Diacetolol Hydrochloride) 

O 

N 

H 

O 

O 

OH 

H 

N 

x HCl 

(A) 

100 mg 

Aceclofenac 

MM 0181.00 

Aceclofenac 

Cl 

O 

O 

NH 

Cl 

O 

(A) 250 mg 

OH 

MM 0181.07 

Imp. A (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid 

(Diclofenac) 

Cl 

OH 

O 

NH 

Cl 

(A) 

100 mg 

MM 0181.08 

Imp. B (EP): Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate 

(Methyl Ester of Diclofenac) 

Cl 

O 

O 

NH 

Cl 

(A) 

100 mg 

MM 0181.09 

Imp. C (EP): Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate 

(Ethyl Ester of Diclofenac) 

Cl 

O 

O 

NH 

Cl 

(A) 

100 mg 

MM 0181.01 

Imp. D (EP): Methyl [[[2-[(2,6-Dichloro- 

phenyl)amino]phenyl]acetyl]oxy]- 

acetate (Methyl Ester of Aceclofenac) 

Cl 

O 

O 

NH 

Cl 

O 

(A) 100 mg 

O 

MM 0181.02 Imp. E (EP): Ethyl [[[2-[(2,6- 

Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate 

(Ethyl Ester of Aceclofenac) 

Cl 

O 

O 

NH 

Cl 

O 

(A) 100 mg 

O 

MM 0181.03 Imp. F (EP): ): Benzyl [[[2-[(2,6- 

Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Benzyl Ester 

of Aceclofenac) 

Cl 

O 

O 

NH 

Cl 

O 

(A) 100 mg 

O 

MM 0181.04 

Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]- 

acetyl]oxy]acetyl]oxy]acetic Acid (Acetic Aceclofenac) 

Cl 

O 

O 

NH 

Cl 

O 

O 

OH 

O 

(A) 

100 mg 

MM 0181.10 

Imp. I (EP):1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one 

Cl 

N 

O 

Cl 

(A) 

100 mg 

MM 0181.06 

Isopropyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate 

(Isopropyl Ester of Diclofenac) 

Cl 

O 

O 

NH 

Cl 

(A) 

100 mg 

Acetazolamide 

MM 0648.00 

Acetazolamide 

H 

N 

S 

O O 

(A) 500 mg 

S NH2 

O 

N 

N 




Acetylcysteine 

MM 0024.00 N-Acetyl-L-cysteine 

O 

HS OH 

HN 

(A) 500 mg 

MM 0024.03 

MM 0024.02 

MM 0024.04 

MM 0024.01 

Imp. A (EP): L-Cystine 

Imp. B (EP): L-Cysteine 

Imp. C (EP): N,N’-Diacetyl-L-cystine 

Imp. D (EP): N,S-Diacetyl-L-cysteine 

HO 

O 

NH 

HO 

O 

O 

O 

S 

S OH 

NH 2 

NH 2 (B) 100 mg 

O 

NH 2 

(B) 100 mg 

HS OH 

O 

(A) 100 mg 

O 

S 

S OH 

HN 

O 

O O 

(A) 100 mg 

S OH 

HN 

MM 0024.05 

Acetylsalicylic Acid 

Sodium 2-Methyl-4,5-dihydro-1,3-thiazol-4-carboxylate 

MM 0133.00 Acetylsalicylic Acid 

O 

HO 

N 

S 

O 

O 

(A) 100 mg 

O 

ONa 

O 

(A) 500 mg 

MM 0133.05 

Imp. A (EP): 4-Hydroxybenzoic Acid 

HO 

O 

(B) 100 mg 

OH 

MM 0133.06 

Imp. B (EP): 4-Hydroxybenzene-1,3-dicarboxylic Acid 

(4-Hydroxyisophthalic Acid) 

HO 

O 

O 

(A) 100 mg 

OH 

OH 

MM 0133.07 

Imp. C (EP): Salicylic Acid 

O 

(A) 

500 mg 

OH 

OH 

MM 0133.01 

Imp. D (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid 

(Acetylsalicylsalicylic Acid) 

O 

OH 

O 

(A) 

100 mg 

O 

O 

O 

MM 0133.03 

Imp. E (EP):2-[(2-Hydroxybenzoyl)oxy]benzoic Acid 

(Salicylsalicylic Acid) 

O 

OH 

(A) 

100 mg 

O 

OH 

O 

MM 0133.02 

Imp. F (EP): 2-(Acetyloxy)benzoic Anhydride 

(Acetylsalicylic Anhydride) 

O O O 

O 

O 

O 

(A) 100 mg 

O 

MM 0133.04 

2-(2,4-Dihydroxybenzoyl)benzoic Acid 

O 

(A) 

100 mg 

OH 

O 

OH 

OH 

Aciclovir 

MM 0061.00 

Aciclovir 

O 

HN 

H 2N N 

N 

N 

O 

OH 

(A) 

500 mg 




MM 0061.01 Imp. A (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9- 

O 

(A) 100 mg 

yl)methoxy]ethyl Acetate 

N 

HN 

O 

H 2 N N N 

O 

O 

MM 0061.02 

Imp. B (EP): 2-Amino-1,7-dihydro-6H-purin-6-one (Guanine) 

HN 

O 

H 

N 

(B) 

100 mg 

H 2 N 

N 

N 

MM 0061.04 

MM 0061.06 

MM 0061.07 

Imp. D (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9- 

yl)methoxy]ethyl Benzoate 

Imp. F (EP): N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9- 

dihydro-1H-purin-2-yl]acetamide 

Imp. G (EP): 2-[[(2-(Acetylamino)-6-oxo-1,6-dihydro-9Hpurin-9-yl]methoxy]ethyl 

Acetate 

H 2 N 

HN 

O 

O 

N 

N 

H 

O 

HN 

N 

H 

N 

N 

HN 

O 

N 

O 

N 

O 

N 

N 

N 

N 

O 

O 

O 

O 

O 

OH 

O 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

MM 0061.08 

Imp. H (EP): 2-[[2-(Acetylamino)-6-oxo-1,6-dihydro- 

9H-purin-9-yl]methoxy]ethyl Benzoate 

O 

N 

H 

HN 

O 

N 

N 

N 

O 

O 

O 

(A) 

100 mg 

MM 0061.13 

Imp. L (Pharmeuropa): 9,N 9 -Diacetylguanine 

O 

HN 

O 

N 

(A) 

100 mg 

N 

H 

N 

N 

O 

MM 0061.10 

2,6-Dichloropurine 

N 

Cl 

N 

(B) 

100 mg 

Cl 

N 

N 

H 

Adenosine 

MM 0784.00 

Adenosine 

N 

NH 2 

N 

(A) 

500 mg 

HO 

N 

O 

N 

OH OH 

Adiphenine Hydrochloride 

New MM 1172.00 

Adiphenine Hydrochloride 

O 

O 

N 

x HCl 

(A) 

250 mg 

Adrenaline Tartrate 

MM 0614.00 

Adrenaline Tartrate 

HO 

OH 

OH 

H 

N 

x 

OH O 

HO 

OH 

O OH 

(A) 

500 mg 

MM 0614.02 

L-Adrenaline 

OH 

H 

N 

(A) 

500 mg 

HO 

OH 

MM 0614.01 

(1R)-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanesulphonic Acid 

(Adrenaline β-Sulphonate) 

SO 3 H 

H (A) 100 mg 

N 

HO 

OH 

MM 0614.05 

Imp. C (EP) as Hydrochloride Monohydrate: 

1-(3,4-Dihydroxyphenyl)-2-(methylamino)- 

ethanone Hydrochloride Monohydrate 

(Adrenalone Hydrochloride Monohydrate) 

HO 

HO 

O 

H 

N 

x HCl 

x H 2 O 

(A) 

100 mg 




Alanine 

MM 0566.00 Alanine 

NH 2 

(A) 500 mg 

OH 

Albendazole 

MM 0382.00 

New MM 0382.01 

MM 0382.02 

MM 0382.03 

MM 0382.04 

MM 0382.05 

Albendazole 

Alfuzosin Hydrochloride 

MM 1004.02 

Allobarbital 

MM 0899.00 

Imp. A (EP): 5-(Propylsulphanyl)-1H-benzimidazol-2-amine 

Imp. B (EP): Methyl [5-Propylsulphinyl)-1H-benzimidazol-2- 

yl]carbamate 

Imp. C (EP): Methyl [5-Propylsulphonyl)-1H-benzimidazol- 

2-yl]carbamate 

Imp. D (EP): 5-(Propylsulphonyl)-1H-benzimidazol-2-amine 

Imp. E (EP): Methyl (1H-Benzimidazol-2-yl)carbamate 

Imp. B (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine 

Allobarbital [Controlled Substance] 

S 

S 

S 

O O 

S 

O 

S 

O O 

O 

O 

H 

N 

N 

H 

N 

N 

O 

H 

N 

N 

H 

N 

N 

H 

N 

N 

O 

O 

(A) 500 mg 

O 

NH 

O 

O 

NH 

O 

NH 

H 

N 

N 

NH 

NH 2 

(A) 100 mg 

O 

NH 2 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

O 

(A) 100 mg 

O 

(A) 

N Cl 

100 mg 

NH 2 

N 

H 

N 

O 

(A) 

100 mg 

NH 

Allopurinol 

MM 0034.00 

MM 0034.01 

MM 0034.05 

MM 0034.06 

MM 0034.07 

Alprazolam 

MM 0136.03 

Allopurinol 

O 

Imp. A (EP) as Hemisulphate: 5-Amino-1H-pyrazole-4- 

carboxamide Hemisulphate NH 2 

Imp. D (EP): Ethyl 5-Amino1H-pyrazole-4-carboxylate 

Imp. E (EP): Ethyl 5-(Formylamino)-1H-pyrazole-4-carboxylate 

Oxypurinol 

Imp. E (EP): (2-Amino-5-chlorophenyl)phenylmethanone 

N 

N 

H 

NH 2 

Cl 

N 

N 

H 

N 

N 

H 

N 

N 

H 

N 

N 

H 

O 

O 

(A) 500 mg 

NH 

N 

x 1 / 2 H 2 SO 4 

(A) 100 mg 

O 

(A) 100 mg 

O 

NH 2 

O 

O 

N O 

H 

O 

N 

H 

NH 

O 

O 

(A) 

(A) 

100 mg 

100 mg 

NH 2 

(B) 100 mg 




Alverine Citrate 

MM 0454.00 

MM 0454.02 

MM 0454.03 

MM 0454.04 

MM 0454.05 

Alverine Citrate 

Amantadine Hydrochloride 

Imp. A (EP): 1-Chloro-3-phenyl-propane 

Imp. B (EP): 3-Phenylpropan-1-ol 

Imp. C (EP) as Hydrochloride: N-Ethyl- 

3-phenylpropan-1-amine Hydrochloride 

Imp. D (EP) as Hydrochloride: N-(3- 

Cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine 

Hydrochloride 

MM 0564.00 Amantadine Hydrochloride 

NH 2 

x HCl 

N 

N 

x 

NH 

O 

O 

OH 

OH 

O 

OH 

OH 

Cl 

OH 

(A) 

(A) 

(A) 

250 mg 

100 mg 

100 mg 

x HCl 

(A) 100 mg 

x HCl 

(A) 100 mg 

(A) 

500 mg 

Ambroxol Hydrochloride 

MM 0005.00 

Ambroxol Hydrochloride 

Br 

N 

H 

OH 

(A) 500 mg 

x HCl 

Br 

NH 2 

MM 0005.01 

Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol 

Br 

OH (A) 100 mg 

Br 

NH 2 

MM 0005.04 

Imp. B (EP) as Hydrochloride: trans-4-(6,8-Dibromo-1,4- 

dihydroquinazolin-3(2H)-yl)cyclohexanol Hydrochloride 

Br 

N 

OH 

(A) 100 mg 

x HCl 

Br 

N 

H 

MM 0005.03 

Imp. C (EP): trans-4-[[(E)-2-Amino-3,5- 

dibromobenzyliden]amino]cyclohexanol 

Br 

N 

OH 

(A) 100 mg 

Br 

NH 2 

MM 0005.05 

Imp. D (EP) as Hydrochloride: cis-4-[(2-Amino-3,5- 

dibromobenzyl)amino]cyclohexanol Hydrochloride 

Br 

N 

H 

OH 

(A) 100 mg 

x HCl 

Br 

NH 2 

MM 0005.02 

Imp. E (EP): 2-Amino-3,5-dibromobenzaldehyde 

Br 

O (A) 100 mg 

Br 

NH 2 

MM 0005.06 

trans-4-Aminocyclohexanol Hydrochloride 

H 2N 

OH 

(A) 100 mg 

x HCl 

MM 0005.07 

cis-4-Aminocyclohexanol Hydrochloride 

H 2N 

OH 

(A) 100 mg 

x HCl 

Amiloride Hydrochloride 

MM 0560.00 Amiloride Hydrochloride Dihydrate 

Aminocaproic Acid 

MM 0896.00 Aminocaproic Acid 

Amiodarone Hydrochloride 

MM 0697.00 Amiodarone Hydrochloride 

O 

O 

Cl 

H 2N 

O NH 

N 

N NH 2 

H 

N NH 2 

H 2 N 

I 

N 

O 

I 

x HCl 

x 2 H 2 O 

OH 

(A) 

500 mg 

O 

(A) 500 mg 

x HCl 

(A) 

250 mg 




MM 0697.02 Imp. A (EP) as Hydrochloride: (2- 

O 

(A) 100 mg 

Butylbenzofuran-3-yl)[4-[2- 

O 

x HCl 

(diethylamino)ethoxy]phenyl]methanone 

N 

O 

Hydrochloride 

New MM 0697.03 

Imp. B (EP) as Hydrochloride: (2-Butylbenzofuran-3-yl)[4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl]methanone 

Hydrochloride 

O 

O 

I 

I 

O 

H 

N 

x HCl 

(D) 

100 mg 

MM 0697.04 Imp. C (EP) as Hydrochloride: (2- 

Butylbenzofuran-3-yl) 

[4-[2-(diethylamino)ethoxy]- 

3-iodophenyl]methanone Hydrochloride 

O 

O 

I 

O 

N 

x HCl 

(A) 

100 mg 

MM 0697.05 

Imp. D (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy-3,5- 

diiodophenyl)methanone 

O 

O 

I 

(A) 

100 mg 

OH 

I 

MM 0697.06 

Imp. E (EP): (2-Butylbenzofuran-3-yl)(4- 

hydroxyphenyl)methanone 

O 

O 

(A) 

100 mg 

OH 

MM 0697.07 

Imp. F (EP): (2-Butylbenzofuran-3-yl)(4-hydroxy-3- 

iodophenyl)methanone 

O 

O 

I 

(A) 

100 mg 

OH 

MM 0697.09 

Imp. H (EP) as Hydrochloride: 2-Chloro-N,N-diethylethanamine 

Hydrochloride (2-Chlorotriethylamine Hydrochloride; 

(2-Chloroethyl)diethylamine Hydrochloride) 

Cl 

N 

x HCl 

(C) 

100 mg 

MM 0697.10 Amiodarone N-Oxide Hydrochloride 

O 

O 

I 

I 

O 

O 

N 

x HCl 

(A) 

100 mg 

Amisulpride 

MM 0793.01 Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine H 2 N 

N 

(A) 

100 mg 

Amitriptyline Hydrochloride 

MM 0062.00 

Amitriptyline Hydrochloride 

(A) 

500 mg 

N 

x HCl 

MM 0062.01 

Imp. A (EP): 10,11-Dihydro-5H-dibenzo-[a,d][7]annulen-5-one 

(Dibenzosuberone) 

O 

(B) 

100 mg 

MM 0062.02 

Imp. B (EP) as Hydrochloride: 3-(5H- 

Dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1- 

amine Hydrochloride (Cyclobenzaprine Hydrochloride) 

N 

x HCl 

(A) 

100 mg 

MM 0062.11 

Imp. C (EP) as Hydrochloride: 3-(10,11-Dihydro-5Hdibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine 

Hydrochloride (Nortriptyline Hydrochloride) 

N 

H 

x HCl 

(A) 

500 mg 

MM 0062.03 

Imp. D (EP): 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5Hdibenzo[a,d][7]annulen-5-ol 

OH 

N 

(A) 

100 mg 




MM 0062.05 Imp. F (EP): (5EZ,10RS)-5-[3-(Dimethyl- 

(A) 100 mg 

amino)propylidene]-10,11-dihydro-5H- 

N 

dibenzo[a,d][7]annulen-10-ol 

HO 

MM 0062.12 

Amitriptyline N-Oxide Hydrochloride 

(A) 

100 mg 

N 

O 

x HCl 

MM 0062.13 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene (Dibenzosuberane) (A) 100 mg 

Amlodipine Besilate 

MM 0383.00 Amlodipine Besilate 

H 

N 

O 

O 

O 

NH 2 

O 

O 

S 

OH 

(D) 

100 mg 

O 

O 

Cl 

x 

MM 0383.01 

Imp. A (EP): 3-Ethyl-5-Methyl (4RS)-4-(2-Chlorophenyl)-2- 

[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6- 

methyl-1,4-dihydropyridine-3,5-dicarboxylate 

O 

H 

N 

O 

O 

O 

N 

O 

(D) 

100 mg 

O 

O 

Cl 

MM 0383.02 

Imp. B (EP): 3-Ethyl 5-Methyl (4RS)-4-(2- 

Chlorophenyl)-6-methyl-2-[[2-[[2- 

(methylcarbamoyl)benzoyl]amino]-ethoxy]methyl]- 

1,4-dihydropyridine-3,5-dicarboxylate 

O 

O 

H 

N 

O 

O 

O 

Cl 

H 

N 

O 

O 

N 

H 

(D) 

100 mg 

MM 0383.03 

Imp. C (EP) as Dihydrochloride: Ethyl Methyl (4RS)- 

2,6-Bis[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)- 

1,4-dihydropyridine-3,5-dicarboxylate Dihydrochloride 

H 2 N 

O 

O 

O 

H 

N 

O 

O 

O 

Cl 

x 2 HCl 

NH 2 

(D) 

100 mg 

MM 0383.04 

Imp. D (EP): 3-Ethyl-5-Methyl 2-[(2-Aminoethoxy)methyl]-4-(2- 

chlorophenyl)-6-methylpyridine-3,5-dicarboxylate 

O 

O 

N 

O 

O 

O 

Cl 

NH 2 

(D) 

100 mg 

MM 0383.05 

Benzenesulfonic Acid 

O 

O 

S 

OH 

(B) 

100 mg 

MM 0383.06 Amlodipine 

H N 

O 

O 

O 

NH 2 

(A) 

100 mg 

O 

O 

Cl 

Amlodipine Maleate 

MM 0631.00 Amlodipine Maleate 

H 

N 

O 

O 

O 

O 

O 

Cl 

NH 2 

x 

O 

OH 

OH 

O 

(D) 

100 mg 

Amlodipine Mesilate 

MM 0592.00 Amlodipine Mesilate 

H 

N 

O 

O 

O 

O 

O 

Cl 

NH 2 

O O 

x 

S 

HO 

on request 




Amodiaquine Dihydrochloride Dihydrate 

Cl N 

MM 0617.00 Amodiaquine Dihydrochloride Dihydrate 

(A) 

500 mg 

HN 

N 

x 2 HCl 

x 2 H 2 O 

OH 

MM 0617.01 

4-Acetamido-2-diethylaminomethylphenol 

H 

N 

N 

(A) 

100 mg 

O 

OH 

Cl N 

MM 0617.02 7-Chloro-4-(4-hydroxyphenylamino)quinoline 

(A) 

100 mg 

HN 

Cl N 

MM0617.03 4,7-Dichloroquinoline 

OH 

(C) 

100 mg 

Cl 

MM 0617.04 

Monodesethylamodiaquine Dihydrochloride 

Cl 

N 

(A) 

100 mg 

HN 

HN 

x 2 HCl 

Amoxicillin Trihydrate 

MM 0232.00 

MM 0232.13 

MM 0232.03 

Amoxicillin Trihydrate 

Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1- 

azabicyclo[3.2.0]-heptane-2-carboxylic Acid 

(6-Aminopenicillanic Acid) 

HO 

O 

NH 2 

H 

N 

O 

O 

Imp. C (EP): (4S)-2-[5-(4-Hydroxyphenyl)-3,6- 

dioxopiperazin-2-yl]-5,5-dimethyl-thiazolidine-4-carboxylic 

HN 

Acid (Amoxicillin Diketopiperazines) H 

O N 

S 

N 

H 

O 

S 

O 

H 2 N 

OH 

OH 

N 

H 

O 

x 3 H 2 O 

S 

OH 

OH 

(A) 

(B) 

(A) 

500 mg 

100 mg 

100 mg 

N 

H 

O 

HO 

MM 0232.04 

Imp. D (EP) as Sodium Salt:(4S)-2-[[[(2R)-2-Amino-2-(4- 

hydroxyphenyl)acetyl]amino]-carboxymethyl]-5,5- 

dimethylthiazolidine-4-carboxylic Acid Sodium Salt 

(Penicilloic Acids of Amoxicillin Sodium Salt) 

H 

N 

HN 

O 

S 

ONa 

(A) 

100 mg 

MM 0232.05 

Imp. E (EP): (2RS,4S)-2-[[[(2R)-2-Amino-2-(4- 

hydroxyphenyl)acetyl]amino]methyl]-5,5- 

dimethylthiazolidine-4-carboxylic Acid 

(Penilloic Acids of Amoxicillin) 

HO 

NH 2 

O 

HO 

NH 2 

H 

N 

O 

O 

O 

HN 

S 

OH (A) 50 mg 

HO 

MM 0232.06 

Imp. F (EP): 3-(4-Hydroxyphenyl)pyrazin-2-ol 

HO N 

(A) 100 mg 

N 

HO 

MM 0232.08 

Imp. H (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2- 

(4-hydroxyphenyl)acetic Acid 

O 

NH 

OH 

(A) 

100 mg 

MM 0232.09 

Imp. I (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid 

HO 

O 

NH 2 

OH 

(B) 

100 mg 

HO 

O 

MM 0232.12 

(2R)-2-Amino-2-(4-hydroxyphenyl)acetamide 

NH 2 

NH 2 

(A) 

100 mg 

HO 

O 




Ampicillin Sodium 

MM 0253.00 

Ampicillin Sodium 

O 

NH 2 

H 

N 

O 

N 

H 

O 

S 

ONa 

(A) 

500 mg 

MM 0253.17 


azabicyclo[3.2.0]-heptane-2-carboxylic Acid (6-Aminopenicillanic Acid) 

O 

N 

O 

OH 

(B) 

100 mg 

MM 0253.03 

Imp. C (EP): (4S)-2-(3,6-Dioxo-5-phenylpiperazin-2-yl)-5,5- 

dimethylthiazolidine-4-carboxylic Acid (Diketopiperazines of 

H 2 N 

H 

HN 

O 

S 

OH 

(A) 

100 mg 

Ampicillin) H 

O N 

S 

N 

H 

O 

MM 0253.06 

Imp. F (EP): (2RS,4S)-2-[[[(2R)-2-Amino-2- 

phenylacetyl]amino]methyl]-5,5-dimethyl-thiazolidine-4- 

carboxylic Acid (Penilloic Acids of Ampicillin) 

H 

N 

HN 

O 

S 

OH (A) 100 mg 

NH 2 

O 

MM 0253.08 

Imp. H (EP): 3-Phenylpyrazin-2-ol 

HO N 

(A) 100 mg 

N 

MM 0253.11 

MM 0253.12 

Imp. K (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-phenylacetic 

Acid 

Imp. L (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine) 

O 

(A) 100 mg 

NH 

O 

O 

OH 

NH 2 

(B) 100 mg 

OH 

MM0253.15 

Ampicillin Trihydrate 

O 

NH 2 

H 

N 

O 

O 

N 

S 

H 

OH 

x 3 H 2 O 

(A) 

500 mg 

MM 0253.16 

Ampicillin, anhydrous 

O 

NH 2 

H 

N 

O 

O 

N 

S 

H 

OH 

(A) 

500 mg 

Androstanolone 

MM 0565.00 

Androstanolone 

OH 

(A) 250 mg 

O 

Anise Oil 

MM 0164.01 

trans-Anethole 

(C) 

100 mg 

O 

MM 0164.02 

Estragole 

(C) 

100 mg 

O 

MM 0164.03 

Anise Aldehyde 

O (C) 100 mg 

O 

MM 0164.05 

Linalol 

(C) 

100 mg 

HO 

MM 0164.06 

cis-Anethole 

(D) 

100 mg 

O 




Antazoline Hydrochloride 

MM 0171.00 

MM 0171.01 

Antazoline Hydrochloride 

Imp. A (EP) as Dihydrochloride: N-(2-Aminoethyl)-2- 

(benzylphenylamino)acetamide Dihydrochloride 

N 

O 

N 

H 

N 

N 

NH 2 

N 

H 

x HCl 

x 2 HCl 

(A) 

(A) 

500 mg 

100 mg 

MM 0171.03 N-Benzylaniline NH (B) 100 mg 

MM 0171.04 2-Chloromethyl-4,5-dihydro-1H-imidazole Hydrochloride 

Antazoline Phosphate 

MM 0561.00 Antazoline Phosphate 

H 

N 

N 

N 

Cl 

H 

N 

N 

x HCl 

(A) 100 mg 

x H 3 PO 4 

(A) 500 mg 

Apomorphine Hydrochloride 

MM 0562.00 

Apomorphine Hydrochloride Hemihydrate 

HO 

OH 

N 

H 

x HCl 

x ½ H 2O 

(A) 

250 mg 

MM 0562.02 

Imp. B (EP) as Hydrochloride Trihydrate: Morphine 

Hydrochloride Trihydrate 

[Controlled Substance] 

N 

x HCl 

x 3 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

Aprindine Hydrochloride 

MM 0467.00 

Aprindine Hydrochloride 

N 

on request 

N 

HCl 

Arginine 

MM 0568.00 

Arginine 

H 2 N 

H 

N 

NH 2 

(A) 500 mg 

OH 

NH 

O 

Arginine Hydrochloride 

MM 0569.00 

Arginine Hydrochloride 

H 2 N 

H 

N 

NH 2 

OH 

x HCl 

(A) 

500 mg 

NH 

O 

Articaine Hydrochloride 

MM 0369.00 

Articaine Hydrochloride 

O 

S 

O 

H 

N 

O 

N 

H 

x HCl 

(A) 

100 mg 

MM 0369.01 Imp. A (EP) as Hydrochloride: Methyl 3-[[2- 

(Propylamino)acetyl]amino]-4-methylthiophene-2- 

carboxylate Hydrochloride (Acetamidoarticaine 

Hydrochloride) 

O 

O 

S 

H 

N 

O 

N 

H 

x HCl 

(A) 

100 mg 

MM 0369.02 

Imp. B (EP) as Hydrochloride: 4-Methyl-3-[[(2RS)-2- 

(propylamino)propanoyl]amino]thiophene-2-carboxylic Acid 

Hydrochloride (Articaine Acid Hydrochloride) 

O 

HO 

S 

H 

N 

O 

N 

H 

x HCl 

(A) 

50 mg 

MM 0369.03 

Imp. C (EP) as Hydrochloride: 1-Methylethyl 4-Methyl-3- 

[[(2RS)-2-(propylamino)propanoyl]amino]thiophene-2- 

carboxylate Hydrochloride (Articaine Isopropyl Ester 


O 

O 

S 

H 

N 

O 

N 

H 

x HCl 

(A) 

100 mg 

MM 0369.04 

Imp. D (EP) as Hydrochloride: Methyl 3-[[(2RS)-2- 

(Ethylamino)propanoyl]amino]-4-methylthiophene-2- 

carboxylate Hydrochloride (Ethylarticaine Hydrochloride) 

O 

O 

S 

H 

N 

O 

N 

H 

x HCl 

(A) 

100 mg 




MM 0369.05 

MM 0369.06 

MM 0369.07 

MM 0369.08 

Imp. E (EP) as Hydrochloride: Methyl 4-Methyl-3-[[(2RS)-2- 

[(1-methylethyl)amino]propanoyl]amino]thiophene-2- 

carboxylate Hydrochloride (Isopropylarticaine 


Imp. F (EP) as Hydrochloride: 4-Methyl-N-propyl-3- 

[[(2RS)-2-(propylamino)propanoyl]amino]thiophene-2- 

carboxamide Hydrochloride (Articaine Acid 

Propionamide Hydrochloride) 

Imp. G (EP) as Hydrochloride: Methyl 3-[[(2RS)-2- 

(Butylamino)propanoyl]amino]-4-methylthiophene-2- 

carboxylate Hydrochloride (Butylarticaine Hydrochloride) 

Imp. H (EP) as Hydrochloride: Methyl 3-[[(2RS)-2- 

(Dipropylamino)propanoyl]amino]-4-methylthiophene-2- 

carboxylate Hydrochloride (Dipropylarticaine Hydrochloride) 

MM 0369.09 Imp. I (EP): Methyl 3-Amino-4-methylthiophene-2-carboxylate (3- 

Aminoarticaine) 

O 

H 

N 

O 

O 

S 

S 

S 

S 

O 

O 

O 

O 

H 

N 

H 

N 

H 

N 

H 

N 

O 

O 

O 

O 

N 

H 

N 

H 

N 

H 

N 

O 

S 

x HCl 

x HCl 

x HCl 

x HCl 

NH 2 

(A) 

(A) 

(A) 

(A) 

100 mg 

50 mg 

100 mg 

100 mg 

O 

(C) 100 mg 

MM 0369.10 

Imp. J (EP): Methyl 3-[[(2RS)-2-Bromopropanoyl]amino]-4- 

methylthiophene-2-carboxylate (Bromo Compound) 

O 

S 

O 

H 

N 

O 

Br 

(A) 

100 mg 

Ascorbic Acid 

MM 0166.00 L-Ascorbic Acid 

Asparagine Monohydrate 

MM 0765.01 Phenylacetylasparagine 

OH 

HO 

O 

O 

HO OH 

(A) 500 mg 

O (A) 100 mg 

Aspartame 

O HN 

OH 

H 2 N 

O 

O NH 

MM 0314.00 Aspartame 2 H 

O 

(A) 500 mg 

N 

HO 

O 

O 

MM 0314.01 

Imp. A (EP): 2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid 

(Diketopiperazine) 

O 

HO 

O 

(A) 100 mg 

HN 

NH 

O 

O NH 

MM 0314.02 Imp. B (EP): L-Aspartyl-L-phenylalanine 2 H 

O 

(A) 100 mg 

HO 

O 

N 

OH 

MM 0314.03 

Imp. C (EP): Phenylalanine 

H 2 N 

O 

(B) 100 mg 

OH 

Aspartic Acid 

MM 0567.00 

Astemizole 

MM 0184.00 

Aspartic Acid 

Astemizole 

HN 

N 

N 

O 

(A) 500 mg 

NH 2 

OH 

HO 

O 

F 

(A) 250 mg 

N 

O 

MM 0184.13 

Desmethyl Astemizole Hydrochloride 

F 

N 

HN 

N 

N 

OH 

(A) 

100 mg 

x HCl 




Atenolol 

MM 0013.00 Atenolol 

O 

O 

H 2N 

OH HN (A) 500 mg 

MM 0013.03 

Imp. A (EP): 2-(4-Hydroxyphenyl)acetamide 

O 

OH 

(B) 100 mg 

H 2N 

MM 0013.05 

Imp. B (EP): 2-[4-[(2RS)-2,3- 

Dihydroxypropoxy)phenyl]acetamide 

H 2N 

O 

O 

OH 

OH 

(A) 

100 mg 

MM 0013.01 

Imp. C (EP): 2-[4-[[(2RS)-Oxiran-2-yl]methoxy]phenyl]acetamide 

O 

O 

O 

(A) 100 mg 

H 2N 

MM 0013.06 

Imp. D (EP): 2-[4-[(2RS)-3-Chloro-2- 

hydroxypropoxy]phenyl]acetamide 

O 

H 2N 

O 

OH 

Cl 

(A) 

50 mg 

MM 0013.07 

Imp.E (EP): 2,2'-[2-Hydroxypropan-1,3-diylbis- 

(oxy-4,1-phenylene)]diacetamide 

H 2N 

O 

O 

OH 

(A) 50 mg 

O 

O 

NH 2 

MM 0013.02 

Imp. F (EP): 2,2'-[(1-Methylethyl)-iminobis(2- 

hydroxypropan-3,1-diyloxy-4,1- 

phenylene)]diacetamide 

H 2N 

O 

O 

OH 

N 

OH (A) 50 mg 

O 

O 

NH 2 

MM 0013.04 

Imp. G (EP): 2-[4-[(2RS)-2-Hydroxy-3-[(1- 

methylethyl)amino]propoxy]phenyl]acetic Acid 

O 

HO 

O 


MM 0013.08 

Imp. H (EP): 2-[4-[(2RS)-2-Hydroxy-3-[(1- 

methylethyl)amino]propoxy]phenyl]acetonitrile 

N 

O 

OH 

HN 

(A) 

100 mg 

MM 0013.13 

4-Hydroxyphenylacetic Acid 

O 

OH 

(B) 100 mg 

HO 

Atorvastatin Calcium 

MM 0400.00 

Atorvastatin Calcium 

O 

O 

on request 

OH 

OH 

H 

N 

O 

N 

F 

2 

Ca 2+ 

MM 0400.04 

1,1-Dimethylethyl (4R-cis)-6-[2-[2-(4-Fluorophenyl)-5-(1- 

methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1-Hpyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate 

O O 

(A) 100 mg 

O 

O 

N 

F 

H 

N 

O 

MM 0400.05 

1,1-Dimethylethyl (4R-cis)-6-Aminoethyl-2,2-dimethyl-1,3- 

dioxane-4-acetate 

O 

O 

O 

O 

NH 2 

(A) 100 mg 

Atracurium Besilate 

MM 0858.13 

Imp. J (EP): Methyl Benzenesulphonate 

O O 

(A) 100 mg 

S 

O 

Atropine 

MM 0289.18 

Atropine 

O 

H 

O 

H 

N 

(A) 

250 mg 

OH H 

and enantiomer 




MM 0289.00 

MM 0289.01 

MM 0289.15 

Atropine Sulphate 

Imp. A (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl-8- 

azabicyclo[3.2.1]oct-3-yl 2-Phenylpropenoate 

Hydrochloride 

(Apoatropine Hydrochloride) 

O 

H 

Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) 

OH 

O 

H 

(A) 500 mg 

H 

N 

O 

H 

O 

x H 2 SO 4 

x H 2 O 


2 

H 

(D) 100 mg 

H 

N 

x HCl 

O (A) 100 mg 

OH 

OH 

MM 0289.16 

Imp. F (EP) as Hydrobromide Trihydrate: Hyoscine 

Hydrobromide Trihydrate 

O 

H 

O 

H 

N 

H 

O 

x HBr 

x 3 H 2 O 

(A) 

500 mg 

OH 

H 

H 

MM 0289.03 

Atropic Acid 

O (A) 100 mg 

OH 

Avobenzone 

MM 0902.00 Avobenzone 

O O 

(A) 

500 mg 

O 

Azelaic Acid 

MM 0687.00 Azelaic Acid 

Azelastine Hydrochloride 

MM 0362.00 Azelastine Hydrochloride 

HO 

O O 

(A) 500 mg 

O 

N 

N 

N 

OH 

x HCl 

on request 

Cl 

MM 0362.04 

Imp. A (EP): Benzoyldiazane (Benzohydrazide) 

O 

NH 

NH 2 

(C) 100 mg 

MM 0362.02 

MM 0362.05 

Imp. B (EP) as Hydrochloride: 1-Benzoyl-2-[(4RS)-1- 

methylhexahydro-1H-azepin-4-yl]diazane Hydrochloride 

Imp. C (EP): 2-[(4-Chlorophenyl)acetyl]benzoic Acid 

H 

N 

N 

H 

O 

N 

x HCl 

O 

(A) 

(A) 

100 mg 

100 mg 

OH 

O 

Cl 

MM 0362.01 

Imp. D (EP): 4-(4-Chlorobenzyl)phthalazin-1(2H)-one 

O 

NH 

(A) 

100 mg 

N 

Cl 

MM 0362.06 

Imp. E (EP) Z-Isomer: (Z)-3-(4-Chlorobenzylidene)- 

isobenzofuran-1(3H)-one 

O 

O 

(A) 

100 mg 

Cl 

MM 0362.03 

1-Methylazepan-4-one Hydrochloride 

O 

N 

x HCl 

(A) 

100 mg 




Bambuterol Hydrochloride 

MM 0773.04 

Imp. D (EP): 5-[(1RS)-1-Hydroxyethyl]-1,3-phenylene 

Bis(dimethylcarbamate) 

N 

O 

O 

OH 

(A) 

100 mg 

N 

O 

O 

MM 0773.05 

Imp. E (EP): 5-Acetyl-1,3-phenylene Bis-(dimethylcarbamate) 

N 

O 

O 

(A) 

100 mg 

O 

N 

O 

Basic Butylated Methacrylate Copolymer 

MM 0753.01 Imp. A (EP): Butyl Methacrylate 

O 

O 

O 

(A) 

100 mg 

MM 0753.02 Imp. B (EP): Methyl Methacrylate 

O 

O 

(A) 

100 mg 

MM 0753.03 Imp. C (EP): 2-(Dimethylamino)ethyl Methacrylate 

O 

O 

N 

(A) 

100 mg 

Beclometasone Dipropionate 

MM 0199.00 

Beclometasone Dipropionate 

O 

O 

O 

O 

(A) 250 mg 

HO 

O 

O 

Cl 

New MM 0199.06 

Imp. B (EP): 21-(Acetyloxy)-9-chloro-11βhydroxy-16β-methyl-3,20-dioxopregna-1,4- 

dien-17-yl Propanoate (Beclometasone 21- 

Acetate 17-Propionate) 

HO 

O 

O 

O 

O 

O 

(A) 

100 mg 

Cl 

O 

New MM 0199.01 

Imp. H (EP): 9-Chloro-11,21-dihydroxy-16methyl-3,20-dioxopregna-1,4-dien-17-yl 

Propanoate (Beclometasone 17-Propionate) 

HO 

O 

O 

OH 

O 

(A) 100 mg 

Cl 

O 

MM 0199.03 

Imp. G (EP): 9-Chloro-11β,17,21-trihydroxy-16βmethylpregna-1,4-diene-3,20-dione 

(Beclometasone) 

HO 

O 

OH 

OH 

(A) 100 mg 

Bendroflumethiazide 

MM 0674.01 

Imp. A (EP): 4-Amino-6-(trifluoromethyl)benzene-1,3- 

disulphonamide 

O 

Cl 

O O O 

H S S 

2 N 

NH 2 

F 

NH 2 

F F 

O (A) 100 mg 

Benperidol 

MM 0113.00 

Benperidol 

O 

N 

O 

(A) 100 mg 

N 

NH 

F 

MM 0113.03 

Imp. A (EP): 1-(Piperidin-4-yl)-1,3-dihydro-2Hbenzimidazol-2-one 

O 

(A) 100 mg 

N 

NH 

HN 

MM 0113.07 

4-Chloro-4'-fluorobutyrophenone 

O 

Cl 

(B) 

100 mg 

F 




Benzalkonium Chloride 

MM 0224.00 Benzalkonium Chloride 

Cl 

N 

n 

(A) 500 mg 

New MM 0224.04 Imp. A (Pharmeuropa): Benzyl Alcohol OH (A) 500 mg 

New MM 0224.05 Imp. B (Pharmeuropa): Benzaldehyde O (B) 100 mg 

MM 0224.01 

Benzyldimethyldodecylammonium Chloride 

N 

Cl 

5 

(A) 

500 mg 

MM 0224.02 

Benzyldimethyltetradecylammonium Chloride 

N 

Cl 

6 

(A) 

500 mg 

MM 0224.03 

Benzyldimethylhexadecylammonium Chloride 

N 

Cl 

7 

(A) 

500 mg 

Benzbromarone 

MM 0456.00 Benzbromarone 

O 

O 

Br 

Br 

OH 

(A) 

500 mg 

Benzocaine 

MM 0094.00 

Benzocaine 

O 

(A) 500 mg 

O 

H 2 N 

MM 0094.01 

Benzocaine Acetylsalicylamide 

O 

(A) 

100 mg 

O 

O 

N 

H 

O 

O 

MM 0094.02 

N-Acetylbenzocaine 

O 

(A) 

100 mg 

O 

O 

N 

H 

MM 0094.03 

4-Aminobenzoic Acid 

O 

(B) 100 mg 

OH 

H 2 N 

MM 0094.04 

Ethyl 4-Nitrobenzoate 

O 

(B) 100 mg 

O 

O 2 N 

Benzydamine Hydrochloride 

MM 0142.00 

Benzydamine Hydrochloride 

N 

N 

x HCl 

(A) 

500 mg 

O 

N 

New MM 0142.04 

Imp. C (BP): 1-Benzyl-1H-indazol-3-ol 

(A) 

100 mg 

N 

N 

OH 

MM 0142.08 

Benzydamine N-Oxide Hydrochloride 

(A) 

100 mg 

N 

N 

x HCl 

O 

N 

O 

MM 0142.05 1-Chloropropyl(dimethyl)amine Hydrochloride Cl N x HCl (B) 100 mg 




Benzyl Alcohol 

MM 0795.00 Benzyl Alcohol OH (A) 500 mg 

MM 0795.01 Imp. A (EP): Benzaldehyde O (B) 100 mg 

MM 0795.02 Imp. B (EP): Cyclohexylmethanol OH (A) 100 mg 

Benzyl Benzoate 

MM 0570.00 

Benzyl Benzoate 

O 

(A) 500 mg 

O 

Benzyl Nicotinate 

MM 0104.00 


N 

O 

(A) 500 mg 

O 

MM 0104.01 

Nicotinic Acid 

N 

O 

(A) 500 mg 

OH 

Benzylpenicillin Benzathine 

MM 0513.00 

Benzylpenicillin Benzathine 

MM 0513.02 Imp. A (EP): Monobenzylethylendiamine HN 

H 

N 

N 

H 

x 

O 

H 

N 

O 

N 

H 

O 

S 

OH 

2 

(A) 500 mg 

NH 2 

(C) 100 mg 

MM 0513.03 Imp. B (EP): Phenylacetic Acid [Controlled Substance] 

OH 

O 

(B) 

100 mg 

MM 0513.04 

MM 0513.05 

Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7atetrahydroimidazo[5,1-b]-thiazole-3,7-dicarboxylic 

Acid (Penillic Acid 

of Benzylpenicillin) 

Imp. E (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]-5,5- 

dimethylthiazolidine-4-carboxylic Acid (Penicilloic Acids of 

Benzylpenicillin) 

O 

N 

N 

S 

H 

HO 

O 

OH 

(A) 

100 mg 

O 

OH (A) 100 mg 

HN 

H 

N 

S 

O O OH 

MM 0513.06 

Imp. F (EP): (2RS,4S)-2-[[(Phenylacetyl)amino]methyl]-5,5- 

dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of 


H 

N 

O 

HN 

S 

OH 

(A) 

100 mg 

O 

MM 0513.01 

N,N’-Dibenzylethylenediamine Diacetate 

H 

N 

N 

H 

x 

HO 

O 

2 

(C) 

100 mg 

Benzylpenicillin Potassium 

MM 0160.00 

MM 0160.11 

Benzylpenicillin Potassium 



MM 0160.03 Imp. B (EP): Phenylacetic Acid [Controlled Substance] O 

O 

O 

N 

H 

O 

H 2N 

O 

N 

S 

H 

O 

N 

S 

H 

OK (A) 250 mg 

OH (B) 100 mg 

OH 

(B) 

100 mg 




MM 0160.07 

MM 0160.01 

Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7atetrahydroimidazo[5,1-b]-thiazole-3,7-dicarboxylic 

Acid (Penillic 

Acid of Benzylpenicillin) 

Imp. E (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]-5,5- 

dimethyl-thiazolidine-4-carboxylic Acid (Penicilloic Acids of 


O 

N 

N 

S 

H 

HO 

O 

OH 

(A) 

100 mg 

O 

OH (A) 100 mg 

HN 

H 

N 

S 

O O OH 

MM 0160.05 

Imp. F (EP): (2RS,4S)-2-[[(Phenylacetyl)amino]methyl]-5,5- 

dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of 


H 

N 

O 

HN 

S 

OH 

(A) 

100 mg 

O 

Benzylpenicillin Procaine 

New MM 0302.01 

Imp. A (EP): 4-Aminobenzoic Acid 

O 

(B) 100 mg 

OH 

New MM 0302.02 

Imp. B (EP): (4S)-2-[Carboxy[(phenylacetyl)amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic 

Acid 

(Penicilloic Acids of Benzylpenicillin) 

H 2 N 

O 

OH (A) 100 mg 

HN 

H 

N 

S 

O 

O OH 

New MM 0302.03 

Imp. C (EP): (2RS,4S)-2-[[(Phenylacetyl)- 

amino]methyl]-5,5-dimethylthiazolidine-4- 

carboxylic Acid (Penilloic Acids of 


O 

H 

N 

HN 

O 

S 

OH 

(A) 

100 mg 

New MM 0302.04 

Imp. D (EP): (3S,7R,7aR)-5-Benzyl-2,2- 

dimethyl-2,3,7,7a-tetrahydroimidazo[5,1- 

b]thiazole-3,7-dicarboxylic Acid (Penillic 

Acid of Benzylpenicillin) 

New MM 0302.05 Imp. E (EP): Phenylacetic Acid 

OH 

HO 

N 

O 

N 

H 

O 

S 

O 

OH 

(A) 

(B) 

100 mg 

100 mg 

Betahistine Dihydrochloride 

MM 0587.00 Betahistine Dihydrochloride 

N 

H 

N 

x 2 HCl 

(A) 

500 mg 

MM 0587.01 Imp. A (EP): 2-Ethenylpyridine (2-Vinylpyridine) 

N 

(C) 100 mg 

MM 0587.02 Imp. B (EP): 2-(Pyridin-2-yl)ethanol (2-(2-Hydroxyethyl)pyridine) 

N OH 

(B) 100 mg 

MM 0587.03 

Imp. C (EP) as Trihydrochloride: N-Methyl-2-(pyridin-2- 

yl)-N-[2-(pyridin-2-yl)ethyl]ethanamine Trihydrochloride 

N N N 

x 3 HCl 

(A) 

100 mg 

MM 0587.04 

Imp. C (EP) as Trimesilate: N-Methyl-2-(pyridin-2-yl)- 

N-[2-(pyridin-2-yl)ethyl]ethanamine Trimesilate 

N N N 

x 3 

O O 

(A) 100 mg 

S OH 

Betaine Hydrochloride 

MM 0611.00 

Betaine Hydrochloride 

N 

O 

OH 

Cl 

(A) 

500 mg 

Betamethasone 

MM 0200.00 

Betamethasone 

HO 

O 

OH 

OH 

(A) 

250 mg 

F 

O 

MM 0200.11 

Imp. A (EP): Dexamethasone 

HO 

O 

OH 

OH 

(A) 

250 mg 

F 

O 




MM 0200.01 

Imp. B (EP): 21-Chloro-9-fluoro-11β,17-dihydroxy-16βmethylpregna-1,4-diene-3,20-dione 

(Clobetasol) 

HO 

O 

Cl 

OH 

(A) 

100 mg 

F 

O 

Betamethasone Acetate 

MM 0201.00 

Betamethasone Acetate 

HO 

O 

O 

OH 

O 

(A) 250 mg 

O 

F 

MM 0201.05 

Imp. A (EP): Betamethasone 

HO 

O 

OH 

OH (A) 250 mg 

O 

F 

MM 0201.02 

Imp. B (EP): Dexamethasone Acetate 

HO 

O 

O 

OH 

O 

(A) 250 mg 

MM 0201.03 

Imp. C (EP): Betamethasone 11,21-Diacetate 

F 

O 

O O 

O 

(A) 100 mg 

O 

O 

OH 

F 

O 

Betamethasone Dipropionate 

MM 0202.00 

Betamethasone Dipropionate 

O 

O 

O 

O 

(A) 

250 mg 

HO 

O 

O 

F 

MM 0202.04 

Betamethasone 21-Propionate 

O 

O 

O 

(A) 100 mg 

HO 

OH 

F 

O 

Betamethasone Sodium Phosphate 

MM 0303.00 

Betamethasone Sodium Phosphate 

O 

O 

O 

P ONa 

ONa 

on request 

HO 

OH 

O 

F 

Betamethasone 17-Valerate 

MM 0203.00 

Betamethasone 17-Valerate 

O 

OH 

O 

(A) 250 mg 

HO 

O 

O 

F 

New MM 0203.02 

Imp. A (Pharmeuropa): (11β,16β)-9-Fluoro- 

11,17,21-trihydroxy-16-methylpregna-1,4- 

diene-3,20-dione (Betamethasone) 

HO 

O 

OH 

OH 

(A) 250 mg 

F 

O 

Betaxolol Hydrochloride 

MM 0436.00 

Betaxolol Hydrochloride 

O 

OH 

HN 

on request 

O 

x HCl 




MM 0436.02 Imp. B (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]- 

OH 

HN (A) 100 mg 

3-[(1-methylethyl)amino]propan-2-ol 

O 

HO 

Bezafibrate 

MM 0063.00 

Bezafibrate 

O 

O 

O 

(A) 500 mg 

OH 

Cl 

N 

H 

MM 0063.01 

Imp. A (EP): 4-Chloro-N-[2-(4- 

hydroxyphenyl)ethyl]benzamide (4-Chlorobenzoyltyramine) 

Cl 

O 

N 

H 

OH 

(A) 100 mg 

MM 0063.03 

Imp. B (EP): 4-Chlorobenzoic Acid 

O 

OH 

(B) 

100 mg 

Cl 

MM 0063.04 Imp. C (EP): Methyl 2-[4-[2-[(4- 

Chlorobenzoyl)amino]ethyl]phenoxy]-2- 

methylpropanoate 

Cl 

O 

N 

H 

O 

O 

(A) 100 mg 

O 

MM 0063.02 

Imp. D (EP): Ethyl 2-[4-[2-[(4-Chlorobenzoyl)amino]- 

ethyl]phenoxy]-2-methylpropanoate 

Cl 

O 

N 

H 

O 

O 

(A) 100 mg 

O 

MM 0063.05 

Imp. E (EP): Butyl 2-[4-[2-[(4-Chlorobenzoyl)amino]- 

ethyl]phenoxy]-2-methylpropanoate 

Cl 

O 

N 

H 

O 

O 

(A) 100 mg 

O 

MM 0063.06 

Tyramine 

OH 

(B) 100 mg 

H 2N 

MM 0063.07 

N,O-Bis-(4-chlorobenzoyl)tyramine 

Cl 

O 

N 

H 

O 

O 

Cl 

(A) 100 mg 

Bicalutamide 

MM 0894.00 Bicalutamide F 

S 

O O 

O 

OH 

N 

H 

F 

N 

F 

F 

(A) 

100 mg 

Bifonazole 

MM 0318.00 

Bifonazole 

(A) 

500 mg 

N 

N 

MM 0318.01 

Imp. A (EP): (RS)-(Biphenyl-4-yl)phenylmethanol 

(A) 

100 mg 

OH 

MM 0318.04 

Imp. C (EP): 1H-Imidazole 

H 

N (B) 100 mg 

N 

MM 0318.03 

Imp. D (EP) as Chloride: 1,3-Bis[(biphenyl-4-yl)phenylmethyl]- 

1H-imidazolium Chloride 

N + N 

Cl - (D) 100 mg 

Bisacodyl 

MM 0031.00 

Bisacodyl 

O 

O 

O 

O 

(A) 

500 mg 

N 




MM 0031.01 Imp. A (EP): 4,4'-(Pyridin-2-ylmethylene)diphenol 

HO OH 

(A) 100 mg 

N 

MM 0031.04 

Imp. B (EP): 2-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl) 

methyl]phenol 

OH OH 

(A) 50 mg 

N 

MM 0031.02 

Imp. C (EP): 4-[(RS)-(4-Hydroxyphenyl)(pyridin-2- 

yl)methyl]phenyl Acetate 

HO 

O 

O 

(A) 

100 mg 

N 

MM 0031.03 

Imp. E (EP): 2-[(RS)-[4-(Acetyloxy)phenyl](pyridin-2- 

yl)methyl]phenyl Acetate 

O 

O 

O 

(A) 

50 mg 

O 

N 

MM 0031.05 

Sodium 4-[(4-Hydroxyphenyl)-(2-pyridinyl)methyl]phenyl 

Hydrogensulphate 

HO 

O 

S 

ONa 

O 

O 

(A) 

100 mg 

N 

MM 0031.06 

Disodium 2,4'-(2-Pyridinylmethylene)bisphenyl 

Bis(hydrogensulphate) 

NaO O 

S 

O O 

(D) 

50 mg 

N 

O ONa 

S 

O O 

Bisoprolol Hemifumarate 

MM 0460.00 

Bisoprolol 

O 

OH 

H 

N 

(A) 

100 mg 

O 

O 

MM 0460.08 

Bisoprolol Hemifumarate 

O 

OH 

HN 

O 

OH 

(A) 

100 mg 

x 1/2 

O 

O 

HO 

O 

MM 0460.01 

Imp. A (Pharmeuropa): (RS)-1-(4-Hydroxymethylphenoxy)- 

3-isopropylaminopropan-2-ol 

O 

OH 

HN 

(A) 

100 mg 

OH 

MM 0460.07 

Imp. B (Pharmeuropa): (RS)-1-Isopropylamino-3-[4-(2- 

propoxyethoxymethyl)phenoxy]propan-2-ol 

O 

OH 

HN 

(A) 

100 mg 

MM 0460.15 

New MM 0460.21 

Imp. C (Pharmeuropa): (RS)-1-[4-[4-(2- 

Hydroxy-3-isopropopylaminopropoxy)- 

benzyl]phenoxy]-3- 

isopropylaminopropan-2-ol 

Imp. G (Pharmeuropa): (2RS)-1-[4-(((2-Isopropoxyethoxy)methoxy)methyl)phenoxy]-3-(isopropylamino)-2-propanol 

H 

N 

O 

O 

OH OH 

O 

O 

HN (A) 100 mg 

O 

OH 

HN 

(D) 

100 mg 

O 

O 

O 

MM 0460.24 

Imp. J (Pharmeuropa): (2RS)-3-[4-((2- 

Isopropoxyethoxy)methyl)phenoxy]-1,2-propanediol 

O 

O 

O 

OH 

OH 

(A) 

100 mg 

New MM 0460.18 Imp. K (Pharmeuropa): 2-Isopropoxyethyl 4- 

[((2RS)-2-Hydroxy-3-(isopropylamino)propyl)- 

oxy]benzoate (Bisoprolol Ester) 

O 

O 

O 

OH 

HN 

(A) 

100 mg 

O 




MM 0460.09 

Imp. L (Pharmeuropa) as Hydrochloride: 4-[((2RS)-2- 

Hydroxy-3-(isopropylamino)-propyl)oxy]benzaldehyde 

Hydrochloride 

O 

OH 

HN 

x HCl 

(A) 

100 mg 

O 

MM 0460.02 

Imp. M (Pharmeuropa): 4-[(2-Isopropoxyethoxy) 

methyl]phenol 

O 

O 

OH 

(A) 

100 mg 

MM 0460.25 

Imp. N (Pharmeuropa): (2RS)-1-[4-((2- 

Ethoxyethoxy)methyl)phenoxy]-3-(isopropylamino)- 

2-propanol 

O 

O 

O 

OH 

HN 

(A) 

100 mg 

MM 0460.05 

Imp. Q (Pharmeuropa): (2RS)-1-Isopropylamino-3-[4- 

(2-methoxyethoxy)methyl]- 

phenoxy-2-propanol 

O 

O 

O 

OH 

HN 

(A) 

100 mg 

MM 0460.03 2-[4-(2-Isopropoxyethoxymethyl)phenoxymethyl]oxirane O 

O 

(A) 100 mg 

O 

O 

MM 0460.06 4-Hydroxybenzyl Alcohol 

OH 

HO 

(B) 

100 mg 

MM 0460.10 

Fumaric Acid 

HO 

O 

O 

(B) 100 mg 

OH 

MM 0460.14 4-Hydroxybenzaldehyde 

OH 

Boldenone 

O 

(C) 

100 mg 

MM 0864.00 

Boldenone 

OH 

(A) 100 mg 

O 

Bromazepam 

MM 0064.00 

Bromazepam [Controlled Substance] 

H 

N 

O 

(A) 

100 mg 

Br 

N 

N 

MM 0064.01 

Imp. A (EP): (2-Amino-5-bromophenyl)(pyridin-2-yl)methanone 

(A) 

100 mg 

NH 2 

O 

Br 

N 

Bromhexine Hydrochloride 

MM 0065.00 Bromhexine Hydrochloride 

Br 

(A) 

500 mg 

Br 

N 

x HCl 

NH 2 

MM 0065.06 

Imp. A (EP): (2-Amino-3,5-dibromophenyl)methanol 

Br 

OH (A) 100 mg 

Br 

NH 2 

MM 0065.07 

Imp. B (EP): 2-Amino-3,5-dibromobenzaldehyde 

Br 

O (A) 100 mg 

Br 

NH 2 

MM 0065.02 

Imp. C (EP): N-(2-Aminobenzyl)-N-methylcyclohexanamine 

(A) 

100 mg 

N 

NH 2 

MM 0065.03 

Imp. D (EP) as Dihydrochloride: N-(2-Amino-5-bromobenzyl)-Nmethylcyclohexanamine 

Dihydrochloride 

Br 

N 

x 2 HCl 

(A) 

100 mg 

NH 2 

MM 0065.01 

N-(2-Nitrobenzyl)-N-cyclohexyl-N-methylamine 

N 

(A) 

100 mg 

NO 2 




MM 0065.05 6,8-Dibromo-3-cyclohexyl-3,4-dihydro-2(1H)-quinazolinone 

Br 

(A) 

100 mg 

Br 

HN 

N 

O 

MM 0065.09 Bromhexine N-Oxide 

Br 

(A) 

100 mg 

Br 

NH 2 

N 

O 

Bromisoval 

MM 1128.01 

Ethyl 2-Bromoisovalerate 

O 

(A) 100 mg 

O 

Br 

Brompheniramine 

MM 0271.00 Brompheniramine 

Br 

(A) 

100 mg 

N 

N 

Brompheniramine Maleate 

MM 0060.00 Brompheniramine Maleate O 

MM 0060.13 Imp. A (EP) as Maleate: Chlorphenamine Maleate O 

MM 0060.15 Imp. B (EP) as Maleate: Dexchlorpheniramine Maleate O 

MM 0060.11 

Imp. C (EP): (3RS)-N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)- 

propan-1-amine (Pheniramine) 

Br 

Cl 

Cl 

N 

N 

N 

N 

N 

N 

x 

x 

x 

N 

O 

O 

O 

OH 

OH 

OH 

OH 

OH 

OH 

(A) 

(A) 

(A) 

(A) 

500 mg 

500 mg 

100 mg 

100 mg 

N 

MM 0060.14 

Imp. C (EP) as Maleate: (3RS)-N,N-Dimethyl- 

3-phenyl-3-(pyridin-2-yl)propan-1-amine 

Maleate (Pheniramine Maleate) 

N 

N 

x 

O 

OH 

OH 

(A) 

100 mg 

O 

MM 0060.12 

Brompheniramine N-Oxide 

on request 

N 

N 

O 

MM 0060.16 Desmethylbrompheniramine Maleate O 

Buclizine Hydrochloride 

Br 

Br 

N 

N 

H 

x 

O 

OH 

OH 

(A) 

100 mg 

MM 0475.01 

Imp. A (BP): 1,4-Bis(4-chlorobenzhydryl)piperazine 

(A) 

100 mg 

Cl 

N 

N 

Cl 




MM 0475.02 4-Chlorobenzhydrol 

Cl 

(B) 100 mg 

OH 

MM 0475.03 

4-Chlorobenzophenone 

Cl 

(B) 100 mg 

O 

Cl 

MM 0475.04 1-(4-Chlorobenzhydryl)piperazine NH (A) 100 mg 

N 

Budesonide 

New MM 0204.01 

Imp. A (EP): 11β,16α,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione 

(16α-Hydroxyprednisolone) 

HO 

O 

OH OH 

OH 

(A) 

100 mg 

O 

Bufexamac 

MM 0179.00 

Bufexamac 

H 

N OH 

(A) 

500 mg 

O 

O 

MM 0179.01 

Imp. A (EP): 2-(4-Butoxyphenyl)acetic Acid 

O 

OH 

O 

(A) 

100 mg 

MM 0179.02 

Imp. B (EP): Methyl 2-(4-Butoxyphenyl)acetate 

O 

O 

O 

(A) 

100 mg 

MM 0179.03 

Imp. C (EP): Butyl 2-(4-Butoxyphenyl)acetate 

O 

O 

O 

(A) 

100 mg 

MM 0179.04 

Imp. D (EP): 2-(4-Butoxyphenyl)acetamide 

O 

NH 2 

O 

(A) 

100 mg 

MM 0179.05 

4'-Butoxyacetophenone 

O 

(A) 100 mg 

MM 0179.06 

Buflomedil Hydrochloride 

MM 0066.00 

MM 0066.01 

MM 0066.02 

MM 0066.03 

Ethyl 2-(4-Butoxyphenyl)acetate 

Buflomedil Hydrochloride 

Imp. A (EP) as Hydrochloride: 4-(Pyrrolidin- 

1-yl)-1-(2-hydroxy-4,6-dimethoxyphenyl)- 

butan-1-one Hydrochloride 

(o-Desmethyl-Buflomedil Hydrochloride) 

Imp. B (EP) as Hydrochloride: 4-(Pyrrolidin-1-yl)-1-(4- 

hydroxy-2,6-dimethoxyphenyl)butan-1-one Hydrochloride 

(p-Desmethyl-Buflomedil Hydrochloride) 

4-(1-Pyrrolidino)butyronitrile 

O 

O 

HO 

O 

OH 

O 

O 

O 

O 

O 

O 

O 

O 

O 

N 

N 

N 

O 

O 

x HCl 

x HCl 

x HCl 

(A) 

(A) 

(A) 

on request 

500 mg 

100 mg 

100 mg 

N (C) 100 mg 

N 

MM 0066.05 1,3,5-Trimethoxybenzene O 

(C) 

100 mg 

O 

O 

Bunolol Hydrochloride 

MM 0642.00 

Bunolol Hydrochloride 

O 

O 

OH HN 

x HCl 

(A) 

100 mg 




Buphenine Hydrochloride 

MM 0710.00 Buphenine Hydrochloride 

OH 

(A) 500 mg 

HO 

HN 

x HCl 

Bupivacaine Hydrochloride 

MM 0613.00 

Bupivacaine Hydrochloride Monohydrate 

H 

N 

O 

N 

x HCl 

x H 2 O 

(A) 

500 mg 

MM 0613.06 

Imp. F (EP): 2,6-Dimethylaniline 

NH 2 

(B) 100 mg 

MM 0613.07 

Bupivacaine N-Oxide 

H 

N 

O 

N 

O 

(A) 100 mg 

Bupropion Hydrochloride 

MM 0745.00 

Bupropion Hydrochloride 

Cl 

O 

H 

N 

x HCl 

(A) 

100 mg 

MM 0745.02 2-(tert-Butylamino)-4'-chloropropiophenone Hydrochloride O 

H 

N 

x HCl 

(A) 

100 mg 

Cl 

MM 0745.03 2-(tert-Butylamino)-3'-bromopropiophenone Hydrochloride O 

Br 

H 

N 

x HCl 

(A) 

100 mg 

MM 0745.05 2-(tert-Butylamino)propiophenone Hydrochloride 

O 

H 

N 

x HCl 

(A) 

100 mg 

MM 0745.08 

3-Chloropropiophenone 

Cl 

O 

(B) 100 mg 

Buspirone Hydrochloride 

MM 0464.00 Buspirone Hydrochloride O 

N 

(A) 

500 mg 

N 

O 

N 

N 

N 

x HCl 

New MM 0464.02 

Imp. A (EP) as Dihydrochloride: 2-(Piperazin- 

1-yl)pyrimidine Dihydrochloride 

HN 

N 

N 

x 2 HCl 

(A) 

100 mg 

N 

MM 0464.08 

Imp. K (EP): 8-Azaspiro[4,5]-decane-7,9-dione 

O 

(B) 

100 mg 

NH 

Butenafine Hydrochloride 

MM 1041.00 

Butenafine Hydrochloride 

O 

on request 

N 

x HCl 

Butetamate Citrate 

MM 0606.00 

Butetamate Citrate 

O 

O 

N 

x 

O 

O 

OH 

OH 

O 

OH 

OH 

(A) 

500 mg 

Butyl Parahydroxybenzoate 

MM 0496.00 

Butyl Parahydroxybenzoate 

O 

(A) 500 mg 

O 

HO 




MM 0496.01 Imp. A (EP): 4-Hydroxybenzoic Acid 

O 

(B) 100 mg 

OH 

HO 

MM0496.02 

Imp. B (EP): Methyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0496.03 

Imp. C (EP): Ethyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0496.04 

Imp. D (EP): Propyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0496.05 

Isobutyl Parahydroxybenzoate 

O 

(A) 100 mg 

O 

HO 


MM 0679.00 


(A) 

500 mg 

OH 

Caffeine 

MM 0494.00 

Caffeine 

O 

N 

N 

(A) 

500 mg 

O 

N 

N 

MM 0494.01 

Imp. A (EP): Theophylline 

N 

O N 

O 

(A) 500 mg 

H 

N 

N 

MM 0494.02 

Imp. B (EP): N-[6-Amino-1,3-dimethyl-2,4(1H,3H)-dioxopyrimidin-5- 

yl]formamide 

O 

N 

H 

N 

O 

on request 

O 

N 

NH 2 

MM 0494.03 

Imp. C (EP): 1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione (Isocaffeine) 

O 

N 

N 

(A) 

50 mg 

O 

N 

N 

MM 0494.08 

Imp. D (Pharmeuropa): 3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione 

(Theobromine) 

O 

HN 

N 

(A) 

500 mg 

O 

N 

N 

MM 0494.06 

O 

Imp. E (Pharmeuropa) as Nitrate: N,1-Dimethyl-4-(methylamino)- 

1H-imidazole-5-carboxamide Nitrate (Caffeidine Nitrate) 

N 

N 

H 

HN N 

x HNO 3 

(A) 100 mg 

MM 0494.04 

Captopril 

MM 0067.00 

Imp. F (Pharmeuropa): 1,7-Dimethyl-3,7-dihydro-1H-purine-2,6- 

dione(Paraxanthine; 1,7-Dimethylxanthine) 

Captopril 

HS 

O 

N 

O 

N 

H 

N 

N 

N 

(D) 

50 mg 

O O OH (A) 500 mg 

MM 0067.01 

Imp. A (EP): (2S,2'S)-1,1'-[Disulphanediyl-bis[(2S)-2- 

methyl-1-oxopropane-3,1-diyl]-bis[pyrrolidine-2-carboxylic] 

Acid (Captopril-Disulphide) 

HO 

N 

O 

O 

S 

S 

O O 

N 

OH 

(A) 

100 mg 

MM 0067.02 

Imp. C (Pharmeuropa): (2RS)-2-Methyl-3-sulphanylpropanoic Acid 

HS 

O 

(A) 100 mg 

OH 

MM 0067.06 Imp. D (Pharmeuropa): (2RS)-3-Bromo-2-methylpropanoic Acid 

O 

Br 

OH 

(A) 

100 mg 

MM 0067.08 

Imp. E (Pharmeuropa): (2S)-1-[2-Methylpropanoyl]- 

pyrrolidine-2-carboxylic Acid 

O O OH (A) 100 mg 

N 




MM 0067.03 Captopril Ethyl Ester 

O O O on request 

HS 

N 

MM 0067.04 

(S)-(-)-3-Acetylthio-2-methylpropanoic Acid 

O O 

(C) 100 mg 

S 

OH 

MM 0067.05 

(2S)-1-[(2S)-3-Acetylthio-2-methylpropanoyl]pyrrolidine-2- 

carboxylic Acid Hydrate (S-Acetylcaptopril Hydrate) 

O 

S 

O O 

N 

OH 

x H 2 O 

(A) 

100 mg 

Carbamazepine 

MM 0076.00 Carbamazepine O 

(A) 

250 mg 

N 

NH 2 

MM 0076.04 

Imp. A (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine-5-carboxamide 

(10,11-Dihydrocarbamazepine) 

N 

O 

NH 2 

(A) 

100 mg 

MM 0076.09 

Imp. B (EP): 9-Methylacridine 

(A) 

100 mg 

N 

MM 0076.12 

Imp. C (EP): (5H-Dibenzo[b,f]azepin-5-yl-carbonyl)urea(N- 

Carbamoylcarbamazepine) 

O 

N N NH 2 

H 

O (A) 100 mg 

MM 0076.08 

Imp. D (EP): 5H-Dibenzo[b,f]azepine (Iminostilbene) 

(B) 

100 mg 

NH 

MM 0076.06 

Imp. E (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine (Iminodibenzyl) 

(B) 

100 mg 

NH 

MM 0076.01 Carbamazepine 10,11-Epoxide O 

(A) 

100 mg 

N 

NH 2 

O 

MM 0076.05 10-Bromocarbamazepine O 

(A) 

100 mg 

N 

NH 2 

MM 0076.10 10-Hydroxy-10,11-dihydrocarbamazepine O 

Br 

(A) 

100 mg 

N 

NH 2 

MM 0076.17 Oxcarbazepine O 

HO 

(A) 

100 mg 

N 

NH 2 

O 

Carbasalate Calcium 

MM 0353.01 

Imp. A (EP): 2-(Acetyloxy)benzoic Anhydride (Acetylsalicylic 

Anhydride) 

O O O 

O 

(A) 

100 mg 

O 

O 

O 




MM 0353.02 Imp. B (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid 

O 

(A) 100 mg 

(Acetylsalicylsalicylic Acid) 

OH O 

O 

O 

O 

MM 0353.03 

Imp. C (EP): 2-Hydroxybenzoic Acid (Salicylic Acid) 

O 

(A) 

500 mg 

OH 

Carbendazim 

MM 2500.00 

MM 2500.01 

MM 2500.02 

Carbendazim 

2,3-Diaminophenazine 

2-Amino-3-hydroxyphenazine 

H 

N 

N 

N 

NH 

OH 

O 

(A) 100 mg 

O 

N NH 2 

N NH 2 

NH 2 

(A) 100 mg 

(A) 

100 mg 

N 

OH 

Carbenicillin Sodium 

MM 0805.00 

Carbenicillin Sodium 

O 

O 

N 

O 

ONa 

(A) 

250 mg 

Carbocisteine 

MM 0236.00 

MM 0236.01 

MM 0236.02 

Carbocisteine 

O 

N 

H 

ONa 

HO 

O 

S 

H 

S 

O 

OH 

NH 2 

(S)-Carboxymethyl-L-cysteine 

(R/S)-Sulphoxide 

HO 

S OH 

Lactam of (S)-Carboxymethyl-L-cysteine 

O 

O 

S 

NH 2 

O 

NH 

OH 

(A) 

(A) 

500 mg 

100 mg 

O 

(A) 100 mg 

O 

MM 0236.03 

L-Cysteinesulfinic Acid 

HO 

S 

O 

O 

OH 

NH 2 

(C) 

100 mg 

Carisoprodol 

MM 0782.03 Imp. C (EP): 2-Methyl-2-propylpropane-1,3-diol HO OH (A) 100 mg 

Carteolol Hydrochloride 

MM 0437.00 

Carteolol Hydrochloride 

O 

HN 

O 

OH 

HN 

x HCl 

on request 

Carvedilol 

MM 0291.00 

Carvedilol 

O 

OH 

H 

N 

O 

O 

(A) 

100 mg 

HN 

MM 0291.02 

Imp. B (EP): 1,1'-[[2-(2- 

Methoxyphenoxy)ethyl]nitrilo]bis[3-(9H-carbazol-4- 

yloxy)propan-2-ol] 

O 

OH 

N 

OH 

O 

O 

O 

NH 

(A) 

100 mg 

HN 

MM 0291.04 Imp. D (Pharmeuropa): Toluene (C) 100 mg 




New MM 0291.11 2-(2-Methoxyphenoxy)ethylamine Hydrochloride 

H 2 N 

O 

O x HCl 

(A) 100 mg 

MM 0291.10 

4-(2,3-Epoxypropoxy)carbazole 

O 

O 

(A) 100 mg 

HN 

Cefaclor 

MM 0326.00 

Cefaclor Monohydrate 

NH 2 

O 

H 

N 

O 

O OH 

Cl 

N 

S 

H 

x H 2 O 

(A) 

100 mg 

MM 0326.07 

MM 0326.08 

Imp. A (EP): (2R)-2-Amino-2-phenylacetic Acid (D-Phenylglycine) 

Imp. F (EP): 3-Phenylpyrazin-2-ol 

N 

NH 2 

(B) 100 mg 

OH 

O 

N OH 

(A) 100 mg 

Cefadroxil Monohydrate 

MM 0972.01 

Imp. A (EP): (2R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid 

NH 2 

OH 

(B) 

100 mg 

MM 0972.02 

Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-1- 

azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ADCA) 

HO 

O 

O 

N 

O 

OH 

(A) 

100 mg 

Cefalexin Monohydrate 

MM 0605.00 

Cefalexin Monohydrate 

O 

NH 2 H 

N 

O 

H S 

2 N 

H 

O OH 

(A) 500 mg 

N 

x H 2O 

S 

H 

MM 0605.01 

Imp. A (EP): (2R)-2-Amino-2-phenylacetic Acid 

(D-Phenylglycine) 

NH 2 

(B) 100 mg 

OH 

O 

MM 0605.02 

Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-1- 

azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7- 

Aminodesacetoxycephalosporanic Acid; 7-ADCA) 

O 

H 2 N 

O OH 

N 

S 

H 

(A) 

100 mg 

Cefazolin Sodium 

MM 0238.00 

Cefazolin Sodium 

N 

N 

N 

N 

O 

O 

H 

N 

O ONa 

N 

S 

S 

H 

S N 

N 

(A) 

100 mg 

MM 0238.05 

Imp. E (EP): 5-Methyl-1,3,4-thiadiazol-2-thiol (MMTD) 

SH 

(A) 100 mg 

S 

N 

N 

MM 0238.08 

Imp. H (EP): (6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo-5- 

thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ACA) 

O 

O 

N 

OH 

O 

O (A) 100 mg 

H 2 N 

H 

S 

Cefetamet 

MM 0811.01 

7-Aminodesacetoxycephalosporanic Aicd 

O 

O 

N 

OH 

(A) 

100 mg 

H 2 N 

H 

S 




Cefoperazone Sodium 

MM 0853.03 

MM 0853.05 

Cefradine 

New MM 0833.01 

Celecoxib 

MM 0344.02 

MM 0344.03 

Imp. C (EP): 1-Methyl-1H-tetrazole-5-thiol 

Imp. E (EP): (6R,7R)-3-[(Acetyloxy)methyl]-7-amino- 

8-oxo-5-thia-1-azabicyclo- 

[4.2.0]oct-2-ene-2-carboxylic Acid (7-ACA) 

Imp. A (EP): (6R,7R)-7-Amino-3-methyl-8-oxo- 

5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic 

Acid (7-Aminodeacetoxycephalosporanic Acid, 

7-ADCA) 

4-[5-[4-(Hydroxymethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol- 

1-yl]-benzenesulfonamide 

4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol- 

5-yl]benzoic Acid 

O 

H 2 N 

O O 

S 

H 2 N 

HO 

O O 

S 

H 2 N 

O 

N 

S 

H 

O 

H 2 N 

N 

N 

N N 

OH 

N 

O 

N 

SH 

(A) 100 mg 

O 

S 

H 

N 

F 

F 

O (A) 100 mg 

OH 

F 

N N F 

F 

F 

(A) 

(D) 

100 mg 

100 mg 

on request 

HO 

O 

Celiprolol Hydrochloride 

MM 0128.00 Celiprolol Hydrochloride 

O 

(A) 

100 mg 

OH 

HN 

x HCl 

O 

O 

N 

N 

H 

MM 0128.01 

Imp. A (EP): 1-[5-Amino-2-[(2RS)-3-[(1,1- 

dimethylethyl)amino]-2-hydroxypropoxy]phenyl]ethanone 

O 

O 

OH 

HN 

(A) 100 mg 

H 2 N 

MM 0128.03 

MM 0128.10 

Imp. C (EP): 1-[3-Acetyl-4-[(2RS)-3-[(1,1- 

dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-3- 

(1,1-dimethylethyl)urea 

Imp. D (EP):3-[3-Acetyl-4-[(RS)-3-(diethylamino)-2- 

hydroxypropoxy]phenyl]-1,1-diethylurea 

N 

H 

O 

O 

O 

N 

H 

O 

O 

O 

OH 

HN 

(A) 100 mg 

OH 

N 

(D) 100 mg 

N 

N 

H 

MM 0128.05 

Imp. E (EP): 1,1'-[[(1,1-Dimethylethyl)- 

imino]bis[(2-hydroxypropane-1,3-diyl)-oxy(3- 

acetyl-1,4-phenylene)]]bis(3,3-diethylurea) 

O 

O 

OH 

N 

OH 

O 

O 

(D) 

50 mg 

HN 

NH 

O 

N 

N 

O 

MM 0128.07 Imp. F (EP): 3-(3-Acetyl-4-hydroxyphenyl)-1,1-diethylurea 

O 

(A) 

100 mg 

O 

OH 

N 

N 

H 

MM 0128.06 

Imp. G (EP): 3-[3-Acetyl-4-[[(RS)-oxiranyl]methoxy]phenyl]- 

1,1-diethylurea 

O 

O 

O 

O 

(A) 

100 mg 

N 

N 

H 




MM 0128.04 

Imp. H (EP): 3-[3-Acetyl-4-[(2RS)-3-bromo-2- 

hydroxypropoxy]phenyl]-1,1-diethylurea (Bromhydrin 

Compound) 

N 

O 

N 

H 

O 

O 

OH 

Br 

(A) 

100 mg 

MM 0128.11 3-Acetyl-4-hydroxyaniline Hydrochloride 

O 

OH x HCl 

(A) 100 mg 

H 2 N 

MM 0128.58 5-Acetamido-2-hydroxyacetophenone 

O 

(A) 

100 mg 

O 

OH 

N 

H 

Cethexonium Bromide 

MM 0501.01 

rac-trans-2-Dimethylaminocyclohexanol Hydrochloride 

N 

OH 

x HCl 

(A) 

100 mg 


Cetirizine Dihydrochloride 

MM 0380.00 

Cetirizine Dihydrochloride 

Cl 

N 

N 

O 

O 

(A) 100 mg 

OH 

x 2 HCl 

MM 0380.01 

Imp. A (EP): (RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine 

Cl 

(A) 100 mg 

N 

NH 

MM 0380.02 

Imp. B (EP) as Dihydrochloride: (RS)-2-[4-[(4- 

Chlorophenyl)phenylmethyl]- 

piperazin-1-yl]acetic Acid Dihydrochloride 

Cl 

N 

N 

OH 

O 

x 2 HCl 

(A) 

100 mg 

MM 0380.03 

Imp. C (EP) as Dihydrochloride: (RS)-2-[2-[4-[(2-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic 

Acid 


Cl 

N 

N 

O 

O 

OH 

x 2 HCl 

(A) 

50 mg 

MM 0380.04 

Imp. D (EP): 1,4-Bis[(4- 

chlorophenyl)phenylmethyl]piperazine 

Cl 

N 

N 

Cl 

(A) 

100 mg 

MM 0380.12 

Imp. E (EP): (RS)-2-[2-[2-[4-[(4- 

Chlorophenyl)phenylmethyl]piperazin-1-yl] 

ethoxy]ethoxy]acetic Acid (Ethoxycetirizine) 

Cl 

N 

N 

O 

O 

OH 

O 

(D) 

100 mg 

MM 0380.06 Imp. F (EP) as Dihydrochloride: [2-[4- 

[Diphenylmethyl]piperazin-1-yl]ethoxy]acetic Acid 


N 

N 

O 

O 

OH 

(A) 

100 mg 

x 2 HCl 

MM 0380.11 

Imp. G (EP) as Dihydrochloride: 2-[4-[(RS)-(4- 

Chlorophenyl)phenylmethyl]-piperazin-1-yl]ethanol 


Cl 

N 

N 

OH 

x 2 HCl 

(A) 

100 mg 

MM 0380.07 

Ethyl Ester of Cetirizine 

Cl 

N 

N 

O 

O 

(A) 100 mg 

O 




MM 0380.08 Isopropyl Ester of Cetirizine 

Cl 

O 

N 

O 

N 

O 

(A) 100 mg 

MM 0380.09 4-Chlorobenzhydrol 

OH 

(B) 

100 mg 

MM 0380.10 4-Chlorobenzophenone 

O 

Cl 

(B) 

100 mg 

Cl 

MM 0380.13 

Cetirizine N-Oxide 

Cl 

N 

O 

O (A) 100 mg 

O 

N 

OH 

Chlorambucil 

MM 0821.00 Chlorambucil 

OH 

Cl 

O 

N 

(A) 

500 mg 

Chloramphenicol 

OH NO 

MM 0516.00 Chloramphenicol 2 

OH NO 

MM 0516.01 (D)-(-)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol 2 

Cl 

Cl 

Cl 

O 

N 

H 

OH 

(A) 

(A) 

500 mg 

100 mg 

H 2 N 

OH 

Chlordiazepoxide Hydrochloride 

MM 0028.02 

Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4- 

benzodiazepin-2-one 4-Oxide (Demoxepam) 

H 

N 

O 

(A) 

100 mg 

Cl 

N 

O 

MM 0028.04 Imp. B (EP): 6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3- 

Oxide 

Cl 

N 

N 

O 

Cl (A) 100 mg 

MM 0028.03 

Imp. C (EP): (2-Amino-5-chlorophenyl)phenyl-methanone 

(Aminochlorobenzophenone) 

Cl 

NH 2 

O 

(B) 

100 mg 

Chlorhexidine Diacetate 

MM 0162.00 

Chlorhexidine Diacetate 

MM 0162.05 4-Chloroaniline 

NH 2 

MM 0162.07 (4-Chlorophenyl)urea 

H 

N NH2 

MM 0162.08 (4-Chlorophenyl)guanidine Hydrochloride 

H 

N NH2 

Cl 

H 

N 

NH 

H 

N 

NH 

H 

N 

x 2 

O 

OH 

Cl 

N 

H 

NH 

Cl 

N 

H 

NH 

Cl 

N 

H 

NH 

O 

Cl 

x HCl 

(A) 

(B) 

(A) 

(A) 

500 mg 

100 mg 

100 mg 

100 mg 




Chlorhexidine Dihydrochloride 

MM 0946.00 

Chlorhexidine Dihydrochloride 

H 

N 

H 

N 

H 

N 

(A) 

500 mg 

Cl 

Cl 

NH 

NH 

NH 

NH 

x 2 HCl 

N 

H 

N 

H 

N 

H 

Chlormezanone 

MM 0017.00 

Chlormezanone 

O O 

S 

Cl 

(A) 250 mg 

N 

O 

MM 0017.02 

2-(4-Chlorophenyl)-3-methylperhydro-1,3-thiazin-4-one 

S 

Cl 

on request 

MM 0017.03 

4-Chlorobenzaldehyde 

Chlorobutanol Hemihydrate 

OH 

MM 0535.00 Chlorobutanol Hemihydrate Cl 

Chlorocresol 

MM 0459.00 Chlorocresol 

OH 

Cl 

O 

H 

N 

O 

(B) 100 mg 

Cl 

Cl 

Cl 

x ½ H 2 O 

(A) 

(A) 

500 mg 

500 mg 

Chlorphenamine Maleate 

MM 0090.00 

Chlorphenamine Maleate 

Cl 

(A) 500 mg 

O 

N 

N 

x 

OH 

OH 

O 

MM 0090.03 

Imp. A (EP) as Dihydrochloride: 2-(4-Chlorophenyl)-4- 

(dimethylamino)-2- 

[2-(dimethylamino)ethyl]butanenitrile Dihydrochloride 

Cl 

N 

x 2 HCl 

(A) 

100 mg 

N 

N 

H 

MM 0090.04 Imp. B (EP): N-(Pyridin-2-yl)pyridin-2-amine(2,2'-Dipyridylamine) N N 

(A) 

100 mg 

N 

New MM 0090.13 

Imp. C (EP) as Maleate: (3RS)-3-(4-Chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1- 

amine Maleate 

N 

Cl 

(A) 100 mg 

O 

OH 

x 

OH 

NH 

O 

MM 0090.05 

Imp. D (EP) as Maleate: (2RS)-2-(4-Chlorophenyl)-4- 

(dimethylamino)-2- 

(pyridin-2-yl)butanenitrile Maleate 

Cl 

N 

N 

N 

x 

O 

OH 

OH 

O 

(A) 

100 mg 

MM 0090.11 

Chlorphenamine N-Oxide Dihydrochloride 

Cl 

(A) 

100 mg 

x 2 HCl 

N 

N 

O 




Chlorpromazine Hydrochloride 

MM 0420.00 Chlorpromazine Hydrochloride 

(A) 500 mg 

S 

N 

N 

x HCl 

Cl 

MM 0420.01 

Imp. A (EP): 3-(2-Chloro-10H-phenothiazin-10-yl)-N,Ndimethylpropan-1-amine 

S-Oxide (Chlorpromazine Sulphoxide) 

S 

O 

N 

N 

(A) 

100 mg 

Cl 

MM 0420.06 

Imp. B (EP) as Dihydrochloride: N-[3-(2-Chloro-10H- 

phenothiazin-10-yl)propyl]-N,N',N'-trimethylpropane-1,2- 

diamine Dihydrochloride 

S 

N 

N 

x 2 HCl 

N 

(A) 

100 mg 

Cl 

MM 0420.03 

Imp. C (EP) as Hydrochloride: Promazine Hydrochloride 

(A) 

500 mg 

S 

N 

N 

x HCl 

MM 0420.07 

Imp. D (EP) as Hydrochloride: 3-(2-Chloro-10H-phenothiazin- 

10-yl)-N-methylpropan-1-amine Hydrochloride 

(Desmethylchlorpromazine Hydrochloride) 

S 

N 

NH x HCl 

(A) 100 mg 

Cl 

MM 0420.04 

Imp. E (EP): 2-Chloro-10H-phenothiazine 

(A) 

100 mg 

S 

NH 

Cl 

MM 0420.02 

Chlorpromazine Sulphoxide N-Oxide Maleate 

O 

(A) 

100 mg 

S 

O 

N 

N 

O 

x 

OH 

OH 

Cl 

O 

Chlorquinaldol 

MM 0390.00 Chlorquinaldol 

OH 

Cl 

N 

(A) 

500 mg 

Cl 

Chlortalidone 

MM 0297.00 Chlortalidone HN 

O O 

S 

H 2 N 

HO 

O 

(A) 

250 mg 

Cl 

Chlortetracycline Hydrochloride 

MM 0607.00 Chlortetracycline Hydrochloride 

OH O OH O 

OH 

O 

(A) 

500 mg 

Cl 

H 

OH 

H 

N 

OH 

NH 2 

x HCl 

MM 0607.02 

Imp. B (EP) as Hydrochloride: Demeclocycline 

Hydrochloride 

OH O OH O 

OH 

H 

Cl OH 

H 

N 

O 

NH 2 

OH 

x HCl 

(A) 

250 mg 

MM 0607.03 Tetracycline Hydrochloride 

OH O OH O 

OH 

O 

(A) 

500 mg 

HO 

H 

H 

N 

OH 

NH 2 

x HCl 




Cholecalciferol 

MM 0249.02 

Imp. B (EP): Cholesta-5,7-dien-3β-ol 

(7,8-Didehydrocholesterol; Provitamin D3) 

(A) 

100 mg 

HO 

Ciclopirox Olamine 

MM 0418.00 

Ciclopirox Olamine 

OH 

N 

O 

x 

H 2 N 

OH 

(A) 

250 mg 

Cimetidine Hydrochloride 

MM 0020.00 

Cimetidine 

N 

(A) 500 mg 

MM 0020.08 

MM 0020.12 

MM 0020.03 

MM 0020.06 

MM 0020.04 

MM 0020.15 

Imp. A (EP): 3-Cyano-2-methyl-1-[2- 

[[(5-methyl-1H-imidazol-4-yl)methyl]- 

sulphanyl]ethyl]isothiourea 

Imp. B (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl-1Himidazol-4-yl)methyl]-sulphanyl]ethyl]isourea 

Imp. C (EP) as Dihydrochloride: 1-[(Methylamino)[[2- 

[[(5-methyl-1H-imidazol-4-yl)- 

methyl]sulphanyl]ethyl]amino]- 

methylene]urea Dihydrochloride 

(Cimetidine Amide Dihydrochloride) 

Imp. D (EP) as Dihydrochloride:1-Methyl-3-[2-[[(5- 

methyl-1H-imidazol-4- 

yl)methyl]sulphanyl]ethyl]guanidine Dihydrochloride 

Imp. E (EP): 2-Cyano-1-methyl-3-[2-[[(5-methyl-1Himidazol-4-yl)methyl]sulphinyl]ethyl]guanidine 

(Cimetidine Sulphoxide) 

Imp. G (Pharmeuropa): 2-Cyano-1,3-dimethylguanidine 

HN 

N 

HN 

HN 

HN 

S 

N 

N 

N 

N 

H 

S 

S 

S 

N 

N 

H 

N 

H 

N 

H 

N 

H 

N 

N 

N 

H 

N 

(A) 100 mg 

N 

S 

N 

(A) 100 mg 

O 

O NH 2 

(A) 100 mg 

x 2 HCl 

N 

NH 

(A) 100 mg 

HN 

S 

x 2 HCl 

N N 

H H 

HN 

N 

O 

S 

N 

H 

N 

N 

N 

H 

(A) 

100 mg 

N 

(A) 100 mg 

MM 0020.07 

Imp. H (Pharmeuropa): 2-Cyano-3-[2-[[2-[[(1Z)- 

(cyanoamino)(methylamino)methylene]amino]- 

ethyl]disulphanyl]ethyl]-1-methylguanidine 

N 

H 

N 

N 

H 

S 

S 

N 

H 

H 

N 

N 

N 

N 

H 

N 

(A) 100 mg 

H 

N 

MM 0020.50 

MM 0020.10 

Imp. J (Pharmeuropa) as Dihydrobromide: 2-[[(5-Methyl- 

1H-imidazol-4-yl)methyl]-sulphanyl]ethanamine 

Dihydrobromide 

1,1-Dimethyl-3-cyanoguanidine 

MM 0020.13 Cyanoguanidine H 2N 

Cinchocaine Hydrochloride 

MM 0604.00 

Cinchocaine Hydrochloride 

N 

N 

(A) 100 mg 

HN 

S 

x 2 HBr 

NH 2 

O 

N 

O 

N 

H 

H 

N N 

NH 

H 

N 

NH 

N 

N 

N 

x HCl 

(A) 

(B) 

(A) 

100 mg 

100 mg 

500 mg 




MM 0604.02 

Imp. B (EP): 2-Hydroxyquinoline-4-carboxylic Acid 

HO 

O 

OH 

(A) 

100 mg 

N 

MM 0604.05 

Cinchocaine N-Oxide 

O 

on request 

O 

N 

N 

H 

N 

O 

Ciprofloxacin Hydrochloride 

MM 0018.06 

Ciprofloxacin Hydrochloride Monohydrate 

HN 

(A) 

500 mg 

N 

F 

N 

OH 

x HCl 

x H 2 O 

O 

O 

MM 0018.01 

Imp. A (EP): 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4- 

dihydroquinoline-3-carboxylic Acid (Fluoroquinolonic Acid) 

Cl 

N 

(A) 

100 mg 

F 

OH 

O 

O 

MM 0018.05 

Imp. B (EP): 1-Cyclopropyl-4-oxo-7-(piperazin-1-yl)-1,4- 

dihydroquinoline-3-carboxylic Acid (Desfluoro Compound) 

HN 

(A) 100 mg 

N N 

OH 

O 

O 

MM 0018.04 

Imp. C (EP): 7-(2-Aminoethylamino)-1-cyclopropyl-6-fluoro-4- 

oxo-1,4-dihydroquinoline-3-carboxylic Acid (Ethylenediamine 

Compound) 

H 2N 

H 

N 

F 

N 

OH 

(D) 

50 mg 

O 

O 

MM 0018.02 

Imp. D (EP): 7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)- 

1,4-dihydroquinoline-3-carboxylic Acid 

Cl 

N 

(D) 

50 mg 

N 

OH 

HN 

O 

O 

MM 0018.03 

Imp. E (EP): 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)- 

quinolin-4(1H)-one (Decarboxylated Compound) 

HN 

N 

N 

(A) 

100 mg 

F 

O 

MM 0018.10 

6-(2-Aminoethylamino)-7-chloro-1-cyclopropyl-4-oxo- 

1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride 

Cl 

N 

x HCl 

(D) 

100 mg 

H 2 N 

N 

H 

O 

O 

OH 

Citalopram Hydrobromide 

MM 0242.00 

Citalopram Hydrobromide 

F 

(A) 

250 mg 

x HBr 

O 

N 

N 

MM 0242.14 

Imp. A (Pharmeuropa): (1RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide 

(Citalopram- 

Amide) 

H 2 N 

F 

O 

N 

(A) 

100 mg 

O 

MM 0242.16 

Imp. B (Pharmeuropa): 1-[3-(Dimethylamino)- 

propyl]-1-(4-fluoropheny)-3-hydroxy-1,3- 

dihydroisobenzofuran-5-carbonitrile 

F 

(A) 

100 mg 

O 

N 

N 

OH 




MM 0242.17 

Imp. C (Pharmeuropa): (3RS)-6-Cyano-3-[3- 

(dimethylamino)propyl]-3-(4-fluorophenyl)isobenzofuran-1(3H)-one 

F 

(A) 

100 mg 

O 

N 

MM 0242.09 

Imp. D (Pharmeuropa) as Hydrochloride: (1RS)- 

1-(4-Fluorophenyl)-1-[3-(methylamino)propyl]-1,3- 

dihydroisobenzofuran-5-carbonitrile Hydrochloride 

(Desmethyl-Citalopram Hydrochloride) 

N 

O 

F 

O 

x HCl 

N 

H 

(A) 

100 mg 

Citric Acid Monohydrate 

MM 0575.00 

Citric Acid Monohydrate 

N 

O OH (A) 500 mg 

O HO O 

x H 2 O 

HO 

OH 

Clarithromycin 

MM 0057.00 

Clarithromycin 

O 

on request 

OH 

OH 

O 

O 

HO 

O 

O 

N 

O 

O 

O 

O 

OH 

Clioquinol 

MM 0312.00 

Clioquinol 

I 

OH 

N 

(A) 

500 mg 

MM 0312.01 

Imp. A (EP): 5-Chloroquinolin-8-ol 

Cl 

OH 

(B) 100 mg 

N 

Cl 

MM 0312.02 

Imp. B (EP): 5,7-Dichloroquinolin-8-ol 

Cl 

OH 

N 

(B) 

100 mg 

Cl 

MM 0312.03 

Imp. C (EP): 5,7-Diiodoquinolin-8-ol 

I 

OH 

N 

(B) 

100 mg 

I 

Clobenzorex Hydrochloride 

MM 0649.00 Clobenzorex Hydrochloride 

H 

N 

x HCl 

(A) 

500 mg 

Cl 

Clobetasol Propionate 

MM 0769.00 

Clobetasol Propionate 

O 

Cl 

O 

(A) 

100 mg 

HO 

O 

F 

O 

MM 0769.01 

Imp. G (EP): 21-Chloro-9-fluoro-11β,17-dihydroxy-16βmethylpregna-1,4-diene-3,20-dione 

(Clobetasol) 

HO 

O 

Cl 

OH 

(A) 

100 mg 

O 

F 




New MM 0769.08 Imp. K (EP):9-Fluoro-11β,17-dihydroxy- 

16β-methyl-3,20-dioxopregna-1,4-dien- 

O 

O 

21-yl Propanoate (Betamethasone 21- 

O 

(A) 100 mg 

Propionate) 

HO 

OH 

F 

O 

Clobetasone Butyrate 

MM 0207.00 

Clobetasone Butyrate 

O 

Cl 

O 

on request 

O 

O 

O 

F 

Clobutinol Hydrochloride 

MM 0038.00 

Clobutinol Hydrochloride 

Cl 

OH 

N 

x HCl 

(A) 

100 mg 

MM 0038.01 

1-Dimethylamino-2-methylbutan-3-one 

N 

(A) 

100 mg 

O 

Clomifene Citrate 

MM 0650.00 

Clomifene Citrate 

Cl 

O 

N 

and Z-Isomer 

x 

O 

O 

OH 

OH 

O 

OH 

OH 

(A) 

250 mg 

MM 0650.01 

Clomifene N-Oxide Hydrochloride 

Cl 

O 

N 

O 

(A) 

100 mg 


x HCl 

MM 0650.03 

Desethylclomifene Hydrochloride 

Cl 

O 

N 

H 

(A) 

100 mg 


x HCl 

Clomipramine Hydrochloride 

MM 0545.00 

Clomipramine Hydrochloride 

Cl 

(A) 500 mg 

N 

N 

x HCl 

MM 0545.01 

Imp. A (EP) as Dihydrochloride: N-[3-(3- 

Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin- 

5-yl)propyl]-N,N',N'-trimethylpropane-1,3- 

diamine Dihydrochloride 

Cl 

N 

N 

N 

(A) 

100 mg 

x 2 HCl 

MM 0545.02 

Imp. B (EP) as Hydrochloride: Imipramine Hydrochloride 

(A) 

500 mg 

N 

N 

x HCl 

MM 0545.03 

Imp. C (EP) as Hydrochloride: 3-(3-Chloro-5Hdibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine 

Hydrochloride 

Cl 

(A) 50 mg 

N 

N 

x HCl 




MM 0545.04 Imp. D (EP) as Hydrochloride: 3-(3,7-Dichloro- 

Cl 

on request 

10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine 

Hydrochloride 

N 

N 

x HCl 

Cl 

MM 0545.05 

Imp. E (EP): 10,11-Dihydro-5H-dibenzo[b,f]-azepine (Iminodibenzyl) 

(B) 

100 mg 

NH 

MM 0545.06 

Imp. F (EP): 3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine 

Cl 

(A) 100 mg 

NH 

MM 0545.07 

Imp. G (EP): 3-Chloro-5-(prop-2-enyl)-10,11-dihydro-5Hdibenzo[b,f]azepine 

Cl 

(A) 100 mg 

N 

MM 0545.08 

Desmethylclomipramine Hydrochloride 

Cl 

(A) 100 mg 

N 

N 

H 

x HCl 

MM 0545.09 

Clomipramine N-Oxide 

Cl 

(A) 

100 mg 

N 

N 

O 

MM 0545.13 

3-Chloro-10-[3(dimethylamino)propyl]-9-acridanone 

Cl 

(A) 100 mg 

N 

N 

O 

Clonidine Hydrochloride 

MM 0983.00 Clonidine Hydrochloride 

MM 0983.01 Imp. C (EP): 2,6-Dichloroaniline 

Cl 

Cl 

HN 

N 

N 

H 

x HCl 

(A) 

100 mg 

Cl 

(B) 100 mg 

NH 2 

MM 0983.02 

1-(2,6-Dichlorophenyl)thiourea 

Cl 

Cl 

S (A) 100 mg 

Cl 

N 

H 

NH 2 

Clopidogrel Hydrogen Sulphate 

MM 0455.10 

Clopidogrel Hydrogen Sulphate 

O 

N 

O 

x H 2 SO 4 

(A) 100 mg 

MM 0455.09 

Clopidogrel Alcohol 

S 

Cl 

OH 

(D) 

100 mg 

N 

MM 0455.12 

(R)-Clopidogrel Hydrogen Sulphate 

O 

N 

S 

O 

Cl 

x H 2 SO 4 

(A) 100 mg 

S 

Cl 




O O 

MM 0455.13 Methyl (+/-)-(o-Chlorophenyl)-4,5-dihydrothieno-[2,3- 

(A) 100 mg 

c]pyridine-6(7H)-acetate Hydrogen Sulphate 

S x H 

N 

2 SO 4 

Cl 

Clotrimazole 

MM 0015.00 

Clotrimazole 

Cl 

(A) 500 mg 

N 

N 

MM 0015.01 

Imp. A (Pharmeuropa): (2-Chlorophenyl)diphenylmethanol 

(A) 

100 mg 

MM 0015.10 

Imp. B (Pharmeuropa): 1-[(4-Chlorophenyl)diphenylmethyl]-1Himidazole 

Cl 

OH 

Cl (A) 100 mg 

N 

N 

MM 0015.03 

Imp. C (Pharmeuropa): 1-Chloro-2-(chlorodiphenylmethyl)benzene 

(A) 

100 mg 

Cl 

Cl 

MM 0015.02 

Imp. D (Pharmeuropa): Imidazole 

H 

N (B) 100 mg 

N 

MM 0015.06 

Imp. E (Pharmeuropa): (2-Chlorophenyl)phenylmethanone 

(A) 

100 mg 

MM 0015.11 

Imp. F (Pharmeuropa): 1-Triphenylmethyl-1H-imidazole 

(Deschloroclotrimazole) 

Cl 

O 

(A) 

100 mg 

N 

N 

MM 0015.04 

(2-Chlorophenyl)diphenylmethane 

(A) 

100 mg 

Cl 

MM 0015.05 

(2-Chlorophenyl)diphenylmethyl Ethyl Ether 

(A) 

100 mg 

Cl 

O 

MM 0015.07 

(2-Chlorophenyl)phenyldichloromethane 

(A) 

100 mg 

Cl Cl 

Cl 

MM 0015.08 

(2-Chlorophenyl)trichlormethane 

Cl 

(A) 

100 mg 

Cl Cl 

Cl 

MM 0015.09 

1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole 

(A) 

100 mg 

Cl 

N 

N 

Cloxacillin Sodium 

MM 0682.00 

MM 0682.03 

Cloxacillin Sodium Monohydrate 

Imp. C (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1- 

azabicyclo[3.2.0]heptane-2-carboxylic Acid 


Cl O 

(A) 500 mg 

ONa 

O 

N 

N 

H 

x H 2 O 

O N 

S 

H 

O 

O 

H 2 N 

N 

H 

O 

S 

OH 

(B) 

100 mg 




MM 0682.04 

Imp. D (EP): 3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic Acid 

N 

O 

Cl 

OH 

(A) 

100 mg 

Cloxiquine 

MM 0391.00 Cloxiquine 

OH 

O 

N 

(A) 

500 mg 

Clozapine 

MM 0480.00 

Clozapine 

Cl 

Cl N (A) 100 mg 

N N 

HN 

MM 0480.01 

MM 0480.03 

Imp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin- 

11-one 

Imp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5Hdibenzo[b,e][1,4]diazepine 

Cl 

(A) 100 mg 

HN 

H 

N 

O 

Cl NH (A) 100 mg 

N N 

HN 

Codeine 

MM 0442.00 

Codeine Phosphate Hemihydrate [Controlled Substance] 

N 

(A) 100 mg 

x ½ H 2 O 

O 

O 

OH 

MM 0004.00 

Codeine Monohydrate [Controlled Substance] 

N 

(A) 

100 mg 

x H 2O 

O 

O 

OH 

MM 0004.03 

Imp. A (EP): 7,8-Didehydro-4,5α-epoxy-3,6α-dimethoxy- 

17-methylmorphinan 

(O-Methylcodeine) [Controlled Substance] 

N 

(A) 100 mg 

O 

O 

O 

MM 0004.16 


Hydrochloride Trihydrate [Controlled Substance] 

N 

x HCl 

x 3 H 2 O 

(A) 

250 mg 

MM 0004.17 

Imp. B (EP) as Hemisulphate Pentahemihydrate: 

Morphine Hemisulphate Pentahemihydrate 


HO 

O 

N 

OH 

x H 2 SO 4 

x 5 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

2 

MM 0004.15 

Imp. C (EP): 7,7',8,8'-Tetradehydro-4,5α:4',5'α-diepoxy- 

3,3'-dimethoxy-17,17'-dimethyl-2,2'-bimorphinanyl-6α,6'αdiol 

(Codeine Dimer; Dimethyl Pseudomorphine) 

HO 

O 

O 

N 

(A) 

100 mg 

N 

O 

O 

OH 

MM 0004.01 

Codeine N-Oxide [Controlled Substance] 

O 

(A) 250 mg 

N 

O 

O 

OH 

MM 0004.02 

Codeinone 

N 

(A) 100 mg 

O 

O 

O 




MM 0004.04 Codeimethine 

(A) 100 mg 

N 

O 

O 

OH 

MM 0004.05 

Norcodeine [Controlled Substance] 

HN 

(A) 100 mg 

O 

O 

OH 

MM 0004.06 

Acetylcodeine [Controlled Substance] 

N 

(A) 

100 mg 

O 

O 

O 

O 

MM 0004.08 

Isocodeine [Controlled Substance] 

N 

(A) 100 mg 

O 

O 

OH 

MM 0004.14 

Pseudomorphine 

HO 

O 

OH 

N 

(A) 

100 mg 

N 

HO 

O 

OH 

Colchicine 

MM 1083.00 Colchicine 

O 

O 

O 

NH 

O 

O 

(A) 

100 mg 

O 

MM 1083.04 

Imp. D (EP): N-[(7S,12aS)-3-(β-D-Glucopyranosyloxy)- 

1,2,10-trimethoxy-9-oxo-5,6,7,9- 

tetrahydrobenzo[a]heptalen-7-yl]acetamide 

(Colchicoside) 

HO 

O 

OH 

HO 

OH 

O 

O 

O 

NH 

O 

O 

(A) 

100 mg 

O 

Cortisone 

MM 0214.00 

Cortisone 

O 

O 

OH 

OH 

(A) 

500 mg 

O 

Cortisone Acetate 

MM 0186.00 

Cortisone Acetate 

O 

O 

O 

OH 

O 

(A) 500 mg 

O 

MM 0186.01 

Imp. A (EP): Hydrocortisone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

Cyclopentolate Hydrochloride 

MM 0580.00 Cyclopentolate Hydrochloride O 

O 

HO 

N 

x HCl 

(A) 

500 mg 

MM 0580.02 

MM 0580.03 

Imp. B (Pharmeuropa): Phenylacetic Acid 


Imp. C (Pharmeuropa) as Hydrochloride: 

2-(Dimethylamino)ethyl Phenylacetate 

Hydrochloride 

O 

O 

N 

O 

OH 

x HCl 

(B) 

(A) 

100 mg 

100 mg 




Cynarine 

MM 0048.01 3,4-Dihydroxycinnamic Acid (Caffeic Acid) 

O 

HO 

OH 

HO 

(B) 100 mg 

Cyproheptadine Hydrochloride 

MM 0609.00 Cyproheptadine Hydrochloride Sesquihydrate N 

(A) 

500 mg 

x HCl x 1 1 / 2 H 2O 

MM 0609.02 

Imp. B (EP): 5H-Dibenzo[a,d]cyclohepten-5-one 

(Dibenzosuberenone) 

O 

(C) 

100 mg 

MM 0609.04 Demethylcyproheptadine Hydrochloride NH 

(A) 

100 mg 

x HCl 

MM 0609.05 

Cyproheptadine α-N-Oxide 

O 

(A) 100 mg 

N 

MM 0609.06 

Cyproheptadine β-N-Oxide 

O 

(A) 100 mg 

N 

Cyproterone Acetate 

MM 0215.00 

Cyproterone Acetate 

O 

O 

(A) 

250 mg 

O 

O 

Cl 

DDT 

New MM 2513.01 

2,2-Bis(4-chlorophenyl)-1-chloroethane 

Cl 

(A) 

100 mg 

Cl 

Cl 

New MM 2513.02 

1-Chloro-3-[1-(4-chlorophenyl)ethyl]benzene 

Cl 

(A) 

100 mg 

Dembrexine Hydrochloride Monohydrate 

New MM 1200.04 

Imp. D (EP): 2-Hydroxybenzaldehyde 

(Salicylaldehyde) 

Cl 

O 

(A) 100 mg 

OH 

Demeclocycline Hydrochloride 

MM 0636.00 Demeclocycline Hydrochloride 

OH O OH O 

OH 

O 

(A) 

250 mg 

Cl 

H 

OH 

H 

N 

OH 

NH 2 

x HCl 

Desipramine Hydrochloride 

MM 0589.00 


(A) 

250 mg 

N 

N 

H 

x HCl 




MM 0589.02 Imipramine Hydrochloride 

(A) 500 mg 

N 

N 

x HCl 

MM 0589.03 

Iminodibenzyl 

(B) 

100 mg 

NH 

Dexamethasone 

MM 0213.00 

Dexamethasone 

HO 

O 

OH 

OH 

(A) 

250 mg 

F 

O 

MM 0213.02 

Betamethasone 

HO 

O 

OH 

OH 

(A) 

250 mg 

F 

O 

MM 0213.01 

9-α-Fluoro-11β,17α,21-trihydroxy-16α-methylpregn- 

4-ene-3,20-dione 

HO 

O 

OH 

OH 

(D) 

50 mg 

F 

O 

Dexamethasone Acetate 

MM 0445.00 

Dexamethasone Acetate 

O 

O 

(A) 250 mg 

HO 

O 

OH 

F 

O 

Dexamethasone Sodium Phosphate 

MM 0210.00 

Dexamethasone Sodium Phosphate 

HO 

O 

O ONa 

(A) 250 mg 

O P OH ONa 

F 

O 

MM 0210.01 

Imp. A (EP): Dexamethasone 

HO 

O 

OH 

OH 

(A) 

250 mg 

F 

O 

MM 0210.02 

Imp. B (EP): Betamethasone Sodium Phosphate 

HO 

O 

O ONa 

on request 

O P OH ONa 

F 

O 

Dexchlorpheniramine Maleate 

MM 1114.00 

Dexchlorpheniramine Maleate 

Cl 

O 

(A) 

100 mg 

N 

N 

x 

O 

OH 

OH 

MM 1114.01 

Imp. A (EP) as Maleate: (3RS)-N,N-Dimethyl-3-phenyl-3- 

(pyridin-2-yl)propan-1-amine Maleate 

N 

N 

x 

O 

OH 

OH 

O 

(A) 

100 mg 




Dextromethorphan Hydrobromide 

MM 0033.00 

Dextromethorphan Hydrobromide Monohydrate 

N 

x HBr 

x H 2O 

(A) 

500 mg 

O 

MM 0033.10 

Imp. A (EP) as Hydrochloride: ent-3-Methoxymorphinan 

Hydrochloride 

HN 

x HCl 

(A) 

100 mg 

O 

MM 0033.09 

Imp. B (EP) as (L)-Tartrate: ent-17-Methylmorphinan-3- 

ol (L)-Tartrate 

N 

x 

HO 

O 

OH 

OH 

O 

OH 

(A) 

100 mg 

HO 

MM 0033.02 

Imp. C (EP): ent-3-Methoxy-17-methylmorphinan-10-one 

(D) 100 mg 

O N 

O 

MM 0033.11 

Dextromethorphan N-Oxide Hydrochloride 

O 

(A) 100 mg 

N 

x HCl 

O 

Dextropropoxyphene Hydrochloride 

MM 0098.01 

Dextropropoxyphene Hydrochloride 


N 

O 

(A) 

50 mg 

O 

x HCl 

MM 0098.00 

Dextropropoxyphene [Controlled Substance] 

N (A) 50 mg 

O 

O 

MM 0098.06 

Imp. A (EP): (2S,3R)-4-(Dimethylamino)-1,2-diphenyl-3- 

methylbutan-2-ol 

N (A) 100 mg 

OH 

MM 0098.07 

Imp. B (EP) as Hydrochloride: (1S,2R)-1- 

Benzyl-3-(dimethylamino)-2-methyl-1- 

phenylpropyl Acetate Hydrochloride 

(Acetoxyphene Hydrochloride) 

N 

O 

O 

x HCl 

(A) 

100 mg 

New MM 0098.10 Imp. E (Pharmeuropa): Toluene (C) 100 mg 

Diazepam 

MM 0023.00 

Diazepam [Controlled Substance] 

N 

O 

(A) 

100 mg 

Cl 

N 

MM 0023.02 

Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2- 

one (Nordazepam) [Controlled Substance] 

Cl 

H 

N 

N 

O 

(A) 

100 mg 




MM 0023.04 

Imp. B (EP): 2-Chloro-N-(4-chloro-2-benzoylphenyl)-Nmethylacetamide 

O 

N 

Cl (A) 100 mg 

Cl 

O 

MM 0023.03 

Imp. C (EP): 3-Amino-6-chloro-1-methyl-4-phenylquinolin- 

2(1H)-one 

N 

O 

(A) 

100 mg 

Cl 

NH 2 

MM 0023.01 

Imp. D (EP): [5-Chloro-2-(methylamino)phenyl]phenylmethanone 

(5-Chloro-2-(methylamino)benzophenone) 

Cl 

NH 

O 

(B) 

100 mg 

MM 0023.05 

2'-Benzoyl-2,4'-dichloroacetanilide 

O 

NH 

Cl (A) 100 mg 

Cl 

O 

Dibutyl Sebacate 

O O 

MM 0925.00 Dibutyl Sebacate 

(A) 

500 mg 

O 

O 

Dichlorobenzyl Alcohol 

MM 0739.01 

Bis-(2,4-dichlorobenzyl)Ether 

O 

(A) 

100 mg 

Cl 

Cl 

Cl 

Cl 

Diclofenac Sodium 

MM 0006.00 

Diclofenac Sodium 

O 

ONa 

(A) 

500 mg 

Cl 

NH 

Cl 

MM 0006.01 

Imp. A (EP): 1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one 

Cl 

N 

O 

Cl 

(A) 

100 mg 

MM 0006.03 

Imp. B (EP): 2-[(2,6-Dichlorophenyl)amino]benzaldehyde 

O (A) 100 mg 

Cl 

NH 

Cl 

MM 0006.04 

Imp. C (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]methanol 

OH (A) 100 mg 

Cl 

NH 

Cl 

MM 0006.09 

Imp. D (EP): 2-[2-[(2-Bromo-6-chlorophenyl)amino]phenyl]acetic Acid 

OH 

(D) 

100 mg 

Br 

O 

NH 

Cl 

MM 0006.05 

Imp. D (EP) as Sodium Salt: Sodium 2-[2-[(2-Bromo-6-chlorophenyl)- 

amino]phenyl]acetate 

Br 

ONa 

O 

NH 

Cl 

(D) 

100 mg 

MM 0006.02 

Imp. E (EP): 1,3-Dihydro-2H-indol-2-one 

N 

H 

O 

(B) 

100 mg 




MM 0006.06 1-(2-Bromo-6-chlorophenyl)indolin-2-one 

O 

N 

Br Cl 

(D) 100 mg 

MM 0006.10 

Methyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate 

(Methyl Ester of Diclofenac) 

Cl 

O 

O 

NH 

Cl 

(A) 

100 mg 

MM 0006.11 

Ethyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate 

(Ethyl Ester of Diclofenac) 

Cl 

O 

O 

NH 

Cl 

(A) 

100 mg 

MM 0006.26 

Isopropyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate 

(Isopropyl Ester of Diclofenac) 

Cl 

O 

O 

NH 

Cl 

(A) 

100 mg 

MM 0006.12 

2-(2,6-Dichlorophenylamino)benzoic Acid 

O 

(A) 100 mg 

OH 

Cl 

NH 

Cl 

MM 0006.15 

2,6-Dichlorodiphenylamine 

(A) 

100 mg 

Cl 

NH 

Cl 

MM 0006.16 

2-Bromo-6-chlorodiphenylamine 

(A) 

100 mg 

Br 

NH 

Cl 

MM 0006.17 

1-(2,6-Dichlorophenyl)indolin-2,3-dione 

O 

(A) 100 mg 

Cl 

N 

O 

Cl 

MM 0006.18 

Diclofenac Potassium 

Cl 

OK 

O 

NH 

Cl 

(A) 

100 mg 

MM 0006.19 

2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide 

Cl 

(A) 100 mg 

Cl 

N 

O 

Cl 

MM 0006.20 

2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac) 

Cl 

OH 

O 

NH 

Cl 

(A) 

100 mg 

NH 

MM 0006.21 2,6-Dichloroaniline 2 

Cl Cl 

(B) 

100 mg 

NH 

MM 0006.22 2-Bromo-6-chloroaniline 2 

Br Cl 

on request 

MM0006.27 

N-Acetyl-N-phenyl-2,6-dichloroaniline 

O (A) 100 mg 

Cl 

N 

Cl 

MM 0006.28 

Diethyl Phthalate 

O 

O 

O 

(C) 

100 mg 

O 




Dicloxacillim Sodium 

MM 0229.00 

MM 0229.03 

Diflucortolone Valerate 

MM 0600.00 

Dicloxacillin Sodium Monohydrate 




Diflucortolone Valerate 

O 

Cl ONa 

on request 

O 

N Cl N 

H 

O N 

S 

x H 2 O 

H 

O 

HO 

O 

O 

H 2N 

O 

O 

N 

S 

H 

OH (B) 100 mg 

O 

(A) 100 mg 

O 

F 

F 

Digitoxin 

MM 0336.01 

Digitoxigenin 

O O 

on request 

HO 

OH 

Digoxin 

MM 0212.00 

Digoxin 

O 

O 

(A) 

250 mg 

OH 

OO 

H 

OH 

OO 

OH 

OO 

OH 

HO 

OH 

Diltiazem Hydrochloride 

MM 0068.00 

Diltiazem Hydrochloride 

O 

(A) 

500 mg 

S 

N 

O 

O 

O 

N 

x HCl 

MM 0068.02 

Imp. B (EP): (2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5- 

tetrahydro-1,5-benzothiazepin-3-yl Acetate 

S 

N 

H 

O 

O 

O 

(A) 100 mg 

O 

MM 0068.03 

Imp. D (EP) as Hydrochloride: (2S,3S)-2-(4-Methoxyphenyl(-5- 

[2-(methylamino)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5- 

benzothiazepin-3-yl Acetate Hydrochloride 

(N-Desmethyldiltiazem Hydrochloride) 

S 

N 

O 

O 

O 

O 

x HCl 

(A) 

100 mg 

HN 

MM0068.04 

Imp. E (EP):(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3- 

dihydro-1,5-benzothiazepin-4(5H)-one 

S 

N 

H 

O 

OH 

O 

(A) 100 mg 




MM 0068.05 

Imp. F (EP):(2S,3S)-5-[2-(Dimethylamino)ethyl]-3-hydroxy-2- 

(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one 

S 

N 

O 

OH 

O 

(A) 100 mg 

N 

MM 0068.07 

Diltiazem Sulphoxide 

O 

(A) 

100 mg 

O 

S 

N 

O 

O 

O 

N 

MM 0068.08 

Diltiazem Maleate 

O 

(A) 

100 mg 

S 

N 

O 

O 

O 

x 

O 

OH 

OH 

O 

N 

Dimenhydrinate 

MM 0599.00 

Dimenhydrinate 

O 

N 

x 

O 

N 

O N 

H 

N 

N 

Cl 

(A) 

500 mg 

MM 0599.05 

Imp. A (Pharmeuropa): Theophylline 

N 

O 

(A) 500 mg 

H 

N 

O 

N 

N 

MM 0599.04 

Imp. B (Pharmeuropa): 8-[(2-(Diphenylmethoxy)- 

ethyl)(methlyl)amino]-1,3-dimethyl-3,7-dihydro-1Hpurine-2,6-dione 

O 

N 

O N 

H 

N 

N 

N 

O 

(A) 

100 mg 

MM 0599.01 

Diphenhydramine Hydrochloride 

(A) 

500 mg 

O 

N 

x HCl 

MM 0599.02 

8-Chlorotheophylline 

O 

N 

O N 

H 

N 

N 

Cl 

(B) 

100 mg 

MM 0599.03 

8-[N-(2-Diphenylmethoxyethyl)-N,N-dimethylaminium]- 

1,3-dimethylxanthine inner salt 

O 

N 

(A) 

100 mg 

O 

N 

N - N 

N + O 

Dimetindene Maleate 

MM 0595.01 Imp. A (EP): 2-Ethylpyridine 

N 

(B) 100 mg 

Diphemanil Metilsulfate 

x 

- 

S 

O O 

New MM 1163.00 Diphemanil Metilsulfate 

N + (D) 100 mg 

O O 




Diphenhydramine Hydrochloride 

MM 0490.00 Diphenhydramine Hydrochloride 

(A) 500 mg 

O 

N 

x HCl 

MM 0490.03 

Imp. A (EP) as Hydrochloride: 2-(Diphenylmethoxy)-Nmethylethanamine 

Hydrochloride 

(Nordiphenhydramine Hydrochloride) 

O 

H 

N 

x HCl 

(A) 

100 mg 

MM 0490.04 

Imp. B (EP) as Hydrochloride: 2-[(RS)(4- 

Methylphenyl)phenylmethoxy]-N,Ndimethylethanamine 

Hydrochloride 

O 

N 

x HCl 

(A) 

100 mg 

MM 0490.08 

Imp. C (EP) as Hydrochloride: 2-[(RS)(4- 

Bromophenyl)phenylmethoxy]-N,Ndimethylethanamine 

Hydrochloride 

O 

N 

x HCl 

(A) 

100 mg 

Br 

MM 0490.02 

Imp. D (EP): Diphenylmethanol (Benzhydrol) 

(B) 

100 mg 

OH 

MM 0490.05 

Imp. E (EP): Diphenylmethanone (Benzophenone) 

(B) 

100 mg 

O 

MM 0490.01 

Diphenhydramine N-Oxide 

O 

N O (A) 100 mg 

Diphenylpyraline Hydrochloride 

MM 0557.00 

Diphenylpyraline Hydrochloride 

O 

N 

x HCl 

(A) 

500 mg 

MM 0557.01 

Diphenylpyraline 

O 

(A) 

100 mg 

N 

MM 0557.02 

Diphenylmethanol (Benzhydrol) 

OH 

(B) 

100 mg 

MM 0557.03 

Diphenylmethanone (Benzophenone) 

O 

(B) 

100 mg 

MM 0557.04 

Diphenylpyraline N-Oxide 

O 

(A) 

100 mg 

N 

O 

Dipipanone Hydrochloride 

MM 0760.01 1,1-Diphenylbut-1-ene (A) 100 mg 




MM 0760.02 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride 

(A) 100 mg 

N 

x HCl 

Dipotassium Clorazepate 

MM 0984.01 

Imp. A (EP): (2-Amino-5-chlorophenyl)phenylmethanone 

(Aminochlorobenzophenone) 

Cl 

NH 2 

O 

(B) 

100 mg 

MM 0984.02 

Imp. B (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin- 

2-one 

(Nordazepam) [Controlled Substance] 

Cl 

H 

N 

N 

O 

(A) 

100 mg 

Diprafenon Hydrochloride 

MM 0428.01 2'-Hydroxy-3-phenylpropiophenone 

O 

(A) 

100 mg 

OH 

Disopyramide 

MM 0108.00 

Disopyramide 

N 

(A) 

500 mg 

N 

NH 2 

O 

Dithranol 

OH O OH 

MM 0137.00 Dithranol (A) 500 mg 

MM 0137.04 Imp. A (EP): Anthracen-9(10H)-one (Anthrone) 

O 

(A) 100 mg 

OH O OH 

MM 0137.01 Imp. B (EP): 1,8-Dihydroxyanthracene-9,10-dione (Danthron) 

(A) 

100 mg 

O 

MM 0137.02 

Imp. C (EP): 4,4',5,5'-Tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)- 

dione (Dithranol Dimer) 

OH 

O 

OH 

(A) 

100 mg 

OH O OH 


Pharmaceutical Impurities 


Dobutamine Hydrochloride 

MM 0675.01 Imp. A (EP) as Hydrochloride: Dopamine Hydrochloride HO 

NH 2 

x HCl 

HO 

(A) 500 mg 

OH 

MM 0675.02 Imp. B (EP): 4-(4-Hydroxyphenyl)butan-2-one 

(C) 100 mg 

O 

Dodecylguanidinium Acetate 

MM 0451.03 Dodecylnitrile 

N 

(B) 100 mg 

MM 0451.05 

Dimethyldodecylamine 

N 

(B) 

100 mg 

Domperidone 

MM 0107.00 

Domperidone 

HN 

O 

N 

N 

O 

N NH 

(D) 

100 mg 

Cl 

MM 0107.06 

Imp. A (EP): 5-Chloro-1-(piperidin-4-yl)-1,3-dihydro-2H-benzimidazol- 

2-one 

HN 

O 

N NH 

(A) 

100 mg 

MM 0107.05 

Imp. B (EP): 4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1- 

formylpiperidine 

Cl 

O 

O (A) 100 mg 

N 

N NH 

MM 0107.03 

Imp. F (EP): 1,3-Bis[3-[4-(5-chloro-2-oxo- 

2,3-dihydro-1H-benzimidazol-1-yl)piperidin- 

1-yl]propyl]-1,3-dihydro-2H-benzimidazol-2- 

one 

MM 0107.07 1,3-Dihydro-2H-benzimidazol-2-one 

H N 

O 

N H 

HN 

Cl 

O 

N 

N 

N 

O 

N 

N 

N 

O 

Cl 

NH 

Cl 

(A) 

(B) 

50 mg 

100 mg 

Donepezil Hydrochloride 

MM 0677.00 

Donepezil Hydrochloride 

on request 

O 

O 

N 

x HCl 

O 

MM 0677.01 

Donepezil 

on request 

O 

O 

N 

Dopamine Hydrochloride 

MM 0384.00 Dopamine Hydrochloride 

HO 

MM 0384.02 

Imp. A (EP) as Hydrochloride: 5-(2-Aminoethyl)-2- 

methoxyphenol Hydrochloride (4-O-Methyldopamine 


MM 0384.04 Imp. C (EP): 2-(3,4-Dimethoxyphenyl)ethanamine 

O 

O 

HO 

HO 

O 

NH 2 

NH 2 

x HCl 

x HCl 

(A) 500 mg 

(A) 100 mg 

NH 2 

(A) 100 mg 

O 

MM 0384.01 (R,S)-α-Methyldopamine Hydrobromide 

HO 

HO 

NH 2 

x HBr 

(A) 

100 mg 

Dosulepin Hydrochloride 

MM 0510.00 

Dosulepin Hydrochloride 

N 

(A) 

100 mg 

x HCl 

S 




MM 0510.02 Imp. B (EP): Dibenzo[b,e]thiepin-11(6H)-one 

(A) 100 mg 

O 

S 

MM 0510.08 

Nordosulepin Hydrochloride 

N 

H 

(A) 

50 mg 

x HCl 

S 

Doxazosin Mesilate 

MM 0386.00 

Doxazosin Mesilate 

O 

O 

N N 

N 

NH 2 

x 

N 

O 

O 

O 

O O 

S 

OH 

(A) 

100 mg 

MM 0386.08 

Doxazosin 

N 

O 

O 

(A) 

100 mg 

O 

O 

N N 

N 

O 

MM 0386.04 

Imp. A (EP): (2RS)-2,3-Dihydro-1,4-benzodioxine-2-carboxylic Acid 

NH 2 

O 

(A) 100 mg 

HO O 

O 

MM 0386.05 

Imp. B (EP) as Hydrochloride: 1-[(2RS)-2,3-Dihydro-1,4- 

benzodioxin-2-ylcarbonyl]piperazine Hydrochloride 

HN 

N 

O 

O 

O 

x HCl 

(A) 

100 mg 

MM 0386.06 

Imp. C (EP): 1,4-Bis(2,3-dihydro-1,4-benzodioxin- 

2-ylcarbonyl)piperazine 

O 

O 

N 

N 

O 

O 

O 

(A) 

100 mg 

O 

MM 0386.10 

Imp. D (EP): 6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione 

O 

H 

N 

O 

(C) 

100 mg 

MM 0386.09 

Imp. E (EP): 2,4-Dichloro-6,7-dimethoxyquinazoline 

O N 

MM 0386.01 Imp. F (EP): 2-Chloro-6,7-dimethoxyquinazolin-4-amine 

New MM 0386.12 

Imp. F (EP) as Mesilate: 2-Chloro-6,7-dimethoxyquinazolin-4-amine 

Mesilate 

O 

O 

N 

O 

O 

O 

N 

O 

Cl 

x 

O 

N 

NH 

N 

Cl 

Cl 

Cl 

N 

O 

NH 2 

O 

S 

OH 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

NH 2 

MM 0386.02 

Imp. G (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4- 

amine 

O 

O 

NH (A) 100 mg 

N N 

N 

NH 2 

MM 0386.03 

Imp. H (EP): 2,2'-(Piperazine-1,4-diyl)bis(6,7- 

dimethoxyquinazolin-4-amine) 

NH 2 

(D) 100 mg 

O 

N 

O 

O 

N N 

N N 

N 

NH 2 

O 

210 All your need for pharmaceutical analysis - email pharma@lgcstandards.com Edition 2008



Doxepin Hydrochloride 

MM 0032.00 Doxepin Hydrochloride 

N 

(A) 500 mg 

O 

x HCl 

Doxycycline Hydrochloride 

MM 0538.00 Doxycycline Hydrochloride 

OH O OH O 

OH 

O 

(A) 

500 mg 

H 

H 

OH 

N 

OH 

NH 2 

x HCl 

Doxylamine Hydrogen Succinate 

MM 0101.00 

Doxylamine Hydrogen Succinate 

O 

(A) 

500 mg 

N 

O 

N 

x 

OH 

OH 

MM 0101.04 

Imp. D (EP): Phenyl(pyridin-2-yl)methanone 

(2-Benzoylpyridine) 

O 

(A) 

100 mg 

N 

O 

New MM 0101.05 

Doxylamine N-Oxide Dihydrochloride 

(A) 

100 mg 

N 

O 

N O 

x 2 HCl 

Drofenine Hydrochloride 

MM 0768.00 

Drofenine Hydrochloride 

(A) 

500 mg 

O 

O 

N 

x HCl 

MM 0768.01 

Drofenine N-Oxide Hydrochloride 

(A) 

100 mg 

O 

O 

N 

O 

x HCl 

Droperidol 

New MM 0138.04 

Imp. D (EP) as Hydrochloride: (1RS)- 

1-[4-(4-Fluorophenyl)-4-oxobutyl]- 

4-(2-oxo-2,3-dihydro-1H-benzimidazol- 

1-yl)-1,2,3,6-tetrahydropyridine 1-Oxide 

Hydrochloride 

F 

O 

O 

N 

O 

N 

NH 

x HCl 

(A) 

100 mg 

Dropropizine 

MM 1017.00 

Dropropizine 

N 

N 

OH 

OH (A) 500 mg 

Ebastine 

MM 0468.00 

Ebastine 

(A) 

100 mg 

O 

N 

O 

New MM 0468.02 

Imp. A (EP): Diphenylmethanol (Benzhydrol) 

(B) 

100 mg 

OH 




Econazole Nitrate 

MM 0524.00 

Econazole Nitrate 

Cl 

(A) 500 mg 

Cl 

x HNO 3 

O 

Cl 

N 

N 

MM 0524.01 

Imp. A (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol 

Cl 

(A) 100 mg 

Cl 

HO 

N 

MM 0524.02 

Imp. B (EP) as Nitrate: (2RS)-2-[(4-Chlorobenzyl)oxy]-2- 

(2,4-dichlorophenyl) ethanamine Nitrate 

N 

Cl 

(D) 100 mg 

Cl 

O 

x HNO 3 

Cl 

NH 2 

Enalapril Maleate 

MM 0010.00 

Enalapril Maleate 

O 

H 

N 

O 

O 

N 

O 

OH O (A) 100 mg 

OH 

x 

OH 

O 

MM 0010.05 

Imp. B (EP): (2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3- 

phenylpropyl]amino]propanoic Acid 

H 

N 

O (A) 100 mg 

OH 

O 

O 

MM 0010.01 

Imp. C (EP): (2S)-1-[(2S)-2-[[(1S)-1-Carboxy- 

3-phenylpropyl]amino]propanoyl]pyrrolidine-2- 

carboxylic Acid (Enalaprilat) 

H 

N 

O 

O 

N 

OH on request 

HO 

O 

MM 0010.06 

Imp. D (EP): Ethyl (2S)-2-[(3S,8aS)-3-Methyl-1,4-dioxooctahydropyrrolo[1,2-α]pyrazin-2-yl]-4-phenylbutanoate 

(Enalapril diketopiperazine) 

H 

(A) 100 mg 

O 

N 

N 

O 

O 

O 

MM 0010.14 

Imp. I (EP): 1H-Imidazole 

H 

N (B) 100 mg 

N 

MM 0010.15 

(2S)-2[[(1S)-1-(Ethoxycarbonyl)-3- 

phenylpropyl]amino]propanoic Acid Ethyl Ester 

Hydrochloride 

O 

H 

N 

O 

O 

O 

x HCl 

(A) 

100 mg 

Enilconazole 

New MM 1228.05 

Imp. E (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol 

Cl 

(A) 100 mg 

Cl 

HO 

N 

N 

Enrofloxacin 

MM 0395.00 

Enrofloxacin 

N 

(A) 

100 mg 

N 

N 

F 

O 

OH 

O 




New MM 0395.04 

New MM 0395.05 

MM 0395.01 

MM 0395.03 

Imp. A (Pharmeuropa): 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline- 

3-carboxylic Acid 

Imp. B (Pharmeuropa) as Hydrochloride 

Monohydrate: 1-Cyclopropyl-6-fluoro-4- 

oxo-7-piperazin-1-yl-1,4-dihydroquinoline- 

3-carboxylic Acid Hydrochloride Monohydrate 

Imp. C (Pharmeuropa) as Hydrochloride: 

1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-4- 

oxo-1,4-dihydroquinoline-3-carboxylic Acid 

Hydrochloride (Desfluoroenrofloxacin 


Enrofloxacin N-Oxide 

HN 

N 

N 

F 

N 

N 

Cl 

F 

N 

N 

O 

N 

O 

O 

N 

O 

OH 

O 

N 

OH 

O 

OH 

x HCl 

x H 2 O 

x HCl 

(A) 

(A) 

(A) 

100 mg 

500 mg 

100 mg 

O 

(A) 100 mg 

F 

O 

O 

OH 

Ephedrine Hydrochloride 

MM 0652.00 Ephedrine Hydrochloride [Controlled Substance] 

OH 

H 

N 

x HCl 

(A) 

500 mg 

MM 0652.02 

Imp. B (EP) as Hydrochloride: Pseudoephedrine Hydrochloride 


OH 

H 

N 

x HCl 

(A) 

500 mg 

Ephedrine Sulphate 

New MM1147.00 

Ephedrine Sulphate [Controlled Substance] 

OH 

H 

N 

x H 2 SO 4 

(A) 250 mg 

2 

Erdosteine 

MM 0544.00 

Erdosteine 

S 

O 

(A) 100 mg 

N 

H 

O 

S 

O 

OH 

MM 0544.01 

2-Chloro-N-(2-oxotetrahydrothiophen-3-yl)acetamide 

S 

O 

(A) 100 mg 

N 

H 

O 

Cl 

Erythromycin 

MM 0132.10 

Imp. E (EP): Erythromycin A Enol Ether 

(A) 

50 mg 

N 

OO 

OH 

OH 

O 

OO 

O OH 

HO 

O 

O 

Esomeprazole Magnesium Trihydrate 

MM 1036.02 

Imp. A (Pharmeuropa): 5-Methoxy-1H-benzimidazole-2-thiol 

O 

(A) 100 mg 

NH 

MM 1036.03 

MM 1036.04 

MM 1036.05 

Imp. B (Pharmeuropa): 2-[(RS)-[(3,5-Dimethylpyridin-2- 

yl)methyl]sulphinyl]- 

5-methoxy-1H-benzimidazole 

Imp. C (Pharmeuropa): 5-Methoxy-2-[[(4-methoxy-3,5- 

dimethylpyridin-2-yl)-methyl]sulphanyl]-1H-benzimidazole 

(Ufiprazole) 

Imp. D (Pharmeuropa): 5-Methoxy-2-[[(4-methoxy-3,5- 

dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole 

(Omeprazole Sulphone) 

NH 

N S 

O N 

N SH 

O 

(A) 100 mg 

O 

(A) 100 mg 

NH 

O 

N S 

N 

O 

NH 

O 

N S 

O O N 

(A) 100 mg 




MM 1036.06 Imp. E (Pharmeuropa): 4-Methoxy-2-[[(RS)-(5-methoxy- 

O 

(A) 100 mg 

NH 

1H-benzimidazol-2-yl)sulphinyl]methyl]-3,5- 

O 

N 

dimethylpyridine 1-Oxide (Omeprazole N-Oxide) 

S 

O N 

O 

Estradiol Benzoate 

MM 0301.00 Estradiol Benzoate 

OH 

(A) 

500 mg 

O 

O 

MM 0301.04 Imp. A (EP) as Hemihydrate: Estradiol Hemihydrate 

OH 

(A) 

500 mg 

x 1 / 2 H 2 O 

HO 

MM 0301.02 

Imp. C (EP): Estra-1,3,5(10)-triene-3,17β-diyl 

Dibenzoate (Estradiol 3,17-Dibenzoate) 

O 

O 

(A) 100 mg 

O 

O 

MM 0301.07 

Imp. D (EP): 3-Hydroxyestra-1,3,5(10)-trien-17β-yl 

Benzoate (Estradiol 17-Benzoate) 

O 

O 

(A) 100 mg 

HO 

MM 0301.03 

Imp. E (EP): 17α-Hydroxyestra-1,3,5(10)-trien-3-yl Benzoate 

(17-epi-Estradiol Benzoate) 

O 

OH 

(D) 

100 mg 

O 

MM 0301.08 

Imp. G (Pharmeuropa): 17-Oxo-estra-1,3,5(10)trien-3-yl 

Benzoate 

O 

(A) 

100 mg 

O 

O 

MM 0301.05 

Benzoic Acid 

O 

(B) 100 mg 

OH 

Estradiol Enanthate 

MM 0473.00 

Estradiol Enanthate 

O 

O 

(A) 100 mg 

Estradiol Hemihydrate 

MM 0300.00 Estradiol Hemihydrate 

OH 

HO 

(A) 

500 mg 

MM 0300.05 Imp. A (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone) 

O 

HO 

x 1 / 2 H 2 O 

(A) 

500 mg 

HO 

MM 0300.01 Imp. B (EP): Estra-1,3,5(10)-triene-3,17α-diol (17α-Estradiol; 17- 

epi-Estradiol) 

OH 

(A) 

100 mg 

HO 

MM 0300.06 Imp. C (EP): 4-Methylestra-1,3,5(10)-triene-3,17β-diol (4- 

Methylestradiol) 

OH 

(A) 

100 mg 

HO 




MM 0300.02 Imp. D (EP): Estra-1,3,5(10),9(11)-tetraene-3,17β-diol (9,11- 

Didehydroestradiol) 

OH 

(D) 

100 mg 

MM 0300.03 6β-Hydroxyestradiol 

OH 

HO 

(D) 

50 mg 

MM 0300.08 6-Ketoestradiol 

OH 

HO 

OH 

(A) 

100 mg 

Estradiol Valerate 

MM 0209.00 

Estradiol Valerate 

HO 

O 

O 

O 

(A) 500 mg 

MM 0209.05 Imp. A (EP) as Hemihydrate:Estradiol Hemihydrate 

OH 

HO 

(A) 

500 mg 

x 1 / 2 H 2 O 

HO 

MM 0209.06 

Imp. B (EP): 17β-Hydroxyestra-1,3,5(10)-trien-3-yl 

Pentanoate (Estradiol 3-Valerate) 

OH 

(A) 

100 mg 

O 

O 

MM 0209.01 

Imp. C (EP): 3-Hydroxyestra-1,3,5(10),9(11)-tetraen-17β-yl 

Pentanoate (9,11-Didehydroestradiol Valerate) 

O 

O 

(D) 100 mg 

HO 

MM 0209.07 

Imp. D (EP): 3-Hydroxy-4-methylestra-1,3,5(10)-trien- 

17β-yl Pentanoate 

(4-Methylestradiol Valerate) 

O 

O 

(D) 100 mg 

HO 

MM 0209.02 

Imp. E (EP): Estra-1,3,5(10)-trien-3,17β-diyl 

Dipentanoate (Estradiol 3,17-Divalerate) 

O 

O 

(A) 

100 mg 

O 

O 

MM 0209.04 

Imp. F (EP): 3-Hydroxyestra-1,3,5(10)-trien-17β-yl Butanoate 

(Estradiol Butyrate) 

O 

O 

(A) 100 mg 

HO 

MM 0209.03 

17-epi-Estradiol Valerate (17α-Estradiol Valerate) 

O 

O 

(D) 100 mg 

HO 

Estramustine Sodium Phosphate 

New MM 0100.01 Estramustine 

OH 

(D) 

100 mg 

Cl 

Cl 

N 

O 

O 




Estriol 

MM 0130.00 Estriol 

OH 

(A) 100 mg 

OH 

HO 

MM 0130.06 Imp. A (EP): Estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol (9,11- 

Didehydroestriol) 

OH 

OH 

(D) 

100 mg 

MM 0130.19 Imp. B (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone) 

O 

HO 

(A) 

500 mg 

HO 

MM 0130.01 

Imp. C (EP): 3-Methoxyestra-1,3,5(10)-triene-16α,17β-diol 

(Estriol 3-Methyl Ether) 

OH 

OH 

(D) 

100 mg 

MM 0130.20 Imp. D (EP) as Hemihydrate: Estradiol Hemihydrate 

OH 

O 

(A) 

500 mg 

x 1 / 2 H 2 O 

HO 

MM 0130.05 

Imp. E (EP): Estra-1,3,5(10)-triene-3,16α,17α-triol 

(17-epi-Estriol) 

OH 

OH 

(D) 

100 mg 

HO 

MM 0130.04 

Imp. F (EP): Estra-1,3,5(10)-triene-3,16β,17β-triol 

(16-epi-Estriol) 

OH 

OH 

(D) 

100 mg 

HO 

MM 0130.03 

Imp. G (EP): Estra-1,3,5(10)-triene-3,16β,17α-triol 

(16,17-epi-Estriol) 

OH 

OH 

(D) 

100 mg 

HO 

MM 0130.22 

Imp. I (EP): 3-Hydroxy-17-oxa-D-homoestra-1,3,5(10)-trien-17aone 

O 

on request 

O 

MM 0130.02 6α-Hydroxyestriol 

OH 

HO 

OH 

(D) 

100 mg 

HO 

OH 

MM 0130.14 

Estriol 16,17-Diacetate 

O 

O 

(D) 

100 mg 

O 

O 

HO 

MM 0130.15 

Estriol Triacetate 

O 

O 

(D) 

100 mg 

O 

O 

O 

MM 0130.16 Estriol 3-Benzyl Ether 

OH 

O 

OH 

(D) 

100 mg 

MM 0130.17 16-Oxoestradiol 

OH 

O 

O 

(D) 

100 mg 

MM 0130.18 6-Oxoestriol 

OH 

HO 

OH 

(D) 

100 mg 

HO 

O 




Estrone 

MM 0282.00 Estrone 

O 

(A) 500 mg 

MM 0282.01 Estrone 3-Methyl Ether 

O 

HO 

(A) 

100 mg 

Ethacridine Lactate Monohydrate 

MM 0798.00 Ethacridine Lactate Monohydrate 

Ethinylestradiol 

O 

NH 2 

O 

O 

x OH x H 2O 

H 2 N 

N 

OH 

MM 0123.00 Ethinylestradiol 

OH 

(A) 

on request 

500 mg 

HO 

MM 0123.02 

Imp. B (EP): 19-Nor-17α-pregna-1,3,5(10),9(11)-tetraen-20- 

yne-3,17-diol (9,11-Didehydroethinylestradiol) 

OH 

(D) 

50 mg 

MM 0123.03 Imp. C (EP): 3-Hydroxyestra-1,3,5(10)-trien-17-one (Estrone) 

O 

HO 

(A) 

500 mg 

HO 

MM 0123.04 

Imp. D (EP) as Hemihydrate: 

Estradiol Hemihydrate 

OH 

x 1 / 2 H 2 O 

(A) 

500 mg 

MM 0123.05 6-Ketoethinylestradiol 

OH 

HO 

(D) 

100 mg 

MM 0123.06 6β-Hydroxyethinylestradiol 

OH 

HO 

O 

(D) 

25 mg 

MM 0123.07 6α-Hydroxyethinylestradiol 

OH 

HO 

OH 

(D) 

100 mg 

HO 

OH 

MM 0123.08 

6,7-Didehydroethinylestradiol 

OH (D) 50 mg 

HO 

Ethionamide 

MM 0845.00 

Ethionamide 

S 

(A) 250 mg 

NH 2 

N 

MM 0845.01 

Ethionamide Sulphoxide 

S 

O 

(D) 100 mg 

NH 2 

N 

Ethosuximide 

MM 0750.00 Ethosuximide 

H 

O N 

O 

(A) 

500 mg 




Ethyl Parahydroxybenzoate 

MM 0498.00 

Ethyl Parahydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0498.05 

Sodium Ethyl Parahydroxybenzoate 

O 

(A) 500 mg 

O 

NaO 

MM 0498.01 


O 

(B) 100 mg 

OH 

HO 

MM 0498.02 


O 

(A) 500 mg 

O 

HO 

MM 0498.03 

Imp. C (EP): Propyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0498.04 

Imp. D (EP): Butyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

Ethylmorphine Hydrochloride 

MM 0799.02 


Hydrochloride Trihydrate 


N 

x HCl 

x 3 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

MM 0799.03 

Imp. B (EP) as Hemisulphate Pentahemihydrate: Morphine 

Hemisulphate Pentahemihydrate [Controlled Substance] 

N 

x H 2 SO 4 

x 5 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

2 

MM 0799.04 

Imp. C (EP) as Monohydrate: Codeine Monohydrate 


N 

x H 2 O 

(A) 

100 mg 

O 

O 

OH 

MM 0799.05 

Imp. C (EP) as Phosphate Hemihydrate: Codeine 

Phosphate Hemihydrate 


N 

x H 3 PO 4 

x 1/2 H 2 O 

(A) 

100 mg 

O 

O 

OH 

Etilefrine Hydrochloride 

MM 0035.00 

Etilefrine Hydrochloride 

HO 

OH HN 

x HCl 

(A) 

500 mg 

MM 0035.02 

MM 0035.03 

MM 0035.05 

Imp. B (EP) as Hydrochloride: (1RS)-1-(3-Hydroxyphenyl)-2- 

(methylamino)ethanol Hydrochloride 

(Phenylephrine Hydrochloride) 

Imp. C (EP) as Hydrochloride: (1RS)-2-Amino-1-(3- 

hydroxyphenyl)ethanol Hydrochloride (Norfenefrine 


Imp. E (EP): 1-(3-Hydroxyphenyl)ethanone (3-Hydroxyacetophenone) 

HO 

HO 

OH 

HN 

x HCl 

OH 

HO 

(A) 500 mg 

NH 

(A) 500 mg 

O 

(C) 100 mg 

MM 0035.06 

Imp. F (EP): N-Benzylethanamine (Benzylethylamine) 

(C) 

100 mg 

HN 

MM 0035.50 

3-Benzoyloxyacetophenone 

O 

O 

(A) 

100 mg 

O 

MM 0035.51 

3-Benzoyloxy-α-bromoacetophenone 

O 

O 

Br 

on request 

O 




Etodolac 

MM 0911.00 

Etodolac 

H 

N 

O 

O 

OH 

(A) 

250 mg 

New MM 0911.02 

Imp. B (EP): 2-[(1RS)-1-Ethyl-8-methyl-1,3,4,9- 

tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid 

(8-Methyl Etodolac) 

H 

N 

O 

O 

OH 

(A) 

100 mg 

New MM 0911.08 

Imp. H (EP): 2-(7-Ethylindol-3-yl)ethanol 

H 

N (A) 100 mg 

OH 

New MM 0911.11 

Imp. K (EP): Methyl 2-[(1RS)-1,8-Diethyl-1,3,4,9- 

tetrahydropyrano[3,4-b]indol-1-yl]acetate 

(Etodolac Methyl Ester) 

H 

N 

O 

O 

O 

(A) 

100 mg 

Etofenamate 

MM 0105.01 

Imp. A (EP): 2-[[3-(Trifluoromethyl)phenyl]-amino]benzoic Acid 

(Flufenamic Acid) 

O 

OH 

(A) 

500 mg 

NH 

F 

MM 0105.02 

Imp. B (EP): Butyl 2-[[3-(Trifluoromethyl)phenyl]-amino]benzoate 

(Butyl Flufenamate) 

O 

O 

F 

F 

(A) 

100 mg 

NH 

F 

MM 0105.04 

Imp. D (EP): 2,2'-Oxybis(ethylene) Bis[2-[[3- 

(trifluoromethyl)phenyl] amino]benzoate] 

O 

O 

O 

F F 

O 

O 

(A) 

100 mg 

NH 

HN 

F 

F 

F F F F 

MM 0105.07 Imp. G (EP): 2-Hydroxyethyl 2-[[3- 

(Trifluoromethyl)phenyl]amino]benzoate 

O 

O 

OH 

(A) 

100 mg 

NH 

F 

F F 

MM 0105.08 Etofenamate Myristate 

O 

O 

O 

O 

O 

(A) 

100 mg 

NH 

F 

F 

F 

MM 0105.09 Etofenamate Palmitate 

O 

O 

O 

O 

O 

(A) 

100 mg 

NH 

F 

F 

F 




MM 0105.10 Etofenamate Stearate 

O 

O 

O 

O 

NH 

O 

(A) 100 mg 

F 

F 

F 

MM 0105.11 Triethylene Glycol Flufenamate 

O 

O 

O 

O 

OH 

(A) 

100 mg 

NH 

F 

F 

F 

Etofylline 

MM 0603.00 

Etofylline 

N 

O 

N 

OH 

(A) 

500 mg 

O 

N 

N 

Etoposide 

MM 0492.00 

Etoposide 

O 

O 

on request 

O 

OH 

O 

O O 

H 

OH 

O 

O 

H 

O 

O 

OH 

Famotidine 

MM 0029.00 

Famotidine 

MM 0029.06 Imp. A (EP) as Hydrochloride: 3-[[[2- 

[(Diaminomethylene)amino]thiazol-4-yl]- 

methyl]sulphanyl]propanimidamide Hydrochloride 

NH 2 

NH 2 

H 2 N N 

S 

N 

N 

S NH 2 

S 

O O 

NH 2 

NH 

H 2 N N 

N 

S NH 2 x HCl 

S 

(A) 

(A) 

250 mg 

100 mg 

MM 0029.05 

Imp. B (EP) as Dimaleate: 3,5-Bis[2-[[[2- 

[(diaminomethylene)amino]thiazol-4-yl]- 

methyl]sulphanyl]ethyl]-4H-1,2,4,6- 

thiatriazine 1,1-Dioxide Dimaleate 

H 2 N 

O O 

S 

NH N N 

2 H 2 N 

N 

S N S 

N NH 2 

N 

H 

N 

S 

S 

O 

(D) 

50 mg 

x 2 

OH 

OH 

MM 0029.01 

MM 0029.02 

MM 0029.07 

MM 0029.03 

MM 0029.09 

MM 0029.04 

Imp. C (EP) as Hydrochloride: 

3-[[[2-[(Diaminomethylene)amino]thiazol-4- 

yl]methyl]sulphanyl]-N-sulphamoylpropanamide 

Hydrochloride 

H 2 N 

O 

NH 

O 

2 

O O 

N 

S 

S 

N NH2 

N 

H 

S 

x HCl 

(A) 

100 mg 

Imp. D (EP): 3-[[[2-[(Diaminomethylene)amino]thiazol-4- 

NH 

O 

2 (A) 100 mg 

H 

yl]methyl]sulphanyl]propanamide 2 N N 

S NH 2 

Imp. E (EP): 2,2'-[Disulphanediylbis- 

(methylenethiazole-4,2-diyl)]diguanidine 

H 2N 

N 

NH 2 

N 

N 

S 

S 

S S 

N 

S 

H 2N 

(A) 100 mg 

Imp. F (EP): 3-[[[2-[(Diaminomethylene)amino]thiazol-4- 

NH 

O 

2 (A) 100 mg 

H 

yl]methyl]sulphanyl]propanoic Acid 2 N N 

S OH 

Imp. G (EP) as Maleate: N-Cyano-3-[[[2- 

(diaminomethylene)amino]thiazol-4- 

yl]methyl]sulphanyl]propanimidamide Maleate 

Famotidine Sulphoxide 

H 2N 

H 2 N 

N 

S 

N 

NH 2 

O 

NH NH 

2 N 

N 

OH 

S N x 

N 

H 

OH 

S 

O 

NH 

NH 2 

2 

N 

S 

N 

N 

S NH 2 

O 

S 

O O 

(A) 

(A) 

100 mg 

100 mg 




MM 0029.10 

MM 0029.51 

O 

3-[[[2-[(Diaminomethylene)amino]thiazol-4- 

yl]methyl]sulphinyl]-N-sulphamoylpropanamide 

H 2 N N 

S N 

H 

2-[(Diaminomethylene)amino]-4-(4-cyanobutyl)thiazole 

Hydrochloride 

NH 2 

S 

NH2 

N 

H 2N 

S 

N 

N 

S 

NH 2 

O 

O 

O 

N 

x HCl 

(D) 

(A) 

50 mg 

100 mg 

Felodipine 

MM 0139.00 Felodipine 

H 

N 

(A) 

100 mg 

O 

O 

O 

O 

Cl 

Cl 

MM 0139.01 

Imp. A (EP): Ethyl Methyl 4-(2,3-Dichlorophenyl)-2,6- 

dimethylpyridine-3,5-dicarboxylate 

O 

N 

O 

(D) 

50 mg 

O 

O 

Cl 

Cl 

MM 0139.02 

Imp. B (EP): Dimethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4- 

dihydropyridine-3,5-dicarboxylate 

O 

H 

N 

O 

(A) 

100 mg 

O 

O 

Cl 

Cl 

MM 0139.03 

Imp. C (EP): Diethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4- 


O 

H 

N 

O 

(A) 

100 mg 

O 

O 

Cl 

Fenbendazole 

MM 0518.03 

MM 0518.01 

MM 0518.02 

Fenbufen 

Imp. A (EP): Methyl (1H-Benzimidazol-2-yl)carbamate 

(Carbendazim) 

Fenbendazole Sulphoxide (Oxfendazole) 

Fenbendazole Sulphone 

MM 0918.00 Fenbufen 

O 

S 

O 

S 

O O 

H 

N 

N 

H 

N 

N 

H 

N 

N 

Cl 

O 

(A) 100 mg 

O 

NH 

O 

NH 

O 

NH 

O 

O 

O 

OH 

(A) 

(A) 

(A) 

100 mg 

100 mg 

500 mg 

MM 0918.03 Imp. C (EP): Biphenyl (A) 100 mg 

MM 0918.05 

Fenfluramine Hydrochloride 

4-(4-Chlorophenyl)-4-oxobutanoic Acid 

(3-(4-Chlorobenzoyl)propionic Acid) 

MM 0608.00 Fenfluramine Hydrochloride 

H 

N 

x HCl 

Cl 

O 

O 

OH 

(A) 

(A) 

100 mg 

500 mg 

MM 0608.01 

Norfenfluramine Hydrochloride 

F 

F 

F 

NH 2 

(A) 

100 mg 

F 

F 

F 

x HCl 




MM 0608.02 N-Nitrosofenfluramine 

N O (A) 100 mg 

N 

F 

F 

F 

Fenofibrate 

MM 0505.00 

Fenofibrate 

Cl 

O 

O 

(A) 500 mg 

O 

O 

MM 0505.01 Imp. A (EP): (4-Chlorophenyl)(4-hydroxyphenyl)methanone 

Cl 

OH 

(C) 100 mg 

O 

New MM 0505.03 

Imp. C (EP): (3RS)-3-[4-(4-Chlorobenzoyl)- 

phenoxy]butan-2-one 

Cl 

O 

O 

(A) 100 mg 

O 

New MM 0505.04 

Imp. D (EP): Methyl 2-[4-(4-Chlorobenzoyl)- 

phenoxy]-2-methylpropanoate 

Cl 

O 

O 

(A) 100 mg 

O 

O 

New MM 0505.05 

Imp. E (EP): Ethyl 2-[4-(4-Chlorobenzoyl)- 

phenoxy]-2-methylpropanoate 

Cl 

O 

O 

(A) 100 mg 

O 

O 

New MM 0505.06 

Imp. F (EP): (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone 

Cl 

O 

(A) 100 mg 

O 

Fenoprofen Calcium 

MM 0790.00 

Fenoprofen Calcium Dihydrate 

O O - 

O 

2 

Ca 2+ 

x 2 H 2 O 

(A) 

500 mg 

Fentanyl 

MM 0528.00 

Fentanyl [Controlled Substance] 

(A) 

100 mg 

O 

N 

N 

MM 0528.01 

Imp. A (EP): N-Phenyl-N-[cis,trans-1-oxido-1- 

(2-phenylethyl)piperidin-4-yl]propanamide 

(Fentanyl N-Oxide) 

O 

N 

O 

N 

(A) 

100 mg 

MM 0528.08 Imp. B (EP): N-Phenyl-N-(piperidin-4-yl)propanamide O NH (A) 100 mg 

N 

MM 0528.03 

Imp. C (EP): N-phenyl-N-[1-(2-phenylethyl)- 

piperidin-4-yl]acetamide 

O 

N 

(A) 

100 mg 

N 

MM 0528.04 

Imp. D (EP): N-phenyl-1-(2-phenylethyl)piperidin-4-amine 

(A) 

100 mg 

N 

HN 




MM 0528.05 Imp. E (EP): Benzaldehyde 

O 

(B) 100 mg 

MM 0528.06 Imp. F (EP): Aniline (Phenylamine) 

NH 2 

(B) 100 mg 

MM 0528.07 

Imp. G (EP): N-Phenylpropanamide 

O 

(A) 100 mg 

NH 

Fexofenadine Hydrochloride 

MM 0507.05 

Imp. E (EP): Diphenyl(piperidin-4-yl)methanol 

(B) 

100 mg 

OH 

Finasteride 

MM 0415.00 

Finasteride 

NH 

O H 

N (A) 100 mg 

O 

N 

H 

Flavoxate Hydrochloride 

MM 0156.00 

Flavoxate Hydrochloride 

O 

(A) 

100 mg 

O 

O 

O 

N 

x HCl 

MM 0156.01 

Imp. A (EP): 3-Methyl-4-oxo-2-phenyl-4H-1- 

benzopyran-8-carboxylic Acid (3-Methylflavone-8-carboxylic 

Acid) 

O 

(A) 100 mg 

O 

MM 0156.02 

Imp. B (EP): Ethyl 3-Methyl-4-oxo-2-phenyl- 

4H-1-benzopyran-8-carboxylate (3-Methylflavone-8-carboxylic 

Acid Ethyl Ester) 

O 

O OH 

O 

(A) 100 mg 

O 

O 

Flubendazole 

MM 0463.00 

Flubendazole 

F 

H 

N 

N 

O 

(A) 100 mg 

O 

NH 

O 

MM 0463.02 

Imp. B (EP): (2-Amino-1H-benzimidazol-5-yl)(4- 

fluorophenyl)methanone 

F 

O 

H 

N 

N 

NH 2 

(A) 100 mg 

MM 0463.03 

Imp. C (EP): (4-Fluorophenyl)(2-hydroxy-1H-benzimidazol-5- 

yl)methanone 

F 

O 

H 

N 

N 

OH 

(A) 

100 mg 

MM 0463.04 

Imp. D (EP): (1H-Benzimidazol-5-yl)(4-fluorophenyl)methanone 

H 

F on request 

N 

N 

O 

MM 0463.05 

Imp. E (EP): Methyl [5-(2-Fluorobenzoyl)-1H-benzimidazol-2- 

yl]carbamate 

F 

O 

H 

N 

N 

O 

O 

NH 

(A) 

100 mg 

MM 0463.06 

Imp. F (EP): Methyl [5-(4-Fluorobenzoyl)-1-methyl-1Hbenzimidazol-2-yl]carbamate 

F 

O 

N 

N 

O 

(A) 100 mg 

O 

NH 

MM 0463.07 

Imp. G (EP): Methyl [5-[4-(1-Methylethoxy)benzoyl]-1Hbenzimidazol-2-yl]carbamate 

O 

O 

H 

N 

N 

O 

(D) 100 mg 

O 

NH 




Flucloxacillin Sodium 

MM 0489.00 

MM 0489.01 

Flucloxacillin Sodium Hydrate 

Imp. A (EP) as Disodium Salt: (4S)-2-[Carboxy[[[3-(2-chloro- 

6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]methyl]- 

5,5-dimethylthiazolidine-4-carboxylic Acid Disodium Salt 

(Penicilloic Acids of Flucloxacillin Disodium Salt) 

Cl 

N 

O 

O 

O 

F 

H 

N 

Cl 

N 

O 

N 

H 

O 

F 

H 

N 

S 

HN 

ONa 

O 

S 

O 

O ONa 

x H 2 O 

ONa 

(A) 

(A) 

500 mg 

100 mg 

MM 0489.02 

Imp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5- 

methylisoxazol-4-yl]-carbonyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic 

Acid (Penilloic Acids of Flucloxacillin) 

Cl 

N 

O 

O 

O 

F HN 

NH 

S 

OH 

(A) 

50 mg 

MM 0489.04 



O 

N 

O 

OH (B) 100 mg 

H 2 N 

S 

H 

MM0489.03 

Imp. D (EP): 3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic 

Acid 

Cl 

N 

O 

F 

OH 

(C) 

100 mg 

O 

Fluconazole 

MM 0235.00 

Fluconazole 

F 

(A) 100 mg 

N 

N 

N 

F 

HO 

MM 0235.13 

Imp. C (EP): 1,1'-(1,3-Phenylene)di-1H-1,2,4-triazole 

N 

N 

N 

N N (A) 50 mg 

N 

MM 0235.02 

Imp. F (EP): (2RS)-2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1- 

yl)propane-1,2-diol 

N 

N 

N 

F 

N 

HO 

N 

N 

F 

(A) 50 mg 

OH 

MM 0235.01 

2-(2,4-Difluorophenyl)propane-1,2,3-triol 

F 

(A) 100 mg 

HO 

F 

HO 

MM 0235.03 1H-1,2,4-Triazol 

H 

N 

MM 0235.04 2-Chloro-2',4'-difluoroacetophenone 

OH 

N 

N 

F 

F 

(B) 

(C) 

100 mg 

100 mg 

MM 0235.06 

1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol 

O 

F 

Cl 

(A) 

100 mg 

F 

HO N 

N 

N 

MM 0235.09 4-Amino-1,2,4-triazole 

NH 2 

N 

N 

N 

(C) 

100 mg 




Flufenamic Acid 

O 

MM 0410.00 Flufenamic Acid (A) 500 mg 

OH 

NH 

F 

F 

F 

Flumetasone Pivalate 

MM 0427.01 

Imp. A (EP): 6α,9-Difluoro-11β,17,21-trihydroxy-16αmethylpregna-1,4-diene-3,20-dione 

(Flumetasone) 

HO 

O 

OH 

OH 

(A) 

100 mg 

F 

O 

F 

Flunarizine Dihydrochloride 

MM 0175.00 

Flunarizine Dihydrochloride 

F 

N 

N 

(A) 

500 mg 

x 2 HCl 

F 

MM 0175.04 

Imp. A (EP) : 1-[Bis(4-fluorophenyl)methyl]piperazine 

F 

N 

NH (A) 100 mg 

F 

MM 0175.03 

Imp. C (EP) as Dihydrochloride: 1-[(RS)-(2- 

Fluorophenyl)(4-fluorophenyl)methyl]-4-[(2E)-3- 

phenylprop-2-enyl]piperazine Dihydrochloride 

F 

N 

F 

N 

x 2 HCl 

(A) 

100 mg 

MM 0175.02 Chlorobis-(4-fluorophenyl)methane 

Cl 

(B) 

100 mg 

F 

F 

MM 0175.05 

1-Bis(4-fluorophenyl)methyl-4-(ethoxycarbonyl)piperazine 

O O 

(A) 100 mg 

N 

N 

F 

F 

MM 0175.06 

Flunarizine N-Oxide Dihydrochloride 

F 

N 

O 

on request 

N 

x 2 HCl 

F 

Flunitrazepam 

MM 0069.00 

Flunitrazepam [Controlled Substance] 

N 

O 

on request 

O 2N 

N 

F 

MM 0069.02 

Imp. B (EP): 5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4- 

benzodiazepin-2-one (Demethylflunitrazepam) 

O 2N 

H 

N 

N 

O 

(A) 

100 mg 

F 




Flunixin Meglumine 

MM 0915.00 

Flunixin Meglumine 

F F 

(A) 100 mg 

F 

N 

NH 

OH 

x 

HO 

HO 

OH 

OH 

H 

N 

OH 

MM 0915.01 Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid 

N 

MM 0915.03 Imp. C (EP): Ethyl 2-Chloropyridine-3-carboxylate 

N 

O 

Cl 

(A) 100 mg 

OH 

O 

Cl 

(A) 100 mg 

O 

O 

Fluorouracil 

MM 0593.00 

Fluorouracil 

HN 

O 

F 

(A) 

500 mg 

O 

N 

H 

MM 0593.02 

Imp. A (EP): Pyrimidine-2,4,6-(1H,3H,5H)- 

trione (Barbituric Acid) 

HN 

O 

(C) 

100 mg 

MM 0593.01 

Imp. B (EP): Dihydropyrimidine-2,4,5(3H)- 

trione (Isobarbituric Acid or 5-Hydroxyuracil) 

O 

HN 

N 

H 

O 

O 

O 

(A) 

100 mg 

MM 0593.03 

Imp. C (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil) 

O 

N 

H 

O 

(C) 100 mg 

HN 

MM 0593.05 

Imp. E (EP): 5-Chloropyrimidine-2,4(1H,3H)dione (5-Chlorouracil) 

HN 

O 

O 

N 

H 

Cl 

(A) 

100 mg 

MM 0593.06 

Imp. F (EP): 2-Ethoxy-5-fluoropyrimidin- 

4(1H)-one (2-Ethoxy-5-fluorouracil) 

O 

N 

N 

H 

O 

F 

(A) 

100 mg 

O 

N 

H 

Fluoxetine Hydrochloride 

MM 0256.00 Fluoxetine Hydrochloride O 

H 

N 

(A) 

50 mg 

F 

F 

F 

x HCl 

MM 0256.01 Imp. A (EP): (1RS)-3-(Methylamino)-1-phenylpropan-1-ol HO 

H 

N (A) 100 mg 

MM 0256.02 

Imp. B (EP) as Hydrochloride: N-Methyl-3- 

phenylpropan-1-amine Hydrochloride 

(Methyl-3-phenylpropylamine Hydrochloride) 


H 

N (A) 100 mg 

x HCl 

MM 0256.03 

Imp. C (EP) as Hydrochloride:(3RS)-N-Methyl-3-phenyl-3- 

[3-(trifluoromethyl]phenoxy]propan-1-amine Hydrochloride 

O 

H 

N 

x HCl 

(A) 

100 mg 

F 

F 

F 

MM 0256.05 4-Hydroxybenzotrifluoride 

OH 

F 

F F 

MM 0256.06 4-Chlorobenzotrifluoride 

Cl 

F 

F F 

(B) 

(B) 

100 mg 

100 mg 




MM 0256.10 3-Dimethylamino-1-phenylpropan-1-ol 

OH 

(A) 100 mg 

N 

Fluoxymesterone 

MM 0959.00 

Fluoxymesterone 

HO 

OH 

(A) 

100 mg 

F 

O 

Flupentixol Decanoate 

MM 0182.00 

Flupentixol Decanoate 

N 

N 

CF 3 

O 

O 

on request 

S 

MM 0182.08 

Imp. B (BP): 2-Trifluoromethylthioxanthone 

O 

(A) 100 mg 

CF 3 

S 

MM 0182.05 1-(2-Hydroxyethyl)piperazine 

HN 

N 

OH (B) 100 mg 

MM 0182.06 

cis/trans-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propene 

on request 

CF 3 

MM 0182.07 4-Chloro-3-nitrobenzotrifluoride 

O 2N CF 3 

S 

(B) 

100 mg 

MM 0182.09 

4-Fluoro-3-nitrobenzotrifluoride 

Cl 

O 2 N CF 3 (B) 100 mg 

F 

Flupentixol Dihydrochloride 

MM 0223.02 

Imp. G (EP): 2-(Trifluoromethyl)-9H-thioxanthen-9-one 

O 

(A) 100 mg 

CF 3 

S 

MM 0223.03 1-(2-Hydroxyethyl)piperazine 

HN 

N 

OH (B) 100 mg 

MM 0223.04 

cis/trans-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propene 

on request 

CF 3 

O CF 

MM 0223.05 4-Chloro-3-nitrobenzotrifluoride 2 N 

3 

Fluphenazine Hydrochloride 

MM 0114.00 

Fluphenazine Dihydrochloride 

S 

Cl 

(B) 

(A) 

100 mg 

500 mg 

S 

N 

F 

N 

N 

OH 

x 2 HCl 

MM 0114.01 

Imp. A (EP): 2-[4-[3-[5-Oxo-2-(trifluoromethyl)- 

10H-5 4 -phenothiazin-10-yl]propyl]piperazin-1- 

yl]ethanol (Fluphenazine S-Oxide) 

F 

S 

O 

F 

N 

F 

N 

N 

OH 

(A) 

100 mg 

MM 0114.04 

Fluphenazine N,N',S-Trioxide Dihydrochloride 

S 

O 

N 

F 

F 

O 

N 

F 

N 

O 

OH 

x 2 HCl 

on request 

F F 

Flurazepam Monohydrochloride 

MM 0070.01 

Imp. A (EP): [5-Chloro-2-[[2-(diethylamino)ethyl]amino]phenyl]-(2- 

fluorophenyl)methanone 

Cl 

H 

N 

O 

F 

N 

on request 




MM 0070.02 Imp. B (EP): 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4- 

H 

N 

O 

(A) 100 mg 

benzodiazepin-2-one 

Cl 

N 

F 

MM 0070.03 

2-Chloro-10-(2-diethylaminoethyl)-9,10-dihydroacridin-9-one 

N (A) 100 mg 

N 

Cl 

O 

MM0070.06 

Flurazepam [Controlled Substance] 

N (A) 100 mg 

N 

O 

Cl 

N 

F 

Flutamide 

MM 0161.00 

Flutamide 

O 

H 

N 

F F 

(A) 500 mg 

F 

NO 2 

MM 0161.03 

Imp. A (EP): 4-Nitro-3-(trifluoromethyl)aniline 

H 2 N 

F F 

(A) 100 mg 

F 

NO 2 

MM 0161.04 

Imp. B (EP): N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide 

O 

H 

N 

F F 

(A) 100 mg 

F 

NO 2 

MM 0161.05 

Imp. C (EP): N-[4-Nitro-3-(trifluoromethyl)phenyl]propanamide 

O 

H 

N 

F F 

(A) 100 mg 

F 

NO 2 

MM 0161.06 

Imp. D (EP): 3-(Trifluoromethyl)aniline 

H 2 N 

F F 

(B) 100 mg 

F 

MM 0161.07 Imp. E (EP): 2-Methyl-N-[3-(trifluoromethyl)phenyl]propanamide H 

N 

MM 0161.08 

MM 0161.01 

MM 0161.09 

Imp. F (EP): 2-Methyl-N-[2-nitro-5- 

(trifluoromethyl)phenyl]propanamide 

2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)- 

phenyl]propanamide (2-Hydroxyflutamide) 

Trifluoromethylbenzene 

O 

H 

N 

O 

O 2 N 

O 

H 

N 

F F 

(A) 100 mg 

F 

F F 

(D) 100 mg 

F 

HO 

(A) 100 mg 

F F 

F 

NO 2 

F F 

(B) 100 mg 

F 

MM 0161.10 

3-Nitrobenzotrifluoride 

O 2 N 

F F 

(B) 100 mg 

F 

MM 0161.12 

3-Trifluoromethyl-4-nitrophenol 

HO 

F F 

(A) 100 mg 

F 

NO 2 

Fluvastatin Sodium 

MM 0676.00 

Fluvastatin Sodium 

F 

(D) 

100 mg 

N 

OH 

OH 

O 

ONa 




Folic Acid 

MM 0621.00 Folic Acid 

O OH 

O 

(A) 500 mg 

MM 0621.01 

MM 0621.02 

MM 0621.04 

MM 0621.07 

O 

N 

H 2 N N 

H 

Imp. A (EP): (2S)-2-[(4-Aminobenzoyl)amino]pentanedioic Acid 

(N-(4-Aminobenzoyl)-L-glutamic Acid) 

Imp. B (EP) as Sulphate: 2,5,6-Triaminopyrimidin-4(1H)-one 

Sulphate 

Imp. D (EP): 4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6- 

yl)methyl]amino]benzoic Acid (Pteroic Acid) 


H 2 N 

N 

N 

N 

O 

N 

H 

N 

H 

H 2 N 

O 

N 

H 2 N N 

H 

N 

N 

N 

H 

O 

H 2 N 

N 

H 

N 

H 

OH 

O 

O OH 

(A) 100 mg 

OH 

O 

(A) 100 mg 

NH 2 

x H SO 

O 

(D) 50 mg 

OH 

O 

(B) 100 mg 

OH 

MM 0621.08 

L-Glutamine 

H 2 N 

OH 

(A) 

500 mg 

NH 2 

O 

O 

Formoterol Fumarate Dihydrate 

MM 0447.00 

Formoterol Fumarate Dihydrate 

(D) 

50 mg 

OH 

HN 

O 

Furosemide 

HO 

HN 

x HO 

O 

O 


MM 0014.00 Furosemide 

O OH 

MM 0014.02 

Imp. A (EP): 2-Chloro-4-[(furan-2-ylmethyl)amino]-5- 

sulphamoylbenzoic Acid 

O 

H 2 N 

S 

O O 

Cl 

O 

x 2 H 

OH 2 O 

H 

N 

H 2 N 

S 

O O 

HN 

MM 0014.03 Imp. B (EP): 2,4-Dichloro-5-sulphamoylbenzoic Acid 

O OH 

OH 

Cl 

H 2 N 

S 

O O 

Cl 

MM 0014.01 Imp. C (EP): 2-Amino-4-chloro-5-sulphamoylbenzoic Acid 

O OH 

H 2 N 

S 

O O 

Cl 

MM 0014.05 Imp. E (EP): 2,4-Dichlorobenzoic Acid 

O OH 

O 

O 

2 

Cl 

NH 2 

Cl 

(A) 

(A) 

(B) 

(A) 

(B) 

500 mg 

100 mg 

100 mg 

100 mg 

100 mg 

MM 0014.50 Ethyl 2,4-Dichloro-5-sulphamoylbenzoate 

O O 

Cl 

Cl 

(A) 

100 mg 

H 2 N 

S 

O O 

Cl 




Gabapentin 

MM 0684.01 3,3-Pentamethylene-4-butyrolactam 

O (A) 100 mg 

NH 

Ganciclovir 

New MM 0485.07 

Imp. F (Pharmeuropa): 2-Amino-1,9-dihydro-6H-purin-6-one (Guanine) 

O 

HN 

H 2 N N 

N 

H 

N 

(B) 

100 mg 

Gemfibrozil 

MM 0641.00 Gemfibrozil 

O OH 

O 

(A) 

250 mg 

MM 0641.08 Imp. A (EP): 2,5-Dimethylphenol (p-Xylenol) 

OH 

(A) 100 mg 

O O 

MM 0641.02 Imp. H (EP): 1,3-Bis(2,5-dimethylphenoxy)propane (A) 100 mg 

MM 0641.01 

3-(2,5-Dimethylphenoxy)propyl Chloride 

(3-(2,5-Xylyloxy)propyl Chloride) 

MM 0641.03 Gemfibrozil Isobutyl Ester 

O O 

O Cl 

(A) 100 mg 

O 

(A) 

100 mg 

Glibenclamide 

MM 0008.00 

Glibenclamide 

O 

O O 

(A) 

500 mg 

Cl 

O 

O 

N 

H 

S N 

H 

N 

H 

MM 0008.01 

Imp. A (EP): 5-Chloro-2-methoxy-N-(2-(4- 

sulfamoylphenyl)ethyl)benzamide 

Cl 

O 

N 

H 

O 

O O 

S NH2 

(A) 

100 mg 

MM 0008.02 

Imp. B (EP): Methyl [[4-[2-[(5-Chloro-2- 

methoxybenzoyl)amino]ethyl]phenyl]- 

sulphonyl]carbamate 

Cl 

O 

N 

H 

O 

O O O 

S NH O 

(A) 

100 mg 

MM 0008.03 

5-Chloro-2-methoxybenzoic Acid 

Cl 

O 

OH 

(B) 

100 mg 

O 

MM 0008.04 

5-Chloro-N-(2-phenylethyl)-2-methoxybenzamide 

Cl 

O 

N 

H 

O 

(A) 

100 mg 

Gliclazide 

MM 0325.00 

Gliclazide 

O O 

S 

N 

H 

O 

N 

H 

N 

(A) 

500 mg 

MM 0325.01 

Imp. A (EP): 4-Methylbenzenesulphonamide 

O O 

(C) 100 mg 

S 

NH 2 

New MM 0325.02 

Imp. B (EP): 2-Nitroso-octahydrocyclopenta[c]pyrrole 

(A) 

100 mg 

New MM 0325.09 

Methyl N-Methyl-p-tolylsulphoncarbamate 

N 

N 

O 

O O O 

(A) 100 mg 

S 

N O 

Glimepiride 

MM 0647.00 

Glimepiride 

O 

O 

O (D) 100 mg 

O 

N 

S 

NH 

N 

H 

O 

N 

H 




MM 0647.02 

Imp. A (EP): 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3- 

dihydro-1H-pyrrol-1-yl)carbonyl]- 

amino]ethyl]phenyl]sulphonyl]-3-(cis-4- 

methylcyclohexyl)urea (cis-Glimepiride) 

O 

N 

O O O 

(D) 100 mg 

S 

NH N 

H 

O 

N 

H 

MM 0647.01 

Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N-[2-(4- 

sulphamoylphenyl)ethyl]-2,3-dihydro-1H-pyrrole-1- 

carboxamide (Glimepiride Sulphonamide) 

N 

O 

N 

H 

O O 

S 

NH2 

(A) 

100 mg 

O 

MM 0647.03 

Imp. C (EP): Methyl [[4-[2-[[(3-Ethyl-4-methyl-2-oxo- 

2,3-dihydro-1H-pyrrol-1-yl) 

carbonyl]amino]ethyl]phenyl]- 

sulphonyl]carbamate (Glimepiride Carbamate) 

N 

O 

N 

H 

O O 

S 

NH 

O 

(A) 100 mg 

O 

O 

MM 0647.08 

cis-4-Methylcyclohexylamine Hydrochloride 

x HCl 

(A) 

100 mg 

H 2 N 

Glipizide 

MM 0942.01 

Imp. A (EP): 5-Methyl-N-[2-(4- 

sulphamoylphenyl)ethyl]pyrazine-2-carboxamide 

O 

O O 

(A) 100 mg 

S 

NH2 

N 

N 

H 

N 

New MM 0942.02 

Imp. B (EP): Cyclohexanamine 

(C) 

100 mg 

H 2 N 

MM 0942.04 

Imp. D (EP): 6-Methyl-N-[2-(4- 

sulphamoylphenyl)ethyl]pyrazine-2-carboxamide 

O 

O O 

(A) 100 mg 

S 

NH2 

N 

N 

H 

N 

Glutamine 

MM 0169.00 

L-Glutamine 

H 2 N 

OH 

(A) 

500 mg 

NH 2 

O 

O 

MM 0169.01 

N-Phenylacetyl-L-glutamine 

(Phenylacetylglutamine) 

O 

HN 

(A) 

100 mg 

H 2 N 

OH 

O 

O 

MM 0169.02 Phenylacetamide 

NH 2 

O 

(A) 

100 mg 

MM 0169.03 

D-Glutamine 

H 2 N 

OH 

(A) 

100 mg 

NH 2 

O 

O 

Glycopyrronium Bromide 

MM 0834.00 

Glycopyrronium Bromide 

O 

N + (A) 100 mg 

O 

OH 

Br - 

MM 0834.05 

Imp. B (Pharmeuropa): 2-Oxo-2-phenylethanoic Acid (Benzoylformic 

Acid) 

O 

OH 

(A) 

100 mg 

O 

MM 0834.03 

Imp. D (Pharmeuropa): Benzoic Acid 

(B) 

100 mg 

OH 

O 

MM 0834.04 

Imp. F (Pharmeuropa): Benzaldehyde 

(B) 

100 mg 

O 

MM 0834.07 

Imp. H (Pharmeuropa): Methyl 2-Oxo-2-phenylethanoate (Methyl 

Benzoylformate) 

O 

O 

(A) 

100 mg 

O 

MM 0834.01 

Imp. J (Pharmeuropa): 2-(RS)-Cyclopentyl-2-hydroxy-2-phenylethanoic 

Acid (α-Cyclopentylmandelic Acid) 

O 

OH 

(A) 

100 mg 

OH 




MM 0834.08 Imp. K (Pharmeuropa): 2-(RS)-Cyclopentyl-2-phenylethanoic Acid 

O (A) 100 mg 

OH 

MM 0834.06 

Imp. M (Pharmeuropa): Cyclopentyl Phenyl Ketone 

O 

(A) 

100 mg 

Granisetron Hydrochloride 

MM 0398.00 

Granisetron Hydrochloride 

H 

on request 

N 

N 

HN 

N 

x HCl 

O 

H 

Griseofulvin 

MM 0582.00 

Griseofulvin 

O 

Cl 

O 

O 

O 

(A) 

500 mg 

O 

O 

Guaiacol 

MM 0814.00 Guaiacol 

OH 

(A) 

500 mg 

MM 0814.04 

Imp. A (EP): Benzene-1,2-diol 

(Pyrocatechol) 

O 

OH 

OH 

(C) 

100 mg 

MM 0814.05 Imp. B (EP): Phenol 

OH 

(B) 100 mg 

MM 0814.06 

MM 0814.08 

Imp. C (EP): 1,2-Dimethoxybenzene 

(Veratrole) 

Imp. E (EP): Methyl Benzoate 

O 

O 

O 

(C) 100 mg 

O 

(C) 100 mg 

New MM 0814.11 Imp. G (Pharmeuropa): 4-Methoxyphenol 

OH 

New MM 0814.12 Imp. H (Pharmeuropa): 3-Methoxyphenol 

OH 

O 

(A) 

(B) 

500 mg 

100 mg 

O 

Guaifenesin 

MM 0354.00 

Guaifenesin 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0354.04 

Imp. A (EP): 2-Methoxyphenol (Guaiacol) 

OH 

(A) 500 mg 

O 

MM 0354.01 

Imp. B (EP): 2-(2-Methoxyphenoxy)propane-1,3-diol 

(B-Isomer) 

HO OH (A) 100 mg 

O 

O 

MM 0354.02 

Imp. C (EP): 1,1'-Oxybis[3-(2- 

methoxyphenoxy)propan-2-ol](Bisether) 

O 

OH 

O 

OH 

O 

(A) 

100 mg 

O 

O 

MM 0354.03 

Imp. D (EP): 1,3-Bis(2-methoxyphenoxy)propan-2-ol 

O 

OH 

O 

(A) 

100 mg 

O 

O 




Halofantrine Hydrochloride 

MM0433.00 Halofantrine Hydrochloride 

Cl 

F 

F 

Cl 

F 

x HCl 

(A) 100 mg 

HO 

N 

Harpagoside 

MM 0370.01 

Methyl trans-Cinnamate 

O 

(B) 100 mg 

O 

Heptaminol Hydrochloride 

MM 0653.00 Heptaminol Hydrochloride 

NH 2 

Hexetidine 

MM 0337.03 

Hexylresorcinol 

Imp. C (EP): 2,6-Bis(2-ethylhexyl)-7amethylhexahydro-1H-imidazo[1,5-c]imidazole 

(Hexedine) 

N 

HO 

N 

N 

x HCl 

on request 

(A) 

100 mg 

MM 0111.00 Hexylresorcinol 

HO OH 

(A) 500 mg 

MM 0111.01 Imp. A (EP): Phenol 

OH 

(B) 100 mg 

MM 0111.02 Imp. B (EP): Resorcinol 

HO OH 

(B) 100 mg 

Homatropine Methylbromide 

MM 0792.00 Homatropine Methylbromide 

MM 0792.03 Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) 

H 

O 

H 

N + 

O 

OH 

H 


Br - 

(A) 250 mg 

O (A) 100 mg 

MM 0792.04 

MM 0792.06 

Hydrochlorothiazide 

MM 0011.00 

Imp. D (EP) as Bromide: (1R,2R,4S,5S,7s)-7-[[(2S)-3- 

Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa- 

9-azoniatricyclo 

[3.3.1.0 2,4 ]nonane Bromide 

(Methylhyoscine Bromide) 

Imp. F (EP): Methyl (2RS)-2-Hydroxy-2-phenylacetate (Methyl 

Mandelate) 

Hydrochlorothiazide 

O 

H 

O 

OH 

OH 

OH 

H H 

N + O 

H H 

S 

H 2 N 

O 

OH 

Br - (A) 100 mg 

O (A) 100 mg 

O O 

(A) 500 mg 

O O 

S 

NH 

MM 0011.03 

MM 0011.01 

Imp. A (EP): Chlorothiazide 

Imp. B (EP): 4-Amino-6-chlorobenzene-1,3-disulphonamide 

(Salamide) 

Cl 

S 

H 2 N 

Cl 

S 

H 2N 

Cl 

N 

H 

O O 

(A) 500 mg 

O O 

S 

NH 

N 

O O 

S 

NH 2 

NH 2 

O O 

(B) 100 mg 

Hydrocodone Hydrogen Tartrate 2.5-Hydrate 

MM 1113.01 

Imp. A (EP) as Hydrochloride Trihydrate: Morphine 

Hydrochloride Trihydrate [Controlled Substance] 

N 

x HCl 

x 3 H 2 O 

(A) 

250 mg 

HO 

O 

OH 




MM 1113.02 

Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine 


N 

x H 2 SO 4 

x 5 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

2 

MM 1113.04 

Imp. C (EP) as Monohydrate: Codeine Monohydrate 


N 

x H 2 O 

(A) 

100 mg 

MM 1113.05 

Imp. C (EP) as Phosphate Hemihydrate: Codeine 

Phosphate Hemihydrate [Controlled Substance] 

O 

O 

N 

OH 

x H 3 PO 4 

x 1/2 H 2 O 

(A) 

100 mg 

MM 1113.06 

MM 1113.07 

Imp. D (EP) as Hydrochloride: 4,5α-Epoxy-14-hydroxy-3- 

methoxy-17-methyl-morphinan-6-one Hydrochloride 

(Oxycodone Hydrochloride) 


Imp. E (EP): 7,8-Didehydro-4,5α-epoxy-3-methoxy-17- 

methylmorphinan-6-one (Codeinone) 

O 

O 

O 

HO 

O 

OH 

N 

x HCl 

O 

(A) 100 mg 

N (A) 100 mg 

MM 1113.08 

Imp. F (EP): 7,8-Didehydro-4,5α-epoxy-3,6α-dimethoxy-17- 

methylmorphinan (Methylcodeine) [Controlled Substance] 

O 

O 

O 

N (A) 100 mg 

O O O 

MM 1113.10 Imp. H (EP): Diphenylmethanone (Benzophenone) 

O 

(B) 100 mg 

Hydrocortisone 

MM 0185.00 

Hydrocortisone (Cortisol) 

HO 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0185.20 

Imp. A (EP): Prednisolone 

HO 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0185.21 

Imp. B (EP): Cortisone 

O 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0185.22 

Imp. C (EP): Hydrocortisone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

MM 0185.06 

Imp. D (EP): 6β,11β,17,21-Tetrahydroxy-pregn-4-ene-3,20-dione 

(6β-Hydroxyhydrocortisone) 

HO 

O 

OH 

OH 

(A) 

100 mg 

O 

OH 

MM 0185.07 

Imp. E (EP): 11β,17,21-Trihydroxypregna-4,6-diene-3,20-dione 

(∆6-Hydrocortisone) 

HO 

O 

OH 

OH 

(D) 

100 mg 

O 

MM 0185.08 

Imp. F (EP): 17,21-Dihydroxypregn-4-ene-3,20-dione 

(Reichstein's Substance S) 

O 

OH 

OH 

(A) 

100 mg 

O 




MM 0185.13 6α-Hydroxyhydrocortisone 

O 

OH 

HO 

OH 

(D) 50 mg 

O 

OH 

Hydrocortisone Acetate 

MM 0187.00 

Hydrocortisone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

MM 0187.06 

Hydrocortisone 11,17,21-Triacetate 

O 

O 

O 

O 

O 

O 

(A) 

100 mg 

O 

O 

MM 0187.09 

11β,17,21-Trihydroxypregna-4,6-diene-3,20-dione 21-Acetate 

HO 

O 

O 

OH 

O 

(D) 100 mg 

O 

Hydrocortisone 17-Butyrate 

MM 0188.00 


HO 

O 

OH 

O 

(A) 

500 mg 

O 

O 

MM 0188.01 


HO 

O 

O 

OH 

O 

(A) 100 mg 

O 

Hydrocortisone Hydrogen Succinate 

MM 0275.00 

Hydrocortisone Hydrogen Succinate 

HO 

O 

O 

OH 

O 

OH 

O 

on request 

O 

MM 0275.01 

Imp. A (EP): Hydrocortisone 

HO 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0275.02 

Imp. B (EP): Hydrocortisone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

Hydroxychloroquine Sulphate 

Cl 

N 

MM 0764.00 Hydroxychloroquine Sulphate 

x H 2 SO 4 

(A) 500 mg 

HN 

N 

OH 

Cl 

N 

MM 0764.02 Desethylhydroxychloroquine Dihydrochloride 

x 2 HCl 

on request 

HN 

N 

H 

OH 

Cl 

N 

MM 0764.04 O-Acetylhydroxychloroquine 

(A) 

100 mg 

HN 

N 

O 

O 




Cl 

N 

MM 0764.05 Hydroxychloroquine N-Oxide Dihydrochloride 

(A) 

100 mg 

HN 

N 

O 

OH 

x 2 HCl 

Hydroxyethyl Salicylate 

MM 0112.00 

Hydroxyethyl Salicylate 

O 

O 

OH 

(A) 

500 mg 

OH 

MM 0112.01 

Imp. A (EP): Salicylic Acid 

O 

(A) 500 mg 

OH 

OH 

Hydroxyzine Hydrochloride 

MM 0852.00 Hydroxyzine Hydrochloride 

Cl 

N 

N 

O 

OH 

x 2 HCl 

(A) 

250 mg 

MM 0852.01 Imp. A (EP): (RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine 

Cl 

N 

NH (A) 100 mg 

Hymechromone 

MM 0294.00 Hymecromone 

HO O O 

(A) 500 mg 

MM 0294.01 Imp. A (EP): 1,3-Dihydroxybenzene (Resorcinol) 

HO OH 

(B) 100 mg 

MM 0294.02 Imp. B (EP): 7-Hydroxy-2-methyl-4H-1-benzopyran-4-one 

HO O 

(A) 

100 mg 

MM 0294.03 2,4-Dihydroxyacetophenone 

HO 

O 

OH 

(B) 100 mg 

O 

MM 0294.04 Hymecromone Acetate O O O 

O 

(A) 

100 mg 

MM 0294.50 7-Acetoxy-3-acetyl-2-4H-1-benzopyran-4-one 

O O 

O 

(A) 

100 mg 

O 

O 

Hyoscine Butylbromide 

MM 0683.00 

Hyoscine Butylbromide 

O 

H 

O 

H 

+ 

N 

O 

Br 

(A) 

500 mg 

OH 

H 

MM 0683.01 

Imp. A (EP) as Hydrobromide Trihydrate: Hyoscine 


O 

H 

O 

H 

N 

H 

O 

x HBr 

x 3 H 2 O 

(A) 

500 mg 

OH 

H 

H 

MM 0683.02 

Imp. B (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic 

Acid) 

O 

OH 

(A) 

100 mg 

OH 

Hyoscine Hydrobromide 

MM 0546.00 

Hyoscine Hydrobromide Trihydrate 

O 

H 

O 

H 

N 

H 

O 

x HBr 

x 3 H 2 O 

(A) 

500 mg 

OH 

H 

H 




New MM 0546.06 

MM 0546.05 

Imp. C (EP): (1R,2R,4S,5S,7s)-9-Methyl-3-oxa- 

9-azatricyclo[3.3.1.0 2,4 ]non-7-yl 2-Phenylprop- 

2-enoate (Apohyoscine) 

Imp. D (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid 

(DL-Tropic Acid) 

O 

H 

O 

H 

H 

N 

H 

H 

O 

OH 

(A) 

100 mg 

O (A) 100 mg 

OH 

Hyoscyamine Sulphate 

MM 0794.01 

Imp. A (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid 

(DL-Tropic Acid) 

O 

OH 

(A) 

100 mg 

OH 

MM 0794.04 

Imp. D (EP) as Hydrobromide Trihydrate: Hyoscine 


O 

H 

O 

H 

N 

H 

O 

x HBr 

x 3 H 2 O 

(A) 

500 mg 

OH 

H 

H 

MM 0794.07 

Imp. G (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl-8- 

azabicyclo[3.2.1]oct-3-yl 2-Phenylprop-2-enoate 

Hydrochloride (Apoatropine Hydrochloride) 

O 

H 

O 

H 

(D) 100 mg 

N 

x HCl 

H 

Ibuprofen 

MM 0002.00 

Ibuprofen 

OH 

(A) 

500 mg 

O 

MM 0002.13 

Imp. A (EP): (2RS)-2-[3-(2-Methylpropyl)phenyl]propanoic Acid 

OH 

(A) 

100 mg 

O 

MM 0002.01 

Imp. B (EP):(2RS)-2-(4-Butylphenyl)propanoic Acid 

OH 

(A) 

100 mg 

O 

MM 0002.10 

Imp. C (EP): (2RS)-2-[4-(Methylpropyl)phenyl]propanamide 

NH 2 

(A) 

100 mg 

O 

MM 0002.11 

Imp. D (EP): (2RS)-2-(4-Methylphenyl)propanoic Acid 

OH 

(A) 

100 mg 

MM 0002.04 Imp. E (EP): 1-[4-(2-Methylpropyl)phenyl]ethanone 

O 

(A) 100 mg 

O 

MM 0002.28 

Imp. F (EP): 3-[4-(2-Methylpropyl)phenyl]propanoic Acid 

O 

(A) 100 mg 

OH 

MM 0002.38 

Imp. G (EP): cis-7-(2-Methylpropyl)-1-[4-(2- 

methylpropyl)phenyl]-1,2,3,4-tetrahydronaphthalene-1,4- 

dicarboxylic Acid 

O OH 

(D) 50 mg 

HO 

O 

MM 0002.30 

Imp. H (EP):(3RS)-1,3-Bis[4-(2-methylpropyl)phenyl]butan- 

1-one 

O 

(D) 100 mg 

MM 0002.31 Imp. I (EP):(3RS)-1,3-Bis[4-(2-methylpropyl)phenyl]butane (A) 50 mg 

MM 0002.02 

Imp. J (EP): (2RS)-2-[4-(2-Methylpropanoyl)phenyl]propanoic Acid 

OH 

(A) 

100 mg 

O 

O 

MM 0002.26 

Imp. K (EP): (2RS)-2-(4-Formylphenyl)propanoic Acid 

OH 

(A) 

100 mg 

O 

O 

MM 0002.24 

Imp. L (EP): 2-[4-(1-Hydroxy-2-methylpropyl)phenyl]propanoic Acid 

(1-Hydroxyibuprofen) 

OH 

O 

(A) 

100 mg 

OH 




MM 0002.34 

Imp. M (EP): (2RS)-2-Hydroxy-2-[4-(2- 

methylpropyl)phenyl]propanoic Acid 

OH 

(A) 100 mg 

OH 

O 

MM 0002.35 Imp. N (EP): (2RS)-2-(4-Ethylphenyl)propanoic Acid 

OH 

O 

(A) 

100 mg 

MM 0002.33 

Imp. O (EP): 2-[4-(1-Methylpropyl)phenyl]propanoic Acid 

OH 

(A) 

100 mg 

O 

MM 0002.19 Imp. P (EP):(2RS)-2-[4-(2-Methylpropyl)phenyl]propan-1-ol 

OH 

(A) 

100 mg 

MM 0002.36 Imp. Q (EP): 2-[4-(2-Methylpropyl)phenyl]ethanol 

OH 

(A) 100 mg 

MM 0002.37 Imp. R (EP):1,1-Bis[4-(2-methylpropyl)phenyl]ethane (A) 100 mg 

MM 0002.03 

4-Isobutylbenzoic Acid 

O 

(A) 100 mg 

OH 

MM 0002.07 

2-(4-Isobutyrylphenyl)propanamide 

NH 2 

(A) 

100 mg 

O 

O 

MM 0002.08 

4-Acetylbenzoic Acid 

O 

OH 

(A) 

100 mg 

MM 0002.09 4-Isobutyrylacetophenone 

O 

O 

(A) 

100 mg 

O 

MM 0002.14 

2-(4-Isobutyrylphenyl)propane 

(A) 

100 mg 

O 

MM 0002.15 

2-Hydroxypropyl 2-(4-Isobutylphenyl)propanoate 

O 

OH 

on request 

O 

MM 0002.16 

1-Hydroxyprop-2-yl 2-(4-Isobutylphenyl)propanoate 

O 

O 

OH 

on request 

MM 0002.17 

2,3-Dihydroxypropyl 2-(4-Isobutylphenyl)propanoate 

O 

OH 

on request 

OH 

O 

MM 0002.18 

1,3-Dihydroxyprop-2-yl 2-(4-Isobutylphenyl)propanonate 

O 

O 

OH 

OH 

on request 

MM 0002.20 

2-(4-n-Propylphenyl)propanoic Acid 

OH 

(A) 

100 mg 

O 

MM 0002.21 

2-(4-Isobutylphenyl)propionitrile 

(A) 

100 mg 

N 

MM 0002.23 

Isopropyl 2-(4-Isobutylphenyl)propanonate 

O 

(A) 

100 mg 

MM 0002.25 1-Ethyl-4-isobutylbenzene (A) 100 mg 

O 

MM 0002.29 

trans-7-(2-Methylpropyl)-1-[4-(2-methylpropyl)phenyl]-1,2,3,4- 

tetrahydronaphthalene-1,4-dicarboxylic Acid 

O OH 

(D) 100 mg 

HO 

O 

MM 0002.32 2-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanoic Acid (2- 

Hydroxyibuprofen) 

HO 

OH 

O 

(A) 

100 mg 




MM 0002.45 

MM 0002.46 

(2SR)-2-(4-Isobutylphenyl)-N-((SR)-1- 

phenylethyl)propanamide 

(2SR)-2-(4-Isobutylphenyl)-N-((RS)-1- 

phenylethyl)propanamide 

O 


O 


H 

N 

H 

N 

(A) 

(A) 

100 mg 

100 mg 

MM 0002.48 4-Isobutylstyrene (A) 100 mg 

MM 0002.50 

1-(4-Isobutylphenyl)ethanol 

OH 

(A) 

100 mg 

MM 0002.51 4-(1-Hydroxy-2-methylpropyl)acetophenone 

O 

(A) 

100 mg 

OH 

MM 0002.53 

Ibuprofen Methyl Ester 

O 

(A) 

100 mg 

O 

MM 0002.57 

1-(4-Isopropylphenyl)ethanone 

(4-Isopropylacetophenone) 

O 

(A) 100 mg 

MM 0002.59 

2-(4-Isopropylphenyl)acrylic Acid 

OH 

(A) 

100 mg 

O 

Idoxuridine 

MM 0791.00 

Idoxuridine 

HO 

O 

HN 

O N 

O 

I 

(A) 

500 mg 

OH 

Imidocarb Dipropionate 

MM 0742.00 Imidocarb Dipropionate O 

H 

N 

N 

N 

H 

N 

H 

N 

H 

N 

x 2 

O 

OH 

(A) 

100 mg 

Imipramine Hydrochloride 

MM 0077.00 

Imipramine Hydrochloride 

(A) 

500 mg 

N 

N 

x HCl 

MM 0077.09 


(A) 

250 mg 

N 

N 

H 

x HCl 

MM 0077.03 

N-[3-(10,11-Dihydro-5H-dibenzo-[b,f]azepin-5-yl)propyl]- 

N,N',N'-trimethylpropane-1,3-diamine Dihydrochloride 

N 

N 

N 

(A) 

100 mg 

x 2 HCl 

MM 0077.04 

10-Hydroxyimipramine 

(A) 

100 mg 

N 

N 

HO 

MM 0077.05 

10,11-Dehydroimipramine 

(A) 

100 mg 

N 

N 




MM 0077.10 

Iminodibenzyl 

(B) 

100 mg 

NH 

MM 0077.08 

10-[3-(Dimethylamino)propyl]- 9-acridanone Hydrochloride 

(A) 

100 mg 

N 

N 

x HCl 

O 

MM 0077.12 

Imipramine N-Oxide 

(A) 

100 mg 

N 

N 

O 

Indanazoline Hydrochloride 

MM 0588.02 

4-Aminoindan Hydrochloride 

(A) 

100 mg 

x HCl 

NH 2 

Indapamide 

MM 0477.00 

Indapamide 

O 

O 

S 

H 2 N 

Cl 

O 

N 

H 

N 

(A) 

250 mg 

New MM 0477.01 

Imp. A (EP): (2RS)-2-Methyl-1-nitroso- 

(A) 100 mg 

2,3-dihydro-1H-indole 

ON N 

MM 0477.02 

Imp. B (EP): 4-Chloro-N-(2-methyl-1H-indol-1-yl)-3-sulphamoylbenzamide 

O 

O 

S 

H 2N 

Cl 

O 

N 

H 

N 

(A) 

100 mg 

MM 0477.04 

4-Chloro-3-sulfamoylbenzoic Acid 

O 

O 

S 

H 2 N 

O 

(C) 100 mg 

OH 

Cl 

MM 0477.05 

N-(4-Chloro-3-sulfamoylbenzoyl)-2-methylindoline 

O 

O 

S 

H 2 N 

O 

N 

(D) 

100 mg 

Cl 

MM 0477.07 

Triethylamine 

N 

(C) 

100 mg 

MM 0477.08 

2-Methylindoline 

(A) 

100 mg 

HN 

MM 0477.09 

1-Amino-2-methylindoline Hydrochloride 

H 2 N N 

x HCl 

(D) 

100 mg 

Indometacin 

MM 0584.00 

Indometacin 

O 

N 

OH 

(A) 

500 mg 

Cl 

O 

O 

MM 0584.01 

Imp. A (EP): 4-Chlorobenzoic Acid 

O 

(B) 

100 mg 

OH 

Cl 

Indoramin Hydrochloride 

MM 0802.01 Indoramin 

H 

N 

N 

H 

N 

(A) 

100 mg 

O 

Ipecacuanha 

MM 0131.02 Emetine Dihydrochloride N 

x 2 HCl 

(A) 

100 mg 

O 

O 

H 

HN 

O 

O 




Iprindole Hydrochloride 

MM 0478.00 Iprindole Hydrochloride 

N 

N 

x HCl 

(A) 100 mg 

Isoamyl Benzoate 

MM 1086.00 

Isoamyl Benzoate 

O 

(A) 500 mg 

O 

Isoconazol Nitrate 

MM 0541.00 

Isoconazole Nitrate 

Cl 

(A) 

100 mg 

Cl 

Cl 

x HNO 3 

O 

Cl 

N 

N 

MM 0541.01 

Imp. A (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl) ethanol 

N 

N 

(A) 100 mg 

HO 

Cl 

Cl 

MM 0541.02 

Imp. B (EP) as Nitrate: (2RS)-2-[(2,6-Dichlorobenzyl)oxy]-2- 

(2,4-dichlorophenyl)ethanamine Nitrate 

Cl 

(D) 

100 mg 

Cl 

Cl 

x HNO 3 

O 

MM 0541.03 

Isoflurane 

MM 0500.02 

MM 0500.03 

MM 0500.04 

MM 0500.05 

Imp. C (EP) as Nitrate: 1-[(2RS)-2-[(2,4- 

Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1Himidazole 

Nitrate (Miconazole Nitrate) 

Imp. B (EP): 2-(Difluoromethoxy)-1,1,1-trifluoroethane 

Imp. C (EP): (2RS)-2-Chloro-2-(chlorodifluoromethoxy)- 

1,1,1-trifluoroethane 

Imp. D (EP): 1,1-Dichloro-1-(difluoromethoxy)-2,2,2-trifluoroethane 

Imp. E (EP): 1,1-Dichloro-1-(chlorodifluoromethoxy)-2,2,2- 

trifluoroethane 

Cl 

Cl 

Cl 

Cl 

O 

Cl 

F 

F 

F 

F 

NH 2 

N 

F 

F 

N 

F 

F 

Cl 

Cl 

F 

x HNO 3 

O 

O 

Cl 

F 

O 

F 

F 

F 

F 

Cl 

F 

Cl Cl F F 

F 

O Cl 

F F 

(A) 

(A) 

(A) 

(A) 

(A) 

500 mg 

100 mg 

100 mg 

100 mg 

100 mg 

MM 0500.06 Imp. F (EP): Acetone 

O 

(C) 100 mg 

Isoproturon 

MM 2503.02 3-(2-Isopropylphenyl)-1,1-dimethylurea 

H 

N N 

(A) 

100 mg 

MM 2503.03 3-(3-Isopropylphenyl)-1,1-dimethylurea H 

N N 

O 

O 

(A) 

100 mg 

Isosorbide Dinitrate 

MM 0126.00 

Isosorbide Dinitrate 

(contains approx. 60% Lactose) 

O 

H 

O 

NO 2 

on request 

O 2 N 

O 

H 

O 




MM 0126.05 Imp. B (EP): Isosorbide 2-Nitrate 

H 

O 

O 

NO 2 

(A) 100 mg 

MM 0126.06 

Imp. C (EP): Isosorbide Mononitrate (Isosorbide 5-Nitrate) 

HO 

O 

H 

H 

O 

OH 

(A) 

500 mg 

O 2 N 

O 

H 

O 

MM 0126.01 

2-Monomethyl Isosorbide 

O 

H 

O 

on request 

MM 0126.02 

Dimethyl Isosorbide 

HO 

O 

O 

H 

H 

O 

(B) 100 mg 

MM 0126.03 

Isosorbide 

O 

O 

H 

H 

OH 

(A) 500 mg 

O 

MM 0126.04 

Isomannit Dinitrate 

HO 

H 

O 

H 

O 

O 

NO 2 

(A) 

100 mg 

O 2 N 

O 

H 

O 

Isosorbide Mononitrate 

MM 0502.00 

Isosorbide Mononitrate 

O 

H 

OH 

(A) 

500 mg 

O 2 N 

O 

H 

O 

MM 0502.02 

Imp. B (EP): Isosorbide Dinitrate (contains approx. 60% Lactose) 

O 

H 

O 

NO 2 

(A) 

500 mg 

O 2 N 

O 

H 

O 

MM 0502.03 

Imp. C (EP): Isosorbide 2-Nitrate 

O 

H 

O 

NO 2 

(A) 100 mg 

MM 0502.04 

Isosorbide 

HO 

O 

H 

H 

OH 

(A) 500 mg 

O 

HO 

H 

O 

Isoxsuprine Hydrochloride 

MM 0576.00 

Isoxsuprine Hydrochloride 

OH 

H 

N 

(A) 

500 mg 

O 

x HCl 

HO 

and enantiomere 

Itraconazole 

MM 0258.00 

Itraconazole 

(A) 

100 mg 

N 

N 

N 

O 

N 

N 


O 

Cl 

Cl 

O 

O 

N 

N 

N 




New MM 0258.04 

Imp. C (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)- 

2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]- 

methoxy]phenyl]piperazin-1-yl]phenyl]-2-propyl- 

2,4-dihydro-3H-1,2,4-triazol-3-one 

N 

N 

N 

O 

(A) 

100 mg 

N 

N 


O 

Cl 

Cl 

New MM 0258.05 

Imp. D (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)- 

2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]- 

methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1- 

methylethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one 

O 

N N 

N 

O 

O 

N 

N 

N 

(A) 

100 mg 

N 

N 


Cl 

Cl 

O 

New MM 0258.07 

Imp. F (EP): 2-Butyl-4-[4-[4-[4-[[cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan- 

4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2,4- 

dihydro-3H-1,2,4-triazol-3-one 

O 

N N 

N 

O 

O 

N 

N 

N 

(A) 

100 mg 

N 

N 


Cl 

Cl 

O 

MM 0258.10 

2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]- 

3H-1,2,4-triazol-3-one 

O 

O 

N 

N 

N 

N NH 

N 

O 

(A) 

100 mg 

N 

N 

O 

MM 0258.11 

cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)- 

1,3-dioxolane-4-methanol Mesilate 


Cl 

Cl 

(A) 

100 mg 

O 

O 

S 

O O 

O 

N 

N 

N 




Josamycin 

OH 

MM 0443.00 Josamycin (A) 100 mg 

O 

N 

OO 

O 

O 

O 

O OO 

OH 

OH 

O 

O 

O 

Ketamine Hydrochloride 

MM0144.00 Ketamine Hydrochloride O 

NH 

x HCl 

(A) 

500 mg 

Cl 

Ketoconazole 

MM 0145.00 

Ketoconazole 

Cl 

(A) 

500 mg 

Cl 

O 

N 

N 

O 

O 

N 

N 

O 

MM 0145.04 

Imp. D (EP): 1-[4-[[(2RS,4SR)-2-(2,4-Dichlorophenyl)-2- 

(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4- 

yl]methoxy]phenyl]piperazine 

HN 

N 

O 

Cl 

O 

O 

Cl 

N 

N 

(A) 

100 mg 

Ketoprofen 

MM 0001.00 

Ketoprofen 

O 

OH 

(A) 

500 mg 

O 

MM 0001.01 

Imp. A (EP):1-(3-Benzoylphenyl)ethanone 

(3-Acetylbenzophenone) 

O O 

(A) 100 mg 

MM 0001.03 

Imp. B (EP): (3-Benzoylphenyl)acetic Acid 

O 

OH 

(A) 

100 mg 

O 

MM 0001.07 

Imp. C (EP):3-[(1RS)-1-Carboxylethyl]benzoic Acid 

O 

HO 

OH 

O 

(A) 

100 mg 

MM 0001.12 

Imp. D (EP): (2RS)-2-[3-(4-Methylbenzoyl)phenyl]propanoic 

Acid 

O 

OH 

O 

(D) 

100 mg 

MM 0001.05 

Imp. E (EP):(2RS)-2-(3-Benzoylphenyl)propanamide 

O 

NH 2 

(A) 

100 mg 

O 

MM 0001.04 Imp. F (EP): (2RS)-2-(3-Benzoylphenyl)propanenitrile 

O 

(A) 

100 mg 

N 

MM 0001.20 

Imp. G (EP): 3-[(1RS)-1-Cyanoethyl]benzoic Acid 

O 

HO 

N 

(A) 

100 mg 

MM 0001.22 

Imp. H (EP): 3-(Cyanomethyl)benzoic Acid 

O 

(A) 

100 mg 

HO 

N 

MM 0001.14 Imp. I (EP): (3-Benzoylphenyl)ethanenitrile 

O 

(A) 

100 mg 

N 

MM 0001.23 

Imp. J (EP): (2RS)-2-[3-(2,4- 

Dimethylbenzoyl)phenyl]propanoic Acid 

O 

O 

OH 

(D) 

100 mg 

MM 0001.02 3-Ethylbenzophenone 

O 

(A) 100 mg 




MM 0001.11 3-(1-Hydroxyethyl)benzophenone 

O OH 

(A) 100 mg 

MM 0001.13 3-Methylbenzophenone 

O 

(B) 100 mg 

MM 0001.17 3-(1-Methoxyethyl)benzophenone O O (A) 100 mg 

MM 0001.18 2-[3-(α-Hydroxybenzyl)phenyl]propanoic Acid 

OH 

OH 

(A) 

100 mg 

O 

MM 0001.19 Ethyl 2-(3-Benzoylphenyl)propionate 

O 

O 

(A) 

100 mg 

O 

MM 0001.21 Isopropyl 2-(3-Benzoylphenyl)propionate 

O 

O 

(A) 

100 mg 

O 

MM 0001.50 3-(1-Acetoxyethyl)benzophenone 

O 

O 

O 

(A) 100 mg 

Ketorolac Trometamol 

MM 0851.00 

Ketorolac Trometamol 

O 

N 

O 

OH 

x 

HO 

OH 

NH 2OH 

(A) 

250 mg 

Ketotifen Hydrogen Fumarate 

MM 0180.00 

Ketotifen Hydrogen Fumarate 

O 

S 

N 

x 

HO 

O 

O 

OH 

(A) 

250 mg 

MM 0180.04 Ketotifen S 

N (A) 100 mg 

O 

MM 0180.07 

Imp. D (EP): 4-[(aRaS)-1-Methylpiperidin-4- 

ylidene]-4,9-dihydro-10H-benzo[4,5]- 

cyclohepta[1,2-b]thiophen-10-one N-Oxide 

(Ketotifen N-Oxide) 

O 

S 

O 

(A) 100 mg 

N 

MM 0180.11 10-Methoxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one S 

O 

O 

(A) 

100 mg 

Labetalol Hydrochloride 


MM 0438.00 Labetalol Hydrochloride 

OH 

HN 

(A) 500 mg 

Lacidipine 

x HCl 

HO 

O NH 2 

MM 0407.00 Lacidipine 

H 

N 

(A) 

100 mg 

O 

O 

O 

O 

O 

O 




New MM 0407.01 

Imp. A (BP): Ethyl Methyl (E)-4-{2-[2-(tert-Butoxycarbonyl)vinyl]phenyl}-1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate 

O 

O 

H 

N 

O 

O 

O 

O 

(A) 

100 mg 

New MM 0407.02 

Imp. B (BP): Diethyl (E)-4-{2-[2-(tert-Butoxycarbonyl)vinyl]phenyl}-2,6-dimethylpyridine- 

3,5-dicarboxylate 

O 

O 

N 

O 

O 

O 

(A) 

100 mg 

O 

Lamivudine 

MM 0749.03 

Imp. C (EP): Salicylic Acid 

O 

(A) 

500 mg 

OH 

OH 

MM 0749.05 

Imp. E (EP): 4-Aminopyrimidin-2(1H)-one(Cytosine) 

NH 2 

(A) 

100 mg 

N 

MM 0749.06 

Imp. F (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil) 

O 

N 

H 

O 

(C) 

100 mg 

HN 

Lamotrigine 

MM 0922.00 Lamotrigine N N NH 2 

(A) 100 mg 

N 

NH 2 

MM 0922.01 

Imp. A (Pharmeuropa): 3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin- 

5(4H)-one 

Cl 

Cl 

O 

N N NH 

N 

H 

NH 2 

(A) 

100 mg 

MM 0922.03 

Imp. C (Pharmeuropa): (Z)-2-(2,3-Dichlorophenyl)-2- 

(guanidinimino)acetonitrile 

Cl 

Cl 

O 

Cl 

N N NH 2 

N 

Cl 

MM 0922.05 Imp. E (Pharmeuropa): 2,3-Dichlorobenzoic Acid 

O 

NH 2 

OH 

(A) 

(A) 

100 mg 

100 mg 

Cl 

Cl 

Lansoprazole 

MM 0474.00 

Lansoprazole 

NH 

N S 

O 

N 

O 

F 

F 

F 

(A) 

100 mg 

MM 0474.07 

Imp. A (EP): 2-[(RS)-[[3-Methyl-1-oxido- 

4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]- 

sulphinyl]-1H-benzimidazole (Lansoprazole 

N-Oxide) 

NH 

N S 

O N 

O 

O 

F 

F 

F 

(D) 

100 mg 

MM 0474.01 

Imp. B (EP): 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1Hbenzimidazole 

(Lansoprazole Sulphone) 

NH 

N S 

O O 

N 

O 

F 

F 

F 

(A) 

100 mg 

MM 0474.06 

Imp. C (EP): 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphanyl]-1Hbenzimidazole 

NH 

N S 

N 

O 

F 

F 

F 

(A) 

100 mg 

MM 0474.03 

Imp. D (EP): 1H-Benzimidazol-2-ol 

NH 

(B) 

100 mg 

N 

OH 




MM 0474.05 Imp. E (EP): 1H-Benzimidazole-2-thiol 

NH 

(A) 100 mg 

MM 0474.04 4-Ethoxyacetophenone O 

N 

SH 

(C) 

100 mg 

O 

MM 0474.08 

MM 0474.09 

Lansoprazole Sulphone N-Oxide 

2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine 

Hydrochloride 

Cl 

NH 

N S 

O O N 

O 

N 

O 

F 

O 

F 

F 

F F 

F 

x HCl 

(A) 

(A) 

100 mg 

100 mg 

Leflunomide 

MM 0859.00 

Leflunomide 

N 

O 

H 

N 

(D) 

100 mg 

O 

F 

Levamisole Hydrochloride 

MM 0706.04 

Imp. D (EP): 6-Phenyl-2,3-dihydroimidazo[2,1-b]thiazole 

F 

N 

F 

N S 

(A) 100 mg 

Levocetirizine Dihydrochloride 

New MM 1035.00 

Levocetirizine Dihydrochloride 

Cl 

N 

N 

O 

O 

OH 

on request 

x 2 HCl 

Levodopa 

MM 0262.00 

New MM 0262.12 

Levodopa 

Imp. B (EP): (2S)-2-Amino-3-(4-hydroxyphenyl)propanoic 

Acid (Tyrosine) 

HO 

HO 

HO 

O 

(A) 500 mg 

NH 2 

OH 

O 

(A) 100 mg 

NH 2 

OH 

MM 0262.05 

Imp. C (EP): (2RS)-2-Amino-3-(4-hydroxy-3- 

methoxyphenyl)propanoic Acid (3-Methoxy-DL-tyrosine; (DL)-3- 

O-Methyldopa) 

HO 

O 

O 

OH 

NH 2 

(A) 

100 mg 

MM 0262.06 

4-Hydroxy-3-methoxymandelic Acid 

OH 

OH 

(A) 

100 mg 

HO 

O 

O 

Levofloxacin 

MM 0846.00 

Levofloxacin 

N 

N 

O 

N 

(A) 

100 mg 

Levomenthol 

OH 

F 

O O 

MM0388.00 Levomenthol 

OH 

(A) 500 mg 

Levomepromazine Hydrochloride 

MM 0266.00 

Levomepromazine Hydrochloride 

(A) 

500 mg 

S 

N 

N 

x HCl 

O 




Levomepromazine Maleate 

MM 0019.00 Levomepromazine Maleate O (A) 100 mg 

S 

N 

N 

x 

OH 

OH 

MM 0019.02 

Imp. A (EP): 2-Methoxyphenothiazine 

O 

O 

(A) 

100 mg 

S 

NH 

O 

MM 0019.01 

Imp. B (EP): 10-[(2R)-3-(Dimethylamino)-2-methylpropyl]-2- 

methoxy-10H-phenothiazine 5-Oxide (Levomepromazine S-Oxide) 

S 

O 

N 

N 

(A) 

100 mg 

O 

MM 0019.07 

N-Demethyllevomepromazine Hydrochloride 

(D) 

100 mg 

S 

N 

N 

H 

x HCl 

O 

MM 0019.09 

Levomepromazine Sulphone Hydrochloride 

(A) 

100 mg 

Levonorgestrel 

N 

N 

x HCl 

O S 

O 

O 

MM 0121.00 Levonorgestrel OH 

(A) 

250 mg 

MM 0121.01 6β-Hydroxylevonorgestrel 

OH 

O 

(D) 

100 mg 

MM 0121.02 6-Ketolevonorgestrel OH 

O 

OH 

(D) 

100 mg 

MM 0121.08 6α-Hydroxylevonorgestrel OH 

O 

O 

(D) 

50 mg 

O 

OH 

Lidocaine Hydrochloride 

MM 0102.04 

Lidocaine Hydrochloride Monohydrate 

H 

N 

O 

N 

x HCl 

x H 2 O 

(A) 

500 mg 

MM 0102.00 

Lidocaine 

H 

N 

O 

N 

(A) 

500 mg 

MM 0102.02 

Imp. A (EP): 2,6-Dimethylaniline 

NH 2 

(B) 100 mg 

MM 0102.01 

Imp. B (EP): 2-(Diethylazinoyl)-N-(2,6- 

dimethylphenyl)acetamide (Lidocaine N 2 - 

Oxide) 

H 

N 

O 

O (A) 100 mg 

N 

MM 0102.10 

Imp. F (EP) as Hydrochloride: 2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide 

Hydrochloride 

H 

N 

O 

N 

x HCl 

(A) 

100 mg 

MM 0102.11 

Imp. G (EP) as Hydrochloride: N-(2,6- 

Dimethylphenyl)-2-[(1-methylethyl)amino]- 

acetamide Hydrochloride 

H 

N 

O 

N 

H 

x HCl 

(A) 

100 mg 




MM 0102.03 Imp. H (EP): 2-Chloro-N-(2,6-dimethylphenyl)acetamide H 

N 

(B) 100 mg 

Cl 

O 

Liothyronine Sodium 

MM 0626.00 

Liothyronine Sodium 

HO 

I 

O 

I 

I 

NH 2 

(A) 50 mg 

ONa 

O 

MM 0626.01 

Liothyronine 

HO 

I 

O 

I 

I 

NH 2 

(A) 100 mg 

OH 

O 

Lisinopril Dihydrate 

MM 0598.00 

Lisinopril Dihydrate 

H 

N 

O 

N 

O 

OH 

x 2 H 2 O 

(A) 

100 mg 

HO 

O 

H 2 N 

MM 0598.01 

Imp. A (EP): (2RS)-2-Amino-4-phenylbutanoic Acid 

(A) 

100 mg 

NH 2 

HO 

O 

MM 0598.02 

Imp. B (EP) as Hydrate: 4-Methylbenzenesulphonic Acid Hydrate 

O O 

S OH 

x H 2 O 

(C) 

100 mg 

Loperamide Hydrochloride 

MM 0025.00 Loperamide Hydrochloride 

Cl 

(A) 

500 mg 

OH 

N 

x HCl 

N 

O 

MM 0025.15 

Imp. B (EP) as Bromide: 4-(4-Chlorophenyl)- 

1,1-bis[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidinium 

Bromide 

Cl 

OH 

N + 

N 

O 

Br - (A) 100 mg 

N 

O 

MM 0025.04 Imp. C (EP): 4-(4-Chlorophenyl)piperidin-4-ol 

Cl 

(B) 

100 mg 

OH 

N 

H 

MM 0025.05 

Imp. D (EP): 4-(4-Hydroxy-4-phenylpiperidin-1-yl)-N,N-dimethyl-2,2- 

diphenylbutanamide 

OH 

(A) 

100 mg 

N 

N 

O 

MM 0025.09 

Imp. F (EP): Loperamide Oxide 

OH 

Cl 

(A) 

100 mg 

N 

O 

N 

O 




MM 0025.11 Imp. H (EP): 4-[4-(4-Chlorophenyl)-3,6-dihydropyridin-1(2H)-yl]-N,Ndimethyl-2,2-diphenylbutanamide 

Cl 

(A) 100 mg 

N 

O 

N 

MM 0025.07 

Ethyl Diphenylacetate 

(A) 

100 mg 

O 

MM 0025.08 α,α-Diphenyl-γ-butyrolactone O 

O 

(A) 

100 mg 

O 

MM 0025.10 

Dimethyl-(tetrahydro-3,3-diphenyl-2-furilidine)ammonium Bromide 

O (A) 100 mg 

Br - 

N + 

Loratadine 

MM 0257.00 

Loratadine 

O 

Cl (A) 100 mg 

N O 

N 

MM 0257.02 

Imp. B (EP): 8-Chloro-5,6-dihydro-11H-benzo[5.6]cyclohepta[1,2- 

b]pyridin-11-one 

Cl 

(A) 100 mg 

O 

N 

MM 0257.01 

Imp. D (EP): 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5Hbenzo[5,6]cyclohepta[1,2-b]pyridine 

(Descarboethoxyloratadine;Desloratadine) 

Cl 

(A) 50 mg 

N 

NH 

MM 0257.05 

Imp. G (EP): 8-Chloro-11-(1-methylpiperidin-4- 

ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta- 

[1,2-b]pyridine 

Cl 

(A) 100 mg 

N 

N 

MM 0257.07 

Imp. H (EP): Ethyl 4-Oxopiperidine-1-carboxylate 

O 

(A) 

100 mg 

N 

O 

O 

Lorazepam 

MM 0071.00 

Lorazepam [Controlled Substance] 

H 

N 

O 

(A) 

100 mg 

Cl 

N 

OH 

Cl 

MM 0071.01 Imp. A (EP): (2-Amino-5-chlorophenyl)(2-chlorophenyl)methanone (2- 

Amino-2',5-dichlorobenzophenone) 

Cl 

NH 2 

O 

Cl 

(B) 

100 mg 

MM 0071.07 

Imp. B (EP): (3RS)-7-Chloro-5-(2-chlorophenyl)- 

2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl 

Acetate (Lorazepam Acetate) 


Cl 

H O 

N 

O 

N 

O 

Cl 

(A) 

100 mg 




MM 0071.06 

Imp. C (EP): 7-Chloro-5-(2-chlorophenyl)- 

1,3-dihydro-2H-1,4-benzodiazepin-2-one 

4-Oxide 

Cl 

H 

N 

O 

N 

O 

Cl 

(A) 

100 mg 

MM 0071.03 

Imp. D (EP): (5RS)-7-Chloro-5-(2-chlorophenyl)- 

4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione 

Cl 

H 

N 

O 

NH 

O 

(A) 

100 mg 

Cl 

MM 0071.02 

Imp. E (EP): 6-Chloro-4-(2-chlorophenyl)- 

quinazoline-2-carbaldehyde 

Cl 

N 

N 

Cl 

O 

(A) 100 mg 

MM 0071.04 

6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid 

Cl 

O 

N 

OH 

N 

Cl 

(A) 

100 mg 

MM 0071.08 

6-Chloro-4-(2-chlorophenyl)-2-quinazolinemethanol 

N 

OH 

(A) 100 mg 

Cl 

N 

Cl 

MM 0071.09 

6-Chloro-4-(2-chlorophenyl)-2(1H)-quinazolinone 

H 

N 

O 

(A) 

100 mg 

Cl 

N 

Cl 

Losartan Potassium 

MM 0168.00 

Losartan 

Cl 

OH 

N 

N 

N N 

N NH 

on request 

MM 0168.08 

Imp. D (Pharmeuropa) : 2-Butyl-4-chloro- 

1H-imidazole-5-carbaldehyde 

Cl 

N 

O 

NH 

(A) 

100 mg 

New MM 0168.09 

Imp. G (Pharmeuropa) : Triphenylmethanol 

OH 

(A) 

100 mg 

Lovastatin 

MM 0050.00 

Lovastatin 

O 

O 

(A) 

100 mg 

H O 

O 

OH 

MM 0050.05 

Imp. A (EP): (1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6- 

oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8ahexahydronaphthalen-1-yl 

(2S)-2-Methylbutanoate (Mevastatin) 

O 

O 

O O 

OH 

(A) 

100 mg 




MM 0050.01 Imp. B (EP) as Sodium Salt: (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6- 

O 

(A) 100 mg 

Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8ahexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic 

OH ONa 

Acid Sodium 

OH 

H 

Salt (Lovastatin Hydroxy Acid Sodium Salt) 

O O 

MM 0050.03 

O 

Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6- 

(A) 100 mg 

dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 

O 

(2S)-2-Methylbutanoate (Dehydrolovastatin) 

H O O 

Maprotiline Hydrochloride 

MM 0820.00 

Maprotiline Hydrochloride 

(A) 

250 mg 

N 

H 

x HCl 

MM 0820.01 

Imp. A (EP): 3-(9,10-Ethanoanthracen-9(10H)-yl)prop-2-enal 

(D) 

100 mg 

O 

MM 0820.02 Imp. B (EP) as Hydrochloride: 3-(9,10- 

Ethanoanthracen-9(10H)-yl)-N-[3-(9,10- 

ethanoanthracen-9(10H)-yl)propyl]-Nmethylpropan-1-amine 

Hydrochloride 

N 

x HCl 

(D) 

100 mg 

MM 0820.03 

NH 2 x HCl 

Imp. C (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen- 

(D) 100 mg 

9(10H)-yl)propan-1-amine Hydrochloride 

MM 0820.04 

Imp. D (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen- 

9(10H)-yl)-N-methylprop-2-en-1-amine Hydrochloride 

(Dehydromaprotiline Hydrochloride) 

N 

H 

x HCl 

(D) 

100 mg 

MM 0820.05 

Imp. E (EP) as Hydrochloride: 3-(9,10-Ethanoanthracen- 

9(10H)-yl)-N,N-dimethylpropan-1-amine Hydrochloride 

N 

x HCl 

(A) 

100 mg 

Mebeverine Hydrochloride 

MM 0319.00 

Mebeverine Hydrochloride 

N 

O 

O 

(A) 

100 mg 

O 

x HCl 

O 

O 

MM 0319.02 

Imp. A (Pharmeuropa): 4-Methoxyphenylacetone 

O 

(B) 100 mg 

O 

MM 0319.03 

MM 0319.01 

Imp. B (Pharmeuropa) as Hydrochloride: N-[(1RS)- 

1-[(4-Methoxyphenyl)methyl]ethyl]ethanamine 

Hydrochloride 

Imp. D (Pharmeuropa): 3,4-Dimethoxybenzoic Acid (Veratric Acid) 

O 

O 

NH 

x HCl 

(A) 

(B) 

100 mg 

100 mg 

HO 

O 

O 

Mechlorethamine Hydrochloride 

MM 0823.00 Mechlorethamine Hydrochloride 

N 

Cl 

Cl 

x HCl (A) 500 mg 




Meclofenoxate Hydrochloride 

MM 0044.00 Meclofenoxate Hydrochloride 

O 

O 

N 

O 

x HCl 

(A) 500 mg 

Cl 

MM 0044.02 

(4-Chlorophenoxy)acetic Acid 

O 

O 

(B) 100 mg 

OH 

Cl 

Meclozine Hydrochloride 

MM 0586.00 

Meclozine Dihydrochloride 

Cl 

N 

N 

(A) 

500 mg 

x 2 HCl 

MM 0586.03 

Imp. B (Pharmeuropa): (RS)-(4-Chlorophenyl)-(phenyl)methanol 

Cl 

(B) 100 mg 

OH 

MM 0586.04 

Imp. C (Pharmeuropa): (4-Chlorophenyl)(phenyl)methanone 

Cl 

(B) 100 mg 

O 

MM 0586.01 N-(3-Methylbenzyl)piperazine N 

HN 

(A) 

100 mg 

MM 0586.02 

(RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine 

Cl 

(A) 100 mg 

N 

NH 

MM 0586.05 

Meclozine N-Oxide 

Cl 

N 

O 

(A) 100 mg 

N 

Medroxyprogesterone 

MM 0635.00 

Medroxyprogesterone 

O 

OH 

(A) 

100 mg 

O 

Medroxyprogesterone Acetate 

MM 0532.00 

Medroxyprogesterone Acetate 

O 

O 

(A) 

100 mg 

O 

O 

MM 0532.01 

Imp. A (EP): 6β-Hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl 

Acetate (6β-Hydroxymedroxyprogesterone Acetate) 

O 

O 

O 

(D) 

100 mg 

O 

OH 

MM 0532.02 

Imp. B (EP):17-Hydroxy-6α-methylpregn-4-ene-3,20-dione 

(Medroxyprogesterone) 

O 

OH 

(A) 

100 mg 

O 

MM 0532.05 

Imp. E (EP): 6-Methylidene-3,20-dioxopregn-4-en-17-yl 

Acetate (6-Methylenehydroxyprogesterone Acetate) 

O 

O 

O 

(A) 

100 mg 

O 




MM 0532.06 Imp. F (EP): 6α-Methyl-3,20-dioxo-5β-pregnan-17-yl Acetate 

O 

(D) 50 mg 

(4,5β-Dihydromedroxyprogesterone Acetate) 

O 

O 

O 

H 

MM 0532.07 

Imp. G (EP): 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl 

Acetate (Megestrol Acetate) 

O 

O 

O 

(A) 

250 mg 

O 

MM 0532.09 

Imp. H (EP): 3,20-Dioxopregn-4-en-17-yl Acetate 

(Hydroxyprogesterone Acetate) 

O 

O 

(A) 

100 mg 

O 

O 

Mefenamic Acid 

MM 0327.00 

Mefenamic Acid 

O 

(A) 

500 mg 

OH 

NH 

MM 0327.01 Imp. A (EP): 2,3-Dimethylaniline 

NH 2 

(B) 100 mg 

MM 0327.02 

Imp. B (EP): N-(2,3-Dimethylphenyl)-2-[(2,3- 

dimethylphenyl)amino]benzamide 

O 

(A) 

100 mg 

N 

H 

NH 

New MM 0327.05 

Imp. C (Pharmeuropa): 2-Chlorobenzoic Acid 

O 

(A) 

100 mg 

OH 

New MM 0327.06 

Imp. D (Pharmeuropa): Benzoic Acid 

Cl 

O 

(B) 100 mg 

OH 

Mefloquine Hydrochloride 

New MM 1198.01 

2,8-Bis-(trifluoromethyl)-4-quinolinol 

F 

F 

F 

N 

F 

F 

F 

(A) 

100 mg 

OH 

Megestrol Acetate 

MM 0573.00 

Megestrol Acetate 

O 

(A) 

250 mg 

O 

O 

O 

MM 0573.01 

Imp. A (EP): 6α-Methyl-3,20-dioxopregn-4-en-17-yl Acetate 

(Medroxyprogesterone Acetate) 

O 

O 

(A) 

100 mg 

O 

O 

Meloxicam 

MM 0246.00 

Meloxicam 

O O 

S 

N 

H 

N 

N 

(A) 

500 mg 

OH 

O 

S 




MM 0246.02 

Imp. A (BP): Ethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3- 

carboxylate 1,1-Dioxide 

O O 

S 

N 

O 

(A) 

100 mg 

MM 0246.01 

Imp. B (BP): 5-Methyl-1,3-thiazol-2-amine 

OH 

O 

H 2 N 

N (A) 100 mg 

S 

MM 0246.04 

Imp. E (BP): Methyl 4-Hydroxy-2-methyl- 

2H-1,2-benzothiazine-3-carboxylate 1,1- 

Dioxide 

O O 

S 

N 

OH 

O 

O 

(A) 

100 mg 

Melperone 

MM 0321.00 

Melperone 

N 

O 

(A) 

100 mg 

Memantine Hydrochloride 

New MM 1045.01 1-Hydroxy-3,5-dimethyladamantane 

OH 

(A) 100 mg 

F 

Mephenesin 

MM 0810.00 

Mephenesin 

O 

OH 

OH 

(A) 

500 mg 

Mephentermine Hemisulphate 

MM 0740.00 Mephentermine Hemisulfate H 

N 

x ½ H 2 SO 4 

(A) 500 mg 

Mepivacaine Hydrochloride 

MM 0368.00 

Mepivacaine Hydrochloride 

H 

N 

O 

N 

x HCl 

(A) 

500 mg 

MM 0368.01 

Imp. A (EP): 2,6-Dimethylaniline 

NH 2 

(B) 100 mg 

MM 0368.03 

Imp. C (EP): N-(2,6-Dimethylphenyl)pyridine-2-carboxamide 

H 

N 

O 

N 

(A) 

100 mg 

MM 0368.06 

Mepivacaine N-Oxide 

H 

N 

O 

N 

O 

(A) 100 mg 

Mepyramine Maleate 

MM 0559.00 Mepyramine Maleate 

O 

N 

N 

OH 

x 

O N 

OH 

O 

MM 0559.02 Imp. A (EP): N-(4-Methoxybenzyl)pyridin-2-amine NH 

(A) 

(A) 

500 mg 

100 mg 

O 

N 

MM 0559.03 

Imp. B (EP): 4-Methoxybenzaldehyde (Anisaldehyde) 

O (C) 100 mg 

O 

MM 0559.04 

Imp. C (EP): Pyridin-2-amine 

NH 2 

(B) 100 mg 

N 

MM 0559.05 

Mepyramine N-Oxide Dihydrochloride 

O 

N 

N 

O 

N 

x 2 HCl 

(A) 

100 mg 




Mequinol 

O 

MM 1131.00 Mequinol 

(A) 500 mg 

HO 

Mesalazine 

MM 0217.00 

Mesalazine 

H 2 N 

O 

(A) 500 mg 

OH 

OH 

MM 0217.04 Imp. A (EP): 4-Aminophenol 

H 2 N 

(B) 

100 mg 

OH 

MM 0217.01 

Imp. B (EP): 3-Aminophenol 

(B) 

100 mg 

H 2 N 

OH 

MM 0217.06 

Imp. C (EP): 2-Aminophenol 

(A) 100 mg 

OH 

NH 2 

MM 0217.07 

Imp. D (EP): 3-Aminobenzoic Acid 

O 

(A) 100 mg 

OH 

NH 2 

MM 0217.08 

Imp. E (EP): 4-Amino-2-hydroxybenzoic Acid 

(4-Aminosalicylic Acid) 

O 

OH 

(A) 

100 mg 

H 2 N 

OH 

MM 0217.09 

Imp. F (EP): 3-Amino-2-hydroxybenzoic 

Acid (3-Aminosalicylic Acid) 

O 

(A) 100 mg 

OH 

OH 

NH 2 

MM 0217.10 

Imp. G (EP): 2,5-Dihydroxybenzoic Acid 

HO 

O 

OH 

(A) 

100 mg 

OH 

MM 0217.11 

Imp. H (EP): 2-Hydroxybenzoic Acid 

(Salicylic Acid) 

O 

OH 

(A) 

500 mg 

MM 0217.13 Imp. K (EP): Aniline 

H 2 N 

(B) 100 mg 

OH 

MM 0217.14 

Imp. L (EP): 2-Chlorobenzoic Acid 

O 

(A) 

100 mg 

OH 

Cl 

MM 0217.15 

Imp. M (EP): 2-Chloro-5-nitrobenzoic Acid 

O 2 N 

O 

OH 

(A) 

100 mg 

Cl 

MM 0217.16 

Imp. N (EP): 2-Hydroxy-5-nitrobenzoic Acid 

(5-Nitrosalicylic Acid) 

O 2 N 

O 

OH 

(A) 

100 mg 

OH 

MM 0217.02 

5-Acetaminosalicylic Acid 

O 

O 

OH 

OH 

(A) 

100 mg 

N 

H 

Metamizole Sodium 

MM 0052.00 

Metamizole Sodium Monohydrate 

O 

N 

N 

N 

O 

S 

O 

ONa 

x H2 O 

(A) 

500 mg 

MM 0052.02 

Imp. A (EP): 4-Formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3Hpyrazol-3-one 

(4-Formylaminophenazone) 

O H N O 

(A) 100 mg 

N 

N 

MM 0052.04 

Imp. B (EP): 4-Amino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol- 

3-one (Ampyrone) 

O 

N 

N 

NH 2 

(A) 100 mg 




O 

MM 0052.10 Imp. C (EP) as Hydrochloride: 4-Methylamino-1,5-dimethyl-2- 

H 

(A) 100 mg 

N 

phenyl-1,2-dihydro-3H-pyrazol-3-one Hydrochloride (4- 

N 

x HCl 

N 

Methylaminophenazone Hydrochloride) 

MM 0052.05 

Imp. D (EP): 4-Dimethylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3Hpyrazol-3-one 

(4,4-Dimethylaminophenazone) 

O 

N 

N 

N 

(A) 

100 mg 

MM 0052.01 

4-Acetylaminophenazone 

O H N O 

(A) 100 mg 

N 

N 

MM 0052.50 

4-Benzylideneaminoantipyrine 

O 

N 

N 

N 

(A) 

100 mg 

Metformin Hydrochloride 

MM 0056.00 Metformin Hydrochloride 

NH 

NH 

H 2 N N 

H 

N 

x HCl 

(A) 

500 mg 

NH 

MM 0056.01 Imp. A (EP): Cyanoguanidine N (B) 100 mg 

H 2 N N 

H 

MM 0056.02 

MM 0056.03 

Imp. B (EP): (4,6-Diamino-1,3,5-triazin-2-yl)guanidine 

Imp. C (EP): N,N-Dimethyl-1,3,5-triazine-2,4,6-triamine 

N 

NH 2 

N NH 

H 2N N N H 

H 2 N N N 

N N 

NH 2 

(A) 100 mg 

NH 2 

(A) 100 mg 

MM 0056.04 

Imp. D (EP): 1,3,5-Triazine-2,4,6-triamine (Melamine) 

H 2N N NH 2 

N 

N 

(B) 

100 mg 

NH 2 

MM 0056.05 Imp. E (EP) as Hydrochloride:1-Methylbiguanide Hydrochloride 

NH 

NH 

H 2N N H 

N H 

x HCl 

(A) 

100 mg 

MM 0056.06 Imp. F (EP) as Hydrochloride: N-Methylmethanamine Hydrochloride 

H 

N x HCl (C) 100 mg 

Methamphetamine Hydrochloride 

MM 0964.00 

Methamphetamine Hydrochloride 


H 

N 

x HCl 

(A) 

100 mg 

Methotrexate 

MM 0040.00 

Methotrexate 

O O 

(A) 

500 mg 

OH 

O 

N 

NH 2 

N 

N 

N 

H 

OH 

H 2 N 

N 

N 

MM 0040.08 

Imp. A (EP) as Hydrochloride: (2,4-Diaminopteridin-6- 

yl)methanol Hydrochloride 

N 

NH 2 

N 

OH 

x HCl 

(A) 

100 mg 

H 2 N 

N 

N 

Methoxsalen 

MM 0555.00 

Methoxsalen 

O 

O 

O (A) 500 mg 

O 

O O 

MM 0555.01 5-Methoxypsoralen (Bergapten) O 

(A) 

100 mg 

Methoxyphenamine Hydrochloride 

O 

MM 0655.00 

Methoxyphenamine Hydrochloride 

O 

H 

N 

x HCl 

(A) 

500 mg 




Methyl Nicotinate 

MM 0549.00 


O 

(A) 500 mg 

N 

O 

MM 0549.01 

Imp. A (EP): Nicotinic Acid 

O 

(A) 500 mg 

N 

OH 

Methyl Parahydroxybenzoate 

MM 0431.00 

Methyl Parahydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0431.02 


O 

(B) 100 mg 

OH 

HO 

MM 0431.03 

Imp. B (EP): Ethyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0431.04 

Imp. C (EP): Propyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0431.05 


O 

(A) 500 mg 

O 

HO 

MM 0431.01 

Sodium Methyl Parahydroxybenzoate 

O 

(A) 500 mg 

O 

NaO 

Methylprednisolone 

MM 0190.00 

Methylprednisolone 

HO 

O 

OH 

OH 

(A) 

100 mg 

O 

MM0190.01 

Imp. A (EP): 17,21-Dihydroxy-6α-methylpregna-1,4-diene- 

3,11,20-trione 

O 

O 

OH 

OH 

(D) 

50 mg 

O 

Methylprednisolone Acetate 

MM 0191.00 

Methylprednisolone Acetate 

HO 

O 

O 

OH 

O 

(D) 100 mg 

O 

MM 0191.02 

Imp. B (EP): Methylprednisolone 

HO 

O 

OH 

OH 

(A) 

100 mg 

O 

MM 0191.05 

Imp. E (EP): Prednisolone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

Methylprednisolone Hydrogen Succinate 

MM 0192.00 

Methylprednisolone Hydrogen Succinate Sodium Salt 

HO 

O 

O 

OH 

O 

ONa 

O 

on request 

O 




MM 0192.04 Imp. A (EP): Methylprednisolone 

O 

OH (A) 100 mg 

HO 

OH 

O 

MM 0192.05 

Imp. C (EP): Methylprednisolone Acetate 

HO 

O 

O 

OH 

O 

(D) 100 mg 

O 

Methyltestosterone 

MM 0558.00 

Methyltestosterone 

OH 

(A) 250 mg 

O 

MM 0558.01 

Testosterone 

OH 

(A) 500 mg 

O 

Metixene Hydrochloride 

MM 0125.01 

Imp. A (EP): 9H-Thioxanthene 

(A) 

100 mg 

S 

MM 0125.02 

Imp. B (EP): 9H-Thioxanthen-9-one 

(Thioxanthone) 

O 

(B) 

100 mg 

S 

MM 0125.03 3-Chloromethyl-1-methylpiperidine Cl 

on request 

N 

MM 0125.04 

Metixene 

on request 

S 

N 

Metoclopramide 

MM 0073.00 

Metoclopramide Hydrochloride Monohydrate 

Cl 

H 2N 

O 

O 

N 

H 

N 

x HCl 

x H 2O 

(A) 

500 mg 

MM 0073.03 

Imp. A (EP): 4-(Acetylamino)-5-chloro-N-[2- 

(diethylamino)ethyl]-2-methoxybenzamide 

Cl 

O 

N 

H 

O 

O 

N 

H 

N 

(A) 

100 mg 

MM 0073.04 

Imp. B (EP): Methyl 4-(Acetylamino)-5-chloro-2-methoxybenzoate 

Cl 

O 

O 

O 

(A) 

100 mg 

N 

H 

O 

MM 0073.02 

Imp. C (EP): 4-Amino-5-chloro-2-methoxybenzoic Acid 

Cl 

O 

OH 

(B) 

100 mg 

H 2N 

O 

MM 0073.05 

Imp. D (EP): Methyl 4-(Acetylamino)-2-methoxybenzoate 

O 

O 

O 

(A) 

100 mg 

N 

H 

O 

MM 0073.01 

Imp. E (EP): N,N-Diethylethane-1,2-diamine 

H 2N 

N 

(B) 

100 mg 

MM 0073.06 

Imp. F (EP): 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2- 

hydroxybenzamide 

Cl 

H 2N 

O 

N 

H 

OH 

N 

(A) 

100 mg 




MM 0073.07 Imp. G (EP): N'-(4-Amino-5-chloro-2-methoxybenzoyl)-N,Ndiethylethane-1,2-diamine 

O 

(A) 100 mg 

N-Oxide (Metoclopramide N-Oxide) 

N 

Cl 

N 

H O 

H 2N O 

MM 0073.08 

Imp. H (EP): 4-(Acetylamino)-2-hydroxybenzoic Acid 

O 

O 

OH 

(A) 

100 mg 

N 

H 

OH 

MM 0073.09 

Methyl 4-Amino-2-hydroxybenzoate 

O 

(A) 100 mg 

O 

H 2N 

OH 

MM 0073.10 

Methyl 4-(Acetylamino)-2-hydroxybenzoate 

O 

O 

O 

(A) 

100 mg 

N 

H 

OH 

Metoprolol Succinate 

MM 0279.00 

Metoprolol Succinate 

O 

(A) 

100 mg 

OH 

HN 

2 

O 

O 

x HO 

OH 

O 

MM 0279.04 

Imp. A (EP): (2RS)-1-(Ethylamino)-3-[4-(2-methoxyethyl)- 

phenoxy]propan-2-ol 

O 


O 

MM 0279.01 

Imp. B (EP): 4-(2-Methoxyethyl)phenol 

OH 

(A) 100 mg 

O 

MM 0279.24 

Imp. C (EP) as Hydrochloride: 4-[(2RS)-2- 

Hydroxy-3-[(1-methylethyl)amino]propoxy]- 

benzaldehyde Hydrochloride 

O 

O 

OH 

H 

N 

x HCl 

(A) 

100 mg 

MM 0279.06 

Imp. D (EP): (2RS)-3-[4-(2-Methoxyethyl)phenoxy]propane- 

1,2-diol 

O 

OH 

OH 

(A) 

100 mg 

O 

MM 0279.07 

Imp. E (EP): (2RS)-1-[2-(2-Methoxyethyl)phenoxy]-3-[(1- 

methylethyl)amino]propan-2-ol 

O 

OH 

HN 

(A) 

100 mg 

O 

MM 0279.08 

Imp. F (EP): (2RS)-1-[(1-Methylethyl)amino]-3-phenoxypropan-2-ol 

O 


MM 0279.09 

Imp. G (EP): 2-(4-Hydroxyphenyl)ethanol 

OH 

(A) 100 mg 

HO 

MM 0279.10 

Imp. H (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]-3-[(1- 

methylethyl)amino]propan-2-ol 

O 


HO 

MM 0279.11 

(2RS)-1-(4-Ethenylphenoxy)-3-[(1-methylethyl)amino]- 

propan-2-ol 

O 


MM 0279.12 

Imp. J (EP): 1-[2-Hydroxy-3-[(1- 

methylethyl)amino]propoxy]-3-[4-(2- 

methoxyethyl)phenoxy]propan-2-ol 

O 

O 

OH 

O 

OH 

HN (A) 50 mg 

MM 0279.13 

(2RS)-1-[4-[(EZ)-2-Methoxyethenyl]phenoxy]-3- 

[(1methylethyl)amino]propan-2-ol 

O 

O 

OH 

HN 

(A) 

100 mg 

MM 0279.28 

Imp. M (EP) as Dihydrochloride: 1,3-Bis[(1- 

methylethyl)amino]propan-2-ol Dihydrochloride 

H 

N 

OH 

HN 

x 2 HCl 

(A) 100 mg 

MM 0279.16 

Imp. N (EP): (2RS)-3-[(1-Methylethyl)amino]propane-1,2-diol 

HO 


MM 0279.03 

Imp. O (EP): 1,1'-[(1-Methylethyl)imino]bis- 

[3-[4-(2-methoxyethyl)phenoxy]propan- 

2-ol] 

O 

O 

OH 

N 

OH (A) 100 mg 

O 

O 




Metoprolol Tartrate 

MM 0027.00 Metoprolol Tartrate 

O 

(A) 500 mg 

OH 

HN 

2 

O 

MM 0027.04 

MM 0027.01 

Imp. A (EP): (2RS)-1-(Ethylamino)-3-[4-(2- 


Imp. B (EP): 4-(2-Methoxyethyl)phenol 

OH O 

x HO 

OH 

O OH 

O 

O 


OH 

(A) 100 mg 

O 

MM 0027.24 

Imp. C (EP) as Hydrochloride: 4-[(2RS)-2- 

Hydroxy-3-[(1-methylethyl)amino]propoxy]- 

benzaldehyde Hydrochloride 

O 

O 

OH 

H 

N 

x HCl 

(A) 

100 mg 

MM 0027.06 

Imp. D (EP): (2RS)-3-[4-(2-Methoxyethyl)phenoxy]propane- 

1,2-diol 

O 

O 

OH 

OH 

(A) 

100 mg 

MM 0027.07 

Imp. E (EP): (2RS)-1-[2-(2-Methoxyethyl)- 

phenoxy]-3-[(1-methylethyl)amino]propan- 

2-ol 

O 

OH 

O 

HN 

(A) 

100 mg 

MM 0027.08 

Imp. F (EP): (2RS)-1-[(1-Methylethyl)amino]-3-phenoxypropan-2-ol 

O 


MM 0027.09 

Imp. G (EP): 2-(4-Hydroxyphenyl)ethanol 

OH 

(A) 100 mg 

HO 

MM 0027.10 

Imp. H (EP): (2RS)-1-[4-(2-Hydroxyethyl)- 

phenoxy]-3-[(1-methylethyl)amino]propan- 

2-ol 

HO 

O 


MM 0027.11 

(2RS)-1-(4-Ethenylphenoxy)-3-[(1-methylethyl)amino]propan-2- 

ol 

O 


MM 0027.12 

MM 0027.13 

Imp. J (EP): 1-[2-Hydroxy-3-[(1- 

methylethyl)amino]propoxy]-3-[4-(2- 


(2RS)-1-[4-[(EZ)-2-Methoxyethenyl]phenoxy]-3- 

[(1methylethyl)amino]propan-2-ol 

O 

O 

O 

OH 

O 

O 

OH 

HN (A) 50 mg 

OH HN 

(A) 100 mg 

MM 0027.28 

Imp. M (EP) as Dihydrochloride: 1,3-Bis[(1- 

methylethyl)amino]propan-2-ol Dihydrochloride 

H 

N 

OH 

HN 

x 2 HCl 

(A) 100 mg 

MM 0027.16 

Imp. N (EP): (2RS)-3-[(1-Methylethyl)amino]propane-1,2-diol 

HO 


MM 0027.03 

Imp. O (EP): 1,1'-[(1-Methylethyl)imino]bis-[3- 

[4-(2-methoxyethyl)phenoxy]propan-2-ol] 

O 

OH 

N 

OH (A) 100 mg 

O 

O 

O 

MM 0027.02 

1-[4-(2-Methoxyethyl)phenoxy]-2,3-epoxypropane 

O 

O 

(A) 100 mg 

O 

MM 0027.17 

1-Chloro-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol 

O 

OH 

(A) 100 mg 

Cl 

O 

MM 0027.18 

4,4'-(2-Hydroxy-1,3-propandiyldioxy)- 

bis[(2-methoxyethyl)benzene)] 

O 

O 

OH 

O 

O 

(A) 

100 mg 

MM 0027.22 

3-Chloropropane-1,2-diol 

Cl 

OH 

OH 

(B) 

100 mg 

MM 0027.26 

1-[2-(2-Methoxyethyl)phenyoxy]-2,3-epoxypropane 

O O (A) 100 mg 

O 




Metronidazole 

MM 0012.00 

Metronidazole 

O 2 N 

N 

N 

OH 

(A) 500 mg 

MM 0012.02 Imp. A (EP): 2-Methyl-4-nitroimidazole 

NH 

O 2 N 

(B) 100 mg 

MM 0012.05 Imp. B (EP): 4-Nitroimidazole NH 

O 2 N 

(C) 100 mg 

MM 0012.01 Imp. E (EP): 2-(2-Methyl-4-nitro-1H-imidazol-1-yl)ethanol N 

MM 0012.04 

Metronidazole Benzoate 

MM 0278.00 

MM 0278.02 

1-(2-Hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole 

(Hydroxymetronidazole) 

Metronidazole Benzoate 

Imp. A (EP): Metronidazole 

O 2 N 

N 

N 

O 2N 

N 

O 2N 

N 

N 

O 2 N 

O 

N 

O 

N 

N 

OH 

OH 

OH 

OH 

(A) 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

500 mg 

N 

MM 0278.03 

Imp. B (EP): 2-Methyl-5-nitroimidazole 

O 2 N 

(B) 100 mg 

NH 

N 

MM 0278.01 

Imp. C (EP): Benzoic Acid 

O 

(B) 100 mg 

OH 

MM 0278.04 

2-(2-Methyl-4-nitro-1H-imidazol-1-yl)ethyl Benzoate 

O 2 N 

N 

N 

O 

O 

(A) 

100 mg 

Mevastatin 

MM 0377.00 

Mevastatin 

O 

O 

(A) 

100 mg 

O 

O 

OH 

Mexiletine Hydrochloride 

MM 0146.00 

Mexiletine Hydrochloride 

O 

NH 2 

x HCl 

(A) 

500 mg 

MM 0146.01 

Imp. A (EP): 2,6-Dimethylphenol 

OH 

(A) 

100 mg 

MM 0146.02 

Imp. B (EP): 1-(2,6-Dimethylphenoxy)propan-2-one 

O 

O 

(A) 100 mg 

Mianserin Hydrochloride 

MM 0147.00 

Mianserin Hydrochloride 

N 

(A) 

100 mg 

N 

x HCl 

MM 0147.01 

Imp. A (EP): [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl] 

phenyl]methanol 

N 

N 

(A) 

100 mg 

MM 0147.04 Imp. C (Pharmeuropa): (2-Aminophenyl)methanol H 2 N 

OH 

(B) 

100 mg 

OH 




MM 0147.06 Mianserin N-Oxide 

O 

(D) 100 mg 

N 

N 

Miconazole Nitrate 

MM 0281.00 

Miconazole Nitrate 

Cl 

(A) 

500 mg 

Cl 

x HNO 3 

O 

Cl 

Cl 

N 

N 

MM 0074.00 

Miconazole 

Cl 

(A) 

250 mg 

Cl 

MM 0281.01 

Imp. A (EP): (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol 

Cl 

O 

N 

Cl 

N 

Cl 

(A) 100 mg 

Cl 

HO 

N 

N 

MM 0281.02 

Imp. B (EP) as Nitrate: 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]- 

2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate 

(Econazole Nitrate) 

Cl 

Cl 

x HNO 3 

(A) 

500 mg 

O 

Cl 

N 

N 

MM 0281.03 

Imp. C (EP) as Nitrate: (2RS)-2-[(2,4-Dichlorobenzyl)oxy]- 

2-(2,4-dichlorophenyl)ethanamine Nitrate 

Cl 

(D) 

100 mg 

Cl 

x HNO 3 

O 

MM 0281.04 

Imp. D (EP) as Nitrate: 1-[(2RS)-2-[(2,6-Dichlorobenzyl)oxy]- 

2-(2,4-dichlorophenyl)- 

ethyl]-1H-imidazole Nitrate (Isoconazole Nitrate) 

Cl 

Cl 

Cl 

Cl 

NH 2 

Cl 

x HNO 3 

(A) 

100 mg 

O 

Cl 

N 

N 

MM 0281.06 

Imp. F (EP) as Nitrate: 1-[(2RS)-2-[(3,4- 


Nitrate 

Cl 

Cl 

x HNO 3 

(A) 

100 mg 

O 

MM 0281.07 

Imp. G (EP) as Nitrate: 1-[(2RS)-2-[(2,5- 


Nitrate 

Cl 

Cl 

Cl 

N 

N 

Cl 

Cl 

O 

N 

Cl 

x HNO 3 

(A) 

100 mg 

N 

MM 0281.08 

Imp. H (EP) as Nitrate: 1-[(2RS)-2-Benzyloxy-2-(2,4- 

dichlorophenyl)ethyl]-1H-imidazole Nitrate 

Cl 

(A) 100 mg 

Cl 

x HNO 3 

O 

N 

N 




MM 0281.09 Imp. I (EP) as Nitrate: 1-[(2RS)-2-[(2-Chlorobenzyl)- 

Cl 

(A) 100 mg 

oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate 

Cl 

x HNO 3 

O 

Cl 

N 

N 

MM 0281.10 

1-(2,4-Dichlorobenzoylmethyl)imidazole 

Cl 

(A) 100 mg 

Cl 

O 

N 

N 

Midazolam 

New MM 1106.02 

Imp. F (EP): 7-Chloro-5-(2-fluorophenyl)-1,3- 

dihydro-2H-1,4-benzodiazepin-2-one 

(1-Des[(diethylamino)ethyl]flurazepam) 

Cl 

H 

N 

N 

O 

(A) 

100 mg 

F 

Minoxidil 

MM 0521.00 

Minoxidil 

N N NH 2 

(A) 

500 mg 

N 

O 

NH 2 

MM 0521.01 

Imp. A (EP): 6-Chloropyrimidine-2,4-diamine 3-Oxide 

Cl N NH 2 

N 

O 

(A) 

100 mg 

NH 2 

MM 0521.02 

Imp. B (EP): 6-Chloropyrimidine-2,4-diamine 

Cl N NH 2 

N 

(C) 

100 mg 

NH 2 

MM 0521.05 

Mirtazapine 

New MM 1005.02 

Imp. E (EP): 6-(Piperidin-1-yl)pyrimidine-2,4-diamine 

(Desoxyminoxidil) 

Imp. A (EP): (14bRS)-2-Methyl-1,2,3,4,10- 

14b-hexahydropyrazino[2,1-a]pyrido[2,3- 

c][2]benzazepine 2-Oxide 

(A) 100 mg 

N N NH 2 

N 

NH 2 

N 

N 

O 

N 

(A) 

100 mg 

MM 1005.07 

1-Methyl-3-phenylpiperazine 

(A) 

100 mg 

HN 

N 

Moclobemide 

MM 0250.00 Moclobemide O 

Molsidomine 

MM 0267.00 

MM 0267.02 

Molsidomine 

Imp. A (Pharmeuropa) as Hydrochloride: 3-(Morpholin-4- 

yl)sydnonimine Hydrochloride (Linsidomine Hydrochloride) 

Cl 

HN 

O 

O 

N 

N 

H 

O N 

- 

N+ 

N 

N 

O N 

- 

N+ 

N 

O 

O (A) 100 mg 

O 

x HCl 

(A) 

(A) 

250 mg 

100 mg 

MM 0267.03 

Imp. B (Pharmeuropa): 4-Nitrosomorpholine 

O 

(A) 100 mg 

N 

N 

O 




New MM 0267.01 Imp. C (Pharmeuropa): (2E)-(Morpholin-4-ylimino)acetonitrile 

New MM 0267.06 Imp. E (Pharmeuropa): Morpholine 

N 

(A) 100 mg 

N 

N 

O 

HN (A) 100 mg 

O 

Montelukast Sodium 

MM 0698.00 

Montelukast Sodium 

NaO 

O on request 

S 

Cl 

N 

OH 

Morphine Hydrochloride 

MM 0037.00 

Morphine Hydrochloride Trihydrate [Controlled Substance] 

N 

(A) 

250 mg 

x HCl 

x 3 H 2 O 

HO 

O 

OH 

MM 0037.10 

Imp. A (EP) as Phosphate Hemihydrate: 

Codeine Phosphate Hemihydrate 


N 

(A) 100 mg 

x ½ H 2 O 

O 

O 

OH 

MM 0037.01 

Imp. B (EP): 7,7',8,8'-Tetradehydro-4,5α:4',5'α-diepoxy- 

17,17'-dimethyl-2,2'-bimorphinanyl-3,3',6α,6'α-tetrol 

(Pseudomorphine; 2,2'-Bimorphine) 

HO 

O 

OH 

N 

(A) 

100 mg 

N 

HO 

O 

OH 

MM 0037.03 

Imp. F (Pharmeuropa): Morphine N-Oxide [Controlled Substance] 

O 

(A) 100 mg 

N 

HO 

O 

OH 

MM 0037.02 

Dimethyl Pseudomorphine 

HO 

O 

O 

N 

(A) 

100 mg 

N 

O 

O 

OH 

Morphine Sulphate 

MM 0280.00 

Morphine Hemisulphate Pentahemihydrate 


N 

x H 2 SO 4 

x 5 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

2 

MM 0280.01 

Imp. A (EP) as Phosphate Hemihydrate: 



N 

(A) 100 mg 

x ½ H 2 O 

O 

O 

OH 

MM 0280.02 

Imp. B (EP): 7,7',8,8'-Tetradehydro-4,5α:4',5'α-diepoxy- 

17,17'-dimethyl-2,2'-bimorphinanyl-3,3',6α,6'α-tetrol 

(Pseudomorphine;2,2'-Bimorphine) 

HO 

O 

OH 

N 

(A) 

100 mg 

N 

HO 

O 

OH 

MM 0280.03 

Imp. F (Pharmeuropa): Morphine N-Oxide [Controlled Substance] 

O 

(A) 100 mg 

N 

HO 

O 

OH 

Moxifloxacin Hydrochloride 

New MM 0885.00 

Moxifloxacine Hydrochloride 

HN 

H 

H 

N 

O 

N 

x HCl 

on request 

F 

O 

OH 

O 




Mycophenolate Mofetil 

New MM 1001.00 Mycophenolate Mofetil 

O OH 

O 

N 

O 

O 

O 

O 

on request 

Nabumetone 

MM 0153.00 

Nabumetone 

O 

(A) 500 mg 

O 

MM 0153.02 

Imp. A (EP): 3-(6-Methoxynaphthalen-2-yl)-5- 

methylcyclohexanone 

O 

(A) 100 mg 

O 

MM 0153.03 

Imp. B (EP): (5RS)-5-(6-Methoxynaphthalen-2-yl)-3- 

methylcyclohex-2-enone 

O 

(A) 100 mg 

O 

MM 0153.04 

Imp. C (EP): (2RS)-4-(6-Methoxynaphthalen-2-yl)-butan-2-ol 

OH 

(A) 100 mg 

O 

MM 0153.05 

Imp. D (EP): (E)-4-(6-Methoxynaphthalen-2-yl)-but-3-en-2-one 

O 

(A) 100 mg 

O 

MM 0153.07 

Imp. F (EP): 6,6'-Dimethoxy-2,2'-binaphthalenyl 

O 

(A) 100 mg 

O 

MM 0153.09 

(6-Methoxy-2-naphthyl)acetic Acid 

O 

OH 

O 

(A) 

100 mg 

Nadolol 

MM 0439.00 

Nadolol 

HO 

OH 

O 

OH 

HN 

on request 

and enantiomers 

Nafcillin Sodium 

MM 0392.00 

Nafcillin Sodium 

O 

O 

NH 

O 

N 

S 

H 

ONa 

on request 

O 

MM 0392.01 

MM 0392.02 

MM 0392.03 

Penicilloic Acids of Nafcillin 

Penilloic Acids of Nafcillin 

6-Aminopenicillanic Acid 

O OH 

MM 0392.04 2-Ethoxynaphthoic Acid 

O 

H 

N 

O 

HO 

O 

O 

H 

N 

O 

H 2 N 

HN 

O 

O 

HN 

S 

HO 

O 

S 

N 

S 

H 

O 

OH 

O 

(D) 

(D) 

100 mg 

100 mg 

OH (B) 100 mg 

(B) 

100 mg 




Naftidrofuryl Hydrogen Oxalate 

MM 0373.00 

Naftidrofuryl Hydrogen Oxalate 

Naloxone Hydrochloride Dihydrate 

MM 0272.00 

Naloxone Hydrochloride Dihydrate 

O 

O 

O 

N O OH 

x 

O OH 

N 

OH 

x HCl 

x 2 H 2O 

(A) 

(A) 

500 mg 

250 mg 

HO 

O 

O 

Naltrexone 

MM 0233.00 

Naltrexone Hydrochloride 

N 

(A) 

100 mg 

HO 

x HCl 

HO 

O 

O 

Nandrolone 

MM 0660.00 

Nandrolone 

OH 

(A) 250 mg 

H 

O 

MM 0660.01 

19-Norandrost-4-ene-3,17-dione (Estr-4-ene-3,17-dione) 

O 

(A) 100 mg 

H 

Nandrolone Decanoate 

MM 0982.00 

Nandrolone Decanoate 

O 

O 

O 

(A) 100 mg 

H 

MM 0982.04 

Imp. D (EP): 17β-Hydroxyestr-4-en-3-one (Nandrolone) 

O 

OH 

(A) 250 mg 

H 

O 

Naphazoline Hydrochloride 

MM 0075.00 

Naphazoline Hydrochloride 

HN 

N 

x HCl 

(A) 

500 mg 

MM 0075.06 

Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2- 

(naphthalen-1-yl)acetamide Hydrochloride 

(Naphthylacetylethylenediamine Hydrochloride) 

O 

N 

H 

NH 2 

x HCl 

(A) 

100 mg 

MM 0075.02 

Imp. B (EP): (Naphthalen-1-yl)acetic Acid 

(1-Naphthylacetic Acid) 

O 

OH 

(B) 

100 mg 

MM 0075.04 

Imp. C (EP): (Naphthalen-1-yl)acetonitrile 

(1-Naphthylacetonitrile) 

N 

(B) 100 mg 

MM 0075.05 Ethyl (1-Naphthyl)acetate 

O 

O 

(A) 

100 mg 




O 

MM 0075.07 (Naphthalen-1-y)lacetamide (1-Naphthylacetamide) (A) 100 mg 

NH 2 

Naphazoline Nitrate 

MM 0286.00 

Naphazoline Nitrate 

HN 

N 

x HNO 3 

(A) 500 mg 

MM 0286.06 

Imp. A (EP) as Hydrochloride: 

N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide 

Hydrochloride (Naphthylacetylethylenediamine 


O 

N 

H 

NH 2 

x HCl 

(A) 

100 mg 

MM 0286.02 

Imp. B (EP): (Naphthalen-1-yl)acetic Acid 

(1-Naphthylacetic Acid) 

O 

OH 

(B) 

100 mg 

MM 0286.03 Imp. C (EP): (Naphthalen-1-yl)acetonitrile (1-Naphthylacetonitrile) 

N 

(B) 100 mg 

MM 0286.05 Ethyl (1-Naphthyl)acetate 

O 

O 

(A) 

100 mg 

MM 0286.07 

(Naphthalen-1-yl)acetamide 

(1-Naphthylacetamide) 

O 

NH 2 

(A) 100 mg 

Naproxen 

MM 0152.00 

Naproxen 

OH 

(A) 

500 mg 

O 

O 

MM 0152.06 

Imp. A (EP): (2S)-2-(6-Hydroxynaphthalen-2-yl)- 

propanoic Acid (O-Demethylnaproxen) 

HO 

OH 

O 

(A) 

100 mg 

MM 0152.09 

Imp. B (EP): (2S)-2-(5-Chloro-6-methoxynaphthalen-2- 

yl)propanoic Acid 

(5-Chloronaproxene) 

O 

Cl 

OH 

O 

(A) 

100 mg 

MM 0152.10 

MM 0152.11 

MM 0152.02 

MM 0152.12 

MM 0152.14 

Imp. C (EP): (2S)-2-(5-Bromo-6-methoxynaphthalen-2- 

yl)propanoic Acid 

(5-Bromonaproxene) 

Imp. D (EP): (2S)-2-(5-Iodo-6-methoxynaphthalen-2-yl)propanoic 

Acid 

(5-Iodonaproxene) 

Imp. E (EP): Methyl (2S)-2-(6-Methoxynaphthalen-2-yl)propanoate 

(Naproxen Methyl Ester) 

Imp. F (EP): Ethyl (2S)-2-(6-Methoxynaphthalen-2-yl)propanoate 

(Naproxen Ethyl Ester) 

Imp. H (EP): 6-Methoxynaphthalen-2-ol (Hydroxynerolin) 

O 

O 

O 

O 

Br 

I 

OH 

O 

OH 

O 

O 

O 

O 

O 

(A) 100 mg 

(A) 100 mg 

(A) 100 mg 

(A) 100 mg 

OH 

(A) 100 mg 

O 

MM 0152.01 

Imp. I (EP): (6-Methoxynaphthalen-2-yl)acetic Acid 

(α-Demethylnaproxen) 

O 

OH 

O 

(A) 

100 mg 

MM 0152.18 

Imp. J (EP): 2-Ethyl-6-methoxynaphthalene (Ethylnerolin) 

(A) 

100 mg 

O 




MM 0152.16 Imp. K (EP): (1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol 

OH 

(A) 100 mg 

O 

MM 0152.07 

Imp. L (EP): 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin) 

O 

(B) 100 mg 

O 

MM 0152.08 

Imp. M (EP): 2-Methoxynaphthalene (Nerolin) 

(B) 

100 mg 

O 

MM 0152.17 

Imp. N (EP): 2-Bromo-6-methoxynaphthalene 

Br 

(C) 100 mg 

O 

MM 0152.04 

Naproxen Sodium 

ONa 

(A) 

500 mg 

MM 0152.15 

2-Carboxy-6-methoxynaphthalene 

O 

O 

O 

(A) 100 mg 

OH 

O 

Nateglinide 

MM 0847.00 

Nateglinide 

O OH 

O on request 

N 

H 

Nevirapine 

Cl N 

MM 1146.04 3-Amino-2-chloro-4-methylpyridine 

H 2 N 

(A) 

100 mg 

Nicardipine Hydrochloride 

MM 0465.00 Nicardipine Hydrochloride 

H 

N 

(A) 

250 mg 

O 

O 

O 

O 

N 

x HCl 

NO 2 

MM 0465.01 

3-Methyl 5-[Methyl(phenylmethyl)amino]- 

ethyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine- 

3,5-dicarboxylate Dihydrochloride 

O 

O 

N 

O 

O 

N 

x 2 HCl 

(A) 

100 mg 

NO 2 

Nicergoline 

MM 0115.00 

Nicergoline 

H 

N 

Br 

(A) 100 mg 

N 

O 

O 

O 

N 

New MM 0115.02 

Imp. A (EP): [(6aR,9R,10aS)-10a-Methoxy- 

4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl 

5-Chloropyridine-3-carboxylate 

N 

H 

N 

O 

O 

O 

Cl 

(D) 50 mg 

N 

MM 0115.04 

Imp. C (EP): [(6aR,9R,10aS)-10a-Methoxy-4,7-dimethyl- 

4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9- 

yl]methanol (Methylmethoxylumilysergol) 

N 

H (D) 100 mg 

N 

OH 

O 

MM 0115.06 

Imp. D (EP): 5-Bromopyridine-3-carboxylic Acid 

Br 

(B) 100 mg 

HO 

N 

O 

MM 0115.03 

5-Debromonicergoline 

H (D) 50 mg 

N 

N 

O 

O 

O 

N 




Nicorandil 

MM 0924.00 

Nicotinamide 

MM 0552.00 

Nicorandil 

Nicotinamide 

N 

O 

N 

H 

N NH 2 

O 

NO2 

(A) 100 mg 

O 

(A) 500 mg 

MM 0552.01 

Isonicotinamide 

O 

(A) 100 mg 

N 

NH 2 

Nicotine 

MM 0517.00 

Nicotine 

N 

N 

(A) 

500 mg 

MM 0517.03 

Imp. C (EP): (5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one (Cotinine) 

N N O 

(A) 

100 mg 

MM 0517.02 

Imp. D (EP): 3-(4,5-Dihydro-3H-pyrrol-2-yl)- 

pyridine (Myosmine) 

N N 

on request 

MM 0517.01 

Imp. G (Pharmeuropa): 3-[(2S)-Piperidin-2-yl]pyridine ((-)-Anabasine) 

(A) 

100 mg 

N 

N 

H 


MM 0553.00 


N 

O 

(A) 500 mg 

OH 

MM 0553.01 


N 

O 

(A) 500 mg 

O 

MM 0553.02 


N 

O 

(A) 500 mg 

O 

MM 0553.03 

Isonicotinic Acid 

O 

(A) 100 mg 

OH 

N 

Nifedipine 

MM 0003.00 

Nifedipine 

O 

O 

H 

N 

(A) 500 mg 

O 

O 

NO 2 

MM 0003.02 

Imp. A (EP): Dimethyl 2,6-Dimethyl-4-(2-nitrophenylpyridine-3,5- 

dicarboxylate (Nitrophenylpyridine Analogue of Nifedipine) 

O 

O 

N 

(A) 100 mg 

O 

O 

NO 

MM 0003.01 

Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(2-nitrosophenylpyridine- 

3,5-dicarboxylate (Nitrosophenylpyridine Analogue of Nifedipine) 

O 

N 

O 

(A) 

100 mg 

O 

O 

NO 

MM 0003.07 

Imp. C (EP) as E/Z-Mixture: Methyl (E/Z)-2-(2-Nitrobenzylidene)-3- 

oxobutanoate 

O 

O 

(A) 

100 mg 

O 

NO 2 




MM 0003.08 Imp. D (EP): Methyl 3-Aminobut-2-enoate 

H 2 N 

(C) 100 mg 

O 

MM 0003.03 2-Nitrobenzaldehyde 

O 

O 

NO 2 

(B) 100 mg 

Niflumic Acid 

MM 0850.00 

Niflumic Acid 

O 

(A) 

250 mg 

OH 

N 

NH 

F 

F F 

MM 0850.04 

Imp. A (Pharmeuropa): 2-Chloropyridine-3- 

carboxylic Acid (2-Chloronicotinic Acid) 

N 

Cl 

(A) 100 mg 

OH 

MM 0850.06 

Imp. C (Pharmeuropa): 3-(Trifluoromethyl)aniline 

F 

O 

F F 

(B) 100 mg 

NH 2 

Nifuroxazide 

MM 0574.00 

Nifuroxazide 

O 2N 

O 

N 

H 

N 

O 

OH 

(A) 

500 mg 

MM 0574.01 

Imp. A (EP): (4-Hydroxybenzoyl)diazane (p-Hydroxybenzohydrazide) 

H 2 N 

H 

N 

O 

OH 

(C) 

100 mg 

MM 0574.02 


OH 

(A) 

500 mg 

O 

O 

MM 0574.03 

Imp. C (EP): (5-Nitrofuran-2-yl)methylene Diacetate 

O 

(A) 

100 mg 

O 2 N 

O 

O 

O 

Nifursol 

MM 0444.00 Nifursol OH 

O 2 N 

O 

N 

H 

N 

O 

O 

NO 2 

(A) 100 mg 

NO 2 

MM 0444.01 

MM 0444.02 

5-Nitro-2-furfural 

5-Nitro-furfural Hydrazone 

MM 0444.03 3,5-Dinitrosalicylic Acid Hydrazide 

OH 

O 2 N 

O (C) 100 mg 

O 

NO 2 

H N 2 N (A) 100 mg 

O 

NO 2 

O 

N 

H 

NH 2 

(A) 100 mg 

NO 2 

Nikethamide 

MM 0627.00 

Nikethamide 

N 

O 

on request 

N 

Nimesulide 

MM 0378.00 

Nimesulide 

H 

N 

S 

(A) 

250 mg 

O 2 N 

O 

O 

O 




MM 0378.01 

Imp. A (EP): N-(2,4-Dinitro-6-phenoxyphenyl)methanesulphonamide 

O 2 N 

NO 2 

(A) 100 mg 

H 

N S 

O O 

O 

MM 0378.02 

Imp. B (EP): N-(2-Phenoxyphenyl)methanesulphonamide 

H 

N S 

O O 

O 

(A) 

100 mg 

MM 0378.03 

Imp. C (EP): 2-Phenoxyaniline 

NH 2 

(A) 100 mg 

O 

New MM 0378.04 

Imp. D (EP): 4-Nitro-2-phenoxyaniline 

NH 2 

(A) 

100 mg 

O 2 N 

O 

New MM 0378.05 

Imp. E (EP): N,N-Bis(methylsulphonyl)-2- 

phenoxyaniline 

O 

O S 

N 

S 

O O 

O 

(A) 

100 mg 

Nimodipine 

MM 0416.00 Nimodipine 

H 

N 

(A) 

100 mg 

O 

O 

O 

O 

O 

NO 2 

MM 0416.01 

Imp. A (EP): 2-Methoxyethyl 1-Methylethyl 2,6-Dimethyl-4-(3- 

nitrophenyl)pyridine-3,5-dicarboxylate 

O 

O 

N 

O 

O 

O 

(A) 

100 mg 

NO 2 

MM 0416.02 

Imp. B (EP): Bis(1-methylethyl) 2,6-Dimethyl-4-(3-nitrophenyl)- 

1,4-dihydropyridine-3,5-dicarboxylate 

O 

O 

H 

N 

O 

O 

NO 2 

(A) 100 mg 

MM 0416.03 

Imp. C (EP): Bis(2-methoxyethyl) 2,6-Dimethyl-4-(3- 

nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 

O 

O 

O 

H 

N 

O 

O 

O 

(A) 

100 mg 

NO 2 

Nitrazepam 

MM 0078.00 

Nitrazepam [Controlled Substance] 

H 

N 

O 

(A) 

100 mg 

O 2N 

N 

MM 0078.02 

Imp. A (EP): 3-Amino-6-nitro-4-phenylquinolin-2(1H)-one 

H 

N 

O (A) 100 mg 

O 2N 

NH 2 

MM 0078.01 

Imp. B (EP): (2-Amino-5-nitrophenyl)phenylmethanone 

(2-Amino-5-nitrobenzophenone) 

O 2N 

NH 2 

O 

(B) 

100 mg 




MM 0078.07 

7-Aminonitrazepam 

H 

N 

O 

(A) 

100 mg 

H 2 N 

N 

Nitrendipine 

MM 0092.00 Nitrendipine 

H N 

NO 2 

O 

(A) 

500 mg 

O 

O 

O 

MM 0092.03 

Imp. A (EP): Ethyl Methyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine- 

3,5-dicarboxylate (Photolysis Product) 

O 

O 

N 

O 

O 

NO 2 

(A) 

100 mg 

MM 0092.01 

Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4- 


O 

O 

H 

N 

O 

O 

NO 2 

(A) 

100 mg 

MM 0092.02 

Imp. C (EP): Diethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4- 


O 

O 

H 

N 

O 

O 

NO 2 

(A) 

100 mg 

MM 0092.04 

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic 

Acid Methyl Ester 

O 

O 

H 

N 

OH 

O 

NO 2 

(A) 

50 mg 

MM 0092.05 

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic 

Acid Ethyl Ester 

O 

O 

H 

N 

OH 

O 

NO 2 

(A) 

50 mg 

Nitrofural 

MM 0943.00 Nitrofural O O 2 N 

MM 0943.02 

Imp. B (EP): (5-Nitrofuran-2-yl)methylene Diacetate 

N 

H 

N NH 2 

O 

O 

(A) 

(A) 

500 mg 

100 mg 

O 2 N 

O 

O 

O 

O 

Nitrofurantoin 

MM 0506.00 

Nitrofurantoin 

O 2 N 

O 

O 

N N H 

N 

O 

(A) 

500 mg 

Nizatidine 

MM 0220.00 

Nizatidine 

MM 0220.01 Imp. A (EP): N,N‘-Dimethyl-2-nitroethene-1,1-diamine 

NO 2 

N 

(A) 500 mg 

S 

N 

S 

N 

H 

NO 2 

N 

H 

(A) 

100 mg 

MM 0220.09 Imp. B (EP): (EZ)-N-Methyl-1-methylsulphanyl)-2-nitroethen-1-amine 

NO 2 

N 

H 

N 

H 

S N 

H 

(A) 100 mg 

MM 0220.02 

Imp. C (EP): (EZ)-N-[2-[[[2-[(Dimethylamino)methyl]thiazol- 

4-yl]methyl]sulphinyl]ethyl]-N‘-methyl-2-nitroethene-1,1- 

diamine 

N 

S 

N 

O 

S 

N 

H 

NO 2 

N 

H 

(A) 

100 mg 




S 

MM 0220.11 Imp. H (EP) as Hydrochloride: 2-(Dimethylamino)thioacetamide 

(A) 100 mg 

x HCl 

N 

Hydrochloride 

NH 2 

MM 0220.12 

Imp. K (EP): 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one Oxime 

S 

N OH (A) 100 mg 

N 

N 

H 

Nonivamide 

MM 1033.00 

MM 1033.01 

Nonivamide 

4-(Aminomethyl)-2-methoxyphenol Hydrochloride 

(Vanillylamine Hydrochloride) 

O 

HO 

N 

H 

O 

HO 

O 

(A) 500 mg 

NH 2 

x HCl 

(A) 

100 mg 

MM 1033.02 

MM 1033.03 

MM 1033.04 

N-[(4-Hydroxy-3-methoxyphenyl)methyl]octanamide 

(N-Vanillyloctanamide) 

N-[(4-Hydroxy-3-methoxyphenyl)methyl]- 

decanamide (N-Vanillyldecanamide) 

N,O-Dinonanoylvanillylamine 

O 

HO 

O 

HO 

O 

O 

N 

H 

N 

H 

O 

(A) 100 mg 

O 

(A) 100 mg 

N 

H 

O 

(A) 

100 mg 

O 

Noradrenaline Tartrate 

MM 0785.01 

Imp. A (EP): Adrenaline 

HO 

OH 

H (A) 500 mg 

N 

HO 

MM 0785.03 Imp. C (EP) as Hydrochloride: Dopamine Hydrochloride 

HO 

NH 2 

x HCl 

(A) 

500 mg 

HO 

Norethisterone 

MM 0218.00 

Norethisterone 

OH 

(A) 250 mg 

O 

MM 0218.04 

Imp. A (EP): 17-Hydroxy-19-nor-17α-pregna-4,6-dien-20-yn-3-one 

(6,7-Didehydronorethisterone) 

OH 

(D) 100 mg 

O 

MM 0218.05 

Imp. B (EP): Estr-4-ene-3,17-dione (Norandrostenedione) 

O 

(A) 100 mg 

O 

MM 0218.01 

Imp. H (EP): 6β,17-Dihydroxy-19-nor-17α-pregn-4-en-20-yn-3-one 

(6β-Hydroxynorethisterone) 

OH 

(D) 

100 mg 

O 

OH 

MM 0218.02 

6α-Hydroxynorethisterone 

OH 

(D) 

50 mg 

O 

OH 

MM 0218.03 

6-Ketonorethisterone 

OH 

(D) 

100 mg 

O 

O 

Norethisterone Acetate 

MM 0219.00 

Norethisterone Acetate 

O 

O 

(A) 100 mg 

O 




MM 0219.11 Imp. A (EP): Norethisterone 

OH 

(A) 250 mg 

O 

MM 0219.10 

Imp. B (EP): 3-Oxo-19-nor-17α-pregn-5(10)-en-20-yn-17-yl 

Acetate 

O 

O 

(D) 100 mg 

O 

MM 0219.01 

Imp. F (EP): 6β-Hydroxy-3-oxo-19-nor-17α-pregn-4-en-20-yn-17- 

yl Acetate 

(6β-Hydroxynorethisterone Acetate) 

O 

O 

(D) 

100 mg 

O 

OH 

MM 0219.03 

Imp. G (EP): 3,6-Dioxo-19-nor-17α-pregn-4-en-20-yn-17-yl 

Acetate 

(6-Ketonorethisterone Acetate) 

O 

O 

(D) 

100 mg 

O 

O 

MM 0219.02 

6α-Hydroxynorethisterone Acetate 

O 

O 

(D) 

50 mg 

O 

OH 

MM 0219.04 

6,7-Didehydronorethisterone Acetate 

O 

O 

(D) 100 mg 

O 

Norfenefrine Hydrochloride 

MM 0973.00 

Norfenefrine Hydrochloride 

HO 

OH 

NH 2 x HCl 

(A) 500 mg 

Norfloxacin 

MM 0350.00 

Norfloxacin 

HN (A) 250 mg 

N 

N 

MM 0350.01 

MM 0350.03 

MM 0350.04 

Nortriptyline Hydrochloride 

MM 0079.00 

MM 0079.08 

Imp. A (EP): 7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline- 


Imp. D (Pharmeuropa): 1-Ethyl-6-fluoro-7-piperazin-1-yl-quinolin- 

4(1H)-one 

Imp. G (Pharmeuropa): 1-Ethyl-6-fluoro-7-(4-formylpiperazin- 

1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid 

Nortriptyline Hydrochloride 

Imp. A (EP): 10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-one 

(Dibenzosuberone) 

Cl 

F 

F 

HN 

N 

F 

N 

O 

O 

O 

OH 

O 

O 

O 

OH 

N 

O 

OH 

(A) 

(D) 

100 mg 

100 mg 

O N 

(D) 100 mg 

N N 

F 

N 

H 

O 

x HCl 

(A) 

(B) 

500 mg 

100 mg 




Ofloxacin 

MM 0228.00 Ofloxacin 

N O 

N N 

(A) 500 mg 

MM 0228.04 

MM 0228.05 

MM 0228.08 

MM 0228.10 

Omeprazole 

MM 0095.00 

MM 0095.03 

MM 0095.04 

MM 0095.06 

MM 0095.05 

MM 0095.07 

MM 0095.01 

Imp. A (EP): (RS)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic 

Acid (FPA) 

Imp. B (EP): (RS)-9-Fluoro-3-methyl-10-(4- 

methylpiperazin-1-yl)-2,3-dihydro-7H-pyrido- 

[1,2,3-de]-1,4-benzoxazin-7-one 

Imp. E (EP): (RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1- 

yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6- 

carboxylic Acid 

Imp. F (EP) as Hydrochloride: 4-[(RS)-6-Carboxy-9- 

fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 

1,4-benzoxazine-10-yl]-1-methylpiperazine 1-Oxide 

Hydrochloride (Ofloxacin N-Oxide Hydrochloride) 

Omeprazole 

Imp. A (EP): 5-Methoxy-1H-benzimidazole-2-thiol 

Imp. B (EP): 2-[(RS)-[(3,5-Dimethylpyridin-2-yl) 

methyl]sulphinyl]-5-methoxy-1H-benzimidazole 

N 

O 

Imp. C (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2- 

yl)methyl]sulphanyl]-1H-benzimidazole (Ufiprazole) 

Imp. D (EP): 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2- 

yl) methyl]sulphonyl]-1H-benzimidazole (Omeprazole 

Sulphone) 

Imp. E (EP): 4-Methoxy-2-[[(RS)-(5-methoxy-1Hbenzimidazol-2-yl)sulphinyl]methyl]-3,5-dimethylpyridine 

1-Oxide (Omeprazole N-Oxide) 

Imp. F (EP): 8-Methoxy-1,3-dimethyl-12- 

thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one 

O 

N 

F 

HN 

O 

O 

O 

O 

O 

O 

F 

F 

N 

F 

F 

O 

N 

O 

O 

OH 

O 

O 

OH 

(A) 

100 mg 

N O 

(A) 100 mg 

N 

N 

N 

O 

O 

H 

N 

N 

O 

H 

N 

N 

H 

N 

N 

F 

O 

N 

O 

S 

O 

S 

O 

S 

OH 

N 

O 

H 

N 

N 

N 

N 

H 

N 

S N 

N 

O 

O 

NH 

N S 

O N 

O 

N 

N 

S 

N 

O 

OH 

x HCl 

O 

O 

O 

SH 

O 

O 

(A) 

(A) 

(A) 

(A) 

(A) 

(A) 

(A) 

(A) 

(D) 

100 mg 

100 mg 

500 mg 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

50 mg 

MM 0095.02 

Imp. G (EP): 9-Methoxy-1,3-dimethyl-12- 

thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one 

O 

S 

(D) 50 mg 

N 

O 

N 

N 

MM 0095.15 

MM 0095.16 

MM 0095.08 

Imp. H (EP): 2-[(RS)-[(4-Chloro-3,5-dimethylpyridin-2- 

yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole 

Imp. I (EP): 4-Methoxy-2-[[(5-methoxy-1H-benzimidazol- 

2-yl)sulphonyl]methyl]-3,5-dimethylpyridine 1-Oxide 

(Omeprazole Sulphone N-Oxide) 

5-Methoxy-2-[[(3,5-dimethylpyridin-2-yl)methyl]sulphanyl]- 

1H-benzimidazole 

O 

NH 

N S 

Cl 

O N 

O 

NH 

N S 

O 

O O N 

O 

NH 

N S 

N 

(D) 100 mg 

(A) 100 mg 

O 

(A) 100 mg 




MM 0095.19 

MM 0095.20 

5-Methoxy-2-[[(4-chloro-3,5-dimethylpyridin-2-yl) 

methyl]sulphanyl]-1H-benzimidazole 

5-Methoxy-1,3-dihydrobenzimidazol-2-one 

O 

(D) 100 mg 

NH 

Cl 

N S 

N 

O 

(A) 100 mg 

NH 

N 

H 

O 

MM 0095.23 

2-[[(4-Methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]-1Hbenzimidazole 

NH 

N S 

O 

(A) 

100 mg 

O 

N 

MM 0095.24 

5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1Hbenzimidazole 

O 

NH 

N 

O 

(A) 

100 mg 

N 

Ondansetron Hydrochloride Dihydrate 

MM 0252.00 Ondansetron Hydrochloride Dihydrate 

N 

N 

N 

x HCl 

x 2 H 2 O 

on request 

MM 0252.09 Ondansetron 

N 

O 

N 

on request 

N 

O 

MM 0252.03 

Imp. A (EP): (3RS)-3-(Dimethylamino)methyl-9-methyl-1,2,3,9- 

tetrahydro-4H-carbazol-4-one 

N 

N 

(A) 

100 mg 

O 

MM 0252.02 

Imp. B (EP): 6,6'-Methylene bis[(3RS)-9- 

methyl-3-[(2-methyl-1H-imidazol-1- 

yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4- 

one] 

N 

N 

N 

O 

N 

O 

N 

N 

(D) 

50 mg 

MM 0252.01 Imp. C (EP): 9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one 

N 

(A) 

100 mg 

O 

MM 0252.04 

Imp. D (EP): 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4- 

one 

N 

(A) 

100 mg 

MM 0252.05 Imp. E (EP): 1H-Imidazole 

N 

O 

N 

H 

(B) 

100 mg 

N 

MM 0252.06 Imp. F (EP): 2-Methyl-1H-imidazole (B) 100 mg 

N 

H 

MM 0252.07 

Imp. G (EP): (3RS)-3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9- 

tetrahydro-4H-carbazol-4-one (C-Demethylondansetron) 

N 

N 

N 

(A) 

100 mg 

O 

MM 0252.08 

Imp. H (EP): (3RS)-3-[(2-Methyl-1H-imidazol-1-yl)methyl]-1,2,3,9- 

tetrahydro-4H-carbazol-4-one (N-Demethylondansetron) 

H 

N 

N 

N 

(A) 

100 mg 

O 

Opipramol Dihydrochloride 

MM 0422.01 

5-(3-Piperazin-1-yl-propyl)-5H-dibenzo[b,f]azepine 


N 

x 2 HCl 

(A) 

100 mg 

N 

NH 

Ornidazole 

MM 0948.00 

Ornidazole 

O 2 N 

(A) 

500 mg 

N 

Cl 

N 

OH 

New MM 0948.01 

2-Methyl-5-nitroimidazole 

O 2 N 

(B) 100 mg 

N 

NH 




New MM 0948.02 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)propane-1,2-diol 

New MM 0948.03 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)-1,2-epoxypropane 

Orphenadrine Hydrochloride 

O 2 N 

N 

OH 

OH 

N 

O 2 N 

N 

O 

N 

(A) 100 mg 

(A) 200 mg 

MM 0801.00 Orphenadrine Hydrochloride 

(A) 500 mg 

O 

N 

x HCl 

MM 0801.01 

Imp. A (EP): (RS)-(2-Methylphenyl)phenylmethanol 

(2-Methylbenzhydrol) 

(A) 

100 mg 

OH 

MM 0801.02 

Imp. B (EP): (2-Methylphenyl)phenylmethanone (2-Methylbenzophenone) 

(A) 

100 mg 

O 

MM 0801.04 

Imp. D (EP) as Hydrochloride: Diphenhydramine 

Hydrochloride 

O 

N 

x HCl 

(A) 

500 mg 

MM 0801.05 

Imp. E (EP) as Hydrochloride: (RS)-N,N-Dimethyl-2-[(3- 

methylphenyl)phenylmethoxy]ethanamine Hydrochloride 

(meta-Methylbenzyl Isomer Hydrochloride) 

O 

N 

x HCl 

(A) 

100 mg 

MM 0801.06 

Imp. F (EP) as Hydrochloride: (RS)-N,N-Dimethyl- 

2-[(4-methylphenyl)phenylmethoxy]ethanamine 

Hydrochloride (para-Methylbenzyl Isomer 


O 

N 

x HCl 

(A) 

100 mg 

MM 0801.07 

N-Desmethylorphenadrine Hydrochloride 

(A) 

100 mg 

O 

H 

N 

x HCl 

Oxacillin Sodium 

MM 0686.00 

Oxacillin Sodium Monohydrate 

N 

O 

O 

O 

N 

H 

O 

N 

S 

H 

ONa 

x H 2 O 

(A) 

250 mg 

New MM 0686.03 

New MM 0686.04 

Oxalic Acid Dihydrate 

MM 0928.00 

Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl- 

7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- 

carboxylic Acid (6-Aminopenicillanic Acid) 

Imp. E (EP) as Sodium Salt Monohydrate: 

Cloxacillin Sodium Monohydrate 

Oxalic Acid Dihydrate 

O 

H 2 N 

N 

H 

O 

S 

OH 

(B) 

100 mg 

Cl O 

(A) 500 mg 

ONa 

O 

N 

N 

H 

x H 2 O 

O N 

S 

H 

O 

O 

O 

OH 

OH 

x 2 H 2 O 

(A) 

500 mg 




Oxazepam 

MM 0080.00 

Oxazepam [Controlled Substance] 

Cl 

H 

N 

N 

O 

OH 

(D) 

100 mg 

MM 0080.07 

Imp. D (EP): (2-Amino-5-chlorophenyl)phenylmethanone 

(2-Amino-5-chlorobenzophenone) 

Cl 

NH 2 

O 

(B) 

100 mg 

MM 0080.03 

6-Chloro-4-phenyl-3,4-dihydroquinazoline-2-carboxylic Acid 

Cl 

O 

N 

OH 

NH 

(A) 

100 mg 

Oxcarbazepine 

MM 0637.00 

Oxcarbazepine 

O 

(A) 100 mg 

N 

MM 0637.01 

10-Hydroxy-10,11-dihydrocarbamazepine 

O NH 2 

HO 

(A) 100 mg 

N 

O NH 2 

Oxeladin Hydrogen Citrate 

MM 0547.00 Oxeladin Hydrogen Citrate 

O 

O 

O 

N 

MM 0547.02 Imp. A (EP): 2-[2-(Diethylamino)ethoxy]ethanol HO 

O 

x 

O 

O 

OH 

O 

OH 

OH 

OH 

(A) 

500 mg 

N (A) 100 mg 

MM 0547.01 

Oxeladin N-Oxide 

O 

O 

O 

N 

O 

(A) 

100 mg 

Oxfendazole 

MM 1012.02 

Imp. B (EP): Methyl [5-(Phenylsulphonyl)-1H-benzimidazol- 

2-yl]carbamate 

S 

O O 

H 

N 

N 

O 

NH 

O 

(A) 

100 mg 

Oxolinic Acid 

MM 0898.00 

Oxolinic Acid 

O 

N 

(A) 

250 mg 

O 

OH 

O 

O 

Oxomemazine 

MM 0957.00 

Oxomemazine 

N 

(A) 

100 mg 

N 

S 

O O 

MM 0957.01 

Trimeprazine Tartrate 

N 

S 

N 

OH O 

x HO 

OH 

O OH 

2 

(A) 

500 mg 




MM 0957.02 Trimeprazine Sulphoxide Hydrochloride 

N 

(A) 100 mg 

N 

x HCl 

S 

O 

MM 0957.04 

Oxomemazine N-Oxide Hydrochloride(Trimeprazine Sulphone 

N-Oxide Hydrochloride) 

N 

N O 

x HCl 

(A) 

100 mg 

S 

O O 

Oxprenolol Hydrochloride 

MM 0129.00 

Oxprenolol Hydrochloride 

O 

OH 

H 

N 

x HCl 

(A) 

500 mg 

O 

Oxybuprocaine Hydrochloride 

MM 0543.00 

Oxybuprocaine Hydrochloride 

H 2 N 

O 

O 

O 

N 

x HCl 

(A) 

500 mg 

MM 0543.01 

Imp. A (EP): 4-Aminobenzoic Acid 

O 

OH 

(B) 

100 mg 

H 2N 

MM 0543.02 

Imp. B (EP): 4-Amino-3-butoxybenzoic Acid 

O 

(A) 

100 mg 

OH 

H 2 N 

O 

MM 0543.03 

Imp. C (EP): 4-Amino-3-hydroxybenzoic Acid 

O 

OH 

(A) 

100 mg 

H 2 N 

OH 

MM 0543.05 

Oxybuprocaine N-Oxide Dihydrochloride 

H 2 N 

O 

O 

O 

N 

O 

x 2 HCl 

(A) 

100 mg 

Oxybutynin Hydrochloride 

MM 0047.00 

Oxybutynin Hydrochloride 

HO 

O 

N 

x HCl 

(A) 

250 mg 

O 

MM 0047.06 

Imp. B (EP): 4-(Diethylamino)but-2-ynyl 

2-Hydroxy-2,2-diphenylacetate 

(Diphenyl analogue of Oxybutynin) 

HO 

O 

O 

N 

(A) 

100 mg 

MM 0047.04 

Imp. C (EP) as Hydrochloride: 4-(Ethylmethylamino)but-2- 

ynyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate Hydrochloride 

(Methylethyl analogue of Oxybutynin 


HO 

O 

O 

N 

x HCl 

(D) 

100 mg 

MM 0047.01 

Imp. D (EP): (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetic Acid 

(Phenylcyclohexylglycolic Acid) 

HO 

OH 

(A) 

100 mg 

O 

MM 0047.07 

Imp. E (EP): 4-(Ethylpropylamino)but-2-ynyl (RS)- 

2-Cyclohexyl-2-hydroxy-2-phenylacetate (Ethylpropyl 

analogue of Oxybutynin) 

HO 

O 

O 

N 

(A) 

100 mg 

MM 0047.02 

Methyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate 

(Phenylcycloheyxlglycolic Acid Methyl Ester) 

HO 

O 

(A) 

100 mg 

MM 0047.03 4-Diethylaminobut-2-yn-1-ol N 

HO 

O 

(A) 

100 mg 




MM 0047.11 

Desethyloxybutynin Hydrochloride 

HO 

O 

O 

N 

H 

x HCl 

(D) 

100 mg 

MM 0047.50 

Propargyl (RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetate 

(Phenylcyclohexylglycolic Acid Propargyl Ester) 

HO 

O 

(A) 

100 mg 

O 

Oxycodone Hydrochloride 

MM 0672.00 

Oxycodone Hydrochloride 


HO 

N 

x HCl 

(A) 

100 mg 

MM 0672.03 

Imp. C (EP) as Hydrochloride: 4,5α-Epoxy-14-hydroxy-3- 

methoxymorphinan-6-one Hydrochloride (Noroxycodone 


O 

O 

HO 

H 

N 

O 

x HCl 

(D) 

50 mg 

MM 0672.05 

MM 0672.06 

4,5α-Epoxy-3-methoxy-17-methylmorphinan-6β,14-diol 

Hydrochloride 

(6β-Oxycodol Hydrochloride) 


Oxycodone N-Oxide 

O 

O 

O 

HO 

O 

N 

O 

x HCl 

OH 

N 

(D) 50 mg 

O 

(D) 50 mg 

HO 

O 

O 

O 

Oxymetazoline Hydrochloride 

MM 0177.00 

Oxymetazoline Hydrochloride 

HO 

HN 

N 

x HCl 

(A) 

250 mg 

MM 0177.01 

Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2-[4-(1,1- 

dimethylethyl)-3-hydroxy-2,6-dimethylphenyl)]acetamide 

Hydrochloride 

HO 

O 

H 

N 

NH 2 x HCl 

(A) 100 mg 

New MM 0177.08 Imp. B (Pharmeuropa) as Hydrochloride: 2-(4- 

tert-Butyl-2,6-dimethylbenzyl)-4,5-dihydro-1Himidazole 

Hydrochloride (Xylometazoline 


N 

N 

H 

x HCl 

(A) 

500 mg 

Oxyphenbutazone 

MM 0933.00 

Oxyphenbutazone Monohydrate 

O 

OH 

(A) 

250 mg 

N 

N 

x H 2 O 

O 

Oxytetracycline Hydrochloride 

MM 0554.00 Oxytetracycline Hydrochloride 

OH O OH O 

OH 

O 

(A) 

500 mg 

HO 

H 

H 

OH 

N 

OH 

NH 2 

x HCl 

MM 0554.02 

Imp. B (EP) as Hydrochloride: Tetracycline 

Hydrochloride 

OH O OH O 

OH 

H H 

HO 

N 

O 

NH 2 

OH 

x HCl 

(A) 

500 mg 

Pantoprazole Sodium Sesquihydrate 

MM 0099.00 

Pantoprazole Sodium 

F 

O 

F 

NNa 

N S 

O 

N 

O 

O 

on request 




MM 0099.01 Pantoprazole 

on request 

O 

NH O 

F 

O 

F N S 

MM 0099.02 

Imp. A (Pharmeuropa): 5-(Difluoromethoxy)-2-[[(3,4- 

dimethoxypyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole 

(Pantoprazole Sulphone) 

F 

O 

F 

O 

N 

NH 

O 

N S O O 

N 

O 

(A) 

100 mg 

MM 0099.03 

Imp. B (Pharmeuropa): 5-(Difluoromethoxy)- 

2-[[(3,4-dimethoxypyridin-2-yl)methyl]thio]-1Hbenzimidazole 

F 

O 

F 

NH 

N S 

O 

N 

O 

(A) 

100 mg 

MM 0099.04 

Imp. C (Pharmeuropa): 5-(Difluoromethoxy)- 

1H-benzimidazole-2-thiol 

New MM 0099.11 Mixture of Imp. D and F (Pharmeuropa): 5- and 6- 

(Difluoromethoxy)-2-[(2RS)-[(3,4-dimethoxypyridin- 

2-yl)methyl]sulfinyl]-1-methyl-1H-benzimidazole 

F 

O 

F 

O 

F 

F 

N 

N S 

O 

NH 

N SH 

O 

O 

N 

(A) 

100 mg 

on request 

F + 

O 

F 

N 

N 

S 

O 

O 

N 

O 

MM 0099.05 

2-Chloromethyl-3,4-dimethoxypyridine Hydrochloride 

Cl 

O 

O 

x HCl 

(A) 

100 mg 

N 

MM 0099.06 

Pantoprazole N-Oxide 

F 

O 

F 

NH O 

N S 

O N 

O 

O 

(D) 

100 mg 

MM 0099.07 

Pantoprazole Sulphone N-Oxide 

F 

O 

F 

NH O 

N S 

O O N 

O 

O 

(A) 

100 mg 

Paracetamol 

MM 0042.00 Paracetamol 

H 

N 

O 

HO 

(A) 

500 mg 

MM 0042.08 

Imp. A (EP): N-(2-Hydroxyphenyl)acetamide 

(2-Acetamidophenol) 

OH 

H 

N 

O 

(B) 

100 mg 

MM 0042.05 

MM0042.09 

Imp. B (EP): N-(4-Hydroxyphenyl)propanamide 

(N-Propionyl-4-aminophenol) 

Imp. C (EP): N-(3-Chloro-4-hydroxyphenyl)acetamide 

(3-Chloro-4-hydroxyacetanilide) 

MM 0042.10 Imp. D (EP): N-Phenylacetamide (Acetanilide) 

H 

N 

MM 0042.11 

Imp. E (EP): 1-(4-Hydroxyphenyl)ethanone 

(4-Hydroxyacetophenone) 

MM 0042.03 Imp. F (EP): 4-Nitrophenol 

NO 2 

HO 

HO 

H 

N 

O 

H 

N 

O 

(A) 

100 mg 

Cl 

(A) 100 mg 

HO 

O 

(B) 

100 mg 

O 

(B) 100 mg 

(B) 

100 mg 

HO 

MM 0042.12 

Imp. G (EP): 1-(4-Hydroxyphenyl)ethanone Oxime 

(4-Hydroxyacetophenone Oxime) 

HO 

N 

(A) 

100 mg 

HO 

MM 0042.04 

Imp. H (EP): 4-(Acetylamino)phenyl Acetate 

(N,O-Diacetyl-4-aminophenol) 

O 

O 

H 

N 

O 

(A) 

100 mg 

MM 0042.13 

Imp. I (EP): 1-(2-Hydroxyphenyl)ethanone 

(2-Hydroxyacetophenone) 

O 

OH 

(B) 

100 mg 




MM 0042.02 

Imp. J (EP): N-(4-Chlorophenyl)acetamide 

(4-Chloroacetanilide) 

MM 0042.01 Imp. K (EP): 4-Aminophenol 

NH 2 

Cl 

HO 

H 

N 

O 

(B) 

(B) 

100 mg 

100 mg 

HO NH 

MM 0042.07 3-Aminophenol 2 (B) 100 mg 

Paroxetine Hydrochloride Anhydrous 

MM 1032.02 Imp. B (EP): 1,3-Benzodioxol-5-ol (Sesamol) O 

OH 

(A) 100 mg 

MM 1032.12 

[(3S,4R)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl]methanol 

O 

F 

(A) 100 mg 

HO 

N 

Pentetrazol 

MM 0692.00 Pentetrazol N 

N 

N N 

(A) 

500 mg 

Pentoxifylline 

MM 0761.00 

Pentoxifylline 

O O 

(A) 500 mg 

N 

N 

O 

N 

N 

MM 0761.03 

Imp. A (EP): Theobromine 

HN 

O 

(A) 500 mg 

N 

O 

N 

N 

MM 0761.04 

Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione 

HN 

O 

(A) 100 mg 

H 

N 

O 

N 

N 

MM 0761.05 

Imp. C (EP): Theophylline 

N 

O 

(A) 500 mg 

H 

N 

O 

N 

N 

MM 0761.08 

Imp. F (EP): Caffeine 

N 

O 

(A) 500 mg 

N 

O 

N 

N 

Peppermint Oil 

MM 0163.03 

(-)-Menthol 

(A) 

500 mg 

OH 

MM 0163.12 

(+)-(R)-Pulegone 

(A) 

100 mg 

O 

Perazine Dimaleate 

MM 0815.00 

Perazine Dimaleate 

N 

N 

N 

x 2 

HO 

HO 

O 

(A) 

100 mg 

S 

O 

Perazine Dimalonate 

MM 0157.00 

Perazine Dimalonate 

N 

S 

N 

N 

O 

x 2 

HO 

OH 

O 

(A) 

100 mg 




MM 0157.01 

Perazine Sulphoxide 

N 

N 

(A) 

100 mg 

N 

S 

O 

MM 0157.02 

Phenothiazine 

H 

N (B) 100 mg 

S 

MM 0157.03 

1-(3-Chloropropyl)-4-methylpiperazine 

Cl 

N 

N 

on request 

Perphenazine 

MM 0826.00 

Perphenazine 

(A) 

250 mg 

N 

N 

S 

N 

OH 

Cl 

MM 0826.01 

Imp. A (Pharmeuropa): 2-[4-[3-(2-Chloro- 

5-oxido-10H-phenothiazin-10-yl)propyl]- 

piperazin-1-yl]ethanol (Perphenazine 

Sulphoxide) 

S 

O 

N 

N 

N 

OH 

(A) 

100 mg 

Cl 

Phenacetin 

MM 0551.00 

Phenacetin 

H 

N 

(A) 

100 mg 

O 

O 

MM 0551.01 Paracetamol 

H 

N 

O 

HO 

(A) 

500 mg 

MM 0551.02 4-Aminophenol 

NH 2 

Phenethyl Alcohol 

HO 

(B) 

100 mg 

MM 0953.00 Phenylethyl Alcohol 

OH 

(A) 500 mg 

Pheniramine Maleate 

MM 0059.00 Pheniramine Maleate N 

O 

N 

OH 

x 

OH 

O 

(A) 

100 mg 

MM 0059.02 Imp. A (EP): 2-Benzylpyridine N (C) 100 mg 

MM 0059.03 Imp. B (EP): 4-Benzylpyridine N (C) 100 mg 

New MM 0059.07 

Imp. C (EP) as Fumarate: (3RS)-N,N-Dimethyl- 

3-phenyl-3-(pyridin-4-yl)propan-1-amine 

Fumarate 

N 

N 

x 

HO 

O 

OH 

(A) 

100 mg 

O 

MM 0059.08 

Imp. D (EP) as Dihydrochloride: N,N,N',N'-Tetramethyl-3- 

phenyl-3-(pyridin-2-yl)pentane-1,5-diamine Dihydrochloride 

N 

N 

(A) 

100 mg 

N 

x 2 HCl 

MM 0059.01 

Pheniramine 

N (A) 100 mg 

N 




MM 0059.05 Pheniramine N-Oxide Dihydrochloride 

N 

O 

N 

x 2 HCl 

(A) 100 mg 

MM 0059.06 

Norpheniramine Maleate 

N 

H 

N 

x 

O 

OH 

OH 

(A) 

100 mg 

O 

Phenobarbital 

MM 0265.01 

Phenylethylacetylurea 

(2-Phenylbutyrylurea) 

O 

N 

H 

O 

(A) 100 mg 

NH 2 

MM 0265.02 

N-Benzoyl-N'-(2-phenyl)butanoylurea 

O 

N 

H 

O O 

(A) 100 mg 

N 

H 

MM 0265.03 

Barbituric Acid 

O 

H 

N O (C) 100 mg 

NH 

Phenoxyethanol 

MM 0952.00 Phenoxyethanol 

O 

O 

OH (A) 500 mg 

Phenoxymethylpenicillin Potassium 

MM 0026.00 

MM 0026.06 

MM 0026.03 

MM 0026.04 

MM 0026.02 

MM 0026.01 

MM 0026.05 

Phenylbutazone 

MM 0548.00 

Phenoxymethylpenicillin Potassium 

Imp. A (EP) as Potassium Salt: Benzylpenicillin 

Potassium 

Imp. B (EP): Phenoxyacetic Acid 




Imp. D (EP): (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[[2-(4- 

hydroxyphenoxy)acetyl]amino]-4-thia-1- 

azabicyclo[3.2.0]heptane-2-carboxylic Acid 

(4-Hydroxyphenoxymethylpenicillin) 

Imp. E (EP): (4S)-2- 

[Carboxy[(phenoxyacetyl)amino]methyl]-5,5- 

dimethylthiazolidine-4-carboxylic Acid (Penicilloic Acids of 

Phenoxymethylpenicillin) 

Imp. F (EP): (2RS,4S)-5,5-Dimethyl-2- 

[[(phenoxyacetyl)amino]methyl]thiazolidine- 


(Penilloic Acids of Phenoxymethylpenicillin) 

Phenylbutazone 

HO 

O 

O 

O 

O 

O 

O 

O 

H 

N 

O 

H 

N 

O 

H 2 N 

O 

H 

N 

H 

N 

O 

O 

O 

O 

N 

H 

N 

H 

N 

H 

N 

H 

HN 

O 

O 

O 

O 

O 

OH 

NH 

O 

N 

N 

O 

S 

S 

S 

S 

S 

O 

O 

HN 

S 

OK 

OK 

OH 

(A) 

(A) 

(B) 

250 mg 

250 mg 

100 mg 

OH (B) 100 mg 

OH 

OH 

OH 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

O 

(A) 500 mg 




New MM 0548.01 

Imp. A (EP): (2RS)-2-[(1,2-Diphenyldiazanyl)- 

carbonyl]hexanoic Acid 

O 

N 

NH 

O 

OH 

(D) 

100 mg 

MM 0548.02 

Imp. B (EP): 4-Butyl-4-hydroxy-1,2-diphenylpyrazolidine-3,5-dione 

O 

(A) 

50 mg 

N 

N 

OH 

O 

MM 0548.03 

Imp. C (EP): 1,2-Diphenyldiazane 

(1,2-Diphenylhydrazine) 

H 

N N 

H 

(A) 

100 mg 

MM 0548.04 

Imp. D (EP): 1,2-Diphenyldiazene 

N N 

(C) 100 mg 

MM 0548.05 

Phenylephrine Hydrochloride 

MM 0081.00 

Imp. E (EP) as Dihydrochloride: Biphenyl-4,4'-diamine 


(Benzidine Dihydrochloride) 

Phenylephrine Hydrochloride 

H 2 N NH 2 

x 2 HCl (A) 100 mg 

HO 

OH 

H 

N 

x HCl 

(A) 

500 mg 

MM 0081.05 

1,2,3,4-Tetrahydro-4,6-dihydroxy-2-methylisoquinoline 

Hydrochloride 

HO 

OH 

N 

x HCl 

(A) 

100 mg 

MM 0081.06 

1,2,3,4-Tetrahydro-4,8-dihydroxy-2-methylisoquinoline 

Hydrochloride 

OH 

N 

x HCl 

(A) 

50 mg 

OH 

Phenylpropanolamine Hydrochloride 

MM 0656.00 

Phenylpropanolamine Hydrochloride [Controlled Substance] 

OH 

NH 2 

x HCl 

(A) 

500 mg 

and enatiomere 

Phenyltoloxamine Citrate 

MM 0770.00 

Phenyltoloxamine Citrate 

O 

N 

x 

O 

OH 

OH 

O 

(A) 

500 mg 

O 

OH 

OH 

Phenytoin 

MM 0630.00 

Phenytoin 

H 

N 

O 

(A) 

500 mg 

NH 

O 

MM 0630.01 

Imp. A (EP): Diphenylmethanone (Benzophenone) 

(B) 

100 mg 

MM 0630.02 

Imp. B (EP): Diphenylethanedione (Benzil) 

O 

O (B) 100 mg 

O 

MM 0630.03 

5-(4-Methylphenyl)hydantoin 

H 

N 

O 

(A) 

100 mg 

NH 

O 

Phenytoin Sodium 

MM 0622.00 

Phenytoin Sodium 

H 

N 

ONa 

(A) 

500 mg 

N 

O 




New MM 0622.01 Imp. A (Pharmeuropa): Diphenylmethanone (Benzophenone) 

(B) 100 mg 

New MM 0622.02 Imp. B (Pharmeuropa): Diphenylethanedione (Benzil) O 

O 

(B) 

100 mg 

O 

Pholcodine 

MM 0733.01 

Imp. A (EP) as Hydrochloride Trihydrate: 

Morphine Hydrochloride Trihydrate 


N 

x HCl 

x 3 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

MM 0733.02 

Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine 


N 

x H 2 SO 4 

x 5 H 2 O 

(A) 

250 mg 

HO 

O 

OH 

2 

MM 0733.03 

Imp. B (EP) as Phosphate Hemihydrate: 



N 

x H 3 PO 4 

x 1/2 H 2 O 

(A) 

100 mg 

O 

O 

OH 

MM 0733.04 

Imp. B (EP) as Monohydrate: Codeine Monohydrate 


N 

x H 2 O 

(A) 

100 mg 

O 

O 

OH 

Pilocarpine Hydrochloride 

MM 0338.00 

Pilocarpine Hydrochloride 

N 

N 

O 

O 

x HCl 

(A) 

500 mg 

MM 0338.01 

Imp. A (EP) as Hydrochloride: (3R,4R)-3-Ethyl-4- 

[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran- 

2(3H)-one Hydrochloride (Isopilocarpine 


N 

N 

O 

O 

x HCl 

(A) 

100 mg 

MM 0338.02 

Imp. B (EP) as Sodium Salt: (2S,3R)-2-Ethyl-3- 

(hydroxymethyl)-4-(1-methyl-1H-imidazol-5- 

yl)butanoic Acid Sodium Salt (Pilocarpic Acid 

Sodium Salt) 

N 

N 

OH 

O (A) 100 mg 

ONa 

MM 0338.03 

Imp. C (EP) as Sodium Salt: (2R,3R)-2-Ethyl-3- 

(hydroxymethyl)-4-(1-methyl-1H-imidazol-5- 

yl)butanoic Acid Sodium Salt (Isopilocarpic 

Acid Sodium Salt) 

N 

N 

OH 

O (A) 100 mg 

ONa 

Pindolol 

MM 0082.00 

Pindolol 

O 

OH 

N 

H 

(A) 

250 mg 

N 

H 

MM 0082.01 

Imp. E (EP): 1H-Indol-4-ol 

OH 

(A) 100 mg 

N 

H 

Pipazetate Hydrochloride 

MM 0486.06 

MM 0486.02 

Bis-(2-piperidinoethyl)ether Dihydrochloride (BPEE 

Dihydrochloride) 

1,2-Dipiperidinoethane (DPE) 

N 

O 

N 

N 

x 2 HCl 

N 

(A) 

(A) 

100 mg 

100 mg 

MM 0486.05 

2-(2-Piperidinoethoxy)ethanol Hydrochloride 

HO 

O 

N 





Pipemidic Acid Trihydrate 

MM 0401.00 Pipemidic Acid Trihydrate 

HN 

N N N 

x 3 H 2 O 

N 

OH 

(A) 250 mg 

Pipenzolate Bromide 

MM 0783.00 

Pipenzolate Bromide 

O O 

N + Br - (A) 500 mg 

O 

O 

OH 

MM 0783.02 

1-Ethyl-3-hydroxy-1-methylpiperidinium Bromide 

N + Br - on request 

OH 

MM 0783.08 

Diphenylmethanone (Benzophenone) 

O 

(B) 

100 mg 

MM 0783.09 Benzilic Acid O 

(B) 

100 mg 

HO 

OH 

Piperacillin 

MM 0295.00 

Piperacillin 

O 

N 

N O 

O NH 

O 

H 

N 

O 

O 

N 

S 

H 

OH 

(A) 

100 mg 

Piperacillin Sodium 

MM 0296.00 

Piperacillin Sodium 

O 

N 

N O 

O 

O NH 

H 

N 

O 

NaO 

N 

S 

H 

O 

(A) 

100 mg 

MM 0296.01 

Imp. A (EP) as Sodium Salt: Ampicillin Sodium 

O 

NH 2 

H 

N 

O 

NaO 

N 

S 

H 

O 

(A) 

500 mg 

MM 0296.05 

MM 0296.07 

Imp. E (EP): 1-Ethylpiperazine-2,3-dione 

Imp. G (EP): (2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)- 

carbonyl]amino]-2-phenylacetic Acid 

NH 

O 

O 

N 

N O 

O 

O NH 

OH 

O 

N (A) 100 mg 

(A) 100 mg 

MM 0296.08 

Imp. H (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1- 


O 

N 

O 

OH (B) 100 mg 

H 2 N 

S 

H 

Piprinhydrinate 

MM 0155.00 

Piprinhydrinate 

O 

N 

O 

N 

O N 

H 

N 

N 

Cl 

on request 




MM 0155.01 Diphenylpyraline 

(A) 100 mg 

O 

N 

MM 0155.02 

8-Chlorotheophylline 

O 

N 

O N 

H 

N 

N 

Cl 

(B) 

100 mg 

MM 0155.03 

Diphenylmethanol (Benzhydrol) 

OH 

(B) 

100 mg 

Piracetam 

MM 0083.00 Piracetam 

MM 0083.05 Imp. A (EP): Pyrrolidin-2-one (2-Pyrrolidone) 

MM 0083.04 Imp. B (EP): Methyl (2-Oxopyrrolidin-1-yl)acetate 

MM 0083.02 Imp. C (EP): Ethyl (2-Oxopyrrolidin-1-yl)acetate 

MM 0083.01 Imp. D (EP): (2-Oxopyrrolidin-1-yl)acetic Acid 

MM 0083.03 N-Vinyl-2-pyrrolidone 

O 

N 

NH 2 

O 

NH 

O 

O 

N 

O 

O 

O 

N 

O 

O 

O 

N 

OH 

O 

N 

O 

MM 0083.06 2-Chloroacetamide 

O 

Cl 

NH 2 

(A) 

(B) 

(A) 

(A) 

(A) 

(A) 

(C) 

500 mg 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

Piroxicam 

MM 0084.00 

Piroxicam 

O O 

S 

N 

H 

N 

N 

(A) 

500 mg 

OH 

O 

MM 0084.01 Imp. A (EP): Pyridin-2-amine (2-Pyridylamine) 

N NH 2 (B) 100 mg 

MM 0084.08 

Imp. B (EP): 4-Hydroxy-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3- 

carboxamide 1,1-Dioxide 

O O 

S 

NH 

H 

N 

N 

(A) 

100 mg 

MM 0084.09 

MM 0084.07 

MM 0084.05 

MM 0084.10 

Imp. C (EP): 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3- 

carboxamide 

1,1-Dioxide 

Imp. D (EP): Methyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)- 

yl)acetate 

Imp. E (EP): Ethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)- 

yl)acetate 

Imp. F (EP): 1-Methylethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol- 

2(3H)-yl)acetate 

OH 

O 

O O 

S 

N 

OH 

O 

S O 

N 

O 

O 

S O 

N 

O 

O 

O O 

S 

N 

O O 

O 

O 

O 

O 

NH 2 

(A) 100 mg 

O 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

MM 0084.04 

Imp. G (EP): Methyl 4-Hydroxy- 2H-1,2-benzothiazine-3-carboxylate 

1,1-Dioxide 

O O 

S 

NH 

O 

(A) 

100 mg 

OH 

O 

MM 0084.06 

Imp. H (EP): Ethyl 4-Hydroxy- 2H-1,2-benzothiazine-3-carboxylate 

1,1-Dioxide 

O O 

S 

NH 

O 

(A) 

100 mg 

OH 

O 




MM 0084.11 

Imp. I (EP): 1-Methylethyl 4-Hydroxy-2H-1,2-benzothiazine-3- 


O O 

S 

NH 

O 

(A) 

100 mg 

OH 

O 

MM 0084.02 

Imp. J (EP): Methyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3- 


O O 

S 

N 

O 

(A) 

100 mg 

OH 

O 

MM 0084.03 

Imp. K (EP): Ethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3- 


O O 

S 

N 

O 

(A) 

100 mg 

OH 

O 

MM 0084.12 

Imp. L (EP): 1-Methylethyl 4-Hydroxy-2-methyl-2H-1,2- 

benzothiazine-3-carboxylate 1,1-Dioxide 

O O 

S 

N 

O 

(A) 

100 mg 

OH 

O 

MM 0084.13 

N-Methylsaccharin 

O 

S O 

N 

(A) 

100 mg 

O 

MM 0084.15 

4-Isopropoxy-2-methyl-N-(2-pyridinyl)-2H- 

1,2-benzothiazine-3-carboxamide 1,1-Dioxide 

O O 

S 

N 

H 

N 

N 

(A) 

100 mg 

O 

O 

MM 0084.16 N,N'-Di-(2-pyridinyl)oxamide 

H N N 

O 

O 

N 

H 

N 

(A) 

100 mg 

MM 0084.17 N-(2-Pyridinyl)oxamic Acid Hydrochloride H 

N N 

O 

O 

OH 

x HCl 

(A) 

100 mg 

MM 0084.20 

2-(1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetamide 

O 

S O 

N 

(A) 

100 mg 

O 

O 

NH 2 

MM 0084.21 

N-(6-Methyl-2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine- 

3-carboxamide-1,1-Dioxide 

O O 

S 

N 

H 

N 

N 

(A) 

100 mg 

OH 

O 

MM 0084.22 

4-Methoxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3- 

carboxamide-1,1-Dioxide 

O O 

S 

N 

H 

N 

N 

(A) 

50 mg 

O 

O 

MM 0084.23 

2-Methyl-N-2-(1-methylpyridinium)-2H-1,2-benzothiazine-3- 

carboxamide-4-olate 1,1-Dioxide 

O O 

S 

N 

H 

N 

N 

(A) 

100 mg 

O 

O 

MM 0084.24 

Potassium Sorbate 

4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide 

O O 

S 

NH 

MM 0955.00 Potassium Sorbate 

O 

Povidone 

MM 0537.02 

Imp. A (EP): 1-Ethenylpyrrolidin-2-one (1-Vinylpyrrolidin-2-one) 

OH 

O 

N 

NH 2 

(A) 100 mg 

OK 

O 

(A) 

(A) 

500 mg 

100 mg 

MM 0537.03 Imp. B (EP): Pyrrolidin-2-one (2-Pyrrolidone) 

H 

N 

O 

(B) 

100 mg 

MM 0537.01 Vinyl Acetate 

O 

O 

(B) 

100 mg 

Pralidoxime Methyl Sulphate 

MM 0689.00 

Pralidoxime Methyl Sulphate 

N 

N OH 

O O 

O S O 

(A) 

100 mg 

New MM 0689.01 

2-Carboxy-N-methylpyridinium Iodide 

N 

O 

OH 

I - (A) 100 mg 




New MM 0689.02 

2-Carbamoyl-N-methylpyridinium Methanesulfonate 

N 

O 

(A) 100 mg 

NH 2 

O O 

O S 

Prasterone 

MM 0651.00 Prasterone 

O 

(A) 

500 mg 

HO 

New MM 0651.02 

16-Dehydropregnenolone Acetate Oxime 

N 

OH 

(A) 

100 mg 

O 

O 

Pravastatin Sodium 

MM 0503.00 

Pravastatin Sodium 

O 

(A) 

100 mg 

OH 

ONa 

H 

O 

O 

OH 

OH 

MM 0503.04 

Imp. D (EP): (1S,3S,7S,8S,8aR)-3-Hydroxy-8-[2-[(2R,4R)-4- 

hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl- 

1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-Methylbutanoate 

(Pravastatin Lactone) 

O 

(D) 100 mg 

O 

OH 

H 

O O 

OH 

Praziquantel 

MM 0615.00 Praziquantel 

O 

N 

H 

N 

O 

(A) 

250 mg 

MM 0615.02 

Imp. B (EP): 2-(Cyclohexylcarbonyl)- 

2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]- 

isoquinolin-4-one 

O 

N 

N 

O 

(A) 

50 mg 

Prazosin Hydrochloride 

MM 0085.00 


O 

(A) 

100 mg 

N 

O 

N 

N 

O 

O 

N 

x HCl 

MM 0085.04 Imp. A (EP): 2-Chloro-6,7-dimethoxyquinazoline-4-amine 

O N 

MM 0085.05 Imp. B (EP): 1,4-Bis(furan-2-ylcarbonyl)piperazine 

NH 2 

Cl 

(A) 100 mg 

N 

O 

O 

O 

N 

N O 

(A) 100 mg 

O 

MM 0085.01 

Imp. C (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)-quinazolin-4-amine 

O 

O 

NH (A) 100 mg 

N N 

N 

NH 2 

MM 0085.02 

Imp. D (EP): 1-(Furan-2-ylcarbonyl)piperazine 

O 

(A) 

100 mg 

N 

HN 

O 




MM 0085.03 

Imp. E (EP): 2,2'-(Piperazin-1,4-diyl)bis- 

(6,7-dimethoxyquinazolin-4-amine 

N 

NH 2 

O 

(D) 

100 mg 

O 

N 

N 

N 

N 

O 

O 

N 

O 

N 

MM 0085.06 2,4-Dichloro-6,7-dimethoxyquinazoline 

MM 0085.07 

6,7-Dimethoxyquinazolin-2,4-dione 

NH 2 

O 

O 

Cl 

H 

N 

N 

Cl 

(A) 100 mg 

O 

(C) 

100 mg 

O 

NH 

O 

Prednisolone 

MM 0193.00 

Prednisolone 

HO 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0193.03 

Imp. A (EP): Hydrocortisone 

HO 

O 

OH 

OH 

(A) 

500 mg 

O 

MM 0193.01 

(20R)-Hydroxyprednisolone 

HO 

HO 

OH 

OH 

(D) 

50 mg 

O 

MM 0193.02 

(20S)-Hydroxyprednisolone 

HO 

HO 

OH 

OH 

(D) 

50 mg 

O 

Prednisolone Acetate 

MM 0194.00 

Prednisolone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

MM 0194.01 

Imp. A (EP): Hydrocortisone Acetate 

HO 

O 

O 

OH 

O 

(A) 500 mg 

O 

MM 0194.02 

Imp. B (EP): Prednisolone 

HO 

O 

OH 

OH 

(A) 

500 mg 

O 

New MM 0194.07 

Prednienic Acid 

HO 

O 

OH (A) 100 mg 

OH 

O 

MM 0194.04 

Prednisolone 17-Acetate 

HO 

O 

O 

OH 

(A) 

100 mg 

O 

O 

Prednisolone Pivalate 

MM 0304.00 

Prednisolone Pivalate 

HO 

O 

O 

OH 

O 

(D) 250 mg 

O 




Prednisolone Sodium Phosphate 

MM 0305.00 Prednisolone Sodium Phosphate 

O 

HO 

O ONa 

(A) 100 mg 

O P ONa 

OH 

O 

Prednisolone Sodium Sulfobenzoate 

MM 0484.01 

Sodium 3-Sulfobenzoate 

HO 

O 

O O (C) 100 mg 

S ONa 

Prednisone 

MM 0482.00 

Prednisone 

O 

O 

OH 

OH 

(A) 

250 mg 

O 

Prednisone Acetate 

MM 0196.00 

Prednisone Acetate 

O 

O 

O 

OH 

O 

(A) 

250 mg 

O 

Prilocaine Hydrochloride 

MM 0563.00 Prilocaine Hydrochloride H 

N 

O 

N 

H 

x HCl 

(A) 

500 mg 

MM 0563.02 

Primidone 

MM 1030.03 

Imp. B (EP): 2-Methylbenzenamine 

(o-Toluidine) 

Imp. C (EP): (2RS)-2-Phenylbutanamide 

NH 2 

(A) 100 mg 

(A) 100 mg 

NH 2 

O 

MM 1030.05 

Imp. E (EP): (2RS)-2-Phenylbutanoic Acid 

OH 

(A) 

100 mg 

O 

Probenecid 

MM 0657.00 

Probenecid 

N 

S 

O O 

O 

OH 

(A) 

500 mg 

Procainamide Hydrochloride 

MM 0550.00 

Procainamide Hydrochloride 

H 2N 

O 

N 

H 

N 

x HCl 

(A) 

500 mg 

MM 0550.02 

Procainamide N-Oxide Dihydrochloride 

H 2 N 

O 

N 

H 

O 

N 

x 2 HCl 

(A) 

100 mg 

Procaine Hydrochloride 

MM 0596.00 

Procaine Hydrochloride 

O 

O 

N 

x HCl 

(A) 

500 mg 

H 2N 

MM 0596.01 


O 

(B) 

100 mg 

OH 

H 2 N 




Progesterone 

MM 0222.00 

Progesterone 

O 

(A) 500 mg 

O 

MM 0222.02 

Imp. A (EP): Pregna-4,14-diene-3,20-dione 

O 

(D) 50 mg 

O 

MM 0222.03 

Imp. C (EP): (20R)-20-Hydroxypregn-4-en-3-one 

HO 

(A) 100 mg 

O 

MM 0222.01 

Imp. E (EP): (20R)-3-Oxopregn-4-en-20-yl Acetate 

O 

(D) 100 mg 

O 

O 

MM 0222.08 

11α-Hydroxyprogesterone 

O 

(A) 

100 mg 

HO 

O 

MM 0222.12 

11-Ketoprogesterone 

O 

(A) 

100 mg 

O 

O 

MM 0222.14 

Pregnanediol (5β-Pregnane-3α,20(S)-diol) 

HO 

(A) 

100 mg 

HO 

H 

MM 0222.15 

Pregnanetriol (5β-Pregnane-3α,17,20(S)-triol) 

HO 

(A) 

50 mg 

OH 

Proguanil Hydrochloride 

HO 

H 

MM 0840.02 Imp. B (EP): 4-Chloroaniline 

Cl 

NH 2 

(B) 100 mg 

Prolintane Hydrochloride 

MM 0663.00 

Prolintane Hydrochloride 

(A) 

100 mg 

N 

x HCl 

Promazine Hydrochloride 

MM 0290.00 

Promazine Hydrochloride 

N 

(A) 

500 mg 

N 

x HCl 

S 

MM 0290.01 

Imp. A (EP): 3-(10H-Phenothiazin-10-yl)-N,N-dimethylpropan-1-amine 

S-Oxide (Promazine Sulphoxide) 

N 

N 

(A) 

100 mg 

S 

O 

MM 0290.02 

MM 0290.03 

N,N-Dimethyl-3-chloropropylamine Hydrochloride 

Phenothiazine 

Cl N x HCl 

(B) 100 mg 

H 

N (B) 100 mg 

S 




Promethazine Hydrochloride 

MM 0412.00 Promethazine Hydrochloride 

(A) 500 mg 

N 

N 

x HCl 

S 

MM 0412.01 

Imp. A (EP): Phenothiazine 

(B) 

100 mg 

S 

NH 

New MM 0412.02 

Imp. B (EP) as Hydrochloride: (2RS)-N,N- 

Dimethyl-2-(10H-phenothiazin-10-yl)propan- 

1-amine Hydrochloride (Isopromethazine 


S 

N 

N 

x HCl 

(A) 

100 mg 

MM 0412.04 

Imp. D (EP): (2RS)-N,N-Dimethyl-1-(10H-phenothiazin-10-yl)propan- 

2-amine S-Oxide (Promethazine Sulphoxide) 

S 

O 

N 

N 

(A) 

100 mg 

MM 0412.05 

Promethazine Sulphoxide N-Oxide Hydrochloride 

S 

O 

N 

O 

N 

x HCl 

(A) 

100 mg 

New MM0412.06 

(2RS)-N-Methyl-2-(10H-phenothiazin-10-yl)propan-1-amine 

Hydrochloride (Norisopromethazine Hydrochloride) 

S 

N 

H 

N 

x HCl 

(A) 

100 mg 

Propafenone Hydrochloride 

MM 0405.00 Propafenone Hydrochloride O O 

OH 

N 

H 

x HCl 

(A) 

500 mg 

MM 0405.01 

5-Hydroxypropafenone Hydrochloride 

O 

O 

OH 

N 

H 

x HCl 

(A) 

100 mg 

OH 

Propentofylline 

MM 0875.01 

3-Methyl-7-propylxanthine 

O 

(A) 

100 mg 

HN 

N 

O 

N 

N 

MM 0875.02 

1-(3-Hydroxypropyl)-3-methyl-7-propylxanthine 

O 

(A) 

100 mg 

HO 

N 

N 

O 

N 

N 

MM 0875.03 

1,7-Bis-(5-oxohexyl)-3-methylxanthine 

O 

(A) 100 mg 

O 

N 

O 

N 

O 

N 

N 

Propofol 

MM 0461.00 Propofol 

OH 

(A) 250 mg 

MM 0461.03 Imp. A (EP): 2,4-Bis(1-methylethyl)phenol 

OH 

(A) 100 mg 

MM 0461.04 Imp. C (EP): 2-(1-Methylethyl)phenol 

OH 

(C) 100 mg 




MM 0461.02 Imp. E (EP): 3,3',5,5'-Tetrakis(1-Methylethyl)bisphenyl-4,4'-diol 

(A) 100 mg 

HO 

OH 

MM 0461.05 Imp. F (EP): 3-(1-Methylethyl)phenol 

HO 

(C) 

100 mg 

MM 0461.08 

Imp. G (EP): 2-(1-Methylethoxy)-1,3-bis(1-methylethyl)benzene 

(A) 

100 mg 

O 

MM 0461.06 Imp. H (EP): 4-(1-Methylethyl)phenol 

HO 

(C) 100 mg 

MM 0461.07 Imp. I (EP): Oxydibenzene 

O 

(B) 100 mg 

MM 0461.11 

Imp. K (EP): 1-(1-Methylethoxy)-2-(1-methylethyl)benzene 

O 

(A) 

100 mg 

Propranolol Hydrochloride 

MM 0043.00 

Propranolol Hydrochloride 

O 

OH H 

N x HCl 

(A) 

500 mg 

MM 0043.01 

Imp. A (EP): (2RS)-3-(Naphthalen-1- 

yloxy)propane-1,2-diol (Diol Derivative) 

O 

OH 

OH 

(A) 

100 mg 

MM 0043.03 

Imp. B (EP) as Hydrochloride: 1,1'-[(1- 

Methylethyl)imino]bis[3-(naphthalen-1- 

yloxy)propan-2-ol] Hydrochloride 

(Tertiary Amine Derivative Hydrochloride) 

O 

OH 

N 

x HCl 

OH 

O 

(A) 

100 mg 

MM 0043.04 1-Naphthol 

OH 

(B) 100 mg 

MM 0043.05 1-(1-Naphtyloxy)-2,3-epoxypropane O 

O 

(A) 

100 mg 

Propyl Gallate 

MM 1037.00 

Propyl Gallate 

HO 

O 

(A) 500 mg 

O 

Propyl Parahydroxybenzoate 

HO 

OH 

MM 0432.00 

Propyl Parahydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0432.02 


O 

(B) 100 mg 

OH 

HO 

MM 0432.03 


O 

(A) 500 mg 

O 

HO 

MM 0432.04 

Imp. C (EP): Ethyl 4-Hydroxybenzoate 

O 

(A) 500 mg 

O 

HO 

MM 0432.05 


O 

(A) 500 mg 

O 

HO 

MM 0432.01 

Sodium Propyl Parahydroxybenzoate 

O 

(B) 100 mg 

O 

NaO 




Propylhexidrine Hydrochloride 

MM 0664.00 

Propylhexidrine Hydrochloride 

NH 


Propyphenazone 

MM 0036.00 

Propyphenazone 

O (A) 500 mg 

N 

N 

MM 0036.05 

Imp. A (EP): Phenazone 

O (A) 100 mg 

N 

N 

Proxymetacaine Hydrochloride 

MM 0404.00 

Proxymetacaine Hydrochloride 

H 2 N 

O 

O 

N 

x HCl 

(A) 

500 mg 

O 

MM 0404.01 

3-Amino-4-propoxybenzoic Acid Hydrochloride 

H 2 N 

O 

OH 

x HCl 

(A) 

100 mg 

O 

MM 0404.02 

Proxymetacaine N-Oxide Dihydrochloride 

H 2 N 

O 

O 

N 

O 

x 2 HCl 

(A) 

100 mg 

O 

Pseudoephedrine Hydrochloride 

MM 2115.01 

Methcathinone Hydrochloride 

(2-Methylamino-1-phenylpropan-1-one Hydrochloride) 


O 

NH 

x HCl 

(A) 

100 mg 

Pyrazinamide 

MM 0385.00 

Pyrazinamide 

N 

O 

on request 

NH 2 

N 

MM 0385.01 

Imp. A (EP): Pyrazine-2-carboxylic Acid 

N 

O 

(A) 100 mg 

OH 

N 

Pyridostigmine Bromide 

MM 0429.02 

Imp. B (EP) as Iodide: 3-Hydroxy-1-methylpyridinium 

Iodide 

HO 

N + 

I - 

(A) 

100 mg 

Pyridoxine Hydrochloride 

MM 0021.00 

Pyridoxine Hydrochloride 

N 

(A) 

500 mg 

HO 

OH 

x HCl 

OH 

MM 0021.02 

Imp. B (EP) as Hydrochloride: 5-(Hydroxymethyl)-2,4- 

dimethylpyridin-3-ol Hydrochloride 

HO 

N 

OH x HCl (A) 100 mg 

MM 0021.03 Pyridoxine Diacetate 

N 

HO 

O 

O 

O 

(A) 

100 mg 

O 

MM 0021.05 Pyridoxal Hydrochloride 

N 

(A) 

100 mg 

HO 

OH 

x HCl 

O 

MM 0021.06 Pyridoxamine Dihydrochloride 

N 

(A) 

100 mg 

HO 

OH 

x 2 HCl 

NH 2 




MM 0021.07 4-Pyridoxic Acid 

N 

Quinapril Hydrochloride 

MM 0628.00 

Quinapril Hydrochloride 

O 

O 

N 

H 

HO 

N 

O 

O 

O 

OH 

OH 

OH 

x HCl 

(D) 

50 mg 

on request 

MM 0628.01 4-Amino-6-chlorobenzene-1,3-disulphonamide 

O O O O 

(B) 100 mg 

S 

H 2 N 

S NH2 

Cl NH 2 

Quinine Dihydrochloride 

MM 0458.00 

Quinine Dihydrochloride 

H 

(A) 

500 mg 

O 

HO 

N 

H 

x 2 HCl 

N 

Quinuclidinyl Benzilate 

MM 0825.01 

Benzilic Acid 

HO 

O 

OH 

(B) 

100 mg 

MM 0825.02 3-Quinuclidinol 

N 

(A) 

100 mg 

Rabeprazole Sodium 

MM 0618.01 

Rabeprazole Sodium 

OH 

O 

on request 

O 

MM0618.00 

Rabeprazole 

Na 

N 

N 

S 

O 

N 

O 

on request 

O 

MM 0618.02 

MM 0618.03 

MM 0618.04 

MM 0618.05 

2-[[[4-(3-Methoxypropoxy)-3-methyl-2- 

pyridinyl]methyl]thio]-1H-benzimidazole 

Rabeprazole Sulphone 

Rabeprazole N-Oxide 

Rabeprazole Sulphone N-Oxide 

H 

N 

N 

H 

N 

N 

H 

N 

N 

H 

N 

N 

H 

N 

N 

S 

O 

S 

N 

N 

O 

O 

(A) 100 mg 

(A) 100 mg 

N 

O 

O 

O 

O 

S 

O 

S 

N 

O 

O 

O 

S 

N 

O 

O 

O 

O 

O 

(D) 

(A) 

100 mg 

100 mg 

MM 0618.07 

2-Chloromethyl-3-methyl-4-(3-methoxy-propoxy)pyridine 

Hydrochloride 

Cl 

O 

O 

x HCl 

(A) 

100 mg 

N 




Raloxifene Hydrochloride 

HO 

MM 0738.00 Raloxifene Hydrochloride S 

OH 

x HCl 

(A) 

100 mg 

O 

O 

N 

Ramipril 

MM 0448.02 

Imp. F (EP): (2S)-2-[[(S)-1-(Ethoxycarbonyl)-3- 

phenylpropyl]amino]propanoic Acid 

H 

N 

O 

OH 

(A) 

100 mg 

O 

O 

MM 0448.03 Imp. G (EP): Toluene (C) 100 mg 

MM 0448.04 

Ranitidine Hydrochloride 

Imp. M (EP): (2R,3R)-2,3-Di(benzoyloxy)butanedioic Acid 

(Dibenzoyltartric Acid) 

MM 0086.00 Ranitidine Hydrochloride O 

MM 0086.02 

MM 0086.01 

MM 0086.03 

MM 0086.06 

MM 0086.05 

MM 0086.04 

MM 0086.07 

Imp. A (EP): N,N'-Bis[2-[[[5- 

[(dimethylamino)methyl]furan-2-yl]- 

methyl]sulphanyl]ethyl]-2-nitroethene-1,1- 

diamine 

Imp. B (EP): 2-[[[5-[(Dimethylamino)methyl]- 

furan-2-yl]methyl]sulphanyl]ethanamine 

Imp. C (EP): N-[2-[[[5-[(Dimethylamino)- 

methyl]furan-2-yl]methyl]sulphinyl]ethyl]-N'- 

methyl-2-nitroethene-1,1-diamine 

(Ranitidine Sulphoxide) 

Imp. D (EP) as Sodium Salt: N-[2-[[[5- 

[(Dimethylamino)methyl]furan-2-yl]- 

methyl]sulphanyl]ethyl]-2-nitroacetamide 

Sodium Salt 

Imp. E (EP): N-[2-[[[5-[(Dimethyloxidoamino) 

methyl]furan-2-yl]methyl]sulphanyl] 

ethyl]-N'-methyl-2-nitroethene-1,1-diamine 

(Ranitidine N-Oxide) 

Imp. F (EP): [5-[(Dimethylamino)methyl]- 

furan-2-yl]methanol 

Imp. G (EP): 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one Oxime 

N 

N 

O 

S 

N 

N 

O 

N 

H 

N 

S 

O 

O 

O 

O 

O 

HO 

H 

N 

NO 2 

N 

O 

H 

N 

S 

O 

S 

O 

S 

S 

O 

OH 

O 

O 

(A) 

100 mg 

H 

N 

NO 2 

(A) 500 mg 

x HCl 

O 

S 

H 

N 

H 

N 

H 

N 

N 

(A) 

100 mg 

NH 2 (A) 100 mg 

H 

N (A) 100 mg 

NO 2 

ONa (A) 100 mg 

NO 2 

H 

N (D) 100 mg 

NO 2 

O 

N OH (A) 100 mg 

S 

N OH (A) 100 mg 

N 

N 

H 

MM 0086.08 

Imp. H (EP): N-Methyl-2-nitroacetamide 

NO 2 

(A) 100 mg 

MM 0086.12 

Imp. K (EP): N-Methyl-1-methylthio-2-nitroethenamine 

O 

N 

H 

NO 2 

(A) 100 mg 

S 

N 

H 

Reagents 

MM 0334.01 

Diethylhexylphthalate (Bis-(2-ethylhexyl) Phthalate) 

O 

O 

O 

(C) 

500 mg 

O 

MM 0334.02 

3-(N-Morpholino)propane Sulfonic Acid (MOPS) 

O 

N 

S OH 

O O 

(C) 

500 mg 

MM 0334.03 

3-(N-Morpholino)ethane Sulfonic Acid (MES) 

O 

N 

O O 

(C) 500 mg 

S 

OH 


N 

N 

H 

N N 

H 



New MM 0334.08 

Salicylaldehyde Azine 

HO 

(A) 

100 mg 

N 

N 

OH 

Ribavirin 

MM 0542.00 

MM 0542.01 

MM 0542.03 

Ribavirin 

Imp. A (EP): 1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxylic Acid 

Imp. C (EP): 1H-1,2,4-Triazole-3-carboxylic Acid 

O 

(A) 250 mg 

H 2 N N 

HO N 

N 

O 

OH OH 

O 

(D) 100 mg 

HO N 

HO N 

N 

O 

OH OH 

O 

(D) 100 mg 

HO N 

MM 0542.04 

Imp. D (EP): 1H-1,2,4-Triazole-3-carboxamide 

H 2N 

O 

(D) 100 mg 

N 

MM 0542.05 

MM 0542.06 

Riboflavin 

Imp. E (EP): 1-(5-O-Benzoyl-β-D-ribofuranosyl)-1H-1,2,4-triazole-3- 

carboxamide (5'-O-Benzoylribavirin) 

Imp. F (EP): 1-(5-O-Acetyl-β-D-ribofuranosyl)-1H-1,2,4-triazole-3- 

carboxamide (5'-O-Acetylribavirin) 

O 

(D) 100 mg 

H 2 N N 

O N 

N 

O O 

OH OH 

O 

(D) 100 mg 

H 2 N N 

O N 

N 

O O 

OH OH 

MM 0030.00 

Riboflavin 

HO 

OH 

OH 

(A) 

500 mg 

OH 

N 

N 

O 

N 

O 

NH 

Rifampicin 

New MM 0514.02 

3-Formylrifamycin Isonicotinylhydrazone 

N 

H 

N 

N 

O 

OH 

O 

O 

(D) 

100 mg 

O 

HN 

O 

OH 

OH 

O 

O 

OH 

O 

OH 

Risperidone 

MM 0491.00 

Risperidone 

N 

on request 

N 

N 

F 

O 

N 

O 

MM 0491.10 

Imp. H (EP): 3-[2-[4-(2,4-Difluorobenzoyl)piperidin-1- 

yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-[1,2- 

a]pyrimidin-4-one 

N 

N 

O 

N 

F 

(A) 

100 mg 

O 

F 

MM 0491.13 

3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2- 

a]pyrimidin-4-one Hydrochloride 

N 

N 

Cl 

x HCl 

(A) 

100 mg 

O 




Ritodrine Hydrochloride 

MM 0800.01 

Imp. A (BP): Tyramine 

NH 2 

(B) 100 mg 

HO 

Ronidazole 

MM 1026.01 

(1-Methyl-5-nitroimidazol-2-yl)methanol 

O 2 N 

N 

N 

OH 

(A) 

100 mg 

Rosiglitazone Maleate 

MM 0522.01 

Rosiglitazone Maleate 

N 

N 

O 

O 

N 

H 

S 

O 

x 

O 

OH 

OH 

O 

on request 

Rutoside Trihydrate 

MM 0109.03 

Imp. C (EP) as Dihydrate: 2-(3,4-Dihydroxyphenyl)- 

3,5,7-trihydroxy-4H-1-benzopyran-4-one Dihydrate 

(Quercetin Dihydrate) 

HO 

O 

HO 

O 

OH 

x 2 H 2 O 

(A) 

100 mg 

OH 

OH 

Saccharin Sodium 

MM 0818.00 

Saccharin Sodium 

O 

O 

S 

NNa 

(A) 

500 mg 

O 

Salbutamol Sulphate 

MM 0381.00 

Salbutamol Sulphate 

(A) 

500 mg 

HO 

x H 2 SO 4 

OHOH 

HN 

2 

MM 0381.03 

Imp. C (EP): (1RS)-2-[(1,1-Dimethylethyl)amino]-1-(4-hydroxy-3- 

methylphenyl)ethanol 

OH 

H 

N 

(A) 

50 mg 

HO 

MM 0381.08 

Imp. H (EP): 4-[2-[1,1-Dimethylethyl)amino]ethyl]-2-methylphenol 

H 

N (A) 100 mg 

HO 

Salicylic Acid 

MM 0045.00 

Salicylic Acid 

O 

(A) 500 mg 

OH 

OH 

MM 0045.01 


O 

(B) 

100 mg 

HO 

OH 

MM 0045.02 

Imp. B (EP): 4-Hydroxyisophthalic Acid 

HO 

O 

O 

(A) 100 mg 

OH 

OH 

MM 0045.11 

Imp. C (EP): Phenol 

(B) 

100 mg 

OH 

MM 0045.12 

Imidazole Salicylate 

O 

O 

H 

N 

(A) 

100 mg 

OH 

N 

H 

MM 0045.13 

Choline Salicylate 

O 

O 

N 

OH 

on request 

OH 

MM 0045.14 

N,N-Diethylsalicylamide 

O 

(A) 100 mg 

N 

OH 




Secnidazole 

MM 0119.00 

Secnidazole 

O 2N 

N 

N 

OH 

(A) 100 mg 

MM 0119.02 2-Methyl-5-nitroimidazole NH 

O 2 N 

(B) 100 mg 

Selegiline Hydrochloride 

MM 0216.03 

Sertraline Hydrochloride 

Imp. C (EP) as Hydrochloride: (1RS, 2SR)-2- 

Amino-1-phenylpropan-1-ol Hydrochloride 

(Phenylpropanolamine Hydrochloride) 

OH 

and enatiomer 

MM 0317.01 Sertraline Hydrochloride HN 

NH 2 

N 

x HCl 

(A) 

(A) 

500 mg 

100 mg 

x HCl 

MM 0317.00 Sertraline HN 

Cl 

Cl 

(A) 

100 mg 

MM 0317.08 

MM 0317.09 

Imp. E (Pharmeuropa): Mandelic Acid 

Imp. F (Pharmeuropa): 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)- 

naphthalenone (Sertraline Tetralone Derivative) 

Cl 

Cl 

O (A) 100 mg 

OH 

OH 

O 

(A) 100 mg 

Cl 

Cl 

Sibutramine Hydrochloride 

MM 0991.02 N-Monodesmethylsibutramine Hydrochloride 

Cl 

HN 

(A) 

100 mg 

x HCl 

MM 0991.03 N,N-Didesmethylsibutramine Hydrochloride 

Cl 

NH 2 

(A) 

100 mg 

x HCl 

Sildenafil Citrate 

MM 0254.00 

MM 0254.09 

MM 0254.01 

MM 0254.02 

Sildenafil Citrate 

Sildenafil 

4-[[2-Ethoxy-5-[(4-methyl-1-piperazinyl)- 

sulfonyl]benzoyl]amino]-1-methyl-3-propyl-1Hpyrazole-5-carboxamide 

N 

O O 

S 

N 

2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoic Acid 

N 

HN 

N 

O 

O 

N 

O O 

S 

N 

N 

N 

O O 

S 

N 

N 

O 

O 

O 

HO 

x HO 

HO 

HN 

O 

H 2 N 

N 

H 

O O 

S 

N 

N 

O 

N 

N 

O 

OH 

on request 

O 

on request 

O 

N 

N 

O 

(A) 

100 mg 

O 

(A) 100 mg 

OH 




MM 0254.04 

MM 0254.05 

Sildenafil N-Oxide 

4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide 

O 

N 

O O 

S 

N 

HN 

O 

H 2 N 

O 

N 

H 2 N 

N 

N 

N 

N 

(A) 

100 mg 

O 

(A) 100 mg 

MM 0254.06 

3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3- 

d]pyrimidin-5-yl)-4-ethoxy-benzenesulfonic Acid 

O O 

S 

HO 

HN 

O 

on request 

N 

N 

N 

MM 0254.08 

MM 0254.11 

1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H- 

pyrazolo[4,3-d]pyrimidin-5-yl)-4- 

ethoxyphenyl]sulfonyl]piperazine 

(Desmethylsildenafil) 

3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3- 

d]pyrimidin-5-yl)-4-ethoxy-N-[2-(methylamino)ethyl]- 

benzenesulfonamide 

MM 0254.21 2-Ethoxy-5-(4-methylpiperazine-1-sulfonyl)benzaldehyde (1- 

[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine) 

MM 0254.22 

Silybin 

MM 0472.00 

Desethylsildenafil (5-[2-Hydroxy-5-(4- 

methylpiperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl- 

1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 

Silybin 

HN 

N 

HO 

NH 

O O 

S 

N 

O O 

S 

N 

H 

N 

O O 

S 

N 

O 

O 

HN 

O 

HN 

O 

O O 

S 

N 

HN 

OH 

O 

O 

O 

(D) 100 mg 

N 

N 

N 

N 

N 

O 

(D) 100 mg 

N 

N 

O 

(A) 100 mg 

O 

O 

(D) 100 mg 

N 

N 

OH on request 

O 

OH 

O 

OH 

OH 

Simvastatin 

MM 0158.00 

Simvastatin 

O 

O 

(A) 

100 mg 

H O 

O 

OH 

MM 0158.01 

Imp. A (EP) as Sodium Salt: (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8- 

[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8ahexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic 

Acid 

OH 

Sodium Salt (Simvastatin Hydroxy Acid Sodium Salt) H 

O O 

O 

OH 

ONa 

(A) 

100 mg 

MM 0158.02 

Imp. B (EP): (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)-6- 

oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8ahexahydronaphthalen-1-yl 

2,2-Dimethylbutanoate (Simvastatin 

Acetate Ester) 

O 

O 

H O O 

O 

O 

(A) 

100 mg 

MM 0158.03 

O 

Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6- 

(A) 100 mg 

dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 

O 

2,2-Dimethylbutanoate (Anhydrosimvastatin) 

H O O 




MM 0158.05 

O 

Imp. E (EP): (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6- 

oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8ahexahydronaphthalen-1-yl 

(2S)-2-Methylbutanoate (Lovastatin) 

O 

H O O 

OH 

(A) 

100 mg 

Sodium Benzoate 

MM 0730.00 

Sodium Benzoate 

O 

(A) 500 mg 

ONa 

Sodium Cromoglicate 

MM 0039.00 

Sodium Cromoglicate 

NaO 

O 

O 

O 

O 

(A) 500 mg 

ONa 

O 

O 

OH 

O 

O 

MM 0039.01 Succinophenone; Diphenacyl O 

(A) 

100 mg 

O 

MM 0039.02 

1,3-Bis(2-acetyl-3-hydroxyphenoxy)-2-propanol 

HO 

OH 

(A) 

100 mg 

O 

O 

OH 

O 

O 

MM 0039.03 2',6'-Dihydroxyacetophenone 

OH 

O 

(B) 100 mg 

OH 

MM 0039.04 

Ethyl Cromoglicate 

O 

O 

O 

O 

O 

(A) 100 mg 

O 

O 

O 

OH 

O 

O 

Sodium Cyclamate 

MM 0678.05 Cyclamic Acid 

H 

N 

S 

OH 

O O 

(A) 

100 mg 

MM 0678.02 Imp. B (EP): Aniline (Phenylamine) 

NH 2 

(B) 100 mg 

MM 0678.03 Imp. C (EP): Cyclohexanamine 

NH 2 

(C) 100 mg 

MM 0678.04 Imp. D (EP): N-Cyclohexylcyclohexanamine 

H 

N (C) 100 mg 

Sodium Fluoride 

MM 0734.00 Sodium Fluoride NaF (A) 500 mg 

Sodium Picosulfate 

MM 0054.00 Sodium Picosulfate 

NaO O 

O ONa 

S 

S 

O O O O 

(A) 500 mg 

N 

MM 0054.01 

Imp. A (EP): 4-[(Pyridin-2-yl)(4- 

hydroxyphenyl)methyl]phenyl Sodium Sulphate 

HO 

O 

S 

ONa 

O 

O 

(A) 

100 mg 

N 

MM 0054.03 

Imp. B (EP): 4,4'-[(Pyridin-2-yl)methylene]bisphenol 

HO OH 

(A) 100 mg 

N 

MM 0054.02 

Imp. C (Pharmeuropa): 2,4'-[(Pyridin-2-yl)- 

methylene]bisphenyl Bis(Sodium Sulphate) 

O 

S ONa 

O O 

(D) 

50 mg 

NaO O 

S N 

O O 




MM 0054.04 2,4'-[(Pyridin-2-yl)methylene]bisphenol 

HO 

(A) 50 mg 

N 

OH 

Sodium Thiophene-2-carboxylate 

MM 1081.00 

Sodium Thiophene-2-carboxylate 

S 

O 

(A) 250 mg 

ONa 

Sorbic Acid 

MM 0954.00 Sorbic Acid 

O 

Sotalol Hydrochloride 

MM 0046.00 

MM 0046.01 

MM 0046.02 

MM 0046.03 

Spironolactone 

MM 0197.00 

Sotalol Hydrochloride 

Imp. A (EP) as Hydrochloride: N-[4-[2- 

[(1-Methylethyl)amino]ethyl]phenyl]- 

methanesulphonamide Hydrochloride 

Imp. B (EP) as Hydrochloride: N-[4-[[(1- 

Methylethyl)amino]acetyl]phenyl]- 

methanesulphonamide Hydrochloride 

Imp. C (EP):N-(4-Formylphenyl)methanesulphonamide 

Spironolactone 

O O 

S 

N 

H 

O O 

S 

N 

H 

OH 

H 

N 

OH 

x HCl 

H 

N 

O O x HCl 

S 

N 

H 

O 

H 

N 

O O 

S 

N 

H 

x HCl 

O 

(A) 

(A) 

(A) 

(A) 

500 mg 

100 mg 

100 mg 

100 mg 

O 

(A) 100 mg 

O 

(A) 500 mg 

O 

S 

Stavudine 

MM 0534.01 

Imp. A (EP): 5-Methylpyrimidine-2,4(1H,3H)-dione (Thymine) 

O 

HN 

O 

(A) 100 mg 

MM 0534.03 

Imp. C (EP): 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5- 

methylpyrimidine-2,4(1H,3H)-dione (Thymidine) 

HO 

O 

HN 

O 

O 

N 

H 

O 

N 

(A) 

100 mg 

Strychnine Nitrate 

MM 0658.00 Strychnine Nitrate 

MM 0658.02 Strychnine N-Oxide Hydrochloride 

OH 

H N 

H 

N 

H 

O O 

H 

N 

x HNO 3 

(A) 500 mg 

O 

on request 

O 

N 

H 

H 

O 

x HCl 

Sulfacetamide 

MM 0579.00 

Sulfacetamide 

O O O 

(A) 500 mg 

S N 

H 

H 2N 




Sulfacetamide Sodium 

MM 1087.00 Sulfacetamide Sodium Monohydrate 

MM 1087.01 Imp. A (Pharmeuropa): Sulfanilamide 

O O O 

S 

N x H 2 O 

Na 

H 2 N 

O O 

S 

NH2 

(A) 500 mg 

(A) 100 mg 

Sulfadiazine 

MM 0623.00 Sulfadiazine 

Sulfadimethoxine Sodium 

MM 1020.00 Sulfadimethoxine Sodium 

H 2N 

H 2 N 

O O 

S 

N 

H 

O 

N (A) 500 mg 

N 

(A) 

500 mg 

H 2 N 

O O N 

S 

N 

Na 

N 

O 

Sulfafurazole 

MM 0583.00 

Sulfafurazole 

O O O N (A) 500 mg 

S N 

H 

H 2N 

Sulfamerazine 

MM 0581.00 

Sulfamerazine 

H 2N 

O O N 

S 

N N 

H 

(A) 

500 mg 

MM 0581.01 

Sulphanilamide 

O 

(A) 100 mg 

O 

S 

NH 2 

Sulfamethoxazole 

MM 0227.00 

MM 0227.01 

MM 0227.03 

MM 0227.02 

MM 0227.04 

MM 0227.05 

Sulfamethoxazole 

Imp. A (EP): N-[4-[(5-Methylisoxazol-3-yl)- 

sulphamoyl]phenyl]acetamide 

Imp. B (EP): 4-[[(4-Aminophenyl)sulphonyl]amino]-N- 

(5-methylisoxazol-3-yl)benzenesulphonamide 

Imp. C (EP): 5-Methylisoxazol-3-amine 

Imp. D (EP): 4-Aminobenzenesulphonic Acid 

(Sulphanilic Acid) 

Imp. E (EP): 4-Aminobenzenesulphonamide (Sulphanilamide) 

H 2 N 

H 2 N 

O 

N 

H 

O O 

S 

N 

H 

H 2 N 

H 2 N 

O O 

S 

N 

H 

O 

S 

O 

N 

H 

O O 

S 

N 

H 

H 2 N 

O 

N 

O 

N 

O 

N 

O 

N 

S 

OH 

(A) 

(A) 

(A) 

(B) 

500 mg 

100 mg 

100 mg 

100 mg 

O O 

(A) 100 mg 

O O 

(A) 100 mg 

S 

NH 2 

H 2 N 




Sulfamethylphenazole 

MM 1108.00 

Sulfamethylphenazole 

H 2 N 

O O 

S 

N 

H 

N 

N 

(A) 

100 mg 

Sulfaquinoxaline Sodium 

MM 0702.00 

Sulfathiazole 

Sulfaquinoxaline Sodium 

N 

MM 0578.00 Sulfathiazole O O 

N 

N 

H 2 N 

Na 

N 

S 

O 

O 

S 

N 

H 

NH 2 

on request 

S 

(A) 

500 mg 

Sulindac 

MM 0624.00 

Sulindac 

OH 

(A) 

500 mg 

S 

O 

F 

O 

Sulpiride 

MM 0051.00 

MM 0051.01 

Sulpiride 

Imp. A (EP): [(2RS)-1-Ethylpyrrolidin-2-yl]methanamine 

O 

O 

S 

H 2 N 

O 

N 

H 

O 

H 2N 

N 

N 

(A) 

(A) 

500 mg 

100 mg 

MM 0051.02 

MM 0051.03 

MM 0051.04 

MM 0051.05 

MM 0051.06 

MM 0051.07 

MM 0051.08 

MM 0051.09 

Suplatast Tosilate 

Imp. B (EP): Methyl 2-Methoxy-5-sulphamoylbenzoate 

Imp. C (EP): Ethyl 2-Methoxy-5-sulphamoylbenzoate 

Imp. D (EP): 2-Methoxy-5-sulphamoylbenzoic Acid 

Imp. E (EP): 2-Methoxy-5-sulphamoylbenzamide 

Imp. F (EP): 1-Ethyl-2-[[(2-methoxy-5- 

sulphamoylbenzoyl)amino]methyl]pyrrolidine 1 

-Oxide (Sulpiride N-Oxide) 

Imp. G (EP): (RS)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2- 

hydroxy-5-sulphamoylbenzamide 

5-Sulphamoylsalicylic Acid 

5-Sulphosalicylic Acid Dihydrate 

O 

H 2 N 

S 

O 

O 

H 2 N 

S 

O 

O NH 2 

S 

O 

O 

H 2 N 

S 

O 

O 

H 2 N 

S 

O 

O 

O 

N 

H 

O 

O 

O 

S 

N 

H 2 N 

H 

OH 

O 

H 2 N 

S 

O 

O 

HO 

S 

O 

O 

OH 

OH 

O 

O 

O 

O 

O 

O 

O 

O 

O 

O 

OH 

NH 2 

O 

N 

O 

OH 

N 

OH 

x 2 H 2 O 

(A) 

(A) 

(A) 

(A) 

(A) 

(A) 

(A) 

(C) 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

O O 

MM 0722.01 Methyl Toluene-4-sulphonate (B) 100 mg 

S 

O 




Tamoxifen Citrate 

MM 0053.00 Tamoxifen Citrate 

O 

O 

N HO OH 

x HO 

HO O 

O 

(A) 100 mg 

MM 0053.02 

Imp. B (EP): 1-[4-(2-Dimethylaminoethoxy)phenyl]-1,2- 

diphenylbutan-1-ol 

O 

N 

(A) 

100 mg 

OH 

MM 0053.14 

Imp. C (EP) Z-Isomer: 2-[4-[(Z)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine 

O 

N 

(A) 

50 mg 

MM 0053.15 

Imp. C (EP) E-Isomer: 2-[4-[(E)-1,2- 

Diphenylethenyl]phenoxy]-N,N-dimethylethanamine 

O 

N (A) 50 mg 

MM 0053.16 

Imp. D (EP) Z-Isomer: 2-[4-[(Z)-1,2-Diphenylprop-1- 

enyl]phenoxy]-N,N-dimethylethanamine 

O 

N 

(A) 

50 mg 

MM 0053.17 

Imp. D (EP) E-Isomer: 2-[4-[(E)-1,2-Diphenylprop-1- 

enyl]phenoxy]-N,N-dimethylethanamine 

O 

N (A) 50 mg 

MM 0053.05 

Imp. E (EP): 2-[2-[(EZ)-1,2-Diphenylbut-1-enyl)phenoxy]-N,Ndimethylethanamine 

(A) 

100 mg 

O 

N 

MM 0053.12 

Imp. F (EP) as Hydrochloride: 2-[4-[(Z)-1,2-Diphenylbut-1- 

enyl]phenoxy]-N-methylethanamine Hydrochloride 

O 

N 

H 

(A) 

100 mg 

x HCl 

MM 0053.07 

Imp. G (EP): (2RS)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2- 

phenylbutan-1-one 

O 

N 

(A) 

100 mg 

O 

MM 0053.08 

1,2-Diphenylbutan-1-one 

(A) 

100 mg 

O 

MM 0053.09 

1-(4-Methoxyphenyl)-1,2-diphenylbutan-1-ol 

O 

(A) 

100 mg 

OH 

MM 0053.10 

(EZ)-1-(4-Hydroxyphenyl)-1,2-diphenylbut-1-ene 

OH 

(A) 

100 mg 




MM 0053.18 Tamoxifen N-Oxide 

on request 

O 

N 

O 

Tamsulosin Hydrochloride 

MM 0938.00 

Tamsulosin Hydrochloride 

O 

H 

N 

O O 

S x HCl NH2 

on request 

MM 0938.03 

Imp. B (EP): 5-[(2R)-2-Aminopropyl]-2- 

methoxybenzenesulfonamide 

O 

H 2 N 

O 

O 

(A) 100 mg 

O 

S 

NH2 

O 

New MM 0938.05 

Imp. D (EP) as Hydrochloride: 2-Methoxy- 

5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]- 

amino]propyl]benzenesulfonamide Hydrochloride 

O 

O 

H 

N 

O O 

S x HCl NH2 

O 

(A) 

100 mg 

New MM 0938.09 

Imp. I (EP): 1-(2-Bromoethoxy)-2-ethoxybenzene 

O 

Br 

(A) 

100 mg 

O 

Temazepam 

MM 0087.00 

Temazepam [Controlled Substance] 

Cl 

O 

N 

OH 

N 

on request 

MM 0087.06 

Imp. A (EP): [5-Chloro-2-(methylamino)- 

phenyl]phenylmethanone 

(5-Chloro-2-(methylamino)benzophenone) 

Cl 

NH 

O 

(B) 

100 mg 

MM 0087.07 

Imp. B (EP): Oxazepam 


Cl 

H 

N 

N 

O 

OH 

(D) 

100 mg 

Tenoxicam 

MM 0247.03 Imp. A (EP): Pyridin-2-amine 

H 2 N 

N 

(B) 

100 mg 

Terazosin Hydrochloride Dihydrate 

MM 0843.00 

Terazosin Hydrochloride Dihydrate 

O 

(A) 

100 mg 

O 

O 

N 

N 

N 

N 

O 

x HCl 

x 2 H 2 O 

NH 2 

MM 0843.01 

Imp. A (EP): 2-Chloro-6,7- 

dimethoxyquinazolin-4-amine 

O 

O 

N Cl 

(A) 100 mg 

NH 2 

N 

MM 0843.02 

Imp. B (EP): 1-(4-Hydroxy-6,7-dimethoxyquinazolin-2- 

yl)-4-[[(2RS)-tetrahydrofuran 

-2-yl]carbonyl]piperazine 

O 

N 

N 

O 

N 

O 

(A) 

100 mg 

O 

N 

OH 

MM 0843.03 

Imp. C (EP): 6,7-Dimethoxy- 

2-(piperazin-1-yl)quinazolin-4-amine 

O 

N 

N 

NH (A) 100 mg 

O 

N 

NH 2 




MM 0843.04 

Imp. D (EP) as Hydrochloride: 1-(4-Amino-6,7- 

dimethoxyquinazolin-2-yl)-4-formylpiperazine 

Hydrochloride 

O 

N 

N 

N 

O 

x HCl 

(A) 

100 mg 

O 

N 

NH 2 

New MM 0843.05 

Imp. E (EP): 2,2'-(Piperazine-1,4-diyl)bis(6,7- 

dimethoxyquinazolin-4-amine) 

N 

NH 2 

O 

(D) 

100 mg 

O 

N 

N 

N 

N 

O 

O 

N 

NH 2 

MM 0843.11 

Imp. K (EP) as Hydrochloride: 


O 

N 

N 

N 

O 

O 

x HCl 

(A) 

100 mg 

O 

N 

NH 2 

MM 0843.13 

Imp. L (EP): 1-(Furan-2-ylcarbonyl)piperazine 

O 

(A) 

100 mg 

N 

HN 

O 

MM 0843.14 

Imp. M (EP): 1,4-Bis(furan-2- 

ylcarbonyl)piperazine 

O 

N 

O 

N 

O 

(A) 

100 mg 

O 

MM 0843.15 

Imp. N (EP): 1-[[(2RS)-Tetrahydrofuran-2-yl]carbonyl]piperazine 

O 

(A) 

100 mg 

N 

HN 

O 

MM 0843.16 

Imp. O (EP): 1,4-Bis[(tetrahydrofuran-2-yl)carbonyl]piperazine 

O 

(A) 

100 mg 

O 

N 

N 

O 

O 

Terbinafine Hydrochloride 

MM 0696.00 

Terbinafine Hydrochloride 

(A) 

100 mg 

N 

x HCl 

MM 0696.02 

Imp. A (EP) as Hydrochloride: N-Methyl-C-(naphthalen-1- 

yl)methanamine Hydrochloride (Secundary Amine Hydrochloride) 

NH 

x HCl 

(A) 

100 mg 

MM 0696.03 

Imp. B (EP) as Hydrochloride: (2Z)-N,6,6-Trimethyl- 

N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine 

Hydrochloride (cis-Terbinafine Hydrochloride) 

N 

x HCl 

(D) 

100 mg 

MM 0696.04 

Imp. C (EP) as Hydrochloride: (2E)-N,6,6- 

Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4- 

yn-1-amine Hydrochloride (trans-iso-Terbinafine 


N 

x HCl 

(D) 

100 mg 

MM 0696.05 

Imp. D (EP) as Hydrochloride: (2E)-N,6,6-Trimethyl- 

N-[(4-methylnaphthalen-1-yl)methyl]-hept-2-en-4-yn- 

1-amine Hydrochloride (4-Methylterbinafine 

Hydrochloride 

N 

x HCl 

(D) 

100 mg 

Terbutaline Sulphate 

MM 0708.01 

Imp. A (EP): 3,5-Dihydroxybenzoic Acid (α-Resorcylic Acid) 

HO 

O 

(B) 100 mg 

OH 

OH 

MM 0708.03 

Imp. B (EP) as Hemisulphate: (4RS)-2-(1,1- 

Dimethylethyl)-1,2,3,4-tetrahydroisoquinoline-4,6,8-triol 

Hemisulphate 

HO 

OH 

N 

x 1/2 H 2 SO 4 

(D) 

100 mg 

OH 




Terfenadine 

MM 0055.00 Terfenadine 

(A) 500 mg 

N 

OH 

OH 

MM 0055.04 

Imp. A (EP): 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4- 

(hydroxydiphenylmethyl) piperidin-1-yl]butan-1-one 

(Terfenadone) 

N 

O 

(A) 

100 mg 

OH 

MM 0055.07 

Imp. B (EP): (1RS)-1-[4-(1,1-Dimethylethyl)phenyl]- 

4-[4-(diphenylmethyl)piperidin-1-yl]butan-1-ol 

(A) 

100 mg 

N 

OH 

MM 0055.12 

Imp. E (EP) as Hydrochloride: 1-[(4RS)-4-[4-(1,1- 

Dimethylethyl)phenyl]-4-hydroxybutyl]piperidine-4- 

carboxylic Acid Hydrochloride 

HO 

N 

OH 

(A) 

100 mg 

O 

x HCl 

MM 0055.09 

Imp. G (EP): [1-[4-[4-(1,1-Dimethylethyl)- 

phenyl]but-3-enyl]piperidin-4- 

yl]diphenylmethanol 

N 

on request 

OH 

MM 0055.10 Imp. H (EP): [1-[4-[4-(1,1- 

Dimethylethyl)phenyl]butyl]piperidin-4- 

yl]diphenylmethanol 

N 

(A) 

100 mg 

OH 

MM 0055.02 

Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol) 

NH (B) 100 mg 

OH 

MM 0055.03 

Imp. J (EP): Ethyl 1-[(4RS)-4-[4-(1,1- 

Dimethylethyl)phenyl]-4-hydroxybutyl]-piperidine-4- 

carboxylate 

O 

N 

OH 

(A) 

100 mg 

O 

Testosterone 

MM 0323.00 

Testosterone 

OH 

(A) 500 mg 

O 

MM 0323.01 

Imp. A (EP): Androst-4-ene-3,17-dione (Androstenedione) 

O 

(A) 100 mg 

O 

MM 0323.02 

Imp. B (EP): 3-Ethoxyandrosta-3,5-dien-17-one (Androstenedione 

Ethylenolether) 

O 

(A) 100 mg 

O 

MM 0323.03 

Imp. C (EP): 17α-Hydroxyandrost-4-en-3-one (Epitestosterone) 

OH 

(A) 100 mg 

O 




MM 0323.04 

Imp. D (EP): Androst-4-ene-3β,17β-diol 

(∆4-Androstenediol) 

OH 

(A) 100 mg 

HO 

MM 0323.05 

Imp. E (EP): 3-Oxoandrost-4-en-17β-yl Acetate (Testosterone 

Acetate) 

O 

O 

(A) 100 mg 

O 

MM 0323.06 

Imp. F (EP): 17β-Hydroxy-5α-androstan-3-one (Androstanolone, 

Stanolone) 

OH 

(A) 

250 mg 

O 

H 

MM 0323.07 

Imp. G (EP): Androsta-1,4-diene-3,17-dione (Androstadienedione) 

O 

(A) 100 mg 

O 

MM 0323.08 

Imp. H (EP): 17β-Hydroxyandrosta-1,4-dien-3-one (Boldenone) 

OH 

(A) 100 mg 

O 

MM 0323.12 

Imp. I (EP): 17β-Hydroxyandrosta-4,6-dien-3-one (∆6- 

testosterone) 

OH 

(A) 100 mg 

O 

MM 0323.13 

Imp. J (EP): 3-Methoxyandrosta-3,5-dien- 

17-one (Androstenedione Methylenolether) 

O 

(A) 100 mg 

O 

Testosterone Benzoate 

MM 0493.00 

Testosterone Benzoate 

O 

O 

(D) 250 mg 

O 

MM 0493.01 

Testosterone 

OH 

(A) 500 mg 

O 

MM 0493.02 

Benzoic Acid 

O 

(B) 100 mg 

OH 

Testosterone Enantate 

MM 1119.00 

Testosterone Enantate 

O 

O 

(A) 100 mg 

O 

MM 1119.02 

Imp. B (EP): 3-Oxoandrost-4-en-17β-yl Hexanoate 

(Testosterone Caproate) 

O 

O 

(A) 100 mg 

MM 1119.04 

Imp. D (EP): 17β-Hydroxyandrost-4-en-3-one (Testosterone) 

O 

OH 

(A) 500 mg 

O 




Testosterone Isocaproate 

O 

MM 0863.00 Testosterone Isocaproate 

(A) 100 mg 

O 

MM 0863.05 

Imp. A (EP): Testosterone 

O 

OH 

(A) 500 mg 

MM 0863.03 

Imp. B (EP): 3-Oxoandrost-4-en-17β-yl Acetate 

(Testosterone Acetate) 

O 

O 

O 

(A) 100 mg 

MM 0863.04 

Imp. C (EP): Testosterone Propionate 

O 

O 

O 

(A) 100 mg 

MM 0863.07 

Imp. D (EP): 3-Oxoandrost-4-en-17β-yl 2-Methylpropanoate 

(Testosterone Isobutyrate) 

O 

O 

O 

(A) 100 mg 

MM 0863.08 

Imp. E (EP): 3-Oxoandrost-4-en-17β-yl Hexanoate 

(Testosterone Caproate) 

O 

O 

O 

(A) 100 mg 

MM 0863.06 

Imp. F (EP): Testosterone Enantate 

O 

O 

O 

(A) 100 mg 

MM 0863.09 Imp. G (EP): 3-Oxoandrost-4-en-17α-yl 4- 

Methylpentanoate 

(Epitestosterone Isocaproate) 

O 

O 

O 

(A) 100 mg 

Testosterone Propionate 

MM 0897.00 

Testosterone Propionate 

O 

O 

O 

(A) 100 mg 

MM 0897.01 

Imp. A (EP): 3-Oxoandrost-4-en-17β-yl Acetate (Testosterone 

Acetate) 

O 

O 

O 

(A) 100 mg 

MM 0897.03 Imp. C (EP): Testosterone 

OH 

O 

(A) 

500 mg 

O 




MM 0897.04 Imp. D (EP): 3-Oxoandrosta-1,4-dien-17β-yl Propanoate 

O 

(A) 100 mg 

O 

O 

MM 0897.05 

Imp. E (EP): 3-Oxoandrosta-4,6-dien-17β-yl 

Propanoate 

O 

O 

(A) 100 mg 

O 

Tetracaine Hydrochloride 

MM 0504.00 

Tetracaine Hydrochloride 

O 

O 

N 

x HCl 

(A) 

500 mg 

N 

H 

MM 0504.03 

Imp. A (Pharmeuropa): 4-Aminobenzoic Acid 

O 

(B) 

100 mg 

OH 

H 2 N 

MM 0504.01 

Imp. B (Pharmeuropa): 4-(Butylamino)benzoic Acid 

O 

OH 

(A) 

100 mg 

New MM 0504.04 

MM 0504.02 

Imp. C (Pharmeuropa): Methyl 4-(Butylamino)- 

benzoate 

Tetracaine N-Oxide 

N 

H 

O 

(A) 100 mg 

O 

N 

H 

O 

N O (A) 100 mg 

O 

N 

H 

Tetracycline Hydrochloride 

MM 0452.00 Tetracycline Hydrochloride 

OH O OH O 

OH 

O 

(A) 

500 mg 

HO 

H 

H 

N 

OH 

NH 2 

x HCl 

Tetramisole Hydrochloride 

MM 0703.00 

Tetramisole Hydrochloride 

N 

N 

S 

x HCl 

(A) 

500 mg 

Tetrazepam 

MM 0091.00 

Tetrazepam [Controlled Substance] 

N 

O 

(A) 

100 mg 

Cl 

N 

MM 0091.06 

Imp. B (EP): 7-Chloro-5-cyclohexyl-1,3-dihydro-2H-1,4- 

benzodiazepin-2-one 

H 

N 

O 

(A) 

100 mg 

Cl 

N 

MM 0091.03 

7-Chloro-5-cyclohexenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 

(Nortetrazepam) 

H 

N 

O 

(A) 

100 mg 

Cl 

N 

MM 0091.04 

6-Chloro-2-methyl-4-oxo-4H-3,1-benzoxazine 

N 

(A) 

100 mg 

Cl 

O 

O 




MM 0091.52 2-Bromo-4'-chloro-2'-(cyclohexylcarbonyl)acetanilide 

O 

NH 

Br on request 

Cl 

O 

Tetryzoline Hydrochloride 

MM 0088.00 

Tetryzoline Hydrochloride 

HN 

N 

(A) 

100 mg 

x HCl 

MM 0088.03 

Imp. A (EP): (1RS)-1,2,3,4-Tetrahydronaphthalene-1-carbonitrile 

(α-Cyanotetraline) 

N 

(A) 100 mg 

MM 0088.02 1,2,3,4-Tetrahydro-1-naphthalenecarboxylic Acid 

O OH 

(A) 100 mg 

MM 0088.04 Methyl 1,2,3,4-Tetrahydro-1-naphthalenecarboxylate 

O O 

(A) 100 mg 

MM 0088.05 

N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-yl-carboxamide 

Hydrochloride 

((1,2,3,4-Tetrahydro-1-naphthyl)formylethylenediamine 


O 

H 

N 

NH 2 

x HCl 

(A) 

100 mg 

Thalidomide 

MM 0940.00 

Thalidomide 

O 

(A) 

100 mg 

Theobromine 

MM 0577.00 

Theobromine 

N 

O 

NH 

O O 

O 

(A) 500 mg 

HN 

N 

O N N 

Theophylline 

MM 0176.00 

Theophylline 

N 

O N 

O 

(A) 500 mg 

H 

N 

N 

MM 0176.06 

Imp. A (EP): Caffeine 

N 

O 

N 

(A) 

500 mg 

O 

N 

N 

MM 0176.03 

Imp. B (EP): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione (3-Methylxanthine) 

O 

(A) 100 mg 

HN 

N 

O N N H 

MM 0176.02 

Imp. C (EP): N-(6-Amino-1,3-dimethyl-2,4- 

dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)- 

formamide 

O 

N 

O N 

H 

N 

O 

NH 2 

on request 

MM 0176.01 

Imp. D (EP): N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide 

O 

(A) 100 mg 

(Theophyllidine) N 

N 

H 

HN N H 

MM 0176.08 

Imp. F (EP): Etofylline 

O 

OH 

(A) 500 mg 

N 

N 

O 

N 

N 

MM 0176.04 

1-Methylxanthine 

N 

O N 

H 

O 

on request 

N 

N 

H 




MM 0176.05 

7-Methylxanthine 

Theophylline-Ethylenediamine 

New MM 1050.01 

Imp. A (Pharmeuropa): Caffeine 

HN 

O N 

H 

N 

O 

O 

(A) 100 mg 

N 

N 

N 

(A) 

500 mg 

O 

N 

N 

New MM 1050.02 

Imp. B (Pharmeuropa): 3-Methyl-3,7-dihydro-1H-purine-2,6-dione 

(3-Methylxanthine) 

HN 

O 

(A) 100 mg 

H 

N 

O 

N 

N 

New MM 1050.04 

Imp. D (Pharmeuropa): N-Methyl-5- 

(methylamino)-1H-imidazole-4- 

carboxamide (Theophyllidine) 

N 

H 

HN 

O 

(A) 100 mg 

N 

H 

N 

New MM 1050.06 

Imp. F (Pharmeuropa): Etofylline 

O 

OH 

(A) 500 mg 

N 

N 

O 

N 

N 

Thiamazole 

MM 0889.00 

Thiamazole 

N 

S 

(A) 500 mg 

NH 

MM 0889.02 Imp. B (EP): 1-Methyl-1H-imidazole N 

(B) 

100 mg 

N 

MM 0889.03 

Imp. C (EP): 1-Methyl-2-(methylsulphanyl)-1H-imidazole 

N 

N 

S 

(A) 100 mg 

MM 0889.04 

Imp. C (EP) as Hydrochloride: 1-Methyl-2-(methylsulphanyl)-1Himidazole 

Hydrochloride 

N 

N 

S 

x HCl 

(A) 

100 mg 

Thiamine Hydrochloride 

MM 0049.00 Thiamine Hydrochloride (Vitamin B 1) 

MM 0049.05 

S N 

HO 

N + N x HCl 

Cl - NH 2 

(A) 500 mg 

Imp. E (EP): 3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-5-(2- 

S 

S N 

(A) 100 mg 

hydroxyethyl)-4-methylthiazol-2(3H)-thione (Thioxothiamine) N N 

HO 

NH 2 

MM 0049.02 5-(2-Hydroxyethyl)-4-methylthiazole 

N 

(A) 

100 mg 

MM 0049.04 4-Amino-5-hydroxymethyl-2-methylpyrimidine Hydrochloride N 

Thiamphenicol 

MM 0737.00 

Thioctic Acid 

MM 0127.00 

Thiamphenicol 

Thioctic Acid 

Thioridazine Hydrochloride 

MM 0116.05 

2-Methylthiophenothiazine 

Cl 

Cl 

O 

S 

N 

N 

H 

S 

S 

OH 

NH 2 

OH 

OH 

OH 

x HCl 

O 

S 

(A) 100 mg 

O 

(A) 500 mg 

O 

(A) 500 mg 

OH 

(A) 100 mg 

S 

NH 

S 




Tiabendazole 

MM 0602.00 

MM 0602.01 

Tiabendazole 

Imp. A (EP): Benzene-1,2-diamine 

H 

N 

N 

S 

N 

NH 2 

(A) 

500 mg 

NH 2 (C) 100 mg 

Tiamulin Hydrogen Fumarate 

MM 0394.00 

Tiamulin Hydrogen Fumarate 

N 

S 

O 

O 

H 

O 

x 

HO 

O 

OH 

(A) 

100 mg 

MM 0394.02 

Fumaric Acid 

HO 

O 

HO 

O 

O 

(B) 100 mg 

OH 

Ticlopidine Hydrochloride 

MM 0150.00 

Ticlopidine Hydrochloride 

N 

S 

x HCl 

(A) 

500 mg 

Cl 

MM 0150.12 

Imp. A (EP): Thieno[3,2-c]pyridine 

N 

S 

(A) 100 mg 

MM 0150.06 

Imp. B (EP): 6,7-Dihydrothieno[3,2-c]pyridin-4(5H)-one 

HN 

S 

(A) 

100 mg 

MM 0150.01 

MM 0150.07 

MM 0150.08 

MM 0150.09 

MM 0150.11 

MM 0150.10 

MM 0150.04 

Imp. C (EP) as Hydrochloride: (2-Chlorophenyl)methanamine 

Hydrochloride NH 2 x HCl 

Imp. D (EP) as Hydrochloride: 5-Benzyl-4,5,6,7- 

tetrahydrothieno[3,2-c]pyridine Hydrochloride 

Imp. G (EP) as Hydrochloride: 5-(3-Chlorobenzyl)-4,5,6,7- 


Imp. H (EP) as Hydrochloride: 5-(4-Chlorobenzyl)-4,5,6,7- 


Imp. I (EP) as Hydrochloride: N-(2-Chlorobenzyl)-2- 

(thiophen-2-yl)ethanamine Hydrochloride 

Imp. J (EP) as Dihydrochloride: N,N'-Bis(2- 

chlorobenzyl)ethane-1,2-diamine Dihydrochloride 

5-(2-Chlorobenzoyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 

Cl 

Cl 

Cl 

Cl 

NH 

Cl 

N 

N 

NH 

N 

H 

Cl 

N 

S 

S 

S 

N 

S 

O 

(A) 

100 mg 

x HCl 

(A) 100 mg 

x HCl 

x HCl 

x HCl 

x 2 HCl 

S 

(A) 

(A) 

(A) 

(A) 

(A) 

100 mg 

100 mg 

100 mg 

100 mg 

100 mg 

Cl 

O 

Tilidine Hydrochloride Hemihydrate 

MM 0134.00 

Tilidine Hydrochloride Hemihydrate [Controlled Substance] 

N 

(A) 

100 mg 

x HCl 

x 1/2 H 2 O 

O O 


MM 0134.01 

Imp. A (EP): Ethyl (1RS,2RS)-2-(Dimethylamino)-1-phenylcyclohex- 

3-enecarboxylate (cis-Tilidine) [Controlled Substance] 

N 

(D) 

100 mg 

O O 


MM 0134.03 

Imp. D (EP) as Hydrochloride: Ethyl (2RS)-3-Dimethylamino-2- 

phenylpropanoate Hydrochloride 

N 

O 

x HCl 

(A) 

100 mg 

O 

MM 0134.05 

Tilidine [Controlled Substance] 

N 

(A) 

100 mg 

O O 





Timolol Maleate 

OH 

MM 0440.00 Timolol Maleate O 

MM 0440.03 

N-Benzyl-tert-butylamine 

N 

S 

N 

O 

N 

O 

HN 

x 

O 

OH 

OH 

(A) 

(B) 

250 mg 

100 mg 

HN 

MM 0440.05 3-Hydroxy-4-morpholino-1,2,5-thiadiazole 1-Oxide N 

O 

S 

N 

OH 

N 

O 

(A) 

100 mg 

Tinidazole 

MM 0151.01 Imp. A (EP): 2-Methyl-5-nitro-1H-imidazole 

Tolazoline Hydrochloride 

MM 0585.00 Tolazoline Hydrochloride 

O 2 N 

(B) 100 mg 

NH 

N 

N 

x HCl 

HN 

(A) 500 mg 

Tolmetin Sodium Dihydrate 

MM 0571.00 

Tolmetin Sodium Dihydrate 

O 

N 

ONa 

O 

x 2 H 2 O 

on request 

Tramadol Hydrochloride 

MM 0007.00 

Tramadol Hydrochloride 

O 

OH 

N 

x HCl 

(A) 

500 mg 


MM 0007.01 

Imp. A (EP) as Hydrochloride: (1RS,2SR)-2- 

[(Dimethylamino)methyl]-1-(3-methoxyphenyl)- 

cyclohexanol Hydrochloride 

O 

OH 

N 

x HCl 

(A) 

100 mg 

MM 0007.03 

Imp. B (EP) as Hydrochloride: [2-(3-Methoxyphenyl)cyclohex-1- 

enyl]-N,N-dimethylmethanamine Hydrochloride 


O 

(A) 100 mg 

x HCl 

N 

MM 0007.04 

Imp. C (EP) as Hydrochloride: (1RS)-[2-(3-Methoxyphenyl)- 

cyclohex-2-enyl]-N,N-dimethylmethanamine Hydrochloride 

O 

(A) 100 mg 

N 

x HCl 

MM 0007.06 

Imp. D (EP) as Hydrochloride: (1RS,2RS)-2-[(Dimethylamino)methyl]-1-(3-hydroxyphenyl)cyclohexanol 

Hydrochloride 

HO 

OH 

N 

x HCl 

(A) 

100 mg 

MM 0007.02 


Imp. E (EP) as Hydrochloride: (2RS)-2-[(Dimethylamino)methyl]- 

O 

(A) 100 mg 

cyclohexanone Hydrochloride N x HCl 

MM 0007.05 3-Bromoanisole 

O Br 

(B) 100 mg 

MM 0007.07 

N-Desmethyltramadol Hydrochloride 

O 

OH 

x HCl 

(A) 

100 mg 

NH 


MM 0007.08 

N,O-Didesmethyltramadol Hydrochloride 

HO 

OH 

N 

H 

x HCl 

(A) 

100 mg 





MM 0007.09 3-Methoxyphenol 

O OH 

(B) 100 mg 

MM 0007.11 

Tramadol N-Oxide 

O 

OH 

(A) 

100 mg 

N 

O 

MM 0007.50 

[2-(3-Hydroxyphenyl)cyclohex-1-enyl]-N,N-dimethylmethanamine 

Hydrochloride 


HO 

(A) 100 mg 

x HCl 

N 

Tranexamic Acid 

MM 0330.00 

Tranexamic Acid 

H 2N 

O 

OH 

(A) 

500 mg 

MM 0330.04 

Imp. D (EP): 4-Aminomethylbenzoic Acid 

H 2 N 

O 

OH 

(B) 

100 mg 

Trazodone Hydrochloride 

MM 0421.00 

Trazodone Hydrochloride 

(A) 

100 mg 

N 

N 

N 

N 

N 

Cl 

x HCl 

O 

MM 0421.13 Imp. A (BP) as Hydrochloride: 4-(3-Chlorophenyl)-1-[3-(3-oxo-2,3-dihydro-1,2,4- 

triazolo[4,3-a]pyridin-2-yl)propyl]piperazine 

N 1 -oxide Hydrochloride (Trazodone N-Oxide 


MM 0421.03 Imp. C (BP) as Dihydrochloride: 2-[3-[4-(4- 

Chlorophenyl)piperazin-1-yl]propyl]-1,2,4- 

triazolo[4,3-a]pyridin-3(2H)-one Dihydrochloride 

N 

N 

N 

O 

N 

N 

N 

N 

O 

N 

N 

N 

Cl 

Cl 

x HCl 

x 2 HCl 

(D) 

(A) 

100 mg 

100 mg 

O 

MM 0421.06 

Imp. F (BP) as Hydrochloride: 1-(3-Chlorophenyl)-4-(3- 

chloropropyl)piperazine Hydrochloride 

Cl 

N 

N 

Cl 

x HCl 

(A) 

100 mg 

MM 0421.08 

Imp. H (BP) as Dihydrochloride: 1,3-Bis-[4-(3- 

chlorophenyl)piperazin-1-yl]propane Dihydrochloride 

Cl 

N 

N 

N 

N 

Cl 

x 2 HCl 

(A) 

100 mg 

MM 0421.10 

3-[4-(3-Chlorophenyl)piperazin-1-yl]propanol 

(A) 

100 mg 

HO 

N 

N 

Cl 

MM 0421.11 

1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one 

N 

N 

NH 

(A) 

100 mg 

O 

MM 0421.12 

1,4-Bis-3-chlorophenylpiperazine 

(A) 

100 mg 

N 

Cl 

Cl 

N 

Triacetin 

MM 0966.00 

Triacetin 

O 

(A) 500 mg 

O 

O 

O 

O 

O 

Triamcinolone 

MM 0508.00 

Triamcinolone 

O 

OH 

(A) 

250 mg 

HO 

OH 

OH 

O 

F 




MM 0508.01 

Imp. A (EP): 9-Fluoro-11β,17-dihydroxy-3,20-dioxopregna- 

1,4-diene-16α,21-diyl Diacetate (Triamcinolone 16,21- 

Diacetate) 

HO 

O 

O 

OH 

O 

O 

(A) 

100 mg 

MM 0508.03 

Imp. C (EP): 9-Fluoro-11β,16α,17,21-tetrahydroxypregn-4- 

ene-3,20-dione (Pretriamcinolone) 

O 

F 

HO 

O 

O 

OH 

OH 

OH 

on request 

F 

O 

Triamcinolone Acetonide 

MM 0198.00 

Triamcinolone Acetonide 

O 

OH 

(A) 250 mg 

HO 

O 

O 

F 

O 

MM 0198.01 

Imp. A (EP): Triamcinolone 

O 

OH 

(A) 250 mg 

HO 

OH 

OH 

F 

O 

MM 0198.02 

Triamcinolone 16,21-Diacetate 

O 

O 

O 

(A) 100 mg 

HO 

F 

OH 

O 

O 

O 

MM 0198.05 

Triamcinolone Acetonide 21-Aldehyde Hydrate 

O 

OH 

(A) 

100 mg 

HO 

OH 

O 

O 

F 

O 

Triamcinolone Hexacetonide 

MM 0306.00 

Triamcinolone Hexacetonide 

O 

(A) 100 mg 

O 

O 

HO 

O 

O 

F 

O 

MM 0306.01 

Imp. A (EP): Triamcinolone Acetonide 

O 

OH 

(A) 250 mg 

HO 

O 

O 

F 

O 

MM 0306.02 

Triamcinolone 

O 

OH 

(A) 250 mg 

HO 

OH 

OH 

F 

O 

Triamterene 

MM 0269.00 

Triamterene 

H 2N N N NH 2 (A) 500 mg 

N 

N 

NH 2 

MM 0269.02 

Imp. A (Pharmeuropa): 2,4,6-Triamino-5-nitrosopyrimidine 

H 2 N N NH 2 

(B) 100 mg 

ON 

N 

NH 2 




MM 0269.01 

Tributyl Acetylcitrate 

Sodium Hydroxytriamterene Sulphate 

O O 

S 

NaO O 

MM 0499.00 Tributyl Acetylcitrate 

O O 

MM 0499.01 

Imp. A (EP): Tributyl 2-Hydroxypropane-1,2,3- 

tricarboxylate (Tributyl Citrate) 

O 

O 

H 2 N 

O 

N 

N 

O 

O O 

O O 

O 

HO 

O 

N 

N 

NH 2 

NH 2 

(A) 

(C) 

100 mg 

on request 

100 mg 

MM 0499.02 

Imp. B (EP) (E-Isomer): Tributyl (E)-Propene-1,2,3- 

tricarboxylate (Tributyl (E)-Aconitate) 

O O 

O O 

O 

O 

(A) 

100 mg 

O 

O 

Triclabendazole 

MM 0313.00 

Triclabendazole 

Cl 

Cl 

O 

Cl 

H 

N 

N 

S 

(D) 

100 mg 

Triclosan 

MM 0610.00 

Triclosan 

Cl 

O 

OH 

(A) 

500 mg 

Cl 

Cl 

Trihexyphenidyl Hydrochloride 

MM 0237.00 

Trihexyphenidyl Hydrochloride 

(A) 

500 mg 

OH 

N 

x HCl 

MM 0237.03 

Imp. A (EP) as Hydrochloride: 1-Phenyl-3-(piperidin-1- 

yl)propan-1-one Hydrochloride 

O 

N 

x HCl 

(A) 

100 mg 

MM 0237.01 Acetophenone 

O 

(B) 100 mg 

MM 0237.04 

Trihexyphenidyl N-Oxide 

(A) 

100 mg 

OH 

O 

N 

Trimebutine 

MM 0417.00 

Trimebutine 

N 

O 

O 

O 

O 

O 

(A) 

500 mg 

MM 0417.05 

Trimebutine Maleate 

N 

O 

O 

O 

O 

x 

O 

OH 

OH 

(A) 

500 mg 

O 

O 

MM 0417.01 2-(N,N-Dimethylamino)-2-phenylbutan-1-ol Hydrochloride OH 

N 

x HCl 

(A) 

100 mg 

MM 0417.06 3,4,5-Trimethoxybenzoic Acid O 

O 

(B) 

100 mg 

O 

OH 

O 


MM 0958.00 


N 

S 

N 

OH O 

x HO 

OH 

O OH 

2 

(A) 

500 mg 




MM 0958.01 Trimeprazine Sulphone (Oxomemazine) 

N 

N 

(A) 100 mg 

MM 0958.02 

Trimeprazine Sulphoxide Hydrochloride 

S 

O O 

N 

(A) 

100 mg 

N 

x HCl 

S 

O 

MM 0958.04 

Trimeprazine Sulphone N-Oxide Hydrochloride 

(Oxomemazine N-Oxide Hydrochloride) 

N 

N O 

x HCl 

(A) 

100 mg 

S 

O O 

Trimetazidine Dihydrochloride 

MM 0539.00 

Trimetazidine Dihydrochloride 

HN 

N 

O 

O 

O 

x 2 HCl 

(A) 

100 mg 

New MM 0539.01 Imp. A (EP) as Dihydrochloride: 1-(3,4,5- 

Trimethoxybenzyl)piperazine Dihydrochloride 

HN 

N 

O 

O 

O 

x 2 HCl 

(A) 

100 mg 

MM 0539.02 

Imp. B (EP): 1,4-Bis(2,3,4-trimethoxybenzyl)piperazine 

O 

O 

O 

N 

N 

O 

O 

O 

(A) 

100 mg 

MM 0539.03 

Imp. C (EP): 2,3,4-Trimethoxybenzaldehyde 

O 

O 

O 

(B) 

100 mg 

O 

MM 0539.04 

Imp. D (EP): (2,3,4-Trimethoxyphenyl)methanol 

HO 

O 

O 

(A) 

100 mg 

O 

New MM 0539.05 Imp. E (EP) as Dihydrochloride: 1-(2,4,5- 

Trimethoxybenzyl)piperazine Dihydrochloride 

HN 

N 

O 

O 

x 2 HCl 

(A) 

100 mg 

O 

MM 0539.06 

Imp. F (EP) as Dihydrochloride: 1-(2,4,6-Trimethoxybenzyl)piperazine 


HN 

N 

O 

O 

O 

x 2 HCl 

(A) 

100 mg 

MM 0539.07 Imp. G (EP) as Hexahydrate: Piperazine Hexahydrate NH 

MM 0539.08 

Trimethoprim 

1-Formyl-4-(2,3,4-trimethoxybenzyl)piperazine 

Hydrochloride 

MM 0093.00 Trimethoprim O 

O 

O 

N 

N 

O 

HN 

O 

O 

O 

x 6 H 2 O 

(B) 100 mg 

N 

x HCl 

N NH 2 

NH 2 

(A) 

(A) 

100 mg 

500 mg 

MM 0093.06 

Imp. A (EP): N 2 -Methyl-5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4- 

diamine 

O 

O 

O 

(A) 100 mg 

N NH 

N 

NH 2 

MM 0093.01 

Imp. B (EP): (2,4-Diaminopyrimidin-5-yl)-(3,4,5-trimethoxyphenyl)methanone 

O 

O 

O 

O 

N NH 2 

N 

NH 2 

(A) 

100 mg 




MM 0093.08 

Imp. C (EP): (RS)-(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanol 

MM 0093.04 Imp. D (EP): 2-Amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-4-ol O 

O 

MM 0093.03 Imp. E (EP): 4-Amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol O 

O 

MM 0093.09 

Imp. F (EP): 5-(3-Bromo-4,5-dimethoxybenzyl)pyrimidine-2,4- 

diamine 

O 

O 

O 

O 

Br 

O 

O 

O 

OH 

N NH 2 

N 

NH 2 

N NH 2 

OH 

N 

(A) 

(A) 

100 mg 

100 mg 

(A) 100 mg 

N OH 

N 

NH 2 

N NH 2 

N 

NH 2 

(A) 

100 mg 

MM 0093.10 

Imp. G (EP): 5-(4-Ethoxy-3,5-dimethoxybenzyl)pyrimidine-2,4- 

diamine 

O 

O 

O 

N NH 2 

N 

(A) 

100 mg 

NH 2 

MM 0093.11 Imp. H (EP): Methyl 3,4,5-Trimethoxybenzoate O 

O 

(A) 

100 mg 

MM 0093.12 

Imp. I (EP): 3-(Phenylamino)-2-(3,4,5-trimethoxybenzyl)prop-2- 

enenitrile 

(E/Z-mixture) 

MM 0093.13 Imp. J (EP): 3,4,5-Trimethoxybenzoic Acid O 

O 

O 

O 

O 

O 

O 

H 

N 

O 

O 

N 

OH 

O 

(A) 

(B) 

100 mg 

100 mg 

MM 0093.15 Imp. K (EP): Aniline 

NH 2 

(B) 100 mg 

MM 0093.02 5-(3,4,5-Trimethoxybenzyl)pyrimidin-2,4-diol O 

O 

N 

OH 

(A) 

100 mg 

O 

N 

OH 

MM 0093.05 2-Amino-5-(4-hydroxy-3,5-dimethoxybenzyl)pyrimidin-4-ol O 

HO 

N NH 2 

(A) 

100 mg 

O 

N 

OH 

MM 0093.07 N 4 -Methyl-5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine O 

O 

N NH 2 

(A) 

100 mg 

O 

N 

NH 

Trimipramine Maleate 

MM 0240.00 

Trimipramine Maleate 

O 

(A) 

500 mg 

N 

N 

x 

OH 

OH 

O 

MM 0240.01 

Trimipramine 

(A) 

100 mg 

N 

N 

MM 0240.04 

Imp. A (EP): (2RS)-3-(10,11-Dihydro-5H-dibenzo- 

[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine 

N-oxide (Trimipramine N-Oxide) 

N 

N 

O 

(A) 

100 mg 




MM 0240.02 

Imp. B (EP) as Hydrochloride: (2RS)-3-(10,11- 

Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,2-dimethylpropan-1-amine 

Hydrochloride 

(Desmethyltrimipramine Hydrochloride) 

N 

N 

H 

x HCl 

(A) 

100 mg 

MM 0240.06 

Imp. D (EP) as Hydrochloride: Imipramine 

(A) 

500 mg 

Hydrochloride 

N 

N 

x HCl 

MM 0240.03 

Imp. F (EP): 10,11-Dihydro-5H-dibenzo[b,f]azepine (Iminodibenzyl) 

(B) 

100 mg 

NH 

Tropicamide 

MM 0601.00 

MM 0601.01 

Tropicamide 

Imp. A (EP): N-(Pyridin-4-ylmethyl)ethanamine 

O 

OH 

N 

N 

(A) 

250 mg 

HN (A) 100 mg 

N 

MM 0601.03 

Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) 

O 

(A) 

100 mg 

OH 

OH 

Tropisetron Hydrochloride 

MM 0763.01 

Imp. A (EP): (1R,3r,5S)-8-Methyl-8- 

azabicyclo[3.2.1]oct-3-ol (Tropine) 

H 

HO 

H 

(A) 100 mg 

N 

H 

MM 0763.02 

Imp. B (EP): 1H-Indole-3-carboxylic Acid 

O 

(A) 100 mg 

HN 

OH 

Tryptophan 

MM 0172.00 L-Tryptophan 

H 

N 

O 

NH 2 

(A) 500 mg 

OH 

MM 0172.09 

Imp. A (EP): 3,3'-[Ethylidenebis(1H-indole-1,3- 

diyl)]bis[(2S)-2-aminopropanoic] Acid 

(1,1'-Ethylidenebistryptophan) 

HO 

NH 2 

N 

N 

NH 2 

OH 

(D) 

100 mg 

MM 0172.03 

Imp. D (EP): (S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoic 

Acid (5-Hydroxytryptophan) 

O 

H 

N 

O 

NH 2 

OH 

(A) 

100 mg 

HO 

O 

O 

(A) 100 mg 

MM 0172.13 N-Acetyltryptophan 

H 

N 

O 

HN 

OH 

Tyrosine 

New MM 0634.00 Tyrosine 

HO 

NH 2 

(A) 100 mg 

OH 

O 

Valaciclovir Hydrochloride 

MM 0619.01 

Imp. A (Pharmeuropa): 2-Amino-1,9-dihydro-6H-purin-6-one (Guanine) 

O 

HN 

H 2 N N 

N 

H 

N 

(B) 

100 mg 




MM 0619.02 

MM 0619.07 

Imp. B (Pharmeuropa): 2-Amino-9-[(2-hydroxyethoxy)methyl]- 

1,9-dihydro-6H-purin-6-one 

Imp. G (Pharmeuropa): N,N-Dimethylpyridin-4-amine 

H 2 N 

HN 

O 

N 

N 

N 

O 

OH 

(A) 

500 mg 

N (A) 100 mg 

New MM 0619.09 

Valproic Acid 

Imp. I (Pharmeuropa): 2-[(2-Amino-6-oxo-1,6- 

dihydro-9H-purin-9-yl)methoxy]ethyl Acetate 

MM 0751.00 Valproic Acid 

O 

H 2 N 

HN 

O 

N 

N 

N 

O 

O 

N 

O 

OH 

(A) 

(A) 

100 mg 

500 mg 

MM 0751.11 Sodium Valproate 

O 

ONa 

(A) 

500 mg 

MM 0751.01 

MM 0751.02 

Imp. A (EP): Pentanoic Acid (Valeric Acid) 

Imp. B (EP): (2RS)-2-Ethylpentanoic Acid 

O 

(C) 100 mg 

OH 

O 

(A) 100 mg 

OH 

MM 0751.03 

Imp. C (EP): (2RS)-2-(1-Methylethyl)pentanoic Acid 

O 

(A) 100 mg 

OH 

MM 0751.04 

Imp. D (EP): 2,2-Dipropylpentanoic Acid 

O 

(A) 100 mg 

OH 

MM 0751.05 

MM 0751.06 

Imp. E (EP): Pentanamide (Valeramide) 

Imp. F (EP): 2-Propylpentanamide 

O 

(A) 100 mg 

NH 2 

O 

(A) 100 mg 

NH 2 

MM 0751.07 

Imp. G (EP): 2,2-Dipropylpentanamide 

O 

(A) 100 mg 

NH 2 

MM 0751.08 Imp. H (EP): Pentanenitrile (Valeronitrile) 

N 

(C) 100 mg 

MM 0751.09 Imp. I (EP): 2-Propylpentanenitrile 

N 

(A) 100 mg 

MM 0751.10 Imp. J (EP): 2,2-Dipropylpentanenitrile 

N 

(A) 100 mg 

Vancomycin Hydrochloride 

MM 0239.00 

Vancomycin Hydrochloride 

HO NH 2 

O 

O 

HO 

OH 

O 

O 

Cl 

O 

O 

OH 

HN 

H 

N 

O 

O 

NH 

(A) 

100 mg 

HO 

Cl 

O 

HN 

NH 

O 

O 

NH 2 

x HCl 

O 

HO 

O 

NH 

O 

N 

H 

OH 

OH 

OH 

OH 




Venlafaxine Hydrochloride 

MM 0393.00 

Venlafaxine Hydrochloride 

OH 

on request 

N 

x HCl 

O 

MM 0393.08 

Imp. C (EP) as Hydrochloride: 1-[(1RS)-2-Amino-1-(4- 

methoxyphenyl)ethyl]cyclohexanol Hydrochloride 

OH 

NH 2 

x HCl 

(A) 

100 mg 

O 

MM 0393.04 

Imp. D (EP) as Hydrochloride: 1-[(1RS)-1-(4- 

Methoxyphenyl)-2-(methylamino)ethyl]cyclohexanol 

Hydrochloride 

OH 

H 

N 

x HCl 

(A) 

100 mg 

O 

MM 0393.09 

Imp. E (EP) as Hydrochloride: (5RS)-5-(4- 

Methoxyphenyl)-3-methyl-1-oxa-3-azaspiro- 

[5.5]undecane Hydrochloride 

O 

N 

x HCl 

(A) 

100 mg 

O 

MM 0393.10 

Imp. F (EP) as Hydrochloride: (2RS)-2- 

(Cyclohex-1-enyl)-2-(4-methoxyphenyl)- 

N,N-dimethylethanamine Hydrochloride 

N 

x HCl 

(A) 

100 mg 

O 

MM 0393.01 

O-Desmethylvenlafaxine 

OH 

(A) 

100 mg 

N 

HO 

Verapamil Hydrochloride 

MM 0022.00 

Verapamil Hydrochloride 

O 

(A) 

500 mg 

O 

O 

O 

N 

MM 0022.07 

MM 0022.08 

Imp. A (EP) as Dihydrochloride: N,N'-Bis[2- 

(3,4-dimethoxyphenyl) 

ethyl]-N,N'-dimethylpropane-1,3-diamine 


Imp. B (EP) as Hydrochloride: 2-(3,4-Dimethoxyphenyl)-Nmethylethanamine 

Hydrochloride 

O 

x HCl 

O N N O 

N 

x 2 HCl O (A) 100 mg 

O 

O 

x HCl 

NH 

(A) 

100 mg 

New MM 0022.09 Imp. C (EP) as Hydrochloride: 2-(3,4- 

Dimethoxyphenyl)-N,N-dimethylethanamine 

Hydrochloride 

O 

O 

N 

x HCl 

(A) 

100 mg 

MM 0022.02 

Imp. D (EP): 3-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-Nmethylpropan-1-amine 

O 

O N Cl 

(A) 

100 mg 

MM 0022.05 Imp. E (EP): (3,4-Dimethoxyphenyl)methanol 

O 

MM 0022.04 Imp. G (EP): 3,4-Dimethoxybenzaldehyde 

O 

OH 

(B) 100 mg 

O (B) 100 mg 

O 

O 

MM 0022.11 

Imp. H (EP) as Hydrochloride: (2RS)-2-(3,4- 

Dimethoxyphenyl)-5-[[2-(3,4- 

dimethoxyphenyl)ethyl](methyl)amino]-2- 

ethylpentanenitrile Hydrochloride 

O 

O 

x HCl 

N 

O 

O 

(A) 

100 mg 

N 

MM 0022.01 

Imp. J (EP): (2RS)-2-(3,4-Dimethoxyphenyl)-5- 

[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-(1- 

methylethyl)pentanenitrile 

(N-Norverapamil) 

O 

O 

O N 

H 

O 

(A) 

100 mg 

N 




MM 0022.03 

Imp. K (EP): (2RS)-2-(3,4-Dimethoxyphenyl)-3-methylbutylnitrile 

O (A) 100 mg 

O 

N 

MM 0022.13 

Imp. L (EP): 1-(3,4-Dimethoxyphenyl)-2- 

methylpropan-1-one 

O (A) 100 mg 

O 

O 

New MM 0022.16 

Imp. O (EP) as Hydrochloride: (2RS)-2-(3,4- 

Dimethoxyphenyl)-5-[2-[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]- 

2-propylpentanenitrile 

Hydrochloride 

O 

O 

x HCl 

N 

O 

O 

(A) 

100 mg 

N 

MM 0022.06 

Diisopropylhomoveratylcyanide 

O (D) 100 mg 

O 

N 

MM 0022.18 

3,4-Dimethoxyphenylacetonitrile 

O 

(A) 

100 mg 

O 

N 

MM 0022.19 

Verapamil N-Oxide Hydrochloride 

O 

(A) 

100 mg 

O 

O 

O 

O 

N 

x HCl 

N 

Vincamine 

MM 0519.00 

Vincamine 

N 

HO 

H 

N 

(A) 

100 mg 

O 

O 

Vinpocetine 

MM 0406.00 

Vinpocetine 

O 

(D) 

100 mg 

O 

N 

N 

H 

MM 0406.02 

Imp. A (EP): Ethyl (12RS,13aSR,13bSR)-13a- 

Ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]- 

naphthyridine-12-carboxylate (Ethyl Vincaminate) 

O 

HO 

O 

N 

N 

H 

(D) 

100 mg 


MM 0406.01 

Imp. B (EP): Methyl (13aS,13bS)-13a-Ethyl- 

2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1- 

de]pyrido[3,2,1-ij][1,5]naphthyridine-12- 

carboxylate (Apovincamine) 

O 

O 

N 

N 

H 

(D) 

100 mg 

Warfarin Sodium 

MM 0732.02 Imp. B (Pharmeuropa): 4-Hydroxycoumarin 

O O 

(A) 

100 mg 

Xylazine Hydrochloride 

OH 

MM 0515.00 Xylazine Hydrochloride H 

S N 

(A) 

500 mg 

N 

x HCl 

MM 0515.01 

Imp. A (EP): 2,6-Dimethylaniline (2,6-Xylidine) 

H 2 N 

(B) 

100 mg 




Xylometazoline Hydrochloride 

MM 0089.00 

Xylometazoline Hydrochloride 

N 

N 

H 

x HCl 

(A) 

500 mg 

MM 0089.07 

Imp. A (EP) as Hydrochloride: N-(2- 

Aminoethyl)-2-[4-(1,1-dimethylethyl)- 

2,6-dimethylphenyl]acetamide 

Hydrochloride 

O 

N 

H 

NH 2 

x HCl 

(A) 

100 mg 

MM 0089.04 

Imp. B (EP): 2-(Chloromethyl)-5-(1,1-dimethylethyl)-1,3- 

dimethylbenzene 

Cl 

(A) 

100 mg 

MM 0089.03 

Imp. C (EP): [4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]acetonitrile 

(A) 

100 mg 

N 

MM 0089.05 Imp. D (EP): 1-(1,1-Dimethylethyl)-3,5-dimethylbenzene (C) 100 mg 

MM 0089.02 

Imp. F (EP): [4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]acetic Acid 

O 

(A) 

100 mg 

OH 

Zidovudine 

MM 0173.01 

Imp. A (EP): 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5- 

methylpyrimidine-2,4(1H,3H)-dione 

HO 

HN 

O N 

O 

O 

(A) 100 mg 

MM 0173.03 

Imp. C (EP): 5-Methylpyrimidine-2,4(1H,3H)dione (Thymine) 

O 

(A) 100 mg 

HN 

MM 0173.04 

Imp. D (EP): Triphenylmethanol 

O 

N 

H 

(A) 

100 mg 

OH 

Zolpidem Tartrate 

MM 0333.01 

Imp. A (EP): N,N-Dimethyl-2-[7-methyl-2-(4- 

methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide 

N 

N 

O 

N 

(D) 

100 mg 

MM 0333.02 

2-[6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridin-3-yl]acetamide 

(A) 

100 mg 

N 

N 

O 

NH 2 

MM 0333.03 

2-[6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridin-3-yl]acetic 

Acid 

N 

N 

O 

OH 

(A) 

100 mg 

MM 0333.04 

Methyl 2-[6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3- 

yl]acetate 

N 

N 

O 

O 

(D) 

50 mg 

MM 0333.05 

6-Methyl-2-(4-methylphenyl)imidazo-[1,2-a]pyridine-3-acetonitrile 

(A) 

100 mg 

N 

N 

N 




MM 0333.06 

MM 0333.07 

Oxozolpidem (N,N,6-Trimethyl-2-(4-methylphenyl)-α-oxo-imidazo 

[1,2-a]pyridine-3-acetamide) 

Zolpaldehyde (6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine- 

3-carboxaldehyde) 

N 

N 

N 

O 

O 

N 

(D) 

(A) 

100 mg 

100 mg 

N 

O 

MM 0333.08 

Zolpyridine (4-Methyl-N-(5-methyl-2-pyridinyl)-benzamide) 

H 

N 

(A) 

100 mg 

N 

O 

New MM 0333.09 

6-Methyl-2-(4-methylphenyl)-α-oxo-imidazo[1,2- 

a]pyridine-3-acetamide 

N 

N 

O 

(A) 

100 mg 

O 

NH 2 

MM 0333.10 

Methyl α-Hydroxy-6-methyl-2-(4-methylphenyl)- 

imidazo[1,2-a]pyridine-3-acetate 

N 

N 

HO 

O 

O 

(A) 

100 mg 

Zopiclone 

MM 0149.00 

Zopiclone 

N 

N 

O 

N 

N 

O N 

O 

N 

Cl 

(D) 

100 mg 

MM 0149.01 

Imp. A (EP): (5RS)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5Hpyrrolo[3,4-b]pyrazin-5-yl 

4-Methylpiperazine-1-carboxylate 4-Oxide 

(Zopiclone Oxide) 

N 

N 

O 

N 

N 

O N 

O 

N 

O 

Cl 

(D) 

100 mg 

MM 0149.02 

Imp. B (EP): (7RS)-6-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro- 

5H-pyrrolo[3,4-b]pyrazin-5-one 

N 

N 

O 

N 

OH 

N 

Cl 

(D) 

100 mg 

MM 0149.04 

2-Amino-5-chloropyridine 

H 2N 

N 

Cl 

(A) 

250 mg 

MM 0149.05 

MM 0149.06 

3-(5-Chloropyridine-2-carbamoyl)-2-pyrazinecarboxylic Acid 

6-(5-Chloropyridin-2-yl)- 6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5,7- 

dione 

N 

N 

N 

N 

O 

O 

N 

N 

H 

OH 

O 

O 

N 

N 

Cl 

Cl 

(A) 

on request 

100 mg 

MM 0149.07 

5-(Chloropyridine-2-yl-carbamoyl)pyrazine 

N 

N 

O 

N 

H 

N 

Cl 

(A) 100 mg 

MM 0149.50 

2-Acetylamino-5-chloropyridine 

O 

N 

Cl 

(A) 100 mg 

NH 

Extended certificates of analysis from LGC 

MMEXTCOA 

The certificates from LGC usually contains one identity test via 1 H-NMR or MS. 

There is - for 90% of the LGC products - the opportunity to extend the certificates to the following content: 

Ia. 1 H-NMR 

Ib. 13 C-NMR 

Ic. MS 

Id. IR 

Extended certificates of analysis 




Certificate construction in contract from LGC 

MMCERCON 

LGC offers the opportunity to set up a certificate of analysis (COA) for your substances. A minimum amount 

of 50 mg of substance is needed for analysis. The COA will contain the following: 

Identity ( 1 H-NMR, 13 C-NMR, MS, IR) 

Purity (HPLC-DAD) 

Assay declaration 

Incl. documentation with your batch identification 

Certificate construction in contract 


Physical 




Genuine ATCC cultures 

and bioproducts for the 

European pharmaceutical 

community 

LGC Standards is the exclusive distributor of ATCC 

cultures and bioproducts in Europe. We are committed 

to providing authentic, high-quality ATCC cultures to 

support quality control and research activities across 

the pharmaceutical industry. 

With a local stock of all key quality control strains and 

a wide selection of other cultures, LGC Standards 

network of offices across Europe is able to offer: 

• Faster delivery of ATCC products 

• Expert technical support 

• Expedited handling of special forms and paperwork 

to meet import regulations 

• Reduced shipping costs 

For further information or to place an order, please visit 

our web site or contact your local LGC Standards office. 

Quality control strains 

Genomic DNA 

Animal and plant viruses 

Cell lines and hybridomas 

cDNA clones, vectors 

and libraries 

Microbial media, 

supplements and 

antibiotics 

Cell culture media, sera 

and reagents 

Cryopreservation 

products 

www.lgcstandards.com/atcc

Introduction 

Physical standards 

Introduction 

For manufacturers of a wide variety of products, the determination of the physical properties of their 

product can be one of the most important steps in assuring quality. This section is a comprehensive 

collection of reference materials intended purely for the determination of physical properties. 

It lists a large range of reference materials and standards covering many physical properties including 

thermal and surface properties, particle shape and size, ion activity, viscosity, electrical, and polymeric 

properties. Of particular interest are products for the determination of optical properties such as molecular 

absorption, luminescence, colour measurement and refractive index. Also featured are the old favourites 

such as melting point standards and standards for use with differential scanning calorimetry (DSC). 

The range includes reference materials and standards from commercial sources as well as national and 

international bodies and each product is accompanied by a certificate of analysis. This section has 

been designed to be simple to use; it provides a brief description of the products with details of the 

relevant parameters from the certificate of analysis. 

Producers of reference materials 

IRMM 

BCR ® and IRMM reference materials (BCR ® is a registered trademark of JRC-EC-IRMM) are the products 

of both research funding and direct action programmes of the European Commission, in which new or 

improved measurement or testing methods are developed. These programmes are aimed at improving, 

harmonising or standardising measurements and testing in the European Union. 

As an authorised distributor of BCR ® reference materials LGC Standards currently holds stock of more than 

5000 units of certified BCR ® and IRMM reference materials under carefully controlled and monitored 

conditions. 

European Reference Materials (ERM ® ) 

The ERM ® range of reference materials was launched in May 2004. It is the result of collaboration between 

three major reference material producers, LGC in the UK, the Institute for Reference Materials and 

Measurement (IRMM) in Belgium and Bundesanstalt für Materialforschung und Prüfung (BAM) in Germany. 

The partners are committed to using the most advanced principles for the production of certified reference 

materials. The certified values have clearly defined and stated traceability and are internationally recognized 

through participation of the partners in key comparisons organized by the Bureau International des Poids et 

Mesures (BIPM). All ERM ® materials are subject to rigorous homogeneity and stability testing guaranteeing 

the certified values for every unit over its complete shelf life. 

The National Institute of Standards and Technology (NIST) 

NIST produces standard reference materials (SRMs ® ). Based in the United States, NIST has provided 

reference materials to industry and commerce for nearly 100 years. NIST collaborates with companies 

to provide academia and industry with SRMs for expanding areas such as air and water pollution, which 

are international issues. 

Others 

Materials from the following organisations are also included in this section: 

- National Research Centre for Certified Reference Materials, China 

- AEA Technology, UK 

- Whitehouse Scientific Ltd, UK 

- Optiglass Ltd, UK 

- Cargille Laboratories Inc., USA 

- H & D Fitzgerald Ltd, UK 

- GE Sensing, UK 

- Poulten Selfe & Lee Ltd, UK 

- Stanhope-Seta, UK 

- Federal Institute for Materials Research and Testing, Germany 

- LabStand Production & Service Company, Poland 

- Central Office of Measures (GUM), Poland 


About proficiency testing (PT) 

The use of reference materials 

Reference materials are instrumental in ensuring the reliability of analytical measurements and so avoiding 

the use of poor quality data as the basis of decision making. 

When choosing a matrix reference material for a particular application the analyst should consider the 

following factors before selecting a material: 

- Matrix match and potential interferences 

- Analytes 

- Measurement range 

- Measurement uncertainties 

- Certification procedures used by the producer 

- Documentation supplied with the material (e.g. certificate or report). 

About proficiency testing (PT) 

Proficiency testing (PT) is a powerful quality assurance tool for laboratories undertaking analytical 

measurements. A PT scheme provider distributes test materials on a regular basis to participating 

laboratories for independent testing.The results are returned to the organiser of the scheme who 

makes an analysis of the results and provides a report to all the participants. 

There are a number of benefits of taking part in a PT scheme: 

- Provides laboratories with a mechanism to compare their measurements with others 

- Enables laboratories to demonstrate the quality of their results to third parties e.g. customers, 

regulators and accreditation bodies 

- Facilitates the monitoring of trends, over time, in the quality of measurements 

- Assists the evaluation of methods and instrumentation 

- Helps and educates laboratory staff and their customers 

The LGC Proficiency Testing Group (incorporating Quality Management Ltd and Aquacheck Ltd) is a 

major international provider of proficiency testing services. It has over twenty years experience in all 

aspects associated with the provision of proficiency testing services to laboratories undertaking chemical 

and microbiological analysis. Schemes of relevance to a wide range of sectors are available and most 

of them are run on an international basis. All LGC schemes are accredited by the United Kingdom 

Accreditation Service (UKAS). 

Current schemes provided include: 

Environmental: 

· AQUACHECK - chemical analysis of clean waters, waste waters, sludges, sediments and soils 

· QWAS - microbiological assessment of waters, effluents and sludges 

· CONTEST - analysis of contaminated soils for a wide range of contaminants 

Food: 

· QMS - microbiological examination of food and food ingredients 

· QDCS - composition and safety testing in the dairy sector 

· QMAS - chemical analysis of meat 

· QGS - analysis of gelatine samples 

· QCS - microbiological testing of chocolate 

· QFCS - chemical testing of food products 

Beverage: 

· BAPS - chemical, microbiological and sensory analysis of a range of beers. 

· DAPS - analysis of a wide range of alcoholic beverages (except beer) 

· QBS - microbiological and chemical testing of soft drinks 

· SODAS - chemical analysis of carbonated and still soft drinks 

· MAPS - analysis of malt and barley used by the malting, brewing and distilling industries 

· SUPS - analysis of raw sugar used in soft drink production. 


Others: 

· QMIS - identification of micro organisms 

· PHARMASSURE - measurement of a range of analytes in pharmaceutical products 

used in hospitals 

· QUARTZ - toxicological analysis of drugs in post-mortem blood 

· TOYTEST - toy safety testing to the European Standard EN71 and American Standard ASTM 

F963 

In addition to these regular schemes LGC is also able to offer customised or closed proficiency 

testing schemes tailored to a specific organisation’s requirements. 

LGC schemes are now available either through LGC Standards or through your local distributor. 

Please contact your local LGC Standards office to find out more. 

Relevant literature 

Applications of Reference Materials in Analytical Chemistry VAM 

V. Barwick, S. Burke, R. Lawn, P. Roper and R. Walker RSC 

Reference Materials in Analytical Chemistry – A Guide for Selection and Use 

A. Zchunke published by Springer-Verlag. 

Reference Materials for Chemical Analysis – Certification, Availability and Proper Usage 

M. Stoeppler, W.R. Wolf, P.J. Jenks published by Wiley-VCH. 

Proficiency Testing in Analytical Chemistry, R.Lawn, M.Thompson and R.Walker published by 

The Royal Society of Chemistry. 

Relevant training courses 

A range of training courses is available from LGC to help laboratory managers and analysts demonstrate 

competence in, and keep abreast of, quality assurance issues and practices. LGC’s analytical quality 

training programme includes: 

- Achieving traceability in chemical testing 

- Using proficiency testing in the analytical laboratory 

- Method validation 

- Principles and practice of measurement uncertainty in chemical testing laboratories 

- Quality systems in testing laboratories 

- Statistics for analytical chemists 

- Further statistical tools for analytical chemists 

- Evaluating measurement uncertainty for chemical testing laboratories 

The majority of the courses are run in Teddington, South West London, UK. In addition, LGC can provide 

training for groups of staff at your own site, where the courses can be customised to meet your exact needs. 

For further information, please contact: 

Lorraine Didinal 

LGC Training Centre 

Queens Road 

Teddington, Middlesex 

TW11 0LY, UK 

Tel: +44 (0)20 8943 7631 

Fax: +44 (0)20 8943 7314 

Email: training@lgc.co.uk 

Web: www.lgc.co.uk 


GlowellTM standards 

Glowell TM standards 

The measurement of light output from luminescence and fluorescence experiments is amongst the most 

common methods used in bio-analytical applications. The Glowell TM range of light output standards provide 

a known and traceable light source for the calibration of luminometers, bioimaging systems and quantitative 

PCR instruments. The standards are available in a variety of different wavelengths and formats to suit many 

different applications. 

Glowell TM standards generate a constant light output over a range of different wavelengths and intensities 

using a gaseous tritium source. A Glowell TM device is particularly useful in experimental applications that 

require the comparison of light output data from different experiments or instruments. Each Glowell TM unit 

can be placed in a single microplate well and can therefore be included in the same plate as the samples 

being analysed. Each Glowell TM product is provided with a certificate of analysis and is guaranteed to 

produce a stable light output for a period of year. 

The Glowell TM Low Light Imaging standards can be used for the calibration of CCD or low light cameras 

and the validation of experimental data using this equipment. 


LUX-GLO-001 Glowell 96 Well Microplate Standard (Green Light) KIT 

LUX-GLO-002 Glowell 96 Well Microplate Standard (Blue Light) KIT 

LUX-GLO-003 Glowell 96 Well Microplate Standard (Red Light) KIT 

LUX-GLO-004 Glowell 96 Well Microplate Standard (Yellow Light) KIT 

LUX-GLO-010 Glowell 384 Well Microplate Standard (Green Light) KIT 

LUX-GLO-011 Glowell 384 Well Microplate Standard (Blue Light) KIT 

LUX-GLO-012 Glowell 384 Well Microplate Standard (Red Light) KIT 

LUX-GLO-013 Glowell 384 Well Microplate Standard (Yellow Light) KIT 

LUX-GLO-014 Glowell Low Light Imaging Standard (Green Light) Unit 

LUX-GLO-015 Glowell Low Light Imaging Standard (Blue Light) Unit 

LUX-GLO-016 Glowell 96 Well Microplate Standard (2 colour, combination) KIT 

Thermal properties 

Enthalpy and heat capacity 


LGC2601 

LGC2603 

LGC2604 

LGC2605 

LGC2606 

LGC2607 

Indium - DSC calibration standard 

This certified reference material is intended for use in the calibration of differential scanning calorimeters and 

similar instruments. 

Certified values 

Enthalpy of fusion..................................3.296 kJ/mol Melting temperature...................................156.61 °C 

Naphthalene - DSC calibration standard 




Enthalpy of fusion................................18.923 kJ/mol Melting temperature.....................................80.23 °C 

Benzil - DSC calibration standard 




Enthalpy of fusion..................................23.26 kJ/mol Melting temperature.....................................94.85 °C 

Acetanilide - DSC calibration standard 




Enthalpy of fusion................................21.793 kJ/mol Melting temperature...................................114.34 °C 

Benzoic acid - DSC calibration standard 





Diphenylacetic acid - DSC calibration standard 





500 mg 

500 mg 

500 mg 

500 mg 

500 mg 

500 mg 




LGC2608 

LGC2609 

LGC2610 

LGC2611 

LGC2612 

LGC2613 

LGC2013 

NIST-2232 

NIST-2234 

NIST-2235 

NIST-2225 

NIST-705A 

NIST-720 

NIST-781D2 

Lead - DSC calibration standard 




Enthalpy of fusion..................................4.765 kJ/mol Melting temperature ..................................327.47 °C 

Tin - DSC calibration standard 





Biphenyl - DSC calibration standard 



Certified Values 

Enthalpy of fusion..................................18.60 kJ/mol Melting temperature ....................................68.93 °C 

Zinc - DSC calibration standard 





Aluminium - DSC calibration standard 




Enthalpy of fusion................................10.827 kJ/mol Melting temperature ..................................660.33 °C 

Phenyl salicylate - DSC calibration standard 




Enthalpy of fusion..................................19.18 kJ/mol Melting temperature ....................................41.79 °C 

DSC purity set 

A series of mixtures of benzil in biphenyl intended for evaluating various features of the DSC technique (e.g. bias, 

repeatability, applicable impurity range) when the technique is used for determining the impurity content of organic 

compounds.. 


Total impurity (mole %) Uncertainty (mole %) Total impurity (mole %) Uncertainty (mole %) 

0.1 ........................................................................ 0.1 2.1 ........................................................................0.2 

1.1 ........................................................................ 0.2 2.6 ........................................................................0.2 

1.6 ........................................................................ 0.2 3.1 ........................................................................0.2 

Indium - DSC calibration standard 

DSC calibration standard 


Enthalpy of fusion....................................... 28.51 J/g Melting temperature ..............................156.5985 °C 

Gallium - DSC calibration standard 


Enthalpy of fusion....................................80.097 kJ/g 

Bismuth - DSC calibration standard 


Enthalpy of fusion..................................... 53.146 J/g 

Mercury - DSC calibration standard 


Enthalpy of fusion................................11.469 kJ/mol 

Polystyrene - Heat capacity and molecular weight 

Fusion temperature .................................302.9146 K 

Fusion temperature ...................................544.556 K 

Melting temperature ....................................234.30 K 

Molecular weight (MW) values, measured using various techniques, and limiting viscosity (LV) numbers. 


M n by membrane osmometry............. 170,900 g/mol LV in benzene (25 °C)...............................74.3 mL/g 

M W by light scattering......................... 179,300 g/mol LV in benzene (25 °C)...............................74.5 mL/g 

M W by sedimentation equilibrium ....... 189,800 g/mol LV in cyclohexane (25 °C).........................35.4 mL/g 

For heat capacity please ask for detailed list 

Synthetic sapphire - Enthalpy and heat capacity 

Relative enthalpy and heat capacity from 10 to 2250 K 

Molybdenum - Enthalpy and heat capacity 

Relative enthalpy and heat capacity from 273.15 to 2800 K 

500 mg 

500 mg 

500 mg 

500 mg 

500 mg 

500 mg 

6 x 500 mg 

1 g 

2 g 

1.5 g 

2.5 g 

5 g 

15 g 

each 




NIST-1514 

Thermal analysis purity set 

Set of 4 x 0.5 g 

A set of materials containing pure phenacetin and phenacetin doped with nominal 0.7, 2 and 5 mol percent of p- 

aminobezoic acid 

set (4) 

Melting, freezing and triple points 

LGC2411 

LGC2401 

LGC2402 

LGC2403 

LGC2404 

LGC2405 

LGC2406 

Phenyl salicylate - Melting point 

This certified reference material is intended for use in checking and calibrating apparatus used for determining 

melting points of samples in glass tubes. 


Thermodynamic melting point..................... 41.50 °C 

Dynamic melting points (0.2 °C/min heating rate): 

Onset of melting...........41.55 °C 

Meniscus point .............41.70 °C 

Liquefaction point .........41.85 °C 

4-Nitrotoluene - Melting point 








Naphthalene - Melting point 









Benzil - Melting point 









Acetanilide - Melting point 




Thermodynamic melting point 113.94 °C 


Onset of melting.........113.46 °C 

Meniscus point ...........113.88 °C 

Liquefaction point .......114.27 °C 

Benzoic acid - Melting point 




Dynamic melting point (0.2 °C/min heating rate) 




Diphenylacetic acid - Melting point 


melting points of samples in glass tubes.^ 


Thermodynamic melting point................... 147.05 °C 





500 mg 

2 x 250 mg 

500 mg 

500 mg 

500 mg 

2 x 0.25 g 

500 mg 




LGC2407 

LGC2408 

LGC2409 

LGC2410 

NCS AS93109 

NCS AS93102B 

NCS AS93110 

NCS AS93111 

NCS AS93103B 

NCS AS93112 

NCS AS93104B 

NCS AS93113 

NCS AS93105A 

NCS AS93114 

NCS AS93115 

NCS AS93116 

NCS AS93106 

Anisic acid - Melting point 








Liquefaction point.......183.72 °C 

2-Chloroanthraquinone - Melting point 









Carbazole - Melting point 









Anthraquinone - Melting point 









Azobenzol - Melting point 

Certified melting point ................................. 68.34 °C 

Napthalene - Melting point 


Methylprotocatechuic - Melting point 


Acetanil - Melting point 

Certified melting point ............................... 114.55 °C 

Benzoic acid - Melting point 


p-Acetophenetidine - Melting point 


1,6-Adipic acid - Melting point 


Albexan - Melting point 


Anisic acid - Melting point 


Amber acid - Melting point 


Sulfadimidine - Melting point 


Cyanoguanidine - Melting point 


Anthracene - Melting point 


500 mg 

500 mg 

500 mg 

500 mg 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 




NCS AS93117 

NCS AS93118 

NCS AS93107B 

NCS AS93101B 

NCS AS93119 

NCS AS93108B 

NIST-741A 

NIST-743 

NIST-1744 

NIST-1745 

NIST-1746 

NIST-1747 

NIST-1748 

NIST-740A 

NIST-45D 

NIST-49E 

NIST-742 

NIST-1968 

NIST-1751 

Saccharin - Melting point 


Coffeine - Melting point 


p-Nitrobenzoic acid - Melting point 


4-Nitrotoluene - Melting point 


Chocolax - Melting point 


Anthraquinone - Melting point 


Tin - Freezing point 

For use in defining fixed points of the International Temperature Scale of 1990 (ITS-90). 

Certified freezing point ............................ 231.928 °C 

Mercury - Triple point 


Certified triple point ................................-38.8344 °C 

Aluminium - Freezing point 



Indium - Freezing point 


Certified freezing point .......................... 156.5985 °C 

Silver - Freezing point 


Certified freezing point .............................. 961.78 °C 

Tin - Freezing point 

A fixed point device for use in the realisation of the International Temperature Scale of 1990 (ITS-90). 


Zinc - Freezing point 

A fixed point device for use in the realisation of the International Temperature Scale of 1990 (ITS-90). 


Zinc - Freezing point 



Copper - Freezing point 

Moderate purity material for use in preparing reference point devices and for calibrating thermometers, 

thermocouples and other temperature measuring devices. 

Certified freezing point .............................. 1084.6 °C 

Lead - Freezing point 




Alumina - Melting point 



Certified melting point .................................. 2052 °C 

Gallium - Melting point/triple point 

A fixed-point device for use in the realisation of internationally accepted secondary reference points and/or triple 

points. They are not intended for calibration of differential scanning calorimeters. 

Certified melting point/triple point............ 29.7646 °C 

Gallium - Melting point 

This Standard Reference Material (SRM ® ) is intended primarily for use as one of the defining fixed points of the 

International Temperature Scale of 1990 (ITS-90). The melting point is realised as the plateau temperature of the 

melting curve of slowly-melting, high-purity (mass ≥ fraction 99.9999 % pure) gallium. 

Certified melting-point temperature..................29.764 6 °C ± 0.000 07 °C 

2 g 

2 g 

2 g 

2 g 

2 g 

2 g 

200 g 

680 g 

200 g 

200 g 

300 g 

1 cell 

1 cell 

200 g 

450 g 

600 g 

10 g 

unit 

200 g 




NIST-1969 

NIST-1970 

NIST-1971 

NIST-1972 

Flash point 

ERM-FC032 

ERM-FC033 

LGC2000 

Rubidium - Melting point/triple point 



Certified melting point/triple point................ 39.30 °C 

Succinonitrile - Melting point/triple point 




Indium - Melting point/triple point 




1,3-Dioxolan-2-one (ethylene carbonate) - Melting point/triple point 




n-Nonane 

The certified value was determined by the Abel closed cup method described in the Institute of Petroleum 

Standard IP170/95 and also published as British Standard BS2000:Part 170: 1995. The certified value is 

corrected to standard barometric pressure at 0°C. 

Certified value 

Non-equilibrium flash point ........................... 32.5 °C 

n-Decane 

The certified value was determined by the Abel closed cup method described in the Institute of Petroleum 

Standard IP170/95 and also published as British Standard BS2000:Part 170: 1995. The certified value is 

corrected to standard barometric pressure at 0°C. 


Non-equilibrium flash point .............................. 50 °C 

Diethyl phthalate 

Combustion calorimetry 

NIST-39J 

NIST-1656 

NIST-1657 

NIST-2151 

NIST-2152 

NIST-2682B 

NIST-2684B 


flash point by closed cup equilibrium methods. The certified value was determined from the results of an 

interlaboratory study, where the participants used IP/304 Pensky-Martens Closed Cup or IP/303 Setaflash 

methods. 


Equilibrium closed cup flash point............... 159.0 °C 

Benzoic acid - Heat of combustion 

Certified value ...... 26.434 MJ/kg 

Thianthrene - Heat of combustion 

Certified value ...... 33.480 MJ/kg 

Synthetic refuse-derived fuel - Heat of combustion 


HHV* (dry)...................................13.87 ± 0.25 MJ/kg Dry ash .......................................... 20.34 ± 0.54 wt% 

HHV* (dry, ash free)....................17.40 ± 0.30 MJ/kg 

*HHV (Higher heating value) is the synonym for gross calorific value. 

Nicotinic acid - Heat of combustion 

Certified value ......................................22.184 MJ/kg 

Urea 

Certified value ......................................10.536 MJ/kg 

Coal (sub-bituminous) - Sulphur, mercury and heat of combustion 


S.................................................................0.4917 % 

Indicative values for Ash content, Gross calorific value 

Coal (bituminous) - Sulphur, mercury and heat of combustion 


S...................................................................3.076 % 

Hg............................................................. 97.4 µg/kg 

Indicative values for Ash content, Gross calorific value 

Hg........................................................... 108.8 µg/kg 

Heat of combustion ............................... 28.56 MJ/kg 

unit 

unit 

60 g 

60 g 

100 mL 

100 mL 

500 mL 

30 g 

30 g 

100 g 

25 g 

25 g 

50 g 

50 g 




NIST-2685B 

NIST-2692b 

Solution calorimetry 

NIST-1655 

Vapour pressure 

NIST-746 

Thermal conductivity 

IRMM-440A 

IRMM-440B 

IRMM-440C 

IRMM-440D 

NIST-RM 8420 

BCR-039A 

BCR-039B 

BCR-039C 

Coal - Sulphur, mercury and heat of combustion 

This Standard Reference Material (SRM ® ) is intended primarily for use in the evaluation of techniques employed 

in the determination of sulphur, mercury, ash content, and calorific value (MJ·kg-1) in coal and materials of a 

similar matrix. NIST-2685b consists of 50 g of bituminous coal ground to pass a 250 µm (60 mesh) sieve, 

homogenized, and packaged in an amber glass bottle. 


S...................................................................4.730 % Cl ..............................................................517 mg/kg 

Hg........................................................... 146.2 µg/kg 

Indicative values for the ash content, gross calorific value and elements 

Coal (bituminous) - Sulphur, mercury and gross calorific value 


S..................................................1.170 % ± 0.020 % 

Reference values 

Ash Content (mass fraction)...........................7.90 % 

Potassium chloride - water solution calorimetry 

Hg........................................133.3 µg/kg ± 4.1 µg/kg 

Gross Calorific Value............................. 32.81 MJ/kg 

Intended for use in verifying or comparing results obtained by calorimeters measuring enthalpies of endothermic 

solution processes. 


Heat of solution (absorbed)...................... 235.86 J/g 

Cadmium - vapour pressure 

Certified values for vapour pressure as a function of temperature (350-594 K) 

Resin bonded fibre board (300 x 300 x 35 mm) - Thermal conductivity 

Certified value for thermal conductivity between -10°C and +50 °C 







Electrolytic iron rod 

0.64 cm (D) x 5.0 cm 

Thermal conductivity and electrical resistivity as a function of temperature (2-1000 K) 

Pyrex glass - Thermal conductivity 

30 cm x 30 cm x 20 mm 

Certified value (23 °C) 

λ .........................1.143 8 W/m.K 

The function to calculate λ for temperature between –75 and 195 °C is given in the CoA 


30 cm x 30 cm x 30 mm 


λ .........................1.143 8 W/m.K 



30 cm x 30 cm x 50 mm 


λ .........................1.143 8 W/m.K 


50 g 

50 g 

30 g 

1 rod 

board 

board 

board 

board 

1 rod 

board 

board 

board 




BCR-724A 

BCR-724B 

BCR-724C 

BCR-724D 

BCR-724E 

Glass-ceramic - Thermal diffusivity, thermal conductivity 

Rod in container (diam.= 13.0 mm height > 18 mm) 

Thermal diffusivity, α 


[m²/s ·10 -6 ] 

α = 4.406 - 1.351.10 -2 . T + 2.133 . 10 -5 . T 2 - 1.541 . 10 -8 . T 3 + 4.147 . 10 -12 T 4 

Uncertainty:6.1% 

Thermal conductivity, λ 


[W/(m·K)] 

λ = 2.332 + 515.1/T 






[m²/s ·10 -6 ] 

α = 4.406 - 1.351.10 -2 . T + 2.133 . 10 -5 . T 2 - 1.541 . 10 -8 . T 3 + 4.147 . 10 -12 T 4 




[W/(m·K)] 

λ = 2.332 + 515.1/T 






[m²/s ·10 -6 ] 

α = 4.406 - 1.351.10 -2 . T + 2.133 . 10 -5 . T 2 - 1.541 . 10 -8 . T 3 + 4.147 . 10 -12 T 4 




[W/(m·K)] 

λ = 2.332 + 515.1/T 






[m²/s ·10 -6 ] 

α = 4.406 - 1.351.10 -2 . T + 2.133 . 10 -5 . T 2 - 1.541 . 10 -8 . T 3 + 4.147 . 10 -12 T 4 




[W/(m·K)] 

λ = 2.332 + 515.1/T 






[m²/s ·10 -6 ] 

α = 4.406 - 1.351.10 -2 . T + 2.133 . 10 -5 . T 2 - 1.541 . 10 -8 . T 3 + 4.147 . 10 -12 T 4 




[W/(m·K)] 

λ = 2.332 + 515.1/T 


rod 

rod 

rod 

rod 

rod 



Thermal expansion 


NIST-731L1 

NIST-731L2 

NIST-731L3 

NIST-738 

Borosilicate glass 

6.4 mm x 51 mm 

Certified values for thermal expansion as a function of temperature (80-680 K) 


6.4 mm x 102 mm 



6.4 mm x 152 mm 


Stainless steel 


5 cm 

10 cm 

15 cm 

51x6.4 mm 

Thermal resistance 

NIST-1449 

NIST-1459 

NIST-1450C 

NIST-1452 

NIST-1453 

Fumed silica board 

60 cm x 60 cm x 2.54 cm 

Certified values for thermal resistance as a function of density and pressure 

Fumed silica board 

30 cm x 30 cm x 2.45 cm 

Certified values for thermal resistance as a function of density and pressure 

Fibrous glass board 

61 cm x 61 cm x 2.54 cm 

Certified values for thermal resistance as a function of bulk density and temperature (280-340 K) 

Fibrous glass blanket for high precison measurements - Thermal resistance 

This Standard Reference Material (SRM ® ) is intended for use in evaluation of a guarded hot plate (GHP) or the 

calibration of a heat flow meter (HFM). It is supplied as a fibrous glass batt of nominal dimensions 60 x 60 x 2.54 

cm. Each unit of NIST-1452 is a individually characterised specimen. 

Expanded polystyrene board 

93 cm x 66 cm x 1.34 cm 

Certified values for thermal resistance as a function of bulk density and temperature (285-310 K) 

board 

board 

board 

each 

board 

Glass liquid temperature 

NIST-773 

NIST-1416 

Soda-lime-silica 

2.5 cm x 2.5 cm x 0.6 cm 

Intended for checking test methods and for calibrating equipment used to determine the liquidus temperature of 

glass by the gradient furnace method per ASTM C 829. 

A (boat) 

Certified value .................988 °C 

B (perforated plate) 

Certified value .................991 °C 

Aluminosilicate glass - Liquidus temperature 

Certified value for the gradient liquidus temperature is 

1147 ± 4 °C 

65 g 

250 g 

Temperature measuring devices 

NIST-934 

NIST-1967 

NIST-1749 

NIST-1750 

Clinical laboratory thermometer 

Calibrated at 4 temperatures 0, 25, 30 and 37 °C 

Platinum thermocouple 

Platinum wire 0.51 mm diameter and 1 m long 

Intended for use as a standard reference thermoelement for calibration of base-metal and noble-metal 

thermocouple materials (-197 °C - 1768 °C) 

Gold vs. Platinum Thermocouple Thermometer 

Certified Thermometer for the range 0°C to 1000°C on the International Temperature Scale of 1990. 

Standard Platinum Resistance Themometer 

Certified Thermometer for the range 13.8033 K to 429.7485 K on the International Temperature Scale of 1990. 

unit 

each 

each 

capsule 


Particles and surface properties 


Particle size 


AEA1001 

Aerosol fibre analogue shape standard (aqueous suspension) 

Reference values: Particles per vial 1.0 x 10 7 , Particle length 3.09 µm, Particle width 1.67 µm, Particle depth 0.96 

µm, Indicative aerodynamic diameter – motion perpendicular to major axis 2.89 µm, Indicative aerodynamic 

diameter – motion parallel to major axis 3.14 µm. 

10 mL 

BCR-066 

BCR-066 - BCR-132 

For these materials the distribution is expressed as a curve of the cumulative mass of particles undersize 

versus particle size. In the case of particles of less than 90 µm diameter their size is expressed as the 

equivalent Stokes’ diameter determined from the settling rate of the particles in a viscous fluid. For larger 

particles the equivalent volume diameter determined by sieving was preferred. 

Quartz - Stokes' diameter 


Stokes’ diameter ................................0.35 - 3.50 µm 

10 g 

BCR-067 

BCR-068 

BCR-069 

BCR-070 

BCR-130 

BCR-131 

BCR-132 



Stokes’ diameter .....................................2.4 - 32 µm 

Quartz - Volume diameter 


Volume diameter..................................160 - 630 µm 



Stokes’ diameter ......................................14 - 90 µm 



Stokes’ diameter .....................................1.2 - 20 µm 



Volume diameter....................................50 - 220 µm 



Volume diameter................................480 - 1800 µm 



Volume diameter..............................1400 - 5000 µm 

10 g 

100 g 

10 g 

10 g 

50 g 

200 g 

700 g 

BCR-165 Latex spheres, nominal 2 µ 

Average particle diameter ............. 2.223 ± 0.013 µm 

Each vial contains 2 mL of an aqueous suspension of latex spheres at a mass concentration of about 0.2 g/L. 

About 0.5% of the particles are agglomerated doublets.. 

BCR-166 Latex spheres, nominal 4.8 µ 


About 0.5% of the particles are agglomerated doublets. 

Average particle diameter ............ 4.821 ± 0.019 µm 

BCR-167 Latex spheres, nominal 9.6 µ 


About 0.5% of the particles are agglomerated doublets. 

Average particle diameter ............. 9.475 ± 0.018 µm 

vial 

vial 

vial 

NIST-659 

NIST-659 - NIST-RM 8010 

These materials are for evaluating and calibrating specific types of particle size measuring 

instruments, including light scattering, electrical zone flow-through counters, optical and scanning 

electron microscopes, sedimentation systems and wire cloth sieving devices. 

Silicon nitride - Particle size 


Particle size..............0.2 - 10 µm 

set (5) 




NIST-1021 

NIST-1003C 

NIST-1004B 

NIST-1017b 

NIST-1018B 

NIST-1019B 

NIST-1690 

NIST-1691 

NIST-1692 

NIST-1961 

NIST-1963A 

NIST-1964 

NIST-1965 

NIST-1978 

NIST-1982 

Glass beads - Particle size 

This Standard Reference Material (SRM ® ) is intended for use in the evaluation and calibration of equipment used 

to measure particle size distributions (PSD) in the 2 µm to 12 µm diameter range. Typical methods for PSD 

determination would be laser light scattering (LLS), electrical sensing zone (ESZ), and sedimentation. Each unit 

of NIST-1021 consists of a single bottle containing approximately 4 g of solid spherical soda-lime glass beads. 


Particle size.................2 - 12 µm 



Particle size.........18.9 - 43.3 µm 



Particle size.............40 - 150 µm 



Particle size...........100 - 400 µm 



Particle size...........220 - 750 µm 



Particle size.........750 - 2450 µm 

Polystyrene (0.5 wt. % in water) - Particle size 


Particle size.................0.895 µm 











This Standard Reference Material (SRM ® ) is intended for the calibration/validation of particle sizing instruments, 

including electron microscopes, differential mobility analysers, scanning surface inspection systems, and other 

light scattering instruments. A unit of NIST-1963a consists of 5 mL of polystyrene spheres in deionized filtered 

(0.2 µm pore size) water. 


Modal sphere diameter ..................... 101.8 ± 1.1 nm 


This Standard Reference Material (SRM ® ) is intended for the calibration/validation of particle sizing instruments, 

including electron microscopes, differential mobility analysers, scanning surface inspection systems, and other 

light scattering instruments. A unit of NIST-1964 consists of 5 mL of polystyrene spheres in deionized filtered 

(0.2 µm pore size) water. 


Modal sphere diameter ................... 60.39 ± 0.63 nm 

Polystyrene - Particle size 

This Standard reference material is intended for use as an optical microscopy measurement standard 

and teaching tool. 


Hexagonal array............9.94 µm Unordered clusters ....... 9.89 µm 

Zirconium oxide - Particle size 


Particle size........0.33 – 2.19 µm 

Zirconia thermal spray powder - Particle size 



4 g 

28 g 

43 g 

70 g 

87 g 

200 g 

5 mL 

5 mL 

5 mL 

5 mL 

5 mL 

5 mL 

1 slide 

5 g 

10 g 




NIST-1984 

NIST-1985 

NIST-RM 8010 

NIST-2806A 

Thermal spray powder - Particle size distribution 

This Standard Reference Material ® (SRM ® ) is primarily intended for use in the calibration of equipment used 

to measure particle size distributions (PSD) in the 9 µm to 30 µm range. NIST-1984 consists of a single bottle 

containing approximately 14 g of tungsten carbide/cobalt powder. 

Certified PSD Values by scanning electron microscopy (SEM) 

Cumulative Mass Fraction Certified Diameter Uncertainty 

(%) (µm) (µm) 

10 ............................................................ 10.3 ......................................................... 0.9 

25 ............................................................ 13.2 ......................................................... 0.9 

50 ............................................................ 17.1 ......................................................... 2.2 

75 ............................................................ 21.3 ......................................................... 1.6 

90 ............................................................ 26.3 ......................................................... 0.9 

Thermal spray powder - Particle size distribution 

This Standard Reference Material (SRM) is intended primarily for use in the calibration of equipment used to 

measure particle size distributions (PSD) in the 18 µm to 55 µm range. NIST-1985 consists of a single bottle 

containing approximately 14 g of tungsten carbide/cobalt powder. 

Certified PSD Values by scanning electron microscopy (SEM) 

Cumulative Mass Fraction Certified Diameter Uncertainty 

(%) (µm) (µm) 

10 ............................................................ 20.2 ......................................................... 1.2 

25 ............................................................ 27.1 ......................................................... 1.7 

50 ............................................................ 36.1 ......................................................... 0.8 

75 ............................................................ 44.2 ......................................................... 2.1 

90 ............................................................ 50.1 ......................................................... 2.5 

Sand - Particle size 

Reference value 


Medium test dust (MTD) in hydraulic fluid 

NIST-2806a can be used in conjunction with the International Organization for Standardisation (ISO) 

method ISO/FDIS 11171, “Hydraulic Fluid Power - Calibration of Liquid Automatic Particle Counters” 


Particle Projected 

Concentration Area u u u u u 

Diameter Sampling Volume Length Digitalization Fractionation 

(Particles/mL) (µm) (µm) (µm) (µm) (µm) 

108400 ................ 1....................... 0.004............ 0.004.............0.0006 ..........0.127 ................0.051 

27035 .................. 2....................... 0.006............ 0.006.............0.00003 ........0.123 ................0.049 

11209 .................. 3....................... 0.009............ 0.010.............0.0005 ..........0.122 ................0.059 

6095 .................... 4....................... 0.011............ 0.013.............0.002 ............0.121 ................0.094 

3737 .................... 5....................... 0.012............ 0.015.............0.004 ............0.121 ................0.167 

2395 .................... 6....................... 0.016............ 0.016.............0.006 ............0.131 ................0.246 

1573 .................... 7....................... 0.019............ 0.017.............0.009 ............0.131 ................0.236 

1055 .................... 8....................... 0.024............ 0.018.............0.013 ............0.131 ................0.210 

725.8 ................... 9....................... 0.031............ 0.019.............0.017 ............0.131 ................0.235 

513.7 ................... 10..................... 0.041............ 0.021.............0.021 ............0.131 ................0.289 

374.6 ................... 11..................... 0.052............ 0.023.............0.025 ............0.131 ................0.351 

281.0 ................... 12..................... 0.065............ 0.025.............0.029 ............0.131 ................0.467 

216.4 ................... 13..................... 0.081............ 0.027.............0.031 ............0.131 ................0.616 

170.4 ................... 14..................... 0.101............ 0.030.............0.033 ............0.131 ................0.810 

136.8 ................... 15..................... 0.123............ 0.032.............0.033 ............0.131 ................1.090 

111.3 ................... 16..................... 0.146............ 0.034.............0.033 ............0.131 ................1.190 

91.33 ................... 17..................... 0.168............ 0.035.............0.033 ............0.131 ................1.439 

75.29 ................... 18..................... 0.187............ 0.036.............0.034 ............0.131 ................1.706 

62.17 ................... 19..................... 0.204............ 0.036.............0.036 ............0.131 ................2.036 

51.35 ................... 20..................... 0.219............ 0.036.............0.041 ............0.131 ................2.509 

42.40 ................... 21..................... 0.235............ 0.036.............0.047 ............0.131 ................2.473 

35.01 ................... 22..................... 0.255............ 0.036.............0.056 ............0.131 ................2.738 

28.95 ................... 23..................... 0.281............ 0.037.............0.068 ............0.131 ................2.953 

23.99 ................... 24..................... 0.314............ 0.038.............0.081 ............0.131 ................3.267 

19.95 ................... 25..................... 0.356............ 0.039.............0.097 ............0.131 ................3.450 

16.66 ................... 26..................... 0.408............ 0.040.............0.115 ............0.131 ................3.603 

13.98 ................... 27..................... 0.468............ 0.041.............0.135 ............0.131 ................3.983 

11.80 ................... 28..................... 0.539............ 0.043.............0.158 ............0.131 ................4.144 

10.02 ................... 29..................... 0.618............ 0.045.............0.184 ............0.131 ................4.247 

8.568 ................... 30..................... 0.706............ 0.047.............0.212 ............0.131 ................4.914 

14 g 

14 g 

3 x 150 g 

2 x 400 mL 

NIST-RM 8632 

For use in preparing suspensions in other types of oil, further information on request. 

This material is intended for use in calibrating the response of particle sizing instrumentation, including 

optical counters, in accordance with National Fluid Power Association (NFPA) and ISO standard methods 

for determining particle contamination in oils. 

NIST-RM 8632 Ultrafine Test Dust 20 g 



Particle size calibration standards from Whitehouse Scientific 

Whitehouse Scientific has been producing precision glass microspheres for calibration for 24 years and is 

the highest ranking European certification laboratory for primary methods of particle size analysis. Having 

filled over 1 million bottles using a unique 100 stage spinning riffler system, they are now the world's leading 

manufacturer of single-shot glass microsphere standards. 

The references, nearly all NIST traceable range in size from 0.1µm - 5.0mm and are available as single 

sizes or broad distribution standards. In addition to calbration, applications include filter testing, space 

research, nuclear fall-out studies, micro-engineering and precision spacers. 

Whether calibrating a particle sizing instrument or any aperture in the range 0.1 - 10,000 microns, 

Whitehouse Scientific has a standard for every application. 

Polydisperse particle standards 


WS-PS180 Polydisperse particle standard - Nominal size: 0.1 - 1 µm 0.01 g 

WS-PS181 Polydisperse particle standard - Nominal size: 0.1 - 1 µm 0.02 g 

WS-PS190 Polydisperse particle standard - Nominal size: 1 - 10 µm 0.025 g 





























NIST traceable monodisperse particle standards 

WS-MS0009 Monodisperse particle standard (9.18 µm) 0.1 g 






























WS-MS0177 Monodisperse particle standard (177 µm) 0.3 g 













WS-MS0315 Monodisperse particle standard (315.3 µm) 1 g 

WS-MS0362 Monodisperse particle standard (361.6 µm) 1 g 


WS-MS0451 Monodisperse particle standard (451 µm) 2 g 



Image analysis standards 

WS-XX015 Image analysis standard - Calibration range: 50 - 250 µm 50 g 






NIST traceable sieve standards 


WS-SS391 Sieve standard - For sieve size: 20 µm 

Mesh.................................................................... 635 Calibration range ................................18.8 - 23.7 µm 





WS-SS394 Sieve standard - For sieve size: 36, 38, 40 µm 


WS-SS395 Sieve standard - For sieve size: 45, 50 µm 











Mesh.................................................................... 140 Calibration range .................................91.4 - 117 µm 


Mesh.................................................................... 120 Calibration range ..................................112 - 139 µm 


Mesh.................................................................... 100 Calibration range ..................................134 - 167 µm 


Mesh...................................................................... 80 Calibration range ..................................161 - 199 µm 




















Mesh...................................................................... 18 Calibration range ................................910 - 1106 µm 


Mesh...................................................................... 16 Calibration range ...............................1091- 1335 µm 


Mesh...................................................................... 14 Calibration range ..............................1292 - 1609 µm 





0.8 g 

0.8 g 

1.0 g 

1.0 g 

1.0 g 

1.0 g 

1.0 g 

1.0 g 

1.0 g 

1.0 g 

1.0 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

2.5 g 

7.0 g 

10.0 g 

15.0 g 

15.0 g 

20.0 g 





Mesh ....................................................................... 8 Calibration range..............................2148 - 2661 µm 





General purpose glass microspheres 

WS-GP0042 General purpose glass microspheres - Sieve fraction: 38 - 45 µm 100 g 









































20.0 g 

25.0 g 

25.0 g 



General purpose basalt microspheres 


WS-BM0083 General purpose basalt microspheres - Sieve fraction: 75 - 90 µm 100 g 





















Surface area 

BCR-169 

alpha-Alumina - Specific surface area (BET) 

60 g 


Specific surface area (BET) .....................0.104 m 2 /g 

BCR-170 

alpha-Alumina - Specific surface area (BET) 

60 g 


Specific surface area (BET) .......................1.05 m 2 /g 

BCR-171 

Alumina - Specific surface area (BET) 

50 g 



BCR-172 

Quartz - Specific surface area (BET) 

10 g 



BCR-173 

Titania - Specific surface area (BET) 

46 g 



BCR-175 

Tungsten - Specific surface area (BET) 

200 g 



BAMPM 101 Silica - Specific surface area (BET) 

10 g 



BAMPM 102 Alpha alumina - Specific surface area (BET) 

10 g 



BAMPM 103 Alumina type 60 

10 g 


Specific surface area (BET) .....................156.0 m 2 /g Mean pore radius..........................................3.18 nm 

Specific pore volume..............................0.250 cm 3 /g 

BAMPM 104 Alumina type 150 


10 g 

Specific surface area (BET) .......................79.8 m 2 /g Mean pore radius..........................................5.31 nm 

Specific pore volume..............................0.210 cm 3 /g 




NIST-1899 

NIST-1900 

Silicon nitride - Specific surface area 

Intended for use in the calibration of BET instruments used to measure specific surface area (SSA) 

in the range 0.1 m 2 /g to 1000m 2 /g. 


Specific surface area (BET) multipoint ........................10.67 m 2 /g 

Specific surface area (BET) single point......................10.52 m 2 /g 

Silicon nitride - Specific surface area 

Intended for use in the calibration of BET instruments used to measure specific surface area (SSA) 

in the range 0.1 m 2 /g to 1000 m 2 /g. 


Specific surface area (BET) multipoint ..........................2.85 m 2 /g 

Specific surface area (BET) single point........................2.79 m 2 /g 

4 g 

4 g 

Micropore volume and width 

BCR-704 

BCR-705 

NIST-1917 

NIST-1918 

Particle flow 

BCR-116 

Faujasite type zeolite 

Adsorption of argon at the temperature of liquid argon (87K) on a microporous material (faujasite type zeolite) 

according to DIN 66135-4. 

Linde type A zeolite 

Adsorption of argon at the temperature of liquid argon (87 K) on a microporous material (Linde type A zeolite) 

according to DIN 66135-4. 

Alumina - Specific pore volume 

This SRM /CRM jointly developed and certified by NIST and BAM is intended for use in calibrating and 

monitoring the performance of mercury porosimeters. The SRM ® /CRM unit consists of a single bottle containing 

approximately 10 g of alumina beads. 

® 

Certified properties: 

A) Pressure-volume curve (mercury intrusion curve) between 0.1 MPa and 400 MPa 

B) Diameter-volume curve (cumulative pore volume curve) between 3.7 nm and 14708 nm 

C) Pore volume values at selected intrusion pressure points; (ii) Values for the pore diameter 

Certified pore volume values at selected intrusion pressures and certified pore diameter 

Property x U 2s Unit 

Specific Pore Volume at 50 MPa ..................... 69.4.............1.5 ............ 8.0 .............mm 3 g -1 

Specific Pore Volume at 100 MPa ................. 625.4.............2.5 .......... 13.6 ............ mm 3 g -1 

Specific Pore Volume at 195 MPa ................. 637.1.............2.6 .......... 14.4 ........... mm 3 ·g -1 

Specific Pore Volume at 395 MPa ................. 638.6.............3.9 .......... 21.6 ........... mm 3 ·g -1 

Mean Pore Diameter d 50 .................................. 24.2.............0.2 ............ 1.0 ....................nm 

Most Frequent Pore Diameter d p,m................... 23.9.............0.5 ............ 2.8 ....................nm 

x - mean of the laboratory means (certified value) 

U - expanded uncertainty (coverage factor 2) 

s - standard deviation of the certified value 

Note: all certified pore volumes are normalized values V'p = Vp(pHg) - Vp(0.1 MPa) 

Silica-alumina - Specific pore volume 

This Standard Material® Reference (SRM®) is intended for use in the calibration of mercury porosimeter intrusion 

analytical instruments. A unit of NIST-1918 consists of one vial containing approximately 12 g of an extruded 

silica-alumina compound. 


Mean Pore Diameter..................... 8.847 ± 0.363 nm 

Median Pore Diameter .................. 8.503 ± 0.218 nm 

Total Intruded Volume.............0.547 ± 0.018 mm 3 /g 

Limestone powders 

The flow of powders or granulated materials under the force of gravity affects the design and operation of silos 

used for their bulk storage. The European Federation of Chemical Engineering (EFCE) therefore developed a test 

method, based on the Jenike Shear Cell, to determine the shear strength of powders under different compaction 

and loading conditions. The complexity of this method is such that errors due to poor technique can easily arise. 

This CRM has therefore been produced with which laboratories can verify both their equipment and experimental 

technique. It is certified for shear stress as a function of normal applied stress for four different powder 

compaction stresses. 

10 g 

10 g 

10 g 

12 g 

3.2 kg 



Microhardness 


NIST-1893 

NIST-1893 - NIST-2830 

These materials are intended for use in calibrating and checking the performance of microhardness testers 

and may be used in conjunction with ASTM E384. 

Bright copper - Hardness (Knoop) 

Load 0.245, 0.490, 0.981N 


Hardness (nominal)................................125 kg/mm 2 

each 

NIST-1894A 

NIST-1895 

NIST-1896B 

NIST-1905 

NIST-1906 

NIST-1907 

NIST-1908 

NIST-1909 

NIST-2798A 

NIST-2830 

Bright copper - Hardness (Vickers) 

This Standard Reference Material ® (SRM ® ) is intended primarily for use in calibrating Vickers-type microhardness 

testers and is certified for mean Vickers hardness values (HV) at loads of 0.245 N, 0.49 N, and 0.98 N (0.025 kgf, 

0.050 kgf, and 0.100 kgf, respectively). NIST-1894a consists of a 1.35 cm square test block of electrodeposited 

bright copper, approximately 1750 µm thick, on an AISI 1010 steel substrate, mounted in a thermosetting epoxy. 

Five indentations were made on the SRM’s polished surface for each load. Hardness values are reported in 

Gigapascal (GPa) and kgf/mm2. The SRM ® was individually measured and bears a serial number imprinted on 

the side of the epoxy mount. 

Bright nickel - Hardness (Knoop) 

Load 0.245, 0.490, 0.981N 



Bright nickel - Hardness (Vickers) 

Load 0.245, 0.490, 0.981N 




Load 2.943 




Load 4.905N 




Load 9.81N 





testers and is certified for mean Vickers hardness values (HV) at a load of 2.943 N (0.300 kgf). NIST-1908 

consists of a 1.35 cm square test block of electrodeposited bright nickel, approximately 750 µm thick, on an AISI 

1010 steel substrate, mounted in a thermosetting epoxy. Five indentations were made on the polished surface of 

the SRM ® . Hardness value is reported in gigapascal (GPa) and kgf/mm2. The SRM ® was individually measured 

and bears a serial number imprinted on the side of the epoxy mount. 



testers and is certified for mean Vickers hardness values (HV) at a load of 9.81 N (1.000 kgf). NIST-1909 consists 

of a 1.35 cm square test block of electrodeposited bright nickel, approximately 750 µm thick, on an AISI 1010 

steel substrate, mounted in a thermosetting epoxy. Five indentations were made on the polished surface of the 

SRM ® . Hardness value is reported in gigapascal (GPa) and kgf/mm2. The SRM ® was individually measured and 

bears a serial number imprinted on the side of the epoxy mount. 


This Standard Reference Material (SRM ® ) is intended primarily for use in calibrating Vickers-type microhardness 

testers and is certified for mean Vickers hardness values (HV) at a load of 4.905 N (0.500 kgf). NIST-2798a 

consists of a 1.35 cm square test block of electrodeposited bright nickel, approximately 750 µm thick, on an AISI 

1010 steel substrate, mounted in a thermosetting epoxy. Five indentations were made on the polished surface of 

the SRM ® . Hardness value is reported in gigapascal (GPa) and kgf/mm2. The SRM® was individually measured 

and bears a serial number imprinted on the side of the epoxy mount. 

Ceramic silicon nitride - Hardness (Knoop) 

Load 19.6N 


Hardness (nominal)..............................1500 kg/mm 2 

each 

each 

each 

each 

each 

each 

each 

each 

each 

each 




NIST-2831 

Vickers Hardness of Ceramics and Hardmetals 

This Standard Reference Material (SRM ® ) is intended for use in the calibration of all hardness and microhardness 

testing machines whereby a Vickers indentation is made and then measured with a microscope. The SRM has 

five NIST-made indents in the middle of a polished face certified for the individual diagonal lengths, the average 

diagonal length, and the average hardness value for indentations made at a load of 9.8 N (1 kgf). A unit of NIST- 

2831 consists of a 25 mm D × 9.5 mm disk that has a nominal hardness of approximately 15.0 GPa (1530 

kgf/mm 2 ) packaged in a wooden box. Each unit is individually certified and bears a serial number scribed on the 

opposite (bottom) face of the disk. Vickers hardness is calculated as HV = α P/d 2 , where P is the indentation load, 

d is the average diagonal size [(d1 + d2 )/2], and α is the indenter constant, which, for an ideal Vickers indenter is 

1.8544. If P is in units of Newton, and d is in units of meters, then HV will be in units of N/m 2 or Pa. A conversion 

factor of 1 × 10 -9 may be used to convert HV to units of GPa. In this certificate, older traditional units of hardness 

expressed as kgf/mm 2 are also included in parenthesis for the convenience of users.. 

each 

Surface roughness 

NIST-2073a 

NIST-2074 

NIST-2075 

NIST-RM 8457 

Electroless-nickel coated steel 

This Standard Reference Material is certified for roughness average R a and surface spatial wavelengh, D, and is 

intended for use as a standard for the calibration of stylus instruments that are used to measure surface 

® 

roughness. 

2.4 cm x 3.3 cm 


Roughness average R a.................................. 3.0 µm Wavelength D...........................................99.099 µm 




® 

roughness. 

2.4 cm x 3.3 cm 


Roughness average R a.................................. 1.0 µm Wavelength D..................................................40 µm 




® 

roughness. 

2.4 cm x 3.3 cm 


Roughness average R a.................................. 1.0 µm Wavelength D................................................800 µm 

Ultra high molecular weight polyethylene 

This Reference Material (RM), is intended for evaluations of cross-linking induced by radiation exposure, such as 

used to improve wear characteristics. Each unit of NIST-RM 8457 consists of 10 cubes of ultra high molecular 

weight polyetheylene (UHMWPE) of nominal dimension 0.5 cm. The cubes are sized for measurement of crosslink 

density by swelling. The material as supplied has not been irradiated, however. 

Reference values 

Cube dimension Dimension (cm) Surface roughness (µm) 

Faces normal to bar direction ............................0.4919 ± 0.005 .................................5.5 ± 0.6 

Faces perpendicular to bar direction..................0.5017 ± 0.006 

each 

each 

each 

10 cubes 

Surface tension 

GUM 11.1 

GUM 11.1 - GUM 11.3 

Reference materials certified by the Physical Chemistry Division of the Central Office of Measures (GUM), 

Warsaw. They are intended for the calibration and checking tensiometers. All standards are supplied with a 

certificate showing value of surface tension with an uncertainty 0.1 mN/m and value of density with an 

uncertainty of 0.1 kg/m 3 . Decimal values are given in the certificate. 

Isooctane 


Surface tension .............................18 mN/m at 20 ºC 

30 mL 

GUM 11.2 

GUM 11.3 

Benzene 



Glycerol 



30 mL 

30 mL 



Depth profiling 


BCR-261T Tantalum pentoxide on tantalum foil 


Areal density of oxygen atoms 

2x4 foils 


Uncertainty 

[10 21 m -2 ] [10 21 m -2 ] 

Oxide thickness n 

30 nm material (nominal) .............. 1.72.......................................................0.07 

100 nm material (nominal) ............ 5.40.......................................................0.12 

Certified ratio 

Uncertainty 

[dimensionless] 

[dimensionless] 

Oxide thickness ratio..................... 0.321.....................................................0.013 

NIST-2134 

NIST-2135C 

NIST-2137 

Coatings 

NIST-1359B 

NIST-1361B 

NIST-1362B 

NIST-1363B 

NIST-1364B 

NIST-2321 

Abrasive wear 

NIST-1857 

Arsenic in silicon - Depth profile 

each 

This Standard Reference Material ® (SRM ® ) is intended for use in calibrating secondary ion response to minor and 

trace levels of arsenic in a silicon matrix by the analytical technique of secondary ion mass spectrometry (SIMS). 

NIST-2134 is intended for calibrating the response of a SIMS instrument for arsenic in a silicon matrix under a 

specific set of instrumental conditions. It may also be used by a laboratory as a transfer standard for the 

calibration of working standards of arsenic in silicon. This SRM consists of a 1 cm x 1 cm single crystal silicon 

substrate that has been ion implanted with the isotope 75 As at a nominal energy of 100 keV. 

NIST-2134 is certified for the retained dose of 75 As atoms. The dose is expressed in units of arsenic mass per 

unit area. Additional noncertified information about the concentration of arsenic atoms as a function of depth 

below the surface is provided by SIMS. 

The total retained dose of 75 As atoms was determined by instrumental neutron activation analysis. 

Certified Retained Dose of 75 As .......................... 0.09120 µg/cm 2 ± 0.00035 µg/cm 2 

Using a value of 74.9216 g/mol for the isotopic mass of 75 As, the retained dose is equivalent to 

7.330 × 10 14 atoms/cm 2 ± 0.028 × 10 14 atoms/cm 2 

Nickel-chromium thin film - Depth profile 

each 

Intended for calibrating equipment used to measure sputtered depth and erosion rates in surface analysis. 

Total thickness 


Cr ..........................206.3 µg/cm 2 Ni .......................... 197.4 µg/cm 2 

Single layer thickness 


Cr ............................41.3 µg/cm 2 Ni ............................ 49.4 µg/cm 2 

Boron implant in silicon - Depth profile 

Intended for calibrating the secondary ion response to minor and trace element levels in a silicon matrix. 


B-10.......1.018 x 10 15 atoms/cm 2 

NIST-1359b - NIST-1364b 

These NIST Standard Reference Materials ® are suitable for calibrating instruments used in the measurement 

of organics and nonmagnetic inorganic coatings on steel. They consist of fine grained copper of varying 

thicknesses electrodeposited onto low carbon steel substrates having the properties of AISI 1010 steel. 

These uniform coatings are then overplated with a thin protective layer of chromium and the total coating 

thickness is then certified. 

Copper and chromium on steel - Coating thickness 

45 mm × 45 mm coupons 









Tin-lead alloy on copper 

Intended for calibrating X-ray fluorescence equipment. Each unit, which consists of a plate of an electroplated tinlead 

alloy coating on a copper substrate, is individually certified for composition and mass per unit area. 

D-2 Tool steel 

0.78 x 2.5 x 7.6 cm 

Certified for the ASTM G65 abrasion test 

each 

set (4) 

set (4) 

set (4) 

set (4) 

set (4) 

each 

2 blocks 


Optical properties 


Molecular absorption and luminescence 


ERM-FB011 

ERM-FB012 

ERM-FB020 

ERM-FB021 

NIST-930E 

NIST-931G 

NIST-935A 

NIST-936A 

GUM 9D.1 

NIST-1921B 

NIST-2032 

UV-Visible absorbance standard - Sodium nitrate/cobalt chloride/nickel chloride solution 

This certified reference material is intended for use in the verification and calibration of the absorbance scales of 

ultraviolet-visible absorption spectrometers. 


3 standard + 1 blank 

UV-visible absorbance at four wavelengths (299.4, 395.0, 512.5 and 719.0 nm) at a 1 nm bandwidth. 

IR wavelength standard - Polystyrene in hexane 

This certified reference material is intended for use in the verification and calibration of infra-red spectrometers, 

within the range of spectral bandwidths quoted 


IR wavelength positions of four peaks (3026.0, 1601.1, 1028.8 and 698.0 cm -1 ). 

UV-Visible wavelength standard for HPLC detectors - Holmium/neodymium oxides solution 

The certified reference material is intended for use in the verification and calibration of the wavelength scale of 

ultra-violet/visible HPLC detectors. 


UV/visible wavelength location of 7 peaks in the spectral range 241 to 797 nm at four spectral bandwidths (1, 4, 7 

and 10 nm). 

UV-Visible absorbance standard for HPLC detectors - Sodium nitrate/cobalt chloride/nickel 

chloride solution 

This certified reference material is intended for checking the linearity of the absorbance scales of UV/Visible 

HPLC detectors 


7 standard + 1 blank 

UV/visible absorbance for four wavelengths (299, 395, 512 and 719 nm) at 4 bandwidths (1, 4, 7, and 10 nm). 

Glass filters 

Visible transmittance at 5 wavelengths (440.0, 465.0, 546.1 590.0 and 635.0 nm). 

Liquid filters 

UV-visible absorbance at 4 wavelengths (302, 395, 512 and 678 nm). 

Liquid Filter 

Nominal Wavelength (nm) 

302 395 512 678 

Level I 0.2925 ± 0.0016 0.3108 ± 0.0017 0.3011 ± 0.0017 0.1169 ± 0.0012 

Level II 0.5969 ± 0.0028 0.6223 ± 0.0029 0.5917 ± 0.0029 0.2344 ± 0.0018 

Level III 0.9668 ± 0.0043 0.9328 ± 0.0042 0.8969 ± 0.0042 0.3517 ± 0.0024 

Potassium dichromate 

UV absorbance at 5 wavelengths (235, 257, 313, 345, and 350 nm). 

Quinine sulphate dihydrate 

For use in the evaluation of methods and the calibration of fluorescence spectrometers. Certified for the relative 

molecular emission spectrum, E (l), in radiometric units for a solution of 1.28 x 10 -6 mol/L quinine sulphate 

dihydrate in 0.105 mol/L perchloric acid using an excitation wavelength of 347.5 nm. The values of the 

molecular emission spectrum are certified at 5 nm wavelength intervals from 375 nm to 675 nm. 

Estrofol film film - Wavenumber standard for infrared range 

This reference material from the Central Office of Measures (Poland) is intended for use in the calibration of the 

wave number scale of spectrophotometers in the infrared (IR) spectral region from 400 cm -1 to 4000 cm -1 (21 

peaks). GUM 9.D1 consists of two cards made of transparent poly(ethylene terephtalate) film 6 mm and 50 mm 

thick, in holders. 

Polystyrene film - IR transmission wavelength 

This Standard Reference Material ® (SRM ® ) is intended primarily for use in calibrating the wavelength 

(wavenumber) scale of spectrophotometers in the infrared (IR) spectral region from 3.2 µm to 18.5 µm (540 cm-1 

to 3125 cm-1). SRM 192lb is a matt finish polystyrene film approximately 38 µm thick with a 25 mm diameter 

exposed area, centered 38 mm from the bottom of a cardboard holder, which is 5 cm × 11 cm × 0.2 cm in size. 

Heterochromatic stray radiation energy standard for UV Spectrophotometry 

Potassium iodide for use in the assessment of heterochromatic stray radiation energy (stray light) below 260 nm 

UV absorbance at 8 wavelengths (240, 245, 250, 255, 260, 265, 270 and 275 nm). 

cuv. (4) 

5 x 1 mL 

2 x 3 mL 

8 x 3 mL 

set 

set (12) 

15 g 

1 g 

set (2) 

1 card 

25 g 

NIST-2940 Relative intensity correction standard for fluorescence spectroscopy (Orange emission) 412 

nm 

This Standard Reference Material ® (SRM ® ) is intended for use for the evaluation and calibration of the relative 

spectral responsivity of steady-state fluorescence spectrometers with a continuous excitation source and for 

determining the day-to-day or instrument-to-instrument intensity variations of a single or similar fluorescence 

instrument(s), respectively. This SRM ® is certified for the relative, corrected emission spectrum, E, in relative 

power units from emission λ wavelengths EM = 500 nm to 800 nm at 1 nm wavelength intervals at a fixed 

excitation (λ wavelength EX) of 412 nm. 

1 contain. 




NIST-2941 Relative intensity correction standard for fluorescence spectroscopy (Green emission) 427 

nm 

This Standard Reference Material ® (SRM ® ) is intended for use for the evaluation and calibration of the relative 

spectral responsivity of steady-state fluorescence spectrometers with a continuous excitation source and for 

determining the day-to-day or instrument-to-instrument intensity variations of a single or similar fluorescence 

instrument(s), respectively. This SRM ® is certified for the relative, corrected emission spectrum, E, in relative 

power units from emission λ wavelengths EM = 450 nm to 650 nm at 1 nm wavelength intervals at a fixed 

excitation (λ wavelength EX) of 427 nm. 

NIST-2035 

Near infrared transmission wavelength standard 

Glass filter certified for the location of the centre of gravity of 7 absorbance bands in the range 10,300 to 5130 cm - 

1 , at 6 bandwidths from 4 to 128 cm -1 . 

1 contain. 

1 filter 

NIST-2036 

NIST-2065 

NIST-2517A 

NIST-2241 

NIST-2242 

NIST-2243 

Near infrared wavelength/reflection standard 

This Standard Reference Material (SRM ® ) is a certified transfer standard intended for the verification and 

calibration of the wavelength/wavenumber scale of Near-Infrared (NIR) spectrometers operating in diffuse 

reflectance mode. NIST-2036 is a glass physically contacted with a piece of sintered polytetrafluoroethylene 

(PTFE). The combination of the rare earth oxide glass with a nearly ideal diffuse reflector provides reflectionabsorption 

bands that range from approximately 15 % R to 40 % R. NIST-2036 is certified for the 10 % band 

fraction centroid of seven bands spanning the spectral region from 975 nm to 1946 nm (air wavelength). In 

addition, it is certified for the 10 % band fraction centroid location of the same seven bands in the spectral 

region from 10300 cm -1 to 5130 cm -1 at 8 cm -1 resolution (vacuum wavenumber). 

Ultraviolet-visible-near-infrared transmission wavelength/vacuum wavenumber standard 

This Standard Reference Material (SRM ® ) is a certified standard intended for the verification and calibration 

of the wavelenght/wavenumber scale of ultraviolet (UV)-Visible-Near-Infrared (NIR) spectrometers operating in 

transmission mode. NIST-2065 is certified for the location of seven absorbance bands (COG) in the spectral 

region from 10300 cm -1 to 5130 cm -1 at 4 cm -1 resoltion. NIST-2065 is a glass consisting of a combination of 

rare earth oxides. The optical filter is 25 mm in diameter and 1.5 mm thick. Please ask for more details. 

High resolution wavelength calibration reference 

Intended for wavelength calibration in the spectral region of 1510 nm to 1540 nm. NIST-2517a is a single-mode 

optical-fibre-coupled absorption cell containing acetylene ( 12 C 2H 2) gas at a pressure of 6.7 kPa (50 Torr). 

The absorption path length is 5 cm and the absorption lines are about 7 pm wide. 

Relative intensity correction standard for Raman spectroscopy 785 nm excitation 

NIST-2241 is a chromium-doped (0.02 mol % Cr 2O 3) sodium borosilicate matrix glass. One unit of this Standard 

Reference Material ® consists of a glass slide that is approximately 10.7 mm in width × 30.4 mm in length × 2.0 

mm in thickness, with one surface optically polished and the opposite surface ground to a frosted finish using a 

400 grit polish. 

This Standard Reference Material ® (SRM ® ) is a certified spectroscopic standard for the correction of the relative 

intensity of Raman spectra obtained with instruments employing 785 nm laser excitation. NIST-2241 consists of 

an optical glass that emits a broadband luminescence spectrum when excited with 785 nm laser radiation. The 

relative spectral intensity of the glass luminescence has been determined through the use of a white-light, 

uniform-source, integrating sphere that has been calibrated for its irradiance at NIST. The shape of the 

luminescence spectrum of this glass is described by a polynomial expression that relates the relative spectral 

intensity to the wavenumber (cm -1 ) expressed as the Raman shift from the excitation wavelength of 785 nm. 

This polynomial, together with a measurement of the luminescence spectrum of the standard, can be used to 

determine the spectral intensity-response correction that is unique to each Raman system. The resulting 

instrument-intensity-response correction may then be used to obtain Raman spectra that are instrument 

independent. This SRM ® is intended for use in measurements over the range of 20 °C to 25 °C and with Raman 

systems that employ laser excitation at 785 nm. It may also be used for Raman excitation with lasers that range 

from 784 nm to 786 nm in excitation wavelength. 

Relative Intensity Correction Standard for Raman Spectroscopy 

NIST-2242 is a certified spectroscopic standard for the correction of the relative intensity of Raman spectra 

obtained with instruments employing 532 nm laser excitation. It consists of an optical glass that emits a 

broadband luminescence spectrum when excited with 532 nm laser radiation. The relative spectral intensity of the 

glass luminescence has been determined through the use of a white-light, uniform-source, integrating sphere that 

has been calibrated for its irradiance at NIST. The shape of the luminescence spectrum of this glass is described 

by a polynomial expression that relates the relative spectral intensity to the wavenumber (cm -1 ) expressed as the 

Raman shift from the excitation wavelength of 532 nm. This polynomial, together with a measurement of the 

luminescence spectrum of the standard, can be used to determine the spectral intensity-response correction that 

is unique to each Raman system. The resulting instrument-intensity-response correction may then be used to 

obtain Raman spectra that are instrument independent. This Standard Reference Material (SRM ® ) is intended for 

use in measurements over the range of 20 °C to 25 °C. 

Relative Intensity Correction Standard for Raman Spectroscopy 

This Standard Reference Material (SRM ® ) is a certified spectroscopic standard for the correction of the relative 

intensity of Raman spectra obtained with instruments employing either 488 nm or 514.5 nm laser excitation. NIST- 

2243 consists of an optical glass that emits a broadband luminescence spectrum when excited with either of 

these two laser wavelengths. The relative spectral intensity of the glass luminescence, for each excitation 

wavelength, has been determined through the use of a white-light, uniform-source, integrating sphere that has 

been calibrated for its irradiance at NIST. The shape of the luminescence spectrum of this glass is described by a 

polynomial expression that relates the relative spectral intensity to the wavenumber (cm -1 ) expressed as the 

Raman shift from the excitation laser wavelength. This polynomial, together with a measurement of the 

luminescence spectrum of the standard, can be used to determine the spectral intensity-response correction that 

is unique to each Raman system. The resulting instrument-intensity-response correction may then be used to 

obtain Raman spectra that are instrument independent. 

1 filter 

each 

1 cell 

each 

each 

each 



Starna optical reference materials 

Absorbance / transmission 

Starna ® optical reference materials produced by Optiglass are now available from LGC Promochem. Optiglass was 

one of the first reference material producers in the UK to receive accreditation to ISO guide 34. The company has 

over 30 years experience in the development and production of liquid-filled, heat sealed quartz cells with good long 

term stability and the optical properties needed to evaluate performance of UV-visible spectrophotometers. The 

range also includes robust solid glass filter materials for both absorbance and wavelength measurements. These 

certified reference materials (CRM) for the validation of wavelength accuracy, absorbance accuracy, stray light and 

resolution in the UV and visible regions, can be used in analytical, clinical and research laboratories. All of the 

Starna ® CRMs are traceable to NIST primary standards. Brief descriptions of the types of products available are 

given below with more detailed product descriptions in the pages that follow. 

Potassium dichromate - UV absorbance and linearity 

The use of potassium dichromate solvated in perchloric acid is an established and recognised 

method for the validation of the absorbance scale of UV and visible spectrophotometers. Starna ® 

provides sets of certified sealed cells covering absorbance values from 0.2 to 3.0 over the 

wavelength range from 235nm to 350nm. For the far UV, nicotinic acid is the recognised standard 

and covers from 210nm to 270nm. 


STRM-0204060810 Potassium dichromate - UV absorbance and linearity 

STRM-0204060810- 

R 

Set of 6 cells 

Each set consists of one blank (0.001M perchloric acid) and five concentrations, with nominal values of 20 mg/L, 

40 mg/L, 60 mg/L, 80 mg/L, and 100 mg/L. 

Recertification: Potassium dichromate - UV absorbance and linearity 

set 

set 

STRM-02040608 


Set of 5 sets 

Each set consists of one blank (0.001M perchloric acid) and four concentrations, with nominal values of 20 mg/L, 

40 mg/L, 60 mg/L and 80 mg/L. 

set 

STRM-02040608-R Recertification: Potassium dichromate - UV absorbance and linearity 

STRM-020406 



Each set consists of one blank (0.001M perchloric acid) and three concentrations, with nominal values of 20 mg/L, 

40 mg/L and 60 mg/L. 

set 

set 

STRM-020406-R Recertification: Potassium dichromate - UV absorbance and linearity set 

STRM-0204 



Each set consists of one blank (0.001M perchloric acid) and two concentrations, with nominal values of 20 mg/L 

and 40 mg/L. 

set 


STRM-02 



Each set consists of one blank (0.001M perchloric acid) and a solution with a nominal value of 20 mg/L. 

set 


STRM-04 




set 


STRM-06 




set 


STRM-08 




set 


STRM-10 




set 


STRM-60 




set 




Neutral density filter - Visible absorbance and linearity 

Schott NG-type glasses are used for the validation of the absorbance scale and linearity of 

spectrophotometers in the visible region. Starna ® neutral density filters are available in sets 

covering nominal transmission values from from 0.1% to 90%. 


STRM-D1D39N 


Set of 3 glass filters and a blank holder 

Consists of one blank holder and three filters with nominal values of 0.1 %T, 0.3 %T, and 90 %T. 

set 

STRM-D1D39N-R Recertification: Neutral density filter - Visible absorbance and linearity set 

STRM-1N2N3N 



Consists of one blank holder and three filters with nominal values of 10 %T, 20 %T, and 30 %T. 

set 

STRM-1N2N3N-R Recertification: Neutral density filter - Visible absorbance and linearity set 

STRM-N1N35N 



Consists of one blank holder and three filters with nominal values of 1 %T, 3 %T, and 50 %T. 

set 

STRM-N1N35N-R Recertification: Neutral density filter - Visible absorbance and linearity set 

STRM-5N 


Set of 1 glass filter and a blank holder 

Consists of one blank holder and one filter with a nominal value 50 %T. 

set 

STRM-5N-R Recertification: Neutral density filter - Visible absorbance and linearity set 

Far UV Absorbance/transmission 

STRM-1A2A3A4A 

Nicotinic acid - UV absorbance and linearity 


Each set consists of one blank (0.1M hydrochloric acid) and four increasing concentrations, with nominal values of 

6 mg/L, 12 mg/L, 18 mg/L and 24 mg/L. 

set 

STRM-1A2A3A4A-R Recertification: Nicotinic acid - UV absorbance and linearity 

set 

Wavelength 

Starna ® sealed liquid references are available covering all wavelengths from the far UV to 

the visible. For the UV and visible, rare earth oxides like holmium oxide, didymium (a mixture 

of neodymium and praseodymium) and samarium solvated in perchloric acid are well 

recognised as suitable wavelength references. 

STRM-HL 

Holmium oxide - UV and visible wavelength 

Description: Holmium oxide (4% m/v) in 10% v/v perchloric acid. 

Primary usage: Assessment of wavelength scale accuracy in both UV and visible regions. 

Useable range: 240 nm to 650 nm, instruments with spectral bandwidth of less than 3 nm. 

Physical configuration: Far UV quartz cells that have been permanently heat sealed. 

Consists of one sealed cell, with certified peak at spectral bandwidth values of 0.10 nm, 0.25 nm, 0.50 nm, 1.00 

nm, 1.50 nm, 2.00 nm and 3.00 nm. 

1 cell 

STRM-HL-R Recertification: Holmium oxide - UV and visible wavelength 1 cell 

STRM-DL 

Didymium (neodymium & praesodymium) - UV and visible wavelength 

Description: Didymium (neodymium praesodymium) in perchloric acid. 






1 cell 

STRM-DL-R Recertification: Didymium (neodymium & praesodymium) - UV and visible wavelength 1 cell 

STRM-SL 

Samarium - UV and visible wavelength 

Description: Samarium (III) oxide in perchloric acid. 






1 cell 

STRM-SL-R Recertification: Samarium - UV and visible wavelength 1 cell 




STRM-HG 

Holmium glass filter - UV and visible wavelength 

Description: Holmium glass filter. 

Primary usage: Assessment of wavelength scale accuracy in the UV and visible regions. 


Physical configuration: Glass filters 'stress free' mounted in anodised aluminium holder. 

Consists of one filter, 'stress free' mounted in a proprietary NIST design, with certified peak at spectral bandwidth 

values of 0.10 nm, 0.25 nm, 0.50 nm, 1.00 nm, 1.50 nm, 2.00 nm, and 3.00 nm. 

1 filter 

STRM-HG-R Recertification: Holmium glass filter - UV and visible wavelength 1 filter 

STRM-DG 

Didymium glass - UV wavelength 

Description: Didymium glass filter. 

Primary usage: Assessment of wavelength scale accuracy in the visible/near infrared region. 


Physical configuration: Glass filters 'stress free' mounted in anodised aluminium holder. 

Consists of one filter, “stress free” mounted in a proprietary NIST design, with certified peak at spectral bandwidth 

values of 0.10 nm, 0.25 nm, 0.50 nm, 1.00 nm, 1.50 nm, 2.00 nm, and 3.00 nm. 

1 filter 

STRM-DG-R Recertification: Didymium glass - UV wavelength 1 filter 

Far UV wavelength 

STRM-RE 

Rare earth - UV and visible wavelength 

Description: Rare earth oxide in dilute sulphuric acid. 

Primary Usage: Assessment of wavelength scale accuracy in the UV region. 

Useable range: 200nm to 300nm, instruments with spectral bandwidth of less than 5nm. 

Physical Configuration: Far UV quartz cells that have been permanently heat sealed. 

Consists of one sealed cell, with certified peak at spectral bandpass values of 0.1 nm, 0.2 nm, 0.5 nm, 1.0 nm, 1.5 

nm, 2.0 nm and 3.0 nm. 

1 cell 

STRM-RE-R Recertification: Rare earth - UV and visible wavelength 1 cell 

Stray light 

Inorganic cut-off filters – UV stray light 

This is a subtle source of error in UV and visible spectrophotometry. A variety of materials is 

available for measuring this parameter at several different wavelengths in the form of 

inorganic cut-off filters. They are designed with sharp cut-offs in transmissions at specified 

wavelengths which will enable any stray light to be measured. 

Description: Materials with sharp cut-offs in transmission at specified wavelengths. 

Primary usage: Detection of stray light in the UV region. 

Useable range: 200 nm to 260 nm, depending on the material. 


STRM-AC Inorganic cut-off filter (acetone) - UV stray light (cut-off at 326 nm) set 

STRM-AC-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 326 nm) set 

STRM-KI Inorganic cut-off filter (potassium iodide; 1% aqueous) - UV stray light (cut-off at 260 nm) set 

STRM-KI-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 260 nm) set 

STRM-LC Inorganic cut-off filter (lithium carbonate; saturated aqueous) - UV stray light (cut-off at 227 

nm) 

STRM-LC-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 227 nm) set 

STRM-KC Inorganic cut-off filter (potassium chloride; 1.2% aqueous) - UV stray light (cut-off at 200 nm) set 

STRM-KC-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 200 nm) set 

STRM-SC Inorganic cut-off filter (sodium chloride; 1% aqueous) - UV stray light (cut-off at 205 nm) set 

STRM-SC-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 205 nm) set 

STRM-SI Inorganic cut-off filter (sodium iodide; 1% aqueous) - UV stray light (cut-off at 260 nm) set 

STRM-SI-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 260 nm) set 

STRM-SN Inorganic cut-off filter (sodium nitrite; 5% aqueous) - UV stray light (cut-off at 390 nm) set 

STRM-SN-R Recertification: Inorganic cut-off filter - UV stray light (cut-off at 390 nm) set 

STRM-AQ Inorganic cut-off filter (water) - UV stray light (blank) 1 cell 

set 



Resolution 


STRM-TX 

Accurate absorbance and wavelength measurements can only be achieved if due 

consideration is given to the resolution of the monochromator in use. In modern instruments 

with grating monochromators, the resolution relates directly to the slit chosen. The smaller 

the slit and its associated spectral bandwidth, the greater the resolution. Simple checks on 

the resolution power of a spectrophotometer with Starna ® resolution CRMs such as benzene 

vapour or toluene in hexane will provide useful references. Benzene vapour is used to 

validate the resolution of instruments with bandpass less than 1nm. Even this material can 

be supplied heat sealed into a quartz cell. An alternative liquid reference, toluene in hexane, 

helps users to meet the recommendations of the current European Pharmacopoeia. 

Toluene in hexane - resolution 

Description: 0.020% v/v solution of toluene in hexane. 

Primary usage: Determination of spectral bandwidth in the UV region. 

Useable range: 265 nm to 270 nm, instruments with a spectral bandwidth of less than 3 nm. 

Physical configuration: Far UV quartz cells that have been permanently sealed. 

This formulation is described and used in the European Pharmacopoeia where the ratio of the peak 

maximum at 269 nm to the minimum at 266 nm gives a measure of the resolution of the instrument. 

Ratio table: 

SBW (nm): 0.5 1.0 1.5 2.0 3.0 

Ratio: 2.5 2.1 1.6 1.4 1.0 

STRM-TX-R Recertification: Toluene in hexane - resolution set 

STRM-BZ 

Benzene vapour 

Description: 0.1 mL benzene in the vapour state. 

Primary usage: Determination of spectral bandwidth in the UV region. 

Useable range: 230 nm to 270 nm, instruments with a spectral bandwidth of less than 1 nm. 


At spectral bandwidths less than 1 nm, the benzene vapour spectrum provides a useful reference that has 

characteristic features that may or may not be displayed – dependent upon the current spectrophotometer 

spectral bandwidth. Benzene vapour will not work well with a photodiode array spectrophotometer as this 

instrument type does not measure a continuum and the peaks will not be resolved well enough to be useable. 

STRM-BZ-R Recertification: Benzene vapour 1 cell 

Sets 

STRM-06HL 

The certified reference material sets have been assembled to make your verification task 

easier, and meet specific regulatory requirements. 

In addition, set prices do offer price savings over the purchase of individual certified reference materials. 

STRM-06 + STRM-HL 


Set of 2 cells: Each set consists of one blank (0.001M perchloric acid) and a 

solution with a nominal value of 60 mg/L. 

STRM-HL Holmium oxide - UV and visible wavelength (Holmium oxide (4% m/v) in 10% 

v/v perchloric acid) 

Consists of one sealed cell, with certified peak at spectral bandwidth values of 

0.10 nm, 0.25 nm, 0.50 nm, 1.00 nm, 1.50 nm, 2.00 nm and 3.00 nm. 

STRM-06HL-R Recertification: STRM-06 + STRM-HL set 

STRM-06DLKI STRM-06 + STRM-DL + STRM-KI 

set 




STRM-DL Didymium (neodymium & praesodymium) - UV and visible wavelength 

Didymium (neodymium praesodymium) in perchloric acid 



STRM-KI Inorganic cut-off filter (potassium iodide; 1% aqueous) - UV stray light (cut-off at 

260 nm) 

STRM-06DLKI-R Recertification: STRM-06 + STRM-DL + STRM-KI set 

STRM-06HLKI STRM-06 + STRM-HL + STRM-KI 

set 









260 nm) 

STRM-06HLKI-R Recertification: STRM-06 + STRM-HL + STRM-KI set 

set 

1 cell 

set 




STRM-06HLSC STRM-06 + STRM-HL + STRM-SC 

set 




STRM-HL Holmium oxide - UV and visible wavelength (Holmium oxide (4% m/v) in 10 




STRM-SC Inorganic cut-off filter (sodium chloride; 1% aqueous) - UV stray light (cut-off at 

205 nm) 

STRM-06HLSC-R Recertification: STRM-06 + STRM-HL + STRM-SC set 

STRM-06HLKIBZ 

STRM-06 + STRM-HL + STRM-KI + STRM-BZ 









260 nm) 

STRM-BZ Benzene vapour (0.1 mL benzene in the vapour state) 

STRM-06HLKIBZ-R Recertification: STRM-06 + STRM-HL + STRM-KI + STRM-BZ 

STRM-06HLKIKC STRM-06 + STRM-HL + STRM-KI + STRM-KC 



solution with a nominal values of 60 mg/L. 






260 nm) 

STRM-KC Inorganic cut-off filter (potassium chloride; 1.2% aqueous) - UV stray light (cut 

off at 200 nm) 

STRM-06HLKIKC-R Recertification: STRM-06 + STRM-HL + STRM-KI + STRM-KC 

STRM-06KIKCTX 

STRM-06 + STRM-KI + STRM-KC + STRM-TX 

STRM-06 

STRM-KI 

STRM-KC 

STRM-TX 




Inorganic cut-off filter (potassium iodide; 1% aqueous) - UV stray light (cut-off at 

260 nm) 

Inorganic cut-off filter (potassium chloride; 1.2% aqueous) - UV stray light (cutoff 

at 200 nm) 

Toluene in hexane - Resolution (0.020% v/v solution of toluene in hexane) 

STRM-06KIKCTX-R Recertification: STRM-06 + STRM-KI + STRM-KC + STRM-TX 

STRM-06HLKITX 

STRM-06 + STRM-HL + STRM-KI + STRM-TX 









260 nm) 

STRM-TX Toluene in hexane - Resolution (0.020% v/v solution of toluene in hexane) 

STRM-06HLKITX-R Recertification: STRM-06 + STRM-HL + STRM-KI + STRM-TX 

STRM-06HLKCBZ 

STRM-06 + STRM-HL + STRM-KC + STRM-BZ 






consists of one sealed cell, with certified peak at spectral bandwidth values of 


STRM-KC Inorganic cut-off filter (potassium chloride; 1.2% aqueous) - UV stray light (cutoff 

at 200 nm) 

STRM-BZ Benzene vapour (0.1 mL benzene in the vapour state) 

STRM-06HLKCBZ-R Recertification: STRM-06 + STRM-HL + STRM-KC + STRM-BZ 

set 

set 

set 

set 

set 

set 

set 

set 

set 

set 




STRM-06SLLCBZ 

STRM-06 + STRM-SL + STRM-LC + STRM-BZ 

STRM-06 

STRM-SL 

STRM-LC 

STRM-BZ 




Samarium - UV and visible wavelength (Samarium (III) oxide in perchloric acid) 

consists of one sealed cell, with certified peak at spectral bandwidth values of 


Inorganic cut-off filter (lithium carbonate; saturated aqueous) - UV stray light (cut 

off at 227 nm) 

Benzene vapour (0.1 mL benzene in the vapour state) 

STRM-06SLLCBZ-R Recertification: STRM-06 + STRM-SL + STRM-LC + STRM-BZ 

STRM-06HLSLKC STRM-06 + STRM-HL+ STRM-SL + STRM-KC 







0.10 nm,0.25 nm, 0.50 nm, 1.00 nm, 1.50 nm, 2.00 nm and 3.00 nm. 

STRM-SL Samarium - UV and visible wavelength (Samarium (III) oxide in perchloric acid) 




at 200 nm) 

STRM-06HLSLKC-R Recertification: STRM-06 + STRM-HL+ STRM-SL + STRM-KC 

STRM-06HLKCSITX UV single absorbance instrument spec. kit 

Each set consists on STRM-06 + STRM-HL + STRM-KC + STRM-SI + STRM-TX 









at 200 nm) 

STRM-SI Inorganic cut-off filter (sodium iodide; 1% aqueous) - UV stray light (cut-off at 

260 nm) 


STRM- 

06HLKCSITX-R 

STRM- 

0660HLKCSITX 

STRM- 

0660HLKCSITX-R 

STRM-06HLKCTX 

Recertification: UV single absorbance instrument spec. kit 

UV and visible instrument spec. kit 

Each set consists on STRM-06 + STRM-60 + STRM-HL + STRM-KC + STRM-SI + STRM-TX 






solution with a nominal value of 600 mg/L 

STRM-HL Holmium oxide - UV and visible wavelength (Holmium oxide (4% m/v) in 10% v/v 

perchloric acid) 



STRM-KC Inorganic cut-off filter (potassium chloride; 1.2% aqueous) - UV stray light (cut-off 

at 200 nm) 

STRM-SI Inorganic cut-off filters (sodium iodide; 1% aqueous) - UV stray light (cut-off at 

260 nm) 


Recertification: UV and visible instrument spec. kit 

Pharmacopoeia kit 

Each set consists on STRM-06 + STRM-HL + STRM-KC + STRM-TX 









at 200 nm) 


STRM-06HLKCTX-R Recertification: Pharmacopoeia kit 

set 

set 

set 

set 

set 

set 

set 

set 

set 

set 




STRM- 

Upgrade/recert. of pharmacopoeia kit (STRM-06HLKCTX) to E.P. 5.2 

0660HLKCTX/R/UG In version 5.2 of the Euro. Pharm., in section 2.2.25, they added an additional Absorbance verification 

using a 600 mg/l solution of potassium dichromate at 430 nm. 

The upgrade price adds this 600 mg/L reference to the existing Euro. Pharm. set, and re-certifies all 

the existing materials. 

STRM-0660HLKCTX E.P. 5.2 Pharmacopoeia kit 

Each set consists on STRM-06 + STRM-60 + STRM-HL + STRM-KC + STRM-TX 






solution with a nominal value of 600 mg/L 






at 200 nm) 


STRM- 

0660HLKCTX-R 

STRM- 

1A2A3A4ARE 

STRM- 

1A2A3A4ARE-R 

STRM- 

020610HLKCTX 

STRM- 

020610HLKCTX-R 

Refractive index 

ERM-BD011 

ERM-BD012 

ERM-BD013 

ERM-BD014 

Recertification: E.P. 5.2 Pharmacopoeia kit 

Far UV combination kit 

Each set consists on STRM-1A2A3A4A + STRM-RE 

Recertification: Far UV combination kit 

Single Box 3-point linearity full spec. kit ( 9 cells ) 

Each set consists on STRM-02 + STRM-06 + STRM-10 + STRM-HL + STRM-KC + STRM-TX 









solution with a nominal values of 100 mg/L. 






at 200 nm) 


Recertification: Single Box 3-point linearity full spec. kit ( 9 cells ) 

Orange juice 

This certified reference material is intended for use in the development, validation or quality control of analytical 

methods for the determination of degrees Brix or Refractive Index of sugar solutions and food extracts. 


Degrees Brix .......................1.26 Refractive index.............. 1.3348 

Orange juice 




Degrees Brix .....................12.72 Refractive index.............. 1.3521 

Orange juice 





Orange juice 





set 

set 

set 

set 

set 

set 

set 

3 mL 

3 mL 

3 mL 

3 mL 




ERM-BD015 

NIST-1822A 

NIST-1922 

PRG 7.21 

PRG 7.1 

PRG 7.11 

PRG 7.2 

Orange juice 





Refractive index standard 


Vacuum Wavelength (nm) Refractive Index (n) Vacuum Wavelength (nm) Refractive Index (n) 

at 22 °C at 22 °C 

480.1254 ................................. 1.526132 ± 0.000016 546.2260..................................1.521629 ± 0.000016 

501.7077 ................................. 1.524468 ± 0.000016 587.7254..................................1.519535 ± 0.000016 

508.7240 ................................. 1.523971 ± 0.000016 644.0250..................................1.517277 ± 0.000016 

Liquid refractive index - Mineral oil 

Intended for use as a calibration material for refractometers, especially for the refractive index range applicable to 

solutions of sugar and water. 

Certified values are given for refractive indices at 6 wavelengths, in the visible light range, at 20°C and for the 

change in refractive index with respect to temperature. 

PRG 7.21 - PRG 7.9 

This group of 11 liquid reference materials, produced by LGC Promochem and certified by the 

Laboratory of Refractometry and Polarimetry of the Central Office of Measures (GUM), Warsaw, 

covers the wide range of refractive index from 1.333 (water) to 1.702 (1-Iodonaphthalene). 

The n values were determined on a Pulfrich refractometer, previously calibrated with solid Class 

1 CRMs, for which values were established using goniometric procedures. 

All reference materials are supplied with a certificate. Certified values to 5 significant figures for 

the refractive index λ at = 589.3 nm, t = 20°C and associated uncertainties are given. 

Reference liquids are packed in glass ampoules (7.1, 7.2, 7.5, 7.6, 7.8, 7.9) or plastic drop-bottles 

(7.11, 7.12, 7.13, 7.20, 7.21). 

Water 




Methylsilicone oil 




3 mL 

plate 

30 mL 

10 mL 

10 mL 

10 mL 

10 mL 

PRG 7.12 Silicone oil DC 556 


10 mL 

PRG 7.20 

PRG 7.5 

PRG 7.6 

Paraffin oil 


Toluene 


Chlorobenzene 


10 mL 

10 mL 

10 mL 

PRG 7.13 Silicone oil AN 140 

Refractive index .................................. 1.560 at 20°C 

10 mL 

PRG 7.8 

PRG 7.9 

RPC18061 

RPC18062 

RPC18065 

RPC1806X 

1-Bromonaphthalene 


1-Iodonaphthalene 


Refractive index liquids 

Refractive index range: 1.400-1.458 (interval 0.002) 





Refractive index liquid 

Any individual standard* 


10 mL 

10 mL 

30 x 7 mL 

15 x 7 mL 

6 x 7 mL 

1 x 7 mL 




RPC1806Y 

RPC18091 

RPC18092 

RPC18095 

RPC1809X 

RPC1809Y 

RPC18121 

RPC18122 

RPC18125 

RPC1812X 

RPC1812Y 


Any individual standard 


























1 x 30 mL 

91 x 7 mL 

46 x 7 mL 

19 x 7 mL 

1 x 7 mL 

1 x 30 mL 

30 x 7 mL 

15 x 7 mL 

6 x 7 mL 

1 x 7 mL 

1 x 30 mL 

Optical rotation 

*For individual standards please state in brackets after the catalogue number the refractive index required. 

GUM 8.1 

Optical fibres 

NIST-2520 

NIST-2522 

NIST-2523 

Sucrose (Saccharose) 


Optical rotation at 20 ºC 

546 nm ............................78.34 ° 589 nm............................ 66.52 ° 

Optical fibre diameter standard - Diameter 

Intended for calibrating video microscopes or gray-scale systems used for fibre geometry measurements. 

The material consists of bare fibre in aluminium housing. Each sample is individually calibrated. 

Pin Guage for Optical Fibre Ferrul 

This Standard Reference Material (SRM ® ) is intended primarily for use in calibrating instruments which measure 

small diameter artifacts such as pin gages, used for optical fibre ferrule hole calibration. Each SRM is individually 

certified and consists of a 60 mm long steel wire. 

Optical Fibre Ferrule Geometry 

This Standard Reference Material (SRM ® ) is intended primarily for use in calibrating instruments which measure 

small diameter artifacts such as optical fibre ferrules. Each SRM is individually certified and consists of a single 

ceramic optical fibre ferrule. 

100 g 

unit 

each 

each 

Colour measurement 

BCR-400 

BCR-406A 

Red ceramic tile (Tomato paste colour) 

100 mm x 100 mm 

A ceramic tile the colour of which is defined by Hunter L, a and b values. Each tile is individually certified. The tile 

is intended for the purpose of calibration and does not represent a standard tomato paste colour. 

Nominal Hunter values: L 26, a 33, b 14.5 

BCR-406A and BCR-406B 

A reference for colorimeters and spectrophotometers measuring colour in reflection. 

The spectral reflectance is certified at 13 wavelengths between 400 nm and 1200 nm with 

a value higher than 93% between 450 nm and 800 nm. 

Opal glass 

50 mmD x 14 mm thick 

tile 

disc 


Ion activity 


BCR-406B 

Photography 

NIST-1010A 

NIST-5001 

NIST-2059 

Microscopy 

NIST-2800 

NIST-1867 

NIST-1866B 

Opal glass 

100 mmD x 14 mm thick 

Microcopy resolution test chart 

Intended to be used to determine the resolving power of microcopy systems in the photographic industry. 

Designed to meet the general requirements for ISO test chart No. 2 as described in ISO 3334: 1989. 

Two-Dimensional Grid Photomask Standard 

This Standard Reference Material (SRM ® ) is intended primarily for calibrating high accuracy two dimensional (X-Y) 

photomask/reticle registration metrology tools such as the IPRO, the IPRO II and the Leica 2020 as well as older 

tools such as the Nicon 5i. 

Photomask linewidth calibration standard 

NIST-2059 is an antireflecting etched chrome binary photomask on a nominal 152.4 mm x 152.4 mm x 6.35 mm 

(the industry standard 6.0 in. x 6.0 in. x 0.25 in.) quartz substrate. It consists of patterns of clear and opaque 

isolated lines with nominal dimensions ranging from 0.25 µm to 32 µm and linespacing (pitch) patterns ranging 

from 0.5 µm to 250 µm. Each mask is individually calibrated, with certified values given for isolated linewidths 

(both clear and opaque) and center-to-center line spacings for one of the eight repeated patterns on the SRM. 

All measurements are averaged over the central 2 µm of each feature to reduce the influence of line edge 

roughness. The certified values are traceable to the definition of the meter with an expanded (k=2) uncertainty 

less than 25 nm for linewidths and spacewidths and less than 9 nm for pitch. 

Other small objects of interest, such as features on IC wafers, magnetic read/write head gaps, biological 

materials, phase shift photomasks, etc., will image differently in a microscope. Consequently, this SRM is 

intended for measurements on binary photomasks only, which represent more than 85 % of all photomasks 

manufactured worldwide in the most recent survey, 

Microscope magnification standard 

This Standard Reference Material ® (SRM ® ) is intended primarily for use in calibrating the magnification or scale of 

microscopes used to make dimensional measurements. These microscopes include optical and scanning electron 

microscopes, imaging in either transmission or reflection modes, and scanning probe microscopes. NIST-2800 

consists of a pattern of parallel lines whose nominal distances from the centerline range from ± 1 µm to ± 5 mm 

(see Figure 1). Certified values are given for the centre-to-centre distance of each line from the centreline; the 

linewidths are not certified. The pattern is printed in chrome on a fused-quartz substrate with nominal dimensions 

of 25 mm × 75 mm × 2.3 mm (1 in × 3 in × 0.09 in) using photomask production techniques. 

Uncommon commercial asbestos 

This Standard Reference Material (SRM ® ) comprises three uncommon commercial asbestos materials (tremolite, 

actinolite asbestos, and anthophyllte asbestos) intended for use in the identification of these minerals by polarised 

light microscopy (PLM). 

Common commercial asbestos 

This standard reference material (SRM ® ) is comprised of three commercial-grade asbestos materials: chrysotile, 

asbestiform grunerite (amosite), and asbestiform riebeckite (crocidolite). These are the types of asbestos that 

were, or are, commonly used in commerce. These asbestos materials are typical of the asbestos found in bulk 

samples during routine asbestos inspections of building materials. The optical properties of these materials have 

been characterized so that this SRM may serve as a primary calibration standard in the identification of asbestos 

with polarized light microscopy (PLM). However, various conditions, such as geographic origin or acid/heat 

treatment 

of the asbestos, could cause the optical properties of the asbestos in bulk insulation samples to vary considerably 

from the materials comprising this SRM. A unit of NIST-1866b consists of a set of three bottles: one bottle 

containing chrysotile, one bottle containing asbestiform grunerite (amosite), and one bottle containing asbestiform 

riebeckite (crocidolite). Each bottle contains between 1 gram and 3 grams of material. 

disc 

set (5) 

each 

each 

each 

set (3) 

set (3) 

Ion activity 

pH calibration 


NIST-185h 

NIST-186G 

Potassium hydrogen phthalate 

This Standard Reference Material (SRM) is intended for use in preparing solutions for calibrating electrodes for 

pH measuring systems. 


pH (25 °C) .........................4.003 

Certified values of the pH at other temperatures are given in the CoA. 

pH Standards 

Potassium dihydrogen phosphate (186Ig) 

Disodium hydrogen phosphate (186IIg) 

NIST-186g is intended for use in preparing solutions for calibrating electrodes for pH measuring systems. NIST- 

186 g consists of two components, each prepared to ensure high purity and uniformity: KH 2PO 4, potassium 

dihydrogen phosphate (186-I-g) and Na 2HPO 4, disodium hydrogen phosphate (186-II-g). A unit of NIST-186g 

consists of 30 g of potassium dihydrogen phosphate (186-I-g) and 45 g of disodium hydrogen phosphate 

(186-II-g), each contained in its respective clear glass bottle. 

60 g 

set 


Ion activity 


NIST-187E 

NIST-2193A 

NIST-188 

NIST-191C 

NIST-RM 8040 

Sodium tetraborate decahydrate (Borax) 

This Standard Reference Material (SRM) is intended for use in preparing solutions for calibrating electrodes for 

pH measuring systems. 

Calcium carbonate pH standard 

This Standard Reference Material ® (SRM ® ) is intended for use in preparing solutions for calibrating electrodes for 

pH measuring systems at pH values above 11.0. This lot of calcium carbonate (CaCO 3) was selected for its low 

level of alkali metal impurities. However, this SRM ® is certified ONLY as a pH standard, NOT as a pure 

substance. Before use for pH calibrations, a freshly filtered, saturated (at 25 °C) solution of Ca(OH) 2 must be 

prepared from NIST-2193a. The certified pH(S) and U of this solution as a function of temperature are given 

below. 

t/°C pH(S) uc(measurement) uc(y) k U 

5 ..................................................................... 13.232...................... 0.0030 0.0058 2.0 0.011 

10 ................................................................... 13.026...................... 0.0025 0.0056 2.0 0.011 

15 ................................................................... 12.830...................... 0.0025 0.0056 2.0 0.011 

20 ................................................................... 12.645...................... 0.0024 0.0056 2.0 0.011 

25 ................................................................... 12.469...................... 0.0024 0.0055 2.0 0.011 

30 ................................................................... 12.303...................... 0.0071 0.0087 2.0 0.017 

35 ................................................................... 12.145...................... 0.0071 0.0087 2.0 0.017 

37 ................................................................... 12.084...................... 0.0071 0.0087 2.0 0.017 

40 ................................................................... 11.995...................... 0.0071 0.0087 2.0 0.017 

45 ................................................................... 11.853...................... 0.0072 0.0087 2.0 0.017 

50 ................................................................... 11.717...................... 0.0074 0.0089 2.0 0.017 

Potassium hydrogen tartrate 


pH (25 °C) .........................3.557 

Other certified values of pH at different temperatures are given in the CoA. 

pH Standards (Carbonate buffers; sodium bicarbonate and sodium carbonate) 

This Standard Reference Material ® (SRM ® ) is intended for use in preparing solutions for calibrating electrodes for 

pH measuring systems. NIST-191c consists of two components, each prepared to ensure high purity and 

uniformity: Sodium bicarbonate, NaHCO 3 (191-I-c) and sodium carbonate, Na 2CO 3 (191-II-c).A unit of NIST-191c 

consists of 25 g of sodium bicarbonate (191-I-c) and 30 grams of sodium carbonate (191-II-c), each contained in 

its respective clear glass bottle. 


pH (25 °C) .......................10.012 

Certified values of pH at 15 °C, 20 °C and 35 °C are given in the CoA. 

Sodium oxalate (Reductometric) 

This Reference Material (RM) was prepared to provide material of uniform, high purity for use as a working 

standard for oxidation-reduction reactions. The material conforms to the American Chemical Society specification 

for reagent-grade material, but should not be considered as entirely free from impurities such as moisture, sodium 

hydrogen oxalate and sodium hydrogen carbonate. A unit of RM 8040 consists of one bottle containing 60 g of 

crystalline sodium oxalate. 

Reference value 

Reductometric Assay (mass fraction): 99.951 % ± 0.038 % 

30 g 

30 g 

60 g 

25 g 

60 g 

Biological buffer systems 

NIST-2181 

NIST-2182 - NIST-2184 

These materials are intended for use in calibrating clinical instruments (e.g. blood pH measurements), in 

the physiologically important range of pH 7-8. They are based on a biological buffer system for clinical pH 

measurements and are certified for use as an admixture only. The pH values for the buffer solutions are 

certified at 0.05 and 0.08 M with respect to the free acid and the sodium salt admixture as a function of 

temperature. The certified temperature range is from 0-50 °C. 

NIST-2181 and NIST-2182 

Both materials are required to prepare a standard solution. 

HEPES free acid 


0.05M 

pH (0-50 °C)............7.832-7.216 

0.08M 

pH (0-50 °C)............7.853-7.222 

60 g 

NIST-2182 

HEPES Sodium Salt 


0.05M 

pH (0-50 °C)............7.832-7.216 

0.08M 

pH (0-50 °C)............7.853-7.222 

60 g 


Ion activity 


NIST-2183 

NIST-2184 

pD calibration 

NIST-2185 

NIST-2186II 

NIST-2191A 

NIST-2192A 


Both materials are required to prepare a standard solution. 

MOPSO free acid 


0.05M 

pH (0-50 °C) ............7.260-6.528 

0.08M 

pH (0-50 °C) ............7.268-6.528 

NaMOPSOate 


0.05M 

pH (0-50 °C) ............7.260-6.528 

0.08M 

pH (0-50 °C) ............7.268-6.524 

Potassium hydrogen phthalate 


pD (25 °C) .........................4.518 

Disodium Hydrogen Phosphate 

Required to prepare a standard solution. 


pD (25 °C) .........................7.428 

Other certified values at different temperatures are given in the CoA. 

Sodium bicarbonate 



pD (25 °C) .........................10.73 


Sodium carbonate 



pD (25 °C) .......................10.732 


50 g 

50 g 

60 g 

30 g 

30 g 

30 g 

Ion-selective electrode calibration 

NIST-2201 

NIST-2202 

NIST-2203 

Sodium chloride 

Certified values for activity coefficients, at 25°C, of the sodium and chloride ions at various concentrations and the 

related values of pNa and pCl. 

Potassium chloride 

Certified values for activity coefficients, at 25°C, of the potassium and chloride ions at various concentrations and 

the related values of pK and pCl. 

Potassium fluoride 

Certified values for activity coefficients, at 25°C, of the potassium and fluoride ions at various concentrations and 

the related value of pF. 

125 g 

160 g 

125 g 

Electrolytic conductivity 

NIST-3199 

NIST-3192 

NIST-3193 

KCl in n-propanol/de-ionised water 


Electrolytic conductivity (25 °C).............15.36 µS/cm 

KCl in de-ionised water 


Electrolytic conductivity (25 °C)...........496.73 µS/cm 

KCl in de-ionised water 


Electrolytic conductivity (25°C)............996.70 µS/cm 

GUM 5.2 - GUM 5.6 

500 mL 

8 x 50 mL 

8 x 50 mL 

These Reference Materials have been certified by the Physical Chemistry Division of the Central Office of 

Measures in Poland. They are intended for calibration of conductivity cells or use in electrolytic conductivity 

measurement as a control sample. These RMs are certified in conformity with standard reference data published 

by the International Organisation of Legal Metrology (OIML). All Reference Materials are supplied with a certificate. 


Ion activity 


GUM 5.1 

GUM 5.2 

GUM 5.3 

GUM 5.4 

GUM 5.5 

GUM 5.6 

KCI solution 


Electrolytic conductivity...............11.13 S/m at 25 ºC 

KCI Solution 


Electrolytic conductivity...............1.285 S/m at 25 ºC 

KCI solution 


Electrolytic conductivity.............0.1410 S/m at 25 ºC 

KCI solution 


Electrolytic conductivity......... 0.01483 S/m at 25 °C 

KCI solution 


Electrolytic conductivity.................0.0720 S/m 25 °C 

KCI solution 


Electrolytic conductivity.............0.0293 S/m at 25 ºC 

100 mL 

100 mL 

100 mL 

100 mL 

100 mL 

100 mL 

Reagecon electrolytic conductivity standards 

Standard values 

REACSKC84 

REACSKCS 

REACSKCL 

REACSKC12880 

REACSKC13 

REACSKC136 

REACSKC5 

REACSKC10 

REACSKC20 

REACSKC50 

REACSKC100 

REACSKC200 

REACSKC500 

REACSKC1000 

REACSKC5M 

REACSKC10M 

REACSKC20M 


Electrolytic conductivity.................84 µS/cm at 25°C 




Electrolytic conductivity............1413 µS/cm at 25°C 


Electrolytic conductivity..........12880 µS/cm at 25°C 






Electrolytic conductivity...................5 µS/cm at 25°C 


















Electrolytic conductivity...........10000 µS/cm at 25°C 


Electrolytic conductivity...........20000 µS/cm at 25°C 

500 mL 

500 mL 

500 mL 

500 mL 

250 mL 

6 x 250 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 


Electrical properties 


REACSKC50M 

REACSKC100M 

REACSKC150M 

REACSKC200M 

REACSKC300M 

REACSKC350M 

REACSKC450M 

REACSKC500M 


Electrolytic conductivity ...........50000 µS/cm at 25°C 


Electrolytic conductivity .........100000 µS/cm at 25°C 








Electrolytic conductivity ........350.000 µS/cm at 25°C 





500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

Conductivity standards according to the European Pharmacopoeia (Chapter 2) 

REAEP1330 

REAEP133 

REAEP266 


Electrolytic conductivity .............1330 µS/cm at 20°C 

Resistivity...................................................752 Ω⋅cm 


Electrolytic conductivity ...............133 µS/cm at 20°C 

Resistivity.................................................7519 Ω⋅cm 


Electrolytic conductivity ..............26.6 µS/cm at 20°C 

Resistivity...............................................37594 Ω⋅cm 

500 mL 

500 mL 

500 mL 


Electrical resistivity and conductivity 


NIST-624 

NIST-2541 

NIST-2546 

NIST-2547 

Lead-silica - dc Resistivity 

Intended for checking test methods and for calibrating equipment used to determine the dc volume resistivity of 

glass per ASTM C 657. 

Certified value: 

Resistivity Temperature 

log 10ρ 11.07 Ω·cm ............250°C 

log 10ρ 9.9Ω·cm .................300°C 

log 10ρ 8.88 Ω·cm ..............350°C 

NIST-2541 - NIST-2547 

Single wafers intended for use as reference standards for sheet resistance and resistivity 

measurements utilising the four-point probe method. 

Silicon chip - Resistivity 

100 mm (D) x 0.625 mm 

Czochralski-grown, boron-doped silicon wafer with (100) crystallographic orientation. 


Resistivity....................0.1 Ω-cm 


100 mm (D) x 0.625 mm 

Float zone silicon with (111) orientation and phosphorus-doped by the neutron transmutation doping process. 


Resistivity...................100 Ω-cm 


100 mm (D) x 0.625 mm 

Float zone silicon with (111) orientation and phosphorus-doped by the neutron transmutation doping process. 


Resistivity...................200 Ω-cm 

200 g 

1 wafer 

1 wafer 

1 wafer 


Viscosity 


NIST-RM 8420 

Electrolytic iron rod 

0.64 cm (D) x 5.0 cm 

Thermal conductivity and electrical resistivity as a function of temperature (2-1000 K) 

1 rod 

Superconducting critical current 

NIST-1457 

Niobium-titanium wire - Critical current 

8.7 cm diameter spool 

Intended for checking the performance of measurement systems used in superconductor technology. It consists of 

2.2 m of a multifilamentary niobium titanium, copper-stabilised superconducting wire wound in a single layer onto 

a spool with a core diameter of 8.7 cm. 

Certified values for critical current at 4.2 k and 0.2 µV/cm 

each 

Dielectric constant 

NIST-774 

Lead-silica - Dielectric constant 

5 cm x 5 cm x 2.5 cm 

Intended for checking methods used to determine dielectric constant and ac loss characteristics of insulating 

materials per ASTM D 150. 

Certified value: K ~7.47 at 100 Hz 

each 

Viscosity 

Viscosity of glass 


NIST-717A 

NIST-717a 

Intended for checking the performance of high temperature viscosity equipment (rotating cylinders) 

and low temperature viscosity equipment (fibre elongation, beam bending, parallel plates, etc). 

Borosilicate 

Certified log 10 viscosity values (1.00-4.50) versus temperature (1555-880 °C) 

Indicative values for softening point, annealing point, strain point 

450 g 

Viscosity fixpoints 

NIST-709 

NIST-709 - NIST-717a 

Intended for calibration of equipment for the determination of the softening, annealing and 

strain points of glass. 

Extra dense lead 


Softening point ................384 °C Annealing point............... 328 °C Strain point......................311 °C 

500 g 

NIST-713 Dense barium crown glass 620/603 



225 g 

NIST-714 

NIST-716 

NIST-717A 

Alkaline earth alumina silicate 



Neutral glass 



Borosilicate 

Certified log 10 viscosity values (1.00-4.50) versus temperature (1555-880 °C) 

Indicative values for softening point, annealing point, strain point 

225 g 

225 g 

450 g 


Viscosity 

Viscosity oil standards 


PSL2700V01 

PSL2700V01 - PSL2700V19 

These standards are calibrated by the PSL Calibration Accredited Laboratory No. 0247 to ISO 17025. 

The Standards will be supplied complete with UKAS calibration certificates and have direct traceability 

to NIST and other international laboratories. Uncertainties of measurement are stated on the calibration 

certificates. Long shelf lives are provided by using stable base oils.The viscosity oil standards are suitable 

for the calibration and verification of the following: 

- Glass Capillary viscometers 

- Automated Kinematic Viscometer Systems 

- Rotational/Cone & Plate Viscometers 

- Low Temperature Viscometer Systems 

- Cold Cranking Simulators 

- Flow Cups 

N4 - Viscosity oil standard 

Kinematic viscosity (nominal) 

0.47 mm 2 /s,cSt (20 °C) 0.45 mm 2 /s,cSt (25 °C) 0.40 mm 2 /s,cSt (40 °C) 

Dynamic viscosity (nominal) 

0.31 mPa.s,cP (20 °C) 0.29 mPa.s,cP (25 °C) 0.26 mPa.s,cP (40°C) 

500 mL 

PSL2700V02 

PSL2700V03 

PSLN2 

PSL2700V04 

PSL2700V05 

PSL2700V06 

PSL2700V07 



1. mm 2 /s,cSt (20 °C) 0.89 mm 2 /s,cSt (25 °C) 0.75 mm 2 /s,cSt (40 °C) 


0.77 mPa.s,cP (20 °C) 0.72 mPa.s,cP (25 °C) 0.56 mPa.s,cP (40 °C) 

N1.0 - Viscosity oil standard 







2.9 mm 2 /s,cSt (20 °C) 2.6 mm 2 /s,cSt (25 °C) 2.0 mm 2 /s,cSt (40 °C) 1.7 mm 2 /s,cSt (50 °C) 


2.2 mPa.s,cP (20 °C) 2.0 mPa.s,cP (25 °C) 1.5 mPa.s,cP (40 °C) 1.3 mPa.s,cP (50 °C) 

S3 - Viscosity oil standard 



4.4 mm 2 /s,cSt (25 °C) 2.6 mm 2 /s,cSt (50 °C) 



3.6 mPa.s,cP (25 °C) 2.1 mPa.s,cP (50 °C) 



11 mm 2 /s,cSt (20 °C) 5.7 mm 2 /s,cSt (40 °C) 1.9 mm 2 /s,cSt (100 °C) 

8.9 mm 2 /s,cSt (25 °C) 4.6 mm 2 /s,cSt (50 °C) 



7.4 mPa.s,cP (25 °C) 3.7 mPa.s,cP (50 °C) 



21 mm 2 /s,cSt (20 °C) 10 mm 2 /s,cSt (40 °C) 2.7 mm 2 /s,cSt (100 °C) 

17 mm 2 /s,cSt (25 °C) 7.5 mm 2 /s,cSt (50 °C) 


17 mPa.s,cP (20 °C) 9.0 mPa.s,cP (40 °C) 2.1 mPa.s,cP (100 °C) 

14 mPa.s,cP (25 °C) 6.2 mPa.s,cP (50 °C) 




37 mm 2 /s,cSt (25 °C) 13 mm 2 /s,cSt (50 °C) 


40 mPa.s,cP (20 °C) 16 mPa.s,cP (40 °C) 3.2 mPa.s,cP (100 °C) 

31 mPa.s,cP (25 °C) 11 mPa.s,cP (50 °C) 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 


Viscosity 


PSL2700V08 

PSL2700V09 

PSL2700V10 

PSLN140 

PSL2700V11 

PSLN230 

PSL2700V12 

PSLN415 

PSL2700V13 































660 mm 2 /s,cSt (20 °C) 180 mm 2 /s,cSt (40 °C) 17 mm 2 /s,cSt (100 °C) 



590 mPa.s,cP (20 °C) 150 mPa.s,cP (40 °C) 14 mPa.s,cP (100 °C) 






























500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 


Viscosity 


PSLN730 

PSL2700V14 

PSLN1300 

PSL2700V15 

PSL2700V16 

PSL2700V17 

PSL2700V18 

PSL2700V19 













4100 mPa.s,cP (20 °C) 800 mPa.s,cP (40°C) 45 mPa.s,cP (100 °C) 

2700 mPa.s,cP (25 °C) 450 mPa.s,cP (50°C) 




































S30000-Viscosity oil standard 


82000 mm 2 /s,cSt (25 °C) 23000 mm 2 /s,cSt (40 °C) 11000 mm 2 /s,cSt (50 °C) 670 mm 2 /s,cSt (100 °C) 


74000 mPa.s,cP (25 °C) 21000 mPa.s,cP (40 °C) 9900 mPa.s,cP (50 °C) 580 mPa.s,cP (100 °C) 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 

500 mL 


Polymeric properties 

Individual molecular weight polymer standards 



NIST-2885 

NIST-2886 

NIST-2887 

NIST-1482A 

Polyethylene 


Molar Mass....... 6.28 x 10 3 g/mol 

Polyethylene 


Molar Mass....... 87.0 x 10 3 g/mol 

Polyethylene 


Molar Mass..... 196.4 x 10 3 g/mol 

Polyethylene 


Mass-average molar mass................... 13,600 g/mol 

Number-average molar mass .............. 11,400 g/mol 

Molecular weight and melt flow 

NIST-705A 

NIST-706A 

NIST-1473B 

NIST-1474A 

NIST-1475A 

NIST-1476A 

NIST-1478 

Polystyrene - Heat capacity and molecular weight 

Intrinsic viscosity .......................................40.1 mL/g 

Molecular weight (MW) values, measured using various techniques, and limiting viscosity (LV) numbers. 


M n by membrane osmometry............. 170,900 g/mol LV in benzene (25 °C)...............................74.3 mL/g 

M W by light scattering......................... 179,300 g/mol LV in benzene (25 °C)...............................74.5 mL/g 

M W by sedimentation equilibrium ....... 189,800 g/mol LV in cyclohexane (25 °C).........................35.4 mL/g 

For heat capacity please ask for detailed list 

Polystyrene - Broad molecular weight distribution 


Mass-average molar mass (M w)......... 285,000 g/mol 

Indicative values for intrinsic viscosity in benzene at 25 °C and cyclohexane at 35 °C 

Low densitiy polyethylene resin 

This material is certified for melt flow rate using ASTM D 1238-00, Test Method for Flow Rates of Thermoplastics 

by Extrusion Plastometer Standard Test Condition 190/2.16. The flow rate of the melt was determined at 190.0 °C 

± 0.1 °C and a load of 2.16 kg by procedure A of the ASTM method. A manually operated extrusion plastometer 

was used. 


Melt flow rate (FR)............................... 1.13 g/10 min 

Polyethylene resin - Melt flow rate 

Certified for melt flow rate, FR-190/2.16, using ASTM Method D 1238-86 at 190 °C. 


Melt flow rate (FR)............................... 5.10 g/10 min 

Polyethylene, linear - Melt flow rate 

Certified for melt flow rate, FR-190/2.16, using ASTM Method D 1238-90b, and Limiting viscosity (LV). 


Melt flow rate.........................................................................................2.02 g/10 min 

Weight average MW (light scattering)....................................................52,000 g/mol 

Number average MW (size exclusion chromatography) ........................18,310 g/mol 

Weight average MW (size exclusion chromatography) .........................53,070 g/mol 

Z-average MW (size exclusion chromatography).................................138,000 g/mol 

LV in 1-chloronaphthalene (130 °C)............................................................89.0 mL/g 

LV in 1,2,4-trichlorobenzene (130 °C).......................................................101.0 mL/g 

LV in decahydronapthalene (130 °C)........................................................118.0 mL/g 

density..................................................................................................0.97844 g/cm 3 

Branched polyethylene resin - Melt flow rate 

This Standard Reference Material ® (SRM ® ) is intended for use in calibration and performance evaluation of 

instruments used in polymer technology and science for the determination of the melt flow rate using ASTM 

Method D1238-00. It is supplied as white pellets of polyethylene. 

This material is certified for melt flow rate using ASTM Method D1238-00 condition 190/2.16. Under this condition 

the melt flow rate is 1.23 g/10 min with a standard deviation of 0.036 g/10 min and with 29 degrees of freedom. 

The certified measurement uncertainty is found to be 0.110 g/10 min and is expressed as a combined expanded 

uncertainty with a coverage factor k = 2, calculated in accordance with ISO and NIST Guides procedure. 

Polystyrene - narrow molecular weight distribution 


Number average MW (membrane osmometry) ....................................................35,800 g/mol 

Weight average MW (sedimentation equilibrium ultracentrifugation) ...................37,400 g/mol 

Limiting viscosity in toluene (25 °C) .........................................................................23.06 mL/g 

300 mg 

300 mg 

300 mg 

0.3 g 

5 g 

18 g 

60 g 

60 g 

50 g 

12 g 

2 g 




NIST-1479 

NIST-2888 

NIST-1480 

Polystyrene - narrow molecular weight distribution 


Weight average MW (light scattering)................. 1,050,000 g/mol 

Polystyrene 


Mass-average molar mass (M w)...... 7.19 x 10 3 g/mol 

Polyurethane 


Weight average MW (light scattering)...................... 47,300 g/mol 

Indicative value for limiting viscosity 

2 g 

0.3 g 

1 g 

NIST-1483A 

Polyethylene, linear 


Mass-Average Molecular Mass (M w) 

Number Average Molecular Mass (M n) 

Intrinsic Viscosity 

32100 g/mol 

28900 g/mol 

80.0 mL/g 

300 mg 

NIST-1484A 

NIST-1487 

NIST-1488 

NIST-1489 

NIST-1496 

NIST-1923 

NIST-1924 

NIST-2491 

Polyethylene, linear - narrow molecular weight distribution 


Number-average MW (membrane osmometry) .................... 100,500 g/mol 

Weight average MW (light scattering)................................... 119,600 g/mol 

Limiting viscosity in 1,2,4-trichlorobenzene (130 °C) ................197.9 mL/g 

Limiting viscosity in 1-chloronaphthalene (130 °C) ....................169.4 mL/g 

Poly(methylmethacrylate) 


Weight-average molecular weight (sedimentation equilibrium ultracentrifugation)............. 63,000 g/mol 

Limiting viscosity number in tetrahydrofuran (25 °C) ................................................................. 7.9 mL/g 



Number-average molecular weight (membrane osmometry).................29,300 g/mol 

Limiting viscosity in tetrahydrofuran (25 °C)................................................15.8 mL/g 



Number-average molecular weight (membrane osmometry)...............115,000 g/mol 

Limiting viscosity in tetrahydrofuran (25 °C)................................................37.4 mL/g 

Polyethylene gas pipe resin (unpigmented) 


Melt flow rate (FR-190/2.16, using ASTM Method D 1238-82) .............0.26 g/10 min 

Intrinsic viscosity in 1,2,4-trichlorobenzene (140 °C) ...................................210 mL/g 

Poly(ethylene oxide) - molecular weight 


Weight average molecular weight........ 26,900 g/mol 

Poly(ethylene oxide) - molecular weight 


Weight average molecular weight...... 120,900 g/mol 

Non-Newtonian polymer melt for rheology 

This Standard Reference Material ® (SRM ® ) is intended primarily for use in calibration and performance evaluation 

of instruments used to determine the viscosity and first normal stress difference in steady shear, or to determine 

the dynamic mechanical storage and loss moduli and shift factors through time-temperature superposition. NIST- 

2491 consists of polydimethylsiloxane. The supplier identifies the polydimethylsiloxane as having a number 

average molecular mass of 308,000 g/mol. Certified values of the viscosity and first normal stress difference as 

functions of shear rate are given in the certificate at temperatures of 0 °C, 25 °C, and 50 °C, respectively. The 

expanded combined uncertainties in the certified values of the viscosity and first normal stress difference are also 

listed. 

The certified values of the storage modulus G’ and loss modulus G” as functions of frequency at 0 °C, 10 °C, 20 

°C, 30 °C, 40 °C, and 50 °C, respectively are also given in the certificate. 

300 mg 

2 g 

2 g 

2 g 

900 g 

200 mg 

200 mg 

100 mL 


Miscellaneous 

Relative humidity 

Miscellaneous 

HM11 - HM90 

Please specify the type of hygrometer to be used to enable the appropriate adapter to be supplied. 


HM11 

HM22 

HM33 

HM54 

HM75 

HM80 

HM90 

Relative humidity standard 

Nominal relative humidity..................................11 % 













Scanning electron microscope 

NIST-2069B 

NIST-RM 8091 

X-ray diffraction 

NIST-656 

SEM Performance Standard 

Graphitised rayon fibres with smooth and uniform edges on a 12.5 mm diameter SEM specimen mount with a 3 

mm peg. One edge of a single fibre is used as a clearly defined boundary across which the electron beam is 

scanned. The slope of the resultant detector signal waveform is a measure of the SEM performance that can be 

related to the resolution capability of the SEM. 

Scanning Electron Microscope Sharpness Standard 

This Reference Material (RM) is intended primarily for use in checking the sharpness of scanning electron 

microscopes. It is supplied as a small (3mm x 2 mm) diced semiconductor chip. Please ask for further details. 

Silicon nitride 

unit 

unit 

unit 

unit 

unit 

unit 

unit 

each 

each 

2 x 10 g 

This Standard Reference Material (SRM ® ) consists of two powders intended for quantitative analysis of α the 

β and polymorphs of silicon nitride via powder diffraction methods. The powders are combinations of α the 

β and polymorphs; one is high in α the phase (α content 656), while the other contains a larger amount of the 

polymorph (β 656). 

β 

NIST-674B 

NIST-675 

NIST-1976 

X-Ray powder diffraction intensity set 

This Standard Reference Material (SRM ® ) consists of four oxide powders intended primarily for use as internal 

standards for quantitative X-ray diffraction analysis. The powders are ZnO (wurtzite structure), TiO 2 (rutile 

structure), Cr 2O 3 (corundum structure), and CeO 2 (fluorite structure). These four oxides offer a range of linear 

attenuations Cu-Kα for radiation: 279 cm -1 , 536 cm -1 , 912 cm -1 , and 2203 cm -1 , respectively, that allow the user to 

nominally match that of standard to the unknown in order to minimize the effects of microabsorption. A unit of 

NIST-674b consists of approximately 10 g of each powder, bottled in an argon atmosphere. 


Phase purity and uncertainty 

Crystalline component Phase Purity Crystalline component Phase Purity 

ZnO ...............................................95.28 % ± 0.64 % Cr 2O 3 ............................................ 95.91 % ± 0.60 % 

TiO 2...............................................89.47 % ± 0.62 % CeO 2............................................. 91.36 % ± 0.55 % 

Mica x-ray diffraction 

Intended for use as an external or internal low 2 (large d-spacing) calibration standard for powder diffractometry. 

Certified value ..................d(001) 9.98104 Å (based on the average of 28 refined d values at 25 °C 

uncorrected for refraction) 

Alumina plate, sintered 

Intended for use in the calibration of powder X-ray equipment for diffraction intensity as a function of 2θ angle 

(instrument sensitivity). 

Certified values (for lattice parameters) 

a ......................................................... 0.4758846 nm c............................................................1.299306 nm 

σ............................................................... 0.0000109 σ ............0.0000238 (where (CuKα 1) 0.1540629 nm) 

set 

7.5 g 

plate 


Miscellaneous 


NIST-1990 

NIST-1994 

Density 

NIST-211D 

Single Crystal Diffractometer Alignment Standard - Ruby Sphere 

Standard Reference Material (SRM ® ) 1990 is intended primarily for use as an alignment standard for single crystal 

diffractometry. One unit consists of three chromium-doped single crystal aluminum oxide (ruby) spheres. The 

spheres are nominally 152 mm in diameter with 1.3 mm sphericity. The spherical geometry was chosen to 

facilitate alignment and to avoid corrections for absorption. These spheres produce reflections at high angles for 

copper and molybdenum radiation. The space group is R3c. 

Certified lattice parameters of NIST-1990 at 25 °C are: 

a: 0.476080 nm ± 0.000029 nm 

c: 1.299568 nm ± 0.000087 nm 

Standard silicon single crystal wafer for crystalline orientation 

This Standard Reference Material (SRM ® ) is intended for use in the calibration of instruments (X-ray 

diffractometers) used to measure the crystal orientation of wafers relative to the crystal surface. The SRM unit 

consists of a 100-mm diameter silicon wafer. The crystal orientation of the (001) silicon crystal planes relative to 

the surface normal has been measured both parallel and perpendicular to an edge flat that is manufactured into 

the wafer. 

Toluene 


Temperature [°C] Density [kg/m 3 ] 

15 .................................................... 871.476 ± 0.025 

20 .................................................... 866.828 ± 0.025 

25 ................................................... 862.170 ± 0.025 

3 spheres 

wafer 

4 x 5 mL 

NIST-2214 

Isooctane (2, 2, 4-Trimethylpentane) - Density 

4x5mL 

Certified Values of NIST-2214 at three sample temperatures 

Temperature °C Density, Temperature °C Density, 

15.000 ...................................695.969 ± 0.035 kg/m 3 25.000....................................687.753 ± 0.035 kg/m 3 

20.000 ...................................691.872 ± 0.035 kg/m 3 

HDF01 

HDF02 

HDF01 - HDF-012 

Certified densities were determined by means of hydrostatic weighing. 


Temperature range 15-25 °C 


Liquid density (20 °C)................................692 kg/m 3 

Dodecane 




10 mL 

10 mL 

HDF04 Base lubricating oil approx. 8 mPa.s at 40°C 




HDF05 Base lubricating oil approx. 30 mPa s at 40°C 




HDF06 Base lubricating oil approx. 110 mPa s at 40°C 




HDF07 Lubricating oil A90 approx. 160 mPa s at 40°C 




10 mL 

10 mL 

10 mL 

10 mL 

HDF08 

HDF09 

Ethanol in water approx. 41 % ABV 

Use of this material is not recommended unless required by fiscal authorities. 



Ethanol in water approx. 11 % ABV 




10 mL 

10 mL 


Miscellaneous 


HDF15 

HDF10 

Water 


Liquid density (20°C).................................998 kg/m 3 

Dextrose in water approx. 10 % by weight 



Liquid density (20 °C)..............................1037 kg/m 3 

10 mL 

10 mL 

HDF11 Dimethylphthalate approx. 17 mPa s at 20°C 

Temperature range 15 to 25°C 



10 mL 

HDF13 

HDF14 

HDF12 

Sodium bromide in water 




Caesium chloride in water approx. 47% by weight 


Liquid density (20°C)...............................1525 kg/m 3 

Tetrachloroethylene 




10 mL 

10 mL 

10 mL 

GUM 1.1 

GUM1.1 - GUM1.11 

Liquid density standards certified by the Central Office of Measures (GUM). Intended for calibration and 

checking densimeters used for measuring density of liquids. Supplied with a certificate showing density 

values at temperatures from 20 °C to 50 °C, with an uncertainty 0.05 kg/m 3 . Values for the first and second 

decimal place are given in the certificate for particular series. 

n-Hexane 


Density ..........659 kg/m³ at 20°C 

10 mL 

GUM 1.2 

GUM 1.3 

GUM 1.4 

GUM 1.5 

GUM 1.6 

GUM 1.7 

GUM 1.8 

GUM 1.10 

GUM 1.11 

n-Heptane 






n-Nonane 



n-Octane 

Certifed value 





Cyclohexane 



Toluene 



2,4-Dichlorotoluene 


Density ........1249 kg/m³ at 20°C 

Tetrachloroethylene 


Density ........1623 kg/m³ at 20°C 

10 mL 

10 mL 

10 mL 

10 mL 

10 mL 

10 mL 

10 mL 

10 mL 

10 mL 


Miscellaneous 


Chemical resistance (durability) of glass 

NIST-622 


These NIST Standard Reference Materials ® are for checking test methods and calibrating equipment used to 

determine the resistance of glass containers to chemical attack. The values given represent the volume of 

fiftieth-normal sulphuric acid used to titrate to the methyl red end point of the alkaline extract from a crushed 

sample of glass after exposure to high purity water at 121 0 C. 

Soda lime silica (durability) 


Volume of 0.02N H 2SO 4............................... 7.67 mL 

2.2 kg 

NIST-623 



Volume of 0.02N H 2SO 4............................... 0.34 mL 

2.2 kg 

Multi-test verification materials (MTVMs) 

The Multi-Test Verification Materials (MTVMs) are unique because they enable a laboratory to use a single 

sample to validate different tests and instrumentation. Each unit is supplied with data for multiple types of 

internationally accepted test methods. 

SS99850-0 

SS99851-0 

SS99852-0 

SS99853-0 

SETA MTVM Kerosine (Jet turbine fuel) 

Test Name ASTM-IP Method Range Amount/test 

Distillation IBP ......................... D86-IP123......................... 140-180 °C................. 100 mL 

Distillation 10 %....................... D86-IP123......................... 159-188 °C................. 100 mL 

Distillation 50 % ...................... D86-IP123......................... 192-218 °C................. 100 mL 

Distillation 90 %....................... D86-IP123......................... 220-247 °C................. 100 mL 

Distillation FBP........................ D86-IP123......................... 244-268 °C................. 100 mL 

Distillation residue................... D86-IP123....................... 1.1-1.3 %vol................. 100 mL 

Distillation loss ........................ D86-IP123....................... 0.4-0.7 %vol................. 100 mL 

Flashpoint........................................IP170............................. 35-60 °C................... 85 mL 

Freezing point........................ D2386-IP16....................... –62 to -44°C................... 25 mL 

Aromatics FIA...................... D1319-IP156................... 18.1-22.7 %vol................ 0.75 mL 

Smoke point ...................................D1322........................... 20-25 mm................... 20 mL 

Acid number........................ D3242-IP354..............

Miscellaneous 


SS99854-0 

SS99856-0 

Mechanical properties 

ERM-FA013 

ERM-FA014 

ERM-FA015 

ERM-FA016 

ERM-FA415 

SETA MTVM motor gasoline 


Motor octane no. ............................D2700.................................. 83-90 

Research octane no.......................D2699................................ 96-101 

Density at 15 °C .................. D1298-IP160...................0.71-0.763 kg/L ........................200 mL 

Distillation IBP......................... D86-IP123....................... 32.0-39.0 °C ........................100 mL 

Distillation 70 °C...................... D86-IP123..........................15-36 %vol ........................100 mL 

Distillation 100 °C.................... D86-IP123..........................36-58 %vol ........................100 mL 

Distillation 150 °C.................... D86-IP123..........................75-90 %vol ........................100 mL 

Distillation FBP........................ D86-IP123......................... 175-205 °C .........................100mL 

Aromatics FIA ..................... D1319-IP156..........................19-42 %vol .......................0.75 mL 

Olefins FIA .......................... D1319-IP156.........................1.5-15 %vol .......................0.75 mL 

Saturates FIA ...................... D1319-IP156..........................42-72 %vol .......................0.75 mL 

Vapour Pressure ................ D5191; IP394....................... 50 to 85 kPa ............................3 mL 

SETA MTVM bitumen 


Softening point ..................................IP58...................... 37-54 °C..................7.5 mL 

Needle penetration............................IP49..................41-200 Pen.................130 mL 

Charpy specimens 30 J (bars) 

A unit consists of five Charpy V-notch test pieces, which are rectangular steel bars of nominal dimensions 55 mm 

x 10 mm x 10 mm, with one V-notch, accurately machined to tolerances imposed in EN 10045-1 and ISO 148. 

Absorbed energy (KV) at 20 ± 2 °C........30J nominal 












Absorbed energy (KV) at 20 ± 2 °C......120J nominal 

Charpy specimens 160 J 



Absorbed energy (KV) at 20 ± 2 °C......160J nominal 

NIST-2092 Low-Energy Charpy (10 -20 J) 

NIST-2092 is intended primarily for the verification of Charpy V-Notch machines in accordance with the current 

ASTM Standard E23. 

NIST-2096 High Energy Charpy (88 - 136J) 



NIST-2098 Super High-Energy Charpy (176 - 244J) 

BCR-425 

BCR-661A 



Nimonic 75 - Creep rate 

150 mm long 14 mm diameter bars of Nimonic 75. 

Testing conditions: T = 600 σ °C, = 160 Mpa 


Creep rate at 400 h .................................. 72 x 10 -6 /h 

time to 2 % strain ............................................. 278 h 

Nimonic 75 for ambient air tensile properties 

time to 4 % strain .............................................557 h 

The material is Nimonic 75 nickel base alloy. It will be issued in units of three bars each about 

150 mm long x 14 mm diameter, sufficient for the manufacture of three test-pieces. 

Certified values for tensile properties according to EN10002-1 

0.2% Proof stress R p0.2 .........................300 ± 7 MPa Elongation at fracture A.........................40.9 ± 0.9 % 

0.5% Proof stress R p0.5 .........................318 ± 7 MPa Reduction in area at fracture Z....................60 ± 4 % 

Tensile strength R m.............................750 ± 13 MPa 

500 mL 

500 mL 

set (5) 

set (5) 

set (5) 

set (5) 

set (5) 

set 

set 

set 

set (3) 

set (3) 


Miscellaneous 


BCR-661B 

BCR-692 

NIST-2100 

Nimonic 75 for ambient air tensile properties 

The material is Nimonic 75 nickel base alloy. It will be issued as one bar with about 500 mm long x 14 mm 

diameter. 

Certified values for tensile properties according to EN10002-1 

0.2% Proof stress R p0.2..........................300 ± 7 MPa Elongation at fracture A.........................40.9 ± 0.9 % 

0.5% Proof stress R p0.5..........................318 ± 7 MPa Reduction in area at fracture Z....................60 ± 4 % 

Tensile strength R m .............................750 ± 13 MPa 

Scratch test reference material 

A reference material certified for critical loads for cohesive/adhesive failures during scratch testing (prEN 1071-3). 

The reference samples are (30x30x5) mm steel coupons coated with a diamond-like carbon coating (DLC)applied 

by plasma-assisted chemical vapour deposition. The coupons are distributed in a reusable plastic box containing 

desiccant. 

Fracture Toughness of Ceramics 

NIST-2100 is intended for verification of fracture toughness testing procedures and consists of a set of five hotpressed 

silicon nitride flexure specimens cut from a single billet (plate) of material. This SRM may be used with 

any fracture toughness test method, but is optimized for beam bending testing configurations. 

The SRM may be used in conjunction with American Society of Testing and Materials (ASTM) fracture toughness 

standard C1421-99 (or the Provisional Standard PS070-97 which preceded it) [1]. This SRM may also be used 

with two International Organization for Standardization (ISO) standard tests under development by ISO Technical 

Committee TC 206, Fine Ceramics. 

rod 

coupons 

5 bars 

Physico-chemical properties 

Magnetic moment 

NIST-762 

NIST-764A 

NIST-2853 

NIST-772A 

Miscellaneous 

NIST-953 

NIST-963A 

NIST-1002D 

Magnetic moment standard - Nickel disk 

This Standard Reference Material (SRM ) is intended for use in the calibration of magnetometers (such as 

vibrating sample magnetometers) used in the measurement of the magnetic properties of materials. NIST-762 

® ® 

consists of a nickel disk nominally 6 mm in diameter with a thickness of 0.127 mm and a mass of 32 mg ± 1 mg. 

The NIST-762 lot was produced from rolled nickel sheet with a purity of 99.999 %. Disks were punched from the 

sheet. Before measurement, the disks were ultrasonically cleaned in acetone, then methyl alcohol. 

The certified value for σ specific magnetization, at 298 K and in an applied magnetic field of 398 kA/m (5000 

oersted, Oe) with the magnetic field aligned parallel to the plane of the disk is: 

σ= 54.78 A m 2 /kg ± 0.15 A m 2 /kg (54.78 emu/g ± 0.15 emu/g) 

Magnetic susceptibility standard - Platinum cylinder 

This Standard Reference Material (SRM ® ) is intended for use in the calibration of magnetometers (such as 

vibrating sample magnetometers) used in the measurement of the magnetic properties of materials. NIST-764a 

consists of 

a platinum (Pt) cylinder with a nominal diameter of 3 mm, a nominal length of 3.42 mm, and a nominal mass of 

620 mg. NIST-764a lot was produced by slicing a pure (99.99 %) platinum rod into 3.42 mm long pieces. 

Magnetic moment standard yttrium iron garnet sphere 

This Standard Reference Material (SRM ® ) is intended for use in calibrating of magnetometers (such as vibrating 

sample magnetometers) used in the measurement of the magnetic propterties of materials. NIST-2883 consists 

of a yttrium iron garnet (YIG) sphere with a nominal diameter of 1 mm and a nominal mass of 2.8 mg. 

Nickel sphere for magnetic moment 

This Standard Reference Material (SRM) is intended for use in the calibration of magnetometers (such as 

vibrating sample magnetometers) used in the measurement of the magnetic properties of materials. SRM 772a 

consists of a nickel sphere 2.383 mm in diameter with a mass of 63.16 mg. The SRM 772a lot was produced from 

annealed nickel wire with a purity of 99.999 %. The wire was ground into spheres. The spheres were then 

ultrasonically cleaned in acetone and methyl alcohol and annealed at 1220 K in a dry hydrogen atmosphere for 2 

h. The microstructure is equiaxed with an average grain size of about 100 µm. 

The certified value for magnetic moment, m, at 298 K and in an applied field of 398 kA/m (5000 Oe) is 

m = 3.47 mA•m 2 ± 0.01 mA•m 2 (3.47 emu ± 0.01 emu) 

Cobalt in aluminium - Neutron density monitor wire 

The standard is provided as a reference source of cobalt in aluminium alloy to serve as a neutron density monitor 

wire standard. 

Fission track glass 

This Standard Reference Material (SRM ® ) was produced and certified for use in uranium fission track analysis 

and monitoring neutron fluences. The SRM is made up of: four unirradiated glass wafers, two irradiated glass 

wafers, a muscovite mica and polycarbonate detectors. 

Hard Board - Surface flammability 

This Standard Reference Material (SRM ® ) is intended for use in checking the operation of radiant-panel 

equipment in accordance with the calibration and standardisation technique describes in ASTM Standard E162-78 

Test for Surface Flammibility using a Radiant Heat Source. 

6 mm dia. 

3 mm dia. 

each 

each 

1 m 

set (6) 

set (4) 


Miscellaneous 


NIST-1082 

NIST-1006D 

NIST-1810A 

Cigarette ignition strength standard 

This Standard Reference Material (SRM ® ) is intended for use by test laboratories to assess and control their 

testing of cigarette ignition strength in accordance with ASTM Standard Methods E 2187-04 (or ASTM E2187- 

02b). The SRM unit consists of one carton of cigarettes containing 10 packs of 20 cigarettes each. 


Measurand ASTM Method Certified Value and Expanded Uncertainty 

Ignition Strength............................ E 2187-04(a).......................... 12.6 % ± 3.3 % 

(on 10 layers of filter paper) 

Smoke density chamber standard for non-flaming exposure condition 

This Standard Reference Material consists of paper sheets, principally -cellulose, derived from wood chips. The 

SRM is intended primarily for checking the operation of smoke density chambers under non-flaming exposure 

conditions in accordance with the prescribed calibration and standardization techniques outlined in the American 

Society for Testing and Materials (ASTM) Standard Test Method E 662-95 “Standard Test Method for Specific 

Optical Density of Smoke Generated by Solid Materials”, and in National Fire Protection Association (NFPA) 258- 

1998, “Standard Research Test Method for Determining Smoke Generation of Solid Materials”. A unit consists of 

nine single layer sheets, each 172 mm x 254 mm x 1.65 mm thick. 

The certified value and expanded uncertainty [3] for maximum specific optical density of a single layer thickness 

is: 

Dm = 210 ± 18 (without correction for window deposit) 

Dm corr. = 193 ± 20 

Linerboard - Tape adhesion testing (sheet form) 

This Standard Reference Material (SRM ® ) is intended to provide a uniform source of linerboard for use with ASTM 

D 2860 Standard Test Method for Adhesion of pressure-sensitive tape to fiberboard at 90 degree angle and 

constant stress. Each unit consists fo fifty 21.6 cm x 28 cm (8.5 in x 11 in) linerboard sheets of Mosinee 696-C 

paper, sealed in a moisture resistent foil-lined package. 

10 packs 

9 sheets 

50 each 

NIST-2490 Non-Newtonian Polymer Solution for Rheology - Polyisobutylene Dissolved in 2,6,10,14- 

Tetramethylpentadecane 

Please ask for details 

100 mL 

NIST-2810 

NIST-2811 

NIST-2812 

NIST-RM 8130 

NIST-RM 8458 

Rockwell C Scale Hardness (High Range) 

This Standard Reference Material (SRM ® ) is a transfer standard intended primarily for use in calibration and 

verification of the performance of Rockwell hardness equipment using the Rockwell C Hardness Scale (HRC). 







Coplanar waveguide calibration set 

This Reference Material (RM) is intended for use by industrial laboratories that wish to implement the procedure 

described in Part 1 of the NIST/Industrial MMIC Consortium´s "Proposed Procedures for Verifying Probe Station 

Integrity and On-wafer Measurement Accuracy" for the measurement of microwave probe station stability and for 

verifying the ability to repeat on-wafer microwave measurements performed at NIST. 

Artificial flaw for eddy current nondestructive evaluation 

This Research Material (RM), the Capobianco, Dube, Fizer (CDF) notch, provides a reproducibility flaw of a 

known size and geometry that closely resembles an actual fatigue crack. It is intended to produce a response 

suitable for calibrating an eddy current nondestructive evaluation (NDE) system. 

each 

each 

each 

each 

each 


Miscellaneous 








High Purity 

Solvents 



Reference materials for 

physical properties 

LGC Standards, Europe’s most comprehensive single 

source of reference materials, offers over 750 reference 

materials for physical properties. For manufacturers, the 

determination of the physical properties of their product 

can be one of the most important steps in quality 

assurance. 

Our range covers many physical properties including 

thermal, surface properties, particle shape and size, ion 

activity, viscosity, electrical, and polymeric properties. 

Of particular interest are the products for determination 

of optical properties such as molecular absorption, 

luminescence, colour measurement and refractive index. 

• Materials and standards from commercial sources 

and international bodies 

• Fast delivery of high quality materials 




Surface properties 

Particle shape and size 

Ion activity 

Viscosity 




Introduction 

Picograde ® solvents for residue analysis 

Introduction 

Picograde ® solvents form the heart of the LGC Standards solvent range. Each batch undergoes rigorous 

testing in order to meet the demanding requirements of organic trace analysis every time. 

Environmental analysts are now expected to detect trace levels of an increasingly wide range of organic 

environmental contaminants including pesticides. PAHs, PCBs, PCDDs/PCDFs and so on. with the highest 

possible accuracy. Consequently even the lowest levels of impurity in the solvent can affect the precision of 

analytical results. Picograde ® solvents are specifically tailored to this application. 

Carefully selected raw materials are chemically pre-treated and then fractionated in glass in the absence of 

air. Distillation and filling are similarly carried out in air free conditions. The glass bottles are sterile and dust 

free and are rinsed with the appropriate solvent prior to filling. Caps used to seal the bottles are subjected to 

the same stringent cleaning processes. The specification of the solvent includes the determination of water 

content, residue on evaporation and a comprehensive gas chromatographic analysis. 

To confirm the absence of contaminants samples of the solvent are concentrated to varying degrees and 

then analysed by gas chromatography. Flame ionisation and electron capture detectors (ECD) are used for 

the quantification of the contaminants. The specification of the Picograde ® solvent guarantees that no signal 

due to contamination will be larger than the internal standard peak (10 pg/mL heptachlor-epoxide) in the 

retention time window from 1,4-dichlorobenzene to decachlorobiphenyl. The very high specification of the 

Picograde ® solvents allows them to be used for residue analysis of trace quantities of organic contaminants 

right down to ppb and ppt levels. 

Optigrade ® - High purity solvents for HPLC 

High performance liquid chromatography is now an essential analytical tool especially in the areas of 

research and development, pharmaceutical quality control and analysis in the food and environmental 

sectors. This technique demands the highest quality solvents to allow reproducible separations. The basic 

requirements include a high UV-transmission factor, low particle levels, slight acidity and alkalinity coupled 

with low levels of water and other non-volatile components. In addition there must be consistency between 

batches. 

Solvents for isocratic analytical HPLC together with gradient grade quality solvents are included in the HPLC 

range. Gradient grade has the highest purity and is specially designed for use with gradient elution HPLC 

using reversed phase materials and UV or fluorescence detection. Quality assurance procedures allow 

LGC Standards to offer a consistently premium quality product. Each batch is checked to make sure that 

the solvent has the required high level of UV-transmission in the wavelength range 190-350 nm. 

Solvents for LC/MS 

The presence of alkali and alkaline earth metals in the mobile phase when using LC/MS can make the 

interpretation of the mass spectrum very difficult. LGC Standards offers solvents designed for this technique 

with extremely low levels of these metals, at 0.1 ppm and less. 

Solvents for ULC/MS 

ULTRA Liquid Chromatography (ULC) requires solvents of superior quality. A new range of ULC/MSsolvents 

from LGC Standards has been designed to allow high resolution and sensitivity. Such ULC/MS 

solvents combine the highest specification for: UV, low gradient shift, minimal peak impurities and lowest 

ionic background for MS detection. All ULC/MS solvents are micro filtered at 0.1 µm, have a residue 

following evaporation of max 1 ppm and are packed under inert gas for improved shelf life. For mobile phase 

preparation selected buffers are also available. In addition several ULC/MS blends of water and acetonitrile 

with formic acid, acetic acid and trifluoroacetic acid are offered. 


Introduction 

Specialist solvents 

Solvents for VOCs and aromatic hydrocarbons 

It has become increasingly necessary to be able to determine a range of organic compounds in 

environmental samples including volatile organic compounds (VOCs) and BTEX-aromatics. Various 

extraction techniques are used for the separation and concentration of organic trace constituents from the 

sample matrix and it is essential to use solvents with very low levels of contamination. LGC Standards can 

provide the solvents to meet these exacting requirements. 

Solvents for GC headspace techniques 

Analysis of volatile organic impurities using the GC headspace technique, has become an important quality 

control tool in pharmaceutical and food related industries. The International Conference on Harmonization of 

technical requirements for registration of pharmaceuticals for Human use (ICH) has issued 

recommendations concerning the safe levels of residual solvents in pharmaceutical compounds. 

These solvents are divided into 3 classes according to their toxicity. Limit values of residual solvents in 

pharmaceutical products are specified by the United States and European Pharmacopeia. The quality of the 

solvent used to dissolve the sample is of prime importance. It must be of the highest purity and show virtually 

no background signal with both polar and non polar GC capillary columns. The new headspace solvents are 

high boiling point solvents, specifically developed, analysed and packed for the headspace analysis of 

volatile solvent impurities. 

Solvents for the analysis of nitrosamines 

When extracting trace levels of nitrosamines in samples it is important to use a solvent that is free of 

nitrosamine contamination. For this application LGC Standards has solvents with a maximum level of 

0.1ppb of specific nitrosamines. 

Solvents for the tobacco-industry 

High purity acids 

LGC Standards offers the most frequently used mineral acids for trace analysis: hydrochloric acid, nitric acid, 

hydrofluoric acid, sulfuric acid, perchloric acid and acetic acid. These are produced by subboiling distillation 

of very pure starting materials. This purification results in most metallic impurities reduced to (or bellow) ppb 

ranges. The acids are delivered in special bottles (long - term leached borosilicate glass or modified HDPE) 

which ensure minimum contamination of the acid from the material of the bottle. 

Important note: Element concentrations are at the point of bottling. Concentrations of some elements may 

increase due to the storage container. 

Cyclotainer ® 

The Cyclotainer ® is a stainless steel re-usable container that is available to customers on a loan basis. 

Cyclotainer ® are not available in all countries. Please contact your local office for more details. 

Trademarks 

Cyclotainer ® , Picograde ® and Optigrade ® are registered trademarks of the LGC Standards company. 

FLORISIL ® is a registered trademark of U.S.SILICA COMPANY. 


Reagents / Sorbents 

Reagents / Sorbents 


SC-4592-A005 

SC-4568-A005 

SC-4569-A005 

SC-4181-B005 

SC-4181-S010 

SC-4182-B005 

SC-4182-S010 

SC-4182-S020 

SC-9700-B005 

ICN-Aluminia A - Super I (acid) 

(50 - 200 µm) 

ICN-Alumina B - Super I (basic) 

(50 - 200 µm) 

ICN-Alumina B - Super I (50 - 200 µm) 

for dioxin analysis 

FLORISIL ® (Standard), 60 - 100 mesh 

(150 - 250 µm) 


(150 - 250 µm) 

FLORISIL ® PR for residue analysis, 

60 - 100 mesh (150 - 250 µm) 

FLORISIL ® PR for residue analysis, 

60 - 100 mesh (150 - 250 µm) 

FLORISIL ® PR for residue analysis 

60 - 100 mesh (150 - 250 µm) 


(suitable for ISO 9377-2/H53) 

SC-9982-B010 Silica gel 60 (63 - 200 µm) 1 kg 

500 g 

500 g 

500 g 

500 g 

10 kg 

500 g 

10 kg 

20 kg 

500 g 

SC-9950-B005 

SC-9950-B025 

SC-8024-B005 

SC-8024-B025 

SC-8024-S025 

SC-1024-B005 

SC-1024-B005 

Sodium sulfate anhydrous, 

for analysis (ACS), powder 


for analysis (ACS), powder 


in granular form 


for analysis (ACS), in granular form 


for analysis (ACS), in granular form 

Sodium sulfate Picograde ® anhydrous, 

for residue analysis (ACS), in granular form 

Sodium sulfate Picograde ® anhydrous, 

for residue analysis (ACS), in granular form 

500 g 

2.5 kg 

500 g 

2.5 kg 

25 kg 

500 g 

2.5 kg 


LC-MS additives 

LC-MS additives 


SO-9685-B001 Ammonium acetate ULC-MS Optigrade ® 

100 g 

CAS number 631-61-8 

Assay (GC, on anhydrous basis) ................... 99-100 % 

Water (KF) ........................................................ 0-0.1 % 

Filter test (1M in water) ...............................Passes test 

pH (1M in water)................................................. 6.0-7.5 

Transmission 

at 260 nm (1M in water) ................................. 96-100 % 

at 280 nm (1M in water) ................................. 98-100 % 

Chloride (Cl)................................................. 0-0.0005% 

Sulfate (SO 4)..................................................... 0-001% 

Al ..................................................................... 0-1 ppm 

Ca .................................................................... 0-5 ppm 

Fe..................................................................... 0-1 ppm 

K....................................................................... 0-5 ppm 

Mg .................................................................... 0-1 ppm 

Na .................................................................... 0-5 ppm 

SO-9679-B001 Formic acid ULC-MS Optigrade ® 

100 mL 

UN 1779 


Assay (T, on anhydrous basis)...............................99-100 % 

Water (KF) ...................................................................0-1 % 

Residue after evaporation.............................. 0-0.001 %w/w 

Color (APHA) .................................................................0-10 

Gradient specification 

HPLC gradient at 254 nm - H. Peak ...................0-0.005 AU 

HPLC gradient at 254 nm - Drift ...........................0-0.02 AU 

Transmission 

at 260 nm ...............................................................15-100 % 

at 270 nm ...............................................................83-100 % 

at 280 nm ...............................................................90-100 % 

at 300 nm ...............................................................97-100 % 

at 320 nm ...............................................................98-100 % 

SO-9668-B001 Trifluoroacetic acid ULC- MS Optigrade ® 

100 mL 

UN 2699 


Assay (T)...........................................................99.95-100 % 

Water (KF) ..............................................................0-0.02 % 

Residue after evaporation.............................. 0-0.001 %w/w 

Color (APHA) .................................................................0-10 


HPLC gradient at 254 nm - H. Peak ...................0-0.002 AU 

HPLC gradient at 254 nm - Drift .........................0-0.010 AU 

Fluorescence at 254 nm (25%, as quinine) ..............0-1 ppb 

Fluorescence at 365 nm (25%, as quinine) ..............0-1 ppb 

Transmission 

at 260 nm ...............................................................10-100 % 

at 270 nm ...............................................................79-100 % 

at 280 nm ...............................................................93-100 % 

at 300 nm ...............................................................95-100 % 

at 320 nm ...............................................................96-100 % 


High purity solvents and acids 



Acetic acid 

HPA-0050-B010 Acetic acid for trace analysis min 99.5 % (glass bottle) 

1 L 

Acetone 

UN 2789 

Assay ..........................................................> 99.5 % Chloride.....................................................< 0.4 ppm 

Colour (APHA) ................................................... < 10 Phosphate .................................................< 0.5 ppm 

Residue........................................................ < 2 ppm Sulfate .......................................................< 0.4 ppm 

Ag................................< 0.1 ppb Cr................................ < 0.1 ppb Ni.................................< 0.1 ppb 

Al.................................< 0.1 ppb Cu ............................... < 0.1 ppb Pb................................< 0.1 ppb 

As................................< 0.1 ppb Fe ............................... < 0.5 ppb Se................................< 0.5 ppb 

Ba................................< 0.1 ppb K ................................. < 0.1 ppb Sn................................< 0.1 ppb 

Be................................< 0.1 ppb Li................................. < 0.1 ppb Sr.................................< 0.1 ppb 

Bi.................................< 0.1 ppb Mg............................... < 0.1 ppb Th................................< 0.1 ppb 

Ca................................< 0.5 ppb Mn............................... < 0.1 ppb Ti .................................< 0.1 ppb 

Cd................................< 0.1 ppb Mo............................... < 0.1 ppb V..................................< 0.1 ppb 

Co................................< 0.1 ppb Na ............................... < 0.5 ppb Zn................................< 0.5 ppb 

Hydrochloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si. 

SO-2435-B010 Acetone HPLC Optigrade ® 1 L 

SO-2435-B025 Acetone HPLC Optigrade ® 2.5 L 

SO-2435-B040 Acetone HPLC Optigrade ® 

4 L 

UN 1090 


C 3H 6O 

Assay ...................................................... 99.5% min. 

Water ....................................................... 0.5% max. 

Non-volatile matter............................. 0.0005% max. 

Filtered through 0.2 µm 

1 L = 0.792 kg (at 20°C) 

Optical absorbance 

wavelength 

1.0 max. ........................................................ 330 nm 

0.1................................................................. 340 nm 

0.05............................................................... 350 nm 

0.01............................................................... 370 nm 

SO-1142-B010 Acetone Picograde ® for residue analysis 1 L 

SO-1142-B025 Acetone Picograde ® for residue analysis 2.5 L 

SO-1142-B040 Acetone Picograde ® for residue analysis 4 L 

SO-1142-C011 Acetone Picograde ® for residue analysis ( Cyclotainer ® ) 10 L 

SO-1142-C032 Acetone Picograde ® for residue analysis ( Cyclotainer ® ) 

30 L 

UN 1090 


C 3H 6O 

Assay 

99.0% min. 

Water ....................................................... 0.5% max. 


1 L = 0.792 kg (at 20°C) 

Specification 

GC/ECD 

In the GC-ECD chromatogram there are no interfering single signals in the retention time interval between 1,4- 

dichlorobenzene and decachlorobiphenyl, by a 500-fold concentration greater than that, given by 10 pg/mL 

heptachlor-epoxide. 

GC/FID 

In the GC-FID chromatogram there are no interfering single signals in the retention time interval between n-octane 

(C 8) and n-tetracontane (C 40), by a 500-fold concentration greater than that, given by 50 ng/mL n-undecane (C 11). 




Acetonitrile 

SO-9128-B010 Acetonitrile HPLC Optigrade ® Gradient Grade 1 L 

SO-9128-B025 Acetonitrile HPLC Optigrade ® Gradient Grade 2.5 L 

SO-9128-B040 Acetonitrile HPLC Optigrade ® Gradient Grade 4 L 

SO-9128-C012 Acetonitrile HPLC Optigrade ® Gradient Grade (Cyclotainer ® ) 10 L 

SO-9128-C032 Acetonitrile HPLC Optigrade ® Gradient Grade (Cyclotainer ® ) 30 L 

SO-9128-C200 Acetonitrile HPLC Optigrade ® Gradient Grade 

200 L 

UN 1648 


C 2H 3N 

Assay ..................................................... 99.8% min. 

Water ..................................................... 0.02% max. 


Gradient specification (210 nm)......... 3.0 mAU max. 

Fluorescence (as quinine at 254 nm).......1 ppb max. 


1 L = 0.783 kg (at 20°C) 


Wavelength 

0.7 max ......................................................... 190 nm 

0.21 ............................................................... 193 nm 

0.12 ............................................................... 195 nm 

0.05 .............................................................. 210 nm 

0.02 .............................................................. 220 nm 

0.009 ............................................................. 230 nm 

0.005 ............................................................. 235 nm 

This solvent in glass bottles fulfills the specifications according to chapter 4 of the European Pharmacopoeia. 

SO-9154-B010 Acetonitrile HPLC Optigrade ® Super Gradient Grade 1 L 

SO-9154-B025 Acetonitrile HPLC Optigrade ® Super Gradient Grade 2.5 L 

SO-9154-C012 Acetonitrile HPLC Optigrade ® Super Gradient Grade (Cyclotainer ® ) 

10 L 

UN 1648 


C 2H 3N 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.02% max. 


Gradient specification (210 nm)..........3.0 mAE max. 

Fluorescence (as quinine at 254 nm).......1 ppb max. 


1 L = 0.783 kg (at 20°C) 


Wavelength 

0.4 max ......................................................... 190 nm 

0.3 ................................................................. 191 nm 

0.18 ............................................................... 193 nm 

0.08 ............................................................... 195 nm 

0.02 ............................................................... 200 nm 

0.009 ............................................................. 215 nm 

0.005 ............................................................. 230 nm 





SO-2856-B010 Acetonitrile HPLC Optigrade ® 1 L 

SO-2856-B025 Acetonitrile HPLC Optigrade ® 2.5 L 

SO-2856-B040 Acetonitrile HPLC Optigrade ® 4 L 

SO-2856-C012 Acetonitrile HPLC Optigrade ® (Cyclotainer ® ) 10 L 

SO-2856-C032 Acetonitrile HPLC Optigrade ® (Cyclotainer ® ) 

30 L 

UN 1648 


C 2H 3N 

Assay ..................................................... 99.8% min. 

Water ..................................................... 0.02% max. 



1 L = 0.783 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 190 nm 

0.1................................................................. 200 nm 

0.05............................................................... 210 nm 

0.02............................................................... 220 nm 

0.01............................................................... 230 nm 

0.005............................................................. 235 nm 

SO-9184-B010 Acetonitrile HPLC Optigrade ® 

(for analysis of PAHs and pesticides) 

SO-9184-B025 Acetonitrile HPLC Optigrade ® 

(for analysis of PAHs and pesticides) 

1 L 

2.5 L 

UN 1648 


C 2H 3N 

Assay ....................................................... 99.8% min 

Water ..................................................... 0.02% max. 



1 L = 0.783 kg (at 20°C) 


Wavelength 

0.097 max ..................................................... 195 nm 

0.018............................................................. 200 nm 

0.009............................................................. 215 nm 

0.004............................................................. 230 nm 

SO-9340-B010 Acetonitrile for LC-MS Optigrade ® 1 L 

SO-9340-B025 Acetonitrile for LC-MS Optigrade ® 

2.5 L 

UN 1648 


C 2H 3N 

Assay ....................................................... 99.8% min 

Water ..................................................... 0.02% max. 



1 L = 0.783 kg (at 20°C) 

Ca ........................................................0.1 ppm max. 

K ..........................................................0.1 ppm max. 

Mg........................................................0.1 ppm max. 

Na ........................................................0.1 ppm max. 

Transmission 

at 195 nm.................................................. 78 % min. 

at 200 nm.................................................. 95 % min. 

at 220 nm.................................................. 98 % min. 

at 240 nm.................................................. 99 % min. 




SO-9640-B010 Acetonitrile ULC-MS Optigrade ® 

1 L 

UN 1648 


C 2H 3N 

Assay (GC, on anhydrous basis) .............................99.97-100 % 

Water (KF) .....................................................................0-0.01 % 

Residue after evaporation....................................0-0.0001 %w/w 

Acidity (as acetic acid ) ................................................0-0.001 % 

Alkalinity (as ammonia)..............................................0-0.0001 % 

Color (APHA) .......................................................................... 0-5 


HPLC gradient at 210 nm - Drift ................................ 0-0.006 AU 

HPLC gradient at 254 nm - Drift ................................ 0-0.002 AU 

HPLC gradient at 210 nm - H. Peak .......................... 0-0.001 AU 

HPLC gradient at 254 nm - H. Peak ........................ 0-0.0003 AU 

Fluorescence at 254 nm (as quinine)............................ 0-0.3 ppb 

Fluorescence at 365 nm (as quinine)............................ 0-0.3 ppb 

1 L = 0.792 kg (at 20°C) 

Transmission 

at 191 nm ......................................................................30-100 % 

at 195 nm ......................................................................85-100 % 

at 200 nm ......................................................................97-100 % 

at 215 nm ......................................................................98-100 % 

at >230 nm....................................................................99-100 % 

Al ................................................................................... 0-20 ppb 

Ca .................................................................................. 0-50 ppb 

Fe................................................................................... 0-20 ppb 

K..................................................................................... 0-50 ppb 

Mg .................................................................................. 0-20 ppb 

Na ................................................................................ 0-100 ppb 

Microfiltered through 0.1 µm/bottled under inert gas 

SO-4680-B025 Acetonitrile 0.1 % formic acid ULC-MS Optigrade ® 

1 L 

UN 1648 


C 2H 3N 

Assay .....................................................................0.095-0.105 % 

Water (KF) ......................................................................0-0.02 % 

Purity of ACN (GC) ...................................................99.97-100 % 

Purity of formic acid ....................................................99.0-100 % 


HPLC gradient at 254 nm - H. Peak ........................... 0-0.002 AU 

Fluorescence at 254 nm (as quinine)............................. 0-0.5 ppb 


Transmission 

at 210 nm .........................................................................5-100 % 

at 230 nm .......................................................................15-100 % 

at 254 nm .......................................................................90-100 % 

Al .................................................................................... 0-30 ppb 

Ca ................................................................................. 0-100 ppb 

Fe.................................................................................... 0-50 ppb 

K.................................................................................... 0-100 ppb 

Mg ................................................................................... 0-30 ppb 

Na ................................................................................. 0-100 ppb 





SO-4686-B025 Acetonitrile 0.1 % acetic acid ULC-MS Optigrade ® 

1 L 

UN 1648 


C 2H 3N 

Assay ..................................................................... 0.095-0.105 % 

Purity of ACN (GC) ................................................... 99.97-100 % 

Purity of acetic acid (GC)............................................ 99.9-100 % 



HPLC gradient at 254 nm - Drift ................................. 0-0.010 AU 

Fluorescence at 254 nm (as quinine) ............................ 0-0.5 ppb 


Transmission 

at 210 nm....................................................................... 20-100 % 

at 230 nm....................................................................... 50-100 % 

at 254 nm....................................................................... 98-100 % 

Al .................................................................................... 0-30 ppb 

Ca ................................................................................. 0-100 ppb 

Fe.................................................................................... 0-50 ppb 

K ................................................................................... 0-100 ppb 

Mg................................................................................... 0-30 ppb 

Na ................................................................................. 0-100 ppb 


SO-4692-B025 Acetonitrile 0.1 % trifluoroacetic acid ULC-MS Optigrade ® 

1 L 

SO-9186-B025 

UN 1648 


C 2H 3N 

Assay ..................................................................... 0.095-0.105 % 

Water (KF) ...................................................................... 0-0.02 % 

Purity of ACN (GC) ................................................... 99.97-100 % 

Purity of trifluoroacetic acid....................................... 99.95-100 % 


HPLC gradient at 254 nm - H. Peak ......................... 0-0.0002 AU 



Transmission 

at 210 nm....................................................................... 20-100 % 

at 230 nm....................................................................... 50-100 % 

at 254 nm....................................................................... 90-100 % 

Al .................................................................................... 0-30 ppb 

Ca ................................................................................. 0-100 ppb 

Fe.................................................................................... 0-50 ppb 

K ................................................................................... 0-100 ppb 

Mg................................................................................... 0-30 ppb 

Na ................................................................................. 0-100 ppb 


Acetonitrile DNA. max. 0.001% water 

2.5 L 

UN 1648 


C 2H 3N 

Assay ...................................................... 99.9% min. 

Water by Karl Fischer titration ............. 0.001% max. 


1 L = 0.783 kg (at 20°C) 




SO-9180-B025 Acetonitrile DNA. max. 0.003% water 

2.5 L 

UN 1648 


C 2H 3N 

Assay ...................................................... 99.9% min. 

Water by Karl Fischer titration ............. 0.003% max. 


1 L = 0.783 kg (at 20°C) 

SO-1151-B010 Acetonitrile Picograde ® for residue analysis 1 L 

SO-1151-B025 Acetonitrile Picograde ® for residue analysis 2.5 L 

SO-1151-B040 Acetonitrile Picograde ® for residue analysis 

4 L 

UN 1648 


C 2H 3N 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.02% max. 

Non-volatile matter............................... 0.001% max. 

1 L = 0.783 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



Ammonia solution 

HPA-0070-B010 

Ammonia solution for trace analysis (glass bottle) 

1 L 

Benzene 

UN 2672 

Assay..............................................................> 21 % Chloride .....................................................< 500 ppb 

Colour (Hazen)...................................................< 10 Phosphate ...................................................< 50 ppb 

Carbonate .................................................< 10 ppm Sulfat/Sulfate .............................................< 500 ppb 

Al .................................< 0.5 ppb Cu ............................... < 0.5 ppb Se................................< 0.1 ppb 

As ................................< 0.1 ppb Fe................................ < 0.5 ppb Ag................................< 0.1 ppb 

Ba................................< 0.1 ppb Pb ............................... < 0.1 ppb Na................................< 0.5 ppb 


Bi .................................< 0.1 ppb Mg............................... < 0.2 ppb Th ................................< 0.1 ppb 

Cd................................< 0.1 ppb Mn............................... < 0.1 ppb Sn................................< 0.1 ppb 

Ca................................< 0.5 ppb Mo............................... < 0.1 ppb Ti .................................< 0.1 ppb 

Cr ................................< 0.1 ppb Ni ................................ < 0.1 ppb V..................................< 0.1 ppb 

Co................................< 0.1 ppb K ................................. < 0.2 ppb Zn ................................< 0.2 ppb 

SO-1163-B010 Benzene Picograde ® for residue analysis 1 L 

SO-1163-B025 

Benzene Picograde ® for residue analysis 

2.5 L 

UN 1114 


C 6H 6 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.05% max. 


1 L = 0.871 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






Benzyl alcohol 

SO-9505-B005 

Benzyl alcohol for the analysis of highly volatile halogenated compounds and EOX 

500 mL 


C 7H 8O 

Assay ...................................................... 99.0% min. 

Water ....................................................... 0.1% max. 

Non-volatile matter................................. 0.05% max. 

1 L = 1.05 kg (at 20°C) 

Specification 

Highly volatile halogenated hydrocarbons 

In the GC/ECD chromatorgram there are no interfering single signals in the retention time interval between 1,1- 

dichloroethene and tribromomethane greater than that, given by 5 µg/L parathion-methyl. 

BTEX for FID 

In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, 

given by 10 µg/L n-Decane. 

Coulometric determination of EOX gives a halogen content as chloride of less than 0.3 mg/L. 

Carbon disulfide 

SO-9056-B005 

Carbon disulfide free from aromatic hydrocarbons (max. 0.5 ppm) 

500 mL 

UN 1131 


CS 2 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.03% max. 


1 L = 1.261 kg (at 20°C) 

Specification 

BTEX for FID 

In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, 

given by 10 µg/L n-Decane. 

Chloroform 

SO-4443-B010 Chloroform HPLC Optigrade ® (alcohol-free. stab. with amylene) 1 L 

SO-4443-B025 Chloroform HPLC Optigrade ® (alcohol-free. stab. with amylene ) 2.5 L 

SO-4443-B040 Chloroform HPLC Optigrade ® (alcohol-free. stab. with amylene) 

4 L 

UN 1888 


CHCl 3 

Assay ...................................................... 99.9% min. 

Water ..................................................... 0.03% max. 



1 L = 1.475 kg (at 20°C) 

stabilised with 60 - 100 ppm amylene 


Wavelength 

1.0 max ......................................................... 245 nm 

0.15............................................................... 255 nm 

0.05............................................................... 260 nm 

0.02............................................................... 270 nm 

0.01............................................................... 290 nm 

SO-1174-B010 

SO-1174-B025 

Chloroform Picograde ® for residue analysis 

(stab.with 0.2 - 1.8 % ethanol) 


(stab. with 0.2 - 1.8 % ethanol) 

1 L 

2.5 L 




SO-1174-B040 



4 L 

UN 1888 


CHCl 3 

Assay ...................................................... 99.8% min. 

Acid and phosgene (as HCI).............. 0.0005% max. 


1 L = 1.475 kg (at 20°C) 

stabilised with 0.2 - 1.8% Ethanol 

Specification 

GC/ECD 




GC/FID 



Cyclohexane 

SO-9052-B010 Cyclohexane HPLC Optigrade ® 1 L 

SO-9052-B025 Cyclohexane HPLC Optigrade ® 

2.5 L 

UN 1145 


C 6H 12 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.02% max. 



1 L = 0.779 kg (at 20°C) 

Optical absorbance................................ Wavelength 

0.700 max ..................................................... 210 nm 

0.320 ............................................................. 220 nm 

0.125 ............................................................. 230 nm 

0.025 ............................................................. 245 nm 

0.005 ............................................................. 260 nm 

SO-1179-B010 Cyclohexane Picograde ® for residue analysis 1 L 

SO-1179-B025 Cyclohexane Picograde ® for residue analysis 2.5 L 

SO-1179-B040 Cyclohexane Picograde ® for residue analysis 4 L 

SO-1179-C011 Cyclohexane Picograde ® for residue analysis (Cyclotainer ® ) 10 L 

SO-1179-C032 Cyclohexane Picograde ® for residue analysis (Cyclotainer ® ) 

30 L 

UN 1145 


C 6H 12 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.779 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






Cyclopentane 

SO-6157-B010 Cyclopentane HPLC Optigrade ® 

1 L 

UN 1146 


C 5H 10 

Assay ......................................................... 75% min. 

Water ................................................... 0.005% max. 



1 L = 0.751 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 200 nm 

0.3................................................................. 215 nm 

0.02............................................................... 225 nm 

0.005............................................................. 300 nm 

n-Decane 

SO-1182-B010 

n-Decane Picograde ® for residue analysis 

1 L 

UN 2247 


CH 3(CH 2) 8CH 3 

Assay ...................................................... 97.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.731 kg (at 20°C) 

Specification 




GC/FID 



Dichloromethane 

SO-4879-B010 Dichloromethane HPLC Optigrade ® (stab. with amylene) 1 L 

SO-4879-B025 Dichloromethane HPLC Optigrade ® (stab. with amylene) 2.5 L 

SO-4879-B040 Dichloromethane HPLC Optigrade ® (stab. with amylene) 

4 L 

UN 1593 


CH 2Cl 2 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.02% max. 



1 L = 1.335 kg (at 20°C) 



Wavelength 

1.0 max ......................................................... 233 nm 

0.15............................................................... 240 nm 

0.01............................................................... 254 nm 

0.005............................................................. 280 nm 




SO-1185-B010 

SO-1185-B025 

SO-1185-B040 

Dichloromethane Picograde ® for residue analysis 

(stab. with amylene) 





SO-1185-C011 Dichloromethane Picograde ® for residue analysis (Cyclotainer ® ) 


SO-1185-C032 Dichloromethane Picograde ® for residue analysis (Cyclotainer ® ) 


1 L 

2.5 L 

4 L 

10 L 

30 L 

UN 1593 


CH 2Cl 2 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.02% max. 


1 L = 1.335 kg (at 20°C) 


Specification 

GC/ECD 




GC/FID 



SO-9800-B025 Dichloromethane nitrosamine-free 2.5 L 

SO-9800-B040 Dichloromethane nitrosamine-free 

4 L 

Specification 

N-Nitrosodimethylamine........................0.1 ppb max. 

N-Nitrosodiethylamine...........................0.1 ppb max. 

N-Nitrosodi-n-propylamine ....................0.1 ppb max. 

N-Nitrosodi-i-propylamine .....................0.1 ppb max. 

N-Nitrosodi-n-butylamine ......................0.1 ppb max. 

N-Nitrosopiperidine ...............................0.1 ppb max. 

N-Nitrosopyrrolidine ..............................0.1 ppb max. 

N-Nitrosomorpholine.............................0.1 ppb max. 

Diethyl ether 

SO-9012-B010 Diethyl ether HPLC Optigrade ® (stab. with ethanol) 1 L 

SO-9012-B025 Diethyl ether HPLC Optigrade ® (stab. with ethanol) 

2.5 L 

UN 1155 


C 4H 10O 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.01% max. 


Peroxide................................................ 5 ppm max. 


1 L = 0.713 kg (at 20°C) 

stabilised with 2% ethanol 


Wavelength 

1.0 max ......................................................... 215 nm 

0.3 ................................................................. 230 nm 

0.08 ............................................................... 254 nm 

0.04 ............................................................... 270 nm 

0.02 ............................................................... 280 nm 

0.005 ............................................................. 300 nm 




SO-2854-B010 Diethyl ether HPLC Optigrade ® (not stabilised) 

1 L 

UN 1155 


C 4H 10O 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.01% max. 


Peroxide..................................................5 ppm max. 


1 L = 0.713 kg (at 20°C) 

not stabilised 


Wavelength 

1.0 max ......................................................... 215 nm 

0.08............................................................... 254 nm 

0.02............................................................... 280 nm 

SO-1187-B010 

SO-1187-B025 

Diethyl ether Picograde ® for residue analysis 


Diethyl ether Picograde ® for residue analysis 


1 L 

2.5 L 

UN 1155 


C 4H 10O 

Assay ...................................................... 99.0% min. 

Water ........................................................ 0.1%max. 

Non-volatile matter................................ 0.001%max. 

Peroxide..................................................5 ppm max. 

1 L = 0.6502 kg (at 20°C) 

stabilised with 1.5 - 2.5% ethanol 

Specification 

GC/ECD 




GC/FID 



N.N-Dimethylacetamide 

SO-5407-B025 N.N-Dimethylacetamide HPLC Optigrade ® 2.5 L 

SO-5407-B040 N.N-Dimethylacetamide HPLC Optigrade ® 

4 L 


C 4H 9NO 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.03% max. 



1 L = 0.937 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 270 nm 

0.3................................................................. 280 nm 

0.15............................................................... 290 nm 

0.05............................................................... 310 nm 

0.01............................................................... 360 nm 




SO-3240-B010 N,N-Dimethylacetamide Headspace Grade 

1 L 


C 4H 9NO 

Assay (GC, on anhydrous basis)...........99.99-100 % 

Acidity (as acetic acid) ............................ 0-0-0.05 % 

Water (KF) ..................................................0-0.03 % 

UV cutoff wavelength .............................190-268 nm 

Transmission 

at 268 nm ...................................................10-100 % 

at 275 nm ...................................................55-100 % 

at 300 nm ...................................................85-100 % 

at 350 nm ...................................................98-100 % 

at 400 nm ...................................................99-100 % 

Headspace test for O.V.I.........................passes test 

N.N-Dimethylformamide 

SO-5356-B025 N.N-Dimethylformamide HPLC Optigrade ® 2.5 L 

SO-5356-B040 N.N-Dimethylformamide HPLC Optigrade ® 

4 L 

UN 2265 


C 3H 7NO 

Assay ...................................................... 99.7% min. 

Water ..................................................... 0.05% max. 



1 L = 0.951 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 270 nm 

0.3 ................................................................. 275 nm 

0.1 ................................................................. 295 nm 

0.05 ............................................................... 310 nm 

0.01 ............................................................... 340 nm 

SO-1189-B010 N.N-Dimethylformamide Picograde ® for residue analysis 1 L 

SO-1189-B025 N.N-Dimethylformamide Picograde ® for residue analysis 

2.5 L 

UN 2265 


C 3H 7NO 

Assay ...................................................... 99.0% min. 

Water ....................................................... 0.2% max. 


1 L = 0.951 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






SO-3230-B010 N,N-Dimethylformamide Headspace Grade 

1 L 

UN 2265 


C 3H 7NO 

Assay (GC, on anhydrous basis) ..........99.99-100 % 

Refractive index (20 °C)......................... 1.430-1.440 

Water (KF) ..................................................0-0.03 % 


Transmission 

at 270 nm ...................................................30-100 % 

at 275 nm ...................................................60-100 % 

at 300 nm ...................................................90-100 % 

at 320 nm ...................................................97-100 % 


1,3-Dimethyl-2-imidazolidinone (N,N'-Dimethylethyleneurea) 

SO-3260-B005 

1,3-Dimethyl-2-imidazolidinone (DMI) Headspace Grade 

500 ml 

Assay (GC, on anhydrous basis) ............99.5-100 % 

Refractive index (20 °C).......................... 1.470-1473 

Water (KF) ....................................................0-0.1 % 


Transmission 

at 275 nm ...................................................40-100 % 

at 300 nm ...................................................85-100 % 

at 325 nm ...................................................95-100 % 

at >350 nm .................................................98-100 % 


Dimethylsulfoxide (DMSO) 

SO-3210-B010 

Dimethylsulfoxide Headspace Grade 

1 L 

CAS-Nr 67-68-5 

Assay (GC, on anhydrous basis) ..........99.99-100 % 

Refractive index (20 °C)......................... 1.477-1.480 

Water (KF) ..................................................0-0.04 % 


Transmission 

at 268 nm ...................................................30-100 % 

at 275 nm ...................................................60-100 % 

at 300 nm ...................................................85-100 % 

at 350 nm ...................................................95-100 % 

at 400 nm ...................................................98-100 % 





1.4-Dioxan 

SO-9002-B010 1.4-Dioxan HPLC Optigrade ® (not stabilised) 1 L 

SO-9002-B025 

1.4-Dioxan HPLC Optigrade ® (not stabilised) 

2.5 L 

UN 1165 


C 4H 8O 2 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.05% max. 



1 L = 1.034 kg (at 20°C) 



Wavelength 

0.5 max ......................................................... 225 nm 

0.25 .............................................................. 250 nm 

0.1 ................................................................. 270 nm 

0.05 .............................................................. 280 nm 

0.01 ............................................................... 295 nm 

Ethanol 

SO-9063-B010 Ethanol HPLC Optigrade ® 1 L 

SO-9063-B025 Ethanol HPLC Optigrade ® 

2.5 L 

UN 1170 


C 2H 5OH 

Assay ...................................................... 99.7% min. 

Water ....................................................... 0.1% max. 

Non-volatile matter............................ 0.0004% max. 


1 L = 0.789 kg (at 20°C) 


Wavelength 

0.7 max ......................................................... 210 nm 

0.1 ................................................................. 240 nm 

0.01 ............................................................... 260 nm 

SO-9812-B025 

Ethanol nitrosamine-free 

Specification 

N-Nitrosodimethylamine........................0.1 ppb max. 

N-Nitrosodiethylamine...........................0.1 ppb max. 

N-Nitrosodi-n-propylamine ....................0.1 ppb max. 






2.5 L 

2-Ethoxyethanol 

SO-2925-B025 2-Ethoxyethanol HPLC Optigrade ® 

2.5 L 

UN 1171 


C 4H 10O 2 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.08% max. 



1 L = 0.932 kg (at 20°C) 


Wavelength 

1.0 max....................................................... .. 222 nm 

0.75 ............................................................... 225 nm 

0.25 ............................................................... 250 nm 

0.01 ............................................................... 300 nm 




Ethyl acetate 

SO-3442-B010 Ethyl acetate HPLC Optigrade ® 1 L 

SO-3442-B025 Ethyl acetate HPLC Optigrade ® 2.5 L 

SO-3442-B040 Ethyl acetate HPLC Optigrade ® 

4 L 

UN 1173 


CH 3COOC 2H 5 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.05% max. 



1 L = 0.897 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 255 nm 

0.1................................................................. 260 nm 

0.05............................................................... 280 nm 

0.01............................................................... 300 nm 

SO-9345-B010 Ethyl acetate for LC-MS Optigrade ® 1 L 

SO-9345-B025 Ethyl acetate for LC-MS Optigrade ® 

2.5 L 

UN 1173 


CH 3COOC 2H 5 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.05% max. 



1 L = 0.897 kg (at 20°C) 

Ca ........................................................0.1 ppm max. 

K ..........................................................0.1 ppm max. 

Mg........................................................0.1 ppm max. 

Na ........................................................0.1 ppm max. 

Transmission 

at 260 nm.................................................. 70 % min. 

at 280 nm.................................................. 99 % min. 

SO-1191-B010 Ethyl acetate Picograde ® for residue analysis 1 L 

SO-1191-B025 Ethyl acetate Picograde ® for residue analysis 2.5 L 

SO-1191-B040 Ethyl acetate Picograde ® for residue analysis 4 L 

SO-1191-C011 Ethyl acetate Picograde ® for residue analysis (Cyclotainer ® ) 10 L 

SO-1191-C032 Ethyl acetate Picograde ® for residue analysis (Cyclotainer ® ) 

30 L 

UN 1173 


CH 3COOC 2H 5 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.05% max. 


1 L = 0.897 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






n-Heptane 

SO-5139-B010 n-Heptane HPLC Optigrade ® 1 L 

SO-5139-B025 n-Heptane HPLC Optigrade ® 2.5 L 

SO-5139-B040 n-Heptane HPLC Optigrade ® 

4 L 

UN 1206 


C 7H 16 

Assay ...................................................... 95.0% min. 

Water ..................................................... 0.02% max. 



1 L = 0.685 kg (at 20°C) 


Wavelength 

1.0 max...........................................…...........197 nm 

0.4.................................................................210 nm 

0.1.................................................................225 nm 

0.01...............................................................254 nm 

SO-1210-B025 

n-Heptane Picograde ® for residue analysis 

2.5 L 

UN 1206 


C 7H 16 

Assay ...................................................... 97.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.682 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



n-Hexane 

SO-5167-B010 n-Hexane HPLC Optigrade ® 1 L 

SO-5167-B025 n-Hexane HPLC Optigrade ® 2.5 L 

SO-5167-B040 n-Hexane HPLC Optigrade ® 4 L 

SO-5167-C012 n-Hexane HPLC Optigrade ® (Cyclotainer ® ) 10 L 

SO-5167-C032 n-Hexane HPLC Optigrade ® (Cyclotainer ® ) 

30 L 

UN 1208 


C 6H 14 

Assay (of C 6-isomers) ............................. 99.8% min. 

Water ....................................................... 0.1% max. 



1 L = 0.659 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 195 nm 

0.25 ............................................................... 210 nm 

0.1 ................................................................. 220 nm 

0.01 ............................................................... 254 nm 

0.005 ............................................................. 280 nm 

0.005 ............................................................. 350 nm 




SO-1244-B010 n-Hexane Picograde ® for residue analysis 1 L 

SO-1244-B025 n-Hexane Picograde ® for residue analysis 2.5 L 

SO-1244-B040 n-Hexane Picograde ® for residue analysis 4 L 

SO-1244-C011 n-Hexane Picograde ® for residue analysis (Cyclotainer ® ) 10 L 

SO-1244-C032 n-Hexane Picograde ® for residue analysis (Cyclotainer ® ) 

UN 1208 


C 6H 14 

Assay (of C 6-isomers)............................. 97.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.659 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



30 L 

SO-9500-B010 n-Hexane for the analysis of highly volatile halogenated hydrocarbons and EOX 1 L 

SO-9500-B025 n-Hexane for the analysis of highly volatile halogenated hydrocarbons and EOX 

2.5 L 

UN 1208 


C 6H 14 

Assay (of C 6-isomers)............................. 95.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.651 kg (at 20°C) 

Specification 

Highly volatile halogenated hydrocarbons/EOX 




SO-9823-B040 

Hexane nitrosamine-free 

4 L 

Specification 

N-Nitrosodimethylamine .......................0.1 ppb max. 

N-Nitrosodiethylamine ..........................0.1 ppb max. 

N-Nitrosodi-n-propylamine....................0.1 ppb max. 









Iso-Hexane 

SO-9043-B025 Iso-Hexane HPLC Optigrade ® 

2.5 L 

UN 1208 


C 6H 14 


Water ..................................................... 0.01% max. 


1 L = 0.653 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 195 nm 

0.25 ............................................................... 210 nm 

0.2 ................................................................. 217 nm 

0.125 ............................................................. 220 nm 

0.02 ............................................................... 245 nm 

SO-1251-B025 

Iso-Hexane Picograde ® for residue analysis 

2.5 L 

UN 1208 


C 6H 14 


Water ..................................................... 0.01% max. 


1 L = 0.653 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



Hydrochloric acid 

HPA-0010-B010 

Hydrochloric acid for trace analysis min. 36 % (glass bottle) 

1 L 

UN 1789 

Assay..............................................................> 36 % 

Residue ........................................................< 3 ppm 

Colour (APHA) ...................................................< 10 

Bromide......................................................< 50 ppm 

free chlorine...............................................< 0.5 ppm 

Phosphate ...............................................< 0.05 ppm 

Sulfite ........................................................< 0.5 ppm 

Sulfate .......................................................< 0.5 ppm 

Ag................................< 0.1 ppb Cu ............................... < 0.1 ppb Sb................................< 0.1 ppb 

Al .................................< 0.5 ppb Fe................................... < 1 ppb Se................................< 0.1 ppb 

As ................................< 0.1 ppb Hg ............................... < 0.2 ppb Sn................................< 0.1 ppb 

B.....................................< 1 ppb K ................................. < 0.1 ppb Sr.................................< 0.1 ppb 

Ba................................< 0.1 ppb Li................................. < 0.1 ppb Th ................................< 0.1 ppb 

Be................................< 0.1 ppb Mg............................... < 0.5 ppb Ti .................................< 0.1 ppb 

Bi .................................< 0.1 ppb Mn............................... < 0.1 ppb U..................................< 0.1 ppb 

Ca................................< 0.5 ppb Mo............................... < 0.1 ppb V..................................< 0.1 ppb 

Cd................................< 0.1 ppb Na ............................... < 0.5 ppb Zn ................................< 0.5 ppb 

Co................................< 0.1 ppb Ni ................................ < 0.1 ppb Zr.................................< 0.1 ppb 

Cr ................................< 0.1 ppb Pb ............................... < 0.1 ppb 

Hydrochloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si. 




Hydrofluoric acid 

HPA-0030-B010 Hydrofluoric acid for trace analysis min. 48 % ( HDPE bottle) 

1 L 

Methanol 

SO-9510-B010 

UN 1790 

Assay .............................................................> 48 % Phosphate .................................................< 0.1 ppm 

Colour (HAZEN)................................................. < 10 Sulfate .......................................................< 0.5 ppm 

Chloride........................................................ < 1 ppm Hexafluorosilicate.......................................< 20 ppm 

Ag...................................< 1 ppb Cu .................................. < 1 ppb Pb...................................< 1 ppb 

Al....................................< 1 ppb Fe .................................. < 1 ppb Se...................................< 1 ppb 

As...................................< 1 ppb Hg .................................. < 1 ppb Si....................................< 1 ppb 

Ba...................................< 1 ppb K .................................... < 1 ppb Sn...................................< 1 ppb 

Be...................................< 1 ppb Li.................................... < 1 ppb Sr....................................< 1 ppb 

Bi....................................< 1 ppb Mg.................................. < 1 ppb Ti ....................................< 1 ppb 

Ca...................................< 1 ppb Mn.................................. < 1 ppb V.....................................< 1 ppb 

Cd...................................< 1 ppb Mo.................................. < 1 ppb Zn...................................< 1 ppb 

Co...................................< 1 ppb Na .................................. < 1 ppb 

Cr ...................................< 1 ppb Ni ................................... < 1 ppb 

Hydrofluoric acid stored in polyethylene bottles will see a rise in: Al, Ca, Fe, Na and Zn. 

Methanol Purge & Trap 

1 L 

UN 1230 


CH 3OH 

Assay ...................................................... 99.9% min. 

Water .......................................................... < 1 mg/L 

Non-volatile matter....................................... < 0.10% 

2-Butanone (GC/MS; P&T)........................ < 10 µg/L 

Other volatile impurities ........................ passes tests 

1 L = 0.792 kg (at 20°C) 

SO-9260-B010 Methanol HPLC Optigrade ® Gradient Grade 1 L 

SO-9260-B025 Methanol HPLC Optigrade ® Gradient Grade 2.5 L 

SO-9260-C012 Methanol HPLC Optigrade ® Gradient Grade (Cyclotainer ® ) 10 L 

SO-9260-C032 Methanol HPLC Optigrade ® Gradient Grade (Cyclotainer ® ) 

30 L 

UN 1230 


CH 3OH 

Assay ...................................................... 99.9% min. 

Water ..................................................... 0.05% max. 


Gradient specification (235 nm).........0.002 AE max. 

Gradient specification (254 nm).........0.001 AE max. 

Fluorescence (as quinine at 254 nm) ......1 ppb max. 


1 L = 0.792 kg (at 20°C) 


Wavelength 

0.43 max ....................................................... 210 nm 

0.25............................................................... 220 nm 

0.12............................................................... 230 nm 

0.08............................................................... 235 nm 

0.015............................................................. 254 nm 

0.005............................................................. 280 nm 





SO-3041-B010 Methanol HPLC Optigrade ® 1 L 

SO-3041-B025 Methanol HPLC Optigrade ® 2.5 L 

SO-3041-B040 Methanol HPLC Optigrade ® 4 L 

SO-3041-C012 Methanol HPLC Optigrade ® (Cyclotainer ® ) 10 L 

SO-3041-C032 Methanol HPLC Optigrade ® (Cyclotainer ® ) 

30 L 

UN 1230 


CH 3OH 

Assay ...................................................... 99.9% min. 

Water ..................................................... 0.05% max. 



1 L = 0.792 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 205 nm 

0.25 ............................................................... 220 nm 

0.05 ............................................................... 240 nm 

0.015 ............................................................. 254 nm 

0.005 ............................................................. 280 nm 

0.005 ............................................................. 350 nm 


SO-9658-B010 Methanol ULC-MS Optigrade ® 

1 L 

UN 1230 


CH 3OH 

Assay (GC, on anhydrous basis)...............................99.98-100 % 

Water (KF) .......................................................................0-0.03% 

Residue after evaporation .....................................0-0.0001 %w/w 

Acidity (as acetic acid) ..................................................0-0.002 % 

Alkalinity (as ammonia)...............................................0-0.0001 % 

Color (APHA) ...........................................................................0-5 


HPLC gradient at 220 nm - Drift....................................0-0.01 AU 

HPLC gradient at 235 nm - Drift..................................0-0.005 AU 

HPLC gradient at 220 nm - H. Peak ...........................0-0.004 AU 


Fluorescence at 254 nm (as quinine).............................0-0.5 ppb 


1 L = 0.783 kg (at 20°C) 

Transmission 

at 210 nm .......................................................................40-100 % 

at 220 nm .......................................................................65-100 % 

at 230 nm .......................................................................80-100 % 

at 260 nm .......................................................................98-100 % 

Al ....................................................................................0-20 ppb 

Ca..................................................................................0-100 ppb 

Fe ....................................................................................0-20 ppb 

K......................................................................................0-50 ppb 

Mg ...................................................................................0-20 ppb 

Na..................................................................................0-100 ppb 





SO-9356-B010 Methanol for LC-MS Optigrade ® 1 L 

SO-9356-B025 Methanol for LC-MS Optigrade ® 

2.5 L 

UN 1230 


CH 3OH 

Assay ...................................................... 99.9% min. 

Water ..................................................... 0.05% max. 



1 L = 0.792 kg (at 20°C) 

Ca ........................................................0.1 ppm max. 

K ..........................................................0.1 ppm max. 

Mg........................................................0.1 ppm max. 

Na ........................................................0.1 ppm max. 

Transmission 

at 210 nm.................................................. 40 % min. 

at 220 nm.................................................. 60 % min. 

at 235 nm.................................................. 80 % min. 

at 260 nm.................................................. 98 % min. 

SO-1263-B010 Methanol Picograde ® for residue analysis 1 L 

SO-1263-B025 Methanol Picograde ® for residue analysis 2.5 L 

SO-1263-B040 Methanol Picograde ® for residue analysis 4 L 

SO-1263-C011 Methanol Picograde ® for residue analysis (Cyclotainer ® ) 

10 L 

UN 1230 


CH 3OH 

Assay ...................................................... 99.0% min. 

Water ....................................................... 0.1% max. 


1 L = 0.792 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



SO-9835-B010 Methanol nitrosamine-free 1 L 

SO-9835-B040 Methanol nitrosamine-free 

4 L 

Specification 

N-Nitrosodimethylamine .......................0.1 ppb max. 

N-Nitrosodiethylamine ..........................0.1 ppb max. 

N-Nitrosodi-n-propylamine....................0.1 ppb max. 









2-Methoxyethanol 

SO-9509-B010 

2-Methoxyethanol for the analysis of highly volatile halogenated hydrocarbons 

UN 1188 


C 3H 8O 2 

Assay ...................................................... 99.7% min. 

Water ..................................................... 0.08% max. 


1 L = 0.961 kg (at 20°C) 

Specification 




BTEX for FID 

In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 

10 µg/L n-Decane. 

1 L 

Methyl-tert-butyl ether 

SO-5398-B025 Methyl-tert-butyl ether HPLC Optigrade ® 

2.5 L 

UN 2398 


C 5H 12O 

Assay ...................................................... 99.7% min. 

Water ..................................................... 0.05% max. 



1 L = 0.742 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 270 nm 

0.3 ................................................................. 275 nm 

0.1 ................................................................. 295 nm 

0.05 ............................................................... 310 nm 

0.01 ............................................................... 340 nm 

SO-1265-B010 Methyl-tert-butyl ether for residue analysis Picograde ® 1 L 

SO-1265-B025 Methyl-tert-butyl ether for residue analysis Picograde ® 

UN 2398 


C 5H 12O 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.05% max. 


1 L = 0.742 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



2.5 L 




Nitric acid 

HPA-0020-B010 Nitric acid for trace analysis min 67 % (glass bottle) 

1 L 

n-Nonane 

UN 2031 

Assay .............................................................> 67 % Phosphate .................................................< 0.1 ppm 

Residue........................................................ < 1 ppm Sulfate .......................................................< 0.5 ppm 

Chloride................................................... < 0.08 ppm 

Ag................................< 0.1 ppb Cu ............................... < 0.1 ppb Pb................................< 0.1 ppb 

Al.................................< 0.5 ppb Fe ............................... < 0.5 ppb Se................................< 0.1 ppb 

As................................< 0.1 ppb Hg ............................... < 0.2 ppb Sn................................< 0.1 ppb 

Ba................................< 0.1 ppb K ................................. < 0.2 ppb Sr.................................< 0.1 ppb 

Be................................< 0.1 ppb Li................................. < 0.1 ppb Th................................< 0.1 ppb 

Bi.................................< 0.1 ppb Mg............................... < 0.5 ppb Ti .................................< 0.1 ppb 

Ca................................< 0.5 ppb Mn............................... < 0.1 ppb V..................................< 0.1 ppb 

Cd................................< 0.1 ppb Mo............................... < 0.1 ppb Zn................................< 0.5 ppb 

Co................................< 0.1 ppb Na ............................... < 0.5 ppb 

Cr ................................< 0.2 ppb Ni ................................ < 0.1 ppb 

Nitric Acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si. 

SO-4436-B010 n-Nonane HPLC Optigrade ® 

1 L 

UN 1920 


C 9H 20 

Assay ......................................................... 95% min. 

Water ..................................................... 0.01% max. 



1 L = 0.719 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 200 nm 

0.1................................................................. 225 nm 

0.05............................................................... 250 nm 

0.005............................................................. 300 nm 

SO-1271-B010 n-Nonane Picograde ® for residue analysis 1 L 

SO-1271-B025 n-Nonane Picograde ® for residue analysis 

2.5 L 

UN 1920 


C 9H 20 

Assay ...................................................... 95.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.719 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






n-Octane 

SO-1279-B010 

n-Octane Picograde ® for residue analysis 

1 L 

UN 1262 


CH 3(CH 2) 6CH 3 

Assay ...................................................... 95.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.703 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



n-Pentane 

SO-9081-B010 n-Pentane HPLC Optigrade ® 

1 L 

UN 1265 


C 5H 12 

Assay ...................................................... 99.0% min. 

Water ..................................................... 0.01% max. 



1 L = 0.626 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 200 nm 

0.7 ................................................................. 210 nm 

0.3 ................................................................. 215 nm 

0.05 ............................................................... 225 nm 

0.01 ............................................................... 240 nm 

SO-1282-B010 n-Pentane Picograde ® for residue analysis 1 L 

SO-1282-B025 n-Pentane Picograde ® for residue analysis 2.5 L 

SO-1282-B040 n-Pentane Picograde ® for residue analysis 

4 L 

UN 1265 


C 5H 12 

Assay ...................................................... 98.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.626 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






SO-9501-B010 n-Pentane for the analysis of highly volatile halogenated hydrocarbons 

1 L 

UN 1265 


C 5H 12 

Assay ...................................................... 95.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.632 kg (at 20°C) 

Specification 




SO-9610-B005 

n-Pentane for the analysis of highly volatile halogenated hydrocarbons, aromatic 

hydrocarbons and EOX 

500 mL 

UN 1265 


C 5H 12 

Assay ...................................................... 98.0% min. 

Water ..................................................... 0.01% max. 


1 L = 0.626 kg (at 20°C) 

Specification 




BTEX for FID 

In the GC-FID chromatogram the sum of the signals of BTEX-compounds is not greater than the signal, given by 

10 µg/L n-Decane. 


Perchloric acid 

HPA-0060-B010 

Perchloric acid for trace analysis min 68 % (glass bottle) 

1 L 

UN 1802 

Assay .............................................................> 68 % Sulfate ..........................................................< 5 ppm 

Colour (APHA) ................................................... < 10 Total nitrogen .............................................< 10 ppm 

Phosphate................................................. < 0.1 ppm 

Ag................................< 0.1 ppb Cu ............................... < 0.1 ppb Ni.................................< 0.1 ppb 

Al.................................< 0.5 ppb Fe ............................... < 0.5 ppb Pb................................< 0.1 ppb 

Ba................................< 0.1 ppb K ................................. < 0.5 ppb Sn................................< 0.1 ppb 


Bi.................................< 0.1 ppb Mg............................... < 0.5 ppb Th................................< 0.1 ppb 

Ca................................< 0.5 ppb Mn............................... < 0.1 ppb Tl .................................< 0.1 ppb 

Cd................................< 0.1 ppb Mo............................... < 0.1 ppb V..................................< 0.5 ppb 

Co................................< 0.1 ppb Na ............................... < 0.5 ppb Zn................................< 0.5 ppb 

Perchloric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si. 




Petroleum ether 

SO-1320-B010 Petroleum ether Picograde ® for residue analysis (30 - 60°C) 1 L 

SO-1320-B025 Petroleum ether Picograde ® for residue analysis (30 - 60°C) 2.5 L 

SO-1320-B040 Petroleum ether Picograde ® for residue analysis (30 - 60°C) 4 L 

SO-1320-C011 Petroleum ether Picograde ® for residue analysis (Cyclotainer ® ) (30 - 60°C) 10 L 

SO-1320-C032 

Petroleum ether Picograde ® for residue analysis (Cyclotainer ® ) (30 - 60°C) 

UN 1268 


Boiling point range ............................. 30 - 60°C min. 

Water ..................................................... 0.01% max. 


1 L = 0.625...0.655 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 



30 L 

SO-9502-B010 

SO-9502-B025 

Petroleum ether for the analysis of highly volatile halogenated hydrocarbons and EOX 

(40 - 60°C) 

Petroleum ether for the analysis of highly volatile halogenated hydrocarbons and EOX 

(40 - 60°C) 

1 L 

2.5 L 

UN 1268 


Boiling point ....................................... 40 - 60°C min. 

Water ..................................................... 0.01% max. 


1 L = 0.625...0.655 kg (at 20°C) 

Specification 

Highly volatile halogenated hydrocarbons/EOX 




Propan-1-ol 

SO-5351-B025 Propan-1-ol HPLC Optigrade ® 

2.5 L 

UN 1274 


CH 3CH 2CH 2OH 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.05% max. 



1 L = 0.804 kg (at 20°C) 


Wavelength 

0.5 max ......................................................... 225 nm 

0.05 ............................................................... 250 nm 

0.01 ............................................................... 270 nm 

0.005 ............................................................. 300 nm 




Propan-2-ol 

SO-3043-B010 Propan-2-ol HPLC Optigrade ® 1 L 

SO-3043-B025 Propan-2-ol HPLC Optigrade ® 2.5 L 

SO-3043-B040 Propan-2-ol HPLC Optigrade ® 4 L 

SO-3043-C012 Propan-2-ol HPLC Optigrade ® (Cyclotainer ® ) 10 L 

SO-3043-C032 Propan-2-ol HPLC Optigrade ® (Cyclotainer ® ) 

30 L 

UN 1219 


C 3H 8O 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.05% max. 



1 L = 0.786 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 205 nm 

0.3................................................................. 220 nm 

0.15............................................................... 230 nm 

0.02............................................................... 254 nm 

0.01............................................................... 350 nm 

SO-9352-B010 Propan-2-ol for LC-MS Optigrade ® 1 L 

SO-9352-B025 Propan-2-ol for LC-MS Optigrade ® 

2.5 L 

UN 1219 


C 3H 8O 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.05% max. 



1 L = 0.786 kg (at 20°C) 

Ca ........................................................0.1 ppm max. 

K ..........................................................0.1 ppm max. 

Mg........................................................0.1 ppm max. 

Na ........................................................0.1 ppm max. 

Transmission 

at 220 nm.................................................. 60 % min. 

at 250 nm.................................................. 99 % min. 

SO-1334-B010 Propan-2-ol Picograde ® for residue analysis 1 L 

SO-1334-B025 Propan-2-ol Picograde ® for residue analysis 2.5 L 

SO-1334-B040 Propan-2-ol Picograde ® for residue analysis 

4 L 

UN 1219 


C 3H 8O 

Assay ..................................................... 99.5% min. 

Water ....................................................... 0.2% max. 


1 L = 0.786 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






SO-3044-B040 Propan-2-ol for the tobacco industry 

4 L 

contains 

n-Heptadecane ............... 0.3 g/L 

Ethanol............................ 2.0 g/L 


4 L 

contains 

n-Heptandecane ............. 0.8 g/L 

Ethanol abs..................... 4.0 g/L 

Water ................................0.1 % 


contains 

n-Heptandecane ............. 0.4 g/L 

Ethanol abs.................... 2.0 g/ L 

4 L 

Sulfuric acid 

HPA-0040-B010 Sulfuric acid min 95 % (glass bottle) 

1 L 

Tetrahydrofuran 

UN 1830 

Assay.................................................................95 % Chloride ........................................................< 0.1 pp 

Density ..................................................... 1.83 g/mL Phosphate .................................................< 0.5 ppm 

Colour (APHA) ...................................................< 10 Nitrate......................................................< 0.07 ppm 

Residue ........................................................< 2 ppm 

Ag................................< 0.1 ppb Fe................................ < 0.5 ppb Se..................................< 5 ppb 

Al .................................< 0.5 ppb Hg .................................. < 1 ppb Sn................................< 0.1 ppb 

As ...................................< 1 ppb K ................................. < 0.5 ppb Sr.................................< 0.1 ppb 

Ba................................< 0.1 ppb Li................................. < 0.1 ppb Th ................................< 0.1 ppb 

Be................................< 0.1 ppb Mg............................... < 0.5 ppb Ti ....................................< 1 ppb 

Bi .................................< 0.1 ppb Mn............................... < 0.1 ppb U..................................< 0.1 ppb 

Ca................................< 0.5 ppb Mo............................... < 0.1 ppb V..................................< 0.1 ppb 

Cd................................< 0.1 ppb Na ............................... < 0.5 ppb Zn ................................< 0.1 ppb 

Co................................< 0.1 ppb Ni ................................ < 0.1 ppb Zr.................................< 0.1 ppb 

Cr ................................< 0.1 ppb Pb ............................... < 0.1 ppb 

Cu................................< 0.1 ppb Sb ............................... < 0.1 ppb 

Sulfuric acid stored in glass bottles will see a rise in: Al, B, Ca, K, Mg, Mn, Na and Si. 

SO-2858-B010 Tetrahydrofuran HPLC Optigrade ® (not stabilised) 1 L 

SO-2858-B025 Tetrahydrofuran HPLC Optigrade ® (not stabilised) 2.5 L 

SO-2858-B040 Tetrahydrofuran HPLC Optigrade ® (not stabilised) 

4 L 

UN 2056 


C 4H 8O 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.03% max. 



1 L = 0.887 kg (at 20°C) 



Wavelength 

1.0 max ......................................................... 212 nm 

0.5 ................................................................. 225 nm 

0.17 ............................................................... 250 nm 

0.01 ............................................................... 300 nm 




SO-9364-B010 Tetrahydrofuran for LC-MS Optigrade ® (not stabilised) 1 L 

SO-9364-B025 Tetrahydrofuran for LC-MS Optigrade ® (not stabilised) 

2.5 L 

UN 2056 


C 4H 8O 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.03% max. 



1 L = 0.887 kg (at 20°C) 


Ca ........................................................0.1 ppm max. 

K ..........................................................0.1 ppm max. 

Mg........................................................0.1 ppm max. 

Na ........................................................0.1 ppm max. 

Transmission 

at 250 nm.................................................. 80 % min. 

at 290 nm.................................................. 99 % min. 

Toluene 

SO-4483-B010 Toluene HPLC Optigrade ® 1 L 

SO-4483-B025 Toluene HPLC Optigrade ® 2.5 L 

SO-4483-B040 Toluene HPLC Optigrade ® 

4 L 

UN 1294 


C 7H 8 

Assay ...................................................... 99.7% min. 

Water ..................................................... 0.03% max. 


1 L = 0.866 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 285 nm 

0.4................................................................. 288 nm 

0.15............................................................... 300 nm 

0.02............................................................... 335 nm 

0.01............................................................... 350 nm 

SO-1350-B010 Toluene Picograde ® for residue analysis 1 L 

SO-1350-B025 Toluene Picograde ® for residue analysis 2.5 L 

SO-1350-B040 Toluene Picograde ® for residue analysis 4 L 

SO-1350-C011 Toluene Picograde ® for residue analysis (Cyclotainer ® ) 10 L 

SO-1350-C032 Toluene Picograde ® for residue analysis (Cyclotainer ® ) 

30 L 

UN 1294 


C 7H 8 

Assay ...................................................... 99.8% min. 

Water ..................................................... 0.02% max. 


1 L = 0.866 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






1,1,2-Trichloro-1,2,2-trifluoroethane 

SO-9145-B025 

1,1,2-Trichloro-1,2,2-trifluoroethane for IR-spectroscopy 

2.5 L 

UN 3082 


C 2Cl 3F 3 

Assay ...................................................... 99.8% min. 

Non-volatile matter................................ 2 mg/L max. 

Water .................................................10 mg/kg max. 

Hydrocarbons.......................................5 mg/kg max. 

1 L = 1.57 kg (at 20°C) 


SO-6043-B010 2,2,4-Trimethylpentane (Isooctane) HPLC Optigrade ® 1 L 

SO-6043-B025 2,2,4-Trimethylpentane (Isooctane) HPLC Optigrade ® 2.5 L 

SO-6043-B040 2,2,4-Trimethylpentane (Isooctane) HPLC Optigrade ® 

4 L 

UN 1262 


C 8H 18 

Assay ...................................................... 99.5% min. 

Water ..................................................... 0.02% max. 



1 L = 0.690 kg (at 20°C) 


Wavelength 

1.0 max ......................................................... 205 nm 

0.2 ................................................................. 220 nm 

0.1 ................................................................. 230 nm 

0.01 ............................................................... 254 nm 

SO-1364-B010 2,2,4-Trimethylpentane (Isooctane) Picograde ® for residue analysis 1 L 

SO-1364-B025 2,2,4-Trimethylpentane (Isooctane) Picograde ® for residue analysis 2.5 L 

SO-1364-B040 2,2,4-Trimethylpentane (Isooctane) Picograde ® for residue analysis 

4 L 

UN 1262 


C 8H 18 

Assay ...................................................... 95.0% min. 

Water ..................................................... 0.02% max. 


1 L = 0.690 kg (at 20°C) 

Specification 

GC/ECD 




GC/FID 






Water 

SO-6795-B025 Water HPLC Optigrade ® 2.5 L 

SO-6795-B040 Water HPLC Optigrade ® 

4 L 


H 2O 

Fluorescence (as quinine at 450 nm) .................... 1.10-7 g max. 

Non-volatile matter....................................................1 mg/L max. 


pH ................................................................................... 5.0 - 8.0 


SO-9662-B010 Water ULC-MS Optigrade ® 

1 L 


H 2O 

Residue after evaporation.....................................0-0.0001 %w/w 

Acidity (as Acetic acid)..................................................0-0.002 % 

Alkalinity (as Ammonia) ............................................0-0.00005 % 

Resistivity (at manuf.).....................................18.2-100 Mohm*cm 



HPLC gradient at 254 nm - H. Peak ......................... 0-0.0005 AU 



TOC ................................................................................ 0-10 ppb 

Filter test .....................................................................Passes test 

Ca.................................................................................. 0-0.1 ppm 

K.................................................................................... 0-0.1 ppm 

Mg ................................................................................. 0-0.1 ppm 

Na.................................................................................. 0-0.1 ppm 


SO-4661-B025 Water 0.1 % formic acid ULC-MS Optigrade ® 

2.5 L 

Assay .....................................................................0.095-0.105 % 

Purity of formic acid (GC)............................................99.0-100 % 



HPLC gradient at 254 nm - Drift.................................. 0-0.010 AU 



Transmission 

at 210 nm .........................................................................5-100 % 

at 230 nm .......................................................................45-100 % 

at 254 nm .......................................................................99-100 % 

Al .................................................................................... 0-30 ppb 

Ca.................................................................................. 0-100 ppb 

Fe.................................................................................... 0-50 ppb 

K.................................................................................... 0-100 ppb 

Mg ................................................................................... 0-30 ppb 

Na.................................................................................. 0-100 ppb 





SO-4667-B025 Water 0.1 % acetic acid ULC-MS Optigrade ® 

2.5 L 

Assay......................................................................0.095-0.105 % 

pH.......................................................................................3.2-3.4 

Purity of acetic acid (GC) ............................................99.9-100 % 






Transmission 

at 210 nm .......................................................................20-100 % 

at 230 nm .......................................................................75-100 % 

at 254 nm .......................................................................99-100 % 

Al ....................................................................................0-30 ppb 

Ca..................................................................................0-100 ppb 

Fe ....................................................................................0-50 ppb 

K....................................................................................0-100 ppb 

Mg ...................................................................................0-30 ppb 

Na..................................................................................0-100 ppb 


SO-4673-B025 Water 0.1 % trifluoroacetic acid ULC-MS Optigrade ® 

2.5 L 

Assay......................................................................0.095-0.105 % 

Purity of trifluoroacetic acid (GC) ..............................99.95-100 % 






Transmission 

at 210 nm .......................................................................25-100 % 

at 230 nm .......................................................................85-100 % 

at 254 nm .......................................................................99-100 % 

Al ....................................................................................0-30 ppb 

Ca..................................................................................0-100 ppb 

Fe ....................................................................................0-50 ppb 

K....................................................................................0-100 ppb 

Mg ...................................................................................0-30 ppb 

Na..................................................................................0-100 ppb 


SO-9368-B010 Water for LC-MS Optigrade ® 1 L 

SO-9368-B025 Water for LC-MS Optigrade ® 

2.5 L 


H 2O 

Fluorescence (as quinine at 450 nm)...1x10 -7 g max. 

Non-volatile matter................................ 1 mg/L max. 

pH ................................................................ 5.0 - 8.0 


Ca ....................................................... 0.1 ppm max. 

K.......................................................... 0.1 ppm max. 

Mg ....................................................... 0.1 ppm max. 

Na ....................................................... 0.1 ppm max. 

Transmission 

at 200 nm - 400 nm................................... 99 % min. 


Solvent mixtures 



SO-9534-B040 Mixture cyclohexane/ethyl acetate 1:1 Picograde ® for residue analysis 4 L 

SO-9534-C011 Mixture cyclohexane/ethyl acetate 1:1 Picograde ® for residue analysis (Cyclotainer ® ) 10 L 

SO-9534-C201 

Mixture cyclohexane/ethyl acetate 1:1 Picograde ® for residue analysis 

Specification 

GC/ECD 




GC/FID 



200 L 










LGC Standards, Queens Road, Teddington, Middlesex TW11 0LY, UK 


No part of this publication may be reproduced or transmitted in any form or by any means, 

electronic or mechanical, including photocopying, recording or any retrieval system, without the written 

permission of the copyright holder. 

© LGC Limited, 2008. All rights reserved.

Pharmaceutical reference substances and impurities ... - Kriticos.eu

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?